cell_line_id,drug_id,response
Namalwa,246676,4.721429897591315
HCC1954,selumetinib-GDC-0941 (4-1 mol-mol),0.8258284821582321
Kasumi-2,10322450,3.5434418993684114
SNU-601,148198,-4.403803461658863
SNU-387,107985,-2.31227385081207
DEL,409805,3.7809568559059783
GOS-3,54618164,5.027817061073729
HCT 116,12003241,-0.2623292503702257
COLO 320,10322450,3.382399386681384
SNU-840,9936388,2.507111845662591
NCI-H1395,44491742,3.9607165302769514
Namalwa,10322450,3.877307531453308
BT 228,262093,2.371515805144491
MDA-MB-453,46943432,1.9398007817238585
NCI-H1341,148198,-4.8101463840826595
Kasumi-2,136227924,1.9658135956042504
SW579,tanespimycin-bortezomib (250-1 mol-mol),-2.6338348381850283
KALS-1,9926054,2.3431755062482487
COV434,24180125,1.5082438286662294
KYO-1,selumetinib-vorinostat (8-1 mol-mol),2.230088152579139
BT-16,409805,3.917898602968281
Ku812,selumetinib-GDC-0941 (4-1 mol-mol),-2.0259411915786294
JHOS-2,sirolimus-bortezomib (250-1 mol-mol),0.7378509581797704
HEC-1-A,24180125,2.8351912410354925
GSU,9936388,1.1039291708072954
UO-31,8515,2.1346366627261304
A-549,107985,-1.903643524605076
MHH-CALL-3,168313200,3.032301492705872
HEC-265,9926054,2.077081644507314
PE/CA-PJ34 (clone C12),9903786,2.211143495082886
QGP-1,12003241,-0.3742156649429844
SNB-75,selumetinib-vorinostat (8-1 mol-mol),3.46881104269872
LS1034,8515,4.162892919499596
OCI-Ly3,44491742,3.926689861618192
SNU-16,3689413,-2.4569670929316656
NCI-H2106,9903786,3.304741679115025
YH-13,26596,-1.6020780091570677
NCI-H358,3689413,0.3269344418253172
NCI-H522,36462,3.1215227661343925
BDCM,135423438,1.7676973941849825
Panc 04.03,44491742,4.30815140156182
NCI-H1563,3689413,0.532874202175122
ChaGo-K-1,selumetinib-vorinostat (8-1 mol-mol),2.615914600490853
Hs 940.T,36462,4.160294821791898
NB1,JQ-1-carboplatin (1-1 mol-mol),2.7630745664593426
SK-N-DZ,168313200,1.8110359561996645
UACC-62,3136844,4.456880165901645
KYSE-410,selumetinib-vorinostat (8-1 mol-mol),2.854769391791397
CAL-27,6610216,4.47029742988655
ESS-1,262093,3.0427773228942057
SNU-175,6918878,0.7323937469600013
NCI-H446,selumetinib-vorinostat (8-1 mol-mol),2.5724030712671904
KMS-21-BM,9936388,-8.048894686182319
SW982,24180125,3.159304808237073
NCI-H1693,26596,0.3286565515580511
NCI-H69,5460769,3.1019087351608037
SK-CO-1,262093,3.1807391377127376
BT 131,10296883,4.294985704877121
NCI-H2405,3689413,-0.5066399807315675
PE/CA-PJ15,9911830,3.3068944538526672
SYO-1,selumetinib-vorinostat (8-1 mol-mol),2.478385861383767
NUGC-4,5460769,4.378159421113783
IPC-298,selumetinib-vorinostat (8-1 mol-mol),-1.8986379893326115
KE-97,11485656,-0.8260984210127809
A-549,9911830,2.245916242551202
HT-1197,168313200,2.2416260588252546
PK-1,9903786,5.672212413868687
Sq-1,9911830,3.1818230032109587
SNU-620,54618164,3.868609371723324
RERF-LC-Ad2,selumetinib-vorinostat (8-1 mol-mol),3.1653662861701157
SK-MEL-2,11404337,0.550817025493175
COLO 320,selumetinib-GDC-0941 (4-1 mol-mol),1.1921670353492264
NCI-H2087,409805,3.9409208481005864
CAL-120,selumetinib-vorinostat (8-1 mol-mol),2.2507147717347737
TE-9,107985,-3.4628702596877856
SW1783,409805,4.510325829942446
F-36P,54618164,3.98982096718309
RERF-LC-Ad2,168313200,4.3712795765743255
EKVX,12003241,-0.995524269330736
OCI-Ly3,54618164,3.7608035112102
SIG-M5,5460769,1.4726407580947376
NCI-H1435,54618164,2.9434068497251147
HSC-2,148124,-0.6160192527791234
OAW42,selumetinib-vorinostat (8-1 mol-mol),4.452734121336326
SK-UT-1,9936388,-5.820733292214098
NCI-H810,262093,0.9896842517721274
KMS-20,6610216,3.669058069013872
UACC-257,3136844,4.720155538783931
UACC-812,6610216,4.947422623598504
SK-MEL-2,107985,-2.782254692074657
BT 444,9927531,5.530041138420047
OE21,11404337,-3.0833954848691234
HCC4006,sirolimus-bortezomib (250-1 mol-mol),0.6132308595616923
P3HR-1,JQ-1-carboplatin (1-1 mol-mol),0.4067249254374854
HT-1197,9911830,3.1425347559811967
SNU-1077,135875424,3.798963502018643
NCI-H2405,6918878,3.798851909367276
MOLP-2,159324,4.04341209915365
KE-97,136227924,2.279256150432482
SNU-449,135875424,4.841371934548395
KE-37,44493528,4.221773830878064
PLC/PRF/5,10322450,3.983384699735352
U-BLC1,6505803,-1.6216028529729
NCI-H2342,6505803,3.6269686653214497
HuH-6,9911830,2.45331857773806
WSU-DLCL2,6918878,-0.6073942074631477
LS411N,148198,-2.2204558676981576
MOLM-13,135875424,3.721528356214304
HCC38,10296883,4.206787389129117
Lu-65,9926054,1.7186862089776234
Karpas-422,44491742,3.8079113446891424
SCC-25,8515,2.6450161299147035
SU-DHL-6,439501,-2.4303946334698057
MCF-7,107985,-3.975928290403253
SW982,49836020,1.3794416609441722
MCAS,159324,3.426184358584357
NB1,8515,3.7226851195951287
OCI-AML-2,107985,-4.717077032009498
Hs 888.T,10322450,3.2748281083496114
SK-N-BE(2),9911830,2.858435058455609
Hs 611.T,409805,3.119650007352079
NCI-H1355,sirolimus-bortezomib (250-1 mol-mol),1.1332482572843785
SIG-M5,44491742,3.8291239619503905
KYSE-510,10296883,4.094303304653805
NCI-H1341,9903786,1.643545486774536
EoL-1,10296883,0.2540444549811657
PE/CA-PJ34 (clone C12),10322450,3.5530253232214664
BICR 6,9911830,2.371136443682152
SK-LU-1,11485656,3.4042769893477023
BC-3C,9903786,3.0556905946174537
MOLP-2,26596,-4.180731486004902
YD-38,54618164,4.14569311536785
HEC-108,409805,5.771065107307232
OCI-AML-3,12003241,-2.086986892339566
MDA-MB-468,44491742,4.175044772115959
AsPC-1,selumetinib-vorinostat (8-1 mol-mol),2.1619817893004805
TUHR14TKB,6610216,3.9404746180356063
MDA-MB-435S,9936388,-7.051147394229912
SK-MEL-30,148198,-1.6076704799075907
Hs 578T,148124,-8.012392121848073
697,10322450,2.5214685909488037
SW48,3689413,2.066117060158584
HuCC-T1,6505803,-2.738852814934829
SIG-M5,439501,-3.273907668571148
RD,tanespimycin-bortezomib (250-1 mol-mol),-1.016006094021389
SF295,5460769,2.0646753609737125
NCI-H838,selumetinib-GDC-0941 (4-1 mol-mol),1.9940738428957552
KO52,6610216,4.150836928578526
BT 172,54618164,4.156516720158305
LoVo,JQ-1-carboplatin (1-1 mol-mol),1.9010825713651585
P12-Ichikawa,439501,-2.449202945881867
COLO 684,9936388,-6.416738093665191
SHP-77,262093,3.3265672360163374
U-118MG,11485656,3.079828371250999
HT-1197,9927531,4.678863685283018
Mono-Mac-1,11404337,-0.2219879905670924
YAPC,159324,3.323857793241652
SET-2,9927531,4.801393694643548
NCI-H727,409805,5.9670224431598875
CAL-12T,49836020,4.6523718910669745
NCI-H1105,6918878,0.6747069848870151
SNU-489,selumetinib-GDC-0941 (4-1 mol-mol),2.3199148187504592
ZR-75-30,168313200,2.927725098790728
SCC-4,262093,2.191736984960853
UO-31,100016,6.129898752942045
NB4,5460769,1.5499271806248969
PaTu 8988t,8515,4.36808886077581
DMS 53,168313200,1.6369614504907055
ONS-76,54618164,4.167815792355048
OCI-Ly3,6918878,1.2341920253485832
CAL-54,6505803,2.0649330507339183
GA-10,439501,-3.812594537001909
MKN7,36462,2.3552750815740326
MDST8,9926054,1.8075400364112937
ALL-SIL,159324,0.7144692186053382
MEC-1,49836020,4.363121412189612
RCH-ACV,5460769,1.517415725106548
OCI-AML-2,54618164,3.470070844486401
NUGC-3,5460769,1.9333841225118369
RL,10296883,3.466522300927401
NCI-H810,10296883,3.337359136658117
KMS-21-BM,439501,-2.3809491999533003
EoL-1,8515,1.249672185146308
SNU-1272,135875424,4.314381098584833
ECC10,135875424,2.912404124811061
KMS-11,6918878,0.4342035359825867
42-MG-BA,9903786,3.3707760791071184
JHUEM-2,439501,-3.5756847183572704
Hs 746.T,135423438,3.2102823304550463
NCI-H810,JQ-1-carboplatin (1-1 mol-mol),0.4173048947939034
A-253,selumetinib-vorinostat (8-1 mol-mol),3.961861986632096
L-363,6918878,1.1741715547952762
SUP-B15,9903786,1.6008803071908635
SNU-1272,9936388,1.7321766128233604
COLO 201,9926054,1.9430022433891496
SK-MEL-3,136227924,3.573502388362414
SNU-449,148124,1.515559327544478
HSC-4,sirolimus-bortezomib (250-1 mol-mol),1.2607817332731768
T84,100016,6.649554415164183
IA-LM,54618164,4.43488746250501
KNS-42,9936388,1.888318570516148
HPAF-II,159324,5.40988875272192
AGS,9911830,2.854606152747599
G-361,46943432,0.7031306283020791
DK-MG,262093,3.1450288318092596
NMC-G1,12003241,-0.7597442114064075
KYSE-70,44493528,4.735176242945038
PaTu 8988s,262093,3.243938357884203
SiMa,selumetinib-GDC-0941 (4-1 mol-mol),0.1893088365447134
SK-ES-1,11404337,-1.5843384891531491
CAS-1,9936388,1.0698428320732736
YD-8,44491742,4.162245932134171
NCI-H1838,9936388,2.03456358859775
PE/CA-PJ34 (clone C12),5460769,-0.2838566207500756
SK-MEL-31,135875424,3.140384739154431
PaTu 8988t,12003241,-0.7673639150441187
OCI-M1,12003241,0.3090538594406519
SK-N-SH,JQ-1-carboplatin (1-1 mol-mol),2.4267481661369734
WSU-DLCL2,100016,5.8333868406138585
SNU-1214,26596,-1.0463524319184982
SK-MEL-24,10296883,3.9886960310238178
MCAS,9903786,3.9207216019302007
KMS-34,6505803,0.7585459942154548
23132/87,6918878,2.237150389930482
CAL-78,439501,-1.7848444921283717
A2780,409805,4.989244714218352
NCI-H1869,44493528,4.333760189181675
RERF-LC-Ad2,11404337,1.0614824386793822
HMC-1-8,9911830,2.6920274268432904
JM-1,10296883,2.092198976716966
RPMI-7951,selumetinib-vorinostat (8-1 mol-mol),2.1108488039083775
SK-LU-1,9936388,2.205073285427917
HSC-4,6918878,5.2813290465493505
CCF-STTG1,54618164,4.4288958648043915
COLO 792,selumetinib-vorinostat (8-1 mol-mol),-0.2959640740097565
NCI-H508,11485656,2.212922909681824
OVCAR-5,3136844,4.270801813463405
NALM-6,6505803,0.3598749037472731
BT 482,439501,-3.1816156321337186
A-549,36462,3.3558444938413707
Hs 294T,6918878,2.824841658679541
SK-MEL-24,9903786,3.6296294578661494
COLO 320,439501,-3.5765221681419805
LoVo,159324,-0.9516179858777442
BICR 31,9903786,2.10396775229317
NCI-H292,6505803,0.1482155149138876
NCI-H2009,409805,3.859994247591149
Hs 683,36462,2.0938427707720786
MKN74,439501,-1.7547166912858625
RS4;11,selumetinib-vorinostat (8-1 mol-mol),2.060931955458443
NCI-H1838,6610216,4.831533607411558
ACHN,9926054,1.8123369817060109
ECC10,36462,0.1453148822762285
EFO-27,6918878,4.955152670116511
Capan-1,JQ-1-carboplatin (1-1 mol-mol),2.2044130423038477
BT-16,6505803,-2.626677217469799
U-118MG,135875424,4.484841768193188
TE-5,168313200,1.9838946788634588
CFPAC-1,409805,5.9431710343838136
NCI-H889,26596,-2.687353168028847
CAL-33,26596,-1.0071366013877838
SNU-1033,11485656,2.0602946184269917
SNU-61,tanespimycin-bortezomib (250-1 mol-mol),-0.3977146693406259
HeLa,12003241,1.4760559160729645
CAL-29,tanespimycin-bortezomib (250-1 mol-mol),-0.8282025305629461
TALL-1 [Human adult T-ALL],262093,1.1652608151765906
JM-1,3136844,3.4340507925237307
NCI-H520,409805,3.8213964278284953
SK-N-MC,5460769,1.627780458373646
Hs 611.T,136227924,1.5120677878583844
HMC-1-8,54618164,4.128727023921018
U-CH1,6505803,-2.0509718148007408
MOLT-13,54618164,3.06844415075447
SUP-M2,9926054,1.703022301763295
NCI-N87,36462,0.3600781388020123
QGP-1,6610216,4.870188716890213
NCI-H1373,JQ-1-carboplatin (1-1 mol-mol),1.2259768292567783
KP-4,3136844,3.746119336549442
EFO-21,3136844,4.440382388298354
G-292 clone A141B1,107985,-4.329663865653352
BHT-101,6505803,-0.1519656140432062
Mel Ho,tanespimycin-bortezomib (250-1 mol-mol),0.3102733441080628
WM793,3689413,0.565505634508756
PE/CA-PJ41 (clone D2),9926054,1.8762765503479524
AML-193,135423438,1.545921076680538
Karpas-422,12003241,0.4573968210074843
NCI-H1105,262093,1.4948338370067744
CCF-STTG1,6505803,-1.8344087076537687
A-375,148198,-2.551882325467432
MOLP-8,26596,-2.4791577040777812
Yamato-SS,6610216,4.637948726074207
MDA-MB-361,selumetinib-GDC-0941 (4-1 mol-mol),-0.5607130395634891
BT 224,3136844,4.520412214194052
LP-1,10296883,3.461993801411865
TE-10,selumetinib-vorinostat (8-1 mol-mol),3.4900763661530907
SNU-1066,148198,-2.6456216345814636
COR-L95,148124,-0.3758104123213183
PE/CA-PJ15,3136844,3.987949830303945
SNU-5,5460769,1.0227075924286728
CAL-51,8515,3.5852991976047863
HCC1395,409805,3.7256484492152087
COLO 741,24180125,2.98778240195572
BT 147,11485656,1.8934022107121244
GA-10,6610216,3.4837383876323975
KNS-60,11485656,1.5594601831806838
SK-N-DZ,9911830,2.3225536262502096
CJM [Human melanoma],11404337,-0.6079802482567472
OCI-AML-2,9926054,1.545607447345451
SK-UT-1,selumetinib-GDC-0941 (4-1 mol-mol),2.9282697370514716
CML-T1,26596,-2.14043660837674
639V,9903786,3.738179934930431
NCI-H1355,9903786,1.6922210610733373
Ci-1,107985,-3.0068407615661537
HOS,26596,0.4724890056436647
NCC-StC-K140,46943432,0.3281345750011573
SW1271,tanespimycin-bortezomib (250-1 mol-mol),1.119789259321392
NCI-H650,11485656,2.145946589400594
Hs 729.T,36462,1.157787126399629
TE-6,selumetinib-vorinostat (8-1 mol-mol),2.420365581709828
KYSE-510,107985,-3.785009433750071
OPM-2,100016,3.804278037815123
JHUEM-7,11404337,0.6000529311141187
SUP-B15,8515,4.235192067683924
KG-1-C,9903786,3.898193715125589
RL,9911830,2.0994910319073155
SNU-387,9926054,2.4528482629879655
SYO-1,6505803,-0.5697677300157696
L-540,136227924,2.3931383545900524
BT 271,168313200,1.412028571962601
HD-MY-Z,11485656,2.631776760715326
TE-6,159324,2.2752469114709695
KMS-11,9936388,-7.371852791095938
RCM-1 [Human rectal adenocarcinoma],135398744,7.791771320405332
NCI-H1869,JQ-1-carboplatin (1-1 mol-mol),3.1851237183291765
SNU-449,135398744,6.632733291537939
WM266-4,selumetinib-GDC-0941 (4-1 mol-mol),-1.002003549431085
NCI-H2085,107985,-2.9768129287712957
MOR/CPR,159324,3.1882046410016187
HCC1937,135875424,4.325388188219658
NCI-H1869,9911830,2.4210721600025344
A-498,JQ-1-carboplatin (1-1 mol-mol),4.434303177287225
HCC-56,sirolimus-bortezomib (250-1 mol-mol),0.5000391743337353
CAL-51,26596,-1.4638590943230956
HT-144,3689413,-0.1147563319413739
HuP-T4,9911830,2.218307107656478
SK-LU-1,sirolimus-bortezomib (250-1 mol-mol),1.1916216925923933
AM-38,26596,-1.378118107802664
NCI-H1650,148198,-2.4983400542684895
T3M-10,6505803,-2.029388568048509
RCM-1 [Human rectal adenocarcinoma],JQ-1-carboplatin (1-1 mol-mol),2.0139488398740637
CMK,6918878,-0.1657773111612524
SNU-1066,12003241,-0.4993915951512702
SK-MEL-2,tanespimycin-bortezomib (250-1 mol-mol),2.677378887587516
BT 147,sirolimus-bortezomib (250-1 mol-mol),0.9412516099169256
SK-LU-1,54618164,4.502535850506955
IM95,246676,4.3722455515816
NCI-H810,135875424,3.034466151027353
NCI-H2444,10322450,5.0413898485773
BT 440,selumetinib-GDC-0941 (4-1 mol-mol),0.7235694327018775
NCI-H2122,8515,3.1724007167677297
DMS 273,6918878,0.6913807013381441
HEC-265,36462,2.4271485175942207
OCI-Ly3,8515,4.021036490140995
Lu-99,46943432,2.664503794915281
SNU-626,49836020,-1.879821731308555
SK-MEL-28,10296883,3.852008110979885
NCI-H1975,JQ-1-carboplatin (1-1 mol-mol),1.6464051642952602
RD,107985,-3.493701313545662
KP-N-YN,11404337,1.502474208515668
GDM-1,409805,4.531290163313776
BT 239,136227924,1.4188260158561712
HCC-56,9911830,2.5458240358277724
HGC-27,439501,-3.477587502070629
ESS-1,107985,-4.436359650155883
NCI-H211,54618164,3.4322787963353747
TE-4,11485656,2.067320929780226
SW1990,44493528,4.327134813333531
SF295,9911830,5.317347771430753
EKVX,262093,3.2676110256725712
OCI-AML-2,168313200,3.6920405549769906
Toledo,6610216,4.001631927569148
ML-1 [Human thyroid carcinoma],100016,6.6260589736745015
T-47D,135875424,2.636297002166631
2004,11485656,0.272935055916473
HOP-92,10296883,4.19032829919567
NH-6,9911830,1.6859081436729209
LS123,439501,-0.5553663251516828
NCI-H1838,409805,4.710230209082149
RKN,135875424,3.6230459419726526
HCC38,36462,1.0526574988311552
PK-1,9936388,-3.885789608116406
CAL-148,54618164,3.890764234949744
Ri-1,246676,4.619716207885173
Kelly,159324,0.6122930076289157
NCI-H841,9903786,1.3953234404083057
NH-6,6918878,2.514515394091436
KMM-1,11404337,0.5617812148360622
SR,9911830,3.2159510774302964
MDA-MB-415,tanespimycin-bortezomib (250-1 mol-mol),-3.006075352171784
TE-4,9927531,4.138970102101572
SIG-M5,46943432,-0.2982882437064111
HCC1438,6505803,-2.462970464658383
HuT 78,sirolimus-bortezomib (250-1 mol-mol),-0.0760803060705267
TCCSUP,148198,-2.229154528716237
Daudi,135423438,1.6157885595086947
Hs 688(A).T,135875424,5.335047490558406
SNU-16,439501,-4.306216522257499
NCI-H929,9936388,-5.492803140929198
HLF,100016,6.001250521147636
NCI-H889,3689413,1.8557298697874456
GaMG,409805,3.7457473501027394
Mel Ho,6918878,1.2989066172636972
RL,11404337,-1.4009299024824362
NCI-H2228,JQ-1-carboplatin (1-1 mol-mol),3.687353697289914
HCC202,148198,-2.7548108602388783
Mino,9926054,1.8004792382140618
BT 440,135875424,2.9900391536065354
SH-4,11485656,1.4824886275930502
NCI-H508,9903786,0.5730721211303239
NCI-H508,107985,-2.9102482212123126
SNU-423,tanespimycin-bortezomib (250-1 mol-mol),0.0994607736746136
SH-10-TC,11404337,0.4880521649819775
HCC1500,262093,2.85046563878574
BT 231,6505803,0.1418659460842767
NCI-N87,12003241,-2.470820657410725
MOLP-8,9927531,5.438833274000949
SK-MM-2,6610216,4.027814295753668
SNU-387,9903786,4.748130611639421
SNU-182,selumetinib-vorinostat (8-1 mol-mol),1.2344831556208138
SR,3136844,3.973436776427639
Ri-1,148198,-2.551976890306858
Lu-65,9936388,-8.009646164485344
NCO2,54618164,3.044626652273742
MHH-NB-11,8515,2.6125195663266183
TE 441.T,49836020,3.964912597269393
CAL-85-1,6505803,0.4315173316533146
JHH-6,168313200,3.15578355324536
SNU-61,9926054,1.8929452670989917
BFTC-909,selumetinib-vorinostat (8-1 mol-mol),1.99531584260594
MCAS,11404337,-0.3191442981427469
JHH-1,439501,-0.896844817014076
KYSE-450,3689413,-0.3124621453247139
BT 330,135875424,2.80821579250056
KO52,3136844,3.587765010729267
HCC1143,148198,-3.881060339055355
A-172,409805,3.206630291974944
TE 441.T,409805,4.133178498098395
BT-474,262093,2.736655857570439
HEC-1-B,107985,-3.3155337139042413
HuNS1,49836020,4.176817793282971
SNG-M,11404337,-0.7896933791605669
KALS-1,409805,4.7781064352481835
A-375,24180125,3.577996774573621
ESS-1,sirolimus-bortezomib (250-1 mol-mol),0.3261097694928553
639V,12003241,3.941533367074586
NH-6,6610216,4.244539451905319
NCI-H747,9936388,1.1116037034519244
NCI-H929,262093,-0.1267697569252451
SF268,6918878,2.998810751846559
COLO 680N,100016,6.604594090356929
M-07e,409805,3.874432405180439
PK-59,9903786,2.9850600541065764
HCC1195,10296883,4.230054584219755
MEC-1,3689413,-2.5144055984412903
HCT 15,409805,5.978368929801831
EM-2,sirolimus-bortezomib (250-1 mol-mol),-5.681511220612078
NCI-H2228,6610216,4.4838321019833
RD,9911830,2.165941328253821
SUP-B15,26596,-1.8657043517312688
SNU-387,409805,3.771748093437339
MIA PaCa-2,10296883,4.037005331930825
KMS-18,409805,4.843227783060013
SW1990,tanespimycin-bortezomib (250-1 mol-mol),-3.036947159692904
NCI-H2170,54618164,4.169811342731195
COLO 680N,sirolimus-bortezomib (250-1 mol-mol),1.5905576307574611
BHT-101,159324,4.240701145250969
NCI-H1355,selumetinib-vorinostat (8-1 mol-mol),2.6424962463643316
NCI-H292,159324,3.210621191245253
MHH-CALL-3,100016,3.61949081353442
U-CH1,9911830,3.557998201307897
TC-71,26596,-3.193308290167961
NCI-H2087,439501,-1.341118756842812
OVK18,26596,-0.4420601425641566
HDQ-P1,3689413,0.8200542052424229
PC-3,5460769,3.04554817499368
CGTH-W-1,selumetinib-GDC-0941 (4-1 mol-mol),1.204610504332706
NCI-H747,selumetinib-GDC-0941 (4-1 mol-mol),-3.828774406071909
BT 231,11485656,1.3713674681165906
DU145,tanespimycin-bortezomib (250-1 mol-mol),-0.7432626565730119
YD-10B,136227924,2.2440881554064105
NCI-H441,selumetinib-GDC-0941 (4-1 mol-mol),1.6335298040025916
OPM-2,3689413,-4.501811354570108
ZR-75-30,9903786,5.791062866548605
OAW42,44491742,3.912370337658794
Ku812,439501,-2.3195298765386587
BL-70,3689413,-1.0284037004933524
NU-DUL-1,107985,-4.8298197755406935
BT 112,5460769,1.283415330936559
MCAS,44493528,4.628123206531076
Granta-519,136227924,1.3333863896282263
CAL-62,9936388,-6.3411138463637
BT 231,sirolimus-bortezomib (250-1 mol-mol),0.2590844427623678
GDM-1,168313200,1.9234507371216816
Hs 294T,11404337,-1.3657699869791882
SNU-1033,148198,-5.122632724392466
ZR-75-30,12003241,0.0052055629667129
SiMa,159324,2.416941297651996
SNU-398,159324,0.2037987580554599
SUIT-2,9911830,3.581224696062468
HCC78,selumetinib-GDC-0941 (4-1 mol-mol),2.9308548857555303
JIMT-1,9936388,-4.798396731889527
SET-2,11404337,0.2728842638306079
HT-55,11485656,1.9068584581515573
Li-7,3689413,2.782987463580999
TE 441.T,9936388,-8.412031296278057
JHOS-2,36462,1.7385216355636115
GP2d,36462,0.7877061806446254
LoVo,12003241,-2.8621949377385465
MOLT-13,409805,3.680221382907752
CML-T1,9903786,2.526700219209825
VMRC-LCD,439501,-2.2001056287042715
JL-1,9936388,-5.012158882257613
ZR-75-30,136227924,3.5756469644058613
HEC-265,9903786,3.4431873939131536
COLO 741,439501,-2.122340896395585
OVSAHO,9936388,2.2943852117568944
639V,8515,4.442840674475755
CML-T1,136227924,1.8923919385229255
IM95,sirolimus-bortezomib (250-1 mol-mol),0.6284965219885708
NCI-H2110,54618164,3.868151773731383
MEC-1,9926054,1.8123305243841612
NCI-H1755,135875424,3.1335901028630393
JHUEM-1,8515,2.058426071264184
NCI-H2170,selumetinib-GDC-0941 (4-1 mol-mol),2.2424418004959654
EM-2,26596,-2.2140652847735027
G-402,439501,-3.32986520483416
UM-UC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.98446738693651
HSC-3,409805,5.892445537848464
DMS 454,10322450,3.6931379827732664
U-937,135875424,3.4051518074460487
KMS-34,148198,-3.0196318169893224
U-251MG,6505803,-1.162158161162463
RMG-I,135875424,4.352584072598887
SH-10-TC,JQ-1-carboplatin (1-1 mol-mol),1.9237782728423225
LCLC-97TM1,11485656,2.4293249862604913
NCI-H650,6918878,3.840209584182324
HOS,100016,6.425173790511516
Becker,26596,-2.013233579681989
TE 441.T,11485656,0.4823826130235241
RERF-LC-MS,JQ-1-carboplatin (1-1 mol-mol),4.276053499927872
KE-97,148198,-2.582378915330286
CA46,10296883,3.259152671675197
SH-10-TC,tanespimycin-bortezomib (250-1 mol-mol),1.41172754635421
T-47D,107985,-3.0431317154238564
IGR-1,12003241,0.2975109917194724
DMS 114,11485656,2.3249247552624936
KHM-1B,44493528,1.720576936641076
PLC/PRF/5,246676,4.431557533323378
DEL,44491742,3.848906849757271
HCC95,sirolimus-bortezomib (250-1 mol-mol),1.734022258386224
COLO 684,11485656,1.9881024376461365
SK-N-BE(2),9927531,3.511797224243287
Hs 294T,439501,-2.312914558527944
HCC38,sirolimus-bortezomib (250-1 mol-mol),0.3307101764486495
HEL 92.1.7,46943432,1.358208914963814
TE 617.T,9911830,2.045260681155165
Peer,3136844,3.6444833246639785
CW-2,439501,-2.020246340202773
TT2609-C02,9926054,1.870565341301735
HCC1954,36462,1.6698517772269752
MEC-1,44491742,3.700583986314622
MOR/CPR,9926054,1.7872025764961004
Daoy,148198,-1.968278269262657
SW1271,36462,1.4389686814792042
HCC1833,36462,3.6976539288717927
JURL-MK1,tanespimycin-bortezomib (250-1 mol-mol),-1.9568027387357825
MOLM-6,148198,-4.479963053870103
NCI-H2023,9926054,1.8656368845898197
LS411N,6918878,3.507421995092854
IGROV-1,262093,3.169376516915595
MHH-CALL-4,49836020,-0.2445846673370129
IGR-37,135875424,3.259806736853938
SNU-C5,12003241,-1.9279387541899935
HSC-4,135875424,3.4627713632233537
PK-1,11485656,1.889467088034988
RVH-421,148124,3.535615476070291
NU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.2455773179911887
JHH-6,24180125,3.104630647099568
ALL-SIL,26596,-3.0181503922951674
WM115,148198,-2.543343591950365
JVM-3,24180125,1.9129401450909584
MKN74,159324,3.1954005731407604
SNU-423,9911830,2.1086837652762473
NCI-H1184,46943432,1.3653708283217592
OV-90,262093,3.163621030526785
BT 416,24180125,3.4995177261532917
AML-193,136227924,2.0129973822753735
Hs 934.T,6610216,4.346139991195847
GOS-3,262093,3.1165245547903804
WM115,10296883,3.9273376390568138
Namalwa,JQ-1-carboplatin (1-1 mol-mol),-0.7629380597950661
GOS-3,24180125,3.35218152246705
AN3-CA,148124,-1.73779448723161
NB4,11404337,-1.1437955432104374
A-253,6610216,4.2278797808455595
HD-MY-Z,439501,-3.7474534787438714
MOLT-16,11485656,1.9305016234574737
A-253,9926054,1.90575113373639
SNU-423,148124,-5.293921885870976
RPMI-8402,100016,6.7779334067701145
IGR-1,selumetinib-GDC-0941 (4-1 mol-mol),0.2767905376035742
JHUEM-3,10322450,4.4054488453060525
PaTu 8988s,148198,-4.140903608928441
OV56,262093,3.284870427010587
JHUEM-1,136227924,2.224041693066133
OE19,107985,-3.5723109607204084
SNU-C5,3689413,0.7822461761518839
CJM [Human melanoma],8515,4.376116146258834
A3/Kawakami,246676,3.7408216321489256
IGR-37,44491742,4.84582247034579
WM115,selumetinib-GDC-0941 (4-1 mol-mol),-1.581349987351192
SW1710,439501,-1.6962022164368444
SBC-5,439501,-2.4874901722547977
COLO 800,selumetinib-GDC-0941 (4-1 mol-mol),-0.6648524830772472
KHM-1B,409805,3.6418621708763945
SK-LMS-1,12003241,-1.0710207153229787
SNU-182,5460769,4.45196550133433
SJSA-1,3136844,4.45528511425521
NCI-H146,44491742,2.6808030102351323
NCI-H524,148198,-1.189369331000223
KNS-62,11485656,3.204340501575354
KYM-1,11404337,-1.4539042664575286
SK-CO-1,6610216,4.838209270425191
SK-MEL-1,6610216,4.20996876122129
JHUEM-3,46943432,2.585182446151882
MHH-CALL-3,11404337,0.3136523516674954
MOLP-2,9903786,4.729359936369518
HGC-27,148198,-6.389013328136406
LS123,409805,5.70006510405378
VMRC-RCW,3689413,-0.2709078941714827
NCI-H1563,3136844,4.35288827743353
WM266-4,6610216,3.751452940387017
BT 416,148198,-4.446669528218965
Hs 683,sirolimus-bortezomib (250-1 mol-mol),1.0884212532476678
JHH-1,selumetinib-vorinostat (8-1 mol-mol),1.767604008553774
LC-1/sq-SF,409805,5.500722861245553
ME-1 [Human leukemia],409805,5.503532465022727
JHOC-5,3689413,-2.3603805845843913
H-STS,6918878,0.8588702567283845
KMBC-2,11404337,0.8852156711792197
CJM [Human melanoma],10296883,4.108453768620905
NCI-H716,26596,0.0248584598201427
ST486,136227924,1.8715049257554837
SUP-M2,JQ-1-carboplatin (1-1 mol-mol),-0.9276851107158648
ML-1 [Human thyroid carcinoma],107985,-3.3059977696559204
L-540,6610216,3.6364714067937265
OVCAR-8,3689413,0.7986129838675038
OE33,54618164,4.547083841535975
NCI-H1915,148198,-3.0728174941376603
BT 231,11404337,-1.7001463923522222
NCI-H2023,selumetinib-GDC-0941 (4-1 mol-mol),2.6884050561180253
Hs 822.T,439501,-2.4556830232378712
HEC-6,11485656,2.017714855695412
MG-63,11485656,3.0709685561149076
SBC-5,selumetinib-vorinostat (8-1 mol-mol),2.6526809527728603
JM-1,9911830,1.0886367976495992
COV362,148124,-5.7927287034799395
L-428,3689413,-2.385530955592741
HEC-59,9926054,2.31296864465942
DLD-1,11485656,2.3568944712776565
SNU-478,246676,4.356671197134432
NCI-H716,9926054,1.9023068554939984
HT-29,selumetinib-vorinostat (8-1 mol-mol),2.6415975495156596
5637,6918878,1.296349641015509
SNU-423,11404337,0.0022687984612849
A-549,3689413,0.7236603744186211
IST-Mes1,409805,5.880779442140838
Kelly,selumetinib-vorinostat (8-1 mol-mol),2.3555800551092356
KYM-1,36462,0.7671444744551638
CML-T1,44491742,2.876043803936746
NCI-H1869,9936388,1.425696213804551
WM266-4,36462,0.1003965458983716
NCI-N87,135875424,4.206412745126992
SH-10-TC,11485656,3.549629960388959
Ki-JK,246676,5.098695936612285
MDA-MB-453,107985,-4.386344018126506
MM1.S,26596,-1.4234323398175248
DMS 454,44491742,3.21829880696891
Hs 294T,sirolimus-bortezomib (250-1 mol-mol),0.1024720435012197
OE21,5460769,0.0529032243874579
JIMT-1,159324,3.5615073929278016
NCI-H2196,100016,7.101599749729703
PL-21,26596,-4.324956328818882
SK-MES-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4427487573604268
HCT 15,12003241,-0.9489590343068364
YD-15,tanespimycin-bortezomib (250-1 mol-mol),-1.46921905291906
T84,36462,3.2461268076235283
MKN74,9936388,-0.1480822399843773
Hs 294T,10322450,5.012803504486345
MPP 89,tanespimycin-bortezomib (250-1 mol-mol),-0.3809360105117337
CAL-12T,100016,6.470654025405006
SNU-869,44491742,4.0762801195520675
Namalwa,10296883,3.754455655563699
WM115,10322450,3.651827454662003
HuG1-N,168313200,3.1832418774206332
SNU-478,9926054,1.8304489551937344
NCI-H1581,54639024,4.478978545564096
Karpas-620,5460769,3.7991710121936304
KYSE-520,6610216,4.362727317650632
RERF-LC-A1,12003241,-0.839480669213789
NCI-H2342,6610216,3.8793869903029408
NCI-H1944,54618164,4.026280621410548
SW948,5460769,-0.6640669541383749
SU-DHL-1,26596,-2.3613305357908625
NU-DHL-1,409805,5.5181498055430565
HuH-6,6505803,-0.5786152978547117
CAL-27,26596,-1.6130291256541474
D283 Med,5460769,1.125938178392905
SNU-601,3689413,0.8443240779543064
NCI-H1869,24180125,4.3941927227643145
PSN1,148198,-4.413280426545966
K-562,JQ-1-carboplatin (1-1 mol-mol),0.3966707315482991
HSC-4,107985,-2.2656284906222144
Kasumi-2,9927531,4.453654232617923
IGROV-1,12003241,-2.0122972114546904
G-292 clone A141B1,9926054,1.742102063355914
NCI-H520,73707440,4.350001287035215
NCI-H2170,6918878,3.5865994784010877
MV4-11,3136844,3.5314596756146357
YD-8,tanespimycin-bortezomib (250-1 mol-mol),-0.6090982455977105
LS180,12003241,-0.6460664270988897
RCH-ACV,6610216,4.070722186568696
WM793,148198,-1.495249919530428
SNU-449,12003241,0.2005365129445947
SK-N-MC,107985,-4.0250065656934115
Panc 08.13,54618164,4.453700486080014
EM-2,9927531,3.4413075859413556
Lu-65,36462,1.7650112764581103
SNU-1,12003241,-2.3799966933109262
CAL-148,100016,6.461133409351435
SNU-1105,11404337,0.7156656202798479
L3.3,409805,5.10307456372432
SNU-685,12003241,-1.0976198055590074
NCI-H226,3689413,2.4864282663543302
THP-1,5460769,3.8427937277030497
HCC38,6505803,-2.5112247246736787
KE-37,100016,3.280443906920473
Lu-65,148124,-0.361922200988903
ZR-75-30,148124,3.761125086824371
SR,6918878,0.5705211353922425
HCC78,sirolimus-bortezomib (250-1 mol-mol),1.3217046818023197
LC-1/sq-SF,6918878,2.773369353230006
MDA-MB-157,26596,-2.8480155125253623
UACC-62,6505803,1.051812418083976
BT 112,9926054,1.759668872476805
MV4-11,46943432,-1.773964414014851
EKVX,6610216,3.33628219638057
REC-1,9927531,3.800278065681949
JHOC-5,24180125,3.9180102124030407
SNU-1077,159324,3.2853516722485994
HCC202,11485656,2.3105434374490734
EM-2,6610216,3.792859820218109
VCaP,148124,3.889989547535533
MHH-CALL-3,148198,-0.6982118974436664
KMS-12-BM,3136844,3.1587649853094795
MHH-ES-1,6918878,0.8942123313539464
NB4,54618164,3.68838507272964
OAW28,148198,-3.8662210541116977
SCC-4,46943432,2.425809878502144
Hs 729.T,6610216,4.1475026688344
Hs 940.T,8515,3.5056691644991087
PE/CA-PJ15,44493528,4.269836707696998
PF-382,100016,3.957595275699552
HCC1954,10322450,3.841021204455557
BT 245,JQ-1-carboplatin (1-1 mol-mol),4.46215850472978
SK-N-SH,9903786,1.912941590488841
DAN-G,3689413,2.9814511815134943
JVM-3,44493528,3.702239764390707
OAW42,409805,5.898373871499896
ACC-MESO-1,9903786,5.156493229165983
P12-Ichikawa,8515,3.077919808593495
VMRC-RCW,9911830,2.7315472167375505
HCT 8,9911830,2.7561206776295712
HeLa,26596,-2.0330393314508868
JHH-5,10296883,4.145444689794886
SNU-398,10296883,3.408276810721882
Karpas-299,136227924,2.4546473500331576
MHH-ES-1,107985,-3.8860683176627098
HGC-27,6610216,3.4161175560596244
YAPC,36462,2.246335150310725
KO52,107985,-4.972333164700203
KYM-1,100016,6.934049900113359
OCI-AML-2,9936388,-7.199814294099559
NCI-H1373,11485656,2.0239924132240117
NALM-6,100016,5.173644166821544
KE-37,36462,-2.890328899467379
KPL-1,11404337,1.240920910385959
SK-CO-1,9911830,2.5560928673864676
Hs 766T,JQ-1-carboplatin (1-1 mol-mol),-0.2736789980960341
AsPC-1,54618164,4.187549957668634
NCI-H2141,26596,-3.569863113976208
LAMA-84,24180125,2.7759007450862065
GI-1,5460769,1.3544320917610908
TE-9,36462,2.2329796959977894
PL-21,sirolimus-bortezomib (250-1 mol-mol),-0.8951196231855002
Panc 10.05,10296883,3.775390801263641
KMS-21-BM,9877608,6.031837359251096
LOX-IMVI,107985,-4.647027352160178
SUP-T11,46943432,2.7244636388334658
SNU-478,262093,2.3459041938371112
RERF-LC-A1,26596,-2.038549310603685
IM95,26596,-1.182221472210093
HCC2218,246676,3.234854854561146
ST486,439501,-3.700540877794945
OCI-AML-5,168313200,3.898123624233607
HuP-T4,8515,2.1627340479037183
HuG1-N,tanespimycin-bortezomib (250-1 mol-mol),-2.4884631877439207
Sq-1,5460769,2.958314651359677
U-118MG,107985,-3.8386417530991777
HPB-ALL,selumetinib-GDC-0941 (4-1 mol-mol),3.2361225802608593
KP-4,54618164,4.199260962007676
BT 224,6610216,4.396023390217125
SW948,24180125,1.460789729891403
253J,12003241,-2.2004462353623775
WM266-4,9911830,1.496270687043537
NCI-H2052,selumetinib-GDC-0941 (4-1 mol-mol),-0.0438612547991499
G-402,36462,0.8225931821467894
BHY,6505803,-1.0358392928215592
BT 112,168313200,1.7991755506997456
RERF-LC-A1,135398744,8.259619126952485
D283 Med,44493528,4.1397828788754465
SU-DHL-8,9936388,-6.541298738392362
HT,JQ-1-carboplatin (1-1 mol-mol),-0.8971683298362426
NCI-H1623,136227924,2.959018127447204
ES-2,148198,-2.2318104062196102
BV-173,tanespimycin-bortezomib (250-1 mol-mol),-0.4619705859834364
PLC/PRF/5,44493528,4.794092403972537
Ku812,6505803,-1.520866948509506
HPAF-II,3689413,1.4854609616797476
AsPC-1,409805,5.083096669481897
BCP-1,26596,-2.6141791098451934
CCF-STTG1,135875424,4.233748796461769
NCI-H146,135423438,2.8528911509997137
YD-38,159324,3.3433539214120516
Panc 02.03,409805,5.9877775932277615
JM-1,selumetinib-vorinostat (8-1 mol-mol),2.137722454720046
A-253,107985,-4.608002410712629
SNU-8,11404337,-0.4750422228003279
HuH-28,409805,5.781601088371211
HCC2279,8515,5.4381882059058775
UACC-257,selumetinib-GDC-0941 (4-1 mol-mol),-0.8117172075049729
L-363,11485656,1.816293106463241
SW579,11404337,-1.5327232138346547
A-204,6610216,3.86099530765105
HT-29,11404337,-0.847378289342427
FTC-133,439501,-1.0725688155870328
TT2609-C02,9927531,6.514577910597335
UACC-62,12003241,-2.2941993438250865
Karpas-620,9927531,5.121600131108068
A-172,9903786,3.6235991814079545
NCI-H69,9926054,1.6669613133383836
JHUEM-2,136227924,1.8669676160402808
SKM-1,11485656,1.846158462004935
VCaP,selumetinib-GDC-0941 (4-1 mol-mol),1.6951262679306962
BT 271,tanespimycin-bortezomib (250-1 mol-mol),-3.34346586365967
Sq-1,selumetinib-GDC-0941 (4-1 mol-mol),2.237150148829387
Kelly,439501,-0.837700217244781
DU4475,9911830,1.6292365330787766
RKO,9926054,1.883626680074333
EBC-1,262093,3.282088123658991
CGTH-W-1,9911830,-1.7904254886383355
Daoy,100016,6.878604021612681
DMS 454,sirolimus-bortezomib (250-1 mol-mol),0.5194696170938634
BICR 22,3136844,4.306912771504561
MDA-MB-157,6505803,-0.678815881739905
SNU-1105,6610216,4.763085557010596
SNU-387,148124,3.5836786309908515
L-1236,100016,5.644363792904431
F-36P,44491742,3.961170859118446
COLO 680N,12003241,-0.3137141462022448
OCI-AML-3,5460769,2.571994692264208
NUGC-4,54618164,3.9566801833139063
HCT 15,6610216,4.137452944205724
KMS-27,44491742,4.7290458888071765
BICR 16,tanespimycin-bortezomib (250-1 mol-mol),-2.3692511571094244
VMRC-RCW,11485656,3.110603770288861
PE/CA-PJ49,selumetinib-vorinostat (8-1 mol-mol),1.4585612568832638
SNU-407,12003241,-0.5168922712641052
HEC-251,JQ-1-carboplatin (1-1 mol-mol),0.3625171381701316
MFE-296,9911830,1.8484539115793903
RL,selumetinib-vorinostat (8-1 mol-mol),2.3848455335656347
NCO2,36462,-0.655679332462451
BICR 56,6610216,5.354149970854336
SNU-668,11485656,2.3773285837214444
HCC1954,439501,-2.308794181663851
Yamato-SS,3689413,-0.7026666605397593
DoHH2,6918878,-1.0189821819047025
NCI-H2029,262093,2.84677790575948
NCI-H322,24180125,3.2183123555478703
ECC12,148198,-2.5550218392093624
KMS-34,409805,4.804529897984003
SNU-119,409805,3.7561778624984585
CCF-STTG1,3689413,0.3028996084806184
U-BLC1,44491742,3.768443657215341
HCC1500,24180125,3.164669305988548
SK-ES-1,100016,7.4795645853927475
OE19,sirolimus-bortezomib (250-1 mol-mol),2.347707563651812
BT 428,12003241,-1.1639537703903158
OAW42,10322450,4.813249082593069
KO52,54618164,3.705714044840163
Panc 03.27,36462,1.4276751747001344
Mino,44491742,3.5991371763887616
A-253,24180125,3.693466028102568
COLO 205,11404337,1.3467239664016557
GA-10,3136844,3.529954962395684
TCCSUP,6610216,4.746461050840166
KYO-1,tanespimycin-bortezomib (250-1 mol-mol),0.6215111489817027
BC-3C,sirolimus-bortezomib (250-1 mol-mol),0.3697062841938496
KCL-22,12003241,-4.05956124354109
Li-7,8515,3.090070672715684
MIA PaCa-2,5460769,2.8270884799697833
JHH-2,sirolimus-bortezomib (250-1 mol-mol),0.503615314024041
RL,sirolimus-bortezomib (250-1 mol-mol),-0.1936565509728958
HSC-3,9936388,1.0714511856923938
8-MG-BA,JQ-1-carboplatin (1-1 mol-mol),3.7753986930145658
Ki-JK,selumetinib-GDC-0941 (4-1 mol-mol),1.348149232454661
EBC-1,6505803,-3.073804899709993
NCI-H196,9927531,5.55374615852481
HOS,262093,1.0531886567175572
HCC2279,3689413,-1.8306201481389968
A-172,9911830,1.400166382809974
MKN45,3689413,3.361842209441358
RKO,44491742,4.905526099010324
KPL-1,262093,3.0634356984830298
SaOS-2,168313200,1.7182390433527042
T98G,409805,5.844803307866975
RMG-I,9903786,4.466562574504816
NCI-H1650,6610216,4.520029622813093
HPB-ALL,9911830,3.048089074029996
RS4;11,tanespimycin-bortezomib (250-1 mol-mol),-0.3918084072183652
NCI-H1975,9911830,1.490717109847118
PLC/PRF/5,135875424,4.546560112708509
SJSA-1,262093,2.9524375383319468
BT 504,136227924,2.4961671253802957
WM88,6610216,4.233732506418395
KE-37,9911830,1.9882864572277257
HT-144,49836020,4.351286347642034
SKM-1,10296883,3.074274434558128
CAL-148,6610216,4.859622527364858
COLO 205,36462,2.948773828131636
RVH-421,3136844,4.3872607284954395
SNU-626,9926054,2.31791428562488
PaTu 8902,44493528,4.360494725244959
IMR-32,9903786,1.34691800492683
WSU-DLCL2,sirolimus-bortezomib (250-1 mol-mol),-6.394861252001346
BT 428,3136844,3.909056651603449
OVISE,36462,4.611657944155446
SNU-1077,24180125,4.514438880816518
RPMI-6666,11485656,1.824028622976644
Hs 839.T,107985,-2.4712975807156403
AML-193,46943432,2.338266793436764
DV-90,44493528,4.133930960270083
KLE,11485656,3.08308998793154
G-401,136227924,2.3105932180874365
SK-MES-1,6505803,-1.6452904236752195
SK-N-AS,100016,6.379811774246359
U266B1,100016,6.458228016262307
EC-GI-10,6610216,4.746695759285481
JVM-3,selumetinib-GDC-0941 (4-1 mol-mol),1.8327445847214063
JIMT-1,26596,-0.816309459972074
YD-38,sirolimus-bortezomib (250-1 mol-mol),1.3505427312079858
SNU-899,148198,-1.9308055104707893
OV-90,148124,3.1650494027578953
A-204,409805,5.78694452018541
SK-N-FI,selumetinib-GDC-0941 (4-1 mol-mol),0.5932957788770222
Calu-6,135398744,6.4194279820254465
PK-45H,3689413,-1.0199295796729335
HCC1195,9936388,-5.972335548961908
HCC-56,10296883,4.321936359264917
TE-4,54618164,4.0804928749027525
G-401,148124,-6.018913106580182
C2BBe1,54618164,3.820082525950668
CAL-29,439501,-2.337192610313779
BT 139,5460769,4.859801196456228
SBC-5,135398744,6.447254342428179
YD-38,6610216,4.740393089069458
HH [Human lymphoma],3136844,3.64321069115676
22Rv1,262093,2.6846165954285386
KALS-1,24180125,2.594623206570859
HuP-T3,tanespimycin-bortezomib (250-1 mol-mol),0.6963202387947334
NCI-H1693,9927531,4.77981113730065
OVK18,selumetinib-vorinostat (8-1 mol-mol),1.7946932468084609
HCT 116,439501,-2.291145672790816
HCC202,9926054,2.1190704993467917
UM-UC-3,6610216,4.133120450303845
RCM-1 [Human rectal adenocarcinoma],9911830,2.5852143987743883
DU4475,262093,2.0152969052094725
WM115,selumetinib-vorinostat (8-1 mol-mol),-1.5219389321344234
MOLM-13,tanespimycin-bortezomib (250-1 mol-mol),-1.8317105130308673
KHM-1B,26596,-2.1296194509234576
SW1990,100016,6.759971253936254
SJSA-1,3689413,0.2987109884776379
BV-173,selumetinib-vorinostat (8-1 mol-mol),2.207862220069229
EM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.8534548568665049
WM266-4,44493528,4.3133023998571565
RCM-1 [Human rectal adenocarcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1580465121550203
T24,26596,0.1047033051772514
A-375,11404337,-0.2038231220320669
HARA [Human squamous cell lung carcinoma],135423438,3.0787654328489986
HCC827,36462,2.605539354003478
NCI-H929,11485656,1.7872822459041733
COLO 680N,5460769,3.8284698218745055
SNU-1,107985,-4.014141337071334
Panc 10.05,24180125,2.67983729473107
RKN,439501,-1.5558449248177562
BICR 22,148198,-3.168643556299537
TE-4,9903786,1.7247018760374746
HCC15,9936388,-3.3305479025951783
M059K,selumetinib-vorinostat (8-1 mol-mol),2.381985012022912
HCC44,135423438,1.5851293275166212
23132/87,11404337,0.4022152079144664
Peer,6505803,-0.1877996402044426
SNU-466,sirolimus-bortezomib (250-1 mol-mol),-0.4040247740859908
TCCSUP,selumetinib-GDC-0941 (4-1 mol-mol),1.9950465927761605
LOX-IMVI,168313200,4.329297638154407
KMRC-3,136227924,3.033903598858876
HuH-6,selumetinib-vorinostat (8-1 mol-mol),2.590919017707307
Granta-519,10296883,3.749738066673353
L-540,159324,1.0115426220210637
Karpas-620,409805,3.9082623873755344
RT-112,409805,3.4444606673833875
Panc 03.27,tanespimycin-bortezomib (250-1 mol-mol),-1.5321411216647824
P12-Ichikawa,246676,5.130179134655631
SK-HEP-1,8515,5.0523689066797495
HCC44,246676,5.33842573528245
RCM-1 [Human rectal adenocarcinoma],6918878,1.3044693080210874
BT 422,36462,4.524557226357963
LOU-NH91,8515,5.2113767400480775
T84,9911830,2.4807327035496662
EBC-1,selumetinib-vorinostat (8-1 mol-mol),0.7518479217217616
NCI-H747,6505803,-2.758197562665133
IMR-32,9927531,3.188320479836116
SNU-1105,12003241,-1.0789157776023728
TCCSUP,sirolimus-bortezomib (250-1 mol-mol),0.3356822516851041
SNU-81,3689413,1.1974270464491454
BDCM,12003241,-3.7863516552935415
PE/CA-PJ34 (clone C12),selumetinib-vorinostat (8-1 mol-mol),2.6799974676882883
GA-10,24180125,1.046455253129036
KMS-18,JQ-1-carboplatin (1-1 mol-mol),0.042136194628161
OVCAR-8,107985,-2.4814474476882205
RS4;11,107985,-3.735535817739186
NCI-H2110,6610216,4.402528376622354
KLE,36462,1.5319564725809691
HH [Human lymphoma],9926054,1.7922289040675246
AN3-CA,tanespimycin-bortezomib (250-1 mol-mol),-2.8889708448552196
NCI-H1694,148124,-5.208031501758842
GI-1,9926054,1.7357819318992778
HuP-T4,36462,1.609645546776352
TE 441.T,246676,4.366193760638462
HCC1806,6918878,4.322415868136736
KYSE-140,9926054,1.9800704230635255
COLO 678,36462,3.8196751045227786
MOLM-13,3136844,3.815118683612459
SNU-387,100016,7.682207014450764
Jurkat,73707440,5.030996622710699
MCAS,selumetinib-vorinostat (8-1 mol-mol),1.2956109897166193
KMRC-2,9903786,3.847767222952075
NCI-H1155,159324,2.1677160102648263
MV4-11,54618164,2.9131493918068205
NCI-H1105,3689413,0.7120747688732703
CHP-126,46943432,1.4569747849475687
HuG1-N,8515,4.737419441534161
TE-5,107985,-4.713560731593774
BT 320,409805,6.1406982436622
NCI-H1793,54618164,4.479745006931856
EFE-184,11485656,3.681714040860518
IST-Mes1,6918878,2.524010054300984
WM983B,136227924,4.383113443662036
BT 224,409805,5.8322302656386045
HT-1080,12003241,-0.8718791582683669
H-STS,12003241,-1.720451684377523
COLO 792,439501,-2.3600745539186994
NCI-H1092,107985,-3.3152950865622564
NU-DUL-1,136227924,1.961051427269065
VMRC-RCZ,8515,5.1867896592063545
769-P,439501,-0.7998429700142536
ChaGo-K-1,148198,-4.908529159972166
Yamato-SS,262093,2.7505818299570897
BT-474,148198,-3.4060318714272984
SK-MM-2,11485656,1.7777783316384888
IST-Mes1,9903786,2.7623614356082458
BT-12,6505803,0.2176692391310213
NCI-H211,9926054,1.5085991120248008
LUDLU-1,44491742,3.9054426641243873
NCI-H1944,tanespimycin-bortezomib (250-1 mol-mol),-2.853694695712997
MDA-MB-361,439501,-3.0458993456169168
SUP-HD1,148198,-3.3843356772130826
G-402,6505803,-2.2482825610741095
TE-6,9926054,1.628264374651606
DU145,262093,3.2967412726475187
M-07e,11404337,-0.615837130994534
OV7,selumetinib-vorinostat (8-1 mol-mol),3.5480660941155424
Panc 03.27,6610216,4.487781163899809
A-375,9936388,-2.2482939434629223
SK-MEL-3,54618164,4.268913642051635
JHOS-2,12003241,-0.473680569939606
PE/CA-PJ41 (clone D2),12003241,-1.240840898142407
F-36P,11485656,2.0495534401946647
Lu-99,107985,-3.777908529109632
OCI-Ly10,5460769,4.307631470824749
Hs 852.T,9911830,2.9837526499964935
DV-90,5460769,-1.416729974856236
GMS-10,tanespimycin-bortezomib (250-1 mol-mol),0.0800415609138278
MOLT-3,11404337,-3.211450754750083
PE/CA-PJ41 (clone D2),9911830,2.474692527897134
BT 286,selumetinib-GDC-0941 (4-1 mol-mol),-1.4527059239825568
COR-L105,selumetinib-GDC-0941 (4-1 mol-mol),0.702191872416662
ML-1 [Human thyroid carcinoma],tanespimycin-bortezomib (250-1 mol-mol),-0.335060121238308
NOMO-1,54618164,3.731990472759892
KMS-12-BM,135875424,3.5247186168283453
KE-37,439501,-2.40992471859013
BICR 6,409805,3.8715471361387848
COLO 829,148124,-4.326485260562876
SK-OV-3,49836020,-5.2191550029019025
NCI-H211,selumetinib-GDC-0941 (4-1 mol-mol),1.1345350253302544
Tm87-16,12003241,-0.0978800802816917
KO52,tanespimycin-bortezomib (250-1 mol-mol),1.3473417684314797
BT-16,9936388,1.3930931201421013
JHUEM-2,12003241,-3.1995756847172108
LOX-IMVI,136227924,2.635687863612288
SNU-5,135875424,3.5820845007608555
G-402,sirolimus-bortezomib (250-1 mol-mol),0.1655413434951251
NALM-6,73707440,6.057800002109687
SR,9926054,1.591402599592269
SIG-M5,6918878,0.8815480847980426
COLO 201,54618164,4.070639238227262
Karpas-620,3689413,-2.001578563648977
NCI-H520,9903786,3.332228860924169
L-363,tanespimycin-bortezomib (250-1 mol-mol),-2.487698550401284
HEL,9926054,1.596813412273358
HH [Human lymphoma],439501,-4.820803116801483
Calu-1,54618164,4.35336798848697
EJM,11485656,1.52616093441074
RCH-ACV,10296883,2.7404232752674273
Hs 936.T,JQ-1-carboplatin (1-1 mol-mol),2.819300005463285
NU-DUL-1,168313200,3.0422997950716346
MDA-MB-435S,9911830,2.892652836059052
MCF-7,selumetinib-vorinostat (8-1 mol-mol),2.344882073871156
Ishikawa (Heraklio) 02 ER-,107985,-3.239655509933191
KCL-22,11404337,-1.0119839618424291
BT 333,selumetinib-vorinostat (8-1 mol-mol),3.1081878072417015
MCAS,6918878,0.9071397786754258
RMG-I,11404337,0.6551142499064945
SU.86.86,10322450,5.077156891369805
HEC-1-A,36462,1.2405106229854406
RKN,6610216,4.220445612403551
ES-2,11404337,1.4427511575724656
ES-2,9903786,4.393151500832027
PE/CA-PJ41 (clone D2),9936388,2.7789010886628422
KU-19-19,262093,2.7281718696395303
MKN1,11404337,1.138047347798436
BT 440,168313200,1.843181494702656
NCI-H1793,11485656,2.9016215508551064
SNU-601,11404337,-0.2592209107038837
HuCC-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.370448841464423
MKN74,36462,3.612647213890312
Hs 683,9903786,4.056971165383086
IM95,selumetinib-vorinostat (8-1 mol-mol),1.7782724211956276
NCI-H446,54618164,3.912679414201531
A-172,sirolimus-bortezomib (250-1 mol-mol),0.3443286616456003
HCC1806,selumetinib-GDC-0941 (4-1 mol-mol),2.757254827906479
BT 359,12003241,0.8363622600991807
SF126,3136844,4.520107500269934
KP-4,6505803,-3.0608028116863464
MOLP-2,selumetinib-GDC-0941 (4-1 mol-mol),2.6485727489944555
HOP-92,9927531,4.8467416959319625
A-253,3689413,0.6147211160043753
MPP 89,107985,-3.4631963812311892
YKG-1,6610216,4.705494965359816
MHH-NB-11,54618164,4.186809252576314
OE33,3689413,1.522493576982794
Hep 3B2.1-7,6610216,4.203161900181635
M-07e,100016,5.065678373530031
SF268,135423438,1.590927583342323
NCI-H1755,439501,-3.104182815210806
BL-70,6505803,0.7841621895069785
Yamato-SS,36462,3.621475553611929
OVK18,136227924,2.593591625928113
COR-L95,11404337,0.1032061359669597
BICR 31,36462,3.088359748996336
KMS-34,6918878,-1.4354831854515095
FTC-238,54618164,3.8997014526037272
HCC1419,54618164,4.916120867107994
SK-N-DZ,107985,-4.521449423175934
CAL-51,selumetinib-vorinostat (8-1 mol-mol),2.7100607191382187
Rh41,36462,0.7491505234443768
EJM,262093,1.353461350978494
HARA [Human squamous cell lung carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.088944743887487
NCI-H838,6610216,4.350007220120111
NUGC-4,8515,3.8971798863642615
SNU-761,24180125,2.7199190915281326
ZR-75-1,36462,3.527244858285703
SNU-738,9911830,2.353180115035864
NCI-H1299,9911830,3.0840556106234653
NCI-H2110,107985,-2.7030092125020713
CAL-51,168313200,3.900876548563449
MCAS,135398744,6.37399282177603
GA-10,100016,3.803284916821312
BT-474,44491742,4.780448859314668
SNU-466,3136844,3.991625575491356
Panc 05.04,selumetinib-vorinostat (8-1 mol-mol),1.2713698550685717
A3/Kawakami,JQ-1-carboplatin (1-1 mol-mol),-1.0104542056691184
SNU-C1,9926054,1.821636344159182
SK-MEL-28,135875424,5.515491244041513
NCI-H2009,9903786,1.8298580590992315
NCI-H1435,24180125,2.7176040628753357
Calu-1,36462,2.444973660840076
JHH-2,9926054,3.1999514592679508
KYO-1,148198,-3.141944756892253
RKO,159324,3.5523933893017583
SW48,11485656,-1.6768123952056315
Panc 02.03,36462,3.4500230117265933
BV-173,135398744,4.1083578998819945
TYK-nu,selumetinib-vorinostat (8-1 mol-mol),2.6103059793632246
RL,JQ-1-carboplatin (1-1 mol-mol),-0.1816781364388249
Mono-Mac-1,3136844,3.2810332522096575
Lu-99,3136844,4.029336359876744
JURL-MK1,136227924,2.4264924164691135
NCI-H1869,12003241,-1.5114527115730307
MKN74,3689413,0.9993219534405752
BV-173,8515,3.3679633726453027
OCI-AML-3,9926054,1.7279388216590237
EoL-1,24180125,2.1114997357358485
SF268,3689413,-1.0049822928368335
SNU-685,262093,3.0570612245027027
HCC1438,44491742,5.362050315054713
HCC-56,9926054,1.8387784948097223
KG-1-C,sirolimus-bortezomib (250-1 mol-mol),1.4643068357470623
SJSA-1,8515,4.468492195997185
DLD-1,9936388,-0.5378287493970375
UM-UC-3,159324,3.5386000070846992
A-375,9926054,2.393426871996004
KATO III,148198,-3.9142793385091186
NCI-H23,3689413,-2.6057234529472098
A4/Fukuda,9911830,0.8865121451383732
CAS-1,11404337,-0.7290961346307245
Panc 05.04,11404337,1.2043196407136412
NCI-H661,159324,2.633762936698375
DMS 454,409805,6.063702183445294
HCC38,148198,-4.709757817936847
SK-ES-1,9911830,2.1477528747801995
NCI-H1623,36462,0.862958596391428
SNU-478,6610216,4.6316446091950665
ChaGo-K-1,107985,-4.444294596677252
OCI-AML-2,409805,3.662205368916432
RERF-LC-Ad2,tanespimycin-bortezomib (250-1 mol-mol),0.3910876035437155
DK-MG,100016,7.056187444773538
Daudi,11485656,1.7254760898020216
SNU-C1,439501,-1.3608922935267702
Capan-1,tanespimycin-bortezomib (250-1 mol-mol),1.8501996853499856
NCI-H1568,5460769,1.1324377767406906
BCP-1,JQ-1-carboplatin (1-1 mol-mol),0.3849655191585445
U-CH1,11485656,3.664474394273293
SU-DHL-8,36462,-2.8837378073360163
MFE-296,5460769,1.1407160363759563
HCC1500,9911830,2.253316240952314
Hs 888.T,12003241,-1.970204906844497
OV7,12003241,-1.6318982026296969
FTC-133,selumetinib-GDC-0941 (4-1 mol-mol),4.492269110406249
EFO-21,54618164,4.387147520518085
Panc 03.27,439501,-1.8758236187541328
ECC12,3689413,0.1011873229267039
A-375,JQ-1-carboplatin (1-1 mol-mol),5.457971854061129
MeWo,246676,0.2399157367161025
CW-2,159324,0.8988860789988596
Panc 08.13,6505803,-2.482053644474571
BL-41,44491742,3.779286328341323
BT 147,9927531,5.037418148394567
CCF-STTG1,168313200,3.710540265594596
HCT 8,10296883,4.100696094904368
BDCM,439501,-2.7334853290513497
NCI-H1869,9911830,2.4210721600025344
8505C,tanespimycin-bortezomib (250-1 mol-mol),0.1990697698035682
NCI-H1975,26596,-2.5930273814391196
BT-474,107985,-3.5381874365688293
SW1088,148198,-1.1652739532057856
SK-N-MC,26596,-3.660625750775288
CAL-51,11485656,2.6541256228973773
RL,262093,2.402242412116004
697,409805,3.1910228760525103
K029AX,135398744,6.420759462552213
NCI-H1184,159324,2.6311703367057735
MeWo,selumetinib-GDC-0941 (4-1 mol-mol),-0.6155502943571556
NCI-H1792,selumetinib-GDC-0941 (4-1 mol-mol),1.680387740806623
NCI-H196,439501,-2.4399998682634023
OV-90,tanespimycin-bortezomib (250-1 mol-mol),-2.825248650811712
HDLM-2,136227924,3.1256787357030937
DMS 53,36462,1.5723952514738209
GP2d,6505803,-3.22314968715238
U-251MG,9903786,4.913889261363981
MFE-319,9911830,2.7406441465342555
DMS 273,136227924,2.538513279360657
LNCaP clone FGC,168313200,2.110708126530363
SF268,44491742,4.062737154124887
8305C,5460769,5.099577444912903
EC-GI-10,100016,6.57909581265972
BEN,9936388,2.3760143279303096
JK-1,9911830,-2.4986203746696245
PC-14,9927531,4.079128694018213
A3/Kawakami,tanespimycin-bortezomib (250-1 mol-mol),-0.2399210374743367
NCI-H838,107985,-2.6563013352867677
IGROV-1,8515,2.1861539315976053
CAS-1,136227924,2.284810237581045
769-P,9911830,3.2901090522207803
OCI-AML-2,135875424,3.3371422768909857
D283 Med,46943432,1.9673056187100668
NCI-H1693,11485656,1.8796712280136327
NCI-H2081,11485656,1.3595446454141742
BT 340,409805,5.754055033760214
P31/FUJ,tanespimycin-bortezomib (250-1 mol-mol),0.0118872693017982
RL95-2,54618164,3.997329839475735
JM-1,JQ-1-carboplatin (1-1 mol-mol),-0.8945850233452926
NOMO-1,44493528,4.211717002525977
Mono-Mac-1,100016,3.734497226962008
BT 164,6918878,4.639370732128339
COLO 680N,6610216,4.637912806621915
MOLT-16,9936388,-8.915282355135908
JJN-3,tanespimycin-bortezomib (250-1 mol-mol),-0.8037062174146113
COLO 668,26596,-1.2429093822877924
TCCSUP,3136844,3.997105269832927
NCI-H524,159324,-0.4298723686665758
PF-382,sirolimus-bortezomib (250-1 mol-mol),-1.8345993475450983
LUDLU-1,44493528,4.4309476749658625
PL-21,12003241,-0.83006256212438
HuH-1,12003241,0.2926250163716364
HCC1954,24180125,2.3643947156873546
PK-59,9926054,1.7891376671835462
SK-N-AS,3136844,3.6976917377368976
NH-6,409805,3.714423410444853
Granta-519,54618164,3.794628352719798
HT115,107985,-3.2937342736448074
HOS,9911830,2.3433546648440275
FaDu,44493528,4.321653522203767
TTC-709,107985,-3.8889296232752737
NCI-N87,148198,-3.7864178683693774
Granta-519,24180125,1.2477770260094014
NCI-H526,6505803,0.072926475224881
SNU-761,159324,2.4588772330633115
SW982,11404337,-0.6290614073029407
NCI-H522,54618164,3.979913879048498
CHP-212,6610216,3.760481483683652
NCI-H2452,100016,6.6405878618594985
EB1,8515,1.7583266480090207
AGS,9936388,-0.8886821418021683
OV-90,5460769,5.624374105443753
NCI-H2122,9911830,3.1197421381222212
HT,26596,-2.1592273986948394
CAL-51,135875424,4.33643967165441
BC-3C,9926054,1.793966289929591
Hs 611.T,11485656,1.370862895697381
OCI-Ly3,46943432,0.8013367057950229
CHP-126,148198,-3.388805594241749
HCC1428,3136844,3.8669733332791534
HEY A8,262093,2.6286127201317835
BT 231,54618164,4.074270092547043
HCC1171,136227924,3.688896594319452
SU-DHL-8,sirolimus-bortezomib (250-1 mol-mol),-6.359979517729665
KYSE-450,135875424,4.8684130020868235
SW1353,135875424,4.282925625560305
SNU-407,3689413,0.4751617374249986
RS4;11,9926054,1.3996833727357625
HARA [Human squamous cell lung carcinoma],8515,3.1956320485149265
SNU-449,sirolimus-bortezomib (250-1 mol-mol),1.1578809609780345
NCI-H1341,262093,2.9706231896058823
EJM,135875424,3.8151689174566665
HT-29,44484440,3.2642973149552947
NCI-H1155,selumetinib-GDC-0941 (4-1 mol-mol),2.5268470929641964
A-549,9936388,1.4749208650316612
NCI-H1734,12003241,-3.2634619258307644
C2BBe1,9911830,2.216190650017955
KYSE-510,tanespimycin-bortezomib (250-1 mol-mol),-1.5212875758875433
Mel Ho,11404337,-0.9675830815963552
SF539,135423438,0.8139499502196877
MOLM-6,262093,0.6748168893327547
HPAF-II,selumetinib-GDC-0941 (4-1 mol-mol),0.3156523393039555
Jurkat,36462,0.5890465632038882
HOP-92,9903786,4.828960304549442
SK-N-AS,54618164,3.832348053095005
U-BLC1,12003241,-2.3919609664555543
BV-173,11404337,-1.6839007353956104
HCC1588,135875424,4.102110498165806
A-498,148198,-1.0809020747576437
PK-59,54618164,4.180437133735424
T24,12003241,-0.6434481559725229
SK-MEL-30,409805,5.464609868118714
BFTC-909,11485656,2.882750602975944
LS1034,49836020,4.406866434657065
BT 271,148198,-6.332121949886553
RPMI-6666,selumetinib-vorinostat (8-1 mol-mol),2.222116520325129
HCC44,tanespimycin-bortezomib (250-1 mol-mol),-2.3281487607595515
COR-L95,11485656,1.8696119642586884
G-402,9927531,4.821419019473558
Reh,11404337,2.5289524412183964
HCC1195,9927531,5.131359962593503
HGC-27,3136844,3.764945838611833
NCI-H1341,JQ-1-carboplatin (1-1 mol-mol),1.5093857547528675
NCI-H211,6505803,-2.3118945325693216
LC-1/sq-SF,12003241,1.312627912595186
SNU-119,10322450,3.771322180088625
MHH-ES-1,54618164,3.950702257104535
SNU-899,selumetinib-GDC-0941 (4-1 mol-mol),0.9114020833269496
SK-N-BE(2),135875424,2.863964710968437
NCI-H446,409805,4.60093780948022
SW1783,54618164,3.832878612817737
TE-6,135423438,1.6945535495060131
COLO 800,107985,-2.5958331032462785
HeLa,36462,3.354174189337733
Daoy,9927531,4.407816470136583
COLO 201,sirolimus-bortezomib (250-1 mol-mol),2.3709690887392516
8-MG-BA,9911830,4.587743718068256
Hs 940.T,11404337,-0.6222132136822929
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076
MSTO-211H,26596,-0.5653018529577997
VCaP,6918878,1.128697538684366
Panc 02.03,3689413,0.2165954212360822
NU-DUL-1,3136844,3.2536244088531503
NCI-H196,3689413,0.3068410473600975
TE-11,5460769,-1.6571855134906777
AU565,46943432,5.0196372017891555
KYSE-410,136227924,3.831866760516254
NCI-H841,439501,-5.095559559459305
NCI-H1573,selumetinib-vorinostat (8-1 mol-mol),1.3032639466540858
SHP-77,36462,5.483645487837697
RERF-LC-A1,24180125,3.739716378366165
SW948,3689413,-2.2648112033429824
Mono-Mac-6,409805,4.403577666381438
BT 164,36462,-0.9210275826088992
Rh41,135875424,2.4863940955705517
SNU-1077,selumetinib-vorinostat (8-1 mol-mol),2.452404658166729
P12-Ichikawa,selumetinib-vorinostat (8-1 mol-mol),1.6236889428800614
RERF-LC-Ad2,135398744,6.529632870190649
G-402,135423438,-0.2175800815480045
U-937,11485656,1.9475205448486337
SIG-M5,6505803,-0.1487060693646739
HSC-4,135423438,1.814117839489682
TUHR10TKB,11485656,1.859700421768517
Mino,selumetinib-vorinostat (8-1 mol-mol),1.4107779642854583
A-172,135875424,4.966488760073994
SW1088,11485656,3.080394465182635
SNU-668,54618164,3.824849623749051
COR-L51,9926054,1.8572799108466955
ChaGo-K-1,24180125,3.6677801491975006
BT-549,3689413,-0.9397914335397376
COLO 792,135875424,3.9911927217813385
CCF-STTG1,107985,-2.0025512814929525
JHH-4,9926054,1.9011355280949385
Mel Ho,3689413,0.6432726542837045
PC-3,6610216,4.524675902616183
RT-112,44493528,4.644994177683236
SW1271,9903786,4.005340236032604
HD-MY-Z,6610216,4.0359125052118685
TT,36462,5.01376764525677
BT 359,136227924,4.313964424354799
KMBC-2,6918878,5.016118473072515
NCI-H1395,148124,3.756905797674181
DLD-1,3689413,0.9147561458684622
GA-10,8515,2.077027098708472
P31/FUJ,9911830,2.020541196825024
HSC-2,107985,-4.058574397989757
Hs 944.T,262093,3.8646335441234823
BT 271,24180125,2.523261757319675
LNCaP clone FGC,439501,-2.4937134944398176
BICR 18,9936388,2.6183672071363175
BICR 16,selumetinib-GDC-0941 (4-1 mol-mol),2.023123629912069
Panc 05.04,9903786,4.601199939689659
OVCAR-5,262093,2.868361777233285
KMRC-1,8515,4.713762602344707
UM-UC-3,135423438,2.517852030384128
IGR-37,9903786,4.593363058361211
OAW42,135423438,3.883711298971531
NCI-H1563,135423438,1.6420520323004266
RPMI-7951,36462,0.7881901219926554
SNU-C5,11485656,2.423735661577291
BT 416,36462,1.1914496621950696
HCC1143,54618164,3.885707225557291
MDA-MB-453,148198,-6.384072425395857
NCI-H929,JQ-1-carboplatin (1-1 mol-mol),-1.5945452678807737
MDA-MB-453,selumetinib-vorinostat (8-1 mol-mol),2.0806958823850485
AsPC-1,44491742,4.429887143828186
VCaP,107985,-3.79754975163278
RERF-LC-A1,135875424,3.889170235593284
HEC-151,selumetinib-vorinostat (8-1 mol-mol),2.0752491992861537
SNU-466,selumetinib-vorinostat (8-1 mol-mol),2.658498622478202
CCF-STTG1,9911830,2.0742504991173103
BxPC-3,409805,3.7922849099240734
NCI-H661,44493528,5.823125515558819
JURL-MK1,6918878,0.1569871198909033
SK-N-SH,6505803,1.028408820078618
NCI-H1838,9903786,2.204739159527363
H-STS,11404337,-0.7903033287308603
8505C,136227924,3.0385484032115215
FTC-133,135875424,4.265925786122884
COLO 678,135875424,4.367651695561652
MCF-7,9927531,5.854182634805009
HCC1195,6505803,0.0153756164057107
PC-3,135398744,6.536880900821883
OV56,10296883,4.933118307038668
Hs 294T,5460769,3.362841605128932
PL-21,135398744,6.318867550173511
RMG-I,9911830,2.9966783912607142
NCI-H1581,sirolimus-bortezomib (250-1 mol-mol),0.461020209130116
OVSAHO,409805,5.076222131658727
KMS-12-BM,6610216,3.741234433073347
NCI-H1355,3136844,3.667407981584634
JK-1,10296883,2.2916856247126263
8-MG-BA,10296883,4.312011375690635
SNU-423,44491742,3.863177146863686
SNU-C4,148198,-4.665423205896986
EC-GI-10,12003241,-1.9756752078564588
KYSE-180,sirolimus-bortezomib (250-1 mol-mol),1.6916229080787213
OVCAR-8,439501,-0.7603560285089889
NCI-H1563,107985,-3.7003517008173
A-549,168313200,3.5389649746345815
SNU-16,9926054,1.81351744877406
NCI-H1385,11404337,-0.5225028243847427
Lu-99,12003241,-1.7463019078510122
KATO III,11404337,-0.4970359765575001
HuH-1,409805,5.845530039707077
HCC202,tanespimycin-bortezomib (250-1 mol-mol),-2.788227280084804
SNU-478,159324,3.0477747725876645
PF-382,12003241,-3.7051147214471114
Capan-2,11485656,2.4723123479129727
SK-N-BE(2),8515,2.7204268583320785
OV7,54618164,3.910711080289417
NCI-H1734,262093,2.5864421448130632
NCI-H1693,6610216,3.7517214461557193
WSU-DLCL2,262093,1.9390116112389448
Mono-Mac-1,11485656,2.9972427080576836
IPC-298,11485656,2.382322261654795
Rh41,selumetinib-GDC-0941 (4-1 mol-mol),-0.3258971504305004
Calu-6,3689413,-1.4925549301996452
SYO-1,24180125,2.3390732294097587
Ku812,262093,1.3423418533813145
Lu-99,3689413,0.965763177110082
BT 422,3136844,4.362921846485201
EoL-1,49836020,1.4161576765733714
RS4;11,9903786,1.046136748247593
MEC-1,168313200,1.7851966829253256
42-MG-BA,135875424,2.570592080360526
OS-RC-2,136227924,4.587923384885118
NCI-H2052,439501,-0.5583326091598753
LP-1,tanespimycin-bortezomib (250-1 mol-mol),0.6048283757885538
RVH-421,tanespimycin-bortezomib (250-1 mol-mol),-0.2539281679768233
MHH-ES-1,44484440,3.491046763532364
SNU-119,9903786,3.393165032525661
Panc 10.05,6610216,4.284201088218815
MKN7,9936388,1.0718801330101393
KNS-60,26596,-3.4190498423081026
Karpas-620,JQ-1-carboplatin (1-1 mol-mol),4.330604154257919
TYK-nu,54618164,3.99587115064654
OCUM-1,159324,3.056322890666483
WM115,107985,-2.5041726579949857
253J,sirolimus-bortezomib (250-1 mol-mol),1.7518558579799193
SR,168313200,3.9565761385686895
VMRC-LCD,11404337,0.4104249926978496
FaDu,6610216,4.337478991098613
SK-CO-1,9936388,-6.4137542305703015
NCI-H2029,11485656,1.831867006041765
KNS-81,262093,3.063139326584166
KMS-34,54618164,2.8126038622481717
MOLM-6,24180125,2.3884082924328007
HCC1438,10296883,4.228487573080105
Karpas-422,135875424,4.0020075582939
MDA-MB-468,10296883,4.0590713051476115
NCI-H1793,11404337,1.9243754153186607
PE/CA-PJ34 (clone C12),9911830,2.0683867467094657
KP-3,136227924,3.03068470875373
BT 216,12003241,2.6409098560740243
UACC-257,9911830,3.1260296610953513
ChaGo-K-1,5460769,6.469611673758945
HEC-108,9911830,3.642303707567872
KMRC-1,6918878,5.2070030404450485
TE-1,10296883,4.161455110097264
NCI-H1703,24180125,3.814977015486634
MOLP-8,12003241,-1.4499361325619826
PLC/PRF/5,9936388,3.289212143502143
CCF-STTG1,11404337,1.400188980811807
BT 112,6610216,4.1837874586497765
U-937,159324,0.4160428463027863
COLO 205,11485656,2.198859686609949
CAL-27,9926054,1.784787570446616
COR-L95,tanespimycin-bortezomib (250-1 mol-mol),-0.3690826099539636
Panc 04.03,246676,4.5210437514033615
Li-7,135875424,4.067344810022126
TUHR14TKB,9927531,5.242660147082698
NCI-H2196,168313200,1.6514605130076123
NCI-H23,6918878,0.8393847568953688
L-1236,9903786,-0.7492109399697982
EM-2,44493528,3.698991403338848
HARA [Human squamous cell lung carcinoma],11404337,-1.2743672881567891
SU-DHL-1,36462,-1.6063137198477124
NCI-H1568,3689413,-2.0602171008804935
COLO 829,6505803,-0.4572347239935848
RERF-LC-MS,9926054,1.8051014319834384
SNU-503,168313200,2.972776504185133
COLO 201,11404337,-0.0610215360634596
Daoy,54618164,4.1710348513042
IPC-298,54618164,4.245603036980359
T98G,24180125,5.608131007588369
CGTH-W-1,9903786,1.99445591465905
SHP-77,3689413,-2.4730953136867297
KYM-1,6505803,-2.3943028473817005
SUP-M2,135875424,2.961544383480745
NCI-H23,JQ-1-carboplatin (1-1 mol-mol),0.4166506199838714
COR-L95,3136844,6.4544258549997675
SU-DHL-10,12003241,2.591682900303347
HCC4006,135875424,2.723174656617446
SNU-16,10296883,1.9530696041557936
CAS-1,selumetinib-GDC-0941 (4-1 mol-mol),1.9599714674157864
DND-41,136227924,1.87568318170164
OAW42,6918878,4.7005705812756045
BL-41,11404337,-2.6110172879458244
EM-2,JQ-1-carboplatin (1-1 mol-mol),-1.2961188335461022
HEL,tanespimycin-bortezomib (250-1 mol-mol),0.901321339562179
NCI-H1666,24180125,3.343290006666379
JeKo-1,262093,0.8663217724360005
BFTC-909,136227924,2.3418993883842134
PE/CA-PJ49,10296883,4.094155197512124
NCI-H841,selumetinib-vorinostat (8-1 mol-mol),3.748508447954211
CCF-STTG1,6610216,4.787403157480984
LN-18,6918878,2.9794738938478966
MeWo,11485656,1.6470015852450477
Panc 10.05,9926054,2.010421160581402
NCO2,selumetinib-vorinostat (8-1 mol-mol),0.8624505474898547
CAL-27,135875424,4.567542159153124
TOV-21G,54618164,4.2128283407896685
HEC-265,54618164,4.75947982853325
BT 482,148198,-3.9999181754289097
Panc 04.03,36462,3.526332093717117
SNU-1077,9936388,2.8901032001990954
OCUM-1,6505803,-2.038766132244714
RL95-2,136227924,2.901366933043705
PSN1,135423438,3.9890178070104927
KMRC-3,3136844,6.205385041811965
SUP-T11,9927531,4.66163575559017
SUP-T11,36462,-0.1109472671926892
EKVX,selumetinib-vorinostat (8-1 mol-mol),2.797043783468325
CAL-51,439501,-2.444412450902406
Rh18,9911830,2.105757574516919
JVM-3,26596,-2.348515642559758
SK-UT-1,sirolimus-bortezomib (250-1 mol-mol),0.646773190163625
DMS 114,3689413,-0.1355634310043713
A-673,12003241,-2.2168793422392103
Hs 888.Lu,44491742,4.101401149351862
SNU-C1,409805,3.9064210448467054
NCI-H838,11485656,2.6537102203842613
NU-DHL-1,46943432,0.1764476025909112
Hs 944.T,9911830,3.285627635276784
SNU-1105,159324,3.821652429773296
ES-2,409805,6.0186236492097365
BT 145,100016,5.857999875396141
KMH-2,73707440,5.915660341573708
ACC-MESO-1,36462,2.9779299416618237
RERF-LC-Ad2,107985,-4.355232294484495
MHH-CALL-4,12003241,-1.7117307202040182
SW948,selumetinib-vorinostat (8-1 mol-mol),-0.2109654118959779
HCC2935,9927531,5.26637836845999
Detroit 562,107985,-3.6999488288767313
HCC1500,44491742,3.6723474636183537
MOTN-1,tanespimycin-bortezomib (250-1 mol-mol),0.3345366577649379
NCI-H1339,6918878,2.975408494274888
JHOC-5,5460769,2.0469189795608447
SNU-C1,sirolimus-bortezomib (250-1 mol-mol),0.1319095851992196
HCC1395,54618164,3.623383383409561
SNU-119,12003241,-0.7435067493629696
LC-1F,selumetinib-vorinostat (8-1 mol-mol),0.4234700662281405
Ki-JK,9936388,-3.4426986748299955
BL-70,54618164,2.8033577999904633
Granta-519,9911830,2.3469616146388033
DLD-1,sirolimus-bortezomib (250-1 mol-mol),1.5948066539629249
OCI-AML-5,135423438,1.842047430976123
BL-70,8515,3.824466165102045
CAL-33,44491742,3.945687581773722
KMS-12-BM,9936388,-7.442749057312851
LS180,148198,-2.644013472885731
FaDu,3136844,4.222212972409319
SYO-1,54618164,4.764499368515595
LoVo,26596,-4.043483931746528
BICR 6,sirolimus-bortezomib (250-1 mol-mol),1.9744607450620832
COLO 680N,44493528,4.52378169119992
SW48,selumetinib-GDC-0941 (4-1 mol-mol),-3.255152499343646
SK-N-FI,selumetinib-vorinostat (8-1 mol-mol),1.423109443377603
SNU-449,tanespimycin-bortezomib (250-1 mol-mol),1.8616843727931585
ST486,262093,0.8785422298451224
NCI-H520,135423438,3.6436020684370463
SW1271,148198,-2.630785543453804
U-87MG ATCC,selumetinib-vorinostat (8-1 mol-mol),4.060549041627366
786-O,246676,6.023561482429134
HuH-28,9926054,2.302050382507772
RVH-421,10322450,7.0717457529323875
IGROV-1,3136844,5.214591389089975
Ishikawa (Heraklio) 02 ER-,36462,2.657616435798718
RCM-1 [Human rectal adenocarcinoma],262093,3.1357995089449058
Hs 895.T,148124,5.776719693412514
KYO-1,9926054,1.8377950360183533
PANC-1,409805,5.697873707527969
DU145,36462,1.0541002135373008
CAL-12T,9926054,1.6569209752811729
NCI-H660,135875424,2.723331707113997
BT 504,26596,-1.373211017914528
BT-474,409805,3.72373361463483
OCI-Ly19,9911830,2.044000143992489
MKN1,sirolimus-bortezomib (250-1 mol-mol),0.957329263001516
DOV13,44493528,4.286577642766648
IGR-37,tanespimycin-bortezomib (250-1 mol-mol),1.387795726757113
SUP-M2,11404337,-2.6173632126758313
KYSE-510,9926054,1.8672783124576204
CMK,100016,5.771362707779288
Karpas-620,selumetinib-vorinostat (8-1 mol-mol),4.853039642331254
DMS 79,159324,2.5822231714188493
MDA-MB-157,6610216,4.481014218943506
CAL-85-1,11404337,-0.674659950000608
T98G,36462,3.3490251622126985
BT 422,8515,4.965432900049668
JHH-2,439501,-1.6705307194191004
HT-1376,11485656,2.207084161817658
NCI-H838,9911830,2.2761510361102495
JHUEM-2,159324,-0.5047456010637043
AsPC-1,10296883,4.32215490848641
K-562,148124,-7.41486725283878
RERF-LC-A1,100016,6.9126876628990885
SW1990,6610216,4.556945274841773
KCL-22,107985,-4.081423087872043
JHUEM-7,44493528,4.303413387370261
MES-SA,135423438,4.43653608071916
TE-14,selumetinib-vorinostat (8-1 mol-mol),2.42996649499285
B-CPAP,439501,-2.790842155958922
EPLC-272H,11485656,2.043332000791837
IGROV-1,246676,4.485924799339535
RPMI-8226,JQ-1-carboplatin (1-1 mol-mol),-0.0653783177632561
JeKo-1,11404337,-1.0082771831534074
MEC-1,136227924,1.9415739350117864
KMH-2,9936388,-5.258192279265897
HuG1-N,12003241,-0.7398422629882291
SNU-1076,11404337,0.2265563836106352
FU-OV-1,6610216,4.742914927321441
PE/CA-PJ41 (clone D2),11485656,2.035669448740327
NCI-H522,9903786,3.9217135447784783
JHUEM-7,6918878,3.0932283055268512
HT-1376,9911830,2.852403545688706
K-562,100016,4.034095210213227
NCI-H508,9911830,2.7644631186921003
RCH-ACV,168313200,2.215457911819633
DU145,11404337,1.4411442495527176
NCI-H2170,11485656,1.87102057919161
EBC-1,9911830,2.187384370509422
Ishikawa (Heraklio) 02 ER-,9911830,3.5571735826815827
Fu97,3689413,-0.2126169445323924
JURL-MK1,11404337,-0.8501595942866039
Panc 02.03,148198,-4.053337817942692
NCI-H2081,11404337,-2.077246389622244
NCI-H1373,135398744,6.356905852078599
BT 172,136227924,2.3975770198101545
KMS-12-BM,100016,3.5545657198194873
DMS 53,11404337,-2.5635745994207677
SNU-216,135875424,3.0610068784934885
FTC-133,3689413,-0.3036251064519336
TE-6,9911830,2.4550424696072803
L-540,46943432,0.6608749912510412
SNU-668,107985,-3.9199396069518
NCI-H460,36462,3.103581216464206
Panc 04.03,107985,-4.416167995938274
MOLM-6,46943432,0.7708727335506564
SUP-B15,44493528,3.997635669118944
BT 504,3689413,0.2401102984502228
BT 328,439501,-3.1360046964577983
G-402,3136844,4.085335095917159
LCLC-97TM1,36462,0.8347023875377979
SW948,135875424,4.663257041681152
B-CPAP,26596,-2.034534215785694
NCI-H322,409805,3.9848119699309303
P12-Ichikawa,6505803,0.5806976705214316
NU-DHL-1,10296883,3.6667794076879594
A101D,3689413,0.2698790344581709
U-118MG,148198,-4.8447991211514685
KO52,3689413,-4.063517257373306
YD-8,409805,3.827275743082073
NCI-H1341,9911830,-0.0779226397197478
SF126,selumetinib-GDC-0941 (4-1 mol-mol),2.749668996319385
HCC4006,11485656,1.7497368979267094
ALL-SIL,136227924,2.439460537978413
TUHR4TKB,tanespimycin-bortezomib (250-1 mol-mol),0.8308277028090468
NCI-H1838,159324,3.097235526410686
SCC-25,9903786,1.6185741180598072
EFM-192A,135875424,3.7105346659107834
NCI-H146,5460769,1.8747395178404
TE-5,3136844,4.144020247347827
SW1990,9936388,2.7870062891486613
GA-10,44491742,3.5610264108230365
SK-MEL-28,9926054,3.4888277398466765
Hs 683,11404337,-0.8094527425397864
SNU-475,10296883,4.244707148014393
Hs 940.T,3689413,0.3650733663514719
NCI-H2405,11485656,2.273940058944612
NCI-H889,159324,2.6623068972323085
TTC-709,12003241,-2.491438610606954
AML-193,11404337,0.8563534093329411
BT 359,11404337,-0.8986671728734847
SK-LU-1,36462,1.0548894968192253
SNU-C5,135875424,2.310166721767538
PE/CA-PJ49,107985,-3.897981701971708
SK-HEP-1,9926054,1.934364320328667
NCI-H810,selumetinib-vorinostat (8-1 mol-mol),2.083433754987742
NCI-H1944,24180125,3.7624051932211233
CMK,11404337,1.5948104345564638
IGROV-1,135875424,3.3275053166921347
KMS-20,9936388,-8.248983770505305
PE/CA-PJ15,6505803,-4.077813218319251
SIG-M5,selumetinib-GDC-0941 (4-1 mol-mol),-3.523170450051492
Hs 852.T,24180125,3.655045721094024
VCaP,135875424,4.074355595909067
NU-DHL-1,44491742,4.098367852004394
BT 333,24180125,2.910102236403659
MCAS,26596,-1.466898780296629
NCI-H520,3136844,4.52894652674819
PE/CA-PJ34 (clone C12),107985,-3.5683543961091138
EFO-27,26596,4.577324640946523
SCC-9,5460769,4.655053652221148
HT-55,9903786,2.6159451586769156
Calu-6,9903786,1.9563383465911224
KYSE-30,9926054,2.699990284064641
OCUM-1,10296883,3.433101608728151
COLO 800,409805,3.923609141822486
T84,135875424,3.2008335504024963
HuP-T3,6610216,4.722811341582641
Daoy,135875424,3.817686781191165
TUHR4TKB,selumetinib-vorinostat (8-1 mol-mol),2.39126332276638
DBTRG-05MG,409805,5.910721068124035
SET-2,44493528,4.2834335976641205
SNU-387,11404337,1.3618084362793803
MOLM-13,49836020,-0.1965532240483963
NCI-H2030,selumetinib-vorinostat (8-1 mol-mol),2.944898179545911
SK-BR-3,11485656,1.9391537366026357
HCC1954,54618164,3.861561263773434
CML-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.4350289295501254
BT 328,148198,-4.14614868661324
Ku812,9927531,3.686533687467188
JHH-2,6610216,3.9742495338356263
P12-Ichikawa,9903786,1.487769039842012
KYM-1,54618164,4.171782985216563
MDA-MB-231,168313200,3.9490295578631778
Karpas-299,9911830,3.0958071479181104
JIMT-1,12003241,-0.563362100663344
SCC-9,11404337,-1.771041191231111
Ki-JK,6610216,3.665629915437924
HCC1419,9927531,5.21935192048334
PF-382,46943432,0.0711232205860505
LCLC-97TM1,9903786,1.8016114643921617
SNU-308,selumetinib-vorinostat (8-1 mol-mol),3.2167042029880264
M-07e,6918878,-1.034225078902853
OAW28,9926054,1.976123345191561
BICR 18,36462,2.3233990494988856
SU-DHL-8,26596,-2.3999944738407257
OVTOKO,9903786,2.0414174754656544
COLO 205,selumetinib-vorinostat (8-1 mol-mol),0.3968296952392246
GA-10,135875424,2.5269087035880844
SCC-4,107985,-3.940753988745582
MIA PaCa-2,11404337,-1.8965485173920145
A2780,6505803,-1.803583295606165
RVH-421,6610216,4.139285692264737
NCI-H526,107985,-2.411297633681474
KP-2,54618164,4.176470394746258
COLO 684,8515,4.467603665883123
A-253,selumetinib-GDC-0941 (4-1 mol-mol),2.2204781544732284
SK-OV-3,3689413,0.6002437290843657
Lu-65,11404337,-0.485331944829254
NCI-H460,11485656,2.6212830818798065
HPAC,10296883,3.470080354686621
BV-173,46943432,0.5850233145807464
GSS,148198,-4.278267230656994
DMS 79,107985,-3.6946025137175273
WM266-4,11404337,0.1712081153064202
BICR 18,5460769,1.6305268231033057
ChaGo-K-1,selumetinib-GDC-0941 (4-1 mol-mol),3.55355178033839
NCI-H650,5460769,3.805855578074832
MCAS,168313200,3.057905648422764
AU565,9911830,3.457946854316075
BT 232,9911830,3.5363082238879504
VMRC-RCW,54618164,4.1951410650073235
JeKo-1,11485656,1.8076114759672557
WM793,9911830,2.975609583515234
HCC2108,9911830,2.581322243172156
SNU-C2A,54618164,3.882205124522901
769-P,26596,-0.9592747509105644
BT 248,44491742,4.160095989296475
WSU-DLCL2,24180125,1.7087294222704126
OE33,selumetinib-vorinostat (8-1 mol-mol),1.9103124902448312
CAL-148,26596,-0.995899107261143
HPAC,11485656,1.4709930999197478
NCI-H1623,168313200,4.911870039242249
HGC-27,9927531,3.8749849093672744
Hs 936.T,6610216,4.507566402989384
SNU-201,9936388,2.3725441363874236
LK-2,3689413,0.6891361192494543
NCI-H1092,11404337,-0.107357005094737
ESS-1,168313200,3.675041672586614
NUGC-3,11404337,-0.7682490419788565
YD-15,100016,6.01418803247364
KATO III,3689413,2.9835896213027673
Ki-JK,26596,-2.118639995094933
COLO 320,44491742,4.01582606797262
NCI-H1915,9936388,2.519208351388662
NCI-N87,54618164,3.997308077582706
SUP-T11,10296883,3.5958048269755114
AML-193,26596,-1.9434141476174296
CAL-62,6505803,1.4700941326099095
SNU-685,selumetinib-vorinostat (8-1 mol-mol),2.4986183869313696
BT 164,409805,3.8898564349489297
A101D,148198,-1.280940502528239
ACHN,selumetinib-GDC-0941 (4-1 mol-mol),3.1627804075909727
SNU-1041,selumetinib-GDC-0941 (4-1 mol-mol),1.9285895192057112
SK-HEP-1,148124,3.734435411699081
639V,tanespimycin-bortezomib (250-1 mol-mol),0.3038823340698895
RD-ES,439501,-2.2858768035402623
SNU-5,9911830,2.804822100655287
KMS-11,3689413,-0.1519254071205927
Kasumi-1,26596,-2.5055411121240705
PE/CA-PJ49,262093,3.242343498921695
COR-L51,409805,3.3081108683837477
WM88,148124,-3.466813167585588
KMS-21-BM,6918878,-0.4417684198636811
TE-11,sirolimus-bortezomib (250-1 mol-mol),1.0808686364833595
LoVo,148198,-1.1147075342847712
J82,262093,3.090491521434039
UACC-62,135875424,4.412505043477628
NCI-H1734,3689413,-2.032752334102639
NCI-H841,9911830,1.1409704574647217
HuG1-N,selumetinib-GDC-0941 (4-1 mol-mol),-3.3555719378633375
BT 320,9926054,4.941319925063275
HCC44,9936388,-7.032744443363015
VM-CUB-1,9903786,3.0676048433352268
PaTu 8988t,409805,3.676693079768219
253J,BRD-K16130065,4.180822895879859
HDQ-P1,6505803,-0.3319389932283364
BT 330,24180125,2.435960640097673
SHP-77,409805,5.959913467190761
KYO-1,26596,-1.5121743902030458
OPM-2,168313200,1.8002020874491595
KCL-22,409805,3.899318616941848
HCC1428,6918878,2.7540515093698392
OCI-AML-3,136227924,1.3599145322416812
8-MG-BA,8515,4.986041270201842
HT115,selumetinib-vorinostat (8-1 mol-mol),0.9982252810504696
NCI-H2087,12003241,-2.8362492565909543
A-204,9926054,1.5825801354867326
SH-4,107985,-4.329814093111425
SNG-M,10296883,3.727661706333134
LS123,54618164,4.135891189073094
A4/Fukuda,136227924,1.9204852137512072
NCI-H211,3689413,-2.259187530744643
OCI-Ly3,6610216,3.964539819675791
NCI-H446,JQ-1-carboplatin (1-1 mol-mol),0.8362654932665712
HEC-151,100016,5.913951457428463
NCI-H1155,6918878,5.221396551562706
BT 232,54618164,4.582446279989421
SNB-75,12003241,-1.444419761785008
BT 139,9936388,1.6173516252245872
CJM [Human melanoma],9927531,5.046484804612069
Daoy,409805,5.985033994430834
KHM-1B,262093,0.9728016968076376
SK-N-DZ,3689413,-4.934308383981231
THP-1,6610216,3.770684705131464
SYO-1,409805,3.616112790347393
NCI-H1341,sirolimus-bortezomib (250-1 mol-mol),-0.2391500871709352
PE/CA-PJ49,148198,-3.4268639622300516
HDQ-P1,46943432,4.5128763102829
BT 333,12003241,1.72597197998683
NCI-H441,6918878,3.68052778399386
MeWo,168313200,2.0312188098871595
SW1990,6505803,-2.4928933936476048
SNU-119,selumetinib-vorinostat (8-1 mol-mol),2.4531148017097726
JVM-2,73707440,4.245846854009652
SNU-1077,JQ-1-carboplatin (1-1 mol-mol),3.099930951012761
BT 428,54618164,4.165032933518285
DEL,10322450,3.0359282026720575
SYO-1,439501,-5.087995993751375
KNS-62,9926054,2.478814606658306
COLO 205,6505803,-3.0495951977326774
A-172,12003241,-1.0086398080644707
RCC10RGB,3689413,-2.0864832427963336
JHUEM-7,46943432,1.400588495445252
DV-90,26596,-3.568331067432308
TUHR14TKB,24180125,2.812325476546893
SJSA-1,73707440,4.290448161515078
YD-15,6610216,4.291781319192343
Capan-2,5460769,2.6167760530795654
SK-HEP-1,11404337,1.0852289139958715
MV4-11,26596,-2.2629821538239576
HCC1569,tanespimycin-bortezomib (250-1 mol-mol),-0.2642860947186173
MOTN-1,sirolimus-bortezomib (250-1 mol-mol),-0.1578046305827232
GSS,44493528,3.3523152661805526
JHH-2,262093,1.5917989690275902
Rh41,262093,2.4502999940067225
KMS-21-BM,5460769,1.875881845654493
SaOS-2,135875424,3.0421388786055727
TE-6,10322450,4.821445801682838
A-204,439501,-3.495173266920804
TE-1,159324,2.9187839778055795
COR-L105,54618164,4.149947168538197
NCI-H226,107985,-3.130066790773439
NCI-H1755,44491742,6.2867569407900215
HuG1-N,107985,-3.587499337326945
CW-2,262093,1.6035183288099986
NCI-H2196,11485656,1.855781545293995
TTC-709,36462,1.4655456556845978
NALM-6,246676,4.335918622435807
SW948,9911830,2.1163810502856344
NCI-H1155,6610216,4.350100771446706
Panc 03.27,148198,-3.6739287682620967
KYSE-520,selumetinib-vorinostat (8-1 mol-mol),3.2709887922226555
OE21,sirolimus-bortezomib (250-1 mol-mol),-0.2095744240897051
LCLC-103H,9911830,2.9324210354523195
Mel Ho,44493528,4.666691199289373
SK-LMS-1,9927531,4.694028683387814
KM12,409805,5.283979490760359
HCC2935,135423438,1.9147959056392905
NALM-6,409805,3.549692379883557
SK-N-FI,262093,0.9859061166754924
KMS-11,44491742,3.7132617808424704
WM88,11485656,3.1313220477108996
COLO 684,sirolimus-bortezomib (250-1 mol-mol),-6.565635252448311
KYSE-140,9911830,2.9872527631338324
FTC-238,selumetinib-vorinostat (8-1 mol-mol),2.4763413555506677
JeKo-1,10296883,3.632586939598192
Mono-Mac-1,107985,-4.510683187416183
Lu-65,3136844,3.9390005430833184
NCI-H2228,6918878,3.8749229001505023
KMS-18,100016,3.3973864073508864
DV-90,135423438,2.6619709505145637
Hs 746.T,6505803,-0.4653374975150369
OAW28,6610216,3.9661844518771185
Hs 729.T,tanespimycin-bortezomib (250-1 mol-mol),1.0644356767516514
OE33,6610216,4.3835431989355635
SNU-423,148198,-4.2261536044419765
8505C,107985,-2.648849109047195
GB-1,9911830,2.9088848274798034
NCI-H650,11404337,0.16531704112611
HDQ-P1,135875424,4.477728258448439
NCI-H520,9911830,1.0152339024945511
QGP-1,262093,3.244803388046988
KP-N-SI9s,6918878,0.8318262524883683
CAMA-1,3689413,0.0263776901636627
VMRC-RCZ,12003241,-1.8843773680512867
COLO 320,3136844,3.6466466760898224
Caki-1,tanespimycin-bortezomib (250-1 mol-mol),2.360215695891997
TT,148198,-1.9923096051392415
WM88,262093,2.979155040217876
HMC-1-8,439501,-2.9619639493833247
SCC-9,9903786,2.6448761987997917
MDA-MB-468,6610216,4.200899612670793
COR-L105,262093,2.940873643596252
TALL-1 [Human adult T-ALL],8515,3.885007345208586
P-STS,selumetinib-vorinostat (8-1 mol-mol),2.362145867213819
L3.3,100016,6.042484334243821
SK-LMS-1,11485656,3.417878040932413
Hs 746.T,49836020,5.866178883912361
WM983B,439501,-2.1469095584384608
KATO III,36462,2.9602968750282743
A4/Fukuda,54618164,3.3817410387547575
KYSE-180,12003241,-0.805265861116592
647V,409805,3.493912848864435
Sq-1,9926054,2.1337916564135906
MEC-1,6610216,4.139223176042876
SNU-398,6918878,3.49080692783625
Granta-519,9926054,1.8135939424605243
YD-38,409805,3.7875636051814663
J82,tanespimycin-bortezomib (250-1 mol-mol),2.212384566230415
KPL-1,409805,3.94742453602603
NCI-H2087,6610216,3.791496413970123
OV7,11485656,2.0479156787278257
EFO-21,44493528,4.429307418549765
OCI-AML-3,selumetinib-GDC-0941 (4-1 mol-mol),-2.601986773064445
CFPAC-1,3689413,3.8323467943354337
NH-6,44493528,5.783725141488281
HEC-1-B,selumetinib-vorinostat (8-1 mol-mol),2.5148214875762687
LS123,9936388,0.5461115096373947
SNU-213,selumetinib-GDC-0941 (4-1 mol-mol),-0.6282749341279102
EoL-1,54618164,2.9471076229602717
NCI-H146,tanespimycin-bortezomib (250-1 mol-mol),-0.2657593294173981
ONCO-DG-1,136227924,3.186548860778023
H-STS,tanespimycin-bortezomib (250-1 mol-mol),0.0434064671940078
PSN1,6505803,-2.1554317854287097
CL-11,135875424,4.310840427091723
MOLT-3,3689413,-1.814335700031944
KO52,selumetinib-GDC-0941 (4-1 mol-mol),-0.8937445174658034
HEC-251,262093,2.9573459973674985
U-BLC1,selumetinib-GDC-0941 (4-1 mol-mol),-2.579214218567442
HSC-4,selumetinib-vorinostat (8-1 mol-mol),2.2215922063973648
KE-97,73707440,4.317298801738101
CL-11,6918878,2.8566461728921646
BHY,44491742,4.864491079150181
BICR 6,262093,3.032842470666603
MJ,135875424,3.3337154689139914
TF-1,9927531,3.351583098746858
BT 239,135875424,2.359781873979594
NUGC-3,24180125,1.117540206425308
SK-MEL-31,262093,3.561171585686889
BT 422,6610216,4.133334878582925
NCI-H2029,5460769,4.253529576580681
NCI-H2009,100016,6.24887408197215
CCF-STTG1,24180125,3.0142725993324064
Daudi,8515,3.193004700442435
NCI-H1869,9927531,5.985290716685452
U-118MG,5460769,3.4252823056372845
KMS-27,selumetinib-vorinostat (8-1 mol-mol),-1.5585431850605205
VMRC-RCW,107985,-3.1958686120278847
Hs 766T,selumetinib-vorinostat (8-1 mol-mol),-1.4002604234783536
JMSU-1,9936388,-5.635407745986741
HuP-T4,107985,-3.5574573773350995
SW1417,262093,3.3040552673447907
BT 139,10296883,4.347610797549644
SNU-478,12003241,-2.4220393479516025
NCI-H1666,selumetinib-vorinostat (8-1 mol-mol),-1.7632853469855017
M-07e,439501,-3.111960923766982
OV56,107985,-4.137987723895467
SNU-61,135875424,3.609444893060012
AML-193,sirolimus-bortezomib (250-1 mol-mol),0.7759141374550513
BT 359,10322450,5.961347508750194
HEC-1-B,9936388,1.5004168586274125
BT 482,6610216,4.181360569534401
HDLM-2,9936388,-6.699544688001925
YD-15,54618164,4.077612524706247
Caov-3,24180125,3.119929607419975
JMSU-1,sirolimus-bortezomib (250-1 mol-mol),0.8204079064012788
JVM-3,12003241,-2.550977818363364
HCC827,100016,4.431453048958875
HPB-ALL,9936388,-8.275368871773662
SNU-C5,135423438,1.6231432447945644
EJM,24180125,2.4307327863044215
A-549,107985,-1.903643524605076
IGR-1,11404337,-1.4130106945473468
RCH-ACV,135875424,3.077448855642363
JHUEM-2,3689413,-0.0908621852790934
VM-CUB-1,9911830,2.850961180647016
Hs 940.T,9936388,1.1653253774918717
HSC-3,159324,3.228445723809223
OVTOKO,6610216,4.538768148253175
LS123,36462,3.241084731511916
COV434,36462,-0.4470127244502256
A4/Fukuda,sirolimus-bortezomib (250-1 mol-mol),-5.340339704000633
FTC-133,44493528,6.31419839504633
OVCAR-5,409805,6.058763261482215
U-BLC1,36462,2.690560707412892
NCI-H1651,26596,-1.4213694669265446
BT-20,262093,3.15256529620894
KYSE-510,44491742,4.7429938042096245
C2BBe1,6505803,1.1561047092337646
MEC-1,9911830,1.5566898660599335
Yamato-SS,tanespimycin-bortezomib (250-1 mol-mol),-1.0267358122656502
Pfeiffer,44491742,3.3297086723950553
RERF-LC-MS,246676,4.480243243269967
HT-1080,tanespimycin-bortezomib (250-1 mol-mol),0.0826003622808549
NCI-H226,6610216,4.973981761059399
WSU-DLCL2,9936388,-6.090870232080744
GI-1,3136844,3.975654927056496
SK-MEL-5,135875424,3.6602054011582137
HOS,9926054,1.8874056753100945
HuP-T4,tanespimycin-bortezomib (250-1 mol-mol),-1.134384257023078
NCI-H2110,sirolimus-bortezomib (250-1 mol-mol),0.8725557491519701
KCL-22,sirolimus-bortezomib (250-1 mol-mol),-0.943153613452708
LC-1/sq-SF,44491742,4.404829993178961
SNU-449,3136844,4.333259755823753
LCLC-103H,136227924,3.302464114309801
MDST8,11485656,2.867381561993162
Kasumi-2,100016,5.973936097539331
Hs 578T,439501,-3.2814601954597915
PSN1,9936388,-1.558535767626658
SNU-16,12003241,-4.948615651726049
SaOS-2,11404337,-0.7935370479535776
LS180,107985,-4.080313435814333
SK-BR-3,246676,6.129452787407131
JHOC-5,148198,-2.0741521634031033
EFM-192A,3689413,0.6464751811970497
EFO-21,10296883,4.412303624074482
NCI-H358,6610216,4.626865746041361
L3.3,135875424,3.974579804692541
ACC-MESO-1,5460769,5.633127442709169
Peer,135398744,6.7016638444522325
KMS-21-BM,11404337,-1.2049963736057572
CAL-51,JQ-1-carboplatin (1-1 mol-mol),2.422524169436591
IMR-32,262093,1.1917781979548805
SNU-685,148124,-0.1872847523301088
OCI-AML-2,3689413,-0.7025216224577658
SU-DHL-10,9926054,1.7621581525939023
TC-71,36462,0.2309996783752871
GP2d,6918878,0.9016706015977336
SW948,JQ-1-carboplatin (1-1 mol-mol),1.423261364200352
SNU-478,JQ-1-carboplatin (1-1 mol-mol),1.5753140485557118
HT-1376,6505803,-1.649820321739373
HEC-1-A,262093,2.5793359656763784
KMRC-2,10296883,4.145802538683136
Hs 944.T,11485656,2.842031194485269
SCC-9,6918878,3.402250236896725
NCI-H747,11404337,-0.8176088644523414
Mel Ho,8515,4.383639407664171
LS1034,9927531,5.052618610074112
PK-1,11404337,1.355004976466392
SNU-1076,159324,3.988028562574038
TALL-1 [Human adult T-ALL],selumetinib-vorinostat (8-1 mol-mol),1.1410654288760709
Panc 10.05,3136844,4.5591931216454
BT-549,136227924,3.266068806496957
MOLM-6,36462,-1.03155130204684
ECC10,11485656,1.639857171829123
TE-4,tanespimycin-bortezomib (250-1 mol-mol),-0.9407472033022316
TUHR14TKB,6918878,4.584602463554373
NCI-H2452,8515,2.9816658051225344
HMC-1-8,selumetinib-vorinostat (8-1 mol-mol),2.4417596727205466
HL-60,107985,-4.705805511662373
CAL-54,168313200,2.733747480595619
HEC-151,6918878,2.1820464530462163
TALL-1 [Human adult T-ALL],11404337,-1.3736940548636651
CMK,5460769,4.702047832953649
769-P,9936388,1.480470549487973
NCI-H1184,3689413,-2.309621936722181
SK-MES-1,49836020,5.814503877703118
NCI-H1755,49836020,-0.0301714782676706
HEC-6,100016,5.931518422248653
NCI-H1581,100016,6.5572943300427795
VMRC-RCW,9936388,-1.838517301167892
HSC-4,44491742,4.173988284907792
PL-21,9926054,1.453737550570679
SW1573,tanespimycin-bortezomib (250-1 mol-mol),0.6931535757645308
HT-1197,6505803,0.6995636823670472
MOLM-13,3689413,-2.8005667715254017
MM1.S,409805,4.03743481309792
OAW28,selumetinib-vorinostat (8-1 mol-mol),2.294734084050853
SNU-685,6918878,1.9823636258756765
Reh,46943432,1.093926651360919
MM1.S,12003241,-0.8577985614667851
NCI-H647,9926054,1.878907234482811
HH [Human lymphoma],135423438,1.7493298511702722
RERF-LC-A1,9911830,2.8330661508640542
SW1271,136227924,3.2074421772411372
A-549,36462,3.3558444938413707
OV7,148198,-4.147703554410761
NCI-N87,tanespimycin-bortezomib (250-1 mol-mol),-5.300963645653278
BT 245,tanespimycin-bortezomib (250-1 mol-mol),-0.2118058496398642
COLO 678,168313200,3.5853655224611907
NCI-H2170,168313200,2.9481522397603452
Hs 839.T,135875424,5.214579617970531
Mel JuSo,159324,1.5841553738768115
L-540,107985,-4.794689037122787
IA-LM,3689413,-4.432004355370191
Hs 688(A).T,selumetinib-GDC-0941 (4-1 mol-mol),3.4396417778201305
KMS-11,135423438,-0.4348123575852698
TUHR14TKB,11404337,-1.071885756009756
SK-HEP-1,9936388,2.725726666175631
HuCC-T1,159324,4.160356668133178
MG-63,sirolimus-bortezomib (250-1 mol-mol),0.1277203686177557
VMRC-RCZ,9927531,5.06353509308392
SW48,24180125,2.6937498240420457
ML-1 [Human thyroid carcinoma],9926054,2.0491703403306056
OPM-2,262093,0.5720462757198622
NCI-H508,tanespimycin-bortezomib (250-1 mol-mol),-0.2037245877334007
SNU-201,54618164,6.248621486824713
LNCaP clone FGC,9903786,4.486079979714403
HOP-62,36462,1.2556592517294145
A-375,11485656,2.720000014361131
SUP-HD1,5460769,1.3370486215581097
HEC-1-A,sirolimus-bortezomib (250-1 mol-mol),1.0212510715684435
RPMI-7951,262093,2.547304876719483
NCI-H211,9911830,2.242620960008613
CL-34,selumetinib-vorinostat (8-1 mol-mol),-1.1139178490326602
TUHR4TKB,262093,2.707007825366508
NCI-H716,6505803,-2.390779236038046
OVK18,9936388,-8.646346484628276
JeKo-1,6505803,0.6415741653854196
BT 286,10296883,4.151589590813863
YD-10B,9936388,-5.330714776422858
SNU-182,9936388,-8.600901067529309
EFO-27,5460769,4.47484627366887
COLO 668,262093,3.0831926825612586
NCI-H358,11404337,-0.2316736333548727
253J,10322450,3.648031599175377
A-204,262093,2.2081126884410764
CHP-212,12003241,-2.3110623292084695
YAPC,148198,-3.117185181322903
OE33,9927531,5.791665708309609
IM95,44491742,3.8617516807929873
Hep-G2,6610216,4.162282260552703
DB,439501,-2.823022710491889
Li-7,46943432,1.2726339003447924
647V,54618164,4.239215376560979
OAW42,selumetinib-GDC-0941 (4-1 mol-mol),2.1178159599202626
Li-7,5460769,-0.8720138445783291
TYK-nu,135875424,3.095355061385467
M059K,136227924,2.883059674155944
NCI-H2106,6505803,-2.4996848836853176
NCI-H2196,44491742,4.104688837740398
ESS-1,409805,3.6702401515474135
KMBC-2,262093,2.431705852322835
KMRC-1,11404337,1.3121470144090095
NCI-H2126,6610216,4.369254418230129
A-549,9936388,1.4749208650316612
HCC95,9926054,2.566209783667777
42-MG-BA,6610216,4.456888675297936
TE 617.T,6610216,4.021742193250995
CL-11,9911830,2.834464588234205
DU145,36462,1.0541002135373008
NCI-H508,9926054,1.9520179071989003
KMS-28BM,6918878,-0.2165000071210541
G-401,9911830,0.6760173642929876
Tm87-16,9936388,1.513062418046636
CCF-STTG1,selumetinib-GDC-0941 (4-1 mol-mol),4.2264106032323445
PaTu 8988s,JQ-1-carboplatin (1-1 mol-mol),3.780889611052604
COR-L47,9903786,1.6785820828918676
A2058,selumetinib-vorinostat (8-1 mol-mol),2.9812584938386273
SNU-840,107985,-3.1383267361145335
MKN74,selumetinib-vorinostat (8-1 mol-mol),2.9891343546894267
SNU-685,148198,-4.368451814809559
SNU-182,11485656,2.307342205342044
OE21,168313200,2.14822822620211
JVM-2,9936388,-5.513780712750178
HCC1143,107985,-3.4652614368177432
KMS-21-BM,159324,0.3673742600745772
COLO 678,9911830,2.0775371202718875
Kasumi-2,JQ-1-carboplatin (1-1 mol-mol),-0.6879782047787374
NCI-H526,selumetinib-vorinostat (8-1 mol-mol),2.4769440770126514
WM266-4,9927531,4.893127770626654
SNU-C4,439501,-3.0543903815418547
T98G,262093,3.081379180281475
MFE-319,148124,-4.371578171845129
CAL-12T,selumetinib-vorinostat (8-1 mol-mol),3.341411110328655
SNU-601,26596,-1.2729418504176535
DBTRG-05MG,9926054,3.4438340523747955
U-118MG,9927531,5.792159501722103
LN-229,44491742,4.497083507897472
Hs 746.T,107985,-3.710644419417041
OCI-M1,439501,-2.6275325883029135
KMS-27,JQ-1-carboplatin (1-1 mol-mol),2.20932469874721
SK-N-AS,3689413,-1.598597846908754
CAL-51,24180125,2.8082301472193203
FaDu,168313200,2.388529084723483
BT 330,10296883,4.249787142782667
OCI-M1,tanespimycin-bortezomib (250-1 mol-mol),0.2831250626591589
Hs 578Bst,135875424,2.7019998595734327
CAL-27,54618164,3.951252505952405
SK-N-AS,36462,1.8684432223869436
MFE-296,10296883,4.050843841946721
Panc 08.13,6610216,4.173498185647784
CW-2,9927531,5.678325078717316
RPMI-8402,44493528,4.185952710394156
AsPC-1,148198,-3.729188282050714
JHOC-5,159324,2.904340852422458
BFTC-909,11404337,0.4468911705694049
KMS-20,5460769,-0.4034471516809727
NCI-H69,246676,0.9229049002680756
NOMO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2771882035135704
DND-41,11485656,1.1468177046699728
SR,54618164,4.32790577490103
Rh41,selumetinib-vorinostat (8-1 mol-mol),2.07145353240202
Caov-3,6610216,4.139176998976753
SK-BR-3,9926054,1.6318008391907537
LOX-IMVI,8515,4.202942492571131
WM1799,159324,3.2661346124981008
MV4-11,JQ-1-carboplatin (1-1 mol-mol),-1.9845172656852084
JMSU-1,3689413,-0.0210585182318067
UM-UC-1,9936388,-3.585062742404864
Hs 822.T,11404337,0.2632617923039199
COR-L105,JQ-1-carboplatin (1-1 mol-mol),-0.012244733852177
Panc 04.03,9926054,1.9560696374821285
HCC1143,159324,3.533344711636858
LS1034,6505803,0.7621506671828905
HARA [Human squamous cell lung carcinoma],44491742,4.175098575791361
SNU-1077,9903786,3.350516769184116
OVCAR-5,9936388,1.186466547849794
LCLC-97TM1,44493528,4.18527882332477
AsPC-1,9911830,2.936776162598985
SK-LU-1,439501,-0.3728808637534341
CMK,26596,-3.6157989534219497
SNU-1214,100016,6.334633199659308
Hs 294T,262093,3.0816217922662146
SNU-308,sirolimus-bortezomib (250-1 mol-mol),1.6825510481181765
CMK,3689413,0.9967323135888336
SNU-878,selumetinib-GDC-0941 (4-1 mol-mol),0.5330473997899833
MHH-ES-1,136227924,2.293763722118734
SK-MEL-30,262093,2.857601335601776
JHH-5,sirolimus-bortezomib (250-1 mol-mol),0.7972150153767945
DU4475,tanespimycin-bortezomib (250-1 mol-mol),-2.7587555584503853
JHOC-5,6505803,0.9816960895026916
HPB-ALL,262093,1.2966531532879173
CAL-33,11485656,2.164016105074951
BT 164,9926054,1.7569954478000085
TCCSUP,9926054,2.5470676869748763
JeKo-1,sirolimus-bortezomib (250-1 mol-mol),0.3610522952079053
NCI-H526,46943432,1.817345748951115
SW48,9911830,1.5953282800372102
COV434,6610216,3.508453604079868
NCI-H838,6918878,3.89415780236117
RL95-2,6918878,2.1446331554356126
MSTO-211H,12003241,-2.79016034960529
OCI-Ly3,10296883,3.058188630852339
NCI-H2452,107985,-2.625758680845612
GSS,10322450,2.8723971217143824
BT 330,6505803,-1.6088860696930485
MDST8,9936388,-2.5080849755955485
OCI-Ly10,tanespimycin-bortezomib (250-1 mol-mol),-1.3027926249404789
HMCB,selumetinib-vorinostat (8-1 mol-mol),3.744114804484371
WM1799,439501,-0.7778279608408036
SNU-C2A,9903786,2.8672741986738193
SHP-77,11485656,2.0449362643576854
HT-144,10296883,4.023256164305908
C2BBe1,49836020,4.36863555932656
WM88,selumetinib-vorinostat (8-1 mol-mol),-2.7855359401178825
Detroit 562,409805,5.192900836800339
Hs 944.T,6610216,4.253321078848661
THP-1,135875424,2.9650391263515057
HD-MY-Z,262093,3.0364164526237807
K029AX,selumetinib-GDC-0941 (4-1 mol-mol),-0.0187548496270864
HL-60,168313200,3.790843536474408
MHH-CALL-3,3136844,4.978772227553105
NCI-H1105,9911830,2.511018805637994
SK-MM-2,54618164,2.8377773675531923
LXF 289,JQ-1-carboplatin (1-1 mol-mol),0.2436296236972278
NCI-H2087,selumetinib-vorinostat (8-1 mol-mol),-3.329133987399838
NCI-H1105,148198,-5.386518056256114
COV434,3136844,4.332123987317027
JHUEM-2,9903786,1.0264930895087971
Hep-G2,11485656,-0.7210069253709863
OAW42,sirolimus-bortezomib (250-1 mol-mol),1.527275498618008
NCC-StC-K140,26596,-2.208339007847408
HDLM-2,selumetinib-vorinostat (8-1 mol-mol),2.3904496984026884
NCI-H1792,6610216,4.406425138927489
TE-10,439501,-2.523220580930317
KYSE-410,6610216,4.091315961018864
IST-Mes1,9926054,1.778703370274458
BT 228,selumetinib-GDC-0941 (4-1 mol-mol),1.920248435578852
COV362,54618164,3.998980611100999
SW1353,439501,-2.4341280198681248
Lu-99,136227924,2.52697800854745
NCI-H1563,54618164,4.2887374141786605
VM-CUB-1,11485656,2.4689983316138076
Peer,44491742,1.9885349932687044
TE-11,6505803,-1.6927698953047237
MDA-MB-453,11485656,1.765591398344026
SNU-216,11485656,2.7250861397389463
U-CH1,selumetinib-GDC-0941 (4-1 mol-mol),2.4998386609630834
CAL-148,11485656,2.5370782509727356
SW1573,9936388,3.0507391751654698
NCO2,107985,-5.5165771909272046
KE-39,12003241,0.559414259019648
MFE-319,107985,-2.7027086117071386
NUGC-4,selumetinib-vorinostat (8-1 mol-mol),-1.0651550460583663
HeLa,439501,-2.848382287027866
Hep 3B2.1-7,24180125,2.3898780520203164
SK-N-DZ,12003241,-0.5399118336559388
8305C,54618164,3.798882631789012
PE/CA-PJ15,selumetinib-GDC-0941 (4-1 mol-mol),-0.1113612810066529
Panc 02.03,135875424,4.996461687769912
DMS 53,9926054,1.7188884438075969
TE-11,3136844,5.858140581595825
VMRC-RCZ,9926054,3.085597836740958
SNU-738,262093,2.5728208753018285
NCI-H508,26596,-1.5060721880179218
YKG-1,36462,2.1375754999523915
RS4;11,100016,4.815282587104974
HT-55,10296883,3.42762863324558
BT 504,439501,-3.1394850364876907
NCI-H441,9903786,3.5452366409305887
NCI-H1105,selumetinib-GDC-0941 (4-1 mol-mol),2.7215813635503165
MDA-MB-231,9927531,7.115369189993137
SNU-182,8515,5.711375206756832
TALL-1 [Human adult T-ALL],439501,-2.6089794339614256
BT 333,3689413,0.756626575903668
RCM-1 [Human rectal adenocarcinoma],439501,-1.003670618583837
NH-6,3689413,-2.319645843981955
5637,6505803,-0.9891177489911248
DND-41,135875424,2.6793866497378698
SNU-685,9936388,-1.1795394282273874
PF-382,6505803,0.1218702134100329
TE-5,JQ-1-carboplatin (1-1 mol-mol),0.6958191987342512
KP-4,136227924,3.1314573836961235
HT-1376,49836020,5.287165459832521
COR-L47,9926054,1.681825446292649
NCI-H2291,5460769,2.25244251110153
BFTC-909,3689413,0.9841636034152118
L3.3,3689413,1.7908878640591075
SU.86.86,3689413,-0.2101757274961018
NCI-H460,54618164,4.49670945938676
ZR-75-30,11404337,1.0158794681512644
EPLC-272H,107985,-2.872507953647575
NCI-H69,107985,-6.066304384854357
TF-1,44491742,3.716758320980523
L-363,12003241,0.3787290467646389
NCI-H1573,3136844,3.653401959074723
EC-GI-10,6918878,3.2005227987909826
NCI-H1944,148198,-1.2530067367581603
OV-90,11404337,1.6888356686840926
EFO-27,148124,2.931737870457193
HCC1806,159324,3.5329859542664175
COLO 320,100016,4.196375737127383
NCI-H2342,selumetinib-vorinostat (8-1 mol-mol),3.3714966194337745
NCI-H1975,46943432,1.534293146837258
Daoy,135423438,2.308652476959376
SHP-77,159324,2.7703794768385746
EN,107985,-3.693718586943453
SIG-M5,36462,-1.757249636998404
SH-10-TC,selumetinib-vorinostat (8-1 mol-mol),3.8714348747997978
JURL-MK1,3689413,0.8778438710921479
SW579,11485656,-1.098369360988347
HCC4006,9911830,1.6135942696828955
M059K,6610216,4.531022301416725
OCI-Ly19,409805,2.778499480281169
MKN1,9926054,3.700935468951971
SK-BR-3,9936388,-7.247395712922041
NCI-H929,159324,1.2295170877350825
TE-4,44493528,4.301636360206761
IST-Mes1,12003241,-1.7187710036837192
MOLT-3,9927531,3.2112573350362372
EBC-1,8515,4.407730578981125
TE-5,8515,4.767533818879323
OCI-Ly10,46943432,0.1939232888167296
IM95,8515,4.597489728166281
DK-MG,sirolimus-bortezomib (250-1 mol-mol),0.0484701224362502
KMS-26,5460769,1.6781754946124072
LUDLU-1,135875424,4.724968330377738
U2OS,selumetinib-GDC-0941 (4-1 mol-mol),1.8236240565324096
M-07e,54618164,3.9701708331958585
P12-Ichikawa,selumetinib-GDC-0941 (4-1 mol-mol),1.616010765024319
Fu97,9903786,2.3049271395078827
Mono-Mac-1,9927531,4.461355065468675
AU565,3136844,3.8072298284959385
SNU-761,10296883,3.572250767719841
KE-39,selumetinib-vorinostat (8-1 mol-mol),2.460157439364167
DU4475,11485656,1.359840937957691
COLO 699,3689413,3.029151035827229
HT-144,12003241,-2.1434131709855215
JVM-3,46943432,-0.4792671630818655
WSU-DLCL2,159324,1.4979420988042116
PaTu 8988t,11404337,-0.5897258437911538
SCC-25,136227924,2.958495944269512
Hs 944.T,9926054,2.091458056725466
BICR 31,262093,3.397835562493394
KMS-20,36462,0.8301461091099265
SNB-75,tanespimycin-bortezomib (250-1 mol-mol),-1.317235314034222
UM-UC-3,26596,-0.252554246147762
SF539,262093,2.0596515913386786
L-1236,11404337,0.7595432314307335
HCC95,12003241,-0.8735704800502477
G-401,6505803,-2.085126737120111
KMS-27,6610216,4.611195004957726
NCI-H1734,8515,1.9897267358635304
WM983B,JQ-1-carboplatin (1-1 mol-mol),2.7485302033318084
22Rv1,54618164,3.751112762504955
LoVo,10296883,3.831816674357036
WSU-DLCL2,44493528,4.16645945517617
MOLT-3,10296883,3.393769807045215
A2780,148198,-4.120801514793353
TE-5,tanespimycin-bortezomib (250-1 mol-mol),-0.0271595153409523
BT-474,sirolimus-bortezomib (250-1 mol-mol),2.1782836856662136
NMC-G1,439501,-2.0387411188020024
SUIT-2,44484440,3.710182665930374
MDA-MB-453,246676,1.942789144720036
SYO-1,6610216,4.502442732113343
HARA [Human squamous cell lung carcinoma],9936388,-6.286258703982233
Kasumi-2,9903786,1.7296917357536032
NCI-H28,sirolimus-bortezomib (250-1 mol-mol),0.5571270031367631
LN-18,11404337,-1.073662299758218
COLO 829,36462,2.7479607822495504
OCI-Ly19,tanespimycin-bortezomib (250-1 mol-mol),0.3425077317029711
SK-N-SH,54618164,3.749880315376081
SNU-1076,selumetinib-vorinostat (8-1 mol-mol),1.2031584211744453
TTC-709,11404337,-1.0402819998142765
KYSE-140,409805,5.981415467159753
SNU-1,9936388,-8.466890078347713
KNS-60,9927531,4.453206768801637
LUDLU-1,11404337,0.8726842724577241
COV434,135875424,2.939089760708004
SNU-1041,9936388,0.8457601319500153
SNU-5,tanespimycin-bortezomib (250-1 mol-mol),-4.499312047026259
NCI-H1299,9936388,-0.1781231784373126
NCI-H1105,JQ-1-carboplatin (1-1 mol-mol),2.500241308426971
SNU-407,439501,-0.9775272958011642
B-CPAP,selumetinib-GDC-0941 (4-1 mol-mol),1.9189461116893112
SW620,12003241,-2.6864351641930155
HCC1438,6610216,4.344154848601134
Rh30,24180125,3.823310947482733
NCI-H1563,135875424,2.353629734666018
RD,100016,6.5954800872388155
Kuramochi,9926054,1.9908985756300632
U-BLC1,24180125,2.445144330165959
DMS 79,9926054,1.7240828255931135
SNU-245,439501,-2.452660264273032
WT2-iPS,409805,6.008881915911806
BT 498,136227924,4.389685115045935
UACC-812,148198,-2.7739066615342236
HuP-T4,6610216,3.8293883962639175
OCI-M1,selumetinib-GDC-0941 (4-1 mol-mol),2.201687345778046
MOLM-6,selumetinib-GDC-0941 (4-1 mol-mol),0.1291930510848496
BT 271,3689413,-0.1683301005825848
NB4,44493528,4.205501797319906
NCI-H1568,JQ-1-carboplatin (1-1 mol-mol),3.4150339974619457
MG-63,6610216,5.0810751878936165
KMRC-2,135875424,4.786513298485674
GSS,11485656,1.8292349527382337
SNU-1079,54618164,3.1553824878915955
LAMA-84,135875424,3.803439858623824
NCI-H358,135423438,2.3856947945666587
SNU-423,6918878,2.1961765683595824
SNU-878,11404337,-0.7245810711343122
BT 333,54618164,4.3182634129264805
HLF,11485656,2.0345771970927924
SF539,9911830,1.1022803108352155
SK-N-SH,6610216,4.236086050326451
L3.3,11404337,0.7171912876466348
DMS 79,409805,3.6783125614989656
Karpas-422,107985,-2.8458224127978733
SK-LU-1,9903786,1.4733207164642357
PaTu 8988s,12003241,-0.9111494781164662
OCI-Ly19,6505803,0.7102258486981511
HCC15,409805,6.461768980239098
Sq-1,3689413,-2.2869880122730755
NCI-H929,148198,-3.717368743483661
CAL-85-1,6610216,4.177291709133228
PF-382,3689413,-3.8661032289286488
Hs 766T,44491742,4.434347985078199
PE/CA-PJ49,6505803,-1.5018082269654205
HCC4006,135423438,4.2746750258396835
SUP-T1,46943432,0.6688423816159417
Hs 895.T,409805,5.888268513255627
HEY A8,12003241,-2.767500133031125
KMS-20,262093,1.6065117070445694
SK-MEL-30,246676,4.409971807400667
BICR 31,12003241,-1.4237270953299652
CAL-29,26596,-1.7040802846973448
BICR 22,JQ-1-carboplatin (1-1 mol-mol),2.1312623877062125
COLO 741,selumetinib-GDC-0941 (4-1 mol-mol),3.828549424884254
UACC-62,168313200,3.7263380394473793
GA-10,5460769,2.1295302547958976
OCI-AML-2,6505803,-2.2709004607894583
SK-N-FI,sirolimus-bortezomib (250-1 mol-mol),0.1232342384365411
NCI-H2081,148198,-5.584711698479823
MES-SA,36462,3.892924771749451
CL-11,JQ-1-carboplatin (1-1 mol-mol),-0.9371463412040694
LCLC-97TM1,sirolimus-bortezomib (250-1 mol-mol),0.527232919113557
OVCAR-4,49836020,-3.3998329005368833
MOLT-13,46943432,0.575626036010324
JK-1,159324,-0.6912677372060566
TALL-1 [Human adult T-ALL],10296883,3.2857162294996933
JVM-2,9911830,1.797667981617692
RVH-421,148198,-2.605625112425235
NCI-H929,26596,-1.2167182000669836
A2780,6918878,0.724096247903148
SNU-1077,12003241,-1.4220834787906382
OE19,439501,0.2818425095827352
U-BLC1,tanespimycin-bortezomib (250-1 mol-mol),-2.071210678838922
HSC-3,107985,-3.2412158645238893
WM1799,135875424,3.6898811613748874
L-540,3136844,3.250532199185882
COLO 680N,136227924,3.1124323049819003
NCI-H1299,6610216,4.858778450336318
HuH-6,9903786,2.683606252138214
BT 248,262093,2.0571072545208926
EFE-184,159324,4.113973214034695
SiMa,9903786,1.5237540856212457
M-07e,9903786,0.8629482504426611
BICR 18,9927531,5.5562254884624895
NCI-H2023,3689413,4.096769539099316
Panc 05.04,11485656,2.761392845467755
AU565,262093,2.3992948308197093
LCLC-103H,54618164,4.386311073286264
HEC-1-B,9926054,2.0295913011539173
CHP-126,JQ-1-carboplatin (1-1 mol-mol),1.0753028994481633
HCC44,107985,-3.4962930705571136
SK-N-AS,9927531,4.866192814831014
CCF-STTG1,sirolimus-bortezomib (250-1 mol-mol),2.0360820241023876
HuP-T3,selumetinib-vorinostat (8-1 mol-mol),2.242647534898157
SW1353,6610216,4.8642492591567175
AU565,10322450,3.206832643999438
SET-2,26596,-1.642607786787168
Hs 746.T,439501,-2.632583453917954
DU4475,9926054,1.608890542810364
MCAS,439501,-1.7764971276715424
OE21,44491742,3.708692446594154
DU145,439501,-2.7485794982467637
P-STS,9936388,0.552871605050304
VM-CUB-1,159324,3.221139682544442
BICR 56,36462,3.0627573168213496
Ku812,36462,1.322759060978493
EPLC-272H,9911830,2.69139875314517
UO-31,107985,-3.731329066681621
RT-112,6610216,4.21284209237931
NCI-H1693,9926054,2.0729608249560436
SNU-626,11404337,1.6916289336018857
SUP-HD1,9911830,2.5981111749398704
SK-MEL-24,9926054,2.7611591641517323
JVM-3,9903786,0.2351218463531885
SK-LU-1,JQ-1-carboplatin (1-1 mol-mol),2.4628830674055933
SCaBER,9936388,-6.596808157772059
HSC-2,135423438,4.318138286967173
KMS-34,selumetinib-vorinostat (8-1 mol-mol),2.1105569395835975
JeKo-1,26596,-2.667287216238713
DV-90,6505803,-3.886582260565957
QGP-1,135875424,4.81787572087767
WM88,168313200,2.778601670140009
Hs 888.Lu,6610216,4.537869463630796
NUGC-4,100016,6.130178573368833
T3M-10,3689413,0.3494943823106689
MM1.S,36462,-0.6145210813224762
HCC1500,9927531,5.051014893697188
EC-GI-10,136227924,3.398194138185936
SK-MM-2,9926054,1.3112248924199803
NCI-H460,9903786,4.057661845653794
Ku812,46943432,4.280814189443877
HL-60,3689413,0.2723590351268871
BxPC-3,5460769,-0.1362128387149436
SK-ES-1,3689413,-2.1650070700779582
KE-37,136227924,2.0912429237758796
Toledo,9926054,4.027631226191203
HCC1395,439501,-2.37120422712219
NCI-H522,6610216,4.154510920860766
U-118MG,12003241,-0.1852675851464418
Peer,JQ-1-carboplatin (1-1 mol-mol),-0.0564533853445443
TT2609-C02,168313200,3.68339689842754
HCC78,36462,0.8922368228413601
BT 164,6505803,-0.6124673991006063
IGROV-1,135875424,3.3275053166921347
JURL-MK1,10322450,3.220647204131025
TYK-nu,5460769,2.633431315912765
SW1710,9926054,2.792354936189826
LS1034,selumetinib-GDC-0941 (4-1 mol-mol),-0.3273277386123449
TCCSUP,JQ-1-carboplatin (1-1 mol-mol),4.7242319921213225
COLO 792,262093,2.2000430142721736
EJM,46943432,3.619668904272789
HEC-6,135875424,4.1138725556721685
SF295,selumetinib-vorinostat (8-1 mol-mol),2.6390667810596624
KMBC-2,9927531,4.40438479738659
LP-1,6505803,0.6581900547283019
SW948,6610216,4.184431800680971
JHOS-2,135875424,4.409473105758524
MKN74,selumetinib-vorinostat (8-1 mol-mol),2.9891343546894267
Hs 888.T,6505803,-0.3251966852868098
MOTN-1,8515,4.069271127937523
SK-CO-1,sirolimus-bortezomib (250-1 mol-mol),-0.6660837723392407
SNU-1041,selumetinib-vorinostat (8-1 mol-mol),3.508880149625294
KMS-34,24180125,3.4515242001705015
NCI-H358,135875424,4.435153990168911
Hep 3B2.1-7,136227924,5.40641673036814
HT-144,148124,3.5563459138511595
SUP-B15,135875424,3.3386210567856462
SNU-C1,10296883,2.645859922334997
RCH-ACV,selumetinib-vorinostat (8-1 mol-mol),1.2774108337481205
OUMS-23,36462,4.217798151185395
SW1116,9936388,1.5004696743438164
RERF-LC-Ad1,54618164,4.2675139031657325
RPMI-8226,selumetinib-vorinostat (8-1 mol-mol),2.271353218041498
HEC-265,49836020,-5.012817345393805
EM-2,9911830,-2.087916808060928
KE-97,36462,-1.9325928146088365
NCI-H1703,5460769,1.9042192719561193
JHH-6,10322450,6.3752081259808415
DU145,9911830,2.1364996794005395
NCI-H2110,12003241,-0.2811614102315782
VMRC-LCD,sirolimus-bortezomib (250-1 mol-mol),2.1405006369000232
HCC44,3136844,3.524671899542038
MDA-MB-453,JQ-1-carboplatin (1-1 mol-mol),-0.0296980532629666
IGROV-1,26596,2.910298792762654
BT 224,sirolimus-bortezomib (250-1 mol-mol),0.3912560811158826
ACC-MESO-1,135875424,3.861508499056134
GP2d,tanespimycin-bortezomib (250-1 mol-mol),-3.105115465971025
KPL-1,135423438,2.328481946215466
RPMI-6666,6505803,-0.9166803455399566
SYO-1,49836020,4.445841076102608
PSN1,11485656,1.8304064123419443
RPMI-7951,9927531,5.17840544344631
M059K,11485656,3.642862127299764
IMR-32,409805,3.9011051007010216
HT-29,136227924,3.5079295938152706
SNU-601,44491742,3.984168627416036
A4/Fukuda,135875424,2.943838777845953
HEC-108,135875424,4.07561778301408
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
ECC10,9936388,-3.931527167718931
K029AX,3136844,4.357702082450867
SNU-1196,36462,2.608286274647309
HCC95,9936388,-4.9854278423381135
Karpas-299,3689413,-1.6709269792656412
639V,sirolimus-bortezomib (250-1 mol-mol),1.801043547803399
Panc 04.03,6610216,4.328711123736605
BICR 18,9911830,1.5303849230242863
SK-N-BE(2),3136844,3.630916985639288
JURL-MK1,148198,-3.3107104288363027
LN-18,409805,5.6020657668162706
HSC-3,tanespimycin-bortezomib (250-1 mol-mol),-0.9764630835173828
JJN-3,107985,-5.8157457701198005
HT115,11404337,-1.1807464120641065
SNU-387,9911830,2.6597454725807954
DLD-1,selumetinib-GDC-0941 (4-1 mol-mol),3.851473421315054
NCI-H2452,136227924,3.4253193575490695
QGP-1,11485656,2.192012938394494
NCI-H810,8515,3.5075433046865117
L-428,10322450,3.383753825926629
WM88,44491742,3.817934383194013
TE-8,409805,3.3090914491624557
BT 245,54618164,4.011070558028337
HCC4006,selumetinib-GDC-0941 (4-1 mol-mol),1.2371025715535526
SIG-M5,100016,4.056618507771364
Peer,24180125,1.7201532491127525
DMS 53,selumetinib-GDC-0941 (4-1 mol-mol),1.3170486781657051
SCC-25,tanespimycin-bortezomib (250-1 mol-mol),-2.0789545653070856
SNU-489,9936388,2.9211262102294246
SW1710,6505803,1.2425561690078113
SK-HEP-1,12003241,-1.7510835313415607
A-498,9926054,1.5026788619071982
DOV13,11404337,1.060894937445875
COLO 792,10322450,2.61287912809147
LS411N,409805,5.900990799691521
Becker,168313200,3.791120418398256
COLO 684,10296883,4.095510288741906
253J,107985,-3.879863196899193
HCC1833,135875424,4.246764438360678
MG-63,148124,3.329653323642378
BC-3C,26596,-0.2711171382512473
ACHN,54618164,4.499385578059577
HCC1428,selumetinib-vorinostat (8-1 mol-mol),2.4982790214648087
ME-1 [Human leukemia],46943432,3.4269165120424776
NB4,11485656,1.2735256596960405
SNU-449,168313200,1.9091128501610053
NCI-H1373,159324,3.0208465782791825
SF295,54618164,4.313739773462804
NCI-H460,262093,3.3627537421549314
RL95-2,26596,-0.9803054302492492
UACC-257,135875424,5.07127694251911
23132/87,9936388,-5.399700035064151
HeLa,9936388,2.2030969514797256
NCI-H520,9926054,1.793691213544428
EJM,409805,3.072892420926549
HCC1937,439501,0.0308528134887005
KNS-62,11404337,0.0351027480224998
SNU-423,107985,-4.181882942370829
JHOC-5,409805,5.771239426741445
LNCaP clone FGC,409805,5.792724487332009
TE 617.T,sirolimus-bortezomib (250-1 mol-mol),0.0331781036900695
NCI-H28,409805,5.138383267484091
Hs 578T,409805,3.1145560968207806
ML-1 [Human thyroid carcinoma],9927531,5.643924198323062
HSC-3,44493528,4.631982422980787
BT 228,5460769,3.1734234469755775
UM-UC-3,439501,-1.7316159115926524
SNU-1041,12003241,-1.3076188477929267
DMS 114,selumetinib-GDC-0941 (4-1 mol-mol),1.847196257351989
OAW42,9927531,5.261343543721406
UACC-257,9926054,1.800588068202944
UM-UC-1,10296883,4.123728630230191
CFPAC-1,54618164,4.158502253037373
NCI-H2342,selumetinib-GDC-0941 (4-1 mol-mol),3.1490507666269307
COLO 201,5460769,4.015779319815586
KYSE-140,107985,-2.0809038336660923
NCI-H1792,selumetinib-vorinostat (8-1 mol-mol),2.4401728283589694
LN-229,9926054,2.0012507920531206
NCI-H1339,9936388,3.3861732240332314
PaTu 8988t,148198,-4.283282973565046
NCI-H1299,439501,-2.475221299124019
KYSE-150,439501,-2.052967446367251
GMS-10,11404337,1.4547750638091848
CHP-126,9903786,1.6217083088403044
A-204,10322450,3.769962101678964
Mel Ho,24180125,2.179184648721862
CAL-51,10322450,3.881825194853649
Kasumi-1,10296883,1.6176834941349487
G-402,8515,4.197979847393778
SK-HEP-1,10296883,4.4971190241998835
Panc 02.03,44493528,4.298055948100647
BT 248,3689413,-0.3734654016267222
NCI-H1435,tanespimycin-bortezomib (250-1 mol-mol),-3.816394464229111
COLO 699,262093,2.601705972340985
Mel Ho,409805,3.6793455853418497
CAL-85-1,135875424,4.15034145684821
KP-N-SI9s,26596,-1.674008327181718
GOS-3,135875424,4.516628943420056
SK-MEL-24,12003241,-2.7585414015303424
NU-DHL-1,JQ-1-carboplatin (1-1 mol-mol),-1.21461572309572
BICR 6,11404337,-0.1935615710602951
KYSE-180,11404337,-0.9460930401604244
T98G,6610216,4.441401687083466
Mel JuSo,9911830,3.0067571932730854
MCAS,5460769,1.176961037581758
KMM-1,6610216,4.9199477821818
HCC1395,6610216,4.327049728345092
SK-MEL-1,46943432,2.617200117528874
COLO 699,44491742,4.375917041754564
BICR 16,100016,8.634217681257812
TE-6,36462,3.471406428909744
SNU-C1,100016,6.347812039507436
BT 179,12003241,-1.00247586074096
HARA [Human squamous cell lung carcinoma],54618164,4.558968644978708
NCI-H2286,100016,5.552985583261177
T24,409805,6.178304218667183
CCK-81,100016,4.4296308435579554
SNU-308,159324,3.7188145940777617
HEL 92.1.7,409805,5.884627411024845
OCI-Ly19,6610216,4.329464958402344
EC-GI-10,selumetinib-GDC-0941 (4-1 mol-mol),2.251648827392905
FaDu,sirolimus-bortezomib (250-1 mol-mol),0.8335893601460954
BCP-1,11404337,-1.851006569506268
BT 147,11404337,-1.2546311246387
OUMS-23,6610216,3.941285586562786
HEC-59,selumetinib-vorinostat (8-1 mol-mol),2.380555243275298
SNU-478,136227924,2.019778672481118
OPM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.6034498457254175
BICR 22,100016,6.157225392196351
639V,159324,3.6195466497834543
NCI-H441,sirolimus-bortezomib (250-1 mol-mol),3.489880905955473
BT 139,6505803,-5.215267056081471
U-937,148198,-3.074403033711411
KMRC-1,10296883,4.079927671527966
LUDLU-1,sirolimus-bortezomib (250-1 mol-mol),0.877597095580597
A-549,selumetinib-GDC-0941 (4-1 mol-mol),1.3040363367013357
F-36P,24180125,3.032691070219076
T-47D,262093,1.970232832851439
NCI-H1651,9936388,-1.76189250621897
BT 216,36462,2.576537789076833
D283 Med,3689413,-5.066385831563446
VCaP,409805,3.668756202422648
CJM [Human melanoma],9936388,-7.628341639171254
OVTOKO,107985,-3.799732923526536
MKN74,9936388,-0.1480822399843773
ESS-1,12003241,-1.211695248693708
HARA [Human squamous cell lung carcinoma],6505803,-0.6058988133854029
Reh,246676,2.3151108839907213
DMS 114,148198,-6.558131209279394
VCaP,11485656,1.7583797003884982
DK-MG,6918878,3.526619499271838
RD,selumetinib-vorinostat (8-1 mol-mol),1.6803258761619044
NCI-H358,9926054,2.488331292072961
NCI-H1623,3689413,0.664737487618683
MHH-NB-11,26596,-2.2895666937918673
LOX-IMVI,148198,-2.445772941232649
WT2-iPS,100016,6.129452507999119
NCI-H1975,135875424,3.5608641934024843
MDA-MB-361,6610216,4.523037178271305
DMS 79,9936388,0.9891135195416976
COLO 699,44493528,4.4403065738336345
VM-CUB-1,sirolimus-bortezomib (250-1 mol-mol),1.5945782994961089
LC-1/sq-SF,3136844,5.020905470160487
HCC1428,9926054,2.453077305759455
BT 228,JQ-1-carboplatin (1-1 mol-mol),4.047543030971835
SUP-M2,8515,2.7865906060972647
SF539,3136844,3.725452843586701
TF-1,246676,4.293619273323295
Lu-65,sirolimus-bortezomib (250-1 mol-mol),1.2427816713041802
COLO 320,6505803,1.3976396139000618
EC-GI-10,10296883,4.124587788483945
ECC12,26596,-1.2680544811101384
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
BT 286,262093,2.2473217807206916
DMS 273,54618164,3.989243888703328
ACC-MESO-1,tanespimycin-bortezomib (250-1 mol-mol),1.746490159634885
HPAF-II,439501,-2.2531231348817715
NCI-H2106,262093,0.7594772969687351
U-BLC1,selumetinib-vorinostat (8-1 mol-mol),-1.468805400461474
A-375,9926054,2.393426871996004
HARA [Human squamous cell lung carcinoma],159324,3.9851922367796937
639V,44493528,5.149647090541137
BV-173,3689413,-0.0500702145216063
OE21,selumetinib-vorinostat (8-1 mol-mol),1.753596194788317
IGROV-1,439501,-2.1510551928674557
HPAC,159324,2.927164212591678
HOS,24180125,3.251928139496708
JMSU-1,135875424,3.6629437314109703
SNU-449,148198,-4.785889264279132
NUGC-3,selumetinib-GDC-0941 (4-1 mol-mol),1.725630389990751
NCI-H1869,168313200,3.875520299128645
MKN7,54618164,4.012076431058733
ChaGo-K-1,439501,-4.217436880778372
TE-15,54618164,4.596489817745785
T3M-10,262093,3.0314849196691704
SNG-M,26596,-1.5448516753437405
NCI-H1734,selumetinib-vorinostat (8-1 mol-mol),0.4737362905842023
RT-4,54618164,3.1267558882512803
SCaBER,sirolimus-bortezomib (250-1 mol-mol),0.2620178296114504
MDA-MB-468,439501,-1.8794738155702295
NCI-H1155,54618164,3.6742411601668103
TT,262093,3.6842052963276406
SK-LMS-1,439501,-2.6023396475730967
COV362,9911830,2.6382082801445934
BT-549,selumetinib-GDC-0941 (4-1 mol-mol),2.833725023206459
8-MG-BA,148198,-4.196871599679804
NCO2,8515,2.809674810948928
L-428,9926054,1.7396260856582195
5637,409805,4.649585035607563
Sq-1,44491742,3.879734584111586
Ci-1,5460769,3.784060470776022
NCI-H1581,9911830,1.518181983178349
SJSA-1,409805,4.702457052286149
NCI-H1435,JQ-1-carboplatin (1-1 mol-mol),2.9022740526211765
NCI-H1869,409805,5.751744182014799
Rh18,selumetinib-vorinostat (8-1 mol-mol),2.37781269725146
TM-31,409805,5.9369651846195275
HCC44,12003241,-2.184153343310603
HCC1833,selumetinib-vorinostat (8-1 mol-mol),2.3317673316592753
RL95-2,135875424,3.9099028993279905
SK-MES-1,135875424,4.094460625120135
NCI-H841,3689413,-2.418219785730911
PC-3,135875424,4.657200452224415
MFE-296,6610216,4.401598246385061
LUDLU-1,selumetinib-vorinostat (8-1 mol-mol),2.8227543135070157
COV362,selumetinib-vorinostat (8-1 mol-mol),4.6626475289843965
RPMI-8402,148198,-4.480624262249758
CGTH-W-1,9936388,2.615768469717637
Karpas-422,136227924,2.027369566350396
NCI-H1650,44491742,4.220144565804619
ECC10,9911830,2.8495761448668944
HuG1-N,135398744,6.4115232793077235
Karpas-620,9911830,2.708216754691897
SUP-B15,9926054,1.7233676505424833
COR-L88,tanespimycin-bortezomib (250-1 mol-mol),-0.4696067896304535
WM88,24180125,3.83387165557686
HuT 78,12003241,-1.0527217193191982
Lu-99,135423438,2.1448370442307865
PE/CA-PJ15,11485656,1.9220584297940355
MKN74,3136844,5.110868914339551
SF539,136227924,2.8154987155907905
SF126,6610216,4.855449805426185
BT-474,3689413,-0.6944310513118788
Caki-2,136227924,3.8399348879900854
MG-63,36462,2.529493271020798
HCC1500,135875424,3.5744445956281483
KG-1-C,262093,3.4811701682583847
COV362,107985,-4.013210896315973
KP-2,262093,3.513459327352711
HuP-T3,439501,-2.469428626730465
NCI-H520,3136844,4.52894652674819
PL-21,136227924,2.3397761554923413
MOLT-16,136227924,1.8334417676190544
HEL,JQ-1-carboplatin (1-1 mol-mol),-0.4400207777249079
HCC1569,5460769,3.8365065781624255
Hs 683,9926054,1.7064216062537565
MDA-MB-157,100016,3.517936084480814
YH-13,24180125,3.319627413046534
SNU-5,107985,-4.4289140812757335
BT 271,3136844,4.239137665617565
AN3-CA,262093,3.1058426937478036
RPMI-8402,6918878,-0.944708715782594
SNU-738,3136844,4.419028789423482
BFTC-909,44493528,4.370300807083883
ES-2,246676,5.247336749197189
RERF-LC-Ad2,262093,2.9385372389092197
HT-1080,sirolimus-bortezomib (250-1 mol-mol),0.4645124048276262
BT 444,9936388,1.54368416560238
Fu97,6610216,2.939108753023632
MDA-MB-415,selumetinib-GDC-0941 (4-1 mol-mol),-0.0962287719038293
NCI-H2106,439501,-2.192418172555811
SW1710,11404337,0.2062189220113439
Lu-65,6610216,3.857091251569688
BT 504,135875424,2.85163619011477
HEC-1-A,10296883,3.968185450063831
SK-N-MC,44493528,4.172598643795567
COV644,148198,-3.8315909355374607
JMSU-1,159324,2.2275853880777534
NCI-H1184,11485656,2.662632991644762
OVCAR-5,54618164,4.322369503213112
D283 Med,136227924,2.613464686393682
Hs 766T,3689413,1.3725594081850794
HCC1419,262093,3.0653031319463624
BT 330,148198,-5.294661964865024
BT-20,3689413,-3.3374276278199972
CAL-85-1,3689413,-0.0998650254858705
SW1353,9926054,2.273911586274605
A-549,409805,5.689640893560965
ECC10,JQ-1-carboplatin (1-1 mol-mol),0.0523843610498873
BT 340,3136844,4.3770298163748125
NCI-N87,24180125,2.059368273959215
DV-90,selumetinib-vorinostat (8-1 mol-mol),0.2763091288197432
ME-1 [Human leukemia],136227924,3.8385097232305103
F-36P,9927531,3.277951098444252
HCC1588,54618164,4.057398763745221
JHH-4,24180125,3.2145727224704412
NCI-H647,9911830,1.9312757537429064
TUHR10TKB,9911830,3.088546123697112
RPMI-6666,5460769,0.788563204465766
YD-38,9911830,2.6731616519017827
BT 172,6505803,-5.169287072935626
KP-2,selumetinib-GDC-0941 (4-1 mol-mol),0.2413129500799869
Capan-2,9927531,4.988385726182681
NCI-H2081,9927531,2.933726437844289
D283 Med,100016,3.728925578699804
GSS,6505803,-2.9961696629002956
Ri-1,107985,-4.133158976783472
G-402,136227924,2.8538202085088185
L3.3,selumetinib-GDC-0941 (4-1 mol-mol),2.633566714315937
SNU-8,JQ-1-carboplatin (1-1 mol-mol),1.6259891864743636
KMS-26,10322450,3.1640442596906104
OE19,24180125,1.1253497268177255
HCC1143,135875424,3.1375636080090925
NB1,36462,0.5434852604618556
Hs 936.T,11404337,0.4334403969580954
8305C,135875424,4.357413208917153
LXF 289,135398744,6.087135496005038
SNU-1214,sirolimus-bortezomib (250-1 mol-mol),0.3499333667052599
IMR-32,36462,-1.733502190713641
SK-LU-1,tanespimycin-bortezomib (250-1 mol-mol),1.5987534653894475
NCI-H1623,11485656,1.644044907667622
Hs 944.T,24180125,2.7195236908297247
HEC-151,159324,2.248651561242496
A3/Kawakami,409805,5.980791867932477
LXF 289,12003241,-2.348837864712453
DOV13,54618164,4.008619106307457
DU145,selumetinib-vorinostat (8-1 mol-mol),2.4809592604092305
M059K,107985,-2.8475109777363703
T84,6505803,-1.9695494266623712
HOP-92,100016,6.879559613863246
UM-UC-3,54618164,4.22166534814322
NCI-H1155,12003241,0.5053452290511842
NCI-H1155,107985,-2.9332881194329694
NCI-H841,44491742,3.87806302811964
NCI-H2444,107985,-2.8004583921356465
KNS-42,107985,-0.308667703766746
G-401,5460769,-1.872739736028161
L-428,107985,-3.729853241887149
LOX-IMVI,44493528,4.127526604228942
NCI-H1092,11485656,1.8493866648869597
SEM,44491742,3.581981402307046
NCI-H1184,439501,-1.2905593318516702
MDA-MB-231,148198,-1.1637706942171424
TE-4,3689413,3.3768605304218036
SUP-HD1,439501,-1.483428569132062
Ishikawa (Heraklio) 02 ER-,11485656,3.3351822196084937
RS4;11,6505803,0.6734811242477595
HCT 15,selumetinib-GDC-0941 (4-1 mol-mol),0.3162595465665505
BT 444,3689413,2.494766939004703
BT 504,12003241,-1.3815102310326015
SW1990,JQ-1-carboplatin (1-1 mol-mol),4.363911496200424
BHY,selumetinib-vorinostat (8-1 mol-mol),1.471907668838586
MDA-MB-468,24180125,2.6754361833338773
Kasumi-2,44491742,3.800345149395397
BT 231,24180125,2.6727981322820664
CCF-STTG1,135875424,4.233748796461769
CAL-33,36462,1.471703857493851
KYSE-410,9926054,2.1669765108653483
LS411N,9936388,1.997277136132151
COR-L279,6610216,3.5048681579644527
U2OS,148198,-3.483181142521373
SCC-9,54618164,4.4493976732458576
SNU-182,159324,1.3333674502303892
8305C,JQ-1-carboplatin (1-1 mol-mol),-0.8214093043098781
BV-173,107985,-3.6311226655481086
Hs 852.T,46943432,2.409734436943373
SK-N-BE(2),135398744,6.372852995200929
BT 164,24180125,3.8792207003051984
NCI-H810,36462,1.4290563558220155
HEC-1-B,439501,-2.327113074925545
EFE-184,54618164,4.291032253552879
23132/87,159324,3.098408449311899
SF126,159324,5.495945849667338
MHH-CALL-3,9903786,1.8198372830428096
Panc 10.05,54618164,4.233833301022668
MHH-CALL-4,sirolimus-bortezomib (250-1 mol-mol),0.7403590273968818
COLO 320,6610216,3.982135199873874
EKVX,54618164,3.934714976458277
Kasumi-2,148198,-6.27183434225638
NCI-H1355,135423438,1.8845070459109623
Hs 729.T,selumetinib-GDC-0941 (4-1 mol-mol),3.0623228913945684
HEC-251,100016,6.174926130166858
SK-ES-1,10296883,3.792538750425496
MOLT-13,3689413,-2.356450494712317
KP-4,44493528,4.395451461814576
ChaGo-K-1,148124,-2.510637409875074
NCI-H2106,24180125,2.031975648499319
ZR-75-30,44493528,5.463168492919208
NCI-H2106,148198,-2.940594124176384
HEC-59,5460769,4.548370162463851
NCI-H647,10296883,4.213615092820639
LOU-NH91,439501,-1.197324809082114
HPB-ALL,12003241,-0.6872291231969794
SaOS-2,selumetinib-GDC-0941 (4-1 mol-mol),1.0166144741288403
TE-9,409805,5.86939241633817
LOX-IMVI,54618164,3.986772519561911
COR-L95,262093,1.2094317801688714
647V,11485656,1.780919145003727
JURL-MK1,9926054,0.5883612269898851
Ki-JK,5460769,-2.8439091816710707
SNU-1077,100016,6.64200464659652
J82,9926054,1.9182596726219543
Karpas-299,107985,-4.724970996204854
DAN-G,8515,4.673227824425852
OCI-AML-5,262093,2.6389627250166825
DoHH2,148198,-5.119936658223105
BT 159,tanespimycin-bortezomib (250-1 mol-mol),-0.0268795114387354
JVM-2,6505803,-0.473368143486524
PE/CA-PJ15,tanespimycin-bortezomib (250-1 mol-mol),-3.0373663834156943
WM1799,136227924,5.317137472440357
NCI-H2081,3689413,-0.989992552174664
TE-1,9926054,2.343374218225638
SK-MEL-31,3689413,0.7932345609098049
8505C,3136844,3.920816776867896
DMS 79,44493528,4.912262221382906
ZR-75-30,409805,3.93258642245537
EN,439501,-3.211149849796052
ST486,26596,-3.6953345637142063
NUGC-4,9927531,4.1074548867853045
23132/87,409805,3.587189240784534
PLC/PRF/5,12003241,0.8244509806325866
KYSE-410,26596,0.1189340940832646
KE-97,262093,2.317138698505635
HuG1-N,26596,-1.6967804623376053
DV-90,11404337,-2.4511468256703908
786-O,107985,-3.3525447115072113
NCI-H661,tanespimycin-bortezomib (250-1 mol-mol),0.6505677093345705
SYO-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8383808288745799
Ki-JK,100016,3.514869011895543
SNU-175,26596,-1.9837379159345812
NCI-H1573,12003241,0.8925202340822594
A-549,11485656,2.1977599259975764
OVISE,selumetinib-GDC-0941 (4-1 mol-mol),0.6038813555942163
SNG-M,439501,-1.900276797941319
Hs 746.T,9903786,3.9786506562957857
OCI-Ly19,136227924,2.004549918496879
KP-N-YN,9926054,3.360231389536055
647V,6918878,3.7932946596633834
HSC-3,3689413,-2.2600837113951497
BT 231,100016,7.4946101776766385
K-562,selumetinib-vorinostat (8-1 mol-mol),2.188537608414777
OAW42,JQ-1-carboplatin (1-1 mol-mol),4.198659850424817
JMSU-1,9911830,0.8629404413226613
JHH-4,sirolimus-bortezomib (250-1 mol-mol),0.3887655009012536
SH-10-TC,36462,3.008828443008953
COR-L88,12003241,-0.20090693258686
WM115,JQ-1-carboplatin (1-1 mol-mol),1.8205622185822876
Hs 729.T,409805,3.7605172739266655
SNU-C2A,9911830,2.9981708324913727
PLC/PRF/5,11485656,2.5978340800355544
QGP-1,36462,2.828572455595782
NCI-H1792,159324,5.06662867697722
SNU-878,9936388,-4.0204049031627935
NCI-H1563,9926054,1.9605295654487136
IGR-39,439501,-2.7155182926460832
DBTRG-05MG,9936388,2.4654274854338505
MOTN-1,49836020,2.722382817781131
ME-1 [Human leukemia],9926054,1.888180715398536
SNU-46,148198,-1.481074148002998
SNU-182,135875424,3.9739141814992056
Fu97,9911830,1.8298922650541032
MCF-7,159324,4.695511418264858
SK-N-SH,sirolimus-bortezomib (250-1 mol-mol),0.20777860601932
HCC1428,12003241,3.752026929973328
SNU-1077,246676,5.4377451130468435
CAL-51,9936388,-5.638746232401389
SNU-475,168313200,5.3842891056630275
SK-N-MC,10296883,3.751405483484442
SUP-B15,3689413,-0.2664359486303652
NCI-H2291,selumetinib-GDC-0941 (4-1 mol-mol),-0.2991032125390215
SBC-5,6918878,2.928817535111611
NCI-H2009,6505803,-0.1719772058921901
HCC2279,JQ-1-carboplatin (1-1 mol-mol),3.2942402482720707
HSC-2,10296883,3.989480591678073
YKG-1,24180125,3.6126357196897496
P-STS,selumetinib-GDC-0941 (4-1 mol-mol),4.834100084681968
MOLM-6,8515,1.9113684591576323
KMS-12-BM,36462,-0.0282673998252453
GMS-10,148198,-3.621238851602685
SNU-668,6610216,4.4411016597411095
HuH-1,9926054,1.861851059546876
HCC1395,12003241,-2.06138866466857
NALM-6,54618164,3.178026109202162
L-1236,3689413,-0.1223462388223707
NCI-H446,262093,1.6387081415954237
PK-45H,6610216,4.350521005102969
HSC-4,9926054,2.0278633205902468
OVCAR-5,11404337,-1.1267721710555685
SK-MEL-24,6610216,3.528879249084507
A101D,11404337,-0.7377742007243514
HT115,sirolimus-bortezomib (250-1 mol-mol),0.8189257476447475
SW948,10322450,3.138867511839475
HMCB,107985,-2.41132307847832
5637,selumetinib-vorinostat (8-1 mol-mol),2.341102350030954
BICR 31,49836020,4.313223650735915
IST-Mes1,JQ-1-carboplatin (1-1 mol-mol),0.3758398512274805
MOLP-8,9911830,1.992368688928045
RS4;11,9927531,3.90062082158746
DMS 114,262093,2.4519702544281436
MFE-319,36462,2.8535196136146626
SW579,sirolimus-bortezomib (250-1 mol-mol),0.6765835324099176
TE 441.T,3689413,-1.0112421393817166
EoL-1,6918878,-3.363736043599486
KYSE-520,12003241,-1.836986739794001
U-118MG,26596,0.614033451908362
MKN45,11485656,2.493574157806649
WM266-4,135875424,3.043976656542822
Hs 746.T,10296883,4.016339774932521
P31/FUJ,6610216,4.336076332167018
SNU-886,selumetinib-GDC-0941 (4-1 mol-mol),1.2837780593407424
NCI-H1755,selumetinib-vorinostat (8-1 mol-mol),2.43902185104056
KYSE-30,6505803,0.8895731520069545
LS411N,11485656,1.6093796612349578
COLO 320,11404337,-1.0914685328703808
P3HR-1,409805,3.946032344990011
BT-12,409805,3.8947657591707414
HOS,44491742,4.672695647178855
SNU-C1,54618164,3.867223192302055
BT 159,selumetinib-vorinostat (8-1 mol-mol),2.758617104178697
SNU-620,409805,3.844199200919608
A-549,168313200,3.5389649746345815
Calu-1,selumetinib-GDC-0941 (4-1 mol-mol),1.845580077173201
CAS-1,262093,2.1849008326659636
NCI-H1299,159324,2.855064979130342
ML-1 [Human thyroid carcinoma],439501,-1.5032891627146094
RERF-LC-A1,JQ-1-carboplatin (1-1 mol-mol),5.6290359475230725
EoL-1,26596,-3.796383365572035
NCI-H1793,selumetinib-vorinostat (8-1 mol-mol),2.6768979006350184
SW1573,54618164,4.339091959582753
HCC1500,107985,-3.8501888791364034
KYSE-180,6918878,4.793960218409927
8-MG-BA,409805,5.835769808247416
ST486,6505803,1.144321831733621
Hs 944.T,36462,0.0692561534374343
Kasumi-1,6918878,-1.2432999547253032
RPMI-7951,100016,4.945357769827656
KLE,9911830,2.855789588066899
ZR-75-1,6610216,4.248551703366494
FU-OV-1,54618164,4.603510021761196
DoHH2,159324,-2.321608210889596
Becker,sirolimus-bortezomib (250-1 mol-mol),2.1834069144396393
CAL-33,54618164,4.219830167888796
SNU-685,409805,5.994418908902015
NCI-H1869,11485656,1.8296978789565703
TOV-21G,409805,6.192744001897522
NCI-H2286,409805,5.54195525972207
SNB-75,54618164,4.754323338158202
HT115,409805,4.722359951707107
SCC-9,3136844,4.895725881728452
COLO 678,409805,5.274751310644635
HEC-6,409805,5.177200547925916
COV644,439501,-3.4357426903027273
COLO 668,tanespimycin-bortezomib (250-1 mol-mol),-0.9107908194631724
HT-1080,148198,-4.2926124844234765
U-937,6918878,1.8924990772326455
U2OS,11404337,1.5271724700309952
OVCAR-8,JQ-1-carboplatin (1-1 mol-mol),4.213615448912052
COR-L279,439501,-3.5163381606181243
2004,9936388,0.7178208617873092
BT-474,selumetinib-GDC-0941 (4-1 mol-mol),2.0514491490730142
BT 239,168313200,1.5980864637494772
Kuramochi,selumetinib-vorinostat (8-1 mol-mol),4.455240431430057
TE-14,3689413,2.902593123647125
SNU-C2A,6918878,4.018878788536444
NCI-H650,6610216,4.436979197607946
WM1799,10296883,3.650999018677617
NCI-H1339,10296883,3.881669394748239
QGP-1,148198,-2.838050109034932
BT-12,135398744,6.373256605371206
MOLP-2,409805,3.4926626149278026
BT 271,sirolimus-bortezomib (250-1 mol-mol),0.1057701535973337
HPB-ALL,3689413,0.032224825554501
HSC-4,9903786,4.262681016067309
SNU-840,sirolimus-bortezomib (250-1 mol-mol),-1.042474975863496
HCC2279,36462,3.4584261364752544
MOLM-6,9911830,-0.7023129144143456
IGROV-1,44491742,4.406671418311328
LAMA-84,9911830,-1.7379301723094578
YKG-1,135875424,4.553579428376037
OAW28,148198,-3.8662210541116977
CHP-126,36462,0.1971543123326329
SU-DHL-10,36462,0.5230051322888742
SNU-46,439501,-2.258414005891366
SNU-478,sirolimus-bortezomib (250-1 mol-mol),0.1595579698583019
EJM,10296883,2.9448984253361057
SYO-1,3136844,5.349295836353979
SK-N-FI,54618164,3.861588841514918
SNU-C1,6610216,4.164433839119208
OCUM-1,9927531,5.3600518663523244
Hep-G2,24180125,3.881955939132959
CMK,148198,-5.18058405335292
Calu-1,9911830,3.594040176900685
SK-LU-1,107985,-3.118655364766745
KMRC-2,44491742,3.971638428490517
YAPC,3689413,3.09003195173071
EHEB,sirolimus-bortezomib (250-1 mol-mol),-0.8631286071127797
OPM-2,9927531,3.0625153090482757
TE 441.T,12003241,-1.1939319008466374
LCLC-97TM1,44491742,4.237702230509644
SNU-201,selumetinib-vorinostat (8-1 mol-mol),2.4684445780418023
SNU-1077,148198,-1.03431054543621
DAN-G,tanespimycin-bortezomib (250-1 mol-mol),-0.938511355699207
G-401,6610216,3.9425308150709
HCC1588,107985,-2.184487222231667
RCM-1 [Human rectal adenocarcinoma],9903786,4.3108216230747685
JIMT-1,136227924,4.112902711551938
Capan-1,409805,5.822948169887318
HGC-27,107985,-4.025909310335491
NCI-H1568,44493528,4.1542795967274175
SR,46943432,1.3532913979077017
COLO 829,148198,-3.4268778382536715
Hs 578T,26596,-0.9561374383661984
L-363,136227924,2.122664399399679
NCI-H1915,107985,-3.9185583163314064
VMRC-LCD,3689413,-0.1897073669297062
DK-MG,26596,-1.5409696775062258
F-36P,168313200,3.2109752739746886
SK-MEL-24,9936388,-2.668445536248577
HCC-56,8515,4.24827596622419
P3HR-1,409805,3.946032344990011
SK-N-SH,selumetinib-GDC-0941 (4-1 mol-mol),1.1074164821021857
NB1,6918878,0.3294623972570419
FU-OV-1,409805,4.026686349090877
LCLC-97TM1,10296883,3.762301074740285
WM793,5460769,5.840780592325561
SF539,107985,-2.833720447652478
U-937,9927531,3.434526864785126
BFTC-909,159324,4.114702101808939
NCI-H650,sirolimus-bortezomib (250-1 mol-mol),1.8480757652183293
Rh18,6610216,4.042060041352345
ME-1 [Human leukemia],159324,1.0154515833105568
NCI-H2106,11404337,-0.0060242090595341
23132/87,135875424,3.8304583590646897
KMH-2,24180125,2.3529996714086066
8505C,9911830,2.534826327044656
Hs 683,9927531,5.316569157291169
HCC366,26596,-1.6336746121015082
DEL,8515,2.936663368218975
HEC-1-B,11404337,0.5872322910444284
OCI-AML-3,100016,6.665392900980702
NCI-H2172,168313200,3.683168062347926
BHT-101,6610216,4.6700039739173205
OCI-AML-5,36462,-0.4701169998838825
SNG-M,246676,4.426055935007725
NCI-H2452,selumetinib-vorinostat (8-1 mol-mol),3.054936641040398
Kasumi-1,tanespimycin-bortezomib (250-1 mol-mol),0.2568876868109762
SNU-466,6610216,4.064309540178012
NCI-H2126,135423438,4.586735604556358
A2058,sirolimus-bortezomib (250-1 mol-mol),2.018085480755274
JK-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.1404611397538406
SNU-308,100016,6.582722131637771
OE21,JQ-1-carboplatin (1-1 mol-mol),0.5069290847889931
PE/CA-PJ49,10322450,5.083749464761158
HT-1197,10322450,2.509794666751626
OE21,26596,-3.6158126221637823
OV7,9927531,3.7573149322821937
NCI-H526,24180125,2.1649005849600123
SF539,9926054,1.722417855539817
Caov-3,107985,-4.513463353783752
KMS-27,9926054,0.4648817543416692
TUHR4TKB,148198,-1.0832218520186652
VMRC-RCW,tanespimycin-bortezomib (250-1 mol-mol),1.6092697528768949
NCI-H1944,26596,-1.3994203937624
Becker,tanespimycin-bortezomib (250-1 mol-mol),-0.8898597294862367
T98G,12003241,-0.2247982599387034
AN3-CA,409805,5.126415304640116
DB,26596,-3.691509767021521
T-47D,6610216,3.903210630252733
DEL,9927531,3.262771629290843
EBC-1,11404337,-0.1600536834306797
HT,6918878,0.4537458311997102
697,12003241,-3.737782369602395
LN-18,12003241,2.3352832275998927
KYO-1,44493528,4.460522325437717
HT-1080,168313200,2.6364388215014034
Ku812,107985,-3.8161281001358778
NCI-H23,9911830,1.4364857950022207
OE33,168313200,4.319769864025677
Ri-1,54618164,3.351620474259991
NCI-H1869,12003241,-1.5114527115730307
SJSA-1,107985,-2.8850477592405044
HEC-6,136227924,2.983713037764577
THP-1,11404337,-1.5285516507486518
NCI-H2030,9903786,2.824655549380346
Calu-3,54618164,4.033225679465255
NCI-H2405,409805,5.061737779017571
HDQ-P1,selumetinib-GDC-0941 (4-1 mol-mol),1.336429644847675
MOLM-13,9926054,0.378361077880871
MEC-1,262093,1.0111827141937222
U266B1,selumetinib-vorinostat (8-1 mol-mol),1.5567800488837416
SCC-25,159324,1.9288959923249809
ChaGo-K-1,54618164,3.816944034787713
OCUM-1,11485656,1.6413054231904327
OCI-AML-5,3689413,0.2797126247075585
NCI-H889,24180125,3.2522529388237804
SW982,409805,3.909566266382756
LXF 289,159324,2.685439807189008
Caki-1,11485656,3.9506876057193456
A-253,3136844,4.211620401302874
SCC-9,100016,6.423023301160456
SH-10-TC,148124,-4.410168498577838
BT 340,tanespimycin-bortezomib (250-1 mol-mol),0.797080968963508
AsPC-1,439501,-1.6009280184427317
NCI-H1975,12003241,-2.295585009641022
Daoy,5460769,2.932419907525853
SNU-1196,107985,-3.2649450239606166
KYSE-510,6505803,-1.66043256037682
KNS-81,9926054,3.3411524859237196
SW1417,12003241,-2.0835943723769184
Calu-3,135875424,4.098138876247088
HPB-ALL,26596,-2.8269771859665824
RCM-1 [Human rectal adenocarcinoma],54618164,4.275813843135039
KMS-27,26596,-2.324040117520084
JIMT-1,9926054,3.6367846725262543
LOU-NH91,24180125,2.532676427085935
NCI-H1568,9926054,1.8156743035592564
SNU-668,262093,3.825984415177203
OVCAR-8,11404337,-0.7516792511202276
HEC-108,selumetinib-vorinostat (8-1 mol-mol),3.960684910603258
NCI-H1623,44493528,4.638812765070766
HCC-56,148124,-1.9552943365805164
HCC1395,9877608,6.36391605144629
THP-1,73707440,3.8767846220301254
NCI-H2087,tanespimycin-bortezomib (250-1 mol-mol),-5.178784245038985
SNU-1105,409805,3.776970125526721
MOLP-2,11485656,2.290738081221924
NALM-6,12003241,-1.6085171342218008
COLO 684,107985,-4.706181112932697
MOLP-8,6505803,0.6382990348001342
NCC-StC-K140,11485656,0.9204064726485376
NCI-H2122,409805,6.0508402213506995
JHH-4,148198,-4.065659017093723
COLO 684,9927531,4.094715698749933
JHH-4,135875424,4.647713249642841
SK-N-MC,439501,-1.9559444468392349
MOLT-3,148198,-7.168257541547073
SUIT-2,136227924,3.4861054974924133
BT 164,12003241,-0.888203268787868
SK-MES-1,44491742,3.681896184622424
SNU-503,10296883,4.26792397433306
MJ,439501,-3.472446137047906
JHH-4,148124,-4.377939547333403
MOLT-16,JQ-1-carboplatin (1-1 mol-mol),0.2899951204011434
MES-SA,9927531,4.955649444081026
KO52,10296883,3.770873498157397
CAL-62,136227924,2.2921842664772996
NCI-H1155,136227924,2.9905910988633653
8-MG-BA,6505803,0.3942705554258823
CGTH-W-1,6918878,3.434325794835093
NCI-H647,100016,4.3873613110575045
Calu-3,11404337,-1.5161569407168425
SNU-119,sirolimus-bortezomib (250-1 mol-mol),1.5818216209728622
M-07e,262093,1.9323160486424649
CAMA-1,9877608,5.870182576067418
NCI-H69,6610216,4.4991786369679
DU4475,135423438,2.3536121101855096
PC-3,135423438,4.806220333593262
SUP-T1,5460769,2.284635628978783
MPP 89,439501,-3.0783668430470574
COV644,107985,-3.1393219510283186
KE-97,9911830,1.897580149964957
HCC202,135398744,6.455993552330763
SNU-668,409805,3.673506618604681
Capan-2,12003241,-1.76044802004158
SW982,26596,-1.3061424276940652
TYK-nu,6505803,-1.946353341465887
NCI-H508,6505803,-2.7126843112816927
CAL-54,24180125,3.209095438677072
NCI-H520,6505803,3.2437812579556864
IGROV-1,36462,2.313632721410001
VMRC-LCD,168313200,3.7179740407892905
COR-L95,246676,4.317733637680926
KP-N-SI9s,11485656,2.178887968945585
WM115,9903786,3.894434750277636
SNU-869,148198,-3.291202366312453
HT-1080,135423438,3.624839631641402
SU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8883081844697346
SK-MES-1,168313200,1.727184472049229
BT 416,9911830,2.72024665816752
FTC-133,6610216,5.488595178062795
SK-N-FI,36462,3.092698670043595
GA-10,11485656,1.0334565111558187
RT-4,11404337,1.401838262846579
Panc 08.13,6918878,3.4044480333146967
KP-4,11404337,0.6488423054091234
RPMI-7951,135875424,3.929226739625062
GI-1,24180125,3.248267375077655
ECC12,6918878,5.726458908114562
NCI-H1568,11404337,-0.63897934294681
G-361,135875424,3.221019513636021
TE 617.T,24180125,2.0821537489988544
NCI-H1105,26596,-1.464012997205303
HCC1588,11485656,2.115335412589631
NCI-H2110,49836020,-1.7351781152481929
COLO 741,selumetinib-vorinostat (8-1 mol-mol),2.423544405127772
NCI-H1581,selumetinib-GDC-0941 (4-1 mol-mol),1.7228993365162983
BT 271,10296883,4.284017476819925
Hs 940.T,6610216,3.790705993515773
Fu97,168313200,3.8201234302700495
WM1799,409805,4.869414940452359
CL-34,JQ-1-carboplatin (1-1 mol-mol),-1.7099551390648522
UM-UC-3,5460769,6.395850795756177
SW948,11404337,1.0073661261070797
JJN-3,selumetinib-vorinostat (8-1 mol-mol),2.2771818627598224
TALL-1 [Human adult T-ALL],11485656,1.8418453381137807
LN-229,9911830,2.743513873470427
U-118MG,9911830,2.523465793576531
HEC-1-A,54618164,4.25244148271506
Aska-SS,6918878,2.6155918137055973
HCC1833,9927531,4.651328537031639
T84,9927531,3.2336753080400933
23132/87,tanespimycin-bortezomib (250-1 mol-mol),-3.0777539592464227
HCT 8,11485656,2.552597628159539
BCP-1,11485656,1.531241298696853
NCI-H1869,3136844,4.70710828326211
NALM-6,3136844,3.4851668680664183
SNU-201,44491742,4.436109231936613
NCI-H69,sirolimus-bortezomib (250-1 mol-mol),0.0331466406346395
TE-4,439501,-1.5576935303532289
NCI-H2009,6610216,3.953101400309774
A-673,44493528,4.641329710074662
OCI-AML-3,tanespimycin-bortezomib (250-1 mol-mol),-0.5201119154164948
NUGC-3,100016,7.160996607387645
VM-CUB-1,135875424,5.069346685135383
NCI-H2141,36462,2.278510684114093
Capan-2,11404337,0.168585594733678
F-36P,148198,-5.732875507822739
SNU-175,24180125,-0.5173296686160461
TF-1,3136844,4.662605998237821
KCL-22,6505803,-0.612713471586346
PaTu 8988s,439501,-3.8776790772528864
SNU-C5,selumetinib-vorinostat (8-1 mol-mol),1.5322725159443586
GI-1,168313200,3.205196000452743
NCI-H647,9927531,5.004225610104877
COLO 699,9903786,3.444453349709646
EC-GI-10,135875424,4.9830420551116985
SCC-25,36462,4.497362805225712
NCI-H838,168313200,3.790005263370213
THP-1,3136844,3.371273574787836
CAL-27,439501,-1.3320445705497543
Ri-1,136227924,2.363884089308993
MG-63,9927531,4.972527766781062
Caov-3,sirolimus-bortezomib (250-1 mol-mol),1.7880451090258302
SF126,11485656,3.3837301563498894
Karpas-422,409805,3.3322180704918876
NCI-H1944,135423438,6.01931856981719
TE 441.T,54618164,3.69134760573576
MES-SA,168313200,-2.8250067617566836
Daudi,36462,-1.782907247885185
SW48,9926054,0.5681768331785455
Hs 944.T,6918878,3.000494670640756
U-BLC1,54618164,4.010954810772503
BT 239,36462,-0.612323435298888
OAW42,262093,3.645720807716878
KNS-60,3689413,0.5613903891454114
KMRC-20,44493528,4.509843443263092
TE-11,9903786,1.6089543664279713
OE33,9936388,2.0912313369341287
HT-1376,9936388,2.4935299933788957
SNU-685,5460769,1.3668159641558515
OVCAR-5,3689413,-2.1267579766056297
PF-382,24180125,1.6002910588088834
LS513,selumetinib-GDC-0941 (4-1 mol-mol),-1.1553983681711826
HSC-3,selumetinib-vorinostat (8-1 mol-mol),1.9164073521640128
MDA-MB-468,selumetinib-vorinostat (8-1 mol-mol),2.32454994055681
NCI-H2291,100016,7.4079580735543695
WSU-DLCL2,tanespimycin-bortezomib (250-1 mol-mol),-0.4826072076602557
A4/Fukuda,10322450,2.3588003127389277
QGP-1,439501,-1.697500396570699
A2058,136227924,2.613575897416718
NCI-H522,9911830,2.121034111225194
Hs 888.T,11485656,1.7034904053704143
BT 504,tanespimycin-bortezomib (250-1 mol-mol),-4.273282009198175
UACC-62,tanespimycin-bortezomib (250-1 mol-mol),1.2383620234994217
Hep 3B2.1-7,36462,2.768405314394988
SK-N-FI,12003241,-1.9986022359494329
NUGC-4,9903786,1.3800210436357438
OE21,107985,-4.136076680497118
HT-1080,148124,-7.262422789124051
5637,46943432,1.451495143544235
JHOM-1,3689413,0.7537035675764964
NCI-H1944,10322450,4.686726867812177
Hs 852.T,49836020,3.510211812103559
TCCSUP,246676,4.500819346374967
ACHN,12003241,-1.5952093864502457
YD-10B,5460769,-2.041920161211882
A-549,409805,5.689640893560965
697,168313200,1.615213458575926
SK-MEL-24,24180125,2.040624055714523
A-172,10296883,3.776077319077153
LN-18,148198,-2.0225880392940043
SR,10296883,3.1802245137675533
JK-1,409805,3.271370781273113
HEY A8,9926054,2.010020919181283
SK-MEL-24,tanespimycin-bortezomib (250-1 mol-mol),-0.1831765254782449
G-292 clone A141B1,11485656,2.845386478997394
HCC2108,12003241,-1.7779849182593923
HuNS1,36462,-2.348831996229756
DEL,46943432,4.922842544494177
MPP 89,8515,4.682001144094345
NMC-G1,6610216,4.832544305447151
RMG-I,3136844,3.728255197307183
JHUEM-2,24180125,2.3682289915123107
BT-20,9911830,2.435320622289844
TF-1,24180125,3.3571261304067326
SK-MES-1,9911830,2.0090126357404334
IMR-32,12003241,0.5902035807991148
SW1088,9911830,2.786109605650585
KATO III,409805,6.010441126415053
NCI-H2452,11404337,-0.3859535574072682
NCI-H2444,36462,2.8343186120313875
NCI-H1573,24180125,3.4680270269053173
Rh41,6505803,-0.6098068443145847
HCC1806,107985,-4.0802412440696525
NUGC-4,selumetinib-GDC-0941 (4-1 mol-mol),-2.271366643531445
SNU-886,6918878,0.4224764612922807
CL-11,6505803,0.4915645691833006
ACC-MESO-1,136227924,3.807440016829928
BT 187,262093,2.657149541546316
NCI-H2141,9926054,1.978492871362738
HCC15,selumetinib-GDC-0941 (4-1 mol-mol),-0.1827234466059498
HuP-T3,10296883,4.266239948990751
SU-DHL-8,selumetinib-GDC-0941 (4-1 mol-mol),1.9311696765253152
A-204,26596,-0.948226132815995
MIA PaCa-2,12003241,-0.7993036743010778
THP-1,3689413,0.1739337887776562
TALL-1 [Human adult T-ALL],9903786,1.5190576712457438
Capan-1,5460769,0.8848211247496085
GDM-1,6610216,3.672528817791422
NCI-H2342,262093,3.257524790305271
WM88,8515,4.23444504306986
RD,26596,-1.141843302094684
FTC-133,11485656,4.087051585535102
Hs 895.T,11485656,3.207979584674572
HCC2108,6918878,2.040858445754197
SNU-620,12003241,1.204190065135074
SK-N-DZ,10296883,0.393447388652097
CCF-STTG1,148124,-4.009391944909006
YAPC,54618164,4.31457100114165
HEL 92.1.7,135875424,3.148841904096567
SNU-216,selumetinib-vorinostat (8-1 mol-mol),2.415634869676137
OVSAHO,3689413,-0.988138970272714
SK-N-MC,100016,6.319948334432407
NCI-H1915,24180125,3.781606905137401
FaDu,24180125,2.984010742515135
BT 271,6610216,4.282258740589861
C2BBe1,9936388,0.7937210910014248
TYK-nu,168313200,2.5919880239615702
Mel JuSo,168313200,3.445079379631
SUP-HD1,3689413,-2.4864416841895727
NCI-H1734,36462,-0.544254253022864
LS513,5460769,-0.3272270852290284
KMS-27,12003241,-0.3161890721272481
SNU-620,44493528,3.907657594721087
Daudi,24180125,1.1000611971852634
HEC-59,9936388,2.590780507756847
SNU-46,262093,2.777218393099506
SCC-4,439501,-2.9533139403217397
MOR/CPR,selumetinib-GDC-0941 (4-1 mol-mol),2.600932232406458
HD-MY-Z,6505803,-1.982363986131319
NB1,148198,-3.561565130564965
SNU-216,100016,6.2010021575017085
SF268,148124,-4.891183212360556
MSTO-211H,10296883,3.6762481855456985
ML-1 [Human thyroid carcinoma],54618164,4.279062995535924
Ki-JK,46943432,0.1274829489062179
LXF 289,selumetinib-vorinostat (8-1 mol-mol),2.464198116249673
GI-1,12003241,0.5382171766517799
SNU-620,136227924,2.4539673197881444
CCF-STTG1,24180125,3.0142725993324064
OVCAR-5,135875424,2.7043210388951007
SW1783,3689413,0.540292166648154
HCT 116,5460769,4.292752734346336
MOLP-2,136227924,2.531478892468582
KE-39,11485656,2.227722528153515
2004,148198,-5.483041404726115
WSU-DLCL2,107985,-2.886863580578064
253J,11404337,0.3224352985838272
MOLP-2,9926054,1.6077834745045567
HuP-T4,6918878,0.4133269939354803
KYSE-150,168313200,3.874457481179803
BT 340,6610216,4.188331565981621
HEC-59,409805,5.86459561757921
HPAC,262093,3.184189581983291
SUP-T1,9911830,2.159346176314347
DND-41,selumetinib-GDC-0941 (4-1 mol-mol),0.5695513725916952
NU-DHL-1,9903786,2.0090459538270298
SNU-840,selumetinib-GDC-0941 (4-1 mol-mol),1.257752895410429
Caov-3,159324,2.774791318971609
SNU-1,tanespimycin-bortezomib (250-1 mol-mol),-2.9967147031928247
Mono-Mac-6,9911830,2.162103940200585
COLO 829,168313200,2.1419064065737277
A3/Kawakami,11404337,-1.3571350042405983
Hs 578T,JQ-1-carboplatin (1-1 mol-mol),1.3034632234881312
AML-193,36462,0.2235615608129252
KYO-1,10296883,3.465187781350624
KM12,135875424,3.0557052091310357
SF539,JQ-1-carboplatin (1-1 mol-mol),0.897119179584113
KYSE-450,9936388,-0.9236320595886032
NCI-H889,selumetinib-vorinostat (8-1 mol-mol),2.358779197358101
VMRC-LCD,262093,2.9924485884433496
SK-ES-1,9936388,-6.72300625347337
SNU-601,selumetinib-vorinostat (8-1 mol-mol),2.1558363641207574
AU565,148198,-3.941648532890003
TTC-709,148124,-6.07552333900772
KPL-1,9936388,1.598306973451347
HCC-56,3689413,0.2080037745541134
JHOS-2,9911830,2.474516020576313
MHH-CALL-4,6918878,0.3808806294186813
MIA PaCa-2,46943432,1.539225582233631
NCI-H520,148198,-5.585206831860286
RVH-421,6505803,-0.8379256184936457
BL-70,9926054,1.763509439822291
WM88,tanespimycin-bortezomib (250-1 mol-mol),-2.8916470647545007
SNU-449,10296883,3.939630786750968
A4/Fukuda,selumetinib-GDC-0941 (4-1 mol-mol),-1.0916711617769086
HT-55,selumetinib-vorinostat (8-1 mol-mol),1.1562866602293844
CADO-ES1,11404337,-1.7839684618435203
PaTu 8988s,135423438,2.605491208286135
Kelly,5460769,2.22696841800341
COR-L105,439501,-1.395093001857319
TE 617.T,136227924,1.63601430884803
MHH-CALL-3,11485656,2.28461838550351
Daoy,JQ-1-carboplatin (1-1 mol-mol),4.339760854193934
HEC-251,246676,4.542645339130495
COLO 792,9936388,1.0587943491174894
Kasumi-1,9926054,1.808732421420859
JHUEM-1,107985,-5.021141551070729
WM115,168313200,2.1363369230808593
SKM-1,3136844,3.4979321802253356
BT 498,tanespimycin-bortezomib (250-1 mol-mol),2.266327980943949
GSS,54618164,3.355805594093071
SCaBER,439501,-1.925365534311937
MV4-11,selumetinib-vorinostat (8-1 mol-mol),-0.5147725533384067
OVTOKO,262093,5.058822079580486
SIG-M5,10322450,3.963755242230549
AN3-CA,439501,-3.229124904343767
SNU-398,24180125,2.40534960031443
OE19,409805,5.918872403397379
HCT 15,9926054,1.8634175733293992
TYK-nu,6918878,2.871547029078655
SF126,26596,2.229943441766346
HMCB,9936388,-4.997946026418023
JM-1,135423438,1.5495237102322077
SNU-489,11485656,3.634321717493026
Sq-1,sirolimus-bortezomib (250-1 mol-mol),0.8750306611034651
DMS 53,439501,-4.4060490975057105
HCC1419,sirolimus-bortezomib (250-1 mol-mol),0.331590407982584
EFM-192A,11404337,1.8904479261466252
SCaBER,10296883,4.146798449581147
HT-144,54618164,3.7938447611530943
SNU-8,439501,-2.494664293068585
DV-90,tanespimycin-bortezomib (250-1 mol-mol),-3.2159049827612356
JJN-3,26596,-2.098638975777458
MDST8,10296883,3.644541291105843
LS513,selumetinib-vorinostat (8-1 mol-mol),-1.1646642615707117
NCI-H1184,5460769,-0.2786372914944621
UO-31,3136844,4.104054660565046
Hs 683,5460769,1.3545224877290158
Ri-1,46943432,0.5214586687647272
MDST8,46943432,3.6174081091701886
42-MG-BA,12003241,-1.3085155086024562
AN3-CA,12003241,-2.637522524679412
TE 617.T,6505803,-2.094273905964543
KMS-12-BM,148198,-2.3401169496211778
SNU-398,selumetinib-vorinostat (8-1 mol-mol),2.491417659337193
SNU-410,selumetinib-GDC-0941 (4-1 mol-mol),3.3998532572052205
SU-DHL-10,100016,5.73425222116556
Capan-2,9911830,3.0690916513278665
TCCSUP,9903786,3.558837088709428
L-428,JQ-1-carboplatin (1-1 mol-mol),-0.0487798287789179
Caov-3,26596,-1.3429927330101894
KYSE-30,36462,2.847864502569603
KHM-1B,136227924,1.9174951940989704
NCI-H460,262093,3.3627537421549314
Hs 294T,54618164,3.87714618988063
253J,44491742,4.062821625609178
HCC44,36462,1.2916349335156851
HDQ-P1,11485656,2.7842616734423116
SaOS-2,54618164,4.337585482929099
CCK-81,10296883,3.3537849250565244
BT 164,sirolimus-bortezomib (250-1 mol-mol),-0.1632601406357518
BICR 18,107985,-2.7131410229776916
MFE-296,11404337,-0.7207303053792228
Hs 888.T,135875424,5.931085085521744
AN3-CA,148198,-4.708662281337999
BT 131,148198,-4.140585549230615
Rh41,11485656,2.1642426716140877
DND-41,12003241,-0.2098098510645495
JIMT-1,JQ-1-carboplatin (1-1 mol-mol),6.316159128553351
SYO-1,sirolimus-bortezomib (250-1 mol-mol),0.8994859794760022
HCC44,49836020,-1.9143926504163185
OVTOKO,54618164,4.681056230171988
BT 498,262093,3.072055867790356
CL-11,selumetinib-GDC-0941 (4-1 mol-mol),-0.9577137132947868
HCC2279,sirolimus-bortezomib (250-1 mol-mol),1.5842839132976092
BL-41,3689413,2.890540357567194
CAL-85-1,tanespimycin-bortezomib (250-1 mol-mol),0.6735355915529317
P12-Ichikawa,6610216,3.76430503895136
CAL-85-1,JQ-1-carboplatin (1-1 mol-mol),0.6697793962766999
BICR 18,selumetinib-GDC-0941 (4-1 mol-mol),2.10893562893339
SNU-46,sirolimus-bortezomib (250-1 mol-mol),2.213576797303729
KYSE-30,6610216,4.130988054246519
EKVX,9936388,2.132401654750859
Detroit 562,36462,3.393501213812867
NCI-H2171,JQ-1-carboplatin (1-1 mol-mol),1.7298129528217236
DMS 114,135423438,1.5631091750684547
ONS-76,9911830,2.941904202808556
AML-193,5460769,4.1891717596196205
PF-382,54618164,3.241191825495517
KYSE-520,10296883,4.455912187683782
JIMT-1,3689413,-1.7375587293018775
J82,selumetinib-GDC-0941 (4-1 mol-mol),2.8384419330971147
NCI-H28,10322450,4.072990606284223
NCI-H2342,409805,3.827518181723478
CAMA-1,44493528,5.154958060978957
A-375,54618164,4.173421291280232
SNU-449,54618164,4.194291334344069
SW982,6505803,-2.367469745570856
SK-MEL-28,tanespimycin-bortezomib (250-1 mol-mol),0.8284351953237586
253J,439501,-2.369438844197353
IGR-37,selumetinib-GDC-0941 (4-1 mol-mol),-0.4447244170730294
Hs 888.Lu,136227924,2.7652519196534304
Mono-Mac-1,9903786,0.9536797288397608
NCI-H23,36462,-0.3281376255972362
CML-T1,6918878,-0.7643857619236708
HCC1833,100016,6.427561679501585
HEL 92.1.7,12003241,-0.5838184983387604
Karpas-422,24180125,1.2333390816210612
786-O,11485656,3.3310875403182423
OCI-AML-3,168313200,1.726224147374737
NCI-H196,49836020,1.0558785681395022
Namalwa,11485656,1.3808834074055636
TUHR10TKB,5460769,4.601270489376953
8-MG-BA,selumetinib-GDC-0941 (4-1 mol-mol),3.0365797378883843
SNU-1105,9911830,2.1691133985089195
NCI-H1650,439501,-0.6894352308557807
OV7,36462,2.3597249794920785
BT-549,6610216,4.341228931549091
DU145,10322450,6.851968050616261
Rh30,9936388,1.7390836835977532
A2780,6610216,3.3472253004646593
SK-MEL-24,sirolimus-bortezomib (250-1 mol-mol),0.9554095387328968
YD-8,135423438,0.9954856602627224
HEL,159324,1.7687894675630291
BT 330,sirolimus-bortezomib (250-1 mol-mol),0.7092263662862476
KYSE-410,8515,3.4355456987988666
SCaBER,tanespimycin-bortezomib (250-1 mol-mol),-1.0690096997886145
EFO-27,44491742,4.311239061696844
KMS-27,9903786,2.0838522642379216
KP-2,168313200,3.8973165337888807
AU565,36462,0.154728470238132
ALL-SIL,9911830,-2.857836139869332
EPLC-272H,46943432,1.437902766779572
RL,44491742,3.724190928980732
L-540,12003241,-2.1812715398766844
SIG-M5,9911830,1.8905574063855235
U266B1,135423438,1.4944799516316452
YH-13,12003241,-0.7443010060517422
PF-382,135423438,0.1628237790601052
PaTu 8988s,135875424,4.807406911194583
SK-UT-1,262093,2.998836933826174
SNU-8,9936388,-5.172305126613517
Yamato-SS,JQ-1-carboplatin (1-1 mol-mol),0.686256399915639
NCI-H1339,sirolimus-bortezomib (250-1 mol-mol),1.1828252918019528
MFE-319,10322450,5.941485697503465
SNU-1079,8515,2.981643349971088
SNU-1196,sirolimus-bortezomib (250-1 mol-mol),2.2031976803647075
LAMA-84,9926054,1.7519699359088703
NUGC-3,26596,-0.5443807488000636
MKN74,24180125,3.4034235920876648
DLD-1,11404337,-0.813522825038391
SK-N-MC,3136844,4.1184418986318665
NCI-H1573,tanespimycin-bortezomib (250-1 mol-mol),-1.6539350682626517
Daoy,9911830,3.4961153277182184
GaMG,439501,-0.9687040114702524
NCI-H929,54618164,3.87455268818749
RPMI-8402,135875424,3.838035457399833
EM-2,46943432,-0.289227345087642
8505C,selumetinib-vorinostat (8-1 mol-mol),1.1149126375147471
NCI-H1838,136227924,4.034071845409975
BT 440,409805,5.991281028290434
Sq-1,10296883,4.026329905742616
COV434,54618164,3.97479770969408
GI-1,11404337,-1.291312367049636
NCI-H2286,10296883,4.1413309005393755
HCC1588,9926054,1.7105432403142011
CHP-212,11404337,-1.6031269960117245
DV-90,3136844,3.815667519569427
OUMS-23,148198,-2.1659685214591664
BICR 16,135875424,5.068625182385868
SUP-B15,136227924,1.2725004934322246
KMS-34,100016,4.459610626448404
MHH-NB-11,9927531,4.251740517213762
KNS-81,11404337,0.4763039315570028
RERF-LC-Ad2,9927531,7.758899930646885
KO52,262093,1.2878327274871448
M-07e,148198,-7.025596172971479
SNU-387,JQ-1-carboplatin (1-1 mol-mol),2.560433008803645
CML-T1,148198,-3.9003291277504526
OCI-AML-5,9903786,1.179944382770948
Jurkat,136227924,2.4803602069258712
ME-1 [Human leukemia],54618164,3.464632833073843
SNU-1033,3689413,-2.6391429266703015
DOV13,5460769,1.9787074160604587
Panc 08.13,12003241,-0.6066963298008116
NCI-H226,9903786,4.103639248775795
GSS,9936388,-5.73118994601309
SNU-16,136227924,1.93853165721534
JVM-3,10322450,3.1045130110101335
IST-Mes1,11485656,3.5408910362273835
NCI-H2122,136227924,3.797810316623325
NCI-H1755,sirolimus-bortezomib (250-1 mol-mol),0.7810995530072428
COR-L51,10322450,3.875976126745678
Calu-6,11485656,1.862079385018863
HARA [Human squamous cell lung carcinoma],24180125,3.640570848683534
Panc 10.05,9927531,5.445272240057394
GA-10,54618164,3.873784446701225
NCI-H1838,9927531,5.140983076545055
AML-193,54618164,3.973133793220512
TE-8,26596,-1.186583847807299
SW948,11485656,1.7814283284456571
NCI-H838,24180125,5.001007503284622
RL95-2,159324,-0.02735038906911
LS123,135875424,3.499213265654359
RL95-2,8515,2.830616732584445
Pfeiffer,148198,-5.248523074657563
A-673,9903786,1.5948741514342302
T98G,168313200,3.906117729639882
B-CPAP,10322450,5.621210843033534
EM-2,439501,-2.360437246727397
HEC-265,409805,6.072404202005754
SW982,6610216,5.052310120816527
NCI-H838,246676,4.96378057345008
KMS-11,8515,2.0394013986639066
LCLC-103H,selumetinib-vorinostat (8-1 mol-mol),2.6611498366022763
REC-1,selumetinib-GDC-0941 (4-1 mol-mol),5.111180510517744
SNG-M,49836020,6.278284295689695
Malme-3M,selumetinib-GDC-0941 (4-1 mol-mol),-2.272222861013609
HCC2218,6610216,3.6192910247057113
CAL-51,36462,0.7338920585832341
IPC-298,3689413,3.077795295387571
KYSE-410,107985,-2.92528025460227
IGROV-1,3689413,-0.3633634632064185
VMRC-RCW,100016,5.733604538717687
BICR 16,136227924,2.8848408076895393
786-O,148124,-4.286157152066718
RERF-LC-Ad2,3689413,-2.3718681179327143
PE/CA-PJ49,36462,0.5276653245054587
ONS-76,439501,-2.2755976390662163
Karpas-299,selumetinib-GDC-0941 (4-1 mol-mol),2.273668184734746
SNU-503,JQ-1-carboplatin (1-1 mol-mol),0.9047504626214904
CAL-78,11485656,3.0303268993035233
SET-2,tanespimycin-bortezomib (250-1 mol-mol),0.2740236023779227
IPC-298,5460769,5.755627361996784
HEY A8,159324,3.154250268026962
JIMT-1,135875424,5.902712544312733
DU4475,439501,-1.9980477376201553
EB1,148198,-5.218004052941106
A-549,159324,3.3469799601732366
BT 444,439501,-3.015846554822595
NCI-H1395,9936388,2.8582059793440964
MOLT-3,44491742,3.801093183463652
TTC-709,148198,-6.610156845026196
SUIT-2,11404337,0.4217329969696077
LS1034,107985,-4.1764612715233325
SCC-9,tanespimycin-bortezomib (250-1 mol-mol),-0.5584640053775825
SNU-449,107985,-3.1392486992039235
LXF 289,6918878,2.1668969721619833
KYSE-70,5460769,2.831605222646697
MHH-CALL-4,44493528,4.165612428769394
JVM-3,3689413,-1.6537581501619123
TALL-1 [Human adult T-ALL],12003241,-0.6623785293924347
THP-1,12003241,-0.95805458474302
Hs 729.T,100016,6.726636381823557
NCI-H2081,selumetinib-GDC-0941 (4-1 mol-mol),2.2419889571626146
AN3-CA,JQ-1-carboplatin (1-1 mol-mol),4.617910971387189
SW579,JQ-1-carboplatin (1-1 mol-mol),2.4764812172650905
HuP-T3,54618164,3.3933985234085755
EoL-1,107985,-5.04062397019842
SNU-C1,9927531,4.924275506690927
CGTH-W-1,sirolimus-bortezomib (250-1 mol-mol),1.647706898870075
JHOS-2,11485656,3.1858119636686104
42-MG-BA,5460769,1.54562912999154
MFE-296,JQ-1-carboplatin (1-1 mol-mol),2.681039150373503
G-361,9911830,2.7036070449516956
IPC-298,409805,5.061629156209871
PaTu 8988t,135875424,4.8815767191826325
COLO 320,9927531,3.3062100750903594
WM266-4,12003241,-2.6604387870862745
NCI-H1703,selumetinib-GDC-0941 (4-1 mol-mol),1.0120925414359212
HCC1954,11485656,2.196220765169822
HCC1195,262093,3.0706321230019635
Hs 940.T,9911830,4.550926661212335
647V,3689413,-0.9737590954891844
NCO2,24180125,1.8902157789920653
Capan-1,6610216,4.674579245931144
SNU-387,sirolimus-bortezomib (250-1 mol-mol),0.5952265743447468
HT115,135875424,4.178256004737694
LOX-IMVI,tanespimycin-bortezomib (250-1 mol-mol),-2.013401423677256
OCUM-1,26596,0.6196247278484265
VM-CUB-1,6505803,-3.0574642511129833
CAL-33,selumetinib-vorinostat (8-1 mol-mol),3.0707076397558204
SNU-8,tanespimycin-bortezomib (250-1 mol-mol),1.1303799126997314
TE-15,262093,3.281434334474844
Pfeiffer,54618164,3.4474799956716344
SW48,9936388,-6.68623848822316
TE-14,10322450,4.592810153102171
NCI-H1666,tanespimycin-bortezomib (250-1 mol-mol),-4.94228815381926
SK-MEL-3,24180125,3.765958030378214
Hs 766T,439501,-3.031090708237588
SU-DHL-1,9936388,0.846879508636978
COLO 680N,148198,-2.677671359011621
SW1417,11485656,1.9814975690953165
SNU-C2A,12003241,-1.200287436461147
8505C,11485656,2.524843425328081
TOV-21G,sirolimus-bortezomib (250-1 mol-mol),-0.0646182362217989
FaDu,107985,-4.115257007798789
HEY A8,49836020,5.6501572313244885
SU-DHL-10,26596,-1.8221428143230487
MKN7,9926054,2.9968312406373574
ECC12,135423438,4.440785881559049
DEL,3689413,-2.5284347391762583
ONS-76,100016,6.019166856387977
NCI-H1373,409805,5.070955449061009
647V,26596,-2.3148144516989184
Detroit 562,selumetinib-GDC-0941 (4-1 mol-mol),2.228637480790017
MKN7,9927531,4.538796074024755
UM-UC-1,3689413,0.3078714826369425
Rh30,5460769,3.928559830912204
OVK18,36462,1.291640660059096
PSN1,100016,3.987578982943132
TE-8,9903786,2.2578315560817432
Mino,12003241,-3.278689335869641
KMM-1,246676,5.888531841272029
DMS 273,selumetinib-vorinostat (8-1 mol-mol),1.928257280185898
NCI-H810,tanespimycin-bortezomib (250-1 mol-mol),0.3768886958286864
CAL-62,JQ-1-carboplatin (1-1 mol-mol),1.017398941700892
UM-UC-1,6505803,-2.248189153857155
IGR-1,6610216,4.151123445028036
Rh41,26596,-2.117854193038536
NCI-H520,sirolimus-bortezomib (250-1 mol-mol),-2.273461177298922
KMS-20,135875424,2.456374257858295
LK-2,12003241,-1.6123297720888603
NCI-H146,6505803,-0.3489025917214021
MSTO-211H,36462,1.134601353001676
NMC-G1,26596,5.43387943202461
WM266-4,262093,1.7934582046103504
CAMA-1,11485656,2.6355660526495672
CFPAC-1,selumetinib-GDC-0941 (4-1 mol-mol),3.108186987901354
BT 147,3689413,1.0613743234478148
TTC-709,439501,-6.296451607950602
SNU-878,46943432,1.577791022290007
SNU-719,9903786,2.245774395512323
NCI-H1563,262093,2.947853268609805
A-375,5460769,3.311565919469283
SK-N-MC,24180125,1.1647530142438975
SNU-449,439501,-4.772752939359215
CFPAC-1,12003241,-0.6323170147703681
SNU-308,54618164,4.492572736691696
KP-4,11485656,2.2916969527324778
Detroit 562,tanespimycin-bortezomib (250-1 mol-mol),-0.6563279140280487
DMS 273,135875424,3.231864587804135
MOLP-2,262093,2.2971706880531757
KMS-27,3136844,4.048697620753124
HSC-3,11404337,-0.7786873247989411
BT-549,10296883,4.161421407524775
HT-55,3136844,5.2572616579531495
8-MG-BA,54618164,4.752985073629535
KP-4,36462,0.4570460544879974
KNS-60,107985,-3.3035021977330947
Namalwa,135875424,3.1964963879327355
RERF-LC-A1,6610216,4.83230051596447
NCI-H2030,100016,6.672614959068411
COLO 201,409805,4.408175293808457
Hs 839.T,439501,-1.1818140450451011
SNU-C2A,439501,-1.0520759407127591
BV-173,11485656,1.9026592403549776
SK-N-BE(2),12003241,-2.145069511983118
Capan-2,tanespimycin-bortezomib (250-1 mol-mol),-2.4756483134960385
HDQ-P1,12003241,-0.8789475866858393
KP-4,9936388,-5.247407210845399
NCI-H1563,selumetinib-GDC-0941 (4-1 mol-mol),0.8971079477843085
Peer,9936388,-7.0845020379788375
JL-1,12003241,-1.4801638152381718
NCI-H810,3136844,3.780680530397454
CAL-62,439501,-2.324492116544492
M059K,9911830,3.9545777880747974
MHH-CALL-4,136227924,1.8406000029443903
COV362,26596,-1.9019545485387068
MDA-MB-453,100016,6.0730906594859215
HMC-1-8,6918878,2.927922453067082
SW1710,3689413,-0.3418925228905715
Peer,9911830,1.0689341420266956
NCI-H810,10322450,2.3502016572001696
WM88,5460769,5.637392858071443
SUIT-2,sirolimus-bortezomib (250-1 mol-mol),2.2579269293301527
SNU-182,10322450,3.100358710746125
NCO2,46943432,0.3319797897009531
HPB-ALL,46943432,0.8713024480628602
YD-10B,54618164,3.9161764608824
NCI-H2052,135875424,4.438161541518592
U-118MG,24180125,3.6933555825373983
U-937,6610216,3.792475471520531
Fu97,selumetinib-GDC-0941 (4-1 mol-mol),0.7041233813460074
MCF-7,9903786,3.2865331154211743
BICR 18,44493528,4.352077883289458
KMS-20,selumetinib-GDC-0941 (4-1 mol-mol),-0.2221231396150395
HuG1-N,148198,-4.107954267026698
MDA-MB-231,6505803,0.6630652134402967
EoL-1,tanespimycin-bortezomib (250-1 mol-mol),-1.822520413880902
Raji,9911830,2.8944128431666636
VMRC-RCW,10296883,3.756986073264271
JM-1,5460769,0.6255065324989537
TOV-21G,148124,2.58358749612027
CMK,9903786,0.6507335736439642
FTC-238,8515,4.054693228356072
HSC-4,9911830,2.7717739782698563
BT 498,11404337,1.4735257645837956
BT 271,6505803,-3.278165748164475
NCI-H929,46943432,-0.7846111801119194
GOS-3,3689413,-2.185831490776692
Hs 940.T,10322450,5.493990907316365
YKG-1,10322450,5.46076367923885
KATO III,54618164,4.165114309874091
HCT 15,54618164,4.134275975821386
TE-15,11404337,-0.7391616924820064
PC-3,3689413,-2.1836829404040157
NCI-H2029,9911830,2.286590910296229
OAW42,11404337,-0.3833970130425348
CHP-126,168313200,3.8336822443812686
SCC-9,selumetinib-vorinostat (8-1 mol-mol),3.604672449855193
MEC-1,135875424,2.225432824256911
YD-8,8515,3.9380466861306616
SJSA-1,26596,0.7775759099492098
NB4,100016,6.294523599868374
HEC-108,136227924,3.134071919213167
L-428,135875424,2.6389964210598937
HuT 78,9936388,-7.168553730777331
HCC2279,9936388,-5.134625350026444
HCT 8,6610216,4.632290111635945
SK-MEL-30,10296883,3.708722133804856
CAL-33,136227924,2.366373998099427
MKN74,JQ-1-carboplatin (1-1 mol-mol),1.391387927225722
U-251MG,439501,-1.7120275668154334
LK-2,44493528,4.239006121981403
L-540,9936388,-1.294007802651234
RL,9903786,3.83184195533614
NCI-H526,5460769,4.454179309152686
TE-11,26596,-1.418568182466745
LCLC-103H,12003241,-0.4608233539243975
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
KYSE-70,159324,1.7590392520862297
SK-N-FI,6505803,0.5825551569342805
BT-12,9926054,1.4917142795883798
BT 131,54618164,3.7702820257389273
MHH-ES-1,100016,6.165620846351705
SiMa,9927531,3.724506882989752
HuH-6,3689413,1.6433341745909646
SW1353,JQ-1-carboplatin (1-1 mol-mol),2.2379049663986437
HCT 15,262093,3.178837249101228
OVCAR-4,439501,-2.2754472098367855
SK-CO-1,JQ-1-carboplatin (1-1 mol-mol),4.771818519750647
NCI-H1563,44491742,4.074873654245284
HCC44,262093,3.638344184210184
BT 444,409805,5.849288534866383
NCI-H292,9877608,5.923265260718527
M-07e,26596,-2.7882078019466725
TE-15,135875424,3.16520710682736
HCC1833,49836020,-1.119955366422227
Hs 936.T,9926054,1.615791858991988
CW-2,10296883,4.166950774210748
RD,6918878,2.3101973120271837
SCC-25,44493528,4.171746510853467
PaTu 8988s,409805,3.706044847536148
BT-20,72199289,4.513177041132638
THP-1,10296883,3.2356206516906765
Reh,6610216,3.95214078902228
COLO 699,24180125,2.6222593496169058
NCI-H1341,11404337,-1.9361621115679644
A-204,107985,-4.730756256173954
SaOS-2,9927531,5.410264314347966
OV7,44493528,4.3650629685356055
G-401,9927531,4.9703255494446035
P12-Ichikawa,44493528,4.170368058365218
SU-DHL-1,3689413,-2.511818154735677
SNU-407,9936388,-6.677168792999783
LS180,159324,3.258862193159196
MeWo,135875424,3.994936562823645
SNU-C1,9911830,1.8520542621425748
NCI-H810,9903786,3.328850282444774
OCI-M1,3136844,3.8568484304541992
HCC1438,409805,6.120376102853313
OV-90,439501,-0.6322605477357213
Kasumi-2,3689413,-2.6905586087263043
SNU-1076,9903786,2.0917140595670585
BT 328,135398744,6.520469371663204
MV4-11,11404337,-1.0129181206141806
BICR 18,tanespimycin-bortezomib (250-1 mol-mol),-0.1167236068858008
NCI-H716,3689413,0.3516381459827891
COLO 699,9936388,-4.155221111232459
RKN,sirolimus-bortezomib (250-1 mol-mol),0.997863897964826
COLO 205,107985,-2.774548005987086
769-P,sirolimus-bortezomib (250-1 mol-mol),0.7451378442227841
WM793,135875424,3.1604105075223656
LXF 289,9926054,2.043368643335034
MFE-296,44491742,4.423113386396404
ECC12,6505803,-3.012781394546517
KYSE-180,136227924,3.113518519432139
YD-10B,262093,3.599984263013195
CAL-27,JQ-1-carboplatin (1-1 mol-mol),1.5591369487847715
BT 179,11404337,-0.0288044782393938
HCC2935,3689413,-0.3223376962809587
SW1463,439501,-0.3046644173954531
NCI-H2405,9903786,2.53791171783736
KMRC-3,44491742,3.892317452433475
ACC-MESO-1,6610216,4.642819431262072
MKN74,11485656,1.8439400608742984
WSU-DLCL2,9927531,3.1454575318264495
GA-10,12003241,-5.009664542431325
LNCaP clone FGC,6610216,3.917804193778173
BT 482,409805,5.470910874160514
TT,selumetinib-vorinostat (8-1 mol-mol),2.556499502295621
CCF-STTG1,10296883,4.282837475963798
HCC95,54618164,4.312739423514147
DV-90,12003241,-1.148500998331207
Lu-65,6918878,4.903767394022953
ESS-1,9903786,1.7886366060040666
GaMG,36462,3.666925262154629
U266B1,5460769,3.751565438771286
MOLP-8,10296883,2.725727750190508
NCI-H838,5460769,0.2411735941540018
HEC-1-A,136227924,3.4085098693584603
SK-CO-1,409805,5.790109243945559
HARA [Human squamous cell lung carcinoma],selumetinib-vorinostat (8-1 mol-mol),4.369788913914824
JIMT-1,sirolimus-bortezomib (250-1 mol-mol),1.70536390931118
647V,6610216,4.420166343003129
MCAS,JQ-1-carboplatin (1-1 mol-mol),0.8866425431722468
A2058,JQ-1-carboplatin (1-1 mol-mol),3.692426829341752
NCI-H358,JQ-1-carboplatin (1-1 mol-mol),-0.0841702060243808
MDA-MB-468,tanespimycin-bortezomib (250-1 mol-mol),0.8210992476411649
Hs 888.Lu,107985,-2.999004046519961
Lu-65,3689413,-0.1410308041132627
NCI-H2452,11485656,2.991875358712002
HuP-T4,100016,6.7159168289197915
EFO-21,148124,4.836772792254713
SK-LU-1,12003241,-2.6616586719339725
SCC-9,11485656,3.6663619913543446
JHOC-5,6610216,4.845168251413124
Hs 688(A).T,9926054,3.3187342382489255
JHUEM-1,439501,-3.414887087046791
CGTH-W-1,159324,4.090671308826511
MOLP-2,10296883,2.8483200317166935
OCI-AML-2,100016,4.069849166636085
SNU-620,sirolimus-bortezomib (250-1 mol-mol),0.2829661483143316
SW620,3689413,1.1437224923774536
KMS-27,3689413,0.1610585283674763
BT 416,9936388,-4.783265609756594
HARA [Human squamous cell lung carcinoma],9926054,1.843677597683555
A-673,6505803,0.2745970276233078
ZR-75-1,11485656,2.2776825234983087
BHT-101,26596,-0.678699585519716
Hs 852.T,6505803,-1.3832996341384214
SNU-308,439501,-2.437759024379206
SNU-620,135875424,4.164173792833431
TM-31,12003241,-1.3961411648113156
Panc 03.27,44493528,4.213944098974542
HEL 92.1.7,6610216,4.098541714440695
KMS-21-BM,44493528,3.35720206113814
SNU-620,159324,-4.60695282041012
NCI-H2291,3136844,4.370738516378396
WM115,54618164,3.776567993994872
GCT,3689413,-2.349685112754086
ACHN,11404337,1.842611884457436
TT,159324,2.9854792013895324
LS1034,262093,2.9969405069392963
NCI-H727,9926054,2.0492739470784445
NCI-H322,9903786,4.921113869322727
SF268,5460769,2.7900829317628157
TT,6505803,-1.545669685670545
SNG-M,11485656,2.558394091061047
CGTH-W-1,11485656,-0.4433767239008435
MHH-CALL-3,selumetinib-vorinostat (8-1 mol-mol),2.880180263090181
NCI-H526,135875424,3.753853230919886
OCI-Ly19,9903786,1.1452071440663905
EBC-1,46943432,1.1267327481647815
RT-4,sirolimus-bortezomib (250-1 mol-mol),0.9499468705615456
CAL-51,107985,-4.126908547019261
LP-1,9911830,1.9669881995597704
Hep-G2,159324,2.69530902129888
HT-55,selumetinib-GDC-0941 (4-1 mol-mol),0.6831799344698409
DEL,9903786,1.8347897300097875
ST486,100016,6.384120256869386
IGR-37,148124,-4.42288391393864
MOLT-16,36462,-3.6278358680314136
P-STS,10296883,3.777775874485648
EFO-21,100016,8.032262329904976
BT 112,107985,-2.3005939746155244
KYSE-150,6505803,-1.1236376275824325
SNU-1066,159324,3.912087986150624
HCC1195,12003241,-0.4871999069137717
KPL-1,3689413,3.184676645737856
OCI-AML-5,6505803,-0.3064133467102931
Caki-2,148124,-4.081609911291364
SNU-626,9903786,4.459436811322819
SNU-5,12003241,2.4960585201420247
IPC-298,9911830,3.243562235650486
NCI-H2405,9911830,2.703851499558869
TE-8,11485656,2.0537902737407348
HCC827,selumetinib-GDC-0941 (4-1 mol-mol),0.5704009597174646
DMS 273,262093,2.141936221481062
CAL-120,135398744,6.432645448228996
GDM-1,9936388,-9.102246983309657
WM266-4,44491742,3.776227470260235
NCI-H1915,sirolimus-bortezomib (250-1 mol-mol),0.5181778086955178
SNU-8,409805,5.0276813202923325
BT 145,selumetinib-vorinostat (8-1 mol-mol),0.8536258280861712
OV7,tanespimycin-bortezomib (250-1 mol-mol),-1.2936042067435187
OVTOKO,100016,8.078720974707625
EFO-27,selumetinib-vorinostat (8-1 mol-mol),2.529072801083276
NCI-H2405,9926054,1.7306933863874645
SNU-423,11485656,3.131370831257297
NCI-H1581,3689413,-2.373014481120326
CW-2,selumetinib-vorinostat (8-1 mol-mol),1.834795520359669
NUGC-3,36462,0.7786329645465295
SU-DHL-6,9903786,1.8029536633965553
MKN7,9911830,2.5817691322370315
Kasumi-2,tanespimycin-bortezomib (250-1 mol-mol),-1.599342036270796
SW1783,selumetinib-GDC-0941 (4-1 mol-mol),4.418761768894625
SNU-C5,10296883,3.7798832653502727
Namalwa,6505803,0.5277329545448584
GSS,9877608,3.923769598981982
WM266-4,tanespimycin-bortezomib (250-1 mol-mol),-3.087265381880702
NCI-H1869,54618164,4.0885631456331035
EHEB,9903786,1.657877258917439
LCLC-103H,159324,3.784520620712173
NCI-H647,3136844,4.211694107828882
SUP-B15,439501,-4.354200278672526
NCI-H1793,10322450,3.1720779233297405
BHT-101,9926054,1.1931762912946844
8-MG-BA,136227924,3.3968176736472446
ECC10,selumetinib-GDC-0941 (4-1 mol-mol),1.2320886517075502
MHH-ES-1,9936388,-6.403533054534267
SUIT-2,262093,4.049104877248936
KE-97,selumetinib-vorinostat (8-1 mol-mol),2.0582156479057176
COLO 320,9911830,2.9659936700173506
TE-6,439501,-2.719069941795036
NCI-H2085,54618164,4.2368593069560925
SK-MES-1,sirolimus-bortezomib (250-1 mol-mol),0.6700738424680361
SW948,148198,-4.802987893737634
Hs 852.T,12003241,-1.871479503201469
CCK-81,11404337,-0.4332164579586651
COLO 699,136227924,2.9902058739506385
HT-1197,136227924,5.329383648142769
SK-N-FI,168313200,3.1298360952995674
MOLP-8,168313200,3.062868142984741
NCI-H2081,107985,-4.4331361775732905
EHEB,6505803,-0.4928001321157277
HD-MY-Z,148124,0.7380672872848864
TE 617.T,168313200,1.7162313923101786
Mino,148198,-4.997781998015961
SW1573,selumetinib-GDC-0941 (4-1 mol-mol),3.5855850407433225
L-428,148198,-4.114855824463333
OE21,selumetinib-GDC-0941 (4-1 mol-mol),0.0714781013058572
MDA-MB-468,262093,2.5828402827919064
CW-2,12003241,0.1847256343211754
HuP-T4,135398744,7.1369518257480475
NCI-H1869,136227924,3.4575085361719955
Caov-3,46943432,3.5630834063683774
MDA-MB-231,135875424,3.845545280720972
OVCAR-4,9936388,-2.136102412732439
NU-DUL-1,12003241,-3.7698079605480257
NB1,246676,5.4793915839717515
L-540,9911830,2.3452957340804845
RPMI-6666,44491742,4.997277859824789
Rh18,11404337,-0.8453979019724388
NCI-H716,selumetinib-vorinostat (8-1 mol-mol),1.3365473974528714
BT 416,11485656,1.5705982486329817
OPM-2,6610216,3.8953919440086575
PaTu 8988s,168313200,2.2085646036836786
NCI-H889,44491742,5.742464384520159
769-P,100016,6.594067506922387
Raji,12003241,2.533123505917396
BT 286,24180125,3.4057895340262445
G-402,selumetinib-GDC-0941 (4-1 mol-mol),1.3603902664341745
NCI-N87,6505803,-6.101345662019038
ECC12,439501,0.4068206161036775
SCaBER,8515,2.2629448450847915
COLO 205,262093,3.276906461196508
MCAS,46943432,2.7452690797646553
NCI-H2228,9911830,3.4174310144841087
NCI-H2030,11404337,0.8105383061900018
COLO 205,9911830,2.3516835684506945
JVM-3,9936388,-6.226344313547517
MDA-MB-415,54618164,4.2840965764331935
HCC1833,9936388,0.4384818253571875
Lu-99,8515,3.0709969622454008
JHUEM-2,100016,5.904304927611702
BT 179,107985,-2.8341273333416823
BT 159,6610216,3.4275229189923864
BT 179,262093,3.0912681706054492
NCI-H2023,262093,3.744435284140356
Hep-G2,135875424,4.631021258019282
SNU-478,11404337,-0.3528320268789623
TTC-709,5460769,-2.125391207652167
TE-1,6505803,-1.9402426230347345
MHH-CALL-3,6610216,4.42888193418578
U-CH1,10296883,4.147142232028317
HCC1419,5460769,4.36793897247466
CAL-85-1,3136844,4.064867148097984
MOLP-2,73707440,4.42380771173
BT 112,3136844,3.8258170991022222
T98G,6505803,0.2412993690877728
DAN-G,9911830,2.362643332226753
Kasumi-1,168313200,3.502716754645687
NCI-H727,3136844,6.195563862298742
SK-N-FI,JQ-1-carboplatin (1-1 mol-mol),2.3302491289766825
NCI-H716,JQ-1-carboplatin (1-1 mol-mol),0.4768639572382123
A-549,159324,3.3469799601732366
NCI-H1623,9926054,1.7409203229588674
Reh,11485656,1.8045158177085707
SCC-4,sirolimus-bortezomib (250-1 mol-mol),1.5371967281247725
HEY A8,6505803,-1.5335181028470497
SK-ES-1,3136844,4.517358079108881
JHUEM-2,54618164,4.173544512136638
TUHR14TKB,262093,2.19350220661364
HPAF-II,12003241,0.935672122739968
786-O,148198,-3.6446785838934352
Li-7,sirolimus-bortezomib (250-1 mol-mol),1.648845236287691
YD-8,9903786,2.667696713101927
ALL-SIL,sirolimus-bortezomib (250-1 mol-mol),0.3093926374933456
NCI-H460,409805,5.4278006548731295
SNU-1272,107985,-3.786570861641408
OV-90,409805,5.341612919811814
LP-1,148198,-3.8284047012705846
NCI-H2286,135875424,2.580791603996685
SET-2,148198,-7.743060156944655
SNU-1076,135875424,4.991306630113997
NCI-H747,36462,3.2601408904256757
KLE,12003241,-1.9975693903430911
RD,10296883,3.864434451204585
NCI-H2291,11485656,3.4201367707893424
KMS-21-BM,9911830,1.8558490159042795
HCC1195,sirolimus-bortezomib (250-1 mol-mol),1.8421532111980472
NCI-H2085,9936388,2.2479758965135828
U-BLC1,sirolimus-bortezomib (250-1 mol-mol),-1.829710592484544
SUP-T11,54618164,3.811166364183871
TYK-nu,3136844,4.4274928637938125
RKO,26596,-1.341584325458414
BHT-101,9911830,3.1338358933473716
NCI-H1694,sirolimus-bortezomib (250-1 mol-mol),0.6427280207840891
HuT 78,selumetinib-GDC-0941 (4-1 mol-mol),-3.8107077874530657
JHH-4,selumetinib-GDC-0941 (4-1 mol-mol),1.975979663923368
MHH-CALL-4,9936388,-7.2015851477673785
BT-16,168313200,2.2094468908534144
RMG-I,6610216,3.921958740256552
LK-2,JQ-1-carboplatin (1-1 mol-mol),4.1358496368308035
A-673,tanespimycin-bortezomib (250-1 mol-mol),-0.1560084319129122
NCI-H1694,6505803,0.2523164939163045
Toledo,3689413,1.25181961816846
SNG-M,159324,3.472464596542285
SUP-T1,9936388,-4.413014724970872
MES-SA,3689413,1.9720850460136523
JHH-5,26596,-1.3669217407356802
KMRC-1,24180125,3.3952911821821052
Hs 934.T,44491742,4.305764247310721
HCC366,135875424,4.513036767183396
RT-4,107985,-3.170589180041932
HuH-6,409805,3.23994143121387
23132/87,26596,-1.073494997011525
YD-15,246676,4.797554441862922
LS180,sirolimus-bortezomib (250-1 mol-mol),1.3360442889009512
Lu-65,8515,3.512181420890395
Reh,135875424,2.5875056879374307
SNU-216,148124,-4.152128230067924
NCI-H508,sirolimus-bortezomib (250-1 mol-mol),0.7195278231297386
NCI-H1092,148198,-7.112179510843006
BHY,262093,3.4081401003096548
EB1,24180125,1.0511946414672848
BHT-101,100016,6.007811941047966
SK-N-SH,8515,3.203327445964139
KCL-22,6610216,3.733041732556284
SJSA-1,11485656,2.5808954348958797
PaTu 8988s,36462,3.2992976849858593
HSC-2,148198,-4.582461911697906
SNU-81,sirolimus-bortezomib (250-1 mol-mol),1.681791395416448
CCF-STTG1,6505803,-1.8344087076537687
NCI-H1341,3136844,4.2922784728133285
PaTu 8902,148198,-2.774580136562139
MHH-NB-11,36462,-0.963278155790924
SNU-387,9936388,2.7868328011584924
Panc 05.04,439501,0.2716766298535532
T-47D,sirolimus-bortezomib (250-1 mol-mol),1.0675161294174855
NU-DUL-1,159324,0.0667263038861609
RERF-LC-MS,36462,1.1230283698314445
DMS 79,262093,2.040295424440088
KP-2,12003241,-1.0131753515014823
SW620,9936388,-0.3653098163020092
LOX-IMVI,6610216,4.50475887239393
Hep-G2,3689413,1.297693127771037
NCI-H23,11404337,-2.5552294487119664
MDA-MB-231,9903786,4.774872525437021
U-118MG,6610216,4.6753902919745
REC-1,11485656,4.187438515257482
Peer,36462,-0.261188902535988
RPMI-8226,8515,3.584522978705492
OE19,selumetinib-GDC-0941 (4-1 mol-mol),2.914512652837311
A2780,9927531,3.2712332494904226
BT 340,24180125,3.546136736356622
NCI-H446,11404337,-1.699168171743611
SNU-738,tanespimycin-bortezomib (250-1 mol-mol),1.4501924886201147
TF-1,11485656,1.7797633161963615
LMSU,9911830,1.6369573582733428
Lu-65,26596,-0.6076566338784338
Hs 578T,11485656,1.5061337844813831
COR-L51,6505803,-0.8323566824264805
Panc 10.05,11404337,0.4030412000723416
SNU-1066,107985,-3.742344355961893
BxPC-3,136227924,2.62858882862477
SNU-466,selumetinib-GDC-0941 (4-1 mol-mol),2.355398867195719
Daoy,11404337,-0.8590348859055235
HOP-62,sirolimus-bortezomib (250-1 mol-mol),-1.0582430769109517
CW-2,26596,-0.0212695413567751
K-562,12003241,-5.632155645383806
A101D,12003241,-1.0986495828587448
SF268,409805,5.731991783938672
RMG-I,12003241,-2.7782598646997414
NALM-6,107985,-3.482950091180729
NCI-H716,168313200,3.967262456883907
Hs 294T,12003241,-1.502620378279095
U-BLC1,168313200,1.5998883228525755
SNU-C1,148124,-2.098825987189931
SUP-B15,168313200,2.8000345719543973
SK-MEL-3,6610216,4.385153925999174
ES-2,439501,-2.264854435064497
Kasumi-1,36462,-0.6385365283830048
LOX-IMVI,44491742,5.895851784959737
NCI-H838,148198,-3.726135487587838
VCaP,9927531,5.412919809162458
IPC-298,9936388,2.329968749108903
KE-39,439501,-0.0752815835977172
COLO 741,26596,-0.5200940435510158
EFO-27,168313200,3.5651936579716277
RL95-2,439501,-2.2732011177914586
JHH-4,36462,2.924311920402553
SNG-M,148198,-2.9777183458451324
KMS-27,5460769,1.7009983096984826
OVSAHO,44493528,4.8098678105580674
TF-1,148198,-5.222866140328133
IM95,136227924,1.5571875137371276
Peer,5460769,2.3155061508829107
YD-38,9926054,1.970357209117647
NCI-H28,selumetinib-vorinostat (8-1 mol-mol),2.3549234517364512
MEC-1,10296883,3.7478105751485646
CAL-78,409805,5.304478989871624
CW-2,5460769,1.6725505189692909
BT 416,6505803,-2.5410330503454173
C2BBe1,148124,1.383831912212665
BT 216,selumetinib-GDC-0941 (4-1 mol-mol),3.6929291774805177
A2780,439501,-2.4090624878410316
SNU-1196,9903786,3.851159965091799
786-O,44491742,5.035169002663678
NCI-H226,selumetinib-vorinostat (8-1 mol-mol),4.332500490297142
Aska-SS,tanespimycin-bortezomib (250-1 mol-mol),-0.5241440221117086
Kelly,148198,-5.169099507303906
HLF,44491742,4.796533392480472
NCI-H2170,6610216,4.450913676710835
COV362,168313200,1.936761185306669
Peer,9903786,1.0379810938538272
NCI-H2110,9911830,2.0378965069300112
MDA-MB-453,262093,2.6969191096415113
NCI-H2009,sirolimus-bortezomib (250-1 mol-mol),2.102899194038225
JHOM-1,262093,3.378036000941939
KP-N-SI9s,159324,2.5914550399213376
HT-1197,54618164,4.009562616962898
CML-T1,9911830,-1.528510322337235
SNU-410,44491742,4.2778322604140815
NCI-H1703,11485656,-1.2144145653920837
COLO 678,44493528,4.3871500555160035
OCI-Ly10,9903786,3.2654189555082493
BL-70,10322450,2.4597869877226004
NCI-H322,44491742,4.376212292863665
LS1034,3689413,2.145943189168165
RERF-LC-Ad2,409805,3.938022823911279
SK-N-BE(2),JQ-1-carboplatin (1-1 mol-mol),-0.9274219312218726
WT2-iPS,8515,4.500386586039305
D283 Med,9936388,-6.8022099816120605
NCI-H1666,9927531,4.532813040549954
Hs 888.Lu,262093,3.524644323966992
F-36P,100016,3.924028764616067
SNU-685,54618164,4.365952533334999
G-402,135875424,3.4290798142647776
CAL-148,9936388,-7.397165329324112
SCaBER,11404337,0.8251582568604987
OV-90,8515,4.3083559611212285
BICR 56,9926054,1.8423418764912696
OUMS-23,54618164,4.001891095185354
Hs 895.T,54618164,6.120763798597076
NCI-H1155,9911830,2.618743833039648
LP-1,3689413,0.1149626145640583
KMRC-1,107985,-3.501321688193531
MV4-11,11485656,-4.658244572129019
A2058,439501,-1.4813488072157313
8305C,6610216,4.272424943672388
HuH-28,JQ-1-carboplatin (1-1 mol-mol),1.577793116101398
BICR 6,selumetinib-GDC-0941 (4-1 mol-mol),1.9156863537341864
DB,135423438,1.7960303918163716
SW1417,tanespimycin-bortezomib (250-1 mol-mol),-2.5738545143684064
NCI-H1869,selumetinib-GDC-0941 (4-1 mol-mol),2.116437467611717
SF539,439501,-3.28606941940852
HCC2935,168313200,1.8160572268695407
NCI-H2228,selumetinib-GDC-0941 (4-1 mol-mol),1.1807966887528696
MCF-7,439501,-2.51567390987342
VMRC-RCZ,11485656,3.731080366455795
SNU-C5,9911830,2.8374821007130206
L-428,11485656,2.209073620058958
PSN1,10296883,4.046781040996588
MOLP-8,409805,3.552664043240888
NCI-H358,9911830,1.5651647293107356
BT 271,439501,-3.3712164407205916
RCM-1 [Human rectal adenocarcinoma],168313200,3.953722308471172
JK-1,9936388,-6.833225644440661
SEM,9911830,1.1725597754210613
C2BBe1,5460769,5.889347981048802
Calu-1,12003241,-0.3445186674692038
NCI-H1341,9926054,1.7553356281022332
Hs 611.T,8515,3.543970428456994
Fu97,439501,-2.2730678806091924
LCLC-97TM1,9927531,5.703886109604247
SW620,6610216,4.2277666768570885
SW1088,135423438,1.6657015051140114
Daoy,sirolimus-bortezomib (250-1 mol-mol),0.3965851996199208
NCI-H211,5460769,0.8923450706014173
HCT 8,12003241,1.3953140594908418
NALM-6,36462,-2.029352271609264
RL,12003241,-0.503691110401914
KMBC-2,8515,4.644578296093967
NCI-H211,136227924,1.9167606171360705
SH-4,148198,-4.104582342720325
CAL-62,11404337,0.5781549927115224
GDM-1,136227924,3.363011715884638
NCI-H1869,tanespimycin-bortezomib (250-1 mol-mol),-0.2076934173227629
WM1799,9911830,2.7016436476916623
KYSE-140,11404337,-0.0921040105213257
BT 498,9927531,5.612738328284819
HT,selumetinib-GDC-0941 (4-1 mol-mol),2.035866243674196
KP-3,9911830,3.156441375051414
OAW42,148124,0.6602730639600906
NB1,159324,3.048958177907293
HOS,11485656,1.9269410367905917
L-363,54618164,4.061988189817136
SET-2,24180125,3.520791323049292
MIA PaCa-2,9911830,2.066034374401692
BT-16,36462,3.135379230377269
HuH-6,54618164,3.300518310579967
Hs 936.T,selumetinib-GDC-0941 (4-1 mol-mol),0.993603643141318
T24,10296883,4.197604631060403
OCI-AML-5,selumetinib-vorinostat (8-1 mol-mol),2.268725375318619
SNU-668,9926054,1.9494933006011008
Jurkat,100016,5.920987823967134
SNU-175,159324,0.7701191527474731
RPMI-8226,6505803,-1.0247105512133972
HGC-27,6918878,5.6595455570667585
RPMI-6666,168313200,3.881794248847984
M-07e,selumetinib-GDC-0941 (4-1 mol-mol),-0.1227963657449235
SW48,44493528,3.8128145383765992
SK-CO-1,44493528,4.973545843770428
JM-1,8515,3.19981027650634
OVISE,6610216,4.867128617935935
AML-193,439501,-3.193215284595587
SUP-T11,9911830,2.1480309662360377
NCI-H889,439501,-2.793088249368423
HCC1588,9903786,2.112519242014298
BT 359,100016,6.547217450499836
253J,26596,-1.986846221842857
SU-DHL-1,136227924,2.1802521862386395
HPB-ALL,148198,-3.7758492829938857
NB4,135875424,3.6399380221617936
Caki-1,selumetinib-vorinostat (8-1 mol-mol),3.758908188315328
HCC1588,24180125,2.3655662504796493
SW1116,159324,1.6231393918689625
NCI-H1838,135875424,4.369975669876832
COV434,107985,-5.084835264945118
Hs 888.Lu,9903786,2.210543303670434
SCC-9,439501,-2.6581193485563737
DMS 114,26596,-1.464727194464046
BT 179,135875424,3.093650685325698
IGR-37,6610216,4.326761658529103
ME-1 [Human leukemia],selumetinib-GDC-0941 (4-1 mol-mol),0.4788349760990721
SNU-423,26596,-1.230407332735001
HT-1080,36462,-0.5040503669915217
KMRC-2,3136844,4.810057568138529
SK-MEL-31,selumetinib-vorinostat (8-1 mol-mol),4.169186584807818
PE/CA-PJ41 (clone D2),9927531,5.176178802230399
BT 359,26596,-1.128901879166228
TE-6,148198,-3.788482057513412
SNU-761,9903786,5.568583080204817
SBC-5,3689413,-0.1482568941323282
NU-DHL-1,8515,3.2734160853720105
GCT,6918878,3.950619425957521
BHY,6610216,4.5023703498514855
NCI-H2029,24180125,2.5610139497172257
SYO-1,11485656,2.328444383399514
NCI-H2030,11485656,2.3036086259885526
ES-2,sirolimus-bortezomib (250-1 mol-mol),1.1433658443254404
BL-70,148198,-4.761980486191778
HeLa,9911830,3.0701846369034556
KE-37,135875424,3.024504733607955
WM266-4,selumetinib-vorinostat (8-1 mol-mol),0.5678434966492824
L-540,135875424,3.4045526292316017
HH [Human lymphoma],107985,-4.868177894927375
Ri-1,12003241,-5.9425936829646435
G-361,selumetinib-GDC-0941 (4-1 mol-mol),-0.129609857983409
HLF,262093,3.0135929063245324
NCI-H2106,44493528,4.52361018349812
JHH-1,5460769,4.810019702724217
KP-N-YN,tanespimycin-bortezomib (250-1 mol-mol),2.890328599620326
A-375,44493528,5.0092859091998205
Karpas-299,11485656,1.6568638130307944
HCC827,11485656,1.9566672010968855
GaMG,9936388,1.1516041835416544
22Rv1,54639024,4.398565706055689
HCC1569,409805,3.626117249430006
KMS-26,3689413,-5.054030253725733
HD-MY-Z,3136844,3.914350724657188
A101D,9903786,4.417171452040311
PaTu 8988s,sirolimus-bortezomib (250-1 mol-mol),0.5300595749454592
CML-T1,sirolimus-bortezomib (250-1 mol-mol),-2.349010287951753
ECC12,9936388,-4.873950021290679
MOLM-13,135423438,-5.2048777869707035
JHUEM-2,9936388,-5.407825047744209
KMS-21-BM,9903786,1.778157023990249
ML-1 [Human thyroid carcinoma],6505803,-0.5261965004955029
A4/Fukuda,148198,-4.99238512913244
PK-45H,6505803,-1.06717257205605
SH-10-TC,9903786,4.254901914328344
MCAS,3689413,-1.1400919247426515
RPMI-6666,9926054,1.733679521146624
KMS-18,3689413,0.1282967701093688
EN,9926054,1.746243630057145
DU145,selumetinib-GDC-0941 (4-1 mol-mol),2.8367199519336324
LS1034,10296883,3.964188114120739
DAN-G,26596,4.046660448506208
JIMT-1,409805,5.21285843677131
8-MG-BA,6610216,4.756696338182891
BT-20,135875424,4.4451352594965545
L-428,12003241,-0.2572573546541544
SF268,3136844,3.931645894194253
AsPC-1,136227924,3.2025742465891938
SNU-1272,selumetinib-vorinostat (8-1 mol-mol),4.048227486527485
M-07e,6610216,4.11023848384902
Karpas-422,JQ-1-carboplatin (1-1 mol-mol),-0.5867346052444206
ALL-SIL,selumetinib-GDC-0941 (4-1 mol-mol),1.4850584156304236
A-204,136227924,2.1384474587970113
HCC2108,6610216,4.333266627123119
PE/CA-PJ49,9911830,2.222449473418187
Rh30,6918878,2.298607946223957
MOLT-16,11404337,-3.721146983736032
Lu-99,11485656,1.95403594931143
LN-229,9927531,7.375456166440614
SNU-886,10322450,3.968731934637612
ST486,JQ-1-carboplatin (1-1 mol-mol),-0.3320701641895573
NCO2,9936388,-6.28064659559562
GSU,54618164,4.306708858865339
NCI-H716,409805,5.889888908173006
MG-63,262093,3.0447141305088614
KNS-60,36462,2.6280581981988056
COR-L51,6610216,4.366800356397278
HCC1195,409805,5.2534731416960465
KP-4,8515,3.507883744965969
COLO 792,54618164,3.706316452740556
HT,9911830,3.0639968978476513
KALS-1,selumetinib-vorinostat (8-1 mol-mol),3.138531968281592
HuT 78,9927531,5.1568522769540674
IMR-32,3689413,-3.464498060379514
UACC-257,11404337,0.2193965048118893
RPMI-8402,73707440,5.61171543505587
SNU-1077,3689413,-1.655364429789056
BT 330,3689413,-2.329423623315505
A-375,3689413,-0.7182003405560186
SW1710,9936388,-6.272511442902443
BV-173,135875424,3.775066116863956
KMRC-20,54618164,4.251401203478906
NB1,135875424,2.0724069361168
HCC15,159324,2.6315252421023536
EoL-1,9926054,1.828019217783983
HOP-62,9927531,4.3195662996069855
MOLP-2,sirolimus-bortezomib (250-1 mol-mol),0.2890446382441622
MOLT-3,6505803,0.4924044650744431
NCI-H2444,3689413,-2.223418972852252
BT 216,136227924,4.751796234635162
SW1990,10296883,4.2503704087411025
NB4,10296883,3.07920263263956
HCC366,12003241,-0.2149977364985454
COLO 829,409805,5.20595699419965
639V,selumetinib-GDC-0941 (4-1 mol-mol),4.596668684568556
SNU-1077,54618164,4.137569965283994
647V,44493528,4.175577269384225
SK-OV-3,9911830,2.8997016876614863
SNU-719,selumetinib-vorinostat (8-1 mol-mol),0.3154855809643748
DEL,3136844,3.276807516597485
OS-RC-2,11404337,1.5898749393998126
SNU-387,135875424,4.7667426399208965
NCI-H2087,9911830,2.1008077543098045
IMR-32,selumetinib-vorinostat (8-1 mol-mol),0.9204615438259656
NCI-H1299,11404337,0.8410914432786373
SNU-5,selumetinib-vorinostat (8-1 mol-mol),2.3569567628578176
CJM [Human melanoma],3689413,-1.0332065150817793
HCC2935,6610216,4.132006404666087
EN,168313200,3.9043181429935783
SKM-1,6505803,-1.0817481083509812
NCI-H1693,selumetinib-GDC-0941 (4-1 mol-mol),1.7777896818074843
NCI-H1105,54618164,3.971690507738235
RT-112,9911830,2.2305398910427288
SEM,JQ-1-carboplatin (1-1 mol-mol),-2.3661872454189634
ECC12,11404337,1.5850993718639097
SNU-C1,262093,1.2400206335619155
RCM-1 [Human rectal adenocarcinoma],44493528,4.389573022277453
G-361,6610216,4.217301714160164
MG-63,3689413,-2.4336894587390323
NCI-N87,262093,3.0008468279122607
HCC1833,107985,-3.0980572813804352
HuT 78,135423438,1.6811720044411254
KMH-2,136227924,2.758064098306969
LS411N,6505803,-0.6536233604701492
RPMI-8402,3136844,6.316630545290792
HCC1500,26596,-0.8174609850015592
C2BBe1,148198,-4.96016580080056
RCH-ACV,107985,-4.015124921394137
Mel JuSo,26596,-0.7227371785697827
HCC2218,3689413,-1.7582350299108729
HL-60,135875424,4.0116269121044015
TE-15,6610216,4.337725089015336
JJN-3,168313200,5.49693974456191
MKN74,168313200,3.6921900787072737
SJSA-1,136227924,3.1619398784526176
SK-ES-1,10322450,3.263279499807968
BHY,36462,2.366380052455501
KE-97,54618164,3.878126009924748
SK-MM-2,135875424,1.809957653015655
BT 422,24180125,2.9257600434741384
AsPC-1,262093,3.2992304028365926
253J-BV,12003241,-1.283652626050959
WM88,sirolimus-bortezomib (250-1 mol-mol),-0.0026242391338407
COLO 668,409805,5.83951169667826
TE-4,10296883,4.159951408110945
COLO 829,tanespimycin-bortezomib (250-1 mol-mol),-0.6009535916354974
VMRC-RCW,sirolimus-bortezomib (250-1 mol-mol),0.7357158276025152
NCI-H2291,135875424,4.231484066090065
BT 145,135875424,2.9417434414875374
SU-DHL-10,9903786,1.7653767834986365
NCI-H460,439501,-2.362377537788676
Panc 08.13,107985,-6.582499016918423
P12-Ichikawa,sirolimus-bortezomib (250-1 mol-mol),0.3718187399928814
SK-MM-2,JQ-1-carboplatin (1-1 mol-mol),-2.35535314984042
WM115,sirolimus-bortezomib (250-1 mol-mol),-0.1340053181182992
NCI-H2009,9936388,-6.076047204085024
OAW28,409805,4.888216855585461
LK-2,168313200,2.0373509363171283
OE19,136227924,3.1692952710595557
MeWo,439501,-2.203137437916754
Yamato-SS,5460769,4.640105648822845
HCC2935,11485656,3.30580870934939
BT 286,11404337,-1.6660130116300145
BT-474,6610216,3.6735786534145296
PE/CA-PJ15,136227924,2.633948596133963
786-O,sirolimus-bortezomib (250-1 mol-mol),0.3515124224328601
NCI-H2452,159324,4.677055932941875
TE 441.T,6610216,4.146097180963395
KU-19-19,11404337,0.0275069311149896
DMS 79,439501,-2.1979819291914224
OVCAR-4,9911830,3.2323218486443013
G-402,JQ-1-carboplatin (1-1 mol-mol),0.5216010908440976
NCI-H2030,selumetinib-GDC-0941 (4-1 mol-mol),1.942385025880709
NCC-StC-K140,10322450,2.306971577556796
L-363,5460769,3.1855297672006087
SNU-1214,9936388,-5.365264992891118
VMRC-RCZ,135423438,3.1126992087806427
KO52,5460769,4.4327211318187745
JHUEM-3,11404337,-0.7844272598135029
SW48,46943432,0.8743166493146273
SH-4,100016,6.480724052638794
RL95-2,sirolimus-bortezomib (250-1 mol-mol),1.4009445421830615
Kuramochi,5460769,4.70110979591698
MHH-CALL-3,6918878,0.3935249212272132
SNB-75,3689413,0.0039373561000733
JHH-1,8515,4.044626627434146
SK-MES-1,36462,0.91416353270613
NCI-H2342,6918878,3.672901625623809
HEC-6,JQ-1-carboplatin (1-1 mol-mol),1.897969075910313
HuNS1,26596,-3.648585672469648
NCI-H810,168313200,1.5895353190591883
Hs 936.T,3689413,1.174689206695868
HCC15,136227924,3.0147456858017923
RMG-I,11485656,3.2385452078002883
SJSA-1,10296883,3.777259880045869
KALS-1,10296883,4.367875954814542
DMS 114,9927531,5.183306198807951
SNU-16,9927531,3.2030544942563317
SiMa,JQ-1-carboplatin (1-1 mol-mol),1.754117349948639
NCI-H1581,6610216,3.4507986270156965
CAL-62,6610216,4.866037437234073
UACC-257,10296883,3.905415192758359
BT 112,tanespimycin-bortezomib (250-1 mol-mol),-0.1012397521650829
YD-15,439501,-2.3800052899031985
MHH-CALL-4,246676,1.7310022839692016
JHUEM-1,168313200,2.223638194513654
KM12,168313200,1.821145068810447
HCC1438,135875424,4.418316451963679
NCI-H2110,tanespimycin-bortezomib (250-1 mol-mol),-2.8330652513678274
GOS-3,11485656,3.367022375162814
C2BBe1,11404337,-0.9784657174077572
Hs 852.T,9926054,1.891936574698373
LS1034,tanespimycin-bortezomib (250-1 mol-mol),0.2308030361348307
LS411N,tanespimycin-bortezomib (250-1 mol-mol),-0.7094268710043169
SNU-1105,6918878,3.2048877722828917
Ri-1,9903786,-0.2937603570790111
NCI-H838,36462,2.0025187591380016
HOP-92,44491742,4.695490745837731
HCC2935,12003241,-0.8324751754872037
F-36P,135423438,1.517615115973094
ECC10,sirolimus-bortezomib (250-1 mol-mol),-0.7952118818560531
MOLP-8,11404337,-0.9705317414577028
ECC12,100016,5.969737428755433
Karpas-422,5460769,4.127517160029383
KYM-1,3689413,0.9025287359400416
Rh30,sirolimus-bortezomib (250-1 mol-mol),1.125854390557578
NCI-H838,9936388,2.922779996332477
SNU-626,9936388,2.473476131438239
J82,44491742,4.20149606168553
OE21,3689413,1.0863405783683666
L-540,5460769,1.6720211707369994
MFE-319,148198,-4.2483014049358685
NCI-H1435,439501,-0.9104784538070396
BT 231,148124,-6.361454610291721
EFO-27,12003241,-1.7336155023360622
LS411N,selumetinib-GDC-0941 (4-1 mol-mol),0.0319239505994205
IGROV-1,3689413,-0.3633634632064185
BT 179,439501,-2.97680380093877
SK-N-MC,6918878,0.5874825057793656
GSS,49836020,4.0402801556040036
U-BLC1,6610216,4.090780023293868
MCF-7,135875424,4.503633090652972
HuG1-N,3689413,0.3289715107360669
OPM-2,439501,-4.648238189793765
PC-14,12003241,-2.6584563263219203
ONCO-DG-1,JQ-1-carboplatin (1-1 mol-mol),2.9184611678719667
K029AX,100016,6.8355789955685395
MDA-MB-468,sirolimus-bortezomib (250-1 mol-mol),0.2787318869708576
KYSE-150,3689413,0.7938684230504212
Fu97,24180125,3.629213171199319
EM-2,36462,-1.2083602096213608
Aska-SS,JQ-1-carboplatin (1-1 mol-mol),-0.8718657257645913
NCI-H1755,6918878,0.8747764984861088
COV434,6918878,2.217340917952111
RT-112,11485656,1.7918654430987004
HCC44,26596,-2.4855427767458735
PaTu 8902,409805,5.142449436796194
NCI-H1693,tanespimycin-bortezomib (250-1 mol-mol),0.5051860079997127
KMRC-20,262093,3.714553986632731
P12-Ichikawa,135875424,3.359554329425199
NCI-H1694,136227924,2.5297757130143887
SET-2,sirolimus-bortezomib (250-1 mol-mol),0.175715922868153
Karpas-620,135423438,1.2661543285400736
SW1116,sirolimus-bortezomib (250-1 mol-mol),0.982406512308436
Kasumi-2,54618164,3.8625919459899833
L-363,9926054,1.3998682481230786
Yamato-SS,9911830,3.158388861386652
RS4;11,sirolimus-bortezomib (250-1 mol-mol),0.1711857782285224
PaTu 8902,selumetinib-GDC-0941 (4-1 mol-mol),3.4038309056959424
MOLT-16,8515,3.1215342992263255
Hs 888.Lu,54618164,4.594107940900578
AML-193,11485656,-1.7272529013303597
22Rv1,10322450,3.5094460128480987
PaTu 8902,11485656,3.4031855994132663
697,135423438,1.9125323106681824
NCI-H2023,159324,2.5896832660391795
YH-13,9903786,3.849279075978848
BICR 6,tanespimycin-bortezomib (250-1 mol-mol),-0.3653020091427266
CW-2,9936388,-2.7633080589769885
JHH-5,24180125,3.480923085252071
SNU-761,tanespimycin-bortezomib (250-1 mol-mol),1.2423836146793283
MDA-MB-435S,9926054,2.269822503715403
NCI-H1693,9903786,3.776760773308461
NU-DUL-1,439501,-2.935576515069395
Hs 729.T,12003241,-0.5985537077535523
NCI-H2085,6610216,4.266678057471213
LS411N,54618164,4.167426775220608
EHEB,439501,-2.4217048608799097
KE-39,11485656,2.227722528153515
NCI-H322,10322450,4.379144140600869
NCI-H2291,36462,3.214514942555881
NCI-H650,tanespimycin-bortezomib (250-1 mol-mol),0.4769050892801147
BC-3C,6610216,4.163400857926898
DLD-1,3136844,4.367343669003209
A4/Fukuda,6610216,3.4719570509087445
HCT 8,44491742,4.525976447408572
TE-15,9903786,2.5325936452806723
JHUEM-7,26596,-1.8551798961299688
NCI-H1184,JQ-1-carboplatin (1-1 mol-mol),-0.5864173330660996
DMS 53,46943432,0.4134239365557574
LNCaP clone FGC,9926054,1.750086860049474
A-375,selumetinib-GDC-0941 (4-1 mol-mol),1.473699633531409
COLO 678,JQ-1-carboplatin (1-1 mol-mol),3.427094237994177
SH-10-TC,9926054,2.8749564288273604
HMC-1-8,26596,-1.609914747159897
KMBC-2,6505803,0.8249091565927539
Panc 02.03,11485656,5.602754460209725
U-87MG ATCC,439501,-1.3147544227486891
HLF,11404337,-1.3063321678597395
ECC10,9926054,1.849592705301639
Kelly,100016,6.527674974645037
MOR/CPR,100016,6.350482300205422
Ku812,11485656,2.1573639541519474
MOLM-6,6918878,0.2746011927148629
Karpas-299,9926054,1.611454190499719
HSC-4,5460769,1.9290612526481368
MM1.S,JQ-1-carboplatin (1-1 mol-mol),-0.259196457141764
NCI-H841,262093,3.0633638010395927
OC 314,10322450,5.7270020231574446
NCI-H2110,3689413,0.5131338822863976
MKN74,6918878,3.272631722188731
SYO-1,9903786,1.9235940661883033
TCCSUP,136227924,3.28330337763218
SNU-1076,11485656,2.42943122254484
Capan-1,3689413,0.3362458713829924
SNU-1033,selumetinib-vorinostat (8-1 mol-mol),2.0856562296145187
HT-1197,3689413,0.4105522735593818
SNU-81,5460769,-2.0941921209529575
CAL-85-1,36462,2.3184829377165657
LOX-IMVI,11485656,1.9351920109561
Rh30,439501,-1.3281255322499272
DMS 114,135398744,6.443015881513616
OCI-Ly10,439501,-3.3893615276573783
COV434,8515,3.3303185098504855
SNU-840,9911830,3.7774475917507657
SW1783,sirolimus-bortezomib (250-1 mol-mol),2.8566656968780313
KHM-1B,9903786,1.5275790345873377
SaOS-2,6610216,4.351676798413151
MHH-CALL-4,36462,-1.0581366443015845
JeKo-1,5460769,3.2700758729193526
CGTH-W-1,135875424,4.831147205394264
2004,409805,3.735032742542569
NCI-H2106,3136844,3.951379550487224
C2BBe1,selumetinib-vorinostat (8-1 mol-mol),2.2327261845522774
NCI-H2110,409805,5.766269272797009
HT-1080,24180125,3.242600087423989
Hs 766T,72199289,4.423272467575485
BT 239,262093,1.5843139145133054
JHH-1,9911830,2.2823579854201235
RKO,8515,4.32265921632429
SNU-213,11485656,2.091894408723056
KMRC-1,12003241,-1.418239320082467
BICR 31,selumetinib-vorinostat (8-1 mol-mol),3.0204654665417237
MKN74,5460769,3.534639533895065
LS123,159324,3.095427292134196
NCI-H28,6918878,1.637076159643059
CFPAC-1,9936388,2.1130645315651444
IGR-39,135875424,6.243999816524794
BT-12,54618164,4.2066066788639525
UACC-62,135423438,3.882587391697005
KYSE-70,selumetinib-GDC-0941 (4-1 mol-mol),1.855556078867097
OVCAR-4,selumetinib-vorinostat (8-1 mol-mol),3.885646865602492
SW1088,8515,4.5200926698213255
ECC10,6918878,-1.012115166136148
MCF-7,11404337,-0.4787544229741591
WM88,246676,-1.5613699028719277
SET-2,6610216,4.10264033472901
MDA-MB-415,107985,-3.405012569202664
BT 482,11404337,-1.3517535636718878
KU-19-19,439501,-2.2192304341921205
RVH-421,9926054,1.6904251361057423
Calu-6,11404337,-0.8915888703545986
DMS 454,439501,-2.8107075635854866
LS180,44484440,3.4848015178596343
VMRC-LCD,107985,-2.7871276455414273
KE-39,9911830,2.572250482212608
NCI-H647,107985,-3.43875812490285
PK-1,10296883,4.277974392891681
KMS-11,100016,4.183673123455152
SW1783,9911830,2.094357885918856
NCI-H1395,9911830,2.6279117929683142
BT 131,44491742,4.605626488786133
TM-31,3689413,-2.3957166593643104
EC-GI-10,11485656,1.8249313771859752
SNU-719,24180125,2.565384193053944
MFE-319,168313200,2.8500220727002885
SNU-C1,JQ-1-carboplatin (1-1 mol-mol),1.0012449564207797
JHUEM-1,6610216,4.023660929600166
SK-MEL-3,409805,5.886045786440892
HARA [Human squamous cell lung carcinoma],9911830,2.811378702432749
UACC-257,136227924,2.920939130155667
NCI-H1339,24180125,3.3577258152264635
MES-SA,262093,3.4311342236601567
Mel JuSo,selumetinib-vorinostat (8-1 mol-mol),2.3900440309733804
Calu-3,9926054,2.517272987008367
SF268,sirolimus-bortezomib (250-1 mol-mol),0.3840315084108963
BT 239,9936388,1.03619999927196
ES-2,136227924,4.099714373678264
NCI-H292,9926054,1.8794077191249725
NCI-H1666,44493528,4.3408217178767545
MDA-MB-435S,11485656,2.972471846280711
2004,54618164,4.090816099167248
HEC-6,5460769,3.976458521596205
KMRC-1,11485656,3.5314695534539045
EFO-21,selumetinib-GDC-0941 (4-1 mol-mol),2.070102563498296
NCI-H810,12003241,1.7210077749227564
TE-14,sirolimus-bortezomib (250-1 mol-mol),0.5600865408130824
HCC366,JQ-1-carboplatin (1-1 mol-mol),1.2821420815948563
Becker,246676,4.322247201161359
PaTu 8988s,5460769,4.375147735669684
HDLM-2,11404337,-0.3778039113995139
SUP-T11,107985,-3.2197393672196477
SU.86.86,6610216,4.433785390172563
Hs 839.T,6610216,6.404969449700832
KMS-20,24180125,1.3264637419284662
SNU-201,3689413,-1.5340531054377644
OVCAR-8,selumetinib-vorinostat (8-1 mol-mol),2.9059684430944133
LCLC-97TM1,49836020,1.9924259842665932
JHUEM-1,135423438,4.272448858092011
U2OS,6918878,2.1873023288334745
WSU-DLCL2,9926054,0.3298976492900614
KMRC-2,9936388,3.0990467374612813
NCI-H1666,10296883,3.734666163240881
C2BBe1,26596,5.1914595275269795
LN-229,148198,-2.165786846201969
VMRC-LCD,10296883,4.114131577263389
KYSE-140,439501,-2.2036133964389446
NCI-H146,36462,-0.9223549938225544
NUGC-3,135875424,3.4631977650642396
M-07e,10322450,3.3333673801284944
BFTC-905,44491742,3.9351753124000073
BT 224,439501,-1.0305399865987015
KMRC-2,11485656,3.489579667056433
YAPC,9911830,4.0093640169179325
LS1034,11404337,-0.6299919233148044
LOX-IMVI,100016,4.319089113839007
DoHH2,26596,-2.141975510207564
HCC2108,36462,2.7422106684318077
SK-MEL-1,JQ-1-carboplatin (1-1 mol-mol),3.273117082595556
OCI-Ly3,9926054,1.7075624586647575
HEC-59,12003241,-0.4049011737939335
OAW42,9903786,3.91324183381597
BT-549,107985,-4.157404914346088
COLO 668,11485656,1.801054934064134
SK-ES-1,49836020,6.460464214010888
NCI-H2196,6505803,0.6828723886008686
SW579,selumetinib-GDC-0941 (4-1 mol-mol),1.5749080758485403
Namalwa,168313200,2.5159524673485074
HuP-T4,6505803,-1.7764683089441893
COLO 201,10296883,3.948039741906064
BT 286,9927531,5.383522650777723
HEL,135875424,2.9448279330391927
Panc 04.03,11404337,1.3784278741672673
KCL-22,148198,-2.536000653707389
NCI-H647,5460769,0.6003032928308929
VM-CUB-1,11404337,-0.7362908779657769
NUGC-3,3689413,0.9569280148265664
OCUM-1,8515,2.556079594629699
DMS 53,6610216,3.0530173121612
BDCM,6505803,-1.085958720489184
SNU-C2A,10322450,3.700200592981039
NCI-H322,135875424,4.689474609475431
SNU-1214,9903786,2.1258190574569955
HEC-151,selumetinib-GDC-0941 (4-1 mol-mol),1.9023911399430904
PaTu 8988t,36462,2.8739750906545263
SW620,11485656,1.8999997266011384
NCI-H1755,107985,-3.833306991653346
SHP-77,tanespimycin-bortezomib (250-1 mol-mol),-0.364724393269764
CAL-51,5460769,1.3780575552768597
NCI-H1651,24180125,3.395099452634416
8-MG-BA,9926054,2.058364924251872
BT 216,11485656,3.383904918711706
SK-MEL-24,10322450,6.176718296792277
EFE-184,44491742,4.212174395306579
MKN74,sirolimus-bortezomib (250-1 mol-mol),2.5374597800168446
GP2d,6610216,3.5205675124685025
KALS-1,12003241,-0.678278256964916
IGR-37,8515,3.3809165095861236
EJM,3136844,3.6340399610084537
NCI-H1339,107985,-2.3926548683095885
CAL-29,9911830,3.5730657559572183
NCI-H460,9926054,2.081701465030928
GI-1,6610216,4.189054008604763
TE 617.T,5460769,-1.488012889612994
U266B1,107985,-3.8867784962638927
ML-1 [Human thyroid carcinoma],36462,0.3533243941090192
TUHR14TKB,9911830,0.5860992883874008
SEM,6505803,-1.7011482867291614
RT-112,12003241,-0.7712914992257113
SCC-9,148198,-2.735497552895971
MES-SA,409805,5.855306292131352
KP-N-YN,3689413,-0.8084843339395943
ChaGo-K-1,168313200,1.878692270372672
HPAC,100016,6.325474069382135
PC-14,3136844,4.323237919355452
SW1990,262093,3.247926984778252
LUDLU-1,9927531,4.97566245035899
DMS 454,6918878,5.120668326958831
NCI-H226,11404337,0.9721595611674808
NCI-H28,3689413,-1.886606090231827
BICR 6,26596,-1.5869658496484045
HGC-27,9926054,1.079439551544522
GCT,12003241,-2.363961173456096
HCC15,9927531,3.758901572486559
COV362,11404337,0.8285013906094965
A2780,9926054,1.5482217772077662
U2OS,selumetinib-vorinostat (8-1 mol-mol),2.2777992346093945
T24,135875424,4.724253336521634
NCI-H292,9911830,2.887423578139022
BT 228,12003241,-1.6653206714884845
WM88,26596,-3.3679469356752465
Peer,409805,3.5038183532951837
LCLC-97TM1,26596,-2.266692800551727
CJM [Human melanoma],148198,-2.9746080822797754
SNU-1076,135423438,4.345092573001933
HEC-151,9911830,2.8637422134890342
8305C,136227924,2.5381850582467913
RPMI-8402,439501,-3.664200727311063
KP-2,3689413,-1.979504715969029
YD-10B,selumetinib-vorinostat (8-1 mol-mol),-1.870978615949193
BL-70,12003241,-2.1974938808167477
G-361,12003241,-2.5867066735550623
HCC2935,9936388,1.1235911387260256
LP-1,36462,3.92598939536504
RS4;11,3689413,-2.3954384764538528
RCH-ACV,44493528,4.3115996529369705
NUGC-4,11485656,2.4536140227741776
SUIT-2,409805,6.22384099753819
OE19,11485656,2.020762016730455
AGS,3689413,2.90749290772993
BT 482,11485656,2.703365491527676
FTC-133,44491742,4.538470926749077
ONS-76,12003241,-1.3579895274230906
FaDu,10296883,4.258019240847728
P-STS,148198,-3.9239562601130022
H-STS,JQ-1-carboplatin (1-1 mol-mol),1.6767150892638072
NCI-H2172,11485656,2.8163630892876212
DEL,sirolimus-bortezomib (250-1 mol-mol),-0.5963284229759003
HuCC-T1,44491742,4.260801380076742
SNU-1,409805,3.692783946246232
HCC1588,439501,-0.8839537477169336
ALL-SIL,6918878,-0.682122479171039
MPP 89,sirolimus-bortezomib (250-1 mol-mol),1.5945655725799224
IGROV-1,selumetinib-vorinostat (8-1 mol-mol),2.2605882474472057
JHUEM-1,148124,-4.41926729244999
KP-N-SI9s,6610216,4.1110809925176
Granta-519,selumetinib-vorinostat (8-1 mol-mol),1.614961732306094
L-428,9903786,1.2681458902985745
HEC-1-B,54618164,4.194719040460806
SW982,selumetinib-vorinostat (8-1 mol-mol),2.9958400585589926
JIMT-1,selumetinib-GDC-0941 (4-1 mol-mol),2.201344491734076
SK-MEL-31,44491742,4.695235381351794
HCC38,168313200,3.666246615050688
AM-38,10322450,-5.137257783739551
Daoy,159324,3.1880749066588696
Caki-2,11485656,3.849014723207123
BT 320,11404337,0.6966185269279856
PE/CA-PJ34 (clone C12),136227924,2.74058031223244
Karpas-299,409805,3.4608601578721996
Panc 03.27,10322450,4.4639775206651295
BICR 16,9903786,3.9167102075651785
CAMA-1,246676,1.5036012634543992
CHP-126,5460769,0.9651768958989126
HCC4006,246676,6.339514931848246
NCI-H2286,439501,-0.7884333546830701
SNU-840,11485656,2.295014349130572
AML-193,148124,-4.5095548877680045
A-549,100016,7.181380121169662
HuP-T4,5460769,3.995973336692885
C2BBe1,6610216,4.003349103028762
OE21,49836020,4.665936469802933
MOLP-8,9903786,1.299688823902182
MDA-MB-435S,107985,-2.6395704161452973
SNU-182,JQ-1-carboplatin (1-1 mol-mol),2.6048292871272865
WT2-iPS,36462,0.0247559236952942
HuP-T3,262093,3.018266583248783
PC-3,8515,4.719538552927186
SF539,9903786,2.8297220739955993
SK-OV-3,11404337,1.4011927232423718
BICR 22,54618164,4.171441086739322
MM1.S,11404337,0.2422934532029092
BICR 22,9926054,1.8271931211135617
MeWo,9911830,2.0123615626983593
HEY A8,sirolimus-bortezomib (250-1 mol-mol),1.5777182717045015
NCI-H322,6505803,-2.5278966657136577
BT 245,9926054,2.9422912383021393
HT-1197,tanespimycin-bortezomib (250-1 mol-mol),-0.7318651528628731
SK-N-AS,49836020,4.951261339623108
RT-4,9911830,1.893497559140728
MHH-CALL-3,3689413,-1.9959162007922513
HuCC-T1,9927531,3.6522633748640487
BT 164,6610216,4.359427405637071
GB-1,tanespimycin-bortezomib (250-1 mol-mol),0.6130587014327358
HCC38,107985,-4.581327421068375
ECC12,6610216,4.8480732818751395
BT 224,168313200,3.82077392857396
SK-N-DZ,49836020,4.282357500475809
CAL-85-1,100016,6.683113656599713
M-07e,135875424,2.6099381217800897
NCI-H2087,10296883,3.767340744960793
HPAF-II,selumetinib-vorinostat (8-1 mol-mol),3.0881046895318325
NCI-H727,24180125,3.0565666249941015
LUDLU-1,100016,6.796390484470128
IA-LM,3136844,4.47285753340146
OPM-2,selumetinib-GDC-0941 (4-1 mol-mol),1.4008173274482878
AsPC-1,6610216,4.465191830296224
NCI-H441,9911830,3.026174605149711
NCI-H522,9927531,4.749051096908956
MOLP-2,9927531,5.358514182418203
DBTRG-05MG,8515,3.42193819135595
KMS-26,9911830,2.0574042745338725
SW48,159324,-1.9628962598081805
SK-N-AS,409805,3.819858792673344
T24,9936388,-4.864379366787304
YD-10B,JQ-1-carboplatin (1-1 mol-mol),1.656184810616646
OVK18,409805,4.876837954630626
JURL-MK1,44491742,4.045631279535998
HCC1195,selumetinib-GDC-0941 (4-1 mol-mol),2.113355514825289
NCI-H1581,10322450,2.9109511498380485
ZR-75-1,9926054,2.043336248210882
CCK-81,26596,-1.410251638303959
MKN74,135875424,3.2262010711942484
Calu-3,44493528,4.337619480836725
SNU-8,54618164,4.22532753412944
JURL-MK1,JQ-1-carboplatin (1-1 mol-mol),0.6722664514176999
HCT 15,148198,-4.831487376237021
NUGC-4,3689413,0.1501840734639977
UM-UC-3,148198,-2.7030111325228594
LC-1/sq-SF,9926054,1.8795702077099137
T98G,selumetinib-vorinostat (8-1 mol-mol),4.3337419760383
Mel JuSo,135875424,3.5685872974877824
CAMA-1,9936388,-3.1372789388983944
RERF-LC-A1,9936388,-6.729312283369553
Rh41,9936388,-5.1529677708174235
MM1.S,46943432,0.8040935349772499
KNS-60,262093,2.4239806824503876
P31/FUJ,135875424,3.622681212031297
MHH-ES-1,5460769,-1.13601039501847
PE/CA-PJ49,168313200,2.725673225296459
SNU-869,439501,0.8866471334792935
G-402,148198,-5.197807449941822
SNU-407,8515,3.707708532160579
ACHN,148198,-2.704969639683015
MOLM-13,6505803,-3.0527041000310255
TUHR14TKB,9936388,1.5897685475960623
VM-CUB-1,409805,4.766364955884477
MCAS,49836020,4.94613909678053
COLO 792,3689413,1.4913457514232935
KE-39,selumetinib-GDC-0941 (4-1 mol-mol),2.2885736306774076
DOV13,36462,1.5210800303405427
SNU-8,selumetinib-GDC-0941 (4-1 mol-mol),0.1167274542532347
Sq-1,12003241,-0.6972908416742193
Mino,tanespimycin-bortezomib (250-1 mol-mol),-0.3113346740290634
OVK18,159324,1.778528017414363
HCC827,selumetinib-vorinostat (8-1 mol-mol),2.3127534557071474
SNU-C1,11485656,1.873181014714628
COV434,46943432,3.5633500403525447
Yamato-SS,136227924,3.1022512927874444
HH [Human lymphoma],selumetinib-GDC-0941 (4-1 mol-mol),-1.1427111457994747
A3/Kawakami,36462,0.6765947493601843
Rh41,5460769,3.320988700800296
SK-MEL-2,54618164,3.880613274058296
OS-RC-2,9911830,2.682411797844001
BT 179,36462,3.422327002990244
HuNS1,107985,-4.251008653839981
NCI-H526,54618164,3.913888665030304
Hs 578T,49836020,0.6847429303234678
NCI-H1915,10296883,3.8603336548286498
MOLT-13,6505803,0.7492781623920575
CA46,6918878,-0.7300256707111569
SNU-81,148198,-1.0516438667772403
HuP-T3,36462,3.380707637397105
SH-4,6505803,0.0908209591031931
HuP-T4,49836020,4.250504685299003
LOX-IMVI,168313200,4.329297638154407
NCI-H810,44491742,3.3983932232685756
HCC1937,36462,3.5030981675000974
HDLM-2,9911830,3.146801382603546
HCC1588,8515,3.3452170463409585
SW1990,246676,4.838396695986544
SW620,148198,-3.4206637711010455
MM1.S,439501,-1.8322200924082088
SK-LMS-1,10296883,4.497007332627828
TT,11404337,-1.240692607165932
NCI-H1184,6918878,0.6159518781622964
A-375,8515,4.080476351747669
BT 498,JQ-1-carboplatin (1-1 mol-mol),6.0311872836348535
MOR/CPR,26596,-0.9539590783160214
RCC10RGB,409805,6.020159348453613
Aska-SS,136227924,2.71481465035111
MDA-MB-231,49836020,-4.061290256388782
SNU-685,selumetinib-GDC-0941 (4-1 mol-mol),4.064777169332982
ChaGo-K-1,6505803,0.7391022920837463
SNU-1214,159324,0.6558856370223802
KMH-2,sirolimus-bortezomib (250-1 mol-mol),-3.0653636595991203
MOTN-1,409805,3.656377954751396
KMS-26,107985,-4.9565801235489095
BT 139,tanespimycin-bortezomib (250-1 mol-mol),-4.226590067496966
NCI-H23,12003241,-0.7384604538146603
SU-DHL-10,6505803,-0.3491248670962715
RMG-I,sirolimus-bortezomib (250-1 mol-mol),1.380025279026371
SCC-9,148124,-0.9222891029936632
U2OS,159324,4.284852110349447
A3/Kawakami,54618164,3.8685963187989225
NCI-H841,148198,-4.970110895605647
YD-8,36462,2.7241354710815
697,JQ-1-carboplatin (1-1 mol-mol),-0.9101343627046008
DU145,6918878,5.332800992773371
A-375,44493528,5.0092859091998205
RPMI-6666,26596,-1.6823570129437355
SNU-738,148198,-3.393002799947117
NCI-H1734,135875424,3.3840426001662727
SEM,168313200,1.52373638401344
COLO 699,135875424,3.78821155380287
NCI-H2141,11404337,-1.2716473405568056
HT-1197,409805,5.791869558181375
MeWo,12003241,-1.7569732997280945
HEC-6,3689413,-0.7278233112149324
SNU-1,10322450,2.9825136311356055
PE/CA-PJ15,8515,2.421663775633471
RPMI-6666,107985,-4.274541908591321
SUIT-2,selumetinib-GDC-0941 (4-1 mol-mol),2.4482295182309257
COLO 699,107985,-3.919459078432389
DMS 273,24180125,3.0640550148835812
BT 131,107985,-3.205027267690814
KMRC-1,sirolimus-bortezomib (250-1 mol-mol),0.3840144129269961
SF539,26596,-2.288089999638428
ST486,148198,-7.753163237406848
NCI-H716,tanespimycin-bortezomib (250-1 mol-mol),-2.992165698836288
BT 187,36462,2.6435388163026023
CHP-212,9903786,1.1399886841606115
JHUEM-2,8515,1.9041010044405784
HT115,12003241,-0.6699503648785873
A-375,135398744,6.486116496095493
PE/CA-PJ15,6610216,4.602296752882169
NCI-H1435,12003241,-2.5624704178121274
COLO 699,26596,-1.9597259723317009
OAW42,3136844,4.152260977947288
SW579,107985,-3.0336987926164376
MOLT-3,11485656,1.5036964754289828
KHM-1B,9911830,2.660270688725906
A-549,9926054,1.8971220341716168
TE-5,11404337,-1.6640351718537505
SW1271,3689413,-1.2412691685690602
253J,9927531,4.121406347708415
SET-2,selumetinib-vorinostat (8-1 mol-mol),0.6611589487965128
GSS,9911830,2.005456861006021
NCC-StC-K140,5460769,0.9709750837193912
NCI-H1915,44491742,3.914803792289667
Fu97,6918878,0.0939171270316781
PANC-1,26596,-1.3824156046290312
ONCO-DG-1,54618164,4.156815904485165
Karpas-299,100016,4.52969889794102
L-540,9903786,1.612072273929478
LP-1,10322450,2.4863509324995827
VMRC-LCD,24180125,1.3284719175549995
SK-MEL-3,8515,4.372397104094242
BT 286,9903786,1.725049982792706
OUMS-23,159324,3.593990796600562
DLD-1,9926054,3.0182242883731516
KYSE-140,6505803,1.6434747535859726
OVK18,8515,4.179386139682472
BT 504,11404337,-1.134155028298889
NCI-H526,6918878,1.6300421505134857
LC-1/sq-SF,262093,5.279467675468132
IM95,24180125,2.4219347351026643
P3HR-1,5460769,3.3454995233869957
NCI-H929,49836020,2.30560189930029
KMRC-20,sirolimus-bortezomib (250-1 mol-mol),1.830355580923548
SK-N-DZ,135423438,2.1379059476501023
ONS-76,5460769,1.8809234095271896
LP-1,439501,-3.639573627473922
EN,6610216,4.3529410731248
L-363,selumetinib-GDC-0941 (4-1 mol-mol),2.240470367275986
WT2-iPS,3689413,0.8966057482922113
HOS,135875424,3.0466328118467665
HCC4006,3136844,4.450934465997557
SNU-46,246676,4.376439211619656
LNCaP clone FGC,9911830,1.9985262700964304
OC 314,409805,5.931538015771662
SEM,6610216,3.5318840364079302
SNU-478,100016,6.124719500368946
OV-90,3689413,1.0666322744292105
Karpas-422,439501,-2.968319248514649
NCI-H292,36462,2.4286801987130486
HeLa,148198,-3.5416719655217976
PC-3,10322450,4.846357152814794
Panc 10.05,6505803,-0.9946511088404476
NCI-H1092,6610216,4.21553350442545
SNU-1,148198,-4.8344466851703425
HPB-ALL,9926054,1.8714976527379283
SHP-77,107985,-2.181807844458771
BT-20,3136844,4.330967788293681
HCC1588,5460769,0.1168083541927539
NCI-H1703,262093,3.0674943510667334
NCI-H446,24180125,2.4081916686313765
SK-MEL-5,11485656,3.020253832456298
BT 231,136227924,3.1954768658582378
A-375,100016,6.005492870785018
SK-MEL-2,selumetinib-GDC-0941 (4-1 mol-mol),1.2441784901384163
OPM-2,9926054,1.8132463747821628
DMS 454,3136844,5.4850099435882855
COLO 800,3136844,4.939785515839567
DU145,selumetinib-vorinostat (8-1 mol-mol),2.4809592604092305
ST486,6610216,3.852624167573134
HEC-59,135875424,3.434837292372321
JeKo-1,439501,-6.227788271417287
BICR 18,6610216,4.848962680938815
WT2-iPS,10296883,3.9536732530855647
BICR 6,136227924,2.7894508880651485
P31/FUJ,selumetinib-GDC-0941 (4-1 mol-mol),0.2780140376369148
BT 245,439501,-4.061461225365729
RPMI-6666,8515,3.7122061672302378
RCM-1 [Human rectal adenocarcinoma],sirolimus-bortezomib (250-1 mol-mol),0.4278853760712148
BV-173,10322450,3.6127329477753327
Hs 729.T,9936388,1.6599440767787133
KYSE-510,100016,5.186546688011686
NCI-H929,3689413,-2.331613234092956
ONCO-DG-1,9926054,2.478958665773676
MPP 89,44491742,4.112850541914658
U2OS,9903786,2.225601394928473
OVCAR-5,168313200,1.7680254665185893
HT115,46943432,1.3324028915874655
COLO 741,11404337,-0.2468832755936964
HCC1171,selumetinib-vorinostat (8-1 mol-mol),3.9661582718602273
BT 224,11404337,0.3604838347782244
MHH-ES-1,9911830,2.233704183464704
SNU-761,44491742,4.113182762091863
T24,selumetinib-vorinostat (8-1 mol-mol),4.469268178928029
Mel JuSo,6610216,4.789088987376648
COLO 668,9903786,3.4728233461843745
TE 441.T,9903786,2.9236317230426465
BT 416,10296883,4.010101282848487
SW948,selumetinib-GDC-0941 (4-1 mol-mol),-3.896690328067956
8-MG-BA,11404337,1.0898140469965
DND-41,3689413,-2.0667644412480755
T84,tanespimycin-bortezomib (250-1 mol-mol),-1.3994092588399578
8305C,148198,-1.8799510169056712
KP-4,3689413,-2.736369445880075
G-292 clone A141B1,262093,2.200248075467667
PF-382,9911830,1.7810920372451895
EB1,11404337,-3.430704628521276
Panc 03.27,409805,5.782459205310856
BFTC-909,100016,5.8134150302243865
IGR-39,5460769,4.0932684480850074
HCC202,selumetinib-vorinostat (8-1 mol-mol),2.578552961022298
BT 330,selumetinib-vorinostat (8-1 mol-mol),2.5092548953484184
NCI-H520,36462,2.88085787375963
BT 172,11485656,1.8257973782589136
AsPC-1,36462,3.6552458214160506
TE-9,9936388,-5.179827441506514
KP-N-SI9s,5460769,-0.2609459312778176
EHEB,selumetinib-vorinostat (8-1 mol-mol),1.837404923820544
NCI-H1373,439501,-1.5059395530242756
PC-14,9911830,1.0701556722840508
ME-1 [Human leukemia],9936388,1.383892450807597
OV-90,10296883,4.385218547099001
SUP-T1,24180125,1.3532366602003478
U-118MG,10322450,5.196465804540769
BT 224,3689413,1.7352583151087375
BT 145,12003241,-0.8369227670207208
FU-OV-1,9936388,1.7648084748519457
K029AX,11404337,1.217288155718472
DMS 114,12003241,-1.1763340491850245
SCaBER,100016,6.423492154596734
HCC2279,5460769,5.144403730026711
HCT 8,selumetinib-GDC-0941 (4-1 mol-mol),2.0495496026415307
LOU-NH91,selumetinib-GDC-0941 (4-1 mol-mol),3.122551145262448
RERF-LC-MS,12003241,-0.3897829713203344
SK-BR-3,12003241,-1.7425302549890949
SW1417,409805,5.014574040660532
RERF-LC-Ad2,11485656,2.920676874689175
BT 159,12003241,-1.7931625060077818
Panc 03.27,168313200,2.5506827880834075
BT 164,9911830,1.9009455606432144
SNU-8,135875424,4.308406363333984
KYO-1,selumetinib-GDC-0941 (4-1 mol-mol),1.8614571416094257
DMS 273,36462,2.158918041886743
NMC-G1,136227924,2.469359539544405
Tm87-16,36462,3.553446684320628
TE-5,135423438,3.0033799425211405
JHUEM-1,9903786,2.799765938694702
DU4475,12003241,-2.262419788533744
Mel JuSo,439501,-1.0789226024470335
SNU-626,3136844,4.356334294735604
SCaBER,148198,-2.8787440610496806
Pfeiffer,6505803,0.5055759259934013
COLO 205,selumetinib-GDC-0941 (4-1 mol-mol),-0.1404403717614667
COLO 668,107985,-4.1866229688434
NCI-N87,selumetinib-GDC-0941 (4-1 mol-mol),-0.1269197084307303
TT,9926054,1.79906613528668
LAMA-84,409805,3.9758377692098823
MV4-11,5460769,0.4038466040082859
NALM-6,8515,2.281297065499861
SNU-1033,tanespimycin-bortezomib (250-1 mol-mol),-1.1601474483832803
NCI-H1581,9936388,-5.169397744708478
GMS-10,9903786,4.533895537186943
NUGC-4,409805,5.054333560474846
PK-1,selumetinib-vorinostat (8-1 mol-mol),2.9485876327218077
DK-MG,6610216,4.502429110487552
HGC-27,262093,2.210004437321543
OCI-AML-3,439501,-3.711408671836436
ACHN,439501,-3.3245140147129684
L-1236,107985,-2.039005405341846
GCT,selumetinib-GDC-0941 (4-1 mol-mol),2.439679750854635
PaTu 8988t,10296883,3.999790485906541
SW1710,selumetinib-GDC-0941 (4-1 mol-mol),2.8555583802472277
CAL-148,6918878,1.653954182820303
LUDLU-1,5460769,4.034100561481378
Kasumi-1,12003241,-2.8903721425855284
CML-T1,3689413,-2.671933251411637
JHUEM-3,12003241,-2.0090653802187197
HT,24180125,2.2044358325458004
Ri-1,9911830,1.4351255803096743
CFPAC-1,sirolimus-bortezomib (250-1 mol-mol),1.733251550284772
Kelly,9911830,2.7875551161159615
Panc 03.27,6505803,-2.205442615727637
ChaGo-K-1,6610216,4.215426179079186
EFO-21,9926054,1.8086504581736744
COV434,JQ-1-carboplatin (1-1 mol-mol),2.068766497655691
NCI-H2444,262093,2.966539403917491
Pfeiffer,3689413,-4.622184503253435
KMS-12-BM,54618164,3.5838118675433783
KYO-1,36462,0.4535313414522903
SNU-719,6610216,4.511373507313099
DMS 454,11404337,1.0460109741609804
786-O,54618164,4.145734663592518
MDA-MB-453,9927531,3.885109165752666
SCC-25,6505803,-1.2912802856416608
HSC-2,246676,5.600888719484109
253J,tanespimycin-bortezomib (250-1 mol-mol),-0.9234008422745912
Karpas-299,44493528,4.12106151938678
KYSE-30,3689413,-2.4041486305877497
OVCAR-5,135423438,1.1993513830056843
JMSU-1,11485656,1.6924908794215956
HDLM-2,24180125,2.355202505563582
ST486,11404337,-3.35080317485283
BT 271,selumetinib-GDC-0941 (4-1 mol-mol),1.6032684287566925
BT-20,36462,2.88431470758021
Hep 3B2.1-7,sirolimus-bortezomib (250-1 mol-mol),1.2691143155253628
PLC/PRF/5,tanespimycin-bortezomib (250-1 mol-mol),-0.763786349552494
Panc 03.27,11404337,-0.4411804077325879
SNU-886,9936388,-5.3251547250946825
42-MG-BA,3689413,-1.7117650747651572
LMSU,3689413,-0.2257013593388283
OCI-AML-3,54618164,3.7553618842798726
HCC38,9911830,2.511221746544401
MOLT-16,107985,-4.899451887345495
A2780,12003241,-2.743381978251489
TE-6,136227924,2.9118612520968803
SNU-1079,11485656,2.444580254592115
G-402,5460769,1.138003238352945
EFO-27,3689413,-2.375877948841856
A-172,168313200,3.7321565139608577
TT2609-C02,44491742,4.381647170405731
COLO 800,11485656,3.591351165158368
NCI-H1869,11485656,1.8296978789565703
SNU-761,selumetinib-vorinostat (8-1 mol-mol),0.7909854295550836
KNS-42,3689413,-0.7849742988075888
A-549,159324,3.3469799601732366
KYSE-30,selumetinib-GDC-0941 (4-1 mol-mol),-0.4989491730222611
Yamato-SS,9936388,1.5578978605453773
PC-14,136227924,3.162840410264972
CHP-212,439501,-3.066647647836344
U-251MG,selumetinib-vorinostat (8-1 mol-mol),3.4594447583943757
AN3-CA,sirolimus-bortezomib (250-1 mol-mol),0.0528830702221854
IST-Mes1,9911830,1.5716425903239464
UACC-257,439501,-1.398087538451765
MOLT-16,3689413,-0.0606324778239056
SNU-489,3689413,0.2649172011332545
HT-55,sirolimus-bortezomib (250-1 mol-mol),0.7805175960520967
B-CPAP,262093,2.8121848345775784
Hs 766T,5460769,5.317456208461946
NCI-H1155,3689413,-1.8427844176402348
NCI-H508,3689413,-2.320337530403156
RCM-1 [Human rectal adenocarcinoma],3136844,4.175493618298147
Mono-Mac-1,6918878,0.1376589659678193
OAW28,JQ-1-carboplatin (1-1 mol-mol),2.7763585253391625
SNB-75,10296883,4.213369443684623
LS180,26596,-1.3053249122689552
A-375,9903786,2.3118659059614877
OVK18,tanespimycin-bortezomib (250-1 mol-mol),-0.2590574495112158
J82,sirolimus-bortezomib (250-1 mol-mol),0.3485441031707259
JHUEM-1,JQ-1-carboplatin (1-1 mol-mol),1.8045893002317055
TT2609-C02,148124,-4.668480712908027
Capan-1,26596,-0.6895285509385911
A2058,54618164,4.0086140430818755
Hs 895.T,44491742,4.052136098794782
YD-38,11485656,2.58437498447116
SNU-216,54618164,4.432293411615551
NCI-H69,54618164,2.7748520187560413
HCC1500,439501,-1.4156205398968564
NCI-H520,10296883,3.906496007421639
NCI-H146,JQ-1-carboplatin (1-1 mol-mol),-0.0863429597614012
Mono-Mac-1,135875424,3.0350686584049473
BT-20,9927531,4.105614320548644
MKN74,selumetinib-GDC-0941 (4-1 mol-mol),2.4361199969634924
FTC-133,5460769,4.281031552964228
NCI-H1755,409805,5.780114258541939
TOV-112D,6610216,4.406532142355373
ESS-1,10296883,4.371449070908232
KYSE-180,8515,4.449202894378201
CAL-33,148198,-4.199943057412928
KP-N-YN,136227924,3.0572578369433376
G-402,9911830,-1.8927081799919792
SNU-668,12003241,-0.9113554646183494
Panc 05.04,159324,3.075264483571336
NCI-H2029,sirolimus-bortezomib (250-1 mol-mol),0.2827623623245045
NU-DHL-1,6505803,0.0102011938996583
SUP-M2,100016,3.7473632933772394
BT 145,3136844,4.19351224131949
RPMI-8402,11404337,-1.8259507324161124
CFPAC-1,136227924,3.3404294087361883
FaDu,10322450,3.9560507258071422
ST486,44491742,3.1941323124879393
SK-MEL-3,44491742,3.867059457044452
BT 145,selumetinib-GDC-0941 (4-1 mol-mol),0.1649490649734122
LoVo,46943432,3.050109964187685
MOLP-8,selumetinib-GDC-0941 (4-1 mol-mol),0.1535423507469189
Panc 03.27,9903786,3.06546007586267
TE-15,9911830,2.3751205563534064
SNU-1076,6505803,0.872724284931209
SH-10-TC,6610216,4.446804869208645
BT 416,tanespimycin-bortezomib (250-1 mol-mol),-2.7176161537390837
HuCC-T1,409805,5.126439787387785
TE-8,6610216,4.316653592649421
FTC-238,24180125,2.9412466456842408
KNS-60,6505803,0.337360479400098
T-47D,44491742,4.391034289015602
A-549,selumetinib-GDC-0941 (4-1 mol-mol),1.3040363367013357
TE 441.T,sirolimus-bortezomib (250-1 mol-mol),0.170107693301359
KYO-1,159324,1.12474085264908
SW579,148124,-6.414916163554543
SNU-216,136227924,2.452598137182288
ChaGo-K-1,11485656,1.7653957410813437
KLE,262093,2.3874885119076668
YD-15,26596,-1.9516647022251905
NCI-H211,44493528,3.775895389954296
JHOM-1,409805,6.220624680941808
KP-4,6610216,4.774737819722466
YH-13,409805,5.8043407056117395
Detroit 562,246676,5.339776238455787
TCCSUP,262093,2.756857712955527
Panc 10.05,selumetinib-GDC-0941 (4-1 mol-mol),-0.0838909853180393
NCI-H2030,sirolimus-bortezomib (250-1 mol-mol),1.8055328698484328
PaTu 8988s,148124,-0.8669711950509935
IM95,6610216,4.228352536403903
KYSE-150,262093,2.5847717064108657
NCI-H2196,selumetinib-vorinostat (8-1 mol-mol),2.7260788817347965
RPMI-8402,36462,-2.7936372470857473
NCI-H526,9911830,3.0143515863679955
SJSA-1,135423438,1.6287779060663292
KU-19-19,5460769,4.3332822587900255
L-540,selumetinib-vorinostat (8-1 mol-mol),2.5583527619421123
NCI-H647,selumetinib-vorinostat (8-1 mol-mol),3.465801087956738
SNU-869,9936388,1.2557424623780096
RT-4,36462,2.6630323769700013
HCC44,9903786,0.5279756391305372
CAL-85-1,9926054,1.875240534371988
NOMO-1,9903786,1.612481289648159
LS411N,36462,3.380504085081747
HEL 92.1.7,10296883,3.579285339073021
ML-1 [Human thyroid carcinoma],9936388,-4.434207119356507
NCI-H2106,sirolimus-bortezomib (250-1 mol-mol),0.8781181431398268
HCC1588,9911830,2.990297763031185
HEC-6,107985,-4.054974229274056
CAL-78,159324,3.4477302000775776
U-BLC1,JQ-1-carboplatin (1-1 mol-mol),2.2972315497002156
PC-3,439501,-3.5165301870607903
KMRC-2,168313200,3.0339404412127324
Mel JuSo,6505803,-1.4537757141410834
SCC-4,36462,3.425512380164829
RL95-2,107985,-3.902206557331598
NU-DUL-1,10296883,3.165126973502135
NCI-H2122,439501,-2.460326379579743
BFTC-909,36462,4.374665451212183
HEC-59,44493528,4.437244076863349
NCI-H1869,148198,-2.251684124095355
SNU-601,sirolimus-bortezomib (250-1 mol-mol),0.628067282313429
L-540,148198,-2.923933345267779
Hep-G2,54618164,4.2874336189086115
TOV-112D,54618164,4.105272858221818
Reh,100016,6.483959173055827
MEC-1,24180125,1.2281779471332437
SW1088,36462,2.5002786648987874
OV-90,36462,2.4384690112919793
B-CPAP,100016,6.506572981316216
HCC2108,409805,5.256429084033282
OVCAR-4,54618164,3.9627314558285818
Yamato-SS,11485656,2.8272369805427435
LS180,11404337,-0.0678179476465551
SK-MEL-1,107985,-3.868431540150408
HCC78,100016,6.366939598030235
RKN,36462,2.460575122343829
OVCAR-4,136227924,3.1468518699477097
TE 617.T,36462,-0.1303372273364364
MOLT-3,9903786,0.9925932748260368
SNU-719,JQ-1-carboplatin (1-1 mol-mol),0.748518031379031
KMS-21-BM,8515,3.650954647618241
MHH-CALL-4,10296883,2.742921338749494
HT-1197,148198,-3.334872937201218
WM115,100016,7.477930972064711
VM-CUB-1,46943432,2.632481130332744
CFPAC-1,JQ-1-carboplatin (1-1 mol-mol),2.3512621109850897
UM-UC-1,107985,-2.6380239496901328
KMS-26,159324,-4.353423626038214
UACC-62,selumetinib-vorinostat (8-1 mol-mol),0.2264135589516406
YH-13,136227924,2.93381240838723
SBC-5,159324,3.4028835437957112
D283 Med,148198,-7.782574988452476
HEC-6,11404337,-0.461352025950454
BICR 56,tanespimycin-bortezomib (250-1 mol-mol),-1.185151115756176
TE-5,409805,3.5754851367478624
YKG-1,tanespimycin-bortezomib (250-1 mol-mol),0.0684440375972302
KMS-27,54618164,3.8128826777039047
BT 428,24180125,3.179416514721958
NCI-H2342,10296883,4.213291341725321
TE-8,135875424,3.858903579459316
Kasumi-1,136227924,1.874085610777816
TT2609-C02,12003241,-1.0431647024866548
EFE-184,107985,-2.347351341568452
IGR-39,409805,3.9681890781996314
SNU-1079,9926054,1.5049009904469195
MES-SA,26596,0.3162950796632606
RT-4,6505803,-1.736360108528808
BFTC-905,9936388,0.1811780464508788
ONS-76,6918878,5.0214366982824306
BT 231,8515,4.035696345547394
NCI-H1341,107985,-3.661657007936306
A-204,135875424,2.7744609418453887
LoVo,107985,-3.583734032756361
PE/CA-PJ15,9926054,1.7631963091393454
AsPC-1,6505803,-1.959385905579291
SUP-HD1,sirolimus-bortezomib (250-1 mol-mol),-0.240213465841402
Panc 05.04,9936388,2.125359461331759
SNU-61,9936388,-6.308071034865157
CGTH-W-1,24180125,4.136455430290878
NCI-H647,6505803,-1.8408777306089303
HCC1569,159324,2.5758105004343093
Panc 03.27,3689413,-0.1085312900774309
PE/CA-PJ49,9926054,1.8069972619127008
CAL-54,12003241,-2.3491200847554103
NCI-H841,6610216,4.086730283804729
COR-L47,26596,-5.5673450877852995
SNU-245,11404337,1.1841340979823434
GDM-1,26596,-2.9755879350812964
TT,54618164,4.051891315692752
HCC95,selumetinib-vorinostat (8-1 mol-mol),3.641120192013373
BT-16,136227924,2.1772162484418924
HD-MY-Z,10322450,2.950696163732152
BT 428,sirolimus-bortezomib (250-1 mol-mol),-0.137470191353476
NCI-H1838,10322450,3.614692228512862
KMS-28BM,9926054,1.6939379684191658
SW1271,6610216,4.395476769861187
NCI-H2030,44491742,2.996823060755576
SUP-B15,262093,1.7420921581554918
KMH-2,11485656,1.7580590050514375
Kasumi-2,9926054,1.3771704127752784
OCI-Ly10,JQ-1-carboplatin (1-1 mol-mol),0.3162452949317643
OC 314,9903786,3.545915763256713
KYSE-150,sirolimus-bortezomib (250-1 mol-mol),0.6836910361720296
786-O,selumetinib-GDC-0941 (4-1 mol-mol),2.324696492331355
HDQ-P1,selumetinib-vorinostat (8-1 mol-mol),3.932774068428703
NCI-H1915,5460769,1.211615003674484
MHH-CALL-3,409805,3.975278749178219
SNU-878,8515,3.5916120112772902
MM1.S,44493528,4.254687888851587
CAL-51,148198,-3.728190383000159
LP-1,100016,3.986438392754067
NCI-H69,11404337,-0.840898512834909
TE-1,9936388,1.4235089598374957
RVH-421,135875424,4.136589484266176
TE-5,9936388,-0.0111298591303443
WM793,9936388,1.3359302595984517
JHH-2,12003241,-2.42929005443543
U-118MG,6918878,3.4302366409468754
HT,107985,-2.427751220028882
GOS-3,439501,-3.404828566068769
SW1417,148124,0.4370036719879761
TUHR4TKB,9936388,-4.816282931741809
Pfeiffer,9911830,-0.4100154279991107
OCI-AML-3,36462,-1.1325661730855037
MKN1,9927531,4.774967251580727
HCC95,8515,4.1484820954799915
LXF 289,135875424,3.2815298243266553
TE-15,26596,-3.7197158754991615
SU-DHL-1,9926054,1.6936537424309908
YD-15,selumetinib-GDC-0941 (4-1 mol-mol),0.264386559718112
OCI-AML-3,3136844,3.750330367397955
SNU-213,148198,-1.214073512813324
HT-144,100016,6.638904024373049
NCI-H2052,168313200,3.834081580136544
SIG-M5,11485656,1.8173379361731008
HCC366,selumetinib-vorinostat (8-1 mol-mol),2.631541890513729
OV7,168313200,2.2683947493105627
MOR/CPR,9903786,3.5279183844640305
RPMI-8402,409805,3.6932223426421023
H-STS,262093,1.3358664140686949
HuP-T4,439501,-0.5281906022533748
P12-Ichikawa,148198,-4.791017453717943
NCI-H650,54618164,4.229021786886974
HEL,sirolimus-bortezomib (250-1 mol-mol),0.9395189968578028
BL-70,168313200,1.5744509256656225
Lu-65,11485656,2.4652445580433713
ChaGo-K-1,9903786,4.114689259573735
Karpas-620,9936388,2.8279791192492088
MSTO-211H,selumetinib-vorinostat (8-1 mol-mol),2.5507506919352037
NCI-H1435,36462,2.835502283078309
SUP-B15,36462,-2.1786464367677567
SK-MEL-28,6610216,4.386997968475678
OS-RC-2,9903786,3.8385821896684433
697,135875424,2.464322234177451
HT-1080,3689413,-2.4389842103983583
SK-MEL-1,11485656,2.5093092817296307
SUP-M2,6610216,3.4046920555141
MOLT-3,168313200,1.915492137335788
JHUEM-2,11485656,1.361181565006939
HT,135875424,2.176006504416359
RD,148124,-4.312204426791305
NCI-H2444,selumetinib-GDC-0941 (4-1 mol-mol),3.5798793535857625
Caki-1,sirolimus-bortezomib (250-1 mol-mol),1.904717275884016
MHH-CALL-3,sirolimus-bortezomib (250-1 mol-mol),2.0420007480682925
A-204,44491742,4.019063545989705
FTC-238,136227924,2.431059366258334
NCI-H28,36462,-0.200152211841913
KP-2,107985,-3.092372796276895
HCC4006,262093,2.439333720308208
RVH-421,11485656,3.351347691760053
OCI-AML-3,sirolimus-bortezomib (250-1 mol-mol),0.125209205535959
MDA-MB-361,107985,-3.5291292054176444
KPL-1,9927531,4.948797048783531
CL-34,12003241,-1.25604782594079
YD-15,9926054,1.8520578861045605
NCI-H1694,439501,-3.146903361549278
BT 422,9927531,5.2521428794559
SNU-1041,tanespimycin-bortezomib (250-1 mol-mol),1.783117356671438
MG-63,3136844,4.156249547370532
SK-ES-1,selumetinib-vorinostat (8-1 mol-mol),2.305244767377923
Pfeiffer,24180125,1.142289052885765
TM-31,136227924,2.988827636595516
NCI-H1792,sirolimus-bortezomib (250-1 mol-mol),1.8777414374963155
BICR 6,148124,-7.961236400149058
SU-DHL-1,8515,3.677486404661737
PK-59,148198,-2.6043559024802763
A-673,136227924,1.815433973878695
SNU-685,135875424,4.288569640305719
A4/Fukuda,148124,-6.6912736941139865
VCaP,439501,-3.1099303166106087
HCC1428,9911830,2.8473630821079374
CAL-51,24180125,2.8082301472193203
Hs 294T,selumetinib-vorinostat (8-1 mol-mol),0.6984578471361444
A-204,8515,2.864869889805365
SNU-878,sirolimus-bortezomib (250-1 mol-mol),1.804977895321967
HCC2935,107985,-0.5385208487376155
IGR-37,9927531,5.0345741970674975
MFE-319,tanespimycin-bortezomib (250-1 mol-mol),0.5813484013187771
MDA-MB-435S,54618164,4.082989583633613
NCI-H716,135398744,6.457168364956761
SaOS-2,3136844,3.967600163436525
Aska-SS,6505803,-1.3133371843623132
SW1353,sirolimus-bortezomib (250-1 mol-mol),1.598593802144504
NCI-H524,JQ-1-carboplatin (1-1 mol-mol),1.4939916755553018
SCC-25,selumetinib-GDC-0941 (4-1 mol-mol),-0.1587136183503204
Hs 940.T,selumetinib-vorinostat (8-1 mol-mol),3.949639758307315
647V,tanespimycin-bortezomib (250-1 mol-mol),0.053073240777135
HuNS1,136227924,1.7771734051898846
SNU-46,9911830,2.761121036862751
Granta-519,11485656,1.6660529916447626
SK-MEL-24,148198,-2.756155300346231
FTC-238,148198,-4.9024101761285435
MJ,sirolimus-bortezomib (250-1 mol-mol),-0.1253732166157266
P31/FUJ,9903786,1.0734919883099745
MFE-319,409805,5.809457892580604
NCI-H1975,49836020,-1.0893813245468835
JHH-5,135423438,3.9719572001946344
GB-1,9936388,0.1084454809521914
A-375,5460769,3.311565919469283
TT,46943432,4.6815412381056625
A-549,36462,3.3558444938413707
COR-L51,JQ-1-carboplatin (1-1 mol-mol),0.8526356625711052
SUP-HD1,10296883,3.4620113901204927
NCI-H647,9936388,1.0931922000405532
EM-2,6918878,-0.543914375160734
BT 416,selumetinib-vorinostat (8-1 mol-mol),2.2892282073971737
OV7,148124,0.1757740490601124
SNU-245,24180125,3.6034150813328463
SNU-1105,107985,-1.9707036045790447
HLF,selumetinib-vorinostat (8-1 mol-mol),3.5615159911942267
A-172,439501,-2.9680565651311723
NCI-H1693,12003241,-2.0700110042259072
QGP-1,selumetinib-GDC-0941 (4-1 mol-mol),1.3136510607151746
KG-1-C,11485656,3.6519605363240495
BICR 6,24180125,3.6458211180566935
C2BBe1,9927531,4.784416538426047
SR,9927531,3.5947665035551113
Kelly,8515,3.705301466780827
SF539,36462,1.0067932013019132
Peer,12003241,-2.4634872028083015
Raji,46943432,0.8190341583035305
TE 617.T,selumetinib-vorinostat (8-1 mol-mol),2.763602035928325
OV56,selumetinib-vorinostat (8-1 mol-mol),4.726313652324262
DBTRG-05MG,6610216,4.298255841710492
RPMI-7951,148198,-2.190615440736015
UO-31,5460769,0.456698735836774
MDA-MB-157,JQ-1-carboplatin (1-1 mol-mol),3.3337524262441853
MHH-CALL-4,439501,-2.5308829551991168
COR-L47,tanespimycin-bortezomib (250-1 mol-mol),1.2425942007865165
OE33,44493528,4.497258048563181
JHH-2,9927531,4.777538001331337
SUP-B15,3136844,3.8555340028449745
NCI-H929,107985,-4.785949324647598
JL-1,9911830,2.651716959952657
NCI-H520,11485656,2.0255953186148674
D283 Med,6918878,0.6524959368526162
ECC10,26596,-3.5060948128404874
MDA-MB-453,11404337,-0.3002498088297632
T3M-10,44493528,6.393646010300226
T-47D,439501,-2.5781176863157524
NCI-H211,12003241,-0.3344728899219033
NCI-H1869,148124,3.56569848819375
SK-MEL-30,439501,-0.2056245952948021
SUP-HD1,8515,3.978055127644485
NCI-H2023,11485656,2.100922570819449
KYSE-520,168313200,5.3167549348023675
AGS,9926054,2.4402585627733844
RERF-LC-MS,44493528,4.358183394704722
DU145,9926054,1.942219630113699
SNU-1272,135423438,5.060183017948369
Ku812,26596,-2.18380806647072
RL,6505803,0.5926513253188753
P31/FUJ,9936388,-7.166815071220185
KYSE-450,tanespimycin-bortezomib (250-1 mol-mol),0.2570143843515884
KHM-1B,11485656,1.807132568777105
DND-41,100016,5.882204784714585
WT2-iPS,135875424,4.320167330318722
A-549,136227924,3.1395144761786486
SW579,3136844,4.1885788435527855
NB1,9911830,2.845476067890297
ECC12,12003241,-0.4991552447723122
U-251MG,135875424,2.6316918837604613
YD-38,9936388,-5.278764060182601
Kasumi-2,11404337,-1.9658161518336
U-118MG,44491742,3.985342348777434
KYSE-30,44491742,4.262990240897069
NCI-H23,24180125,3.1166872284315894
HD-MY-Z,selumetinib-GDC-0941 (4-1 mol-mol),1.012079708603172
UM-UC-1,sirolimus-bortezomib (250-1 mol-mol),0.2883897871436763
AU565,136227924,2.2371309282915184
BV-173,24180125,2.570278092429548
TE-4,12003241,-0.733911012282654
SNU-1076,409805,5.848660522218034
Calu-3,11485656,1.9769247449011944
BT 187,8515,5.227478147693905
COLO 678,9927531,4.922936078042476
WM266-4,6918878,2.6851817867241743
SK-CO-1,26596,-2.200264316257102
OV7,135875424,4.527719161863161
A2780,10296883,3.5268945611299927
NCI-H1869,3136844,4.70710828326211
SW48,5460769,-0.8804369809799648
SNU-1196,9926054,2.598124573780665
LOX-IMVI,sirolimus-bortezomib (250-1 mol-mol),0.6922186847217285
KMS-20,54618164,3.4319678497850705
BV-173,9903786,1.323242877126727
KP-N-SI9s,9926054,1.6199423536774489
NCI-H2110,9927531,4.774812830583443
U-937,439501,-2.545607636797326
NU-DUL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.4841470415007147
KMS-26,selumetinib-vorinostat (8-1 mol-mol),-0.8161988345197432
TE-6,10296883,3.6280455791463098
WM793,tanespimycin-bortezomib (250-1 mol-mol),-1.2734227949577797
UO-31,168313200,1.7728778067687565
FU-OV-1,439501,-0.5556149973103641
NCI-H2009,3689413,0.5343246791806224
42-MG-BA,439501,-2.6369598322141967
HCT 15,24180125,3.5081385414094397
769-P,selumetinib-vorinostat (8-1 mol-mol),3.2147834954252734
SNU-626,24180125,2.1450306590662636
JHUEM-3,107985,-4.163953976414814
Ci-1,36462,-0.0663858372189062
KYSE-510,sirolimus-bortezomib (250-1 mol-mol),0.7044078807643728
NCI-H2110,36462,0.5226581571760742
OC 314,24180125,1.1841173792860056
KMRC-1,262093,3.6313310555506817
FTC-133,168313200,3.883948141330694
BT 145,tanespimycin-bortezomib (250-1 mol-mol),-2.391322475110553
LK-2,24180125,3.0932795926537047
OCI-Ly10,6918878,0.7961112669271598
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933
HuT 78,135875424,3.0458075465752694
NCI-H2110,selumetinib-GDC-0941 (4-1 mol-mol),1.414956690857524
SNU-407,44491742,3.765091282887518
SK-MEL-5,262093,3.0272532373657848
ECC12,44491742,5.882219614933299
Caov-3,135398744,6.775001868991772
Hs 578T,6610216,4.144845051199694
JHH-5,10322450,3.916115158181419
NCI-H69,11485656,2.3871214683206152
MKN7,sirolimus-bortezomib (250-1 mol-mol),1.1357480366001242
OCI-M1,136227924,3.580987744477365
253J-BV,262093,3.2913693796929713
SNU-738,46943432,4.250733302993981
BT 482,136227924,3.374884803280594
NB1,selumetinib-GDC-0941 (4-1 mol-mol),2.4185204185307527
KMS-18,3136844,3.695388538890606
42-MG-BA,11404337,0.5565192143599668
HEC-265,tanespimycin-bortezomib (250-1 mol-mol),-1.1174681512441365
HLF,sirolimus-bortezomib (250-1 mol-mol),0.7648448061241114
CA46,44493528,3.81061502276679
SNU-449,9927531,4.924705078398161
NU-DUL-1,44493528,4.021728675000071
OCI-Ly19,3136844,4.322649536745635
CJM [Human melanoma],262093,2.9776663734710582
TE 441.T,168313200,1.7491212896878472
NCI-H1355,10296883,4.3250704024764115
Caki-2,36462,3.5694693954856205
SNU-423,8515,4.7137159265579225
NCI-H1373,selumetinib-GDC-0941 (4-1 mol-mol),2.438730896518944
BT-549,439501,-3.1266914034371567
MCAS,100016,6.4909883414165135
BT 248,selumetinib-GDC-0941 (4-1 mol-mol),1.214957443871495
YD-15,11404337,-0.8850670977234124
COLO 792,12003241,-1.2493881793514412
NCI-H1666,107985,-3.5426960047273655
SF126,12003241,-0.8562047407383144
HEL 92.1.7,107985,-4.351266385158589
NCI-H2196,JQ-1-carboplatin (1-1 mol-mol),4.258041583976656
BT 440,9911830,1.1775891461683867
U-87MG ATCC,selumetinib-GDC-0941 (4-1 mol-mol),3.2770460011243308
SK-MEL-3,11404337,-1.6693959250085673
LC-1/sq-SF,135875424,4.887954422220303
Mel Ho,262093,2.800747953988144
BT 330,9911830,2.954651946077228
MOLM-6,JQ-1-carboplatin (1-1 mol-mol),0.2604997389910982
EFO-27,JQ-1-carboplatin (1-1 mol-mol),5.5199687531263715
HuP-T3,11404337,1.0495167124251128
HL-60,12003241,-0.948434817183572
SBC-5,sirolimus-bortezomib (250-1 mol-mol),0.8879652697006557
AsPC-1,9926054,1.8957621767397328
HuP-T3,9926054,1.9266750805140576
JHUEM-3,9927531,4.734556698770441
K029AX,9926054,1.886633217948548
SK-UT-1,3689413,-2.3572164451465105
CAL-51,11404337,-1.4033364127444676
NCI-H28,49836020,4.481045778865963
SK-N-SH,9911830,1.546281106531784
HEC-6,159324,3.215977706316347
BICR 31,11404337,-0.6318210319309021
MDA-MB-435S,11404337,0.4937179544357896
CAL-33,6610216,4.068225921805276
NU-DHL-1,3689413,-2.5727806443741836
T3M-10,409805,6.215786200217872
LOX-IMVI,439501,-2.207275092585139
NCI-H661,11485656,2.0326011859644075
LP-1,11404337,-1.552804364872206
SNU-213,262093,3.638008939275064
SUP-M2,26596,-3.767571298105125
U-937,409805,5.256471886219303
A101D,49836020,-1.073011415975237
HGC-27,168313200,1.6271310885098942
BT-16,tanespimycin-bortezomib (250-1 mol-mol),-2.3872852877546062
U-87MG ATCC,9926054,2.857820648476152
BT 164,168313200,1.8126035324544545
BEN,JQ-1-carboplatin (1-1 mol-mol),1.5811982122787027
A-375,439501,-2.387181275139254
SNU-1077,439501,-0.9206139201693064
Hs 888.Lu,9911830,2.3425038490808645
CAL-120,tanespimycin-bortezomib (250-1 mol-mol),1.8647047986889285
OV-90,54618164,4.104612796363699
SIG-M5,54618164,3.803874177030029
EFM-192A,148124,-4.4565215369603814
NCI-H838,262093,3.692579673956935
CCF-STTG1,54618164,4.4288958648043915
SW620,135875424,2.207867824891832
NCI-H1650,9911830,2.190997122296158
BT 239,26596,-0.3538471097190154
JVM-3,409805,3.3511108831994045
PaTu 8988s,3136844,4.247292724797891
NCI-H520,tanespimycin-bortezomib (250-1 mol-mol),0.1006968831130432
639V,54618164,4.34294153821181
OUMS-23,44491742,3.6829653315357818
EHEB,148198,-2.104475544842142
NCI-H1395,9926054,1.836702615994444
JeKo-1,9927531,3.3417502019075473
BICR 18,26596,-0.934766780366006
HeLa,sirolimus-bortezomib (250-1 mol-mol),2.2283701197426553
HuCC-T1,107985,-8.637408805931722
TE-6,9903786,2.448917190367821
EN,9936388,2.3210150451577394
Rh18,6918878,2.4358596938791255
RL95-2,46943432,5.824295984202932
KP-N-YN,6610216,5.097327149655238
NCI-H2405,6505803,-2.525065037693204
PK-45H,409805,3.737662637005359
SBC-5,36462,0.3494520767872783
TE-4,8515,3.815282832964878
NCI-H2170,148124,2.714749959152977
SaOS-2,9911830,2.995519789289086
769-P,JQ-1-carboplatin (1-1 mol-mol),2.198713761096946
RERF-LC-A1,11404337,-0.8149390042058701
SK-N-DZ,8515,4.2154161677755395
NCI-H2081,262093,2.026605801788383
TCCSUP,135875424,4.238752084680578
YKG-1,9927531,5.706988241233545
ZR-75-30,3689413,-2.2209436804776805
HPAC,24180125,3.1939061719051196
8305C,439501,-2.556096692618791
CAL-27,11404337,-0.0180137116406381
NCI-H2141,44493528,4.465268919484744
MJ,5460769,-0.0196671860810318
SNU-216,44491742,4.347867819055225
OAW28,3689413,-1.4375749125930504
BT 328,100016,6.778172011931934
BT 320,9936388,1.7913306244505192
KE-39,135875424,3.891762591841876
Capan-2,6610216,4.161327281234416
U2OS,439501,-2.693554795919347
OC 314,135875424,2.7859307759569467
NCI-H1693,148198,-4.945805473712113
YD-15,107985,-3.0618096206093934
HCC1500,5460769,5.1304942195737935
A-375,selumetinib-vorinostat (8-1 mol-mol),1.9790131702817335
BT 482,9926054,2.2206643781764184
BT 231,3136844,3.641211375202356
SH-10-TC,12003241,1.4218324467353134
KMRC-1,54618164,3.981312375484732
HCC-56,36462,3.4551030637348146
HL-60,9926054,1.793392077078212
FaDu,136227924,3.658135500280057
NCI-H2196,sirolimus-bortezomib (250-1 mol-mol),-0.2528324189743298
NCI-H2228,11404337,1.3876441913514168
OV-90,11485656,2.959062717330634
SUP-B15,6610216,4.137405098787568
MKN7,168313200,3.0639752304620274
JVM-3,tanespimycin-bortezomib (250-1 mol-mol),-0.7253415150610979
SUP-B15,tanespimycin-bortezomib (250-1 mol-mol),0.1434284566489843
FTC-133,selumetinib-vorinostat (8-1 mol-mol),4.335548645422765
BT 145,11404337,-1.106330552835472
D283 Med,JQ-1-carboplatin (1-1 mol-mol),3.772418054249175
DU145,6610216,4.286029823589705
JeKo-1,9903786,1.7626830163965443
JHH-4,439501,-2.8819289141126596
786-O,11404337,-0.5189034557080271
SNU-601,5460769,-0.8674559843471038
MDA-MB-435S,12003241,-1.2560113103811834
NCI-H1793,9926054,5.214680491004607
Raji,135875424,2.0989109294233264
HCC2218,11404337,1.2593455770198374
SNB-75,9927531,5.402780165726325
RT-112,9936388,-6.676830833959952
G-402,100016,6.451749665500501
U-251MG,136227924,4.317491880233533
C2BBe1,selumetinib-GDC-0941 (4-1 mol-mol),0.2357334763777015
PSN1,6610216,4.258794252853587
Mino,135398744,6.764750512167438
SK-MEL-3,9927531,5.047514354060135
BT 145,136227924,2.723434550490864
SNU-201,409805,5.283587417567222
MOLM-6,6610216,3.643225548274676
NCI-H1341,6918878,0.3479866102028831
KYM-1,46943432,1.6560210739851535
AM-38,11485656,3.1018952301837155
NCI-H929,136227924,1.899057841083653
HCC-56,tanespimycin-bortezomib (250-1 mol-mol),1.6383234075963011
SW1353,409805,3.732446628282932
TE 617.T,11404337,-2.8418150062947487
NCI-H1299,54618164,5.089847136026273
NCI-H1568,107985,-3.6136890416333665
DV-90,107985,-7.11158707744724
JURL-MK1,3136844,4.063255571879247
UO-31,9926054,1.6709527378064972
NCI-H2106,135875424,3.1880464092319105
JHUEM-7,3689413,-2.2301251225415255
SNU-213,409805,3.467553308221755
OE33,44491742,5.719021846419829
GCT,9911830,2.6925449491003755
8505C,sirolimus-bortezomib (250-1 mol-mol),0.1276397939018833
SNU-449,10322450,2.7236273289045942
GA-10,49836020,3.868484173874789
PaTu 8988t,tanespimycin-bortezomib (250-1 mol-mol),-0.2002957463821567
ESS-1,6918878,4.817127721204009
BFTC-905,11404337,-1.6179925215678757
Capan-2,107985,-3.8437908284665494
TUHR14TKB,12003241,-2.6792741920200815
NCI-H1734,26596,-1.406622025931408
COR-L95,9926054,2.0133423062539726
BT 286,6505803,-2.395900359039176
SNU-478,10322450,3.5512522353536515
Lu-65,44491742,4.485926174539046
BICR 6,3136844,4.212999312185127
BL-70,36462,0.1930899985409087
SEM,9927531,4.847523560791686
MOLT-3,54618164,3.5300048072544596
YD-10B,9926054,1.7388994338775816
OCUM-1,selumetinib-vorinostat (8-1 mol-mol),-0.881751433026724
Hs 578T,5460769,5.961368196562113
Panc 05.04,5460769,1.7514561399814712
A4/Fukuda,262093,3.0357368226896178
SW1990,9911830,1.8136131351030251
A-673,8515,3.2253171108003023
UACC-257,168313200,2.4079622754907
JHUEM-3,5460769,0.399281620663996
BC-3C,6505803,1.2910533343434352
JHUEM-2,6505803,-3.169169021996555
SNU-C4,selumetinib-GDC-0941 (4-1 mol-mol),1.401600163987786
HCC78,409805,5.666316394079404
KNS-62,9911830,3.616191106750715
CHP-126,11404337,-0.8425306912863763
BT 428,11485656,2.0550266467475407
BT 131,439501,-2.852207869991737
MDA-MB-468,6918878,4.588443252654493
PE/CA-PJ15,54618164,4.606818581386584
COLO 800,9936388,0.9254157883591568
Ri-1,11404337,-1.810959317313917
JHOC-5,36462,1.4237720157059233
2004,36462,1.0954964379532657
JHH-2,54618164,3.8508571156127056
GMS-10,36462,2.852515511149566
KHM-1B,148198,-5.169783546510426
HCC1833,439501,-1.5774129771640248
HEC-151,135875424,3.433906350348657
HuH-1,136227924,2.959438331398248
BT 482,9936388,1.0428737774764048
U-937,JQ-1-carboplatin (1-1 mol-mol),3.049803202040864
COLO 668,sirolimus-bortezomib (250-1 mol-mol),1.0327595793559854
NCI-H1869,54618164,4.0885631456331035
BT 333,36462,2.304869296279445
YD-15,12003241,-1.418070390851184
SNU-213,5460769,1.7717518807864931
WM983B,selumetinib-GDC-0941 (4-1 mol-mol),-4.627362213665692
NCI-H1693,439501,-5.586339578501797
SNU-886,9903786,2.951492144984292
COR-L88,JQ-1-carboplatin (1-1 mol-mol),1.7692891259412051
NCI-H1792,148198,-0.2067375055401052
GSU,selumetinib-GDC-0941 (4-1 mol-mol),-0.0301350261262937
CAL-120,36462,3.5842555256529436
HCC1419,10322450,4.752947220118952
J82,11485656,3.7122630536085137
SK-N-DZ,136227924,0.9645463461515836
EM-2,6505803,-0.543849671747512
Pfeiffer,168313200,1.5512920869619469
HCC202,selumetinib-GDC-0941 (4-1 mol-mol),2.1279074309941413
TE-6,selumetinib-GDC-0941 (4-1 mol-mol),3.56930262529698
COLO 800,sirolimus-bortezomib (250-1 mol-mol),0.359649452523933
HCC1419,168313200,2.3751078129153025
KYSE-30,168313200,1.925854495062808
NCI-H446,6610216,4.1198160320329
KP-N-SI9s,12003241,-1.3670670210068214
MM1.S,9926054,1.5897504862532963
NCI-H1666,439501,-0.7596014001034053
SNU-1,262093,3.13624265052581
MCAS,44491742,4.8173197109659
AU565,6610216,3.647426232490327
BT 286,JQ-1-carboplatin (1-1 mol-mol),3.0626602949719226
ES-2,6610216,4.8266103176713155
NCI-H196,sirolimus-bortezomib (250-1 mol-mol),1.900922719750797
PF-382,9903786,1.7632578420268197
KE-39,135875424,3.891762591841876
BT 159,439501,-3.0773792715975685
JL-1,selumetinib-vorinostat (8-1 mol-mol),2.5961200479912714
JMSU-1,9926054,1.0458929376132455
HCC95,148198,-1.75533613321643
U-87MG ATCC,sirolimus-bortezomib (250-1 mol-mol),1.5742671980534302
Panc 04.03,10296883,4.422301293811254
CHP-126,11485656,2.087458763125066
KP-4,9903786,1.7495953596701077
RMG-I,selumetinib-vorinostat (8-1 mol-mol),1.624672886728396
TCCSUP,409805,5.441662511172961
HCC15,107985,-2.9906891972859415
MKN74,107985,-2.988368566005849
NCI-H2126,selumetinib-vorinostat (8-1 mol-mol),2.6137904318766707
SNU-16,24180125,1.3205612093228705
FTC-238,11404337,1.3350239521780074
YH-13,439501,-2.216859157731525
SUIT-2,6610216,4.902807448612422
CCK-81,sirolimus-bortezomib (250-1 mol-mol),0.9757763076184672
BxPC-3,6610216,4.298723179439111
ZR-75-30,24180125,2.6868616439052353
WM115,11404337,-2.7813606850874595
DMS 53,tanespimycin-bortezomib (250-1 mol-mol),0.0429262611809588
HCC-56,9927531,5.667739973718857
TE-10,148198,-2.165511242505793
HCC1806,JQ-1-carboplatin (1-1 mol-mol),3.517828248057606
NCI-H526,11485656,2.2032947019554627
AGS,tanespimycin-bortezomib (250-1 mol-mol),-1.1617791040203864
SW1710,107985,-3.4300855672934447
HCC1195,11485656,3.140969914915027
SiMa,11485656,1.7152313811667237
Panc 02.03,6505803,-1.93196111296706
HPAF-II,9911830,3.274305955299227
RS4;11,136227924,1.742872720779967
SNU-668,9903786,2.616887117986772
HCC2218,12003241,-0.1021817446699859
RERF-LC-Ad1,262093,3.285321037103647
NCI-H1355,148198,-3.013300378590096
Kasumi-2,8515,3.2781378887974775
Hs 683,selumetinib-GDC-0941 (4-1 mol-mol),2.318747786701251
BT 328,sirolimus-bortezomib (250-1 mol-mol),2.117607620911863
TOV-21G,107985,-3.920988354702577
MKN74,selumetinib-GDC-0941 (4-1 mol-mol),2.4361199969634924
HCC1833,262093,2.988096800875125
MIA PaCa-2,439501,-4.331404793236993
CJM [Human melanoma],44493528,4.221846100020477
AML-193,24180125,3.91654561081322
NCI-H1944,sirolimus-bortezomib (250-1 mol-mol),1.314144105484395
NCI-H810,9926054,1.762118845212232
SR,JQ-1-carboplatin (1-1 mol-mol),1.1771203251260662
JHOS-2,9926054,1.95390752128008
23132/87,selumetinib-vorinostat (8-1 mol-mol),2.218713845544177
SNU-1066,3689413,-0.3741974458844401
Hs 578T,9911830,1.8415488310129824
Mino,100016,3.8828597807205023
BT 145,6918878,1.9570363429172144
OCI-AML-2,11404337,-1.0891062211328033
KP-N-SI9s,136227924,1.797924144791439
HEL,36462,0.8349109175120154
L-428,selumetinib-GDC-0941 (4-1 mol-mol),3.762194755166614
JHH-2,168313200,2.204559089339404
YD-15,11485656,1.939430156438133
RCH-ACV,9936388,-7.0347905205950765
PaTu 8988s,tanespimycin-bortezomib (250-1 mol-mol),-2.9825646134003825
647V,36462,0.4218876333700403
NCI-H1666,36462,4.161489561000207
CHP-212,5460769,-1.533156489217473
Granta-519,selumetinib-GDC-0941 (4-1 mol-mol),1.138104902542422
SNU-1105,54618164,4.383989798122411
CAL-33,sirolimus-bortezomib (250-1 mol-mol),0.5156392130456946
MDA-MB-157,107985,-3.8805729202788304
A4/Fukuda,44491742,3.3943913096556444
OVK18,100016,6.632788488948234
BT-20,selumetinib-vorinostat (8-1 mol-mol),4.571320043409551
ZR-75-30,9927531,5.796828878545894
HCT 116,135875424,4.043772794114506
BT 216,10296883,4.1939688234140435
BT 159,107985,-3.1496718736589324
BT 228,44491742,3.950846154014159
HGC-27,46943432,3.3342404916831825
KMS-34,26596,-3.9045844155365304
NCI-H292,148198,-2.0841293800573446
ECC10,selumetinib-vorinostat (8-1 mol-mol),1.623685100455314
CJM [Human melanoma],9911830,2.07393035004485
TE-8,107985,-3.1643692279540026
HCC95,9903786,2.343121552943665
2004,sirolimus-bortezomib (250-1 mol-mol),0.3524960836924493
LK-2,100016,5.670732740144693
KMS-21-BM,24180125,2.4218956668209732
Capan-2,9926054,1.7295951578081552
SW1116,12003241,0.0582707461824652
NCI-H1339,148124,-5.674249092402399
SW1088,selumetinib-GDC-0941 (4-1 mol-mol),3.0866822201862374
SNU-1041,6610216,4.964227197665286
769-P,136227924,4.180099818093012
LS180,5460769,0.3293841533128088
NCI-H1755,6610216,3.888386039352291
EBC-1,6918878,4.574397712517336
PK-45H,11404337,1.3434585990232362
EM-2,107985,-4.199278116415869
HEC-59,159324,3.11725748747758
SF268,36462,1.3172986940401454
BC-3C,selumetinib-GDC-0941 (4-1 mol-mol),1.2071985367174134
PK-59,135875424,3.737021018611698
SU-DHL-1,9927531,2.969590320438058
OV7,439501,-2.8665617033549515
SCC-25,3136844,3.707454380555626
SKM-1,107985,-4.676728901872281
HDLM-2,12003241,-2.9289857152710344
HSC-2,6505803,-0.2270434612108878
LK-2,10296883,4.228835920762888
OV-90,6610216,4.14944929140681
KYSE-520,6505803,-2.015031116266543
A-172,136227924,1.9508876589720905
EFO-27,3136844,4.472321824110979
TT2609-C02,135875424,5.0022625641084755
KMS-27,262093,2.820550232220946
Lu-99,sirolimus-bortezomib (250-1 mol-mol),1.6973589425418654
PaTu 8988s,24180125,3.4136901052211246
Jurkat,9936388,-5.914965617519404
TE 441.T,JQ-1-carboplatin (1-1 mol-mol),3.6275074638677465
MFE-319,selumetinib-vorinostat (8-1 mol-mol),2.3643464051369483
Hs 895.T,12003241,-1.2157135831587602
OVISE,3689413,-2.3316050545360136
CL-11,135423438,1.6097510193323543
ACHN,8515,3.990371766776524
KMRC-20,9903786,3.936421872110463
SU-DHL-10,262093,2.40427265358065
TYK-nu,10296883,3.5391236676051583
HPB-ALL,100016,7.357554409535215
SNG-M,168313200,3.9899004151093416
JHH-6,3136844,4.4083138636484165
NCI-H1341,136227924,2.213362476241057
NCI-H661,11404337,-0.0954545894437525
NCI-H2452,409805,5.262030999116563
TCCSUP,135423438,2.289740320598626
NCI-H526,JQ-1-carboplatin (1-1 mol-mol),2.899547040421834
LS1034,sirolimus-bortezomib (250-1 mol-mol),1.3157999694585985
KNS-81,3689413,2.13740937168454
MOLT-3,8515,2.858943668273086
CL-11,136227924,2.4405671689998027
RERF-LC-A1,409805,5.788230095208666
Pfeiffer,9926054,1.762205807051045
HL-60,409805,3.622853668310883
BT 245,262093,2.3897148405812536
SNU-16,6918878,-0.3446084200312734
OCI-Ly19,6918878,0.9391172615521892
BT 440,24180125,3.8960542559338167
SNU-C1,148198,-4.322316579096634
BHT-101,11485656,2.812775629456312
COLO 680N,3689413,-1.68743506325492
SUP-T11,tanespimycin-bortezomib (250-1 mol-mol),1.9096696973942504
HuH-1,9903786,2.716851853041897
BT 159,10296883,4.294831220705457
SNU-308,9877608,6.965514964870985
HCC1428,6610216,4.184563272791284
KMS-11,11485656,1.7244109146012885
MDST8,3689413,-1.6812703512916511
SNU-449,100016,6.350050439021361
SNU-1079,selumetinib-vorinostat (8-1 mol-mol),4.808622110594304
CAL-27,44493528,4.330239029111345
NCI-H2141,44491742,3.797452560506029
SNG-M,10322450,3.801998973988302
A-549,9911830,2.245916242551202
M-07e,3136844,5.145104949558255
Hs 746.T,6610216,4.135271582579114
A-204,6918878,3.353505817332934
DV-90,49836020,4.269422045712615
OV56,11404337,1.1969378200934953
IGROV-1,6610216,4.310938387105607
T3M-10,9927531,5.241044178261577
FaDu,44491742,4.0645501932383095
HCC-56,6610216,4.543261999492176
HCC1806,44493528,4.3111329846285456
Kasumi-2,409805,3.7279902229812114
SF268,8515,3.901709895631083
BT-12,107985,-4.197722629937788
IGR-39,49836020,4.439074954514643
HCC1428,11485656,3.1033366258565938
SNU-216,262093,2.2180002949269793
TT,9911830,2.7097540561392637
MOLM-13,9911830,-0.5537570191991712
MDA-MB-468,3689413,0.3907824455820104
JHOS-2,6610216,4.585679605860104
WM793,9926054,1.9861694749243135
KLE,49836020,-2.0520357560351714
SCC-4,JQ-1-carboplatin (1-1 mol-mol),1.0548546410991495
Daudi,12003241,-4.903510386182724
HuP-T4,262093,3.072428366481475
SW1353,9936388,-5.283221475424073
697,tanespimycin-bortezomib (250-1 mol-mol),0.0075427877175817
BFTC-909,26596,-1.7437210940555867
OV-90,135875424,4.80016944702245
KALS-1,tanespimycin-bortezomib (250-1 mol-mol),0.1032603454372563
SNU-46,3689413,0.3621274861005061
HCC202,168313200,4.148349775691495
SNU-1,JQ-1-carboplatin (1-1 mol-mol),-0.7235204219761906
NCI-H23,sirolimus-bortezomib (250-1 mol-mol),0.1265190636772679
NCI-H1355,159324,2.5006062648801413
NCI-H211,135875424,3.0832009645931073
SH-4,136227924,2.5718168505003693
LC-1/sq-SF,439501,-1.6562365641481254
G-361,439501,-0.9249859922186838
MHH-CALL-4,9903786,1.9013313990407976
KMS-20,148124,-6.52302823792501
NCI-H2170,9936388,-3.7757464775618104
HOP-62,3689413,-1.4977119259076146
BT 320,439501,-1.927418392306892
NCI-H929,8515,3.198792100225454
MOLT-13,159324,-1.1866760000541376
MeWo,148124,3.0579930768236863
NCI-H1703,12003241,-1.7949432370006393
Rh41,44491742,3.4583513797459537
CAL-148,107985,-4.556226518156489
NCI-H661,36462,2.012090600363037
Hs 683,3689413,-0.4207741938701824
SU-DHL-8,12003241,-0.8632235676270862
SNU-738,9927531,4.827507825762818
CHP-212,135875424,3.192345870347938
JURL-MK1,9927531,3.9851065784934945
HEC-108,3689413,1.021712931431184
SU-DHL-10,439501,-2.5547095883933975
KYSE-150,11404337,1.3102560246616723
NCI-H1944,9927531,4.180597511578871
NCI-H647,24180125,3.804113444039596
Aska-SS,439501,-3.4608963825976686
NCI-H1105,136227924,3.5995085606393955
CHP-212,54618164,3.610920674376875
EB1,6918878,1.1658178771655108
GI-1,3689413,-2.447824191080865
SK-MEL-28,selumetinib-vorinostat (8-1 mol-mol),1.183939454839272
Pfeiffer,9927531,3.43317918273791
SNU-620,24180125,2.1071422943866405
Aska-SS,49836020,4.404663805549638
GSS,selumetinib-GDC-0941 (4-1 mol-mol),0.7443695681674949
DAN-G,262093,4.7024192027781435
NCI-H1435,6505803,-2.6053022646715207
BT 320,sirolimus-bortezomib (250-1 mol-mol),1.2360663463766004
COLO 201,6610216,4.151677108273465
WM983B,135875424,3.018238153031043
NCI-H292,tanespimycin-bortezomib (250-1 mol-mol),-0.1673864119679393
SK-CO-1,6505803,-2.970063061644963
PLC/PRF/5,54618164,4.054681529600222
ZR-75-1,6505803,-2.5048653445309297
KP-4,159324,2.838161812781853
NCO2,12003241,-5.3551857747003
SU-DHL-6,11485656,1.7981230616770194
NUGC-4,6918878,-0.576894766558933
PF-382,148198,-4.947878541405711
SNU-16,135875424,3.101421210140047
GP2d,12003241,-2.636823152177336
SU.86.86,9927531,4.197811757313418
DLD-1,JQ-1-carboplatin (1-1 mol-mol),2.485770842488409
NCI-H1838,148198,-2.358170233860321
SNU-410,11404337,1.1102019570699369
HCC1500,54618164,3.7944844711277264
OVCAR-5,136227924,3.2070295394145782
Hs 944.T,159324,2.0407130641641933
MDA-MB-453,439501,-3.002845657836036
NCI-H810,148198,-5.648047602621706
EB1,439501,-3.6025033052563553
SK-N-DZ,tanespimycin-bortezomib (250-1 mol-mol),0.4242122917353423
NCI-H446,159324,1.5850808860876966
KALS-1,148198,-1.8271090842643645
SNU-503,107985,-1.4472392237999567
DV-90,24180125,3.321191195126123
NCI-H23,46943432,1.7147765418067102
EJM,9911830,2.3498846254734267
NALM-6,11485656,1.650692330200231
SNU-869,10322450,4.162727619764448
8-MG-BA,44493528,4.684736338919144
NOMO-1,409805,3.6617718212828874
SNU-1,135423438,1.6465849203291467
SNU-201,9903786,3.5619464236544336
Capan-2,44491742,5.038963412977017
MDA-MB-231,6918878,4.462349126598544
NCI-H69,135875424,3.823328505000576
L3.3,10296883,4.354494828099719
HEL 92.1.7,148198,-5.4580431363429645
SCC-9,6505803,-0.8932206272709824
HCC1954,9911830,3.1305041112898286
RT-112,8515,3.1628534284940866
KMS-21-BM,46943432,-0.8221930725706761
Mino,3136844,3.4566917217945163
HCT 8,sirolimus-bortezomib (250-1 mol-mol),1.4500182233315906
HT-1080,11485656,1.905187358604855
EPLC-272H,5460769,1.6244755024215547
RERF-LC-MS,439501,-1.3704502050640626
P3HR-1,24180125,2.923923284516129
MOLT-13,100016,6.122983577816604
Jurkat,9911830,2.1111759475111027
DU145,6505803,2.9308640693327126
MFE-296,26596,-0.907337078157821
Hs 683,44491742,3.840304182439804
DMS 454,107985,-4.311392502564405
KP-3,sirolimus-bortezomib (250-1 mol-mol),1.5261353801171291
SNU-407,9926054,1.9660241476439948
HCC1428,9936388,2.06453548249226
CGTH-W-1,selumetinib-vorinostat (8-1 mol-mol),2.294733258472385
Hs 611.T,3689413,-2.7004104072546133
DV-90,54618164,3.589602707510897
NB1,3689413,-0.0909545830460423
HuG1-N,11485656,1.8957868376228804
NCI-H2081,6918878,1.3213602453376416
CW-2,JQ-1-carboplatin (1-1 mol-mol),0.838354754464334
HuH-6,439501,-1.8507525220603604
NCI-H2087,9936388,0.7446762448927194
HOP-92,36462,2.3533766692120737
Daudi,10296883,2.545577320776033
HCC202,11404337,1.6013031156862827
DMS 273,9927531,4.953960158421894
BT 328,11485656,2.729036955069127
HEY A8,9911830,2.4689943419760687
G-292 clone A141B1,9903786,2.9519846446825277
NCI-H1869,100016,6.8338343579730285
SNU-1105,5460769,2.875284182310896
MOLM-6,5460769,2.737785033090413
MOLP-2,9936388,-6.6933037631173695
Mel Ho,439501,-2.4053312201946055
LS513,148198,-2.3506631812777945
SW1088,3136844,4.193807918688758
KYM-1,44491742,4.6632878215143405
NUGC-3,sirolimus-bortezomib (250-1 mol-mol),0.5062722406192697
HCC202,12003241,0.4259304556953664
REC-1,9936388,3.0128299108104306
NCI-H1581,3136844,3.671367482585882
GOS-3,148198,-2.930015056129616
KYO-1,24180125,3.3810336987775353
LCLC-97TM1,46943432,0.977611384475134
Daoy,6918878,5.101229555730873
FTC-133,9936388,3.0046059879710363
NCI-H508,12003241,-0.6008293317473488
KMS-12-BM,selumetinib-vorinostat (8-1 mol-mol),2.1031452809096827
SNU-81,159324,-2.5700546068481502
BT 187,selumetinib-vorinostat (8-1 mol-mol),4.40135270594373
LCLC-103H,409805,5.797514940413998
SUP-T11,262093,-0.249572082043469
KMS-18,46943432,0.7335709559336779
JK-1,6918878,-0.5399507686658914
Caki-1,3689413,-2.406735628687606
KMRC-2,24180125,1.140997225837335
SW579,262093,3.2995610578191683
OC 314,439501,-2.7228413581115105
Rh41,49836020,4.456584836146854
HDLM-2,148198,-3.3078190571311925
RL,136227924,2.481613482211788
TCCSUP,9927531,4.77726983491798
NCI-H446,8515,3.948412073118329
Panc 10.05,sirolimus-bortezomib (250-1 mol-mol),0.3447430037578218
JMSU-1,100016,3.921608363156487
MSTO-211H,tanespimycin-bortezomib (250-1 mol-mol),-0.4503897657817667
HuH-1,9911830,3.3566600016915755
HCC2279,6505803,3.133680214684758
CAL-12T,262093,3.257362917097833
NCI-H2141,9936388,-7.734442160433386
Hs 936.T,24180125,3.7813502708248543
NCI-H1734,selumetinib-GDC-0941 (4-1 mol-mol),-0.5700124177299448
Calu-3,100016,7.471917827082483
BT 145,6610216,4.164156438874729
OC 314,26596,-2.5716994048265964
BEN,159324,3.690228423182978
KMS-12-BM,107985,-5.423573263916533
ML-1 [Human thyroid carcinoma],JQ-1-carboplatin (1-1 mol-mol),0.7562453345428342
LMSU,tanespimycin-bortezomib (250-1 mol-mol),0.1689419151943554
NCI-H292,409805,3.708436738901026
COV434,tanespimycin-bortezomib (250-1 mol-mol),-0.6221104075249205
YKG-1,6505803,-0.4747915631752394
DMS 53,10296883,3.680097664762246
KNS-62,136227924,3.1878911405001236
HT-1080,selumetinib-GDC-0941 (4-1 mol-mol),1.1211488481166476
8305C,44493528,4.453346362405301
HMCB,262093,2.6900614407313355
FaDu,9926054,1.9668207116492555
MFE-319,439501,-2.2775311995949035
NU-DUL-1,54618164,3.711799821766253
SK-N-MC,JQ-1-carboplatin (1-1 mol-mol),0.7192818040209301
Daoy,6505803,0.5477852544594343
UACC-62,409805,5.864664647014031
NCI-H838,11404337,0.7986935268513927
PE/CA-PJ34 (clone C12),9926054,1.748247929323894
HCT 15,168313200,4.218417458600112
NCI-H23,168313200,3.938630562254836
KYM-1,136227924,2.3887987595454594
ONCO-DG-1,36462,2.81533551791567
SCaBER,selumetinib-vorinostat (8-1 mol-mol),0.862558649966769
Hs 888.T,5460769,6.095978340264565
JMSU-1,36462,0.54359798251978
JJN-3,136227924,1.2624051766932831
LCLC-97TM1,3689413,0.1289764847745495
P31/FUJ,12003241,-0.93015536828776
DU145,3136844,4.310051670074563
REC-1,3136844,3.938412595022709
U2OS,54618164,4.008388893072133
JHH-1,9926054,1.7588254192067414
U-937,11404337,-0.2465746995884755
UACC-62,3689413,0.3229546491467058
MOLP-2,168313200,3.90782874190498
JVM-2,9926054,1.9901106639385144
NCI-H2196,262093,1.390749456679199
A-549,8515,3.6622074868184464
HEC-108,26596,-0.981636576627464
BT 159,24180125,3.863363917993721
ONCO-DG-1,11404337,-0.4359581165609131
RS4;11,11404337,-3.5879317876288956
ONCO-DG-1,9903786,3.737117521186133
HuH-6,135423438,1.011063885151324
KALS-1,6610216,5.229804141244247
M-07e,5460769,1.3910333770062682
BC-3C,36462,3.334767376058825
MDA-MB-453,54618164,4.967166731196573
NCI-H2405,12003241,-1.91851712943585
Panc 03.27,8515,4.616547975522318
OCI-AML-2,136227924,1.951984345015637
LoVo,selumetinib-vorinostat (8-1 mol-mol),-0.5614711347851936
ES-2,11485656,2.323063224970118
KALS-1,135423438,2.6558677077861783
TE-15,10322450,3.2140192626835313
NCI-H69,selumetinib-vorinostat (8-1 mol-mol),2.400954503336172
LOX-IMVI,9911830,1.9996336712614449
Ishikawa (Heraklio) 02 ER-,3689413,0.6231985481364082
IGR-39,6610216,4.665927755877599
SW1710,11485656,3.0628562061109976
KMS-20,sirolimus-bortezomib (250-1 mol-mol),-0.3833823463346493
SK-LMS-1,3136844,4.349436037935601
RS4;11,6610216,3.9207416036344855
CGTH-W-1,JQ-1-carboplatin (1-1 mol-mol),2.382639318925406
KE-37,409805,3.6967057157078953
Mel JuSo,9926054,2.008818568190823
Kasumi-2,sirolimus-bortezomib (250-1 mol-mol),-0.078386775418122
SU-DHL-8,tanespimycin-bortezomib (250-1 mol-mol),-0.6950122900269923
MOLM-13,73707440,5.976327057082507
Panc 03.27,selumetinib-GDC-0941 (4-1 mol-mol),1.140504717047802
SW1783,148124,3.5822290901632545
CHP-126,6610216,4.916438855673617
IGR-39,262093,3.5414544189999035
JHUEM-1,44491742,3.7957056019779345
HOP-62,135875424,2.89405317867683
RPMI-8402,9911830,1.9895553724691295
NCI-H446,9911830,2.308414710364549
NCI-H1105,9926054,1.86457745322678
MOTN-1,JQ-1-carboplatin (1-1 mol-mol),-0.1739413245124559
SF268,11404337,-1.2777642443849726
Becker,3136844,4.385531960303477
JL-1,409805,3.9394900151572143
AU565,148124,-5.63717967948206
RKO,6505803,-0.9276151073099124
CAL-120,9911830,3.1779958908995125
SNU-1,24180125,3.3252406480350065
BT 248,6610216,3.912037893092857
OVTOKO,409805,7.558218507012755
KYSE-30,11485656,2.6374732663532794
Sq-1,100016,4.274424361552861
SNU-5,9903786,3.415136592873371
MFE-296,6505803,0.2108940318796544
NCI-H1693,9936388,1.0326729048127057
SHP-77,8515,4.097215117874386
SK-BR-3,49836020,6.022467534114696
MM1.S,selumetinib-GDC-0941 (4-1 mol-mol),0.5513447190034949
HuH-1,107985,-3.042398448679546
TE-5,9903786,3.304893690679265
HCC78,6610216,4.730533991770319
BT 147,439501,-3.335486008920962
AGS,107985,-2.9064741271933636
CJM [Human melanoma],54618164,4.212338227274922
NCI-H1395,9927531,4.9557176619227015
AsPC-1,148198,-3.729188282050714
MKN1,6610216,4.5143406810013005
BT 231,262093,2.1267355779539043
BT 131,6505803,-1.6388820093496137
NCI-H2087,sirolimus-bortezomib (250-1 mol-mol),0.3308566581243162
HEC-59,6918878,2.72911788137472
LS411N,3689413,2.701640891749041
NCI-H28,12003241,-0.6704965456124867
OPM-2,5460769,4.223891374112808
CHP-126,44493528,4.776388586076308
Fu97,JQ-1-carboplatin (1-1 mol-mol),0.0288153653540589
OAW28,5460769,4.044755256654475
NCI-H2009,12003241,-1.6852069192913937
JL-1,136227924,2.288232757655929
OC 314,6610216,4.261307355993507
KYSE-30,selumetinib-vorinostat (8-1 mol-mol),0.7250547393630876
T3M-10,10296883,4.278304655632823
HD-MY-Z,11404337,-0.4126072630667986
TE-4,36462,2.757071429089849
SCC-9,409805,5.497565328609373
HCT 8,9936388,2.3288203761031885
JHUEM-1,9926054,1.7870789981263362
CA46,3689413,-3.563387503989764
OE33,135875424,4.864853081585439
NCI-H2106,selumetinib-GDC-0941 (4-1 mol-mol),2.731448809919849
Kasumi-1,135423438,-3.561696471128374
RPMI-8226,135875424,2.066297647502018
AN3-CA,44491742,4.617223070127138
CL-11,sirolimus-bortezomib (250-1 mol-mol),0.3846215058454166
Panc 10.05,8515,4.8938327251250335
HuT 78,3689413,-1.8719775604380453
SU.86.86,11404337,0.6097421920639037
EPLC-272H,10322450,3.877521478432198
KYM-1,135423438,1.6984584998013297
Rh18,409805,3.5116052994739304
NCI-H1395,12003241,1.698262392733821
LUDLU-1,54618164,4.275975403884661
MFE-296,136227924,3.1639946768284672
MOLT-13,26596,-2.4111257577546565
COLO 829,selumetinib-vorinostat (8-1 mol-mol),0.6653479490850627
NCI-H526,8515,4.139215532971162
OCI-Ly19,10296883,3.222057904422062
A-498,6505803,4.020571046679738
LS180,9936388,-5.017955750811216
22Rv1,JQ-1-carboplatin (1-1 mol-mol),6.088896276058885
GI-1,439501,-2.4273681178364837
SNU-878,selumetinib-vorinostat (8-1 mol-mol),2.250653624443524
COLO 800,135875424,4.447518165388321
MIA PaCa-2,9936388,-9.05612896602556
SW1783,9903786,4.362374850125049
SBC-5,26596,-2.1907470722084414
BT-549,49836020,-1.94641857460656
COLO 205,409805,5.399830169026648
IST-Mes1,44491742,4.903550558956352
NCI-H1869,6918878,4.025973288995393
TALL-1 [Human adult T-ALL],tanespimycin-bortezomib (250-1 mol-mol),0.1356817268288457
MG-63,439501,-2.9607530024491515
NCI-H841,11404337,-0.1615181645680822
JHH-5,54618164,3.840567565900515
TE-9,3689413,4.927394449121957
NCI-H2087,107985,-3.934436633809772
NCI-H1694,JQ-1-carboplatin (1-1 mol-mol),-0.7317263485639335
HuP-T3,JQ-1-carboplatin (1-1 mol-mol),1.982980925186552
T84,12003241,-0.2889439900128532
MOLM-6,168313200,2.7727860502576487
L-540,6918878,0.9528007464651654
Daudi,JQ-1-carboplatin (1-1 mol-mol),-0.7509851402821236
Lu-65,9911830,1.689381922499865
Hs 578T,148198,-5.652583246713905
NCI-H2291,136227924,3.7471032532575457
OPM-2,11404337,-1.9830798838769188
HEC-59,6505803,0.8725276425647639
SET-2,100016,6.077577626399248
SNU-489,6610216,4.923159792300278
MOLP-2,JQ-1-carboplatin (1-1 mol-mol),1.3158368386628676
SNU-1033,6610216,4.08331616990365
GCT,168313200,1.6460729886366328
SU-DHL-10,44493528,4.09014780948348
EFO-21,10322450,5.02193128329613
MOLT-3,12003241,0.5652275410160802
SNU-1077,44493528,3.708438186415119
HuH-6,3136844,4.044359303597411
PE/CA-PJ34 (clone C12),54618164,4.074052686035258
BHY,9936388,1.458207941803915
BT 286,sirolimus-bortezomib (250-1 mol-mol),0.4309119586946818
Lu-65,JQ-1-carboplatin (1-1 mol-mol),1.9478415319376168
Panc 02.03,sirolimus-bortezomib (250-1 mol-mol),1.3966258084955054
SH-10-TC,6505803,1.0685090299796742
Calu-3,262093,2.6683793293156204
BT 147,12003241,0.4037100837513208
HEL,11404337,-0.835651629585067
TE-6,JQ-1-carboplatin (1-1 mol-mol),3.92725328436462
SNU-1,11485656,1.6687756600657273
IMR-32,11485656,1.530549227150807
J82,9911830,1.861677357904933
SNU-216,107985,-4.706172049082236
NCI-H929,439501,-2.3111413664478513
Ki-JK,54618164,3.0258651969868984
EJM,12003241,0.5402616975347148
Hs 852.T,selumetinib-GDC-0941 (4-1 mol-mol),1.139310291685008
OCI-AML-2,5460769,1.9036049524164391
UACC-257,148124,4.26256127916897
JeKo-1,168313200,3.3744952164536537
SK-N-AS,tanespimycin-bortezomib (250-1 mol-mol),0.7232551135734744
RERF-LC-MS,44491742,4.380479941679622
SK-ES-1,6918878,1.485729278279066
U-118MG,148124,-4.102697038278307
COLO 320,10296883,4.10892826768056
THP-1,selumetinib-vorinostat (8-1 mol-mol),-2.0234656075147037
NCI-H1092,5460769,5.922318384562557
BT 482,selumetinib-vorinostat (8-1 mol-mol),1.0923581719220932
HuH-28,54618164,3.756751318056744
BT 482,12003241,-1.3288470463834767
GI-1,262093,2.614529868805307
KYSE-70,6610216,4.087252338732691
NCI-H747,6610216,3.8291236169336007
NCI-H1838,12003241,-1.140669133543194
CAL-51,6505803,-1.1525670311484852
HeLa,selumetinib-GDC-0941 (4-1 mol-mol),4.580619415349248
HCC15,439501,0.3030845703669018
SW1417,107985,-2.8502235433428695
WM115,439501,-0.2667789802830004
TF-1,262093,2.2730814154629573
SW1271,159324,2.241950485620868
CAL-33,3689413,0.5447147166063717
YH-13,11404337,1.1602704800571209
Jurkat,262093,2.316034624316645
BICR 16,439501,-3.169207556484136
GSS,tanespimycin-bortezomib (250-1 mol-mol),-1.8015851395784044
HCC2108,tanespimycin-bortezomib (250-1 mol-mol),-0.3667697976747508
NCI-H1435,9911830,2.666269312606889
Panc 08.13,148198,-3.0939761234000867
OV-90,9926054,2.051582159797273
MDA-MB-468,JQ-1-carboplatin (1-1 mol-mol),3.305072238295291
HCC1419,148124,3.4097288339682863
BT 416,JQ-1-carboplatin (1-1 mol-mol),0.4698269492624847
NCI-H647,409805,3.845998553182997
BICR 22,9911830,2.5765146499323497
NCI-H810,6918878,0.3762952286032847
Lu-65,439501,-2.896459054469027
PaTu 8988s,9926054,1.8956430403525124
RT-112,159324,2.695611824284584
TC-71,24180125,3.7432821305045545
RCH-ACV,54618164,3.616633396112511
LMSU,9936388,2.8786407463456656
AGS,sirolimus-bortezomib (250-1 mol-mol),0.9913550717108452
23132/87,12003241,-0.6974968916735146
HCC15,JQ-1-carboplatin (1-1 mol-mol),2.0328384477438477
Pfeiffer,JQ-1-carboplatin (1-1 mol-mol),-0.9123603269683516
A-375,36462,2.2806967665334894
KYSE-180,44484440,3.483431565437074
CA46,9926054,1.6892727173627182
BT 131,11404337,-0.6302190073571774
Mono-Mac-6,262093,3.4687299225305535
NCI-H1666,selumetinib-GDC-0941 (4-1 mol-mol),-1.4234011879049815
NCI-H2110,135875424,4.423682476800295
HEC-1-A,selumetinib-GDC-0941 (4-1 mol-mol),0.8454811422727944
OVSAHO,selumetinib-vorinostat (8-1 mol-mol),4.369636445771919
Tm87-16,sirolimus-bortezomib (250-1 mol-mol),0.5846669503763354
697,5460769,1.383858776744359
HCC1171,9936388,2.426947381666507
TCCSUP,9936388,1.8313124822353004
VM-CUB-1,6918878,4.620725416155216
SW1417,8515,3.674156008172432
HD-MY-Z,135875424,4.008559842592383
BT 359,sirolimus-bortezomib (250-1 mol-mol),0.4069320029327686
BT 172,262093,2.689184232302602
SU-DHL-10,136227924,2.6642941314249327
C2BBe1,135875424,3.7823394766863863
HDLM-2,selumetinib-GDC-0941 (4-1 mol-mol),3.928521461465485
CMK,sirolimus-bortezomib (250-1 mol-mol),0.3522446092805081
SNU-C5,sirolimus-bortezomib (250-1 mol-mol),1.5938355123050036
Hs 683,148198,-3.2312790086257057
RD,9926054,1.756104923287422
Panc 05.04,409805,4.292025323230266
NCI-H2342,54618164,3.990918802805385
NCI-H2228,sirolimus-bortezomib (250-1 mol-mol),2.3578690583328887
OE19,135875424,5.148848479100124
BT 330,107985,-2.041993977074398
WM793,159324,3.425736366761861
NCI-H1694,9903786,3.3065111756665564
HCC2935,136227924,3.4382607017764473
CAL-62,36462,0.9586944674226984
EJM,54618164,3.6862835131456455
AU565,9936388,-7.122590364363415
MDA-MB-157,9911830,0.0801478348660684
TT,5460769,2.0834356012703155
BICR 18,148124,-4.300616978044816
BICR 22,6610216,4.672862717569176
NH-6,107985,-3.816681183106218
NCI-H1092,3689413,-0.2231155414175143
LUDLU-1,136227924,3.2639698653649254
SK-N-MC,262093,3.06312964755372
U-BLC1,9903786,1.0981923916711085
LN-229,9936388,-1.4821904886179738
TE 441.T,135875424,2.9590043348173225
NCI-H647,148124,-3.9513276226558474
SNU-61,9903786,2.1391845181717373
RERF-LC-A1,136227924,2.978723056085531
MOLT-3,3136844,3.775023570063112
OCI-Ly10,168313200,3.867652157943873
SH-10-TC,3689413,0.5157614607297105
SBC-5,9926054,3.0567796435466628
SW948,6918878,-0.2941800388813576
Peer,136227924,2.1160969435978303
Reh,10296883,2.990424165005631
KYSE-510,54618164,5.681734700355768
MDA-MB-453,3689413,0.605092083526794
KMS-11,148198,-3.359004885153461
KMS-11,9911830,1.2501583095851283
MDA-MB-435S,26596,0.461113315638288
SNU-61,10322450,3.828611192492266
U266B1,148124,-5.9084465946358895
TF-1,46943432,1.9785022897713067
HEL 92.1.7,148124,-2.207552768043412
YD-15,135875424,3.8226191901992377
PE/CA-PJ41 (clone D2),3136844,4.269989384929203
MSTO-211H,54618164,3.0389284404004795
PE/CA-PJ41 (clone D2),44493528,4.345645378925518
BICR 31,148198,-3.2373882564770513
PL-21,11404337,-0.8522775208697388
CAL-27,262093,3.248965473833737
NCI-H508,148198,-2.3107893902367116
MG-63,12003241,-0.4675070550973023
CA46,JQ-1-carboplatin (1-1 mol-mol),-0.7040949114758062
COR-L95,148198,-4.800055382400855
NCI-H1184,148198,-3.201792375751558
KMS-12-BM,6918878,0.6296559584919736
Panc 02.03,439501,0.4668648826805023
TCCSUP,tanespimycin-bortezomib (250-1 mol-mol),-2.003630452657136
JHUEM-7,135875424,3.03961944002969
HOP-92,107985,-1.5945194541124064
MFE-319,9926054,1.8492827713698956
LN-229,135875424,3.7186537763136807
23132/87,54618164,3.944833088107541
BT-549,135875424,3.804392758634582
UM-UC-3,9903786,3.957731160225435
COLO 800,36462,0.9245101871398812
TC-71,8515,3.820519321601544
NCO2,6505803,-0.6279815858005762
Hs 839.T,9926054,1.9387188117771836
MOLM-13,8515,0.8268618162227004
NCI-H727,12003241,-0.657143782776601
NCI-H2452,sirolimus-bortezomib (250-1 mol-mol),-3.2659140212788733
BT 172,9911830,2.6787041281495823
HeLa,9926054,1.7615972318293558
HT-1080,9926054,1.8253134121716592
MKN74,107985,-2.988368566005849
SNU-1077,136227924,3.612132735883527
NCI-H1703,100016,6.215140096774371
A4/Fukuda,3136844,3.333855932915555
A-172,6918878,2.0942740866970557
NCI-H1155,8515,3.600042269708465
Sq-1,JQ-1-carboplatin (1-1 mol-mol),0.7735005611319609
T3M-10,3136844,4.108314579476905
SUP-T11,136227924,2.659905722722051
ZR-75-1,159324,2.7368279541402987
HEC-6,44484440,3.4510994944786817
NUGC-3,107985,-4.895591423275197
TUHR4TKB,6505803,0.1183916105816245
HEC-151,36462,3.471634124285656
SNU-216,24180125,5.748491941008621
GSS,439501,-2.3619517329640782
VM-CUB-1,9936388,-1.2208910173981742
MHH-NB-11,24180125,1.5852022307139904
COLO 320,11485656,1.5000331440446593
PE/CA-PJ41 (clone D2),44491742,4.176291442698054
TCCSUP,36462,2.278863397956304
KO52,36462,1.66960340133658
LCLC-97TM1,tanespimycin-bortezomib (250-1 mol-mol),-0.5611743356408021
NALM-6,9911830,1.7804272403189694
REC-1,9903786,4.191167368609226
RL,44493528,4.146088733572883
COV644,262093,3.243932148063393
F-36P,439501,-3.1981830153040223
JHUEM-7,6610216,4.204761293016812
SUP-M2,44491742,3.782473940408551
IGROV-1,11404337,-0.7659238947812715
ACC-MESO-1,148198,-2.036295291578454
Capan-2,9936388,2.515101489111694
NCI-H322,148124,-6.072159104918049
UM-UC-3,10322450,3.9081248739671945
HCC827,11404337,-0.5987268990428054
VCaP,44491742,3.83752183909955
LS180,11485656,2.0322073649322716
Capan-2,262093,3.612001970240134
Ri-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.0578389272938329
HL-60,3136844,4.272404291000888
U2OS,9936388,-2.745672898623292
8-MG-BA,135875424,3.2007214055219144
LOU-NH91,135875424,2.9424536382603215
HEC-1-A,409805,5.215124771693611
NCI-H1573,439501,-2.416114223913521
OVCAR-5,5460769,4.389197007102137
KMH-2,135875424,3.335950960073661
AU565,54618164,4.092787142183454
GSS,JQ-1-carboplatin (1-1 mol-mol),0.1875541485462026
NCI-H1092,54618164,3.7504442983527104
BT 131,selumetinib-vorinostat (8-1 mol-mol),2.183277043085374
SNU-308,409805,5.466137259646633
P31/FUJ,135398744,5.7727848933678
SNU-738,selumetinib-GDC-0941 (4-1 mol-mol),2.490499311064832
Caki-1,24180125,3.8854994918963377
SK-MEL-24,11485656,3.6100646887708305
NOMO-1,135875424,3.068632733482165
MPP 89,6610216,4.468141875368187
JHOM-1,148124,-4.470730490195969
BT 179,3689413,2.324623273227175
KYSE-510,136227924,3.267869272747249
Mel Ho,5460769,6.181973204258103
G-402,6918878,2.494314051101966
Panc 10.05,168313200,1.837879090184572
HEC-6,9926054,1.6312694597986903
L-428,8515,4.11039212024018
SJSA-1,6610216,5.447146070074806
DK-MG,selumetinib-GDC-0941 (4-1 mol-mol),2.430443160394254
YD-8,24180125,3.6955333195671938
KNS-62,148198,-1.7828109531829757
NCI-H1105,9936388,-6.252003030821692
HCC1833,selumetinib-GDC-0941 (4-1 mol-mol),1.758331297818262
NCI-H441,409805,5.87304569757607
EBC-1,107985,-3.983945161523554
LMSU,10322450,5.4992145641719095
HCC15,9911830,1.9028880277746671
ECC12,159324,3.6946340273911233
U-CH1,9936388,3.1396417887347017
UM-UC-3,9936388,2.2420800599378325
SNU-308,5460769,2.0996672061045976
P3HR-1,44493528,4.479492051657015
SNU-407,10296883,3.619724008843853
KMS-12-BM,6505803,-0.6027320108546551
BT 228,439501,-2.264868941994625
ACHN,168313200,3.9781211738583977
HMCB,54618164,4.179643558652394
TE-1,sirolimus-bortezomib (250-1 mol-mol),1.4536947416119834
2004,tanespimycin-bortezomib (250-1 mol-mol),0.7644529480942643
SF295,11404337,1.1305596027792637
SK-N-AS,44493528,4.35131115030736
SUP-HD1,6918878,1.5390003886608188
NCI-H1155,24180125,4.048296338692506
G-401,6918878,1.5849207586223315
DK-MG,136227924,2.9692161266572707
HT-29,11485656,2.2620864353624786
NCO2,44493528,3.738913102707939
JHUEM-3,44491742,3.947686960056495
Panc 04.03,409805,5.536204895331733
Caki-2,107985,-3.705552980163056
BT 498,24180125,4.887627247892678
BT 231,26596,-1.8186756145502985
MSTO-211H,sirolimus-bortezomib (250-1 mol-mol),-4.356348785591885
CCF-STTG1,11404337,1.400188980811807
FaDu,11485656,1.8671846861559669
FaDu,8515,5.401189505812741
HCC1419,3689413,0.4398043880767979
A-172,9926054,1.9975239370798743
NCI-H810,9927531,3.2474997445381693
OV7,26596,0.3804702126499801
Raji,54618164,3.808171022146071
SNU-216,tanespimycin-bortezomib (250-1 mol-mol),0.2069315895115227
FTC-133,148198,-1.6568063805549866
SBC-5,107985,-2.339881885950972
23132/87,107985,-3.2177510998907572
MHH-ES-1,135875424,3.469224275097477
CAL-85-1,46943432,3.269339830266358
SNU-245,46943432,2.4309238019783095
NCI-H1155,100016,6.5684025185087505
UACC-62,11404337,0.3177271897074518
SNU-620,46943432,0.3384301465912348
ZR-75-1,135875424,4.30667404331582
ONCO-DG-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1798955899961833
Daudi,439501,-2.973914496380735
C2BBe1,136227924,2.0906474270390656
BT 359,selumetinib-GDC-0941 (4-1 mol-mol),2.125695165959512
P-STS,9903786,4.008586814147432
NCI-H2141,9903786,2.15851319161548
NCI-H1373,sirolimus-bortezomib (250-1 mol-mol),1.9040141833310924
LOX-IMVI,9936388,0.4128358081832157
HCT 116,9911830,3.306923912235079
HH [Human lymphoma],168313200,1.5669719889178435
EFM-192A,44491742,3.8805374650465905
SCC-4,6610216,4.252942757315656
D283 Med,409805,5.788391613893814
GSU,11485656,2.5421521977711135
HCC1500,selumetinib-GDC-0941 (4-1 mol-mol),3.80127350150034
NCI-H1339,9903786,4.835064182647526
Calu-3,selumetinib-GDC-0941 (4-1 mol-mol),0.8119052170432226
Kuramochi,24180125,2.543134458262697
BT-549,9926054,1.9687680834705423
KYSE-450,10296883,4.225795837642371
NCI-H2085,9903786,1.6610112484663062
NCI-H322,36462,3.679003516443927
HEC-1-A,6610216,3.9875292357765137
HEC-59,3689413,-1.7900495461220194
Hs 683,6918878,3.497965846629707
NCI-H1155,11404337,-0.9864413542688488
Capan-1,11485656,1.8375535341364733
KMH-2,9911830,2.2989781797044313
IA-LM,6610216,4.173583896241699
MHH-CALL-3,selumetinib-GDC-0941 (4-1 mol-mol),3.01666713959806
CL-11,selumetinib-vorinostat (8-1 mol-mol),-1.2741368590150106
JHUEM-1,selumetinib-GDC-0941 (4-1 mol-mol),1.6430470914092763
SNU-1105,3689413,0.7210916116253745
RS4;11,3136844,2.998558350831012
Panc 08.13,135875424,4.727963468605648
NCI-H2106,12003241,4.508121614525734
Detroit 562,11485656,1.622258504820096
MKN74,3689413,0.9993219534405752
COLO 684,44493528,4.258277772173305
NCI-H522,JQ-1-carboplatin (1-1 mol-mol),0.3092817510850776
PC-14,26596,-1.584314299248499
SNU-61,10296883,3.559313583941647
23132/87,6505803,-2.824747584715181
DMS 454,24180125,3.458274614597035
KHM-1B,11404337,0.2779693874185021
MIA PaCa-2,100016,4.223400842588871
L-428,sirolimus-bortezomib (250-1 mol-mol),-6.443786074450703
MHH-CALL-4,5460769,0.3846301145612474
TE 441.T,262093,1.5238346929960052
TT2609-C02,107985,-2.9617370553841686
SK-N-AS,107985,-4.041624187442296
NCI-H1568,168313200,3.516432771095034
HEL,11485656,1.96241131365886
KMS-11,9927531,3.9884073246481058
Hs 578Bst,sirolimus-bortezomib (250-1 mol-mol),2.6578506949502416
G-292 clone A141B1,tanespimycin-bortezomib (250-1 mol-mol),-0.2188717779378038
KYSE-30,148198,-4.331453900167214
KMH-2,5460769,1.5529919827376786
U-937,9903786,1.2748798795403693
8505C,9903786,3.4608112423981874
NCI-H2087,54618164,3.8851097061175786
NCI-H28,439501,-2.3815897212946333
NUGC-4,36462,2.0627213084673204
NCI-H226,selumetinib-GDC-0941 (4-1 mol-mol),3.612309653965627
KATO III,9903786,1.8271137188030744
KCL-22,159324,2.501491533347955
JHUEM-1,262093,1.0562191495276867
BICR 22,12003241,-0.4808187565312439
M-07e,sirolimus-bortezomib (250-1 mol-mol),-0.1751510828449014
SK-MEL-3,10296883,3.7969706070865423
DU145,9936388,-2.7050109048591287
KMS-11,168313200,1.7445720768361954
Mel JuSo,8515,4.331675363159847
RS4;11,11485656,1.5968543308992733
SUP-HD1,46943432,3.007835920740822
SNU-81,11404337,-1.7380856142345846
ZR-75-1,selumetinib-GDC-0941 (4-1 mol-mol),1.5981380020167046
NCI-H1651,262093,4.029586538433741
KMS-11,36462,1.092413370877101
NCI-H727,3689413,0.3749801507161196
NCI-H647,11404337,-0.2592601702494094
EJM,6918878,1.483002003508878
HCC1806,439501,-1.846359042641554
HMC-1-8,11404337,-0.9366100909278564
COLO 320,tanespimycin-bortezomib (250-1 mol-mol),1.191439437056519
Lu-99,26596,-1.1176086778994336
KMS-27,11404337,-1.6812910673716006
CAL-78,107985,-3.5540444379532747
EPLC-272H,9936388,-6.231113427915417
GSS,12003241,-1.231369265985878
OE21,10296883,3.8232218432120058
HSC-4,6505803,0.688410933428746
T24,3689413,-0.672605759999641
NALM-6,148198,-4.9316309610595335
Pfeiffer,439501,-3.463410019597594
L-540,26596,-2.7361292622141806
MOLT-16,10322450,3.2788415570807
NCI-H1355,107985,-3.217493720542047
Hs 888.T,selumetinib-GDC-0941 (4-1 mol-mol),2.8983060042425484
HDQ-P1,107985,-3.480538079364474
GSS,selumetinib-vorinostat (8-1 mol-mol),1.884936814348228
SW1417,24180125,3.5799680228726065
SW620,9911830,2.3998615697113403
BICR 16,3689413,1.5183083645706292
LS180,100016,6.005443229591697
HSC-2,9911830,2.2689102344436787
HCC4006,6610216,4.265469654914691
JHUEM-7,selumetinib-GDC-0941 (4-1 mol-mol),0.8303698152358163
KYSE-520,100016,6.554858217735662
MCAS,6610216,4.229351733917807
KMRC-1,6610216,4.1544949822147
SNU-423,36462,3.755778828040023
NCI-H2023,36462,1.4668895939390116
HuP-T4,11485656,1.6012031852576112
SUP-T11,409805,3.2172414171416177
MKN74,9926054,2.8513802079001844
HT-55,12003241,-0.758438477023311
SUP-B15,135423438,2.052738806118931
HEL,selumetinib-GDC-0941 (4-1 mol-mol),3.377819044796062
IM95,49836020,4.204800354439791
GI-1,135875424,4.168860245999812
MCF-7,6610216,4.526807222364515
HCC1395,selumetinib-GDC-0941 (4-1 mol-mol),2.648393552264531
SNU-407,100016,6.489561303898527
JHH-1,10296883,4.130591139989607
NCI-H226,9936388,2.9750619483400467
SNU-1076,8515,3.922584555723145
KG-1-C,10322450,5.451010729371517
LNCaP clone FGC,selumetinib-vorinostat (8-1 mol-mol),3.5283733311441208
TYK-nu,36462,1.613744136173373
NU-DHL-1,selumetinib-vorinostat (8-1 mol-mol),0.3575264561509241
JHH-4,107985,-2.4130923287232853
BT 231,36462,1.8404297564151428
HCC1833,9926054,1.8132192248663452
Calu-6,selumetinib-vorinostat (8-1 mol-mol),1.6602418601614706
NCI-H1568,44491742,3.692908194165655
NCI-H508,6610216,4.542164721447458
OAW42,36462,2.75457574041248
GMS-10,3689413,-2.2812112324373057
Calu-3,JQ-1-carboplatin (1-1 mol-mol),2.436391578693632
JVM-2,selumetinib-vorinostat (8-1 mol-mol),-0.8355948375109636
MDA-MB-468,36462,0.7713305657614911
SHP-77,135875424,3.698611964350599
TE-10,9926054,2.0362558072853827
HT-55,6610216,4.122284728338665
RERF-LC-A1,3136844,4.0825258667497515
MDA-MB-453,9903786,4.505035222499518
NCI-H211,262093,1.1438689543119294
SNU-466,36462,2.8940246438070063
COLO 741,9936388,-5.068982881561057
HEC-265,136227924,3.2525592636436405
NCI-H929,9903786,1.9183912305018265
SNU-398,36462,3.0177530100723575
SCC-25,10296883,3.5302402637637145
HCT 8,selumetinib-vorinostat (8-1 mol-mol),2.4555192201587044
Caki-1,262093,3.8219578030465033
SNU-899,6918878,1.4159106193866569
NCI-H2342,3136844,4.9299299565807155
OCI-Ly10,8515,4.645209912252783
NCI-H2087,11485656,1.6190221901711597
OVCAR-4,159324,3.448279522604695
Kasumi-1,11404337,-1.4406380230714082
BT 164,262093,1.918525006614416
NCI-H2452,44493528,4.324080951064212
LoVo,36462,0.97058855741136
HMCB,11485656,2.0030375268355116
TM-31,tanespimycin-bortezomib (250-1 mol-mol),0.6359976993745172
SIG-M5,136227924,2.112174988724855
KYSE-450,9903786,5.350068255808832
RERF-LC-A1,262093,2.373838000571716
BT 239,148124,5.770262355155013
PSN1,3136844,5.05674126194674
ChaGo-K-1,JQ-1-carboplatin (1-1 mol-mol),3.068818553236091
NCI-H1693,107985,-3.260996541727032
Namalwa,6610216,4.155862937962793
COLO 320,135875424,2.711405074162338
CAL-12T,11404337,-1.0513453542481006
Aska-SS,36462,2.182690934298482
LP-1,135875424,2.677692696582144
NCI-H1651,107985,-3.5960692919806085
RERF-LC-MS,26596,-1.2372341703529914
COLO 680N,409805,5.020246083137369
THP-1,10322450,3.145062676752804
BT 286,9926054,2.06315076189255
VMRC-RCZ,246676,4.509007401048671
JHUEM-7,11485656,1.7197285505227566
TOV-21G,148198,-4.474336423229386
JHUEM-7,168313200,3.430060131832228
JeKo-1,36462,0.9579475504198862
NCI-H196,6505803,-2.584709085122825
Calu-3,12003241,-0.8682368391192625
TTC-709,6610216,4.616312272440149
KMH-2,9903786,1.3660293069385576
HuNS1,JQ-1-carboplatin (1-1 mol-mol),1.1759253044065412
PaTu 8988t,262093,3.2462588578894587
T84,9926054,1.9260026490734707
SNU-407,11404337,-0.3690454337107759
SUP-B15,5460769,1.5557801555914603
NCI-H1299,tanespimycin-bortezomib (250-1 mol-mol),0.405614896929535
MOTN-1,26596,-3.629503770216574
EFM-192A,148198,-2.4678841503843363
OUMS-23,JQ-1-carboplatin (1-1 mol-mol),4.676027552287151
MCAS,148198,-2.0312221156390717
NCI-H1395,107985,-3.679096931387758
A-673,3689413,-2.493408888485536
IMR-32,135875424,2.969458523828033
BT 330,6610216,4.420410954018115
NCI-H1563,100016,6.550294719377214
COLO 829,10296883,3.971671939086983
MFE-319,5460769,5.093824644165235
TF-1,26596,-1.8278178688424689
Caki-1,168313200,4.325484294930164
CAL-27,selumetinib-vorinostat (8-1 mol-mol),0.7309790077712324
Ishikawa (Heraklio) 02 ER-,148198,-2.3973242740422407
PLC/PRF/5,9926054,1.9278694567430317
SaOS-2,107985,-4.209612864808627
SW1573,168313200,1.7327341920391253
NCI-H2029,10296883,4.228313124120171
RKN,246676,4.414592383854902
HOP-92,9926054,1.661169949591577
SNU-719,36462,4.921998623089754
H-STS,sirolimus-bortezomib (250-1 mol-mol),0.1241794019468204
SNU-398,3689413,0.8860664930016563
LCLC-103H,11404337,0.85397290991948
P-STS,439501,-3.4977273473127632
CA46,11404337,-2.4021967063511434
SNU-449,9911830,2.1326623866395487
NCI-H650,439501,-2.431498086573591
G-401,sirolimus-bortezomib (250-1 mol-mol),0.0501690880033574
M059K,6505803,0.7247359369416212
Tm87-16,135875424,5.622886388921831
VMRC-RCW,9926054,3.031512586509183
UO-31,9911830,1.1104518342354128
NCO2,409805,3.4174299709806704
SK-MEL-1,439501,-2.4358325657169035
NU-DUL-1,44491742,3.737315333639921
Rh41,24180125,2.1535312924430774
A4/Fukuda,36462,-0.7730347482869518
NH-6,26596,-2.8225281366091375
WM983B,9927531,5.417064832255327
LMSU,36462,2.6264812061116127
HEY A8,11404337,-0.225254822272347
PK-59,262093,2.249881918634125
RPMI-6666,36462,-2.242944553811851
LS411N,135875424,4.300305751936665
HT,3689413,-1.9551613931391472
Karpas-299,6918878,0.998539084256704
HCC-56,9936388,-7.462492097738726
HCC1395,135875424,6.03600729555728
COLO 792,148198,-2.6366713074255475
CCK-81,9926054,1.6277365454540644
GP2d,24180125,3.074858377776044
NCI-H1650,3689413,-2.359636469082647
Detroit 562,6918878,2.821665555465532
NCI-H1666,100016,7.086863626956854
Panc 04.03,sirolimus-bortezomib (250-1 mol-mol),1.3597378595777716
Hs 746.T,sirolimus-bortezomib (250-1 mol-mol),0.2683351273319356
NCI-H929,selumetinib-GDC-0941 (4-1 mol-mol),-0.5028542892584752
HCC2935,selumetinib-GDC-0941 (4-1 mol-mol),0.0464684942355828
COLO 201,6918878,1.2549141344599
SW1710,246676,4.96799578187702
KNS-62,12003241,3.5800547148534165
SEM,sirolimus-bortezomib (250-1 mol-mol),-0.6909485025943941
IGR-37,9911830,3.620959954917233
T84,9936388,-5.402148456291863
Hs 729.T,9927531,5.3265551472820425
HCC-56,6505803,2.324726755657099
JHUEM-3,tanespimycin-bortezomib (250-1 mol-mol),-0.0089826234091154
ESS-1,54618164,4.192374601121606
SW948,439501,-2.1692174321648174
5637,136227924,2.876940542257041
HT115,5460769,1.7158101929675542
KMS-21-BM,54618164,2.5308412572805836
SNU-899,9877608,7.308498444418231
BxPC-3,54618164,4.016743819691475
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725
JeKo-1,409805,3.852708089186558
BT-20,44491742,4.162819949257598
42-MG-BA,selumetinib-GDC-0941 (4-1 mol-mol),0.6620658581773345
OVSAHO,9926054,2.353589005438
KMRC-20,selumetinib-vorinostat (8-1 mol-mol),2.4254013680145663
OV56,11485656,3.4702075496289018
NCI-H1299,54618164,5.089847136026273
REC-1,11404337,-2.3807065169464336
NCI-H520,246676,5.04286293449012
IGR-37,5460769,4.3562687129012625
BT 333,sirolimus-bortezomib (250-1 mol-mol),0.4281916150518835
TOV-112D,168313200,2.88692754776733
PSN1,148124,-2.7634040442066476
SNU-245,24180125,3.6034150813328463
SNU-466,107985,-2.7437947575387196
SK-N-AS,44491742,3.868464169325176
NCI-H1339,439501,-1.6994812988125017
SU.86.86,6918878,2.339512355086355
NCI-H2110,9903786,2.318107893964858
Daudi,46943432,0.8866201698678313
DU145,148198,-3.066698935751989
NCI-H446,439501,-2.615106266936583
IST-Mes1,54618164,4.8538718291352945
BICR 16,148198,-1.045482158065907
RS4;11,6918878,1.8748288832267872
KNS-62,9936388,2.361337776362267
NCI-H522,6505803,-3.5272214952237344
YKG-1,148198,-3.345136621371903
A-549,6610216,4.4512033607640475
SNU-C5,JQ-1-carboplatin (1-1 mol-mol),5.5029017516630345
OPM-2,12003241,-2.9738714531294232
SU.86.86,439501,-1.025939576051134
NCI-H1793,6610216,3.8790622627793225
Hep 3B2.1-7,11485656,2.176020084132011
MOLT-3,135423438,2.3622071216207594
ME-1 [Human leukemia],100016,5.540349228215307
TE-4,selumetinib-vorinostat (8-1 mol-mol),1.7429676419494515
COLO 684,3136844,3.6098808715581976
HCC1171,24180125,3.3495461519544723
LOX-IMVI,100016,4.319089113839007
PK-1,6505803,-1.4956454507755823
SNU-245,54618164,4.324549531674931
KMS-34,JQ-1-carboplatin (1-1 mol-mol),-0.8418856206446907
DLD-1,159324,3.5449234505854617
NCI-H322,135423438,4.4893674583899505
SNU-601,11485656,1.403357522956854
OC 314,10296883,4.120910871567529
SCC-9,10296883,4.238304408621306
NCI-H727,sirolimus-bortezomib (250-1 mol-mol),1.838886799564678
JVM-2,sirolimus-bortezomib (250-1 mol-mol),-7.352032858936448
SNU-201,439501,0.2163207704150155
JHH-2,36462,3.020657700681576
LOX-IMVI,54618164,3.986772519561911
Hep-G2,sirolimus-bortezomib (250-1 mol-mol),1.7771755554565365
LMSU,100016,7.332455698517509
SNU-1076,5460769,2.5468440002865895
COLO 829,6610216,4.231441240568813
NOMO-1,10296883,3.647443685498321
Hs 852.T,9936388,-8.265529958895947
DU145,107985,-2.6553199343257483
SK-N-BE(2),168313200,2.1741727294521933
Granta-519,49836020,3.8229564713378057
TOV-112D,439501,-4.317689883213593
Hs 688(A).T,12003241,-0.4220829795676687
G-361,10296883,3.484714996081857
NCI-H1792,107985,-2.015689810638849
SK-N-DZ,JQ-1-carboplatin (1-1 mol-mol),0.6864490875129473
KALS-1,262093,3.291549071505813
MM1.S,159324,2.619931466693083
A4/Fukuda,9927531,3.7257201794253776
GI-1,9927531,5.508249375264951
NCI-H1734,136227924,2.5893506458509634
RCH-ACV,8515,3.0347140209850973
SUP-M2,11485656,1.133597782869627
WM115,135875424,2.968517855352779
RERF-LC-A1,tanespimycin-bortezomib (250-1 mol-mol),-1.931734288189376
HEY A8,135875424,4.032445855238006
HLF,3689413,-1.4235179966835771
OE19,3689413,2.2009145574363895
HCC1500,136227924,2.675203690625814
SW1088,409805,4.031370410742822
LS513,JQ-1-carboplatin (1-1 mol-mol),4.102727759059396
HLF,148198,-4.949405415415342
SNU-201,11485656,3.6136965071696903
MOLT-16,46943432,0.6588573243704352
KMS-20,8515,3.454893590517526
CAL-27,409805,3.558351659435831
Jurkat,8515,2.2772162456887384
HMC-1-8,selumetinib-GDC-0941 (4-1 mol-mol),-0.1007905970017958
KYSE-180,9903786,3.667884143051944
NCI-H1155,6505803,-2.994970974649892
TE-15,6918878,1.5398675408353943
SF126,11404337,-0.0225096476236154
OVCAR-8,49836020,4.475611867400311
WT2-iPS,6505803,-3.1225934149726156
KP-4,9911830,2.4137773940538487
HCC15,3136844,4.306118753112888
ChaGo-K-1,136227924,2.8574479872364247
OCI-Ly3,JQ-1-carboplatin (1-1 mol-mol),0.1227368323293568
PC-14,9903786,1.3474672632704163
HuH-1,6505803,-0.939416670904982
HEC-1-B,148198,-2.293611900914974
SNU-407,409805,5.485481651178567
HCC2108,439501,-2.3356100476768145
LN-229,6610216,5.1587041728274485
KM12,6505803,-1.021765760780758
SU.86.86,10296883,4.023388867710504
LAMA-84,11404337,0.2635139900443839
COLO 320,107985,-3.942895993457312
YD-10B,46943432,0.8427215449680024
COLO 320,36462,4.829983230652816
EKVX,8515,3.3740935192492594
J82,135875424,4.806406086619794
KYSE-510,9927531,4.748041591600806
MEC-1,100016,3.995806762220144
SK-MEL-3,168313200,3.813993293038376
MDA-MB-468,3136844,4.719849502298336
KMBC-2,6610216,4.214797525140246
PL-21,107985,-4.0458026423659295
HCC2279,148198,-1.731390144529653
IGROV-1,11404337,-0.7659238947812715
ECC12,tanespimycin-bortezomib (250-1 mol-mol),-0.7458523006445992
SNU-489,11404337,0.8809237890954298
SK-HEP-1,selumetinib-GDC-0941 (4-1 mol-mol),2.75141710768083
Jurkat,3689413,-0.8866590036526504
SNU-C1,168313200,1.7390139209303623
HCC1954,3689413,-1.9966165648344365
JJN-3,439501,-3.1655591002540864
BEN,6610216,5.086594972781992
SW948,107985,-3.1361927230844255
HEL 92.1.7,3136844,5.249534134103405
RPMI-6666,135875424,3.217067635076314
JJN-3,46943432,-0.2652979135727038
Panc 04.03,148198,-3.912302089259141
OC 314,46943432,2.002115523030698
SNU-626,6610216,4.899097524700605
GSU,selumetinib-vorinostat (8-1 mol-mol),1.9525647465582676
HT-1197,9936388,2.7630776748899746
IMR-32,6505803,0.9080588170181416
A-549,8515,3.6622074868184464
LAMA-84,6918878,0.7014751238322499
NCI-H2171,sirolimus-bortezomib (250-1 mol-mol),0.0870413029192065
JHH-1,sirolimus-bortezomib (250-1 mol-mol),0.3653196480685532
MDA-MB-231,9926054,2.3849554736036613
SK-MM-2,10296883,1.2028909628230222
JHH-5,12003241,-2.221894796534897
SUP-HD1,168313200,3.656885167019891
Kelly,135875424,1.72735348015212
MHH-NB-11,9911830,2.1273093193707697
MDA-MB-231,159324,3.5380667679319115
Hs 940.T,selumetinib-GDC-0941 (4-1 mol-mol),2.512556445742238
AN3-CA,9903786,1.5268103297033566
KPL-1,11485656,3.597830436123724
IPC-298,10296883,3.818121747972668
OVTOKO,11485656,2.8396644957108923
SEM,262093,0.379936046646312
Hs 729.T,54618164,4.299572624294171
MIA PaCa-2,54618164,3.936263034196557
NCI-H1623,24180125,3.727544824819635
ACHN,36462,1.8555718413800224
NCI-H1838,11485656,2.306632115850396
JM-1,9903786,1.587415218469425
T3M-10,148124,-4.172364991012526
BT 340,selumetinib-vorinostat (8-1 mol-mol),2.9565277200818048
Rh41,3689413,-2.4330549607978984
OV7,9926054,1.9278544510999935
K029AX,409805,4.032491022499592
HEC-251,36462,2.48213942919338
BT 228,8515,3.7604007756554583
SNU-886,9927531,4.416743823533711
AMO1,26596,-3.5101711689538155
8505C,3689413,-3.9181742012691143
HuG1-N,sirolimus-bortezomib (250-1 mol-mol),-0.2161746161621927
T98G,3689413,-0.3099040936553002
BT 340,439501,-2.6874072240019617
CAL-27,24180125,2.5723395665723285
Karpas-422,262093,3.033308575813637
HCC2108,136227924,3.562843531024723
NU-DHL-1,148124,-5.1269699362990195
OCI-Ly10,12003241,1.0181729921478868
KE-39,439501,-0.0752815835977172
HEC-59,9911830,2.883882492883047
JVM-3,73707440,6.054081463346775
MOLT-16,168313200,3.8656491063755207
HCC1806,6505803,-1.844009581745865
LN-18,36462,1.6334561930516676
MDA-MB-415,3689413,0.9318118886316789
NCI-H520,168313200,1.818196575131949
HOP-62,107985,-3.8044998203346383
HCC4006,168313200,2.0042986308460247
BT 440,135423438,-0.018963982293905
HCC2218,135875424,1.4940742692763715
Mono-Mac-1,262093,2.3689622956108107
AsPC-1,3689413,-2.062701377390924
A-549,9903786,1.8644448309659765
EKVX,107985,-2.844082179808488
SNU-1196,JQ-1-carboplatin (1-1 mol-mol),5.1757669603807015
PLC/PRF/5,36462,0.8167490272691379
SNU-1041,9926054,2.2828270152060623
SK-N-BE(2),439501,-3.274978008142144
NCI-H2023,3136844,5.333808930995149
JHH-1,44491742,4.550943997135646
KP-3,6610216,4.430226203729176
MDA-MB-157,10322450,5.067042624032479
Namalwa,107985,-4.241523948583442
SH-4,439501,-2.6634763397724033
NCI-H1373,9903786,3.0736149101448893
BT 179,6610216,4.238536269357804
Ci-1,10322450,2.8273692765810643
SK-N-DZ,6610216,4.064938654399556
HCC1395,5460769,2.101928934987084
TE 617.T,26596,-3.5782456619220246
TCCSUP,9911830,2.7321009507297727
JM-1,49836020,4.6064946369246025
SNU-478,148198,-2.0757049952791835
HCC78,44493528,4.5859040638932385
OV-90,100016,6.511633470460193
FTC-133,3136844,4.271719807093853
TUHR14TKB,135423438,1.0375302517653642
OVISE,9903786,4.69480560533159
HEC-1-B,6610216,4.285731274243315
SF539,54618164,4.674024000945265
RCM-1 [Human rectal adenocarcinoma],5460769,3.958915694045798
JHUEM-7,9911830,1.3841062029972715
SUP-B15,54618164,3.715480597582055
BICR 16,9936388,-6.204978757825023
HT,3136844,4.777937007786701
KYSE-180,selumetinib-GDC-0941 (4-1 mol-mol),2.772952616484782
NCI-H28,159324,1.6675960977646165
253J,3136844,4.199925709762334
HeLa,3689413,0.6540693787829278
NCI-H1568,439501,-2.6831567396736022
A-172,107985,-3.900201208452829
HGC-27,5460769,1.1785967516378393
SW1990,11404337,0.292005149466272
BV-173,sirolimus-bortezomib (250-1 mol-mol),-2.492930235496017
DMS 53,148198,-4.7992801457563665
KYSE-450,6505803,0.925446652115482
OVCAR-8,148198,-5.019835125371004
SK-MEL-2,9927531,5.603550958927875
JHUEM-3,168313200,3.1500775290057543
BT 422,9911830,3.891954985840177
LOX-IMVI,44493528,4.127526604228942
23132/87,24180125,3.7531790021712994
DMS 53,9911830,2.2379705934233307
WM115,148124,-1.9357807696466565
MJ,6505803,-0.8623373124046138
SK-UT-1,439501,-2.663904937582399
KYM-1,8515,3.3441166604006014
BT 422,tanespimycin-bortezomib (250-1 mol-mol),0.0760958733861235
BT 147,3136844,4.230618743679753
JHH-2,3136844,4.740152394211766
DU145,44491742,3.929497920305024
NCI-H292,439501,-2.469830491210978
L-428,selumetinib-vorinostat (8-1 mol-mol),2.5510918509363876
DV-90,9926054,1.8346982871797115
HLF,107985,-3.9797994602354847
HEC-1-A,6505803,-1.1464384293678307
G-361,11404337,-0.7972280561087973
KYO-1,439501,-2.3318531278707555
NCI-H747,5460769,2.4677950435240814
TUHR4TKB,11404337,-1.470690034731614
WM983B,sirolimus-bortezomib (250-1 mol-mol),1.0166833684300536
BT 145,5460769,1.52442130287449
KCL-22,11485656,1.0950104532816525
SK-OV-3,159324,5.082712026660022
Malme-3M,11485656,2.111075680137388
BT 239,5460769,-1.3091160600101754
CAL-85-1,148124,-7.077964947486074
LS411N,selumetinib-vorinostat (8-1 mol-mol),0.590504538579532
MDA-MB-453,tanespimycin-bortezomib (250-1 mol-mol),-3.425148302168821
THP-1,136227924,2.5094113505430737
T98G,tanespimycin-bortezomib (250-1 mol-mol),-0.015927454797827
KE-39,54618164,4.766262408385177
HCC1569,12003241,1.6977916939082411
HCT 15,135875424,3.2134473566688726
BL-70,selumetinib-GDC-0941 (4-1 mol-mol),0.4791238256413206
COR-L95,54618164,3.8157010413732406
NCI-H1092,3136844,4.087353218769457
Reh,168313200,2.040785396929617
LOU-NH91,11485656,3.2972382499502935
LoVo,3136844,3.7568853791466608
KCL-22,selumetinib-GDC-0941 (4-1 mol-mol),1.6879768271667388
SK-N-AS,9936388,-8.947501416398147
Karpas-299,sirolimus-bortezomib (250-1 mol-mol),-3.935889732903339
OVCAR-5,11485656,2.327604850531282
NCI-H1184,6610216,0.5829186651523776
SUP-T1,26596,-4.2216278033342105
SNU-182,100016,8.076902029611453
NCI-H2087,148198,-2.1193068046896255
OVCAR-4,sirolimus-bortezomib (250-1 mol-mol),0.1609764343460656
SUP-B15,selumetinib-vorinostat (8-1 mol-mol),0.2663315428977156
B-CPAP,246676,4.303313026788405
A2780,10322450,2.9165978660974545
NCI-H1869,262093,3.2234761574881485
DU145,sirolimus-bortezomib (250-1 mol-mol),0.8074859592711968
NB4,6505803,-1.6595544122287686
BT 271,5460769,1.6664418058692942
COLO 792,sirolimus-bortezomib (250-1 mol-mol),0.2253153763681567
TUHR10TKB,sirolimus-bortezomib (250-1 mol-mol),1.3489758983524096
NCI-H292,54618164,4.184972812062346
SNU-601,9936388,-4.393234947072901
ST486,selumetinib-vorinostat (8-1 mol-mol),1.5457849466336735
Hs 611.T,9911830,0.7898774616432335
IM95,9911830,1.757633783471113
KMS-12-BM,9911830,2.539717819095299
CL-11,8515,4.039522113658697
G-292 clone A141B1,12003241,-1.351842997684689
BT 147,selumetinib-GDC-0941 (4-1 mol-mol),1.4700877243858868
RERF-LC-A1,246676,4.379402832179336
VMRC-RCZ,148198,-1.950525301286011
MDA-MB-157,262093,2.565616950913742
NCI-H322,6610216,4.294116113185311
Mel Ho,11485656,2.770512917812994
BT 333,11404337,-0.8508015694655927
JM-1,136227924,1.2038413750130548
RERF-LC-MS,5460769,5.094680634820597
Ishikawa (Heraklio) 02 ER-,9926054,2.558951101727927
BT 271,409805,3.7832807554338186
MKN74,44491742,4.321441779997771
LCLC-97TM1,107985,-4.222636663811031
PaTu 8902,3689413,3.662647678116459
NCI-H1339,9926054,1.7994324687191725
LS180,136227924,2.415770069388299
NCI-H2291,JQ-1-carboplatin (1-1 mol-mol),4.431893565977406
BT 187,100016,7.76208292164505
LOU-NH91,409805,5.248055334811583
NCI-H647,12003241,-2.504495302724225
SNU-503,135875424,5.104819930335823
CMK,136227924,3.317343215770968
BT 286,12003241,-0.6969940125697452
Caov-3,9903786,2.8083030393929276
SH-4,168313200,3.5127580598255026
BV-173,44493528,3.470262409540001
HCC1937,159324,3.7699321027619184
KM12,sirolimus-bortezomib (250-1 mol-mol),1.529989038741449
Capan-1,168313200,2.9993325450618022
AGS,selumetinib-GDC-0941 (4-1 mol-mol),0.9665370398813388
Li-7,36462,1.2712954059342498
SK-UT-1,selumetinib-vorinostat (8-1 mol-mol),3.855507066103229
Rh18,148198,-3.372937628836821
Mino,168313200,2.290605070302401
UM-UC-1,409805,5.7723907546588835
GB-1,262093,2.1332737171644913
BICR 56,100016,6.239283130221144
CAL-78,12003241,-1.8526248382085972
NCI-H2081,409805,3.646579192169883
NCI-H716,107985,-2.4124318655022674
SNU-620,9911830,2.304095058614006
MOTN-1,135423438,1.8734384638779549
JVM-3,6918878,-0.1184334237478748
CAL-62,409805,3.837587991386787
OAW28,10296883,4.314409366833216
MOLP-8,9936388,3.4211096692910052
VMRC-RCW,439501,-1.1623161811429144
NCI-H23,148124,-7.582966161502026
NCI-H1155,409805,6.377387432346561
LOX-IMVI,9926054,1.7031980960413209
Hs 934.T,selumetinib-vorinostat (8-1 mol-mol),5.598638890689216
Mino,6918878,-0.6688566059846761
NCI-H1435,6610216,3.78595053779861
HEC-151,10322450,3.547902209799766
KU-19-19,11485656,2.7576201496249264
LUDLU-1,11485656,1.892840713859796
TOV-21G,8515,4.292104860970436
SK-MEL-31,54618164,4.23134710733717
TM-31,11404337,0.421952078244741
KYSE-180,9926054,1.7654325832877988
L-428,9911830,2.739326607569416
SNU-449,36462,4.301758862194218
RL95-2,9936388,-5.708399699553936
COLO 668,136227924,2.7222662640570356
DU4475,sirolimus-bortezomib (250-1 mol-mol),-1.4046623953130444
NU-DUL-1,JQ-1-carboplatin (1-1 mol-mol),-0.6986861691391648
NCI-H2029,36462,0.6188245273183208
ONCO-DG-1,selumetinib-vorinostat (8-1 mol-mol),2.407796834998747
TT,107985,-2.900739403078763
EFM-192A,9927531,5.058042989735013
P3HR-1,9911830,3.3679619343165452
SNU-16,9903786,1.405581496282783
NCI-H1299,11485656,2.4848432250614843
IA-LM,49836020,4.225846480888235
JHUEM-7,12003241,-3.5765771521887246
NCI-H522,tanespimycin-bortezomib (250-1 mol-mol),-2.8316369576725284
HOP-92,selumetinib-vorinostat (8-1 mol-mol),2.322415007077192
SU.86.86,sirolimus-bortezomib (250-1 mol-mol),0.3340737576471567
PE/CA-PJ34 (clone C12),6505803,-2.153335195822847
SK-MEL-5,439501,-0.7759362068872153
8505C,44493528,4.8824892045042585
SK-N-BE(2),36462,0.1963310505924975
JHUEM-3,6610216,3.5445169404516763
HLF,9926054,1.9113272674317217
NOMO-1,26596,-2.074766602044621
WM983B,9926054,1.9818225106954688
TE-8,tanespimycin-bortezomib (250-1 mol-mol),1.1915545878263378
HCC4006,tanespimycin-bortezomib (250-1 mol-mol),1.0336276508061957
A-375,3689413,-0.7182003405560186
KMS-12-BM,9926054,1.301975129823355
NCI-H2029,10322450,2.79312710605276
BC-3C,5460769,2.335900284678582
MOLP-2,107985,-3.941416896107429
TUHR10TKB,44491742,4.130919607533437
OE33,5460769,3.7320924588923465
SK-ES-1,135423438,0.9314581283921904
SK-MEL-5,9936388,2.3503506475790816
COR-L105,6505803,1.059348129706536
RT-4,6610216,4.294846652425395
EoL-1,262093,0.636688142118246
SNU-668,439501,-0.7901558289045547
MKN74,11404337,-0.8129110599609928
NCI-H1869,168313200,3.875520299128645
YH-13,tanespimycin-bortezomib (250-1 mol-mol),-0.5369599682458667
MOLP-8,10322450,4.082153801594249
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353
T98G,9936388,2.8447022467541956
OVK18,107985,-2.9046638122413904
DK-MG,439501,-2.8000262894493653
SNU-398,sirolimus-bortezomib (250-1 mol-mol),0.7620432052454496
NCI-H647,selumetinib-GDC-0941 (4-1 mol-mol),1.4549802874182485
NCI-H526,12003241,1.2765702668014436
Kuramochi,selumetinib-GDC-0941 (4-1 mol-mol),1.9620820620986936
Mono-Mac-1,44491742,3.632264372511232
AU565,135875424,4.732736146663846
WSU-DLCL2,10322450,2.94948924271478
NCI-N87,136227924,3.040461203265333
Rh18,selumetinib-GDC-0941 (4-1 mol-mol),2.126634875194983
EM-2,5460769,2.512608661279844
Hs 852.T,selumetinib-vorinostat (8-1 mol-mol),2.3684973893680024
BT 172,246676,2.57801593089919
RPMI-6666,12003241,-3.2897330659592705
OAW28,selumetinib-vorinostat (8-1 mol-mol),2.294734084050853
MDA-MB-468,26596,-0.798846302362186
LAMA-84,36462,1.556247382234922
NCI-H2342,sirolimus-bortezomib (250-1 mol-mol),2.0659171352443204
HEC-1-B,159324,3.407433154532503
DK-MG,3689413,-2.444320741118214
IGROV-1,9926054,1.8111808945519428
TOV-112D,3689413,0.2430902307838531
IGR-1,9911830,2.4963005826428533
BHY,409805,3.5626332868001787
A-172,6610216,4.231003065610573
SNG-M,36462,3.976185127999424
PaTu 8988s,100016,6.475282567189534
HPAC,tanespimycin-bortezomib (250-1 mol-mol),-0.5212433601902327
U-BLC1,135875424,3.992147868924357
NCI-H1838,11404337,-0.072819025932654
NCI-H2023,135875424,5.909688089564903
JMSU-1,26596,-1.1755063311173417
SNU-407,JQ-1-carboplatin (1-1 mol-mol),0.2520834241289693
SET-2,10322450,3.4472789227229925
EN,8515,5.1955673070106565
Karpas-620,24180125,3.3567090385415477
NCI-H1915,148124,-0.3136547815699751
HuP-T4,selumetinib-GDC-0941 (4-1 mol-mol),-0.95779192570868
BICR 22,11485656,1.7887481250962165
NCI-H510A,11485656,1.795372186053248
RL,selumetinib-GDC-0941 (4-1 mol-mol),2.248792439261428
BT 271,selumetinib-vorinostat (8-1 mol-mol),2.2656019278803665
G-402,409805,3.601387191810419
KMS-21-BM,3689413,-1.8694843012427496
LN-229,54618164,4.032684546454332
HCC827,sirolimus-bortezomib (250-1 mol-mol),1.7939037148295924
Capan-2,9903786,4.9592857340128385
NCI-H2171,6918878,0.0284372668850805
SK-MEL-24,409805,5.296906798765406
BT-16,selumetinib-GDC-0941 (4-1 mol-mol),1.0815618001864344
HCC1806,9911830,3.548402491023982
NCI-H2286,selumetinib-GDC-0941 (4-1 mol-mol),2.0876737367962495
BT-12,sirolimus-bortezomib (250-1 mol-mol),1.3345146082799952
U-251MG,11404337,1.3506850952063736
PC-14,100016,6.551425062945198
BT 232,409805,5.8765116213530195
DMS 454,26596,-0.4599730834169373
KMS-26,6610216,3.996132091239896
ZR-75-1,sirolimus-bortezomib (250-1 mol-mol),-0.944196489916664
OCI-AML-2,135398744,6.3440072866172965
HSC-4,6610216,4.241818899552939
EJM,26596,-3.57565028157041
BT-16,262093,3.676362037858863
COR-L105,24180125,3.5925931777332676
TOV-112D,100016,6.758334848108728
Caov-3,6505803,-1.4448132497594957
IGR-1,26596,-0.0620943147126713
OV7,3689413,-5.087599218712134
OAW28,selumetinib-GDC-0941 (4-1 mol-mol),0.8148216272117433
H-STS,11485656,0.1079902200809361
MOLT-16,sirolimus-bortezomib (250-1 mol-mol),-5.402934760182518
VMRC-LCD,409805,5.2545104964155485
CAL-27,12003241,-1.271388336497811
BT 359,24180125,3.227467986452967
P-STS,6505803,1.2409378245961384
DB,44493528,3.818238435779709
NCI-H1092,9927531,3.406213307022425
BFTC-905,9911830,3.3547693597668524
KNS-62,439501,-2.644603626195061
KE-97,10322450,3.096998499841668
SNU-668,24180125,2.58387790396355
BICR 22,26596,-1.8883514509946957
SNU-216,9926054,1.7628487898715297
Hs 940.T,49836020,0.3433567165193816
JK-1,11404337,-1.9979584162277513
NCI-H522,5460769,0.5614535105182378
SNU-308,selumetinib-GDC-0941 (4-1 mol-mol),1.3521020528190912
NCI-H2029,44491742,3.631304430303769
NCI-H1838,262093,3.1825262883222836
NCI-H1299,262093,2.920458315101783
IMR-32,26596,-3.972445110403932
TE-11,6610216,4.289491420470742
GSU,JQ-1-carboplatin (1-1 mol-mol),3.56440629696987
IST-Mes1,24180125,3.710624760267412
NCI-H226,135423438,1.8109443416998463
DND-41,24180125,1.0570161695352558
SEM,3136844,3.235068436368959
SR,135875424,2.4827533420158376
PL-21,selumetinib-vorinostat (8-1 mol-mol),-0.1981312398958528
JK-1,6505803,-1.233807201849435
253J,6505803,-1.7434391894499837
ES-2,159324,3.623206092591176
SW1990,5460769,2.4608974418371017
BT 112,36462,-0.1329200912201302
GDM-1,135875424,3.346620494935451
SW1271,46943432,0.8939870827443378
KMS-11,12003241,-2.8887213513956147
NUGC-4,12003241,-1.4802161759010128
Hs 895.T,168313200,2.9919479779776395
JM-1,26596,-2.491901301923365
JHUEM-3,135875424,4.829807561587815
SK-MEL-31,10296883,4.185495056611244
Panc 02.03,selumetinib-vorinostat (8-1 mol-mol),2.158693436679715
COV434,44491742,4.086933897953946
KM12,selumetinib-vorinostat (8-1 mol-mol),2.525570037198844
CAL-51,3136844,4.799885860604426
KMH-2,159324,1.5423120810193625
Ri-1,11485656,1.6570467994982818
CA46,148198,-5.7845042531785
HCC95,5460769,4.4862905703550355
NCI-H1568,selumetinib-vorinostat (8-1 mol-mol),2.593817270705759
MPP 89,24180125,2.9094571122086723
SKM-1,136227924,2.5339244468963407
BT 248,9927531,4.7076279917818225
MDA-MB-435S,148198,-3.0522052699566613
NCI-H2029,136227924,2.308767464525173
TE-6,44491742,4.129891650576595
MKN1,36462,1.8541033449175903
TE-5,44491742,3.7855362982761194
KMBC-2,3689413,-0.0193871140642154
HuH-28,107985,-3.906817449798121
GA-10,262093,-0.1751219833238948
U-251MG,107985,-0.8094709308100292
T3M-10,11404337,0.3404159052495322
MOLT-16,tanespimycin-bortezomib (250-1 mol-mol),0.076704677105394
HPAC,135875424,4.409126746837932
Rh18,107985,-2.133985516239094
SK-UT-1,9903786,5.78516391020833
NCI-H2029,409805,3.806732327162768
SNU-216,9911830,2.1398912486664026
UO-31,135875424,2.695151327670827
BT 245,44491742,4.161467905313556
NALM-6,26596,-2.8659414702792128
KYSE-450,6610216,4.803414401111398
KYM-1,9927531,4.58392682790106
HeLa,11404337,0.8471506482049684
U-251MG,148198,-4.2062260455061535
Yamato-SS,46943432,2.439746234122117
KLE,6610216,4.690158924143472
TE-6,9936388,-6.304125795740003
EFM-192A,26596,-0.8945052736311969
Mel Ho,sirolimus-bortezomib (250-1 mol-mol),-0.1905502812400849
COR-L88,54618164,2.493623736891049
SUP-HD1,36462,-0.9379934382543692
HEL,262093,2.3252232523203995
Jurkat,24180125,3.1420055994155787
MPP 89,54618164,4.107126861333459
Ku812,73707440,4.534867519967767
HEC-1-B,3689413,0.3558591242375798
IGR-39,168313200,3.552497438283597
SNU-1076,44493528,4.4421057189980875
IM95,168313200,3.500252264510834
Calu-3,6610216,4.332815727966212
MDA-MB-453,135875424,2.7753375231350104
SK-UT-1,136227924,4.460190875137593
OE21,9926054,1.7334869398194368
HMC-1-8,12003241,-0.3368702938294806
U-CH1,3689413,0.3133886953072482
HPB-ALL,9927531,5.02886546731598
NCI-H1666,9926054,1.8501166706396857
ONCO-DG-1,24180125,3.4172871528516677
Kuramochi,11485656,3.4177082965516328
LC-1/sq-SF,5460769,2.491763650512152
WM115,9927531,5.125567810288171
NCI-H522,sirolimus-bortezomib (250-1 mol-mol),0.2435604528916691
NCI-H1563,sirolimus-bortezomib (250-1 mol-mol),2.9865151808582615
Daudi,9911830,-0.0057102646081846
SNU-1033,11404337,-1.419235655385228
LOU-NH91,11404337,-0.9599092047687252
SBC-5,262093,2.1741934315953726
BT 139,6610216,4.145166206340405
SK-LMS-1,168313200,3.682470833996821
CAL-78,148198,-3.3120211354405953
CAL-85-1,136227924,2.9828253747888067
LS1034,148198,-4.061801759513543
B-CPAP,JQ-1-carboplatin (1-1 mol-mol),6.304556077558474
NCC-StC-K140,136227924,1.8113931494957989
MOR/CPR,selumetinib-vorinostat (8-1 mol-mol),2.4234354673770317
SW1417,136227924,2.767989145735224
SUP-HD1,100016,7.0046366432620735
CCK-81,168313200,3.592391454207574
HCC1954,409805,3.5221605615273095
Mel JuSo,12003241,-0.8749256028494242
DMS 114,6505803,0.1700974971727873
COV362,9926054,1.902525685415388
M059K,JQ-1-carboplatin (1-1 mol-mol),1.2153984105475986
HCC44,JQ-1-carboplatin (1-1 mol-mol),-0.5327946699204261
647V,136227924,2.038450233147295
SF295,6918878,3.614414318774816
NCI-H838,409805,3.793714806116016
NCI-H647,136227924,2.9483035397305164
Mino,54618164,3.08934752103197
TUHR14TKB,36462,3.356624970040771
IM95,9903786,2.260707421178731
SNU-449,9903786,3.696408358539977
KNS-42,24180125,3.2622163839270053
Li-7,6918878,2.8349959182888984
PaTu 8988t,selumetinib-vorinostat (8-1 mol-mol),4.764605515620316
KG-1-C,9926054,3.438726286073136
GB-1,BRD-K16130065,4.42493590422296
BT 328,tanespimycin-bortezomib (250-1 mol-mol),-1.4953584261079875
NCI-H2052,3689413,-1.081433417665549
G-292 clone A141B1,5460769,2.9316291773021095
M-07e,8515,3.3739706216827368
JM-1,168313200,1.89690041567587
NCI-H2286,54618164,4.200940501836108
647V,148198,-4.071650146213555
SEM,9926054,1.3281424685311425
PE/CA-PJ49,11404337,0.0513303948007028
THP-1,54618164,3.674496857626057
SJSA-1,selumetinib-GDC-0941 (4-1 mol-mol),2.9428552640575236
TE-1,11404337,-0.7530649857442655
PE/CA-PJ49,26596,-2.486533753867605
TE-1,24180125,3.0230127528664825
COLO 201,107985,-2.8036862489291066
MKN7,selumetinib-vorinostat (8-1 mol-mol),3.1856910692458102
TE-1,12003241,-0.9529252226933594
OCI-AML-2,6610216,3.58079476566594
OCUM-1,9903786,1.5374110288154037
SNU-466,9911830,2.2807383829055077
HGC-27,3689413,-1.6532214726359813
BT 359,135875424,3.201120817115183
KP-N-SI9s,9911830,2.32550504994579
F-36P,262093,1.6746033026960565
EM-2,selumetinib-vorinostat (8-1 mol-mol),-1.2351306123509636
HuG1-N,9903786,2.6577848330965
CAL-78,6505803,-0.7223654000652794
Calu-3,3689413,-2.218147351051095
GA-10,46943432,0.1410018979279226
Sq-1,6505803,1.095913417774702
SNU-C2A,100016,6.499335908465164
GA-10,107985,-4.472986688211123
Hs 683,439501,-3.4221859538690467
LP-1,44493528,4.0079037689618815
BT 286,409805,3.8987037297039056
CJM [Human melanoma],439501,-2.3505582983790076
DOV13,107985,-3.1919533435482697
BT 231,12003241,-1.271590527231957
JHUEM-3,136227924,3.0400208358424243
COLO 205,26596,-2.0120712396922475
2004,148124,-5.699591779896403
SNU-1,246676,4.276260560619348
Kuramochi,11404337,-0.4054139611353435
Tm87-16,5460769,0.8511670833811608
Ki-JK,3136844,3.767588244624784
Ri-1,JQ-1-carboplatin (1-1 mol-mol),-0.4957222903174305
EJM,136227924,2.8681258655198367
DLD-1,107985,-3.352847665202384
LCLC-103H,6610216,4.684441214447026
Karpas-422,11485656,3.579952167071255
NCI-H1650,11404337,0.7802522611526345
HuP-T4,46943432,0.958551174490495
HSC-2,262093,1.000516110359784
U-118MG,sirolimus-bortezomib (250-1 mol-mol),0.338671350803902
2004,439501,-3.526370090236184
NCI-H1299,159324,2.855064979130342
BT 239,54618164,3.809265619154791
NCI-H2023,6918878,4.699002556016527
DU145,148124,-5.577110103227381
CAL-12T,12003241,-2.021983796416415
PF-382,135875424,3.2130182861195076
Daoy,selumetinib-GDC-0941 (4-1 mol-mol),2.0496212726424914
Tm87-16,107985,-4.232752042376738
MHH-CALL-3,54618164,4.22349519380149
JHH-5,9926054,1.852888607063122
JHOM-1,10296883,4.346647898166674
SNG-M,135875424,3.588544936048006
MFE-296,selumetinib-GDC-0941 (4-1 mol-mol),2.628937371578258
NCI-H1299,100016,6.953805951258825
DAN-G,5460769,3.6980093078585594
OVCAR-4,11404337,-0.6423478354429553
Ci-1,26596,-1.6175201482887698
L-363,44493528,5.083298031137833
TE-14,9903786,3.4903828938175354
NCI-H1581,12003241,-3.141909657100737
8-MG-BA,44491742,6.487107858540147
RPMI-7951,9903786,2.3675771120862485
OAW28,168313200,4.298133692275281
U-BLC1,148124,-4.12148794810048
NCI-H2171,3689413,-2.7117222930063867
IGROV-1,5460769,1.6083174601829917
K029AX,168313200,4.408216364227678
LCLC-97TM1,JQ-1-carboplatin (1-1 mol-mol),1.024195349701644
Panc 02.03,10296883,4.297264305827386
A-204,selumetinib-vorinostat (8-1 mol-mol),2.356272602694142
8505C,159324,3.0622451450386485
ONS-76,3689413,-0.2845128895134612
Ku812,135423438,-2.2335088833738146
SUIT-2,9936388,2.2499280975506393
Daudi,26596,-3.612902475241139
SEM,148124,-5.566475057371884
NU-DUL-1,sirolimus-bortezomib (250-1 mol-mol),-5.630775475246084
NALM-6,selumetinib-GDC-0941 (4-1 mol-mol),-0.5223211713783823
Hs 611.T,9903786,0.3508528062947837
HOP-92,148198,-3.4956728974738756
BT 159,8515,5.527889976942142
22Rv1,135875424,4.290538379246911
HSC-3,148198,-2.120282407341815
NCI-H1623,409805,3.8984511674912943
PaTu 8988t,136227924,2.49705731140334
FTC-133,54618164,4.149608396421597
SNU-1105,11485656,2.972533962775767
SNU-216,12003241,-2.3730818081536955
NCI-H1944,409805,5.441201830264429
SNU-475,5460769,3.649857099977848
OCI-Ly10,6610216,4.298741404567049
THP-1,46943432,-0.1371263588377964
OVCAR-5,148124,-4.373802935738603
HCC1588,selumetinib-GDC-0941 (4-1 mol-mol),-0.6693543343840518
Ku812,6918878,1.294263756548978
Pfeiffer,3136844,3.0442746374060343
ECC12,44493528,5.669506647714131
OS-RC-2,sirolimus-bortezomib (250-1 mol-mol),1.663291645677193
SNU-620,9926054,1.6234040218368857
NCI-H810,100016,4.22640705156995
Rh30,11485656,2.766839981757524
KHM-1B,selumetinib-vorinostat (8-1 mol-mol),0.6358742405488887
NCI-H2023,sirolimus-bortezomib (250-1 mol-mol),2.707809534730406
Panc 10.05,JQ-1-carboplatin (1-1 mol-mol),5.298332174955392
KYM-1,135875424,2.5463366788137427
KYO-1,11485656,2.321902105017357
NCI-H1568,selumetinib-GDC-0941 (4-1 mol-mol),1.6241640738587435
NCI-H520,135875424,4.041449952679746
WM266-4,9903786,4.44287748208762
SJSA-1,selumetinib-vorinostat (8-1 mol-mol),4.163879643350655
NCI-H2452,9911830,3.1691750432917645
KNS-81,selumetinib-vorinostat (8-1 mol-mol),3.903810781537335
JHH-1,12003241,2.181152294070196
Granta-519,8515,3.731909716775835
M-07e,107985,-5.456968892435315
BT 416,46943432,1.605055872741302
EHEB,100016,6.596024177667571
RPMI-8226,10296883,3.535123167046786
HuG1-N,9927531,4.775383733857977
NCI-H322,sirolimus-bortezomib (250-1 mol-mol),2.3812461676498144
A2058,24180125,2.583620117292264
SNU-503,6610216,4.10575364051366
COLO 668,9926054,1.8652250146590224
NCI-H2029,168313200,1.6583948504808603
NCI-H1734,sirolimus-bortezomib (250-1 mol-mol),-0.1121283938952372
NCI-H446,9927531,3.935868593657491
KG-1-C,JQ-1-carboplatin (1-1 mol-mol),1.591651516557658
UO-31,262093,2.5027892995722674
CHP-126,136227924,2.2251507312000576
JHH-4,8515,4.445321980402721
HCC1438,selumetinib-vorinostat (8-1 mol-mol),2.8249795691061736
TUHR4TKB,159324,5.085866388829581
DK-MG,44491742,5.623663094967997
NCI-H747,135875424,3.2442393754776178
NCI-H650,136227924,4.852289363773007
SNU-182,sirolimus-bortezomib (250-1 mol-mol),0.3656732555283032
KO52,44493528,4.373207696272561
NH-6,9926054,1.9034563361062868
OVISE,409805,6.403340651497087
SNU-1,3689413,0.5302948396087109
Tm87-16,3689413,-0.2220957395853978
MOLT-3,9926054,1.73923619089024
Hs 895.T,3689413,-2.343534689562226
42-MG-BA,8515,3.761157629466223
NCI-H1650,12003241,-2.181878019620055
NCI-H2228,10296883,4.1270071752314275
BT-549,5460769,6.35928800843138
OE33,148198,-2.7707811749574196
Hs 934.T,439501,-2.1837618207890808
NCI-H1666,159324,1.3832647781032974
HCC15,9903786,1.5576741113339283
PC-3,9936388,2.7801122668619738
SNU-761,262093,1.8734688668170425
253J-BV,tanespimycin-bortezomib (250-1 mol-mol),1.5580913101671798
COLO 684,136227924,2.900562305918871
BL-70,3136844,3.2643251354787965
SNU-308,JQ-1-carboplatin (1-1 mol-mol),5.335805605025179
TE-5,24180125,3.064941852164732
EM-2,9936388,-5.706813199670236
SCaBER,12003241,-1.3613478880946173
SK-MM-2,9911830,2.774593612970169
KP-4,5460769,4.107177099702386
RPMI-8226,26596,-3.5550255900749623
2004,5460769,0.3983589325904631
GMS-10,136227924,3.0615637003217433
DV-90,148198,-5.605719832518081
NCI-H1651,54618164,4.3359415778445625
SR,12003241,1.5749280257994038
FU-OV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4708101541145827
SW1088,10296883,3.7456002290694954
SCC-25,107985,-3.48065127857335
YD-10B,8515,0.95278205640322
MV4-11,159324,-2.593859532565249
MKN45,11404337,2.918608562534022
A-253,9927531,5.71272933596785
G-401,10322450,4.220475308231234
AML-193,135875424,2.8839431116482803
HCC95,selumetinib-GDC-0941 (4-1 mol-mol),2.25370960012268
TE-14,100016,6.976624848230786
NCI-H2087,9903786,2.3520196427400717
Mino,6610216,4.52250684011298
JHUEM-7,selumetinib-vorinostat (8-1 mol-mol),2.3580216719117284
BICR 22,6918878,1.3704913724877863
Sq-1,135875424,4.0365326385362055
SNU-899,3689413,3.063297937380225
SNU-46,135875424,4.168499733284657
THP-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.4555480818826622
A4/Fukuda,168313200,2.9572494196719723
PL-21,44493528,4.151130838756699
RL95-2,3136844,5.687207148670173
NCI-H2029,6610216,3.944731784894563
Li-7,9936388,-1.419334332710526
MKN74,3136844,5.110868914339551
ONS-76,11485656,2.5953354109263262
Lu-99,selumetinib-vorinostat (8-1 mol-mol),2.3440066330762415
UACC-62,sirolimus-bortezomib (250-1 mol-mol),1.7829668045842757
Kelly,9936388,-6.593577223955802
QGP-1,9903786,2.781324092534045
A2058,148198,-2.943445139558103
KCL-22,36462,1.629414459296742
GB-1,135423438,1.7622813158496486
TE-9,135875424,3.7718205892374943
NCI-H2196,54618164,3.883343219938622
KYSE-140,9903786,2.4605743135261653
L-1236,9936388,2.483385835901907
KMRC-1,3689413,-1.8207429228817171
LoVo,11404337,-0.8407014552816361
HSC-3,246676,5.897694948115853
A-375,262093,2.9970202931790046
T24,9911830,3.4233816907191468
MSTO-211H,8515,1.6806311840995682
HCC366,11404337,0.8660876212905556
SNU-1041,107985,-1.9009359266781765
IM95,6918878,1.9213244540245753
HL-60,10296883,3.84878644864352
Hs 934.T,11485656,3.91753732132253
SNU-407,9911830,2.653274681227129
UACC-812,9926054,1.7122964049751828
BICR 31,107985,-2.559614665868775
COLO 699,12003241,-1.6460659518938752
DMS 53,3689413,-1.7302649812310384
ES-2,3689413,-2.830682661734752
JHH-5,439501,-1.654650544214748
COV434,10322450,3.177068710390827
SNU-81,selumetinib-GDC-0941 (4-1 mol-mol),-2.7364127388649937
TCCSUP,54618164,4.281824636120867
HCC827,6918878,1.7277649495374745
HCC1954,159324,3.165805717384629
JHOC-5,9911830,3.201289712563667
Hs 729.T,44491742,3.716267531008215
SCC-4,9927531,4.977228114447549
KE-37,JQ-1-carboplatin (1-1 mol-mol),-0.7652010802718352
SK-HEP-1,439501,-2.4482777943885856
AU565,9927531,4.912755977802547
COV434,3689413,-2.336562516768729
HCC-56,11404337,1.7100052482003292
JURL-MK1,159324,0.068905787386541
TF-1,135875424,3.0732861246211005
YD-10B,11485656,0.9298228362843758
NCI-H1869,9927531,5.985290716685452
MOTN-1,135398744,7.842138367791958
AN3-CA,26596,-3.5868272426759584
P12-Ichikawa,159324,0.3478252328600322
NCO2,9911830,-2.256494513015068
NCI-H2085,3689413,-0.2448228197387998
NCI-H196,9926054,2.525003076989932
A-253,36462,1.0164756428097503
HEC-251,6610216,4.488517337279306
JHOC-5,44484440,3.4663918753168237
MHH-ES-1,44493528,5.035499242362303
HuG1-N,JQ-1-carboplatin (1-1 mol-mol),3.9513233413995983
SNU-119,439501,-2.3303537311085143
HT-1080,54618164,4.264830967692318
TE-8,6505803,-0.116387849534283
SUP-T11,439501,-2.327064015434822
EB1,3689413,-2.432787849324627
PF-382,439501,-2.5741395884768377
KE-39,9927531,6.019185228760376
HEC-6,46943432,3.440165677285934
MJ,11404337,2.657052353931515
NCI-H2444,selumetinib-vorinostat (8-1 mol-mol),3.1032732552944293
NCI-H929,5460769,1.81013287796662
ST486,11485656,1.65014245999224
KMH-2,selumetinib-vorinostat (8-1 mol-mol),2.389760502831543
EPLC-272H,9926054,1.8633723849420136
L-540,44491742,3.302641301804856
NCI-H1651,5460769,-1.7567427214342684
YAPC,sirolimus-bortezomib (250-1 mol-mol),1.6566311249890242
NCI-H1568,24180125,3.319632294157453
KMS-21-BM,100016,3.297202365361246
8505C,135423438,2.0572853298066036
RERF-LC-MS,selumetinib-GDC-0941 (4-1 mol-mol),0.28876788592482
NB4,159324,-2.3898009821965545
SCaBER,135875424,4.404727092025364
Daudi,10322450,2.3131627402631905
BT 330,selumetinib-GDC-0941 (4-1 mol-mol),1.903493951226084
A-549,439501,-2.483005959928592
HT115,9903786,1.6808315283009525
MDA-MB-453,6918878,0.409116855324534
MIA PaCa-2,3136844,3.9100198187620223
BT 428,9903786,3.72207082245763
COLO 800,3689413,2.0885075938315576
COLO 792,409805,3.780647350221477
U266B1,11404337,-0.4739361104309206
PE/CA-PJ15,sirolimus-bortezomib (250-1 mol-mol),0.416438105686926
SK-CO-1,12003241,-0.9578793579943758
JJN-3,9911830,3.4095867158278623
LOU-NH91,JQ-1-carboplatin (1-1 mol-mol),1.662362738651182
EC-GI-10,5460769,0.497898829273519
FTC-133,148124,-3.926787463073679
NCI-H1694,8515,4.10750470261541
SW1990,44491742,4.13198674266079
5637,54618164,3.894901401799729
LS1034,409805,5.876916886757288
Hs 729.T,10296883,3.893392968394133
NCI-H2009,11404337,-0.0657811746758558
SK-N-FI,9936388,-7.982723182575795
TF-1,9903786,1.2296708534399408
JHH-6,sirolimus-bortezomib (250-1 mol-mol),2.5293285021396277
Pfeiffer,135423438,1.688577361264551
BT 239,24180125,1.280593014526314
Hs 766T,tanespimycin-bortezomib (250-1 mol-mol),-1.398950675536224
NCI-H1435,9936388,0.980131608638386
SK-LMS-1,107985,-2.0791216357249054
ONS-76,selumetinib-vorinostat (8-1 mol-mol),-1.377626233169706
NCI-N87,9903786,2.403456427338335
SUP-HD1,6505803,-0.2605550921206995
NCI-H2081,sirolimus-bortezomib (250-1 mol-mol),-0.0413699313219798
SNU-601,9903786,4.302030389769322
NCI-H1339,5460769,-0.265386406275254
Yamato-SS,168313200,3.0262035577149717
Granta-519,9927531,4.885085469625254
PE/CA-PJ34 (clone C12),3689413,1.240876822848384
BT 216,tanespimycin-bortezomib (250-1 mol-mol),-1.562937593098705
BT 159,11485656,3.350505147528576
HT-144,135423438,3.7063212476270144
TE-8,148198,-4.4276968910766525
HCC2218,9927531,0.7764965952119703
MEC-1,409805,3.8127631340240247
SNU-1066,54618164,4.288929864034331
HCC1588,JQ-1-carboplatin (1-1 mol-mol),4.871781854862913
NCI-H1915,11404337,-0.6754401964347063
SK-N-BE(2),selumetinib-vorinostat (8-1 mol-mol),-0.8893758646967648
SNU-C2A,409805,4.9402914369912
Hs 852.T,JQ-1-carboplatin (1-1 mol-mol),1.014033031882682
NCI-H292,262093,2.9868554632365556
T84,26596,-1.9747226822057509
HT-1080,3136844,4.2254082243396835
Hs 729.T,439501,-2.5302940667967695
HuT 78,148198,-3.964995663982544
ALL-SIL,5460769,0.8731159867521163
RERF-LC-Ad1,9911830,3.638980358065119
DU4475,107985,-4.755590050772039
NCI-H28,tanespimycin-bortezomib (250-1 mol-mol),-3.05578817250867
SNU-398,11485656,1.495673016865192
HeLa,6505803,-0.0506022751267441
SNU-620,6505803,-2.9616664465853115
HT,tanespimycin-bortezomib (250-1 mol-mol),-0.5308149065627191
LOX-IMVI,24180125,3.3051299487129415
SNU-16,148198,-5.297053925095674
KE-37,6610216,4.08860835396977
SW579,24180125,2.7515487502079954
NU-DUL-1,5460769,0.0650786105857349
FTC-133,409805,6.0297974484260655
CAL-51,6610216,4.7761200098267365
COV644,JQ-1-carboplatin (1-1 mol-mol),1.9465163410913973
MDA-MB-468,9903786,1.7748497481459855
NCI-H1339,26596,-1.3893901381267089
Becker,6505803,-1.1443258225494983
TYK-nu,tanespimycin-bortezomib (250-1 mol-mol),-0.3612776377127862
Jurkat,9926054,1.8890918367446592
LMSU,3136844,4.51908400506557
P3HR-1,136227924,2.9304577514896466
NCI-H441,168313200,4.136932083688696
EC-GI-10,9911830,2.325941153808089
KP-4,26596,-2.006035898797214
KYSE-450,11485656,2.990129749938368
BT 248,8515,3.628450909279232
SNU-869,135875424,4.845035654060252
KYSE-140,159324,2.642529178463094
NCI-H1734,107985,-3.677393091141896
NCI-H1694,246676,4.827487057089954
Jurkat,11404337,-1.079312367340039
PK-59,tanespimycin-bortezomib (250-1 mol-mol),-0.1370541411444133
Hep-G2,selumetinib-vorinostat (8-1 mol-mol),-0.2891046147054946
A-172,148124,-4.252719127564102
MOLM-13,36462,-3.0478349617512466
Hs 729.T,49836020,4.229774154263897
CML-T1,159324,0.3275039904336689
IGR-37,10296883,3.844591108282479
PL-21,409805,3.3512475851853067
P31/FUJ,JQ-1-carboplatin (1-1 mol-mol),-0.13727273351174
RCH-ACV,11485656,1.6994895445887253
SNU-308,107985,-2.764112061523982
KP-4,JQ-1-carboplatin (1-1 mol-mol),3.935772405145619
HCC1500,409805,3.5957056987066407
253J-BV,6610216,4.421938005073567
BT-549,9903786,2.513972936103366
A3/Kawakami,3689413,-2.523189913009787
NCI-H747,100016,6.898929440027426
IST-Mes1,3689413,0.9013533734229402
OAW28,9911830,2.567685352724645
LOX-IMVI,135398744,6.429324407359154
253J-BV,26596,-1.8629561826944263
JHH-4,246676,4.666331816889099
SK-MEL-31,6610216,4.2630630920369805
HCC1588,262093,3.0584960901544833
JHUEM-1,5460769,1.70749298340363
THP-1,9926054,1.7604592205221938
NCI-H2141,439501,-3.4118873833208676
TE-15,tanespimycin-bortezomib (250-1 mol-mol),-0.6249388884216994
Peer,54618164,2.8451441287771084
OAW28,11404337,-1.5682838378564492
TM-31,148198,-3.484551999538721
LOX-IMVI,409805,4.011885260759597
KLE,439501,-2.1797784747958477
KE-97,9903786,1.2492215046339803
NCI-H1793,3689413,2.3725709733273663
Kuramochi,409805,5.320822173869509
MOTN-1,107985,-4.057142604614257
MOR/CPR,11404337,-0.964531919151295
KP-3,11404337,-0.3315209931001077
MCF-7,selumetinib-GDC-0941 (4-1 mol-mol),1.646510277694018
NCI-H2405,135875424,3.4546844746128476
SNU-503,sirolimus-bortezomib (250-1 mol-mol),1.3381896958753263
SCaBER,9926054,1.794532433131724
CCF-STTG1,107985,-2.0025512814929525
Calu-6,107985,-3.229797304625017
NCI-H650,9936388,2.384400355821072
G-292 clone A141B1,3689413,-2.069808730051662
FaDu,439501,-1.5866164776842138
SKM-1,5460769,2.732858525958475
BT 359,107985,-0.9981088796808636
TE-4,136227924,2.9171247501964945
OCI-AML-5,135875424,2.7043595166369694
T84,44491742,3.592181787537852
TUHR10TKB,11404337,0.4722597238806724
KMS-27,135875424,3.062949478876591
MFE-319,selumetinib-GDC-0941 (4-1 mol-mol),2.3179582755717356
KYSE-70,3689413,0.9447440025313596
SF126,135423438,1.5830794600000448
SK-N-FI,100016,6.445734787344034
SNU-16,11404337,-2.6898366893784997
NCI-H1975,44491742,4.016351620338357
Detroit 562,159324,3.424275125039322
NCI-H747,10322450,3.8486702496060463
MDST8,409805,3.941558883413243
SCC-9,135875424,4.9754653396039314
TE-1,3689413,2.462483014763608
EFO-21,148198,-3.998028917288756
SK-N-SH,135875424,2.927968967811746
KYSE-410,9936388,-3.552366403662026
JHUEM-7,439501,-3.5721158792487646
DMS 273,26596,-2.1961333269229173
WM983B,11485656,1.9141384633865923
HARA [Human squamous cell lung carcinoma],36462,1.692464431977034
KCL-22,54618164,4.521405657965437
NU-DUL-1,148198,-2.450510583541313
GCT,44491742,4.460609521265373
MFE-319,26596,-1.024111788947852
HARA [Human squamous cell lung carcinoma],9927531,4.552330692797245
NCI-H2029,JQ-1-carboplatin (1-1 mol-mol),2.876722869032902
Fu97,11485656,0.7885414844371695
HARA [Human squamous cell lung carcinoma],26596,-2.1080424946580245
MKN7,11404337,0.0072923391755458
SK-MEL-24,44491742,3.9511074387326337
SNU-1077,9911830,1.9332136731221603
BT 159,262093,2.588782521087668
KYSE-520,3689413,3.1364277290203986
TE-8,54618164,4.10241796815657
A2058,409805,3.820930046521051
M-07e,24180125,2.673847094626436
MOLM-6,100016,5.4880920806856865
YD-8,selumetinib-vorinostat (8-1 mol-mol),2.8906615427618982
CHP-126,3689413,-2.431147866907691
SNU-1214,262093,2.99372726902227
YD-15,sirolimus-bortezomib (250-1 mol-mol),1.709895595212298
SK-ES-1,9926054,1.5618900800676432
COLO 792,JQ-1-carboplatin (1-1 mol-mol),2.0014474236818183
BT 248,9936388,1.117792201973615
WM983B,selumetinib-vorinostat (8-1 mol-mol),-1.7225741889279806
NCI-H1395,JQ-1-carboplatin (1-1 mol-mol),2.36945639284839
HMC-1-8,9936388,-5.4088494773522395
SF539,selumetinib-vorinostat (8-1 mol-mol),3.0121970622277248
GI-1,148198,-4.209323868036209
HEY A8,100016,6.30003295297675
TE 617.T,3136844,3.7181899767171607
HPB-ALL,JQ-1-carboplatin (1-1 mol-mol),1.026609404352011
Rh41,44493528,3.718016939158044
697,24180125,1.1965287917191645
BT 228,24180125,1.4765108272863283
PK-1,12003241,-0.8622642153841519
SK-N-SH,tanespimycin-bortezomib (250-1 mol-mol),0.2020120787076161
HT-1376,159324,4.157820954342544
NCI-H2141,sirolimus-bortezomib (250-1 mol-mol),-0.1693402780002957
JHUEM-7,6505803,0.2461537124409258
DMS 273,JQ-1-carboplatin (1-1 mol-mol),0.4682254596147815
SW1573,11404337,-1.3449252751203844
HLF,5460769,2.8126856105883355
NCI-H520,JQ-1-carboplatin (1-1 mol-mol),1.1909006472445542
SK-MEL-2,3136844,4.246241998610311
HEC-59,9903786,2.2541518083702172
ECC12,selumetinib-vorinostat (8-1 mol-mol),3.230210286741561
PE/CA-PJ15,168313200,2.967546559162406
EFO-27,136227924,3.515702384882397
HEL 92.1.7,439501,-2.540174469055436
SW1417,439501,0.2964546756721697
KP-N-SI9s,selumetinib-GDC-0941 (4-1 mol-mol),1.114910325038949
SK-N-DZ,148198,-7.727965978529101
A-549,6505803,-0.295425809550202
TE 441.T,439501,-2.08185324910289
Namalwa,100016,3.934978584241161
SU.86.86,selumetinib-GDC-0941 (4-1 mol-mol),2.756391846899265
DU145,12003241,-2.0135691280208876
FaDu,246676,4.360118966738819
SK-MEL-30,36462,3.2992643549134932
Panc 02.03,tanespimycin-bortezomib (250-1 mol-mol),-0.3690940442428398
BT-474,439501,-3.058225040966164
DAN-G,11404337,0.1874495042654069
697,6918878,-0.7251919554115005
DU4475,10296883,3.4957672338374204
SNU-878,3136844,3.742053352533965
HCC4006,9927531,5.0093588349321125
HT-55,6505803,-1.0332246956791955
DU4475,6918878,0.2428026319491688
L-540,439501,-2.6441519340115236
SNU-1033,136227924,2.5540912421490387
SU.86.86,135423438,1.7276185076707382
SK-MES-1,439501,-3.0675595474826194
BT 416,135398744,7.827037669937473
TUHR10TKB,168313200,3.817818184854305
KHM-1B,73707440,5.196065246508486
NCI-H23,6610216,4.207957061685163
LC-1/sq-SF,10296883,4.166838405657319
DU145,selumetinib-GDC-0941 (4-1 mol-mol),2.8367199519336324
CHP-126,sirolimus-bortezomib (250-1 mol-mol),1.5217609730856023
DV-90,9903786,1.7610541097937376
BT 239,9926054,3.266360841464617
UACC-257,44493528,4.38032126564653
JHUEM-1,10296883,3.9346694694253657
MV4-11,tanespimycin-bortezomib (250-1 mol-mol),-4.482772377599296
BT 172,tanespimycin-bortezomib (250-1 mol-mol),-3.8739618006203655
HOP-92,49836020,5.403656238129832
NCI-H2126,sirolimus-bortezomib (250-1 mol-mol),2.4996087284391493
MOLT-16,6918878,0.108318299003248
BxPC-3,selumetinib-GDC-0941 (4-1 mol-mol),-1.450319129285142
Hs 294T,24180125,3.2444441745748125
SNU-761,9926054,1.7039655374796845
KHM-1B,46943432,-0.0724756226448156
KP-2,9911830,2.158273821155512
SNU-216,6505803,0.9385001329114314
NCI-H1915,JQ-1-carboplatin (1-1 mol-mol),0.8785852564094064
KE-97,100016,5.841816758085698
NCI-H1568,135875424,3.0063280878885967
ME-1 [Human leukemia],135398744,6.466274911980868
BHY,49836020,5.6544174202433855
JIMT-1,44491742,4.195591062798884
UO-31,9903786,3.174003298065322
NCI-H2029,8515,4.558047697955578
TE-5,9927531,4.466928464790859
SK-UT-1,409805,5.339094874610304
ECC10,159324,-0.9362506976016994
T84,9903786,2.2055003104833553
SNU-C2A,11404337,1.3290101789179258
VMRC-RCW,135875424,3.9669138059560063
HT-55,9936388,-1.3601859214377197
HDLM-2,159324,1.0950285882033006
SUP-M2,12003241,0.982076040273681
Karpas-299,3136844,3.794217653530788
DU145,5460769,5.167808415466422
SK-BR-3,107985,-3.8808400341324543
SNU-1214,5460769,-0.9519860634538546
Ci-1,148198,-4.220925638162102
Karpas-620,135398744,5.497457460597933
SNU-466,135875424,2.3489478767532868
BT 172,409805,4.682235249525739
HCC1500,selumetinib-vorinostat (8-1 mol-mol),2.561295167839282
CAL-29,136227924,2.032112399542908
Granta-519,409805,2.9966967612339417
TE-9,12003241,-0.5375086976849406
A101D,9936388,0.7934880504993692
NMC-G1,9927531,6.6210082677754984
Karpas-299,9927531,5.423795277339213
KCL-22,246676,5.0117921419569935
RPMI-8402,135398744,6.9217830210823434
HPB-ALL,159324,-2.283586200702136
COV362,44491742,3.68091331789624
SK-MEL-2,9911830,2.439526960003118
U-118MG,6505803,-0.4944359132104617
CAL-78,24180125,3.4673071847149157
AsPC-1,136227924,3.2025742465891938
8505C,9926054,2.4332368789969734
SNU-449,11404337,-0.5921655065432572
SK-HEP-1,6918878,4.4325993547595655
SNU-8,44491742,5.735879763811486
BT 286,26596,0.1662425719802319
Peer,selumetinib-GDC-0941 (4-1 mol-mol),3.981609189515586
CW-2,3136844,6.148209705857487
SNU-C2A,selumetinib-GDC-0941 (4-1 mol-mol),0.0090429135503482
NCI-N87,409805,4.5069551273823585
G-401,JQ-1-carboplatin (1-1 mol-mol),0.2473733960236567
IGR-1,168313200,2.5081796884105083
ECC10,12003241,-2.873030940363692
EB1,168313200,1.71707382114801
RPMI-6666,10296883,3.884924501065409
MIA PaCa-2,sirolimus-bortezomib (250-1 mol-mol),0.2138092716811536
NOMO-1,6610216,4.0700997553747325
TE-4,9911830,2.9722016671255003
DAN-G,148198,-3.4486802184893386
COLO 205,136227924,2.4867417586096416
NCI-H1155,26596,-2.1815551982286885
GSS,26596,-1.5813697443428234
GMS-10,10296883,4.265684683390355
SCaBER,107985,-2.9954009190049655
JJN-3,44491742,4.04042701265084
SW1990,selumetinib-GDC-0941 (4-1 mol-mol),1.2183464614228592
Hs 746.T,168313200,2.2627857100827216
FU-OV-1,148198,-3.302287500778492
SUP-B15,44491742,3.782518793178516
CHP-212,6505803,-3.651985635286723
BT 228,9936388,0.9371184139441866
RL,9927531,3.353152417945259
TE-9,11404337,-0.8200746499862688
NCI-H1734,JQ-1-carboplatin (1-1 mol-mol),1.68501877850312
NCI-H1339,100016,8.285361450373896
COLO 829,8515,4.719403655310812
ONCO-DG-1,135875424,3.8536123048292175
ONS-76,8515,4.109060881613791
EN,3136844,4.316590295969748
CML-T1,100016,5.302267949835527
IST-Mes1,107985,-3.865584471784785
EFE-184,11404337,0.1091235831071998
CL-11,9936388,-1.838606364908758
HCC15,11404337,-0.219975280966356
LOX-IMVI,46943432,0.8500052465051992
OAW28,JQ-1-carboplatin (1-1 mol-mol),2.7763585253391625
MOTN-1,148124,-6.513897177118398
OUMS-23,100016,6.512546818056364
KMS-28BM,sirolimus-bortezomib (250-1 mol-mol),0.5815431662005854
TF-1,36462,0.8023388746533783
NCI-H1184,409805,3.865118912577075
JK-1,44493528,3.0964737259791812
JK-1,9926054,1.218283183105194
ESS-1,3689413,-0.979855371465586
MOLT-13,10296883,2.8313852072501966
NCI-H1105,168313200,2.3078853426841732
SK-N-AS,9926054,1.80921327911472
OCI-Ly3,3689413,-2.743608446400997
BICR 16,54618164,4.406569999060278
SNU-449,11485656,3.58452534173841
OUMS-23,24180125,3.5739287540168276
COLO 699,JQ-1-carboplatin (1-1 mol-mol),5.401700421556877
SK-HEP-1,11485656,3.3898088020096324
SF539,5460769,-0.1125532875886319
HEC-151,JQ-1-carboplatin (1-1 mol-mol),1.2344499659819954
G-292 clone A141B1,selumetinib-vorinostat (8-1 mol-mol),4.366985302501173
NH-6,148198,-5.967790177292145
MDA-MB-468,8515,4.214689901867794
GSS,409805,3.734629262000393
MDA-MB-231,11404337,0.2282829933143647
OCI-AML-2,9911830,2.3602217978284816
KMS-18,159324,2.2676031232884375
SNU-601,168313200,3.891936151492726
SU.86.86,tanespimycin-bortezomib (250-1 mol-mol),0.1396013159425142
KE-97,6918878,-0.0604889400041924
SK-N-SH,439501,-1.8318448964157588
Mel Ho,107985,-3.7981321235534855
NCI-H1568,12003241,-1.4870303892505918
CAL-29,6610216,4.4281336083452745
NU-DUL-1,9926054,1.630316493703293
SNU-C2A,tanespimycin-bortezomib (250-1 mol-mol),-0.6320265615754446
HCC44,46943432,0.5777599911467732
Daudi,49836020,3.49644839546437
OAW42,439501,-3.627774271274344
DV-90,9927531,4.273842148602971
NCI-H1703,6918878,3.7756437398204454
KMS-18,9903786,2.604638475406196
A3/Kawakami,9926054,1.6582602288279693
SU-DHL-4,439501,-2.4807393804308777
647V,12003241,-0.2300893498058843
GSS,262093,2.371550442394459
OC 314,sirolimus-bortezomib (250-1 mol-mol),0.336828605445857
MHH-NB-11,9936388,-5.109130573397568
OC 314,9927531,4.337134005776663
HuT 78,11485656,1.3035734242835073
DEL,135423438,0.2559505435004567
CAL-51,10296883,4.0377332681132305
Hs 729.T,11404337,-0.1228627032694511
SNU-1066,tanespimycin-bortezomib (250-1 mol-mol),-0.148232507345562
NCI-H1568,sirolimus-bortezomib (250-1 mol-mol),0.676282688891887
PF-382,9936388,-6.688930185968071
NCI-H1568,6610216,3.52063980115584
NCI-H1355,12003241,-2.4294292569102436
SW982,sirolimus-bortezomib (250-1 mol-mol),1.8750003849027723
LOX-IMVI,409805,4.011885260759597
LK-2,9911830,2.2744958535827227
DU4475,9936388,-6.520654557034823
JIMT-1,11404337,1.30553025443882
TE 617.T,10296883,3.758267174754907
UM-UC-1,9926054,1.7733389617998403
BT 216,49836020,1.982286397666987
SU-DHL-10,107985,-4.179844199483331
HLF,49836020,3.6461336560985087
HOP-62,9911830,2.7524936884021223
ChaGo-K-1,sirolimus-bortezomib (250-1 mol-mol),0.904309234685044
647V,8515,4.838859925138422
BEN,54618164,4.350338596649304
NCI-H841,11485656,1.425453258199406
A-375,135875424,3.696378355879961
VCaP,12003241,1.0138144203532238
697,9903786,0.9408007056276604
SNU-1076,107985,-2.9776717311334777
SUP-B15,107985,-3.9741449173851935
HCC1419,9936388,1.8369004896717465
CAL-27,sirolimus-bortezomib (250-1 mol-mol),0.4239769214934303
OCI-Ly10,6505803,-1.8295734917413131
NCI-H727,9903786,3.725485605999375
SNU-840,44491742,6.442056780348467
SNU-878,9927531,4.662529833906493
D283 Med,54618164,3.747562396348618
BT 286,246676,1.6855048913308266
CAL-78,10296883,4.297149072748996
YAPC,12003241,-0.7644111057992425
IGR-39,44491742,4.786400321878876
SUP-B15,6505803,0.8159138339473696
HEC-251,11404337,-0.8985576004471967
GSU,6505803,-1.4354147992291242
LXF 289,11404337,0.1273620702572638
SK-N-DZ,9936388,-6.025086835164752
PK-59,136227924,3.43326158684526
WM88,135875424,3.748879677238851
LCLC-103H,135875424,4.227127244707997
NCI-H2405,54618164,4.576696764939436
COLO 741,3689413,2.799435260821197
SKM-1,46943432,0.4553858331231263
NCI-H69,439501,-2.497311288560019
KMBC-2,10296883,4.242347433736866
IA-LM,36462,3.5803800151684384
KMH-2,3136844,4.953174257927024
NCI-H211,49836020,0.8643825091547783
OAW28,409805,4.888216855585461
MDA-MB-157,8515,2.4995790404865983
CJM [Human melanoma],9903786,6.367293868352352
SNU-503,selumetinib-GDC-0941 (4-1 mol-mol),1.4877260570474324
SK-OV-3,selumetinib-GDC-0941 (4-1 mol-mol),2.556628673081414
DoHH2,9936388,-6.050878325143338
EBC-1,sirolimus-bortezomib (250-1 mol-mol),-3.1620626490759633
SNU-840,262093,3.393401871162564
Hs 934.T,262093,2.035260189129304
SNU-869,12003241,1.357086277670327
786-O,409805,5.990992975175664
KMBC-2,54618164,4.620014952617177
Hs 729.T,135875424,4.346118730396158
B-CPAP,sirolimus-bortezomib (250-1 mol-mol),1.6590312282318416
JHUEM-2,6918878,2.764621675413101
BT 239,11485656,1.6389778224376736
Calu-3,sirolimus-bortezomib (250-1 mol-mol),-0.667685459302334
NH-6,439501,-1.820365577971014
COR-L279,5460769,2.2116692629451338
GCT,135423438,1.822480313844277
NCI-H520,148198,-5.585206831860286
NCI-H520,136227924,2.065702540466464
SK-MEL-5,8515,4.00227623893396
BxPC-3,tanespimycin-bortezomib (250-1 mol-mol),-1.7059064780517903
HEY A8,36462,2.5086693619029448
SUP-HD1,409805,3.5122766692776852
BT 228,9926054,2.418157139092261
YAPC,409805,4.253424942012428
A2780,JQ-1-carboplatin (1-1 mol-mol),-0.3248944310620366
HDLM-2,6610216,4.231283339415114
NCI-H1694,9927531,4.024250624925043
T-47D,136227924,3.374798567013006
BHY,9903786,2.1017831140065844
RPMI-8402,9927531,3.4344708783390856
Hs 839.T,selumetinib-GDC-0941 (4-1 mol-mol),3.521332428924413
THP-1,6918878,-0.4868610372990268
L3.3,sirolimus-bortezomib (250-1 mol-mol),2.0691121038567144
PK-45H,tanespimycin-bortezomib (250-1 mol-mol),-0.8772986942389263
OV7,11404337,1.1254553955818216
K-562,8515,4.039482215632923
NCI-H2286,5460769,0.0147592339119179
CW-2,sirolimus-bortezomib (250-1 mol-mol),1.6646573064439074
BT 139,44491742,4.209444035840443
HCC44,159324,1.9748678599967435
HCC-56,168313200,3.0468065774377338
SUP-T11,159324,0.229109625943877
SR,selumetinib-GDC-0941 (4-1 mol-mol),2.945554798995567
CAL-85-1,selumetinib-vorinostat (8-1 mol-mol),2.332419733999627
U-87MG ATCC,24180125,3.962930986053808
HOS,36462,1.2276704607974214
RPMI-6666,3689413,0.7706229516172245
SNU-620,JQ-1-carboplatin (1-1 mol-mol),-0.5250735139206945
LUDLU-1,46943432,3.590400948954701
LN-229,selumetinib-vorinostat (8-1 mol-mol),2.9963776796611015
HL-60,11404337,-0.9575342155378792
NCI-H1755,3689413,1.3270015579538552
WM1799,3689413,0.6160914431487012
DBTRG-05MG,36462,4.173854619503818
NCI-H2110,11404337,1.6337523371229576
HLF,168313200,3.4120776318454205
HT115,JQ-1-carboplatin (1-1 mol-mol),2.098973716553155
HCC2218,JQ-1-carboplatin (1-1 mol-mol),4.076746377800596
L3.3,selumetinib-vorinostat (8-1 mol-mol),2.710739742780381
HCC1195,100016,5.060252338886612
L-540,409805,4.181619305997671
Ri-1,36462,-0.3836251292851517
A101D,135875424,4.8786521946508214
BICR 31,9936388,2.7244047649519074
SCaBER,3689413,-2.276836963642964
Rh41,9911830,4.108812674081707
SW1353,selumetinib-GDC-0941 (4-1 mol-mol),2.4649613007554185
LoVo,selumetinib-GDC-0941 (4-1 mol-mol),0.7605582392782264
BT 416,3689413,-0.9545304181237728
A4/Fukuda,11404337,-2.650657466190433
HCC1954,148198,-1.209657619864023
Panc 04.03,135875424,4.739147054003967
KMM-1,6918878,2.377909122493346
ONCO-DG-1,107985,-2.464298331408582
SNU-46,selumetinib-vorinostat (8-1 mol-mol),3.202126820201843
SUP-B15,135398744,6.752582090660733
HCC44,9911830,2.2098918595222696
Hs 683,11485656,3.0003726107919437
OCI-M1,44491742,3.801673396413645
L3.3,44491742,6.349276489474054
SK-N-FI,11485656,1.359995170672745
KMS-11,159324,0.4321441091396028
DMS 454,9911830,2.118692548743365
TE-8,9926054,1.8785619758496184
BICR 6,9927531,3.2709369283144674
SaOS-2,44491742,4.263847553999534
OCI-Ly3,11485656,2.9823721346913654
KE-97,9936388,-5.867495812584186
HPB-ALL,107985,-2.867280224208332
SNU-869,100016,6.487538118719535
BT-549,36462,2.0708174288882075
HDLM-2,10322450,3.293303215923486
CHP-126,9926054,1.6835442403825218
K-562,135875424,2.7247406179323055
MCF-7,36462,5.1077442019933725
TYK-nu,selumetinib-GDC-0941 (4-1 mol-mol),1.6731134624767203
769-P,135875424,4.650591407681101
MOLM-13,54618164,3.841266236609366
TE-6,135875424,3.6628772269399192
COLO 320,148198,-6.470964602076055
H-STS,148124,4.085792664518574
DBTRG-05MG,selumetinib-vorinostat (8-1 mol-mol),3.184987086723066
COV644,136227924,2.3380958896938147
HOP-62,168313200,1.5949515806080656
SNU-620,26596,-1.49043613544065
SNU-1214,9911830,2.476886366604881
HEC-108,100016,6.393272881400893
Rh30,12003241,-2.0054573943466876
RD,262093,3.0387065040185264
Fu97,46943432,1.3928994026129526
AGS,6505803,-2.0321610426726364
HEC-1-B,135875424,4.054775379166637
SNU-840,tanespimycin-bortezomib (250-1 mol-mol),2.584361399969364
COLO 684,9926054,1.5779304975312065
NCI-H292,135875424,4.14052752249008
HCC1588,9936388,-4.959177530840856
DMS 114,136227924,2.8316140416519664
Hs 888.Lu,5460769,5.202141251599371
LN-18,6505803,-2.139737100228386
U-251MG,135423438,1.776157398246975
HT-55,9926054,1.864291830267701
SNU-213,44493528,4.322072480687394
JM-1,148124,-7.840698833354439
HuT 78,46943432,0.3707901357093127
OAW28,54618164,4.207465894202405
KNS-60,selumetinib-GDC-0941 (4-1 mol-mol),3.6071015552128873
HD-MY-Z,JQ-1-carboplatin (1-1 mol-mol),1.7743689460569436
ESS-1,9936388,3.356877818481439
BT 504,selumetinib-vorinostat (8-1 mol-mol),3.416857931230803
SF126,148198,-2.289398797231852
PE/CA-PJ41 (clone D2),262093,3.3360750662244443
JVM-2,439501,-2.3079985652377633
KHM-1B,3689413,-2.4012228391908783
Mino,24180125,1.2507747465119918
IGR-1,9903786,4.216869468062427
PaTu 8988s,9903786,1.8009975173036927
23132/87,selumetinib-GDC-0941 (4-1 mol-mol),-0.1204952013387844
SKM-1,168313200,4.186901063511942
A3/Kawakami,135875424,3.019357204965879
Kasumi-2,107985,-4.524149027848321
SKM-1,6610216,3.825535401377457
SU-DHL-10,9911830,2.8677867441941274
SR,8515,3.9218784416281975
SNU-1,49836020,4.400146563188995
HCT 8,6918878,2.9593846601011395
KYM-1,49836020,-6.165786834710826
WM1799,6610216,4.147204970842896
SHP-77,54618164,3.947626272795489
SNU-475,sirolimus-bortezomib (250-1 mol-mol),1.5218514057883192
P31/FUJ,10322450,3.023071845081992
COV434,409805,3.527199506174152
RL95-2,6610216,4.274118828365147
NCI-H520,44493528,4.24259211168764
MOLP-8,148198,-4.437033387624053
OCI-Ly19,135875424,3.926549898319096
TALL-1 [Human adult T-ALL],sirolimus-bortezomib (250-1 mol-mol),0.4525392365030144
U-118MG,409805,3.6083081108044497
G-402,44491742,3.86820580626592
NCI-H1355,54618164,4.22021081173676
Hep-G2,9936388,0.9252852669938214
BT 179,54618164,3.7942917299361105
NCI-H446,36462,2.3080332043222587
BT 147,6505803,-5.108349885338799
DB,12003241,-2.5818700415802107
TF-1,439501,-2.265040568492349
KYSE-30,10296883,3.7447664313518767
KMH-2,409805,3.8048240258679256
UM-UC-3,246676,5.7049600513092456
PE/CA-PJ15,9903786,2.2611792207171484
HPAC,selumetinib-vorinostat (8-1 mol-mol),1.7368980324290706
HeLa,9911830,3.0701846369034556
HCC1438,selumetinib-GDC-0941 (4-1 mol-mol),1.8999757097381424
IPC-298,selumetinib-GDC-0941 (4-1 mol-mol),-1.1184200059628775
TTC-709,135875424,2.6743897511272454
A-549,selumetinib-vorinostat (8-1 mol-mol),2.322163064753337
CAMA-1,6610216,4.829015970075941
K029AX,10296883,4.016071874543954
NCI-H647,8515,3.931635124559011
IMR-32,107985,-5.071647837163832
Daudi,9927531,3.2507934675389447
TT2609-C02,6505803,-2.0944052734627565
ST486,9936388,-7.5497220296798275
SNU-626,selumetinib-vorinostat (8-1 mol-mol),4.212223566347579
DU4475,9927531,3.2558531780718507
Detroit 562,100016,6.391000104824681
NCI-H889,135875424,4.039374159627762
HMCB,409805,5.980176460908731
G-292 clone A141B1,136227924,3.074698527992838
HEC-59,136227924,4.443118393205084
42-MG-BA,sirolimus-bortezomib (250-1 mol-mol),1.266614497912793
NCI-H522,3689413,-4.273368850016072
NCI-H647,135875424,4.395312958272854
NCI-H1650,135875424,3.5061044557480865
LS513,9926054,1.5640640769912204
KMS-28BM,54618164,3.643335143110872
Caki-1,6610216,4.408834249020041
CGTH-W-1,5460769,2.937857230001596
SW1990,9927531,5.3345214594202695
OCI-AML-3,49836020,4.587745933093821
U-937,135423438,1.73395278295497
COLO 829,11485656,3.3013884087788794
RCM-1 [Human rectal adenocarcinoma],409805,6.9502249218901975
COR-L95,100016,6.620829555802918
OCI-AML-2,148198,-4.39978868082379
BICR 22,44491742,3.912327775797625
A-253,12003241,0.3953648973902781
BT 239,439501,-3.505235897057165
OCI-AML-3,9911830,1.5756891476630688
OCI-Ly19,246676,6.051875422677845
PE/CA-PJ34 (clone C12),selumetinib-GDC-0941 (4-1 mol-mol),0.7203053018358525
NCI-H2291,sirolimus-bortezomib (250-1 mol-mol),1.1125015078342035
TE-8,9936388,-6.617390334695402
HCC2935,6505803,-3.078757042045483
Reh,136227924,1.9009503552795357
NCI-H1568,9911830,1.3917537385715242
HDLM-2,6505803,-0.3959336559510797
NCI-H841,135875424,3.023154313740163
Raji,6610216,4.035753851614817
SK-MEL-24,44493528,4.28603676822274
786-O,36462,2.9279083981584217
SU-DHL-8,54618164,3.0908319012602723
SF126,6505803,1.4927738710676783
KMRC-3,11404337,1.0527621044793514
NCI-H747,10296883,1.2461857502958518
PLC/PRF/5,168313200,3.731927316813972
42-MG-BA,24180125,3.7179190306480527
KMRC-1,6505803,1.455434702084088
NCI-H1869,selumetinib-GDC-0941 (4-1 mol-mol),2.116437467611717
NCI-H1105,107985,-2.481705593652425
SKM-1,6918878,-0.8378415751208989
Caov-3,36462,0.673348876480101
G-292 clone A141B1,sirolimus-bortezomib (250-1 mol-mol),-0.3022581749422651
M059K,54618164,4.134728683938071
MG-63,135875424,4.139194892831929
AN3-CA,6610216,4.1751650141546826
HSC-4,3689413,2.5472025828962055
HD-MY-Z,9903786,3.5223384929798187
Hs 766T,11404337,0.6729236116595668
SNU-601,36462,1.1449893209829207
BT-12,11485656,2.106070398144325
RD,246676,6.440301876830501
U266B1,135398744,6.53135676756175
U-937,10296883,3.442205161599926
NCI-H1838,49836020,4.844484842212348
JHOS-2,selumetinib-vorinostat (8-1 mol-mol),5.50185776695037
Ku812,148198,-4.150507844489635
GCT,9903786,3.1531512143319396
COLO 201,3689413,0.7393302797479664
HCC15,54618164,4.329878027642837
Li-7,54618164,3.841358647410796
AGS,11404337,0.6854213320992603
RPMI-8226,439501,-1.9239295318483216
PE/CA-PJ49,5460769,0.8323029326456293
NCI-H1092,tanespimycin-bortezomib (250-1 mol-mol),0.328880127360426
Kasumi-2,9911830,1.88551459110434
HCC38,100016,6.688694515924342
RL,9926054,1.8760180722442283
SW1783,11404337,0.7381457579106708
BICR 18,46943432,4.49639593671617
P3HR-1,36462,4.280628122452117
SK-MEL-2,439501,1.1166422747690987
KMRC-20,selumetinib-GDC-0941 (4-1 mol-mol),2.922820897966577
HCC1195,3689413,-0.7365828236328352
VMRC-LCD,44491742,4.573213718781489
SW982,9926054,1.795372121114862
MES-SA,9926054,1.7710161106499946
HCC2218,439501,-2.1463275405716495
PC-3,11485656,3.836663422003702
LoVo,262093,2.370412929490009
OVISE,9911830,4.830872688345326
SNU-407,136227924,2.9703344519672785
RERF-LC-A1,148198,-3.1102576281385654
SNU-182,9926054,1.7680094082282705
NCI-H1435,135398744,6.3008870427516115
TE-8,8515,3.692350191417914
Tm87-16,6505803,-2.793426888899639
B-CPAP,3689413,-2.370401360424748
CAL-51,9926054,2.2227862000004577
YH-13,9926054,1.834128888426512
KP-2,9927531,5.1844073401368735
MeWo,44491742,4.0764207569550255
KNS-81,9927531,4.88247851361275
TCCSUP,11404337,-0.4859326706611666
JJN-3,11485656,1.9215217079086016
NCI-H810,49836020,4.546134729481912
TUHR10TKB,6610216,4.052125763672336
NCI-H2081,136227924,2.7498424735477913
BT 245,246676,4.341306530425761
Malme-3M,9936388,1.1290902894019168
EFM-192A,54618164,3.960745971422569
ONS-76,selumetinib-GDC-0941 (4-1 mol-mol),-1.205136839893776
KM12,selumetinib-GDC-0941 (4-1 mol-mol),1.4045070472454428
RVH-421,sirolimus-bortezomib (250-1 mol-mol),0.2798149280233217
Hep 3B2.1-7,9903786,2.792162090587101
A2780,135875424,2.703796648613349
BICR 16,11485656,3.0485171549819476
HuCC-T1,439501,-1.791859675505955
HCC366,9936388,-5.702122369307378
YD-10B,100016,5.941622042216757
PLC/PRF/5,148198,-2.947936464140587
HuP-T4,12003241,-2.8459442311528154
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905
NCI-H226,159324,5.235188537951406
Kuramochi,36462,5.154140048373422
EN,3689413,2.688418705808367
SK-CO-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8128298123800823
EFE-184,sirolimus-bortezomib (250-1 mol-mol),0.9563190078492846
Reh,6505803,1.7551372132350431
KNS-81,sirolimus-bortezomib (250-1 mol-mol),0.8491294280424774
CAL-85-1,107985,-3.5267444048726215
SYO-1,168313200,2.736095144850066
HCC1937,5460769,4.797106987757637
HT115,262093,2.8442241689305123
SNU-245,selumetinib-GDC-0941 (4-1 mol-mol),-0.1076829246144878
Li-7,selumetinib-GDC-0941 (4-1 mol-mol),0.6490035918823776
HuH-6,107985,-3.2482974624876175
SaOS-2,6505803,-1.001039194104569
TOV-21G,6505803,-2.649430601885361
YD-38,100016,6.21667674155364
EPLC-272H,36462,1.6704265037574937
TCC-Pan2,11485656,3.231735678762206
OUMS-23,135875424,4.57705137123218
BT 416,148124,-5.33137477776155
Calu-3,9927531,4.58448758255864
CMK,24180125,3.476288444144944
SK-N-FI,148124,-5.991544192204867
Panc 02.03,6610216,4.56797737488032
HPB-ALL,tanespimycin-bortezomib (250-1 mol-mol),1.0478674895496405
H-STS,168313200,3.688822033835753
KP-2,135398744,6.663666573534304
SK-LU-1,159324,3.7934671922435914
Pfeiffer,100016,6.236222400968574
WM266-4,10296883,3.7855589365633584
NCI-H1703,148198,-3.5169860092327587
GA-10,JQ-1-carboplatin (1-1 mol-mol),-0.7456185194400317
JM-1,9926054,1.6867956204893688
EKVX,10296883,4.140951610899391
DU145,168313200,3.1229023319588363
SCC-25,sirolimus-bortezomib (250-1 mol-mol),0.9940787042699578
KHM-1B,selumetinib-GDC-0941 (4-1 mol-mol),-0.3982194737494156
Karpas-422,26596,-1.4945297758647662
SNU-878,36462,1.024756404830259
SIG-M5,8515,3.548062021757778
KP-3,6505803,-1.05905255098836
SNU-182,12003241,-2.036673656339672
COV434,148198,-5.709180459817414
T98G,107985,-3.0074244908782792
WM1799,54618164,4.23745707986816
HeLa,100016,5.8653655502295
DMS 79,3689413,-2.460389219665011
HCC1833,12003241,-0.598038454038546
G-361,sirolimus-bortezomib (250-1 mol-mol),0.933443297731252
SW579,135875424,4.01544080394069
HEC-1-A,11485656,2.952835409818289
MeWo,409805,5.880050900822264
NCI-H2110,5460769,2.6451142093153326
SK-UT-1,168313200,3.914325756565286
SEM,409805,3.7048315559445575
Mel JuSo,409805,4.551755026005568
NOMO-1,12003241,-0.5951695723430065
SU.86.86,9903786,4.655147385880342
HCC78,tanespimycin-bortezomib (250-1 mol-mol),1.9748974265856916
HEC-265,9936388,-5.092900256875076
KP-2,9926054,2.0579312242664645
2004,136227924,1.8982400348113204
LOX-IMVI,5460769,1.2475955137176375
A101D,sirolimus-bortezomib (250-1 mol-mol),0.247462078551585
Namalwa,44493528,4.097758002058851
GB-1,107985,-1.5886789717003875
UACC-62,selumetinib-GDC-0941 (4-1 mol-mol),-0.701178032611257
SNU-1041,159324,4.667459378229219
SNU-1076,6610216,4.3589064064708145
ALL-SIL,6610216,3.679901693613009
HPB-ALL,6505803,2.1919107783283573
Hs 688(A).T,439501,-2.959985011333181
HT-55,24180125,3.3828154090857288
SYO-1,46943432,-0.013424201476548
BT 245,3136844,4.20302568044611
COV362,9936388,0.426614716920504
TUHR4TKB,46943432,4.891108936063827
HCC1195,107985,-2.277898834430922
SW1417,135875424,4.272780059645497
JHH-2,135875424,3.057763367956565
OVSAHO,439501,-1.6237946984233838
CFPAC-1,selumetinib-vorinostat (8-1 mol-mol),3.6214251657468406
NCI-H2196,3689413,-2.371911217935783
OS-RC-2,439501,-0.684202622279705
IPC-298,9926054,2.387739594101664
SNU-119,3689413,-2.887862499697321
RPMI-8402,46943432,1.849232999724565
JHH-5,11404337,-1.7016316561461169
HuH-28,135875424,3.694475868133385
JeKo-1,107985,-3.6689778441734777
BT 482,9903786,3.918124147791562
SK-MES-1,11485656,2.7243488930071607
NCI-H1155,9927531,3.8709301895195023
NCI-H1650,107985,-2.270753589848381
HL-60,6505803,0.5284927754579164
HCC1195,9911830,3.5554387852718654
ML-1 [Human thyroid carcinoma],44491742,4.3341380025681175
Hs 294T,44493528,4.371769824264516
BT 330,tanespimycin-bortezomib (250-1 mol-mol),-1.5657589280340811
SNU-899,11404337,-0.8978205339796733
YAPC,262093,3.6115167721531343
OV56,135398744,6.336681474599488
OCI-Ly3,100016,3.877117461004623
SNU-16,selumetinib-vorinostat (8-1 mol-mol),1.7213135683170462
RVH-421,409805,3.9378453682817858
BT 330,168313200,1.8051222028456737
697,54618164,3.6802056089192106
CML-T1,12003241,-4.650247315633356
MV4-11,6610216,3.0151553142886844
HCT 15,tanespimycin-bortezomib (250-1 mol-mol),-0.1755556188950918
NCI-H1339,54618164,4.412872879489402
TE-9,148198,-2.1853005512510273
HT-1080,262093,1.0809900576610223
GI-1,107985,-2.483024326686008
SUP-T1,135875424,3.316622158258836
OAW28,44493528,4.631141764792384
HSC-4,12003241,-0.0373048915881231
SNU-478,54618164,3.7807583613099256
SK-ES-1,6610216,3.8025876712947944
MDA-MB-435S,44493528,4.3922375921749195
COLO 205,3689413,0.2425510566398385
JHOS-2,107985,-4.307159387799739
RPMI-6666,44493528,4.272159691282271
COLO 201,168313200,4.336574610328967
KMRC-20,136227924,3.298573049161518
CAL-12T,6610216,4.273060683121512
Ku812,54618164,2.681700331746246
MOLT-16,selumetinib-vorinostat (8-1 mol-mol),2.410769382861759
HSC-4,10322450,4.749470049467763
EB1,JQ-1-carboplatin (1-1 mol-mol),1.505411442976691
MOLT-13,6918878,-0.9704850754109594
P3HR-1,36462,4.280628122452117
COLO 699,159324,2.737921515065639
MeWo,3136844,4.111338143918321
HCC1143,9911830,2.6182666070844447
HCC1428,168313200,3.288386425250625
G-401,26596,-1.5666727843222663
BT 216,3689413,-0.8248802266685408
MDA-MB-435S,selumetinib-GDC-0941 (4-1 mol-mol),0.7675119040231712
CADO-ES1,5460769,-0.4724140531139457
OC 314,selumetinib-GDC-0941 (4-1 mol-mol),0.5636308108859065
RT-112,26596,-1.382463026117804
LNCaP clone FGC,135875424,3.855348592559951
JJN-3,6610216,4.182778929763247
AGS,409805,6.20500134764402
BT 147,9911830,2.6524389287493877
Lu-65,selumetinib-GDC-0941 (4-1 mol-mol),-1.6504739583037105
MOLT-13,12003241,-0.6419644689091649
KALS-1,3136844,4.737550704479588
WT2-iPS,12003241,-2.3723982156624057
HuH-1,439501,-2.8772683526572496
NCI-H1339,3689413,0.3064961832206241
NCI-H520,26596,-1.7163548151943342
SK-MEL-28,sirolimus-bortezomib (250-1 mol-mol),1.3552683647004444
HEC-1-A,12003241,-1.9132267433224897
LS513,tanespimycin-bortezomib (250-1 mol-mol),-1.0041137629262296
Rh41,409805,3.496757496558559
LC-1F,11485656,1.8871769166571817
5637,135875424,2.9776269402245092
SCC-25,100016,6.900174579464034
HCC1395,9927531,6.948950349672662
BICR 22,10296883,3.888864516393213
KO52,26596,-3.758446698642679
Namalwa,439501,-2.8468436546580524
SW48,9903786,0.6824641791663469
GOS-3,8515,4.692167574261379
AU565,11485656,2.0156354686346174
QGP-1,11404337,0.7683818583115465
SNU-1077,262093,2.74279505858148
MKN45,JQ-1-carboplatin (1-1 mol-mol),5.954362231550531
U266B1,54618164,4.486024855885345
IGR-39,9926054,2.0144252699344176
HCC827,tanespimycin-bortezomib (250-1 mol-mol),-1.554763152633591
Daudi,54618164,3.154466747848232
WM983B,9936388,-0.2926482048121987
Panc 08.13,9936388,-1.7608820575386173
KE-39,262093,2.516325504276674
DND-41,9926054,1.3861019613196697
NCI-H226,8515,4.767920255127791
DK-MG,tanespimycin-bortezomib (250-1 mol-mol),0.5926006673391784
MSTO-211H,9936388,-4.464575449065994
SNU-216,6610216,4.217598364125196
LS1034,9911830,2.3866368813346175
RERF-LC-Ad2,selumetinib-GDC-0941 (4-1 mol-mol),0.4804595733416271
HT-1197,8515,4.26553986516295
GCT,9927531,4.599543435598106
TCC-Pan2,6610216,4.233730029946295
BICR 56,selumetinib-GDC-0941 (4-1 mol-mol),-1.0561550719087085
786-O,12003241,0.5866804436375384
FTC-133,135398744,6.510037604259866
KLE,6918878,2.1026972133129616
L-428,262093,2.197551267633171
LS411N,JQ-1-carboplatin (1-1 mol-mol),1.929098606006951
PK-45H,24180125,4.426735459673925
SK-CO-1,3689413,1.2567954519757167
786-O,tanespimycin-bortezomib (250-1 mol-mol),0.0938204565808633
SCC-9,8515,4.77911141452934
SUP-M2,6918878,0.3628250934475796
MKN74,262093,3.405035629450505
NCI-H2171,6505803,-0.0596794204500112
SW48,136227924,1.7122170056378203
RD,3689413,-1.0823038646320762
JHH-6,11485656,3.907926018805903
OE21,6505803,-1.9429365414296416
OVK18,262093,2.4244937883691287
MOLP-2,5460769,4.105160520991768
DB,136227924,2.1225886217744376
DMS 454,9927531,4.138491843589823
JHUEM-2,JQ-1-carboplatin (1-1 mol-mol),1.384634873843588
MES-SA,tanespimycin-bortezomib (250-1 mol-mol),-2.9811279867981635
BT 286,168313200,1.66103693738852
JHUEM-7,36462,0.060815321002826
IGR-1,3689413,2.7517007326117957
HCT 8,148198,-5.465944443336747
KMRC-2,selumetinib-vorinostat (8-1 mol-mol),3.246916366131707
L-428,3136844,3.77587525238044
HCT 8,439501,1.4071558312094663
Hs 683,168313200,1.8001064604931507
MKN74,12003241,-0.9650452844715884
SW982,8515,3.1924163308331073
NB4,9926054,1.6278742802322663
OCI-AML-2,8515,1.7413193486313066
BT 232,sirolimus-bortezomib (250-1 mol-mol),1.5892274515835794
Panc 08.13,148124,-5.426526415917046
SK-MEL-31,9936388,2.306732151838548
CAMA-1,9903786,5.004529624345284
SW1088,107985,-2.686062802475412
T24,sirolimus-bortezomib (250-1 mol-mol),0.798518469796891
Hs 936.T,9903786,5.166198075920313
MCF-7,9926054,1.7310317924725227
MPP 89,5460769,6.230455153292042
Jurkat,44493528,4.481797817086125
MG-63,168313200,3.691285308934156
JMSU-1,44493528,4.427701991229088
TT,44493528,4.253407146513618
NCI-H1869,136227924,3.4575085361719955
SNU-840,6505803,4.055722811765136
KHM-1B,36462,-0.5615447034427615
VMRC-RCZ,tanespimycin-bortezomib (250-1 mol-mol),0.3038563935305308
BT 224,136227924,4.003699925469014
HEC-108,11404337,0.7883165010808656
CAL-78,tanespimycin-bortezomib (250-1 mol-mol),-2.747028808134876
YD-8,136227924,3.733712180219105
NCC-StC-K140,9927531,5.259562635251384
BICR 16,12003241,-0.754422743943259
KG-1-C,54618164,4.428583513385725
MOTN-1,10296883,2.890144008228283
COLO 205,159324,2.8774722055154704
SNB-75,10322450,5.848985655680984
Ki-JK,159324,-1.5316296354530343
PE/CA-PJ34 (clone C12),10296883,4.08655394492647
BT 440,44491742,6.048012757107985
NCI-H211,sirolimus-bortezomib (250-1 mol-mol),1.3707117645726492
Rh18,24180125,1.6950247634535058
KP-4,12003241,-0.2003950722684058
KNS-60,159324,3.3920518874305023
HEC-251,selumetinib-vorinostat (8-1 mol-mol),2.5885002243488153
NCI-H1395,100016,6.569605836811141
HuP-T3,135875424,4.261865095251217
RL95-2,JQ-1-carboplatin (1-1 mol-mol),1.5011912902975624
A-549,44491742,4.437272986024
COLO 201,100016,6.515418099212221
BT 482,6505803,-0.931790010731935
LNCaP clone FGC,12003241,-1.977151768552247
LNCaP clone FGC,3136844,3.761028710298216
JHOS-2,54618164,3.809859961366981
CAS-1,selumetinib-vorinostat (8-1 mol-mol),2.584768719119857
HuP-T3,11485656,3.0565489144797224
BHT-101,136227924,2.4401355841785173
BL-70,439501,-3.7904230490472623
NH-6,9903786,1.6690533510154009
FTC-238,6610216,4.327599165810429
NCI-H841,168313200,1.7438487882833134
TF-1,409805,5.960314574590496
OCI-Ly10,9936388,-5.832060635266597
Hs 852.T,6610216,4.289282312349925
MIA PaCa-2,49836020,4.16350045307359
SNU-1077,8515,4.803726365696702
Mono-Mac-6,44493528,3.657931267862179
HCC78,439501,-1.472903672264699
RERF-LC-Ad2,12003241,0.07971757119013
SR,148198,-2.916135396785668
HCC1428,selumetinib-GDC-0941 (4-1 mol-mol),5.009115635429041
OCI-Ly10,11485656,4.400930200004774
MDA-MB-361,6918878,1.8381888768147752
CAL-29,36462,1.6491569604201617
HSC-2,3689413,-2.0236874476208353
2004,100016,6.70935199674954
CHP-126,262093,1.44556631123722
KYSE-510,9936388,-2.6451183198904373
786-O,6918878,2.9222437996914716
SUP-T11,3689413,-2.394245997939745
BL-70,136227924,2.857298369944604
MCF-7,9911830,3.315374840346173
MKN74,12003241,-0.9650452844715884
JURL-MK1,54618164,4.131613316224029
IGR-1,6918878,-0.3191452202696077
Hs 688(A).T,24180125,2.8493410351508133
SNU-878,100016,5.516104284834857
Calu-1,selumetinib-vorinostat (8-1 mol-mol),3.8564467382040304
LC-1/sq-SF,136227924,3.5583860131764835
5637,159324,1.920461519181454
EC-GI-10,148198,-5.102000128684168
LN-18,46943432,2.786473052677047
RERF-LC-A1,5460769,2.531170153978
TTC-709,262093,1.587813672786524
SW1710,36462,2.141494652685398
HSC-2,12003241,-2.7433654243875214
KO52,sirolimus-bortezomib (250-1 mol-mol),0.090002603096776
647V,selumetinib-vorinostat (8-1 mol-mol),2.3605187203171987
Tm87-16,54618164,4.274519133447958
Hs 936.T,11485656,2.4154558200874803
NCI-H226,9926054,2.2620908490117526
JHUEM-1,135875424,3.0885966905905433
OCI-AML-3,9936388,-8.90406813186184
BL-70,107985,-2.6237617688158044
SK-N-AS,439501,-3.01819280603901
OVCAR-4,107985,-4.727068653630688
MOLT-16,409805,3.602378767851464
L3.3,262093,4.054875705556861
SNG-M,9926054,2.579798992981947
Kasumi-2,24180125,1.6711646659047346
CL-11,9926054,1.919128241871703
HOP-92,selumetinib-GDC-0941 (4-1 mol-mol),0.6606964721280018
NCI-H1339,9927531,5.416434112117517
WM266-4,135423438,3.754515663812223
BL-70,11485656,1.5979505669049718
KMS-11,11404337,-0.8094185492018079
EHEB,3689413,-1.930959129148268
BV-173,6918878,-0.1682703234169372
VMRC-RCW,12003241,-1.0941298808716429
COV644,49836020,0.1306983764226103
OVK18,11485656,1.7406304929162535
SW1088,54618164,4.072630032274273
CL-11,100016,6.945803371228119
MDA-MB-468,54618164,3.7873537253294582
A-375,6918878,1.993858594678216
P-STS,3689413,0.8859178339084445
Kasumi-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.6309006264211411
Hs 611.T,9926054,1.8280926290746755
SK-N-BE(2),10296883,3.8653649395268896
BV-173,168313200,2.966649127022457
WM793,54618164,4.258619603305177
NUGC-4,9926054,2.05156938319837
SK-MEL-30,9936388,2.3653955391527575
K-562,9926054,1.8612748023096723
MEC-1,11404337,-2.8975071038846023
HCC1419,135875424,4.5952897384359215
CAL-62,135875424,4.048990845421642
WM793,11485656,2.688663515558037
U-251MG,11485656,3.6122724638227184
KMS-11,sirolimus-bortezomib (250-1 mol-mol),-4.474522876358157
HCC1438,36462,1.679262377304474
VM-CUB-1,26596,-2.0768458829121745
PE/CA-PJ15,409805,3.811497133930035
LNCaP clone FGC,JQ-1-carboplatin (1-1 mol-mol),-0.8145893926012049
K029AX,11485656,3.468308407397126
HT-144,11404337,-2.6736353860165054
TE 441.T,26596,-1.4712296697044354
NOMO-1,148198,-5.33573798573566
BT 440,439501,-2.9388364994679614
BT 482,246676,4.047789712479496
PK-59,5460769,5.2141758944681635
BxPC-3,sirolimus-bortezomib (250-1 mol-mol),-0.2731425990324966
SK-MM-2,8515,4.243303565094017
ALL-SIL,tanespimycin-bortezomib (250-1 mol-mol),0.6461816419253308
NCI-H1694,46943432,0.9969320768499224
SF295,100016,6.949657377166824
CAL-54,46943432,1.4547387585116591
AsPC-1,44493528,4.313387127964929
Ishikawa (Heraklio) 02 ER-,136227924,3.2224664141246806
WT2-iPS,3136844,4.4939058831559535
BHT-101,46943432,2.878256091901955
SK-N-DZ,409805,3.6668852525503937
M059K,439501,-3.0131166353991703
RCH-ACV,36462,-2.5687954278265535
GDM-1,3689413,-2.3976693518494208
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793
SNU-1033,107985,-3.3872017086874924
TE-6,11404337,-2.253854386513332
SCC-25,168313200,2.150051154835275
DMS 114,107985,-3.855936859666903
MKN74,36462,3.612647213890312
SNU-685,JQ-1-carboplatin (1-1 mol-mol),2.807780609987689
KNS-42,168313200,2.6332995372243757
TCC-Pan2,selumetinib-vorinostat (8-1 mol-mol),4.508948185921673
HOP-62,10296883,4.184861943544038
SW1990,sirolimus-bortezomib (250-1 mol-mol),0.2169201029218291
Daudi,148198,-7.679285276133229
JVM-3,159324,-3.4640255837437333
BT 131,9926054,2.1358376599970397
HCT 15,6918878,2.7836536015959674
SNU-719,159324,3.1054428054736793
RCH-ACV,3689413,-1.349996625899334
MHH-ES-1,8515,3.021519312968192
A2780,9903786,1.372407357095215
SUP-T1,136227924,2.470227214750311
BT 504,6505803,-4.714346364333315
KYSE-520,54618164,5.079154008745419
Ci-1,6505803,1.2287490885597057
SF126,135875424,4.31417208102172
NCI-H1792,9911830,3.3043796692893923
SCC-25,JQ-1-carboplatin (1-1 mol-mol),0.0141568039533375
NCI-H520,135875424,4.041449952679746
SNU-449,5460769,0.9117409452183444
JL-1,6610216,4.5150955732362545
BT 231,107985,-2.768732072411436
SHP-77,selumetinib-GDC-0941 (4-1 mol-mol),3.697439866327475
NCI-H522,100016,6.692385014202011
SNU-1077,6610216,4.195845914467317
Lu-99,54618164,4.227320195350235
SK-LMS-1,26596,1.8216060443410544
NCI-H647,148198,-1.832862483065856
A-253,135423438,3.929129844415613
HeLa,107985,-3.0123177853339262
M059K,3689413,-2.3612434015729336
SNU-201,6610216,5.085362707909801
SNU-1272,10322450,4.07877256776116
SK-N-AS,9903786,2.5201816871089653
Ku812,9926054,1.5145588468111315
NCI-H2052,159324,3.5848490402306
BT 112,6505803,0.1257905254161033
RKN,11404337,0.6786980557761386
HCC1954,selumetinib-vorinostat (8-1 mol-mol),2.207566293158473
ChaGo-K-1,9927531,4.39504142130407
KP-3,9903786,3.3194843074548843
AGS,262093,2.7795414492690953
EN,262093,3.594484397034306
JHUEM-2,44484440,3.1148170237219475
OV-90,selumetinib-vorinostat (8-1 mol-mol),0.8269808058743753
ONCO-DG-1,262093,2.6022952770143197
OE21,100016,6.577886119924336
DLD-1,6610216,5.046668272670703
PK-59,selumetinib-vorinostat (8-1 mol-mol),2.306892423893395
SNU-1066,selumetinib-vorinostat (8-1 mol-mol),3.1459365881963293
CAL-85-1,11485656,1.9018323097644911
NCI-H1869,9903786,3.8309501172404734
PE/CA-PJ34 (clone C12),36462,2.153519991196826
HEC-6,tanespimycin-bortezomib (250-1 mol-mol),0.7644617965871396
U-251MG,6610216,4.237415282438965
JHH-4,409805,6.082410201762188
GSU,44484440,3.793984916615048
ST486,9926054,1.8361941441765457
Daudi,44493528,3.680262260756896
LS1034,168313200,1.9785972892481352
RERF-LC-Ad2,135875424,4.566580865948674
NCI-H2029,3136844,3.920956204498382
HT-1376,3689413,2.4091899536551264
A-673,49836020,4.096681472773702
T24,6610216,4.48789546353662
RERF-LC-MS,148124,-5.592640359076286
Kasumi-2,6918878,1.1877992835952844
HuH-28,11404337,0.2716572522655043
TTC-709,sirolimus-bortezomib (250-1 mol-mol),0.2718728202081833
KO52,136227924,2.4006650771153923
SF126,9911830,2.2004202096383194
P12-Ichikawa,46943432,1.0816569815891666
NCI-H1568,9936388,-8.53108348301746
NCI-H2196,36462,0.5304143478440299
SNU-C4,11485656,2.7013405303612408
KNS-62,10296883,4.284329668268845
TE-4,26596,-1.4080950714953673
JeKo-1,12003241,-2.1711036059300963
SK-N-MC,44491742,4.171908823838076
ONCO-DG-1,148198,-3.7879992500612407
HT-1080,439501,-2.2877487074012026
NCI-H322,selumetinib-GDC-0941 (4-1 mol-mol),1.023926311645034
TE-15,136227924,4.530652264188515
COR-L105,3136844,4.323289843330604
A-673,54618164,3.9765209939943857
DMS 273,10322450,3.6367733537116167
NH-6,6505803,1.7515572770987142
SUP-HD1,selumetinib-GDC-0941 (4-1 mol-mol),2.188403523917611
NU-DHL-1,148198,-4.718908672184396
JHH-5,tanespimycin-bortezomib (250-1 mol-mol),-2.9889336169985454
SNU-478,6505803,-0.3330598781077968
SK-ES-1,168313200,1.7624238003073756
SU-DHL-8,439501,-2.4804073416438626
CAL-78,9903786,2.899593269782219
U266B1,26596,-3.1243600455967906
GDM-1,10322450,3.191264659365354
CAL-51,409805,3.8515087112009656
RERF-LC-MS,sirolimus-bortezomib (250-1 mol-mol),0.955955259392996
BT 444,6610216,4.33218996136642
Panc 05.04,135875424,4.70222110000058
HMCB,selumetinib-GDC-0941 (4-1 mol-mol),1.81562386250498
NCI-H2085,159324,3.0275398658525785
COLO 800,262093,3.3147101233442196
SNG-M,3689413,1.102237357506899
SUP-B15,10296883,2.342173612428345
UM-UC-3,selumetinib-GDC-0941 (4-1 mol-mol),1.321826526721954
Peer,11485656,-0.7259490318952384
NCI-H2228,selumetinib-vorinostat (8-1 mol-mol),2.242438507763082
Ri-1,439501,-2.801888786170529
Namalwa,3136844,3.7255251235468143
SNU-398,11404337,-0.6882395076793462
253J,100016,6.267948749211356
T-47D,148198,-5.010352606662764
SW1088,262093,4.334823497952687
IPC-298,135875424,4.836826203485717
IGR-1,262093,3.048494446765652
U-CH1,JQ-1-carboplatin (1-1 mol-mol),2.2916861581051062
TUHR4TKB,439501,-2.4659071378458544
DU4475,148198,-7.890760961486606
NCI-H211,36462,-0.9711027054177612
Kasumi-2,36462,-1.2000537391874553
SK-MEL-24,3689413,0.3993824056710978
COLO 668,9927531,4.694789725560254
Panc 04.03,12003241,0.3752932920389255
SEM,148198,-7.106649826649242
KMS-20,tanespimycin-bortezomib (250-1 mol-mol),-0.2140039466554119
KP-2,10322450,5.99994747446592
LXF 289,6505803,-2.367756082461904
SNU-475,107985,-2.4628206364316005
JURL-MK1,44493528,4.152814926042147
AN3-CA,3136844,5.019620857220237
HGC-27,36462,-0.1990646362671453
VMRC-LCD,12003241,3.8307047822357343
SNU-387,8515,4.093986926326484
MM1.S,49836020,3.8296017324588942
Hs 852.T,6918878,0.9877817066386854
Ci-1,262093,2.7870589391035443
HMC-1-8,136227924,3.367197210687835
NCI-H810,6610216,3.5606323089389993
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384
SK-MEL-28,JQ-1-carboplatin (1-1 mol-mol),4.173721186553183
TCC-Pan2,46943432,2.922417635476058
VCaP,selumetinib-vorinostat (8-1 mol-mol),2.423309917251552
NCI-H2228,9927531,4.856676083567804
SW620,sirolimus-bortezomib (250-1 mol-mol),0.6778769985308863
Hs 888.Lu,439501,-6.314665191885066
U266B1,6918878,0.9201629454051308
OE21,54618164,3.767482528775002
OAW28,selumetinib-GDC-0941 (4-1 mol-mol),0.8148216272117433
HEL,24180125,3.3188099636510495
HPAF-II,sirolimus-bortezomib (250-1 mol-mol),1.6842797227364328
KYSE-450,262093,3.266752988649651
8505C,54618164,4.142090194837595
SNU-601,9926054,1.5128291451092608
PSN1,selumetinib-GDC-0941 (4-1 mol-mol),0.7617880642657375
LAMA-84,3689413,-1.3009180368872624
NCI-H1184,262093,1.9402045938209425
OV7,9936388,0.389883949605854
RPMI-8226,100016,4.270983790022636
NCI-H1755,tanespimycin-bortezomib (250-1 mol-mol),-0.7433958922894784
G-361,JQ-1-carboplatin (1-1 mol-mol),0.286360842929743
PK-59,11485656,2.1797490126169823
SNU-216,439501,-2.844909600692544
JVM-3,136227924,1.9937281150641608
HEL 92.1.7,5460769,3.8355782077499248
FaDu,54618164,4.2886892470468965
DAN-G,6610216,4.336631036034785
RPMI-7951,6505803,-3.4302306957343434
COR-L105,46943432,2.471907312248233
OCUM-1,439501,-1.255627556410841
SNU-668,148198,-1.6951870968907452
VCaP,100016,6.449384825808392
C2BBe1,9926054,1.888966029374552
SNU-81,24180125,-1.7131691030529954
LN-229,262093,3.033286890634207
DND-41,6918878,2.4367793174834507
REC-1,selumetinib-vorinostat (8-1 mol-mol),5.79386517083513
RMG-I,262093,2.363268635735914
Mel Ho,selumetinib-vorinostat (8-1 mol-mol),-1.2703640044537123
HCC95,24180125,5.4375658391597215
NCI-H647,tanespimycin-bortezomib (250-1 mol-mol),-3.1460893933580727
SNU-423,54618164,4.040713940867877
MKN7,44491742,4.213117229463602
DU145,3689413,-1.3535401671184424
M-07e,9927531,3.229988201288456
BT 245,26596,-1.3254238494846824
COLO 668,135423438,2.664391389217799
C2BBe1,10296883,3.913780393696494
TC-71,44491742,3.7748114564226407
LS513,24180125,2.1717772599454146
Peer,9926054,0.3844122788400798
IGROV-1,3136844,5.214591389089975
KMRC-1,36462,3.0698954920529324
8305C,3689413,-2.5688983672154575
MM1.S,262093,0.96316485237803
MDA-MB-453,148124,-4.8335014079709975
JHH-1,100016,6.434861287132587
NCI-H1915,6505803,-4.13754619223685
HCC1195,11404337,1.6211275323325096
UACC-62,148198,-2.3489315937571016
NCI-H460,9903786,4.057661845653794
TE-15,409805,5.7286558076606955
KE-39,9936388,1.1689372039333712
SU-DHL-1,262093,1.7952973078733698
AU565,JQ-1-carboplatin (1-1 mol-mol),2.695919157809604
MOLP-2,6505803,0.8225151705149113
SK-MEL-28,9936388,2.4934378473061902
LN-229,159324,3.086562742175474
KYSE-450,selumetinib-GDC-0941 (4-1 mol-mol),2.546868719199844
KMS-20,107985,-4.802194252756391
SR,26596,-2.2070280953319283
NCI-H69,26596,-2.134877782649339
ECC12,409805,5.778567326982414
GOS-3,selumetinib-GDC-0941 (4-1 mol-mol),2.3911305512377217
HCC1428,148124,4.22185803984092
HSC-2,9926054,1.7452128350759892
HuG1-N,5460769,5.358196013663695
639V,107985,-2.44668650004491
NH-6,135875424,3.8228230929419182
U-937,12003241,1.6522375422653783
KMRC-20,44491742,5.411645351023098
T-47D,100016,6.980531714745858
OE21,439501,-2.897438407377833
COV362,24180125,3.098482746662586
SW579,168313200,1.6746607195468155
CAL-148,selumetinib-GDC-0941 (4-1 mol-mol),1.314198336751646
CAL-54,148124,-0.1574179702231155
HOP-62,8515,4.458909571137292
MDA-MB-453,24180125,2.9500133631526477
647V,135875424,4.107222785717565
BT 179,selumetinib-vorinostat (8-1 mol-mol),3.4704732436334296
SNU-C2A,3689413,1.145907285408548
PK-59,11404337,0.8851709837592256
BL-70,6918878,-0.6389305360603534
NCI-H1092,168313200,1.6747772833697747
ST486,tanespimycin-bortezomib (250-1 mol-mol),-0.6822883440168558
NCI-H2110,100016,6.079052375839209
CAL-12T,54618164,4.192765891794065
MOTN-1,6505803,1.224860499211516
RKO,36462,3.4370564574699185
BT 330,439501,-3.680620250809701
KMRC-20,148198,-1.1031106323256945
GCT,6610216,3.8449912626290024
HuP-T3,46943432,3.2592232125577665
SNU-5,3689413,0.3799296763624849
OCI-M1,9927531,4.777784518044042
HCC44,100016,5.500199899639815
BxPC-3,36462,3.4182720226712457
BT 271,11485656,2.2293362300863016
Ku812,3136844,4.770484958270985
BT 440,54618164,4.177836021580234
PK-1,148124,-4.413253648153995
HOP-62,54618164,5.192278696523286
JURL-MK1,24180125,3.1743291213422373
A2058,selumetinib-GDC-0941 (4-1 mol-mol),0.6721412852797596
SET-2,JQ-1-carboplatin (1-1 mol-mol),-0.9059473366978348
NCI-H211,9903786,1.4038112191361545
SK-N-SH,409805,5.798286026067844
CGTH-W-1,136227924,3.107802787848976
SK-MEL-1,135423438,4.488053456325811
MDA-MB-468,5460769,3.9216030050456023
GaMG,136227924,2.741790754216058
EPLC-272H,sirolimus-bortezomib (250-1 mol-mol),-1.4049400380442874
SNB-75,selumetinib-GDC-0941 (4-1 mol-mol),0.9916175958844948
NCI-H1650,9927531,5.159202312794284
KYSE-150,44491742,4.452704490333977
HL-60,9936388,-5.148540194165726
CAL-148,11404337,0.0721234409222233
KYSE-410,148198,-1.166924431681682
NCI-H747,JQ-1-carboplatin (1-1 mol-mol),-0.0686546754719674
HCC1569,262093,2.630898961991999
NCI-H1666,148198,-1.1369965956899613
M059K,72199289,4.467934336193957
SNU-1272,9911830,3.883073952142102
BICR 56,9911830,3.637430453593334
T98G,11404337,0.3579674680524426
H-STS,439501,-3.713409181758543
BT 330,54618164,3.911280393833352
NCI-H2009,11485656,2.228831542035607
NALM-6,10322450,2.9761732504638103
SK-ES-1,54618164,4.268925362543446
PF-382,JQ-1-carboplatin (1-1 mol-mol),1.3162007106931592
NCI-H2110,10322450,4.394668434370401
C2BBe1,9903786,1.7742124050197758
KO52,10322450,3.562187913985661
KYSE-70,9911830,3.1951659700149886
UM-UC-3,tanespimycin-bortezomib (250-1 mol-mol),-0.0032411460887714
U-937,100016,4.26159584690163
M059K,9926054,1.7795727491270252
SK-UT-1,246676,5.689307282465742
SW620,11404337,-0.8120361907901654
OVCAR-4,11485656,2.719318989709532
MHH-CALL-3,10322450,4.0007371010331045
HT115,148198,-3.4561057287776653
Capan-1,11404337,1.6610188182670238
SW1990,107985,-4.22199587403486
NCI-H2172,409805,5.805224348451236
MKN7,3689413,-1.1623045029840038
MSTO-211H,9903786,1.212702371904443
Hs 729.T,3689413,-2.0906347621795076
HCC2935,tanespimycin-bortezomib (250-1 mol-mol),-2.9372994580333947
RS4;11,9911830,1.8582637769181332
A3/Kawakami,8515,2.8179142633064416
KYSE-510,3689413,3.0228627584183565
OCI-Ly19,107985,-4.415552151834645
Daudi,9926054,1.7776420054693636
OCI-AML-3,135875424,2.9827106176181735
COLO 792,10296883,3.769618463238052
SW1710,10322450,4.1954905662020305
BICR 22,49836020,2.6142262300183305
SaOS-2,24180125,2.5037581025896896
U266B1,3689413,0.1413723785410366
42-MG-BA,6505803,-4.6954878984778885
KNS-60,135423438,1.647918923583617
WM983B,148124,-4.219347286004686
Karpas-299,46943432,1.2059894220984688
SNU-601,tanespimycin-bortezomib (250-1 mol-mol),0.586889084570332
KCL-22,9926054,1.5140986246434818
SNU-216,3689413,1.0802163076061988
NCI-H446,11485656,1.965301254432185
A-375,100016,6.005492870785018
TE-1,54618164,4.286971927920475
HCC1588,136227924,2.6333776491111585
SEM,5460769,-1.0690415880949575
NCI-H358,44493528,4.323169379797207
KMS-26,136227924,1.9705002365993127
NCI-H1869,6610216,4.465976467686126
Raji,409805,3.871069859266368
SK-N-FI,11404337,-1.561187150233845
MOLT-16,26596,-3.5703441979693245
HCC1500,6610216,3.984830656845064
JM-1,11485656,1.6613246077420758
SNU-16,44493528,3.7043478102813543
BICR 18,12003241,0.2549770836209779
LOU-NH91,9903786,3.184012464559237
HCC1419,11404337,0.8171144747312442
Kasumi-2,5460769,1.467216518279754
KMS-11,135875424,3.01982766210033
HCC78,12003241,-1.0292430450952663
MKN1,159324,3.5689159418986005
KE-97,11404337,-2.252102327608571
CJM [Human melanoma],100016,5.681499096329984
SCC-4,6505803,-0.4511168499672106
COR-L279,8515,3.7910565659393254
NCI-H929,135875424,3.2591057623275006
CAL-27,148198,-3.939292770233757
H-STS,3689413,-4.4758570940331515
NOMO-1,6505803,0.1224616163714439
SW1116,10322450,3.761194873514236
HEC-59,148198,-3.009683743491751
MDST8,26596,-1.25574590011264
HSC-2,36462,1.805398470141545
SNU-466,159324,2.142776155886243
IGR-37,36462,1.327331458277256
Panc 02.03,9911830,3.8856260346392903
Mino,9911830,1.0503076614334173
Panc 04.03,439501,0.3022334331499904
TE-10,9903786,3.070607136357089
YD-8,9927531,5.007831795650313
PK-45H,12003241,-0.6609061403409452
Mel JuSo,9936388,1.578964606957719
PE/CA-PJ15,26596,-1.1054075726167758
253J-BV,159324,4.026452181971724
G-361,54618164,3.8947838668805272
Hs 578Bst,262093,2.4258150356441277
Karpas-299,6505803,-1.557594922161658
MDST8,262093,2.389063867163299
P3HR-1,6610216,4.758792166812945
LP-1,12003241,-0.1215623944522291
MEC-1,9936388,-8.61875613599576
ONCO-DG-1,26596,-2.0057166886721625
KMH-2,3689413,-1.7619354335242607
BT 271,12003241,-0.5875601678545488
HEC-1-A,10322450,3.4172941541878705
OE19,9936388,2.0659697731662083
LoVo,11485656,1.8604760547282393
IST-Mes1,439501,-2.4971864822052767
KYSE-70,11404337,0.2060464556058333
Reh,9936388,-7.618651347698478
HuP-T4,sirolimus-bortezomib (250-1 mol-mol),1.161558608864497
Caki-1,439501,-1.3714154371315346
Jurkat,JQ-1-carboplatin (1-1 mol-mol),0.5557917412854158
SW1088,159324,3.165882485712232
NCI-H1563,439501,-2.9827403425963492
SNU-1214,11485656,2.376217579776436
Li-7,100016,6.9157107863456915
IST-Mes1,10296883,4.238957650390159
SK-OV-3,9903786,2.611217845094376
CJM [Human melanoma],selumetinib-vorinostat (8-1 mol-mol),4.115485086300489
SET-2,3136844,4.073170521818995
LK-2,8515,4.21224929070005
LS123,24180125,2.6195509654232665
HCC1395,11485656,2.290865171040868
BT-20,selumetinib-GDC-0941 (4-1 mol-mol),1.9366034216750805
NCI-H2085,168313200,2.9031279315038954
SK-MEL-5,107985,-2.7442566338787473
SUP-T1,168313200,3.8217155223423
KM12,9927531,4.5473811141762965
BICR 31,168313200,4.293337148285007
SNU-398,246676,5.025344941549461
MIA PaCa-2,262093,3.1147038686055812
IGROV-1,9903786,1.7387584479757865
NCI-H841,136227924,2.950651455010232
SNU-182,44493528,4.330541683560017
BT 179,168313200,2.3040060201960073
OVCAR-8,36462,3.6790944167016097
T24,24180125,4.53885129509785
RPMI-7951,12003241,-0.9511728924240472
NCI-H838,54618164,4.282467198837469
Mono-Mac-1,8515,3.2918667240053643
CML-T1,JQ-1-carboplatin (1-1 mol-mol),0.6334590834009667
PSN1,8515,3.9314106629194017
RERF-LC-Ad2,9936388,1.1598877099292195
KYO-1,409805,5.008777152204713
UACC-257,12003241,-1.8114895383547025
HT-1080,9911830,2.5405256134571044
P12-Ichikawa,9936388,-6.7424079460419435
NCI-H2110,11485656,1.6105476919050796
Panc 04.03,selumetinib-vorinostat (8-1 mol-mol),2.824320658243333
PC-14,11485656,2.0369141609233656
PE/CA-PJ15,selumetinib-vorinostat (8-1 mol-mol),4.124369885528516
Becker,135875424,4.35709039626534
KG-1-C,12003241,-2.4512871070373476
Hs 683,tanespimycin-bortezomib (250-1 mol-mol),-2.2425112205370388
MV4-11,262093,1.4019245337963713
SNU-C1,44491742,3.3879999967260717
BT 428,6505803,-2.216718160472342
SNG-M,44491742,4.516771250419383
BV-173,9911830,-1.2786691567817767
SK-N-AS,5460769,4.709590087634428
BT 159,44491742,4.231002554874911
SNU-899,6505803,-0.0802623134971481
KYSE-150,100016,4.009775484830176
JHUEM-3,9936388,-3.506110274235372
EM-2,selumetinib-GDC-0941 (4-1 mol-mol),-2.656123106456353
BICR 18,6918878,2.2131285944192607
TE-5,54618164,4.06864256728215
COLO 829,135875424,4.104169116255948
CHP-126,8515,3.6293613784004815
IGR-1,8515,4.0894264165501895
JHH-6,9926054,3.460826847853425
HEC-59,tanespimycin-bortezomib (250-1 mol-mol),0.4869715963462457
MOLM-6,3689413,0.3128747542373787
HCC1500,9936388,-2.5304598124234365
CHP-126,6918878,0.7634426694698396
KMS-18,9911830,2.6183763953009023
Pfeiffer,107985,-4.631435651721851
697,246676,4.276106546265392
KMM-1,409805,6.5114621307755
KNS-42,9927531,5.582016236081196
BT 422,168313200,1.7894114416227225
NCC-StC-K140,44491742,3.703030524506224
MM1.S,9936388,-7.097218801181761
CA46,8515,3.648186715161825
647V,46943432,2.2252821644532816
Daoy,3136844,4.220433979575126
SNU-5,409805,3.988167342407501
HDQ-P1,3136844,4.339027020759005
SNU-16,49836020,4.5096990404507125
NCI-H1299,135875424,3.7950147310792257
NCI-H1355,409805,5.032584793280894
VM-CUB-1,44493528,4.312275176745317
NCI-H1568,409805,3.8387714265583592
HCC1833,136227924,3.0159379881399895
BT 444,6505803,-3.5785929274286694
SHP-77,26596,-1.5620029042215733
NCI-H2126,11404337,1.7929049534978918
NCI-H1155,262093,2.304592796713043
BT 228,136227924,3.2498510190278314
OCI-M1,selumetinib-vorinostat (8-1 mol-mol),1.952041230338225
NCI-H1755,159324,3.419106148632872
HeLa,5460769,5.484643109222549
TE-14,9936388,-5.01118425035393
ME-1 [Human leukemia],JQ-1-carboplatin (1-1 mol-mol),0.2037061432721303
TUHR14TKB,107985,-3.513276749954187
NU-DHL-1,11485656,2.738678590842112
U-937,5460769,3.0065623514388298
NCI-H2196,135875424,2.980052195607556
COV434,11485656,1.9147698543097105
DMS 273,107985,-4.548014092027974
BT 145,36462,-0.4946142525250538
SNU-886,tanespimycin-bortezomib (250-1 mol-mol),0.3789441066781652
SU-DHL-1,49836020,5.336381428124731
KMS-18,36462,2.0376871774276557
JeKo-1,135875424,3.073704073284497
Becker,54618164,4.063586417108196
HMCB,136227924,3.0347930044007643
JHOM-1,100016,6.419236010839144
BC-3C,11485656,2.025268186046356
JHUEM-3,9903786,2.091612721233031
HuT 78,10322450,2.3335862951913726
RPMI-8226,44491742,4.60819314657813
HuP-T3,6505803,1.3238670991795596
LS123,9911830,3.2919668415302565
SYO-1,9926054,1.4051151618362918
NCI-H2081,12003241,2.480414390654569
KP-3,12003241,-0.3092638329597765
VMRC-RCZ,6610216,4.14448682308937
Hs 746.T,9911830,2.0393711728362742
Rh30,135875424,2.415792825604233
TF-1,3689413,-2.3947116127493797
BT 147,9936388,1.2294480842266318
UM-UC-3,9926054,2.187616038354346
SF539,148124,-5.79726265481526
UM-UC-3,9911830,3.528897912762674
OCI-AML-5,JQ-1-carboplatin (1-1 mol-mol),0.5116033389333992
RPMI-6666,6610216,4.196045243172535
SNU-46,9903786,2.745048797484884
JHOC-5,11485656,3.0312189412234622
COV434,100016,6.159872289007743
NCI-H522,9926054,1.815484319665427
Hs 888.Lu,135875424,4.614690828514689
NCI-H146,46943432,1.2283557348915184
KYSE-510,selumetinib-vorinostat (8-1 mol-mol),3.1641046161129376
SEM,12003241,-3.075217153076431
KATO III,439501,-0.4584208934437059
NB1,9903786,2.052998466280315
BT 231,246676,5.655367787950382
TE-9,tanespimycin-bortezomib (250-1 mol-mol),-0.7055515782179059
Caov-3,11404337,1.105594084873841
Calu-6,159324,1.441030904225
HuG1-N,10296883,3.840828409406213
YD-10B,409805,3.5619928536153775
Hs 940.T,136227924,0.9830608526546036
Tm87-16,409805,3.644885872826904
SNU-8,100016,6.375529183181613
MOLT-13,44493528,3.6363745725597663
PaTu 8988t,9926054,1.9241127892750265
IPC-298,36462,1.8042428421244965
A4/Fukuda,12003241,-4.192136354440014
MeWo,selumetinib-vorinostat (8-1 mol-mol),0.3610205668495764
SCC-9,107985,-2.37702169012632
A-204,sirolimus-bortezomib (250-1 mol-mol),0.1160777276351835
TE-9,6918878,4.020269827065172
JURL-MK1,9936388,-6.026953880051591
KMS-20,246676,4.441835225578849
SK-BR-3,54618164,4.481980343250785
NCI-H23,11485656,1.2913107211319887
KMS-12-BM,136227924,1.841540408480291
PE/CA-PJ41 (clone D2),135875424,2.9357060771459245
NCI-H146,439501,-3.5641402563292393
SNU-216,148198,-4.857755213358989
SNU-182,135423438,0.1698643444011356
SK-MEL-2,3689413,2.4030655110444767
NALM-6,159324,-2.145978270745669
MKN1,9936388,1.1004986908741188
SW1088,5460769,2.7590684048589025
SNU-1214,54639024,4.425030534008987
HLF,selumetinib-GDC-0941 (4-1 mol-mol),3.676368121214341
NCI-H520,439501,-2.5978412941351405
U266B1,11485656,1.9579580018826064
SNU-61,11404337,-0.7844361329588494
Calu-3,tanespimycin-bortezomib (250-1 mol-mol),0.4939757205414833
NCI-H1694,100016,6.457618599357896
OCI-M1,9936388,-5.157124392155609
BT 164,selumetinib-GDC-0941 (4-1 mol-mol),1.5214027789841535
SW982,12003241,-0.7831418604360746
SW948,9926054,1.8406028662949705
NCI-H1694,5460769,2.288070088951681
DMS 79,54618164,3.1024825189466005
NCI-H1339,6610216,4.6247766816350495
UO-31,JQ-1-carboplatin (1-1 mol-mol),1.475282337781019
OCI-Ly10,100016,6.418038918193145
B-CPAP,tanespimycin-bortezomib (250-1 mol-mol),1.6177879591056448
UM-UC-1,9911830,0.2097316778170632
HD-MY-Z,24180125,4.121222391282799
EFO-27,24180125,3.663788732934096
NCI-H1755,9903786,1.073033240421295
RKO,6610216,3.958403220086871
JeKo-1,44493528,3.836571201329888
KMRC-1,148198,-3.0121915653316953
RERF-LC-A1,54618164,3.9982996694871424
RVH-421,168313200,2.8621224678697903
HCC1395,9903786,3.009593050669707
K-562,36462,1.3855340321895664
A-549,107985,-1.903643524605076
U-937,36462,-0.0459361343740989
HT-55,tanespimycin-bortezomib (250-1 mol-mol),-1.2155769519281892
HEC-151,3136844,3.785721585050869
A-549,JQ-1-carboplatin (1-1 mol-mol),5.034765556590292
SK-MEL-30,sirolimus-bortezomib (250-1 mol-mol),1.4325338004264097
EBC-1,36462,1.5329334165812265
AML-193,262093,1.541807961893536
NCI-H2444,44491742,4.369311972266699
HMCB,135875424,3.5183087899290686
JMSU-1,148198,-4.3097725771524225
OVTOKO,439501,-1.8305159910800708
NCI-H2172,10296883,3.8919469305692256
PE/CA-PJ41 (clone D2),409805,5.090011413594482
SUP-M2,49836020,-3.0340639982218898
HCC1588,49836020,4.436779912961811
EHEB,3136844,4.591447211361851
HEY A8,tanespimycin-bortezomib (250-1 mol-mol),-0.6734038900503383
MG-63,11404337,1.2234517903826516
KMS-18,tanespimycin-bortezomib (250-1 mol-mol),0.4216929170783136
CAL-54,3689413,-3.5113381718602756
SK-N-MC,9911830,0.996799882730039
A-549,11485656,2.1977599259975764
PK-59,9911830,2.647954789959704
RERF-LC-Ad2,5460769,6.029186520623905
NCI-H647,11485656,1.881364727029594
HEL 92.1.7,54618164,3.7534010848013626
SNU-119,107985,-4.156641254925639
TALL-1 [Human adult T-ALL],3136844,3.4484103501110415
VM-CUB-1,9926054,1.9231906197166304
SET-2,136227924,2.6175155289445646
JM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1559529879995699
OE21,9927531,4.992848693668257
LOU-NH91,107985,-2.204555775629559
A-172,3136844,5.731928020646654
PL-21,3689413,-0.2817982428361766
RPMI-8402,159324,-4.775028439509436
NCI-H2009,136227924,2.9896301065010933
HOP-92,9936388,1.480575569609934
KMS-20,10296883,2.054648014794474
HEC-1-B,409805,5.9664773850261055
DB,9903786,1.8629742307315609
A2780,44491742,3.4077888459991774
KNS-42,44491742,4.252498617041353
Ki-JK,409805,3.598242312387121
ESS-1,6610216,4.607428871946369
ML-1 [Human thyroid carcinoma],selumetinib-vorinostat (8-1 mol-mol),1.7610539005616883
LMSU,selumetinib-GDC-0941 (4-1 mol-mol),1.8803724999664797
IMR-32,9926054,1.7425604419011955
NCI-H2141,54618164,3.5839160777119723
SF539,selumetinib-GDC-0941 (4-1 mol-mol),1.3644945034252027
SNU-213,9926054,2.110529432598139
GCT,11404337,-0.3437943087587521
HLF,44493528,4.4251404257348295
NCI-H522,107985,-4.282222583037789
CAL-29,44491742,3.7928020727090392
Hs 936.T,409805,5.094755228809154
TC-71,439501,-2.5028085406649336
OE33,11404337,0.6160671156841868
KMRC-1,135875424,5.075329697898493
KE-39,54639024,4.382341904180532
LOX-IMVI,tanespimycin-bortezomib (250-1 mol-mol),-2.013401423677256
UO-31,148198,-4.317632208433169
BT 359,11485656,2.534841639455838
K029AX,3689413,2.968023656376896
J82,148198,-3.1437568832553837
KYSE-180,selumetinib-vorinostat (8-1 mol-mol),4.1823671735531835
COLO 201,12003241,-1.3508897145637075
SNU-719,11404337,-0.3522965671167558
OV56,36462,2.307029600595231
Jurkat,26596,-2.6358007271857216
HEL 92.1.7,8515,3.031750348813886
NCI-H292,sirolimus-bortezomib (250-1 mol-mol),1.4329016074897702
SNU-489,9926054,2.706160270050288
AU565,439501,-2.8703859168743384
HCC38,135875424,3.1024594516018453
NCI-H1092,selumetinib-vorinostat (8-1 mol-mol),2.4548144613596885
UM-UC-3,12003241,-0.2552051516294621
NCI-H1184,54618164,3.853145757284716
CAL-54,9903786,1.6300874124823186
MFE-296,3689413,0.1325691008190123
RPMI-8226,148198,-2.569854341665414
HGC-27,9911830,1.4787770441539565
TE-10,409805,3.752318426383352
OCI-AML-3,148198,-5.6942586662557035
TE-8,136227924,2.7469773037217715
NCI-H1869,262093,3.2234761574881485
SCC-4,3689413,-0.212283545233458
KCL-22,tanespimycin-bortezomib (250-1 mol-mol),-0.2876767287286612
OV7,JQ-1-carboplatin (1-1 mol-mol),4.300342052298617
T98G,439501,-1.9696613143180952
HEY A8,11485656,2.178163900753691
OVSAHO,107985,-2.879970343748397
OCI-AML-3,JQ-1-carboplatin (1-1 mol-mol),-1.7736109395797492
NCI-H460,107985,-2.632533954936978
VMRC-RCW,24180125,2.498362315316048
PE/CA-PJ49,44491742,3.950119634705539
OCI-AML-3,11404337,-2.717957747989526
JVM-3,107985,-5.208204796904964
EKVX,10322450,4.528299789057068
AMO1,439501,-2.703410930799938
SNB-75,sirolimus-bortezomib (250-1 mol-mol),1.678317962717081
Toledo,9936388,3.05226126712226
Lu-99,9903786,2.034349953938994
PK-1,136227924,2.8943441164421633
HEL 92.1.7,6505803,1.0440378201694858
BT 333,136227924,4.6219554593863075
SNU-C1,11404337,-1.600990625985275
NCI-H1573,135423438,5.2743221635386215
UACC-812,9936388,-5.022392750910281
KMS-20,148198,-4.371887061655697
TE-1,6610216,4.2679140249391505
HuH-6,selumetinib-GDC-0941 (4-1 mol-mol),2.3732024399993965
NCI-H810,54618164,3.7149211791922543
MCAS,36462,1.655496509759999
FTC-133,107985,-2.14591043360211
Hs 766T,sirolimus-bortezomib (250-1 mol-mol),-1.9217809600428275
RERF-LC-A1,selumetinib-vorinostat (8-1 mol-mol),2.1105956202148346
C2BBe1,3689413,0.1296061414739377
SNU-478,6918878,1.340354197188372
KO52,9911830,0.3090306906252232
TT,sirolimus-bortezomib (250-1 mol-mol),1.7489880165366345
LN-18,9927531,5.697950654725697
OVISE,sirolimus-bortezomib (250-1 mol-mol),0.3208269840941957
L-363,selumetinib-vorinostat (8-1 mol-mol),2.56044642347113
SNU-503,9926054,1.9244850158263864
BT 416,8515,1.3533271204830115
SNU-C1,36462,2.395230491502765
JHUEM-1,3136844,4.104089180564857
KP-3,tanespimycin-bortezomib (250-1 mol-mol),-0.1312023090499479
NCI-H1563,selumetinib-vorinostat (8-1 mol-mol),4.426949691687728
TCC-Pan2,36462,3.2804805767376197
HOP-92,12003241,-2.2936384439521156
SK-HEP-1,5460769,6.10306620405049
KE-97,135875424,3.346245315555186
SK-N-SH,9936388,-5.065644908322296
KHM-1B,9926054,1.3720275885206477
IMR-32,6918878,1.5583958621376863
FU-OV-1,24180125,2.037807307003979
SNU-466,9903786,3.45397809087946
VM-CUB-1,136227924,2.7643713240945016
NCI-H1915,54618164,3.9716628355262777
BT 340,262093,2.384282781054805
OAW42,11485656,1.8505528524867976
TUHR10TKB,24180125,2.8782335603201665
BC-3C,148124,-4.411439012775604
IMR-32,selumetinib-GDC-0941 (4-1 mol-mol),2.0130210869415515
RVH-421,26596,1.0810327973270226
RT-112,selumetinib-vorinostat (8-1 mol-mol),2.1628521495611333
8305C,8515,2.895902676854517
BHY,5460769,2.8101975648917468
NCI-H747,44491742,4.012258870504445
RCH-ACV,11404337,-3.4886710255299516
JM-1,6505803,0.12933264701109
NCI-H520,12003241,-2.710304641181941
T24,6505803,1.3138000670292382
SK-LMS-1,148124,-4.355018265532959
SK-N-MC,9926054,1.7404893912673354
NCI-H2023,9936388,2.0021755277076045
DV-90,sirolimus-bortezomib (250-1 mol-mol),0.1354476911070701
Hs 294T,148198,-2.1277510633920325
BT 428,11404337,-0.9400136442546092
SF295,49836020,5.953375339581455
Panc 08.13,36462,3.423383845506473
NU-DUL-1,10322450,3.4880509453639763
HCT 8,107985,-4.208540258416988
UO-31,11485656,2.1661292847689944
RD,148198,-4.957696360654166
OV56,168313200,3.853424001484558
CCK-81,5460769,-0.0536611992608542
NCI-N87,107985,-3.2122311985508136
MOLM-13,409805,3.504188648592109
NCO2,11485656,2.116269191877006
BT 232,tanespimycin-bortezomib (250-1 mol-mol),-2.012927947463912
A2780,168313200,1.7543183926879495
MKN45,136227924,3.646033724215572
P31/FUJ,11485656,1.9746673234827223
COLO 201,136227924,3.2878786819809105
NCI-H508,54618164,4.137087157011227
COLO 201,selumetinib-GDC-0941 (4-1 mol-mol),0.0601925657233566
HL-60,54618164,3.9340481964964336
RT-112,sirolimus-bortezomib (250-1 mol-mol),0.4814883462366654
8-MG-BA,439501,-0.5992510337528919
HT,54618164,3.74446726264799
KMRC-3,selumetinib-vorinostat (8-1 mol-mol),3.1024559431165937
OCI-AML-2,46943432,0.5250106522086783
SNU-C5,9926054,1.8417265889744416
CA46,9903786,1.650432742323398
ES-2,135398744,8.06870751291861
PE/CA-PJ41 (clone D2),3689413,2.5059514962832536
23132/87,135423438,4.4665628389477305
SW1116,54618164,3.73631090457485
NCI-H1944,262093,3.0559716202604834
YD-10B,107985,-2.948727836915783
HPAC,54618164,3.204433172015927
HGC-27,9903786,1.5115157472800849
YD-8,54618164,4.2297332581599525
NCI-H520,selumetinib-vorinostat (8-1 mol-mol),2.5250196264642835
DMS 79,5460769,3.0772238606557623
OAW28,439501,-0.9322268226633188
COLO 678,9936388,0.9023900644309476
CML-T1,selumetinib-vorinostat (8-1 mol-mol),2.04753807538672
COLO 684,262093,1.418781406629004
MOLM-16,9903786,-0.0890634921772537
KMRC-1,selumetinib-vorinostat (8-1 mol-mol),4.1266329667576915
SBC-5,11404337,1.1992857421773124
BICR 6,11485656,1.8767182695378195
MFE-296,135875424,3.004641901934104
CAL-29,246676,4.336236168449078
HT-55,11404337,0.898087242487133
MOLT-16,44493528,3.7613597484696104
KMS-20,100016,6.235059528000449
Malme-3M,168313200,1.6999895311998603
P3HR-1,44493528,4.479492051657015
ES-2,54618164,4.408028245984097
ML-1 [Human thyroid carcinoma],11485656,3.567697107596816
DBTRG-05MG,135398744,6.409074750923468
OCI-M1,100016,6.862784368685653
JURL-MK1,9911830,-2.0665605271093357
NCI-H211,409805,3.643232317573376
MDA-MB-415,6505803,-3.148015366392549
THP-1,26596,-4.239434805167959
KATO III,3136844,4.0824286598426935
EM-2,44491742,3.7753697950117897
SNU-1076,36462,1.8413818217522735
NCI-H1299,409805,5.9960995888447925
NCI-H23,9926054,1.8354921761885392
LOU-NH91,12003241,-1.4006618643370652
TE-14,9926054,1.5943832140078456
MDA-MB-453,9936388,0.6028011486270662
KYO-1,11404337,-0.4735869494306794
EN,12003241,3.248318270429482
NCI-H1792,11485656,2.6862672312545586
Hs 839.T,9936388,3.1884497736912567
JJN-3,8515,3.783800889557933
BT 245,6610216,4.100969243175901
NCI-H1184,tanespimycin-bortezomib (250-1 mol-mol),-0.120544891510118
CAS-1,tanespimycin-bortezomib (250-1 mol-mol),1.4677187949031796
BT 216,148198,-4.022421369072414
KNS-60,9903786,2.981782520240843
HCC15,3689413,0.3467742153458734
KP-3,439501,-2.4441073658124837
SNU-46,11404337,0.6593840830544361
A-204,9903786,2.6800363782821517
DND-41,49836020,1.1250375058635431
HSC-4,148198,-2.795908666323494
HuT 78,44491742,3.833204810123411
BT 498,135423438,1.8216974125096568
KNS-62,409805,6.135262881771345
RCM-1 [Human rectal adenocarcinoma],135875424,4.234717543087367
A-375,sirolimus-bortezomib (250-1 mol-mol),2.0398206768525475
KMS-26,36462,-0.4512101792241657
Malme-3M,9911830,2.489874332588209
22Rv1,107985,-3.2649317078671984
COLO 800,6918878,3.4592533865452006
Ci-1,6610216,5.011861477554625
HMCB,9903786,3.962700823971229
NCI-H2286,168313200,3.816538366273192
NCI-H1355,9911830,2.640098012656491
TT,JQ-1-carboplatin (1-1 mol-mol),3.4641930949375572
JJN-3,sirolimus-bortezomib (250-1 mol-mol),0.0133563437119215
P3HR-1,24180125,2.923923284516129
CCK-81,6610216,3.772274031548382
Karpas-299,439501,-2.5701669510398717
RPMI-6666,49836020,4.712616665171358
SiMa,26596,-2.340944971406374
NCI-H1915,439501,-4.1452565317565995
PSN1,11404337,-0.8573645663798306
NCI-H2085,9926054,3.027383511126382
MPP 89,11404337,-0.8971916884586333
HCT 116,9936388,2.1629557808045146
Panc 04.03,9903786,4.611047286699123
JVM-3,11404337,-0.5913580396426641
SK-LMS-1,9926054,2.9005897081408833
KM12,439501,-0.9697085854354284
SU-DHL-10,selumetinib-vorinostat (8-1 mol-mol),2.662660898832206
HEC-6,12003241,-1.1839534104512932
BICR 6,49836020,4.408429630205201
CW-2,100016,4.445901991176778
KYSE-140,12003241,-0.6057431237522657
SNU-C5,262093,2.527934317013551
YAPC,6610216,4.2275333940091215
COLO 668,148124,-4.465196721579442
Panc 10.05,148124,-2.064207075816084
Panc 04.03,9911830,2.4999304852863404
DB,11404337,-1.658875879170345
SF268,136227924,2.8034077121566967
HLF,26596,-1.3271956114296155
HuNS1,262093,2.5146440588932397
SNU-503,11404337,-0.7009485730992275
SET-2,9911830,2.246088546927402
Hs 688(A).T,11404337,0.289109562279099
NCI-H460,9936388,2.3098343611543415
P31/FUJ,439501,-2.3575947617146475
CMK,135875424,3.145736210165476
HCC2218,9936388,0.977315225187753
DMS 273,148198,-4.27913692458833
OVCAR-4,6610216,5.074160315502063
CAL-85-1,135423438,4.043372499873488
JHH-4,168313200,3.853941558159315
NB4,107985,-4.9939102669296025
HT-1080,135875424,3.167289548700629
HOP-92,5460769,4.612763799526671
8-MG-BA,9903786,3.978061546376923
SW982,6918878,3.508716013504012
SNU-8,9926054,2.0095672828148636
BT 232,12003241,0.7689860927775146
BT 145,11485656,1.8093295586372804
HT-1080,6918878,-0.0881364191088538
ECC10,100016,5.627610035010204
Pfeiffer,136227924,1.7936916860357504
BV-173,135423438,-1.0531729027332817
PLC/PRF/5,3689413,0.4443196233363375
HCC2935,36462,4.359275755872679
HCC1428,10322450,3.77316482135935
HCC95,11404337,-1.0962465907307095
CW-2,11485656,2.601974992122327
FTC-238,44493528,4.472163529420613
OE19,100016,6.21408400033578
G-401,tanespimycin-bortezomib (250-1 mol-mol),-1.7315974865132566
MFE-296,9936388,-7.084516673626579
NCI-H1395,selumetinib-vorinostat (8-1 mol-mol),2.147255996625455
NCI-H841,36462,0.9930050489592408
MOLT-3,135875424,2.964820433196679
SNU-738,12003241,0.0747510600230264
Karpas-422,9926054,1.7787061620357676
RVH-421,262093,2.8806904491125
COLO 684,selumetinib-vorinostat (8-1 mol-mol),2.6955916888531304
T98G,54618164,4.528778720409905
ONCO-DG-1,9936388,-5.057642902396516
NCI-H2029,9903786,4.7445314067007
TOV-112D,148198,-4.684933210891632
SW579,selumetinib-vorinostat (8-1 mol-mol),2.4107277098290782
KE-39,44493528,4.79040409668691
COV644,9903786,3.8438435409952456
Mono-Mac-6,6610216,3.2864580018643452
NCI-H1105,44493528,4.252977962816797
NCI-H1666,135423438,1.706411429493964
TOV-21G,9911830,2.632871994542491
LNCaP clone FGC,8515,4.149767079879017
Hs 611.T,12003241,-4.3632527403619425
SF268,11485656,2.1720991191644994
Hep-G2,409805,4.627773602187177
DMS 114,36462,2.3990046572200803
U-87MG ATCC,135875424,4.458869499205082
Panc 04.03,10322450,4.721553837851545
CAL-54,107985,-3.8206342608889856
DMS 114,10322450,4.614293219898761
CCF-STTG1,148198,-4.129311374884182
KE-37,9903786,1.3543500174719385
LK-2,9903786,3.191424869539257
U266B1,24180125,1.6976262238565638
SK-MEL-28,selumetinib-GDC-0941 (4-1 mol-mol),1.495892975780676
IGROV-1,6918878,1.6706182189896102
KYO-1,9911830,0.3076786264076178
SNU-61,sirolimus-bortezomib (250-1 mol-mol),1.753090501474884
LCLC-97TM1,12003241,-0.8351557307101188
JHOC-5,sirolimus-bortezomib (250-1 mol-mol),1.676278524948005
SNU-1079,135875424,3.1645684861148977
SCC-4,12003241,-1.1287847624263156
BHY,selumetinib-GDC-0941 (4-1 mol-mol),0.2537821037586068
HuT 78,10296883,2.429678266579514
HT-144,107985,-3.4210569798385864
COV362,9903786,6.486394788749974
Namalwa,9903786,1.5886639412240358
F-36P,6918878,-0.3157331643976424
NCI-H508,8515,4.121757487402849
NCI-H69,12003241,2.7316245717871572
NCI-H2405,5460769,3.951574866457585
SK-N-AS,11485656,1.7301696835910343
BT 139,54618164,4.290643622410761
KYSE-30,3136844,4.38425468524212
MOLM-13,439501,-2.531564352317227
COLO 684,6610216,4.066976905700023
NCI-H2452,3689413,1.184555113675537
BT 340,148198,-3.6521537693808654
ML-1 [Human thyroid carcinoma],11404337,0.3501599152959295
ACHN,262093,3.108023323173393
ONCO-DG-1,6505803,-0.2819077176711598
Mel Ho,9903786,4.6138306230888615
MFE-319,3689413,0.3953423105508483
COLO 680N,9926054,2.740733080202674
TE-5,6610216,4.181469364811624
PF-382,262093,0.5149344400111652
KYSE-70,107985,-3.298359335305578
BT 112,54618164,3.5492837733522205
HuH-28,49836020,4.5831032591173635
NCI-H2286,148198,-0.7964524113963312
MOLM-6,11485656,1.973328141098863
HCC1588,9927531,4.588881343798492
HCC38,262093,3.049385257949274
YD-38,6918878,1.9544943666312664
BICR 6,9926054,1.8719413430769756
SNU-1033,6918878,2.3543358775294845
KE-39,54618164,4.766262408385177
NCI-H1341,36462,0.7775762591226743
Hs 888.Lu,selumetinib-GDC-0941 (4-1 mol-mol),2.177806274579951
SW579,136227924,2.120211379000796
RL95-2,24180125,2.972100845265481
DB,5460769,1.8834181213891803
SK-MES-1,10296883,3.8789679823498178
Sq-1,9936388,1.5257442738884122
CAL-85-1,9911830,1.7649505016171554
NCI-H1563,6610216,4.011992180782097
TALL-1 [Human adult T-ALL],159324,0.6712531731090338
JHH-5,11485656,1.7028166663809423
SYO-1,135875424,3.5152559775635
PLC/PRF/5,9927531,3.33785239114395
Karpas-299,49836020,-1.2149928929897504
SNU-869,10296883,4.255396033988242
SK-MM-2,selumetinib-vorinostat (8-1 mol-mol),-0.2857263715636989
RKO,168313200,3.1169425006108455
NCI-H2291,409805,4.599417888514884
VMRC-LCD,9903786,1.8330708335593808
HH [Human lymphoma],8515,3.942777456860918
SNG-M,JQ-1-carboplatin (1-1 mol-mol),1.0442661112179723
GP2d,JQ-1-carboplatin (1-1 mol-mol),1.3751792778879013
YAPC,9936388,2.1810367621372095
SU-DHL-10,tanespimycin-bortezomib (250-1 mol-mol),0.050214335602148
SW1353,136227924,3.029116785491403
Rh18,44491742,3.876019031257375
SF295,148198,-2.5868327776728517
AGS,5460769,2.317513443937506
HSC-2,135875424,3.0509908073629397
Daudi,409805,3.686040208403983
OPM-2,JQ-1-carboplatin (1-1 mol-mol),-2.077921094958442
KYO-1,12003241,-5.7976599099380595
GMS-10,9926054,1.955397909013321
HOP-92,JQ-1-carboplatin (1-1 mol-mol),4.25217637860204
NCI-H1869,439501,-1.575584272947446
RMG-I,9936388,2.101682867932538
NCC-StC-K140,sirolimus-bortezomib (250-1 mol-mol),-1.963369351991784
JHOS-2,44493528,4.374607827213095
SUP-T11,100016,5.673603064365157
OCI-Ly10,148124,-3.653061072186916
UACC-812,sirolimus-bortezomib (250-1 mol-mol),-0.7676605385666967
ACHN,107985,-3.025937225373497
NCI-H1869,135875424,4.489996634847175
HeLa,sirolimus-bortezomib (250-1 mol-mol),2.2283701197426553
GaMG,tanespimycin-bortezomib (250-1 mol-mol),-0.9299125293643992
OCI-M1,262093,1.0880796533665364
MOLM-13,selumetinib-GDC-0941 (4-1 mol-mol),-1.09695682780189
GB-1,6610216,4.739230652843282
CAL-78,44491742,4.7670188278775605
HDLM-2,11485656,1.650668651442868
EHEB,11404337,0.0364567319098325
DB,44491742,3.5309759894848747
CAL-29,12003241,-0.9586511485623302
HOP-62,12003241,-2.147728480634193
SNU-1076,9936388,-5.0107279938232185
Panc 03.27,5460769,1.9093660486325057
COLO 680N,24180125,3.9685709218959744
BL-70,tanespimycin-bortezomib (250-1 mol-mol),0.1795536899591847
Hep 3B2.1-7,262093,2.5027011818139964
P12-Ichikawa,11404337,-1.993052837563161
HPB-ALL,439501,-2.479146853758179
G-361,107985,-3.212600988667039
Kasumi-1,6505803,0.4376823954906434
U266B1,168313200,3.7842669184175497
BT 147,54618164,4.134127896254606
PE/CA-PJ41 (clone D2),selumetinib-GDC-0941 (4-1 mol-mol),0.5865157800426535
CAL-33,5460769,2.348968888608987
BT 139,10322450,4.915425697373417
253J-BV,11485656,2.0873911665192555
YD-8,159324,3.1492291636894416
NCI-H522,selumetinib-vorinostat (8-1 mol-mol),2.6916205553530843
LOX-IMVI,9911830,1.9996336712614449
HCC44,10322450,3.2615133519838775
NCI-H2110,8515,3.3908091407293433
MOLM-16,439501,-2.4166934958345476
HuCC-T1,11404337,-0.917560199382238
CAL-62,9926054,1.583748031587333
HCC95,6610216,4.197174673248092
MOLM-6,135875424,3.809731266515376
SNU-407,54618164,3.677398235586724
SCC-25,6610216,3.3967716099500604
T24,262093,3.3703165306256353
MES-SA,9911830,2.0754479009679065
SW48,12003241,-0.9746028071684796
NUGC-4,107985,-2.8695226927077604
NCI-H1299,selumetinib-GDC-0941 (4-1 mol-mol),0.1290372531898008
GB-1,6505803,1.9427567614251149
RPMI-8226,12003241,-0.708602453849348
RT-4,tanespimycin-bortezomib (250-1 mol-mol),-1.2603421044397636
LS180,3689413,1.3392854552239355
L-1236,6918878,0.8693121041015153
VMRC-LCD,3136844,5.056632986858395
KLE,159324,3.6720597167388
Hs 934.T,3689413,-2.375941767618157
IGROV-1,107985,-2.8971910842184516
Kasumi-1,3136844,4.276559588738789
NU-DUL-1,9911830,2.1462587269693225
HCC1569,JQ-1-carboplatin (1-1 mol-mol),1.570304655964314
MOR/CPR,9936388,-5.6462813856837055
HCC827,24180125,3.832444407587902
Mono-Mac-1,10322450,2.242206847932455
BT 440,11485656,2.455280972559295
BT 286,107985,-3.490112295441736
OV56,9903786,4.181691762553772
NUGC-4,159324,3.728787065585916
CAL-33,135398744,6.573384587063474
KMS-11,409805,4.522377485375502
NCI-H2081,3136844,3.846689018483167
NMC-G1,24180125,3.2827632569676433
RMG-I,159324,2.9156763368001477
HCC202,3689413,-1.588009861739516
TC-71,10322450,2.6904194400167207
DND-41,6505803,0.5178331109157311
NCI-H747,107985,-4.6715942201014125
SNU-182,9903786,3.6716358007160546
BxPC-3,11404337,-0.6361724208993981
HCC366,148198,-3.0667828762214344
KMS-11,selumetinib-GDC-0941 (4-1 mol-mol),1.0292581351367205
IGR-37,54618164,4.309961080908924
MOLP-8,tanespimycin-bortezomib (250-1 mol-mol),0.0565968388812305
MDA-MB-157,12003241,-1.4339892472843776
SNU-1214,12003241,-2.886982661469118
EM-2,100016,3.5566389909433913
SNU-738,36462,3.2633116796246715
NCI-H1693,24180125,1.2211030322641976
SK-N-BE(2),selumetinib-GDC-0941 (4-1 mol-mol),-2.409093744965772
KO52,11404337,0.1772123930911338
JHUEM-2,selumetinib-vorinostat (8-1 mol-mol),2.576668042411364
A-498,tanespimycin-bortezomib (250-1 mol-mol),1.6557393213217402
KYSE-520,135875424,4.420553116763078
HCC1588,100016,6.591658390404969
RCH-ACV,44491742,3.725167954137364
MG-63,135398744,6.808455799902383
TOV-112D,10322450,4.283005252404589
WM983B,409805,3.828493612521517
NCI-H1563,136227924,3.549094897051017
K029AX,sirolimus-bortezomib (250-1 mol-mol),0.2512522437134671
KMS-12-BM,tanespimycin-bortezomib (250-1 mol-mol),-0.6230177375781689
NH-6,11404337,-1.1373922103777243
DMS 79,24180125,1.5282453938940843
SIG-M5,409805,3.8770489658245344
HCC1171,9927531,5.509897026708257
SW1463,6505803,0.5252870082270547
NCI-H1341,tanespimycin-bortezomib (250-1 mol-mol),-2.8449301183923756
U2OS,8515,2.063485731700501
NB1,10296883,3.4933227717672337
2004,9911830,0.791169368139958
SJSA-1,6505803,0.5726906025627778
SUIT-2,9911830,3.581224696062468
MDA-MB-231,409805,5.172988734165277
5637,selumetinib-GDC-0941 (4-1 mol-mol),0.4079577317339777
HCC38,6918878,4.595452272806682
TF-1,6505803,0.7719508977741311
L-428,9936388,-7.639006974415921
BT 145,439501,-4.642543329116397
KG-1-C,tanespimycin-bortezomib (250-1 mol-mol),1.8442829762863937
HCC2218,262093,2.308676672701105
Granta-519,6918878,0.9437787040623058
HCC95,107985,-2.9954438316062784
NCI-H2171,46943432,3.4065574915710735
HGC-27,8515,2.5882195628771565
OCI-M1,148124,-5.179396495011338
OCUM-1,tanespimycin-bortezomib (250-1 mol-mol),-1.6786100630480447
NCI-H1734,9926054,1.950289426848977
OVISE,262093,2.7343448368987597
Kasumi-1,262093,0.9096443237318556
NCI-H1355,tanespimycin-bortezomib (250-1 mol-mol),-4.485986367397168
M-07e,tanespimycin-bortezomib (250-1 mol-mol),-0.2341108641615783
U266B1,sirolimus-bortezomib (250-1 mol-mol),0.0143822479563884
Capan-1,12003241,-1.403867722449874
PaTu 8902,24180125,3.5735575491444505
SK-MEL-2,sirolimus-bortezomib (250-1 mol-mol),0.4660061968632925
A-549,9903786,1.8644448309659765
NCI-H2081,9926054,1.7325996665522785
SCC-25,11404337,-1.9627814938837227
RKO,107985,-4.24085601271806
KYSE-510,11485656,2.507694679939137
NCI-H841,sirolimus-bortezomib (250-1 mol-mol),0.0818724348323602
SET-2,9903786,0.1058309934713531
NCI-H322,12003241,-0.9727084564838948
SW1088,tanespimycin-bortezomib (250-1 mol-mol),0.2648421366318154
P3HR-1,sirolimus-bortezomib (250-1 mol-mol),0.1161782637204882
NCI-H2030,262093,3.6307250181599215
NCI-H2009,36462,0.0033291412741449
NB4,26596,-4.43915063636903
SK-MEL-28,409805,5.67996042379304
Calu-3,246676,5.532559634665407
BT 428,100016,4.306836909333982
OCI-M1,JQ-1-carboplatin (1-1 mol-mol),0.7435952415619963
JM-1,107985,-4.195149425063274
U-CH1,12003241,2.634808409336574
HMC-1-8,8515,4.643530157234318
SK-CO-1,107985,-2.728069079888901
KMRC-2,262093,3.029643780288338
BT 112,148198,-3.0030353997640074
DK-MG,JQ-1-carboplatin (1-1 mol-mol),1.3379136622287715
Fu97,26596,-2.255904398728495
MKN74,148198,-2.653452729835883
769-P,148198,-2.315494485063685
NCI-H2081,tanespimycin-bortezomib (250-1 mol-mol),0.018908734219335
CHP-126,selumetinib-GDC-0941 (4-1 mol-mol),3.8559663060343
JM-1,3689413,-3.612287026066889
CW-2,9903786,2.9588284510461733
PK-59,9936388,2.2614163852650377
SW1573,10322450,3.835483834832597
SNU-308,24180125,4.244524360791015
UM-UC-3,11485656,2.116231508741626
OCI-AML-5,12003241,0.3941324977706439
KMS-11,10322450,3.512225559181566
HH [Human lymphoma],100016,3.957825935624259
GMS-10,439501,-2.5226384823579404
BCP-1,9926054,1.6337686711618178
GA-10,10296883,2.032033381288912
MKN74,44493528,4.689150119305487
BT-12,5460769,4.230264663253868
NCI-H1694,6610216,3.5634403823031975
HCC1806,selumetinib-vorinostat (8-1 mol-mol),4.002360886332026
CAS-1,24180125,2.814372663438922
NCI-H69,136227924,3.1937315471147443
IA-LM,11404337,0.4340662777154989
KMS-28BM,44491742,3.645458914971546
COR-L105,148124,3.589067174421039
ONS-76,11404337,-0.4259392266769182
KO52,JQ-1-carboplatin (1-1 mol-mol),0.6520623811208981
BT 216,selumetinib-vorinostat (8-1 mol-mol),3.701652605226817
TCC-Pan2,6918878,3.085713515012725
UACC-62,262093,0.8846336077087198
NCI-H520,168313200,1.818196575131949
KE-37,8515,3.0439645130974906
ONS-76,44493528,4.396938069944904
NCI-H1341,135875424,1.697371790785142
HEC-6,sirolimus-bortezomib (250-1 mol-mol),1.9105485577838577
MSTO-211H,JQ-1-carboplatin (1-1 mol-mol),2.423353722828544
VCaP,9926054,1.7541172082533985
PE/CA-PJ41 (clone D2),54618164,4.303600867099711
NCI-H1105,3136844,3.656140616492221
YH-13,148198,-2.7695139562786526
Raji,136227924,2.5188827267380116
Hs 852.T,135875424,3.670536454912576
NCC-StC-K140,selumetinib-vorinostat (8-1 mol-mol),0.7044083601205671
GA-10,11404337,-3.9267202398834167
HCC1588,3689413,0.6550602760333641
Hs 683,262093,3.4514070525670295
SNU-869,8515,5.009412536897277
Panc 04.03,3136844,4.698465140769799
CCF-STTG1,168313200,3.710540265594596
COV644,9936388,-1.581655589979093
AML-193,409805,3.6159664447279583
DMS 273,44491742,3.7307306463602545
TF-1,6610216,3.918529921901587
NCI-H508,selumetinib-GDC-0941 (4-1 mol-mol),1.363383946626654
EB1,selumetinib-GDC-0941 (4-1 mol-mol),0.2218139267104855
Ishikawa (Heraklio) 02 ER-,439501,-2.4484029207577347
BL-70,44493528,3.7970898660168584
SNU-423,9927531,5.196680575825113
SKM-1,409805,3.7093603817382337
DB,10296883,3.486914708564097
ESS-1,8515,4.728832630346152
DMS 114,9903786,5.060139909585821
KMRC-1,44491742,6.09620831621162
GB-1,439501,-2.3945114258909532
C2BBe1,11485656,1.765877240742798
KMS-12-BM,9927531,3.2870919606414963
PL-21,6610216,4.06640166284154
HPAC,439501,-1.2049246371580666
BT 245,9936388,0.9041726045525886
CAL-33,8515,3.894510124825054
HT-1376,sirolimus-bortezomib (250-1 mol-mol),1.0351777976040455
MHH-ES-1,409805,3.617894256902542
OS-RC-2,selumetinib-GDC-0941 (4-1 mol-mol),1.8729257102095325
NCI-H1581,JQ-1-carboplatin (1-1 mol-mol),3.147849134537928
G-361,26596,-1.652088739985509
MOLT-13,73707440,5.68984628441443
SNU-387,24180125,3.6779507392233017
RKO,148198,-2.1467795088860875
ACC-MESO-1,sirolimus-bortezomib (250-1 mol-mol),1.905625687431691
BT 145,9911830,1.6824084137272743
ALL-SIL,36462,-1.376242093473402
AGS,6610216,4.185010509359766
NCI-H1869,36462,3.1749992742870923
P-STS,6610216,4.215676656862813
HT-29,262093,3.4460135622894263
MDST8,439501,-2.351670240427255
HCC1954,6505803,-2.3098961788546655
G-292 clone A141B1,6610216,4.8384725678373055
HEL 92.1.7,26596,-1.1995167561269164
REC-1,12003241,3.6312404592907614
NCI-H1395,9903786,3.8864807174358984
SNU-878,3689413,0.601904749344492
Hs 578T,9926054,1.6885826482167057
KMRC-3,6610216,3.658221932699825
HSC-4,159324,3.192829599869501
Hs 888.Lu,3689413,-2.4401760719127092
YD-15,9903786,1.471025688701345
T-47D,selumetinib-GDC-0941 (4-1 mol-mol),3.2531063352612697
SW1417,JQ-1-carboplatin (1-1 mol-mol),0.7027994901214438
HLF,12003241,-1.5273612308967348
CAL-51,11404337,-1.4033364127444676
TT,12003241,-1.2151389854631975
SK-N-AS,6610216,4.189892588331561
HEC-251,46943432,3.087973517815583
NCI-H1355,44491742,3.8267579721093905
OVCAR-4,148198,-2.4399206848241852
LP-1,6918878,0.994044861292223
BT 139,9903786,4.553274987644657
HeLa,135875424,4.463353648372455
OVCAR-4,135875424,4.627520209049134
Calu-3,135423438,2.2441987111134254
SET-2,409805,5.152205992309063
BT-20,tanespimycin-bortezomib (250-1 mol-mol),2.8367182462251788
SK-LMS-1,9911830,2.533802245803789
WM266-4,24180125,3.8729057396991062
HCC366,44491742,5.047439553601353
COLO 205,44491742,4.914749097396915
NCI-H1155,sirolimus-bortezomib (250-1 mol-mol),0.0856236991825952
NCI-H2172,6610216,4.169971132764112
HEC-151,9926054,1.821769205783168
HCC1438,12003241,-0.2782249625748692
CAS-1,36462,2.348698215891486
SW1783,44491742,3.6997355499837217
CAMA-1,409805,5.823044999026108
WSU-DLCL2,11485656,1.973652823958906
JMSU-1,11404337,-0.9331464485977649
SW579,8515,3.4248666995365085
NCI-H2286,9911830,2.040869356534873
ChaGo-K-1,262093,3.038007559777189
SK-LMS-1,10322450,5.260294901094195
NCI-H889,9911830,3.240123701287177
SNU-620,9903786,1.530835439194961
HCC366,6610216,4.78977524933946
CA46,409805,3.3808362620175187
A2780,11485656,1.5628347007454235
COR-L51,26596,-2.461438053418328
COLO 684,100016,6.373471933627605
SW1088,selumetinib-vorinostat (8-1 mol-mol),3.839668411135048
SF295,selumetinib-GDC-0941 (4-1 mol-mol),3.1244208578209736
NCI-H929,3136844,3.56413576716979
NCI-H747,148124,-2.0882502485249788
23132/87,6610216,3.886794888295395
DBTRG-05MG,5460769,5.967153987898797
OCUM-1,24180125,3.1846560803491575
TCC-Pan2,JQ-1-carboplatin (1-1 mol-mol),1.852597236843256
LOU-NH91,selumetinib-vorinostat (8-1 mol-mol),2.951111508603088
CJM [Human melanoma],168313200,4.263181152618082
SUP-T11,JQ-1-carboplatin (1-1 mol-mol),1.338159132216547
OAW42,9936388,-0.5306764798725707
HuH-28,36462,5.296756264251177
NCI-H1755,9911830,2.70191525352941
NCI-H2342,9903786,5.089610325302681
647V,10296883,3.904352101938312
M-07e,6505803,0.1015429750426806
DoHH2,36462,-4.28984156699345
COLO 205,12003241,-1.1256209046349093
WM266-4,5460769,5.368369623882124
LOU-NH91,9936388,-6.294191236399446
Mono-Mac-6,5460769,2.7333685745073457
SUP-M2,5460769,0.4100409038325726
ES-2,selumetinib-GDC-0941 (4-1 mol-mol),6.130354899135342
HCC1937,6610216,4.815854784432885
HCT 8,11404337,0.7757331501446172
SH-10-TC,44491742,3.905889235687173
23132/87,136227924,2.929197271565677
DAN-G,12003241,-0.4522104330137063
OAW28,107985,-3.5497769626209217
MIA PaCa-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.2888147143095668
SW1088,9936388,2.2762478176067504
JVM-2,3689413,-3.874282045367449
JHUEM-7,JQ-1-carboplatin (1-1 mol-mol),-0.0092802597518256
MKN1,11485656,3.044092336546056
VMRC-RCZ,36462,4.480481617354075
COLO 668,54618164,3.5292451402005818
P-STS,168313200,3.851827102868452
CAL-51,439501,-2.444412450902406
BT 444,selumetinib-vorinostat (8-1 mol-mol),2.9884692374196744
OCI-AML-3,3689413,-2.4390268193517275
SCC-25,49836020,1.4878182873068626
K-562,11485656,1.7795111963017332
CAL-51,136227924,2.079284078064279
NH-6,136227924,2.082013315983653
2004,9903786,1.8272851025318924
OCI-Ly10,148198,-3.382160448081964
MOLT-13,9926054,1.5657094756283445
KYSE-150,11485656,2.368580585817062
HLF,148124,-4.484401267484706
HMCB,sirolimus-bortezomib (250-1 mol-mol),0.2910880989689153
DMS 273,168313200,2.725135044490621
CHP-126,6505803,1.8994279506826215
BICR 18,6505803,0.1715229764566586
JHOC-5,9936388,2.2786503857706593
LUDLU-1,9903786,3.064378057627616
Hs 746.T,12003241,0.0057336203254279
253J-BV,9903786,4.2891414604158395
LS1034,44491742,3.738346956467245
SNU-1033,JQ-1-carboplatin (1-1 mol-mol),1.515968870431384
KM12,6918878,3.865155064205213
ESS-1,9911830,2.1910771619648077
KYM-1,168313200,1.7447791340634575
NCI-H1155,9926054,2.490439813838108
SK-N-MC,sirolimus-bortezomib (250-1 mol-mol),-0.0028242639035691
TF-1,107985,-4.016849467396239
NCC-StC-K140,409805,3.739861273702827
Raji,168313200,3.851087858415495
RPMI-7951,9911830,3.3922230843192778
BT 228,11485656,1.932859050078464
NCI-H1355,9936388,0.5035386429798234
HPB-ALL,sirolimus-bortezomib (250-1 mol-mol),0.9475176932995892
CA46,10322450,2.6264913036213606
TE-5,44493528,4.238536644603732
HCC1937,selumetinib-GDC-0941 (4-1 mol-mol),1.9717867215396572
OVTOKO,5460769,2.45887134191899
SK-ES-1,11485656,2.2128952684348286
Mono-Mac-6,9936388,-1.750888467590725
DBTRG-05MG,sirolimus-bortezomib (250-1 mol-mol),2.2547470483609637
SNU-449,9936388,0.4589950900054629
HCC-56,selumetinib-GDC-0941 (4-1 mol-mol),-0.1385009392783674
JHOC-5,9926054,1.8776072884950488
GP2d,26596,-1.9076944219866043
Pfeiffer,selumetinib-GDC-0941 (4-1 mol-mol),-0.3312571594037772
OVISE,107985,-3.603598955800668
JHOM-1,168313200,3.938698311360986
LCLC-103H,6918878,2.1817193013668157
KMS-26,100016,3.884140356330727
LS513,sirolimus-bortezomib (250-1 mol-mol),0.1168577806704952
SNU-1079,439501,-2.542024376307003
BT 131,8515,4.487021263418678
WSU-DLCL2,148198,-3.6374417896025513
KMRC-3,9903786,5.172590154682236
HCC1833,3689413,0.395553245761409
F-36P,9903786,0.2788806994422486
MPP 89,148198,-3.0572841720054007
JURL-MK1,sirolimus-bortezomib (250-1 mol-mol),0.9558536767512098
Reh,107985,-3.632720091318157
TE-14,selumetinib-GDC-0941 (4-1 mol-mol),1.037456532239161
BxPC-3,3689413,-0.056748072256038
NCI-H520,6505803,3.2437812579556864
Hs 944.T,439501,-0.9410683695438108
23132/87,36462,0.0399526858663723
TCC-Pan2,9903786,4.661219913833123
FTC-238,9927531,3.762159625160711
HCC4006,9903786,3.3433056456258585
BT 216,135875424,2.865998902674901
SNU-719,107985,-3.2235683767483607
DMS 273,3689413,-1.7704206659692223
COLO 668,9936388,-5.811086467822447
OCI-Ly10,26596,-0.6290463214568307
COV362,100016,7.994124175315401
NCI-N87,9926054,1.7069639615174013
T84,262093,2.390395114942932
HT-1197,107985,-4.558974920992082
SNU-387,36462,3.501298082679132
NCI-H2126,11485656,1.628640715546943
Hep 3B2.1-7,135875424,3.596529657657783
BT 482,107985,-4.125051999378386
DMS 114,sirolimus-bortezomib (250-1 mol-mol),-2.6988548245768387
JHOS-2,24180125,3.2910798464952045
TE-10,9936388,-5.117656284676294
DK-MG,409805,3.8694402600406206
SW1990,135875424,4.251787213143329
BT-16,11404337,-1.376831419013344
NCI-H1734,409805,3.958491853493927
SNU-466,9936388,1.636304731108846
EN,36462,2.8431128539945414
U-118MG,selumetinib-GDC-0941 (4-1 mol-mol),2.998678120294993
NCI-H522,135423438,2.202740699610144
MES-SA,10322450,4.209540173303182
PK-45H,selumetinib-GDC-0941 (4-1 mol-mol),0.6996398674072702
TE-8,sirolimus-bortezomib (250-1 mol-mol),1.0878251503851162
Granta-519,sirolimus-bortezomib (250-1 mol-mol),-0.0602153873263711
BT 340,8515,6.087313039636692
Rh41,sirolimus-bortezomib (250-1 mol-mol),0.2633406530968948
SBC-5,9936388,-5.234314033557506
SNU-16,tanespimycin-bortezomib (250-1 mol-mol),-3.234515138053412
EHEB,409805,3.764078268707581
SK-MES-1,11404337,-1.915365805563204
TF-1,JQ-1-carboplatin (1-1 mol-mol),-0.0928028716388946
EM-2,10322450,3.0285960061439865
SNU-503,5460769,2.419581709530207
SK-OV-3,9936388,2.038842599711319
SCC-25,135875424,4.102070818018105
MV4-11,49836020,2.655795655295622
TE-14,11485656,2.3244152057135934
AsPC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.9679789776412068
U-BLC1,26596,-0.9383285983925695
HeLa,100016,5.8653655502295
D283 Med,107985,-4.659724680199273
Hs 578Bst,439501,-1.046807547420411
NCI-H2196,9926054,1.658766361497933
TUHR14TKB,46943432,3.23090491736855
SNU-869,3689413,-0.5659806105186423
RS4;11,24180125,2.423594456573407
TE-8,439501,-2.6420993562145925
MES-SA,9936388,2.5692609882827964
NCI-H1395,135875424,3.644181585171065
SUP-B15,9911830,0.1632296563268915
NCI-H211,11404337,-2.184886204882766
DMS 114,tanespimycin-bortezomib (250-1 mol-mol),-0.0529426000704769
ST486,3136844,2.8815145387316883
NCI-H647,168313200,2.222361802043905
HEL,439501,-2.350875236844296
HCC366,11485656,2.823123661586525
SUP-M2,168313200,1.600763528501759
SR,107985,-4.50871259775865
NCI-H1568,26596,-1.690126811671561
SU-DHL-8,44491742,4.1577476289633
HD-MY-Z,5460769,0.4985347726770217
BT 216,44491742,5.368329526940575
NCI-H2196,11404337,1.3261557854884771
AML-193,100016,3.9854178308912074
Karpas-620,262093,2.9084914265438164
SNU-449,selumetinib-vorinostat (8-1 mol-mol),3.605779113828276
BCP-1,9936388,-5.382514367449052
Mono-Mac-1,136227924,2.2269797620359864
SK-MEL-30,9926054,2.6578574468285434
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
SUP-T1,6610216,3.659307734000498
DMS 114,11404337,-0.5972709505558575
A-204,148198,-5.205432048346018
NCI-H2228,6505803,-0.5994588294177822
MIA PaCa-2,26596,-1.1158295610303952
JHOM-1,selumetinib-GDC-0941 (4-1 mol-mol),2.18755430310554
WM115,6610216,3.675624927368402
UACC-62,9903786,5.03427767143789
NCI-H1373,54618164,5.2479619812935425
NCI-H2009,6918878,-0.4863456687538305
WM88,100016,6.2407728308576
SET-2,439501,-3.519167585481613
ME-1 [Human leukemia],sirolimus-bortezomib (250-1 mol-mol),1.2847340597652257
LC-1/sq-SF,107985,-4.128895444338486
HEC-1-B,136227924,3.6469104939920154
SW948,136227924,2.9576701343794145
HCC202,136227924,3.1235993915196723
BL-70,46943432,1.6957346866180731
EoL-1,46943432,-1.6312084333642909
SNU-387,44491742,4.132370196510326
UACC-257,409805,5.778472558974471
SU.86.86,135875424,4.152288157211863
MOLM-6,selumetinib-vorinostat (8-1 mol-mol),-0.0456049176618857
YD-10B,439501,-2.459950710231521
TCC-Pan2,9936388,2.201514810862402
NCI-H322,9927531,5.259442104255536
GaMG,3136844,4.607188312702765
RL95-2,5460769,2.3147567331395753
RPMI-6666,3136844,5.911765377203317
KYSE-510,36462,1.8586989227994473
G-361,159324,1.690399124036534
GI-1,6505803,0.8519906132881799
MEC-1,107985,-5.111442171124094
HuNS1,3689413,-2.2730227081216787
HCC366,6918878,4.087154951350268
Kelly,11485656,1.664007289934324
BT 245,3689413,-2.318316316051159
HGC-27,44491742,3.7914350891371114
PK-1,tanespimycin-bortezomib (250-1 mol-mol),-1.3417753505365824
A101D,107985,-2.8849374617938928
JURL-MK1,46943432,1.476821322825177
NCI-H1944,11485656,1.8149710014494984
PE/CA-PJ34 (clone C12),3136844,4.07403193003179
HCC827,135875424,3.772761345205915
WM115,9936388,-1.175666523167262
NCI-H446,44491742,5.101744314169451
SF295,6505803,0.007344164780963
HCC1143,selumetinib-GDC-0941 (4-1 mol-mol),1.964789015650302
TOV-112D,tanespimycin-bortezomib (250-1 mol-mol),1.1427039773069572
SK-CO-1,54618164,4.180915062416914
SUIT-2,54618164,5.030082257565933
Malme-3M,sirolimus-bortezomib (250-1 mol-mol),2.279282073181017
NCI-H2228,36462,2.406587898355439
NCI-H1184,26596,-3.790175824084468
CAL-51,3689413,0.5709426612715743
NCI-H2122,9936388,-2.3512808318812555
CGTH-W-1,36462,1.432706505120937
Mino,11404337,-2.29299189538819
NCI-H358,10322450,3.5952188723285436
KMS-26,409805,3.707967657643135
SW1417,6505803,-1.211390297431511
DV-90,409805,3.719667841684698
HCT 15,26596,-1.5306161018190547
SNU-761,selumetinib-GDC-0941 (4-1 mol-mol),3.4718208794514167
SU-DHL-8,9911830,2.2532460750044385
DK-MG,12003241,0.4512209867473665
SNU-1,5460769,1.879573497334996
KU-19-19,159324,4.255883770522122
NCI-H508,selumetinib-vorinostat (8-1 mol-mol),2.379388447268019
SNG-M,46943432,3.1600160691323715
HEC-251,12003241,0.0135079560064688
PE/CA-PJ34 (clone C12),409805,3.8621146596524087
AsPC-1,10296883,4.32215490848641
Jurkat,409805,3.8074447971093304
QGP-1,44493528,4.309319516194894
KU-19-19,44493528,4.383684457454455
NCI-H28,6505803,-3.2149479697747534
CHP-212,9927531,5.318398541001747
BT 112,11485656,1.9046121738712176
639V,9926054,0.5445384370060099
ST486,72199289,4.347318676727556
Panc 03.27,10296883,3.962678998629819
JURL-MK1,135875424,3.956954247189128
SU-DHL-1,11485656,1.6397040363022437
SK-HEP-1,54618164,4.274964046269975
COLO 684,3689413,-2.2674920306130764
F-36P,148124,-6.364948087395455
HCC38,136227924,2.8991930932960983
HT-1376,11404337,0.7952974713578591
SNU-182,9927531,4.620682064232075
CCF-STTG1,9911830,2.0742504991173103
SF126,36462,1.4248363949575364
639V,6505803,-0.4780888890381856
SNU-216,135423438,1.816422149531831
BT 172,11404337,-1.2975012169581652
BT 228,tanespimycin-bortezomib (250-1 mol-mol),0.2023623064786018
HCC1419,439501,-1.0086934548500974
OCI-AML-3,11485656,1.6382059446521733
BT 164,5460769,1.5184738603275272
RD,11485656,1.6123587927279353
NCI-H1155,3136844,3.0715399569514723
IGR-1,3136844,4.115084104185429
LS513,9911830,3.013228491628512
Kasumi-2,6505803,-2.445084849944434
Capan-1,10296883,4.201537501236006
BICR 56,3689413,1.5922116280396923
GOS-3,9926054,2.0544356724695776
PC-3,selumetinib-vorinostat (8-1 mol-mol),4.9380309221831755
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
JeKo-1,100016,6.219930850058466
A3/Kawakami,10296883,3.880092254870085
D283 Med,9911830,1.6953738838285617
KP-N-SI9s,6505803,-1.8312599777173428
NMC-G1,8515,3.7052773234568224
LAMA-84,107985,-3.5887213994965195
NCI-H1975,selumetinib-GDC-0941 (4-1 mol-mol),-2.1756384403206326
KE-39,3689413,-1.8420159541718293
COR-L51,9903786,2.9541793607693267
MHH-CALL-4,9911830,3.172534584054814
DBTRG-05MG,135875424,3.4879962097655057
EB1,9926054,1.6799735914328415
TUHR10TKB,262093,3.638427626686601
HCC1806,12003241,-0.1866891199802881
WM793,44493528,4.356787444460569
NCI-H2122,159324,3.624644935210345
MOR/CPR,148198,-2.5838099224586
CAL-12T,107985,-2.701919142348095
COLO 792,9903786,2.6845883070851277
UO-31,selumetinib-GDC-0941 (4-1 mol-mol),-0.0895128254081629
SNU-1196,148198,-2.167238950864192
Panc 03.27,107985,-4.41897786111236
NCI-H520,107985,-4.652189442077367
TE-10,136227924,2.8479301717793435
HT-1376,439501,-0.8291876191032579
NCI-H146,9926054,1.7480459470636802
ACC-MESO-1,135398744,5.83972457285084
GP2d,54618164,4.277742817183889
KYSE-140,136227924,3.3753020930843065
KMS-11,136227924,2.4847849493179406
SK-ES-1,409805,4.963965303720412
LN-229,selumetinib-GDC-0941 (4-1 mol-mol),1.343707265826647
KE-39,44484440,3.4843450825893973
Mono-Mac-1,selumetinib-vorinostat (8-1 mol-mol),2.0513617036591323
OV7,409805,3.837815164614596
SUP-T1,9903786,2.605502996973438
TC-71,9903786,2.1601140442915736
Namalwa,44491742,4.1395858329172235
NCI-H1694,44491742,4.026754305354829
NB1,54618164,3.8017135330145377
OVCAR-8,8515,5.505062921849074
NCI-H1792,135875424,3.896639880830057
KE-97,409805,3.6508236514703176
CAL-120,9877608,5.792965508852075
L3.3,9911830,2.6705572013337195
BICR 56,6918878,1.040555911780174
MES-SA,11404337,-4.5203474212928265
CML-T1,73707440,4.384977554594534
Hs 729.T,168313200,2.1406023043716917
NCI-H146,54618164,3.6762408834701423
5637,8515,2.6197871304529805
A-549,3689413,0.7236603744186211
639V,262093,3.248167953384808
Hs 611.T,439501,-3.691204716302381
KP-2,3136844,4.487496753250611
COV434,selumetinib-GDC-0941 (4-1 mol-mol),1.0563079487833569
OVTOKO,9936388,2.2599066716722707
SW1990,409805,4.048741151107136
PE/CA-PJ49,sirolimus-bortezomib (250-1 mol-mol),0.2701469855669
TE-11,44493528,4.3195742716631615
EBC-1,136227924,2.637152829802991
ALL-SIL,49836020,-3.56746653346715
GMS-10,6505803,0.344915295589296
Daoy,selumetinib-vorinostat (8-1 mol-mol),2.406498201434062
Hs 766T,100016,6.453782329995662
L-363,107985,-3.711160596536445
Hs 294T,9936388,0.7679572566977205
TE-9,54618164,4.023601318956505
ECC10,24180125,2.9361406436920694
CCF-STTG1,11485656,3.67410233042364
TE-5,148124,-6.926392091129738
Mel JuSo,107985,-2.9458205931229897
JVM-3,9926054,1.6493371537606276
DLD-1,tanespimycin-bortezomib (250-1 mol-mol),0.5980844777691691
SK-LMS-1,6505803,0.606445374310417
NCI-H2085,135875424,2.7505706963719243
BT-20,107985,-2.620430033405692
SNU-407,148198,-3.549575176870091
TOV-112D,11485656,3.0452540655775473
KMS-27,46943432,1.1908434425451844
A2780,5460769,-5.6757466443406575
KYSE-450,246676,4.496442396396831
TCCSUP,6918878,3.6529452991011766
SUP-T11,10322450,3.259585661278822
CGTH-W-1,49836020,5.717814266829885
JJN-3,135875424,2.965307149294294
SK-MEL-3,148124,3.772454869250104
BT 216,262093,2.591664883123623
Hs 940.T,107985,-2.5873077806657796
OV-90,12003241,-0.4315626967505086
G-361,262093,2.334861127155717
COR-L88,11404337,0.6108297700178786
CCK-81,11485656,2.133914966176791
MOTN-1,selumetinib-vorinostat (8-1 mol-mol),2.375951826808806
COR-L47,9936388,-7.709676320407029
Mino,44493528,3.6548963085027
SW48,8515,2.6507036204950256
AsPC-1,44493528,4.313387127964929
Hep 3B2.1-7,selumetinib-vorinostat (8-1 mol-mol),2.071849268804795
UACC-257,262093,3.003704805776171
SCC-25,26596,-1.8912501387828335
KNS-62,262093,2.8892264309510014
KMRC-3,107985,-4.753608924350131
Hs 895.T,selumetinib-GDC-0941 (4-1 mol-mol),2.3327892844393374
SW48,selumetinib-vorinostat (8-1 mol-mol),-2.7312432821532724
Sq-1,159324,2.5082178612561976
Reh,5460769,-1.7090111602799842
BT 147,262093,2.7128872808709414
BT 131,JQ-1-carboplatin (1-1 mol-mol),5.021524376247219
HT-1080,107985,-3.5335184718289345
GA-10,3689413,-4.87834364200375
CAL-54,selumetinib-GDC-0941 (4-1 mol-mol),0.8998815087239347
EB1,3136844,2.9947888141791186
TE-15,46943432,2.615867274491135
Ri-1,44491742,3.935960320926185
TC-71,148198,-5.123045083168725
SU-DHL-10,selumetinib-GDC-0941 (4-1 mol-mol),2.1131040208605576
639V,3689413,3.093093365439167
COV644,409805,2.9980382861104724
IA-LM,439501,-4.16745845294267
HCC1438,100016,5.852637802531623
MDA-MB-415,9926054,2.772494701182559
Sq-1,107985,-3.109149408233463
SCC-25,11485656,1.624439793066487
OC 314,9911830,2.778444895405951
NCI-H1299,262093,2.920458315101783
ACC-MESO-1,44491742,5.613898283692527
BT-16,439501,-3.235694513476061
TUHR4TKB,8515,5.826936165080946
HL-60,tanespimycin-bortezomib (250-1 mol-mol),0.1959762790136793
SK-MEL-1,262093,3.2518519489587785
HEC-251,439501,-2.223367930628925
Hs 294T,409805,3.776693304184006
Calu-1,136227924,3.5665542391568774
SNU-C5,54618164,3.725409858172283
JMSU-1,54618164,3.9923887768961306
CAL-51,10322450,3.881825194853649
RVH-421,selumetinib-vorinostat (8-1 mol-mol),1.3960776963459798
ESS-1,selumetinib-GDC-0941 (4-1 mol-mol),2.1616208595010966
BT 286,selumetinib-vorinostat (8-1 mol-mol),-2.316984046450598
SU.86.86,148198,-1.8590332811796892
NU-DUL-1,9927531,4.217714200280878
YD-15,selumetinib-vorinostat (8-1 mol-mol),3.259964348594559
OUMS-23,selumetinib-vorinostat (8-1 mol-mol),2.421949754069272
A-673,135423438,2.29660224903782
NCI-H1573,11485656,1.6192247576925332
HuH-1,36462,2.248539187241854
TE-9,selumetinib-vorinostat (8-1 mol-mol),3.686792839648975
SK-N-DZ,439501,-4.085743704417651
TE-9,6505803,-0.9474092806204982
BICR 31,6505803,0.2507928346620714
OAW28,6610216,3.9661844518771185
JHUEM-3,sirolimus-bortezomib (250-1 mol-mol),0.3977209679383447
SNU-878,10322450,4.398776492188379
TC-71,12003241,0.7010514965491693
TE-11,tanespimycin-bortezomib (250-1 mol-mol),-2.7748536147542167
KMH-2,12003241,-0.520398442259763
HEC-151,44491742,3.809390131450424
GaMG,9926054,2.873858460522757
COLO 800,148198,-3.6591761210846423
BFTC-905,5460769,4.235583914088274
FU-OV-1,36462,2.321134275550796
Hs 888.Lu,9936388,3.0019673480858455
BT 164,148198,-5.587345118223356
NCI-H1581,135423438,0.6953694326358761
FU-OV-1,6505803,0.8019489696335256
NCI-H889,JQ-1-carboplatin (1-1 mol-mol),5.709235070199913
RPMI-8402,12003241,-0.4088888603650127
BT 428,6918878,3.9952196892532896
HCC15,selumetinib-vorinostat (8-1 mol-mol),1.4639379045779866
KALS-1,3689413,-0.2176182562401838
BT 320,11485656,3.3413754154715796
A-673,9911830,1.9751375507094395
SNU-1214,3689413,-0.7711373431609502
8305C,26596,-2.120596559409719
HCC1806,36462,2.6029103476346407
HMC-1-8,148198,-2.948355719333101
COR-L95,409805,3.71634228772174
KMS-34,6610216,3.222571288765256
CML-T1,54618164,3.634689828068523
SNU-1079,107985,-3.0381859059536387
KHM-1B,54618164,3.3281109403552795
NCI-H1650,36462,2.1466146201267833
JHOM-1,11404337,0.0884008871371316
22Rv1,12003241,-0.1253815141985464
WT2-iPS,sirolimus-bortezomib (250-1 mol-mol),0.4538341173925034
TYK-nu,6610216,3.505675319704899
SF539,8515,4.265018963639613
A-549,9903786,1.8644448309659765
Capan-2,10296883,4.260435559241064
OCI-Ly19,selumetinib-vorinostat (8-1 mol-mol),0.6945020606262625
SNU-C5,9936388,-5.010033217973313
Caki-2,3689413,-0.1901377653832866
PLC/PRF/5,9903786,4.947267974127204
BT 131,136227924,1.4796003986288269
G-401,11485656,1.708547873036538
SYO-1,26596,-1.7250044942499454
HEY A8,148198,-3.070106200413562
D283 Med,9927531,3.2144716566788745
Panc 08.13,tanespimycin-bortezomib (250-1 mol-mol),-2.574326454795975
CA46,46943432,1.2105530921386296
NCI-H889,107985,-3.661574603852329
LNCaP clone FGC,3689413,0.5325071990753445
42-MG-BA,11485656,2.199214577741701
EBC-1,26596,-2.071625704215017
SNU-1041,11404337,0.704382749568953
MKN45,246676,4.422534829782778
HCC-56,100016,6.404810900486153
MOLM-13,6610216,4.131122051839403
DoHH2,tanespimycin-bortezomib (250-1 mol-mol),-0.3609676807954009
SNU-C4,135875424,3.2044136454561896
SIG-M5,44493528,4.118953354797346
LoVo,439501,-1.7683171506776545
IM95,135875424,4.902055922324696
HCC2935,54618164,4.374064434375431
GB-1,9926054,2.832614445271179
TE-6,11485656,1.5497099103986265
COR-L51,5460769,2.8872461015254913
JHUEM-3,selumetinib-GDC-0941 (4-1 mol-mol),0.9560042848605832
KMRC-2,409805,5.9581282148190855
SUP-T1,439501,-1.5599134432816564
MOLT-13,136227924,1.9107910741830303
HCC1419,409805,4.912297202709663
Karpas-299,54618164,3.901671399515938
PSN1,24180125,3.947786415385254
SNU-216,sirolimus-bortezomib (250-1 mol-mol),0.3912590686829094
JIMT-1,148198,-2.4064236907207786
NCI-H2023,24180125,3.7677499946881743
SK-MES-1,24180125,2.8011061593725244
NCI-H1299,409805,5.9960995888447925
BICR 31,135875424,5.0736941678127945
COLO 678,10296883,4.183536343390627
SNU-1196,5460769,1.0482928300242556
JHUEM-3,10296883,4.22416361613302
WM88,36462,2.778591866824928
BT 482,135875424,3.0321936879214846
LNCaP clone FGC,9927531,4.548275216558741
HOP-92,11485656,3.011235199919159
EFO-21,11485656,3.611716212098542
Fu97,sirolimus-bortezomib (250-1 mol-mol),-0.4373916466224739
Mel JuSo,11485656,2.451512427332153
SK-MEL-28,262093,2.757579366484628
UACC-812,6918878,3.827620339158657
253J,159324,3.1278100403829696
FaDu,135875424,3.054249321596862
LNCaP clone FGC,148124,-8.012505540487231
HCC1428,44493528,4.080046839622648
TE-6,6610216,4.258406467182382
LS180,6610216,4.524725364990245
AM-38,6505803,-3.272255667195971
SNU-869,136227924,3.0372027283613505
FTC-238,3136844,5.473051206154038
HCC1954,11404337,0.9656290265602768
NCI-H1666,44491742,3.401457772249809
Panc 10.05,11485656,2.563143068622914
LMSU,10296883,4.275438301361486
NCI-H460,9936388,2.3098343611543415
AU565,107985,-3.572249289009051
NCI-H520,36462,2.88085787375963
A-673,11404337,-2.7698937773977033
TE-14,8515,4.691290159599005
HCC15,tanespimycin-bortezomib (250-1 mol-mol),-2.289156821264784
U-CH1,6918878,4.536873355416227
SK-N-BE(2),9903786,2.0499315562907627
Ri-1,9927531,3.385054072969868
TE-8,9911830,2.369831244931197
TE-1,49836020,4.425156685624386
BT 112,100016,6.504213631006025
DOV13,9903786,3.8407513521100975
SF295,439501,-2.4386536619135137
Rh30,54618164,3.8447721242905337
Hs 578Bst,9927531,5.122326242765859
EN,selumetinib-vorinostat (8-1 mol-mol),2.3844723548226336
SK-HEP-1,sirolimus-bortezomib (250-1 mol-mol),1.4424973508492578
SNU-201,9926054,3.435558365800804
NCI-H1666,135875424,3.51211447124405
Granta-519,6610216,4.381057854502396
NCI-H929,sirolimus-bortezomib (250-1 mol-mol),-3.8848205267511817
VM-CUB-1,6610216,4.439081031884477
HCC2279,9926054,2.352300509177514
SNU-216,49836020,4.392080781330326
KG-1-C,selumetinib-GDC-0941 (4-1 mol-mol),0.970562535367186
NCI-H1650,54618164,4.20289726679049
HCC1588,26596,-1.1478060280369464
GMS-10,9936388,1.763954811977491
HT115,36462,3.0779780996301707
B-CPAP,409805,5.0770120967965795
TOV-112D,135875424,3.733970966368142
SK-MES-1,9926054,1.7676300515090215
FTC-238,107985,-3.0403846548585336
A-673,10322450,2.1969870036583323
EN,44493528,3.9032470450473657
NCI-H446,44493528,4.231535039215924
SUP-T1,100016,6.229647258472745
DEL,9936388,-6.471933624576076
HT115,159324,1.560184632739966
NCI-H1838,54618164,4.4678889451925725
HeLa,36462,3.354174189337733
Kasumi-1,46943432,-1.29446682230788
Panc 03.27,135875424,4.313798765654786
NH-6,tanespimycin-bortezomib (250-1 mol-mol),0.3512808047097303
SK-MES-1,10322450,4.30384017318748
HCT 116,262093,3.0489861047493525
SW1353,9903786,3.629285684044714
OCI-Ly3,262093,0.61539030331268
CMK,168313200,3.916925914759029
Kelly,6918878,0.0774693483459061
LN-229,sirolimus-bortezomib (250-1 mol-mol),1.3963325511705935
NCI-H1105,8515,4.559359227152753
HEC-108,262093,2.510970460452122
NCI-H1581,439501,-2.58240650687765
RVH-421,11404337,-0.9304733374413466
OCI-Ly3,10322450,2.4111759735163316
SEM,136227924,1.2424830449991908
NCI-H838,136227924,3.210993191129446
RPMI-8226,24180125,3.774747192059227
HH [Human lymphoma],148124,-7.407928701983839
A-253,9936388,1.4333351862699826
KMS-21-BM,sirolimus-bortezomib (250-1 mol-mol),-4.769329635088173
NCI-H1944,136227924,3.273500409836235
MV4-11,8515,0.673726443721711
Hs 294T,11485656,2.7928532706785143
LK-2,439501,-2.6408972828107053
KMRC-20,409805,5.905260063235434
TE-14,6505803,-1.7378811047388565
Karpas-299,6610216,4.00419918923577
HSC-2,tanespimycin-bortezomib (250-1 mol-mol),-0.2988768157355406
HCC1395,9936388,-7.459318644951684
KMS-18,selumetinib-GDC-0941 (4-1 mol-mol),2.1372948898179462
COLO 699,54618164,3.9618004812637326
KYSE-510,JQ-1-carboplatin (1-1 mol-mol),4.538673492010493
GCT,49836020,-4.509787849566978
M-07e,3689413,-2.11596462386005
Caov-3,10296883,4.16431215306168
HEC-1-A,44491742,4.152626069309694
KYSE-520,9903786,4.522923988599173
Panc 08.13,44491742,4.265130925236368
NCI-H1155,9936388,-5.221468348115442
SNU-466,6918878,5.016142844356089
253J,selumetinib-vorinostat (8-1 mol-mol),2.385104279160593
NCI-H1944,439501,-2.342776450648639
Mino,JQ-1-carboplatin (1-1 mol-mol),-0.9180856967211396
RPMI-8226,135398744,6.232374281438443
SNU-1079,24180125,2.198682285744919
DLD-1,439501,-1.8196175209339427
SK-HEP-1,3689413,-2.4602386660304143
HEY A8,439501,-1.1544595971592837
SNU-410,3689413,1.1161257107979303
SNU-423,sirolimus-bortezomib (250-1 mol-mol),0.1869702268124788
SNU-46,6610216,4.54643046921205
YAPC,135398744,6.484368053683043
KYSE-410,sirolimus-bortezomib (250-1 mol-mol),0.4997693160347982
NCI-H838,439501,-0.7442992299750818
Hs 746.T,36462,3.4545901563724075
COV362,148198,-3.7747045203467313
SW1990,9926054,1.8053433824091036
GB-1,73707440,4.5407422473928785
CAMA-1,135875424,4.608485379364883
SNU-1196,136227924,2.95634276982207
NCI-H661,135875424,2.4725937826628006
A-549,9911830,2.245916242551202
RPMI-7951,11404337,-1.491748801484046
MKN74,6610216,4.33380428824605
HCC15,sirolimus-bortezomib (250-1 mol-mol),2.085701918672026
OS-RC-2,54618164,5.32762570536847
697,9927531,2.816043229727806
SF268,tanespimycin-bortezomib (250-1 mol-mol),-0.3321278091609868
LOX-IMVI,6505803,-1.7860593354464098
MIA PaCa-2,135423438,2.2894715060157553
SNU-761,148198,-3.4808535079888494
Ishikawa (Heraklio) 02 ER-,262093,3.584751515027739
RCH-ACV,tanespimycin-bortezomib (250-1 mol-mol),0.4817586938326316
SU-DHL-1,6918878,1.5556600104975795
RCC10RGB,selumetinib-vorinostat (8-1 mol-mol),3.237241333738756
SNU-8,159324,3.7143577321129393
SNU-5,sirolimus-bortezomib (250-1 mol-mol),-0.1680239232280146
SNU-1066,9936388,2.256482479661346
Panc 10.05,10322450,4.07148015639342
TE-9,26596,-1.3406326261923425
MOLP-8,3136844,3.797428854524256
8-MG-BA,36462,0.9814615543613344
PC-14,409805,5.400742947036561
OUMS-23,3689413,0.7829309194563772
SW48,36462,-1.5563073788110886
IGROV-1,168313200,3.9938362637732983
CAL-51,9911830,2.6702149728757343
SNU-478,36462,0.5519411952993932
SNU-601,54618164,4.367725876257716
H-STS,26596,-2.569417697964928
769-P,selumetinib-GDC-0941 (4-1 mol-mol),2.2458256114397788
NCI-H460,6610216,4.838717363885395
NCI-H526,148198,-3.313175192053609
IMR-32,246676,3.267106458420984
MDA-MB-415,24180125,2.3743547117086887
SNU-C5,tanespimycin-bortezomib (250-1 mol-mol),0.6015716530365237
SNU-626,12003241,0.7059762795421864
NCI-H1581,9927531,4.312096995742435
DMS 114,135875424,2.926439690209593
RCH-ACV,12003241,-2.009657794147886
KYSE-140,9927531,4.387230999589902
NCI-H2009,24180125,3.399696031265864
A-253,409805,5.897270499181996
LCLC-97TM1,54618164,4.1848187977728
LOU-NH91,3136844,4.41334270983783
TC-71,11485656,1.8010543407786783
HeLa,12003241,1.4760559160729645
OCI-M1,11485656,1.896897846334656
IM95,44493528,4.078779126887718
EC-GI-10,168313200,3.768770833109668
PE/CA-PJ15,5460769,-0.4178373813349113
BT 131,168313200,1.7184330352004986
SK-MEL-3,5460769,5.404359476176559
WM983B,36462,1.7671342918989796
MDA-MB-435S,6610216,4.909822803895324
GB-1,9927531,4.312258679101311
BT 340,9926054,4.031759543162761
Hs 294T,9911830,2.199413930106796
BT 147,246676,3.6303996753868466
769-P,262093,3.4485358488357867
KE-39,sirolimus-bortezomib (250-1 mol-mol),2.142327162680567
PL-21,46943432,1.1872479034734134
FTC-238,selumetinib-GDC-0941 (4-1 mol-mol),2.3347122521245396
MCF-7,409805,3.9764139851355305
Ri-1,9926054,1.5974379061435915
SR,100016,4.130694890660373
LN-18,9926054,0.598983976680667
SW948,12003241,-1.7903806895013192
Ci-1,12003241,-0.8991759784993727
SW48,sirolimus-bortezomib (250-1 mol-mol),0.5064948335670021
TTC-709,54618164,4.259345795297247
SJSA-1,12003241,-0.348535560110424
SNU-1,36462,-1.3160240759966046
DK-MG,9926054,2.480223353364803
C2BBe1,135423438,2.0550808175205755
NCI-H322,11485656,1.7917980555041009
LNCaP clone FGC,49836020,4.788899602776088
PK-59,selumetinib-GDC-0941 (4-1 mol-mol),1.3854215252632525
NCI-H1373,11404337,0.111453942184986
NCI-H522,44491742,4.766943404170333
SK-BR-3,sirolimus-bortezomib (250-1 mol-mol),-3.644794085557173
HT-144,sirolimus-bortezomib (250-1 mol-mol),0.2937138425316054
Mino,sirolimus-bortezomib (250-1 mol-mol),-0.0680495630332059
OUMS-23,262093,2.6847920209845886
HCC1195,9903786,3.7437324544379487
TE-14,135875424,2.9954156144381203
NCI-H69,JQ-1-carboplatin (1-1 mol-mol),4.253677409086092
OE33,10296883,3.414380068882816
H-STS,9927531,5.457961831541725
Ki-JK,107985,-4.619834564372043
TE-11,11485656,1.7659776894381034
KNS-60,6610216,4.235845632004621
BT 359,9911830,3.790221030687113
FTC-238,36462,0.2646772322690526
SW1783,44493528,4.220460910824872
TUHR10TKB,JQ-1-carboplatin (1-1 mol-mol),4.175841940785285
SNU-869,36462,3.1715816266138
RL,5460769,2.816259716284544
BT 333,5460769,4.50385990816769
Daudi,44491742,3.5549145676591314
Hs 766T,54618164,4.329849128814947
BICR 56,9927531,5.497555124114839
JHOS-2,148198,-3.889513078207594
MC116,9903786,4.909292458120856
SNU-C2A,107985,-3.3916676058064916
CAL-12T,136227924,2.605918242540546
NCI-H2087,5460769,-1.5102005910697154
SUP-T1,107985,-3.4385434341277565
TE-10,3689413,-0.6087813624831553
DMS 454,tanespimycin-bortezomib (250-1 mol-mol),2.8093099362578746
BFTC-909,439501,-2.4866456286351095
SBC-5,11485656,2.2866280503579812
KMH-2,100016,3.8705403745512017
COV644,6918878,2.7359830872926354
COLO 320,8515,3.7887210443451145
BT 330,246676,6.180038418715505
JJN-3,135423438,1.720470314756554
RCH-ACV,6918878,-0.3632511703905712
NCI-H2122,3689413,3.5396747143031497
NCI-H446,136227924,3.5012378178100487
MPP 89,10296883,4.223562446240864
IGROV-1,26596,2.910298792762654
SNU-C5,159324,2.115220402448434
P-STS,54618164,4.361832979605855
DMS 53,100016,7.1608088069035185
NCI-H209,9936388,1.6716697805480627
WT2-iPS,11485656,-1.624206160773241
KP-2,135875424,4.758790844331061
JMSU-1,5460769,-1.1957562952388658
NCI-H524,12003241,-3.023793196266873
SNU-449,selumetinib-GDC-0941 (4-1 mol-mol),2.576796761551289
DMS 114,44491742,4.749496559747659
NCI-N87,6918878,2.817621762559668
UM-UC-1,135423438,1.3266275240072287
NCI-H510A,409805,3.660940228209235
CAL-85-1,49836020,1.7789600466695898
DEL,11404337,-1.8098726855093707
Ku812,JQ-1-carboplatin (1-1 mol-mol),-1.5108430449944463
HCC44,54618164,3.6703477587961464
NCI-H1651,9926054,1.9046490097522224
LS180,262093,3.1953995116592826
SK-N-SH,3689413,0.7530548018951405
LP-1,168313200,2.9786417938497807
DEL,24180125,2.6043593138043537
BT 482,54618164,4.35481469450108
NCI-H358,107985,-4.0587779380967515
YD-10B,9927531,6.486218545334236
MOLT-16,9903786,1.2441798518109255
KALS-1,136227924,3.4972882997363257
SNU-201,12003241,-1.0113776062533857
SNU-119,11485656,2.5966291939022192
IM95,439501,-2.2673196662301933
BT 444,262093,2.9400297132003623
COR-L95,9936388,1.0197606854481494
OVCAR-8,54618164,4.2136896289865815
Raji,3689413,-1.7827501217470076
DK-MG,148198,-2.831494942566311
PE/CA-PJ41 (clone D2),9903786,4.971136415817363
MKN1,262093,2.3312380194672353
HT,136227924,2.3517784191427613
NB4,136227924,2.0986844076590616
HCC1143,9903786,3.3387804215378885
MFE-319,3136844,4.413081954029845
SNU-C5,9903786,3.1730161972997517
RPMI-8402,sirolimus-bortezomib (250-1 mol-mol),0.331212001560029
BV-173,49836020,4.1850611213091105
TUHR14TKB,3689413,-1.483434528636918
ZR-75-1,3689413,2.979171486892431
Panc 05.04,10296883,5.097523984239884
NCI-H1755,JQ-1-carboplatin (1-1 mol-mol),0.9057830308904904
WSU-DLCL2,12003241,-3.4791532779073373
SW948,168313200,2.3052543991742933
SNU-398,262093,3.8749654719100186
MDST8,6505803,-0.0816923181525763
BT 147,tanespimycin-bortezomib (250-1 mol-mol),-3.7345384366794665
MFE-296,262093,2.4223872491935077
CGTH-W-1,3689413,-0.6568714259027654
SNU-1079,44491742,4.118848224044972
NCI-H2030,tanespimycin-bortezomib (250-1 mol-mol),1.0255259856925616
ME-1 [Human leukemia],168313200,1.6367692901213335
COLO 680N,36462,3.5817544778318213
Lu-99,selumetinib-GDC-0941 (4-1 mol-mol),1.1181366334842004
SUP-T1,9926054,1.5313307080964844
EKVX,sirolimus-bortezomib (250-1 mol-mol),1.945724198864232
SU-DHL-8,44493528,3.935387311306229
NCI-H196,11404337,0.5983725190796483
JJN-3,36462,1.4427355466822882
Karpas-422,49836020,3.572840137931533
SNU-668,selumetinib-GDC-0941 (4-1 mol-mol),1.744810645163071
WM793,136227924,4.7819042035619255
NCI-H146,sirolimus-bortezomib (250-1 mol-mol),-0.0099585964665403
HARA [Human squamous cell lung carcinoma],6610216,4.810637550807952
SF295,9936388,1.8656949469177304
RL95-2,148198,-3.5486250738118654
SNU-8,136227924,2.992589463119238
ECC12,9903786,2.9866335342643953
MDA-MB-468,136227924,1.762243520931147
CL-11,6610216,4.297262569438173
HuH-28,9903786,2.984330186348554
K029AX,12003241,-1.6892437749493532
MM1.S,tanespimycin-bortezomib (250-1 mol-mol),-0.3747840615026737
SNU-216,selumetinib-GDC-0941 (4-1 mol-mol),-0.3522125644534081
NCI-H2172,54618164,4.006615708933043
TALL-1 [Human adult T-ALL],136227924,2.458144705929413
Hs 683,135423438,3.058302675128977
SK-MEL-24,11404337,-2.842069291243037
UACC-257,6610216,4.056795010377407
NCI-H1339,11485656,3.447182893453246
EFO-21,26596,2.967643494346353
IMR-32,148198,-7.685974048863974
DLD-1,9903786,2.1877560593252343
NCI-H2196,246676,4.3795263450239466
BT 422,135423438,1.9130848394222184
EHEB,44491742,5.293750317448726
YD-8,44493528,4.2998537557563346
RS4;11,10322450,3.4392008344478895
SNU-1196,9936388,1.7924578695982027
EFO-27,selumetinib-GDC-0941 (4-1 mol-mol),2.701249599183188
KMH-2,36462,-0.642209166172259
KYSE-140,54618164,4.2081025861503285
BICR 18,8515,4.334551265456708
HEL,3689413,-2.191477482826257
COR-L88,100016,6.409850176158066
DOV13,136227924,2.864785745195549
YD-15,136227924,2.6934840054154834
EBC-1,11485656,1.836879581205612
HD-MY-Z,8515,3.657206097253692
SF539,9927531,4.183842431586729
IA-LM,9926054,3.212619063516659
BT 498,6610216,4.077552585304459
Hs 888.T,10296883,3.7100072063785534
TE 441.T,5460769,2.227250069350157
NCI-H1355,11485656,1.9876880567524768
EPLC-272H,12003241,-2.3102763219954867
BT 330,9936388,0.9619236718444248
IGR-1,sirolimus-bortezomib (250-1 mol-mol),1.4068933313589211
T-47D,11404337,0.5836773446504185
KMS-18,6505803,1.18095143270811
MOLT-13,9911830,2.6271761500921436
M-07e,11485656,1.7704573347594663
MOLM-13,159324,-0.2587959593058327
KP-4,selumetinib-vorinostat (8-1 mol-mol),2.6285521395824527
RL95-2,selumetinib-GDC-0941 (4-1 mol-mol),-1.0392511344110156
Panc 04.03,9936388,2.385451093408398
SU-DHL-8,46943432,0.6195871683667687
SNU-475,11485656,2.631087250262813
HCC1588,409805,5.920497547047897
SNU-119,9877608,5.864690809801913
TE-11,10296883,3.918560367292528
SW1271,11404337,-3.6050810245472382
Karpas-422,6610216,4.297042652021984
NCI-H322,10296883,3.9806006473812
NCI-H2291,11404337,0.0259813589502385
CAL-78,sirolimus-bortezomib (250-1 mol-mol),0.4097773819170223
IST-Mes1,selumetinib-GDC-0941 (4-1 mol-mol),2.032921854049634
NCI-H1373,12003241,-0.7849764131433078
Karpas-422,9903786,1.5566107707645094
CCK-81,136227924,2.050553135971544
Hs 578Bst,6610216,4.2048816923862935
YD-8,262093,2.4929271706284433
SNU-475,9926054,2.638013601993947
MOLP-2,439501,-3.1752212130018163
BT 216,11404337,-0.0425915422639234
CAS-1,9927531,5.442580925984542
LNCaP clone FGC,107985,-3.945098238572166
Fu97,tanespimycin-bortezomib (250-1 mol-mol),-2.3506071651033733
SK-UT-1,3136844,6.414538606040479
RCH-ACV,9926054,1.6841422831368045
Becker,107985,-2.6804749742466347
L-363,168313200,3.338476454499633
RPMI-7951,8515,4.057754260895621
NCI-H1703,54618164,3.5806376010346583
IGR-1,selumetinib-vorinostat (8-1 mol-mol),1.2502749786155671
NCI-H1755,6505803,-1.1693878768610966
JIMT-1,107985,-0.7659824645781472
OCI-AML-2,11485656,1.8915689976488803
K-562,136227924,2.737847329779252
KPL-1,44491742,4.061678740812618
MKN45,selumetinib-vorinostat (8-1 mol-mol),5.20778496027016
KYSE-180,262093,4.394400122480356
NCI-H2196,6610216,4.474259778958852
Hs 611.T,54618164,3.758252372543717
HuT 78,11404337,-1.1966282759274738
G-292 clone A141B1,selumetinib-GDC-0941 (4-1 mol-mol),0.4997156895846377
NCI-H1944,168313200,2.1739063289963254
KMS-21-BM,6505803,-3.224254978227179
NCI-H1395,54618164,4.0783729987601225
KLE,sirolimus-bortezomib (250-1 mol-mol),2.0698040575432572
NCI-H747,24180125,2.088918009184693
KMS-28BM,9903786,-0.1585542654155638
SW1990,148124,-0.559061851738452
Hs 888.Lu,10296883,4.303649203246193
SNU-182,11404337,-2.4504456684550475
RCC10RGB,136227924,3.611686331312014
LNCaP clone FGC,262093,3.5120752927452803
NCI-H650,selumetinib-GDC-0941 (4-1 mol-mol),1.2489714260088474
RKN,9936388,2.306220468641662
TT2609-C02,9911830,3.947893664595907
BHT-101,107985,-3.610598538035865
BT-474,11404337,1.3863676230346815
KNS-42,11404337,1.3884544485554386
CCF-STTG1,12003241,0.9586959919868534
NCI-H226,439501,-0.8440362022647064
NCI-H1184,10296883,3.900599246219188
NU-DUL-1,135875424,2.988818183719918
786-O,136227924,4.54082640186513
LP-1,9926054,1.657631549896095
MSTO-211H,159324,-0.971759723426381
SK-UT-1,135875424,3.143376991018657
Ci-1,136227924,2.861978373437932
RKN,44493528,4.408823872302737
MDA-MB-435S,JQ-1-carboplatin (1-1 mol-mol),5.894688800138277
GCT,262093,1.5309331416086709
BT 333,262093,2.471436519213189
UACC-257,sirolimus-bortezomib (250-1 mol-mol),1.215285215662541
KMS-21-BM,136227924,2.0166655260293487
CAMA-1,54618164,4.317906672812886
42-MG-BA,6918878,5.3299106921978785
MOLT-3,26596,-3.757190091597864
A-498,6918878,4.306638073301365
RS4;11,26596,-3.6621242440749766
U266B1,9926054,1.2913740580373996
JHH-2,tanespimycin-bortezomib (250-1 mol-mol),1.6682234532456457
Hs 294T,148124,-3.306910428366027
RPMI-8402,26596,-2.3009998991377274
NCI-H2029,439501,-1.7622660866331608
OV7,262093,3.0286714339572542
OCI-M1,26596,-2.6046335322938927
KYM-1,selumetinib-GDC-0941 (4-1 mol-mol),1.885650004060589
HuG1-N,10322450,2.6791795001351355
NCI-H889,selumetinib-GDC-0941 (4-1 mol-mol),5.471466100727687
HDLM-2,sirolimus-bortezomib (250-1 mol-mol),0.137697197491076
OE19,148198,-4.200030852664729
LOX-IMVI,136227924,2.635687863612288
OVCAR-5,148198,-5.433409896244414
NCI-H524,11404337,-1.0230582740337757
BT 145,148198,-5.145484796849837
NCI-H358,12003241,-1.009244775405437
NCI-H1651,6610216,4.721038769964527
ST486,6918878,0.2973468061587639
P31/FUJ,409805,3.653161003579303
SNU-620,6918878,-0.2582770914504519
BT 498,439501,-2.816531814980934
GaMG,selumetinib-GDC-0941 (4-1 mol-mol),2.5044066808337644
SBC-5,409805,5.881004535625117
NCI-H2291,107985,-3.367463815189516
SK-MEL-30,11485656,2.585249816423364
NCI-H2452,6505803,0.3706171048891257
SNU-1,9911830,1.637952110808466
TE 441.T,10296883,4.028933328577424
RERF-LC-A1,11485656,2.3794985324061217
SNU-308,3689413,0.3406956707675037
Kelly,9903786,1.651293069080272
NCI-H2081,6610216,3.784534117796005
EPLC-272H,409805,3.901233602819964
MKN74,148198,-2.653452729835883
HT,6505803,-0.8511885729054358
KYM-1,11485656,2.085980626190086
DMS 454,JQ-1-carboplatin (1-1 mol-mol),3.538784914005209
8505C,36462,1.0764276752423854
EFO-27,148198,-4.612142049540045
HeLa,11404337,0.8471506482049684
NCI-H2170,11404337,0.5827033431431107
UACC-257,selumetinib-vorinostat (8-1 mol-mol),0.0439995598921686
MKN1,135875424,4.434731625885322
SNU-478,46943432,1.8221345859000824
HCC2108,262093,2.915848941362045
SNU-620,3689413,0.413852643898191
OE33,sirolimus-bortezomib (250-1 mol-mol),0.234198569818553
Hep-G2,107985,-3.632879499618416
HEC-1-B,46943432,0.7932990906575372
SNU-C1,9903786,1.6227295920089169
HCC1500,JQ-1-carboplatin (1-1 mol-mol),3.891416287519206
KMBC-2,11485656,2.7390953396220588
ALL-SIL,11485656,1.390704841990788
NCI-H1975,159324,-3.209262840922576
Mel Ho,159324,3.173943708119276
KCL-22,9903786,2.593050827774072
NCI-H838,10296883,4.165878010219483
MOTN-1,9926054,1.7711575511093696
HEC-1-B,36462,3.274452342984035
BICR 22,107985,-3.867593954539223
REC-1,9911830,2.634781008938807
Capan-2,sirolimus-bortezomib (250-1 mol-mol),0.8521756904723038
FU-OV-1,9903786,2.8592788804010936
RPMI-8226,107985,-4.099902309572239
KMS-27,409805,3.6220211323899782
SW1710,44491742,4.487431108260269
KE-39,11404337,-0.6939323202576905
Kasumi-2,135398744,8.02054113805855
CAL-12T,6505803,0.5711509755258141
HuH-1,24180125,3.1042255829435543
OV56,54618164,4.260141278815489
BT 139,135875424,2.659641868559938
KMS-26,selumetinib-GDC-0941 (4-1 mol-mol),-0.996356335755467
SW948,44491742,3.910317363967626
WSU-DLCL2,selumetinib-vorinostat (8-1 mol-mol),1.9937136864187064
TYK-nu,10322450,3.7591527396933895
L3.3,9903786,3.5860218860878263
Hs 888.T,9926054,3.017509441424242
HOS,3689413,-0.1573622709293647
DLD-1,5460769,4.378806727859053
SK-MEL-31,409805,6.337253307669649
22Rv1,159324,1.7570868223743523
NCI-H1703,44491742,4.242219664453596
BT 112,9911830,1.5924575123512974
DMS 53,5460769,5.120342551697822
SNU-1041,9903786,3.9190312975923822
NCI-H23,136227924,2.7523480468192254
SCC-9,24180125,3.671852734769843
IGROV-1,49836020,5.658436828096057
TC-71,6918878,1.6710139941964712
MDA-MB-361,11485656,3.163991716829106
DB,36462,0.0092957670554277
KP-2,6610216,4.180671400196187
HCC1500,10296883,3.843895309810077
NCI-H2009,46943432,2.8478796444115835
TCC-Pan2,135875424,4.2350171007948685
Kasumi-2,439501,-3.441659601561783
TE-9,439501,-2.406207557642534
BT 139,439501,-2.1565169223075062
SNU-119,135875424,4.208481763945608
LS411N,44491742,5.693616041532359
NCI-H661,6505803,-0.5859050253944337
KMS-27,9927531,4.171626738694902
A-549,selumetinib-vorinostat (8-1 mol-mol),2.322163064753337
Panc 05.04,107985,-3.471783339815776
CJM [Human melanoma],9926054,2.54173081148122
SNU-423,6610216,4.208625011644533
COV644,selumetinib-GDC-0941 (4-1 mol-mol),0.580143851486064
SNU-620,9936388,-5.286800591769548
RVH-421,9927531,5.089842816937553
Sq-1,11485656,3.136931266066648
MIA PaCa-2,6505803,-3.969520749405985
SUP-T11,6505803,1.7392273117289616
KP-4,409805,5.81471054655713
NCI-H1373,selumetinib-vorinostat (8-1 mol-mol),2.652947864267465
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404
MHH-ES-1,9926054,1.555405413320919
OVCAR-5,36462,3.071671268495135
GSS,36462,-1.7824773633563245
T3M-10,6918878,3.505400016326987
SF268,9911830,1.8163947676875103
NCI-H2196,107985,-4.2483053233771875
SET-2,6918878,0.2720159878545329
GP2d,11485656,0.5695398212792343
Mel Ho,9911830,3.0073204468383192
HT-1080,10296883,4.176429034595713
NCI-H2228,10322450,3.891754335699043
Hs 766T,135875424,5.942184015876385
KP-2,11404337,1.570112378340211
GSS,5460769,0.9437954326098514
SW48,11404337,-1.6842588085779022
M059K,26596,-1.203189408299565
TE-10,11485656,2.3373155876615463
SK-N-DZ,sirolimus-bortezomib (250-1 mol-mol),0.4176185816300255
HOS,9927531,4.717123870748892
CHP-126,409805,3.885062870941733
HMC-1-8,159324,3.1611757337355844
CAL-29,409805,3.6004869851493924
ECC10,tanespimycin-bortezomib (250-1 mol-mol),1.1222379258321835
SNG-M,135398744,7.8429611595155055
639V,5460769,5.247401600018928
KLE,3689413,-1.503166424361693
HEC-251,136227924,4.831338089277502
HEC-1-B,JQ-1-carboplatin (1-1 mol-mol),0.0800794652195035
TE-9,262093,4.268741263772325
BT 147,107985,-3.8275487999717543
HuH-1,3689413,3.5538877505923097
YKG-1,8515,4.7576372381485
SUIT-2,3689413,0.4029780891432681
YD-10B,12003241,-3.1216797421568847
ONS-76,tanespimycin-bortezomib (250-1 mol-mol),1.246384835528882
HEL 92.1.7,9926054,1.77080435305732
647V,24180125,3.086887880848898
Mono-Mac-1,JQ-1-carboplatin (1-1 mol-mol),-0.3034213126939502
8305C,159324,2.7489494667199774
BT 159,148198,-4.153567410174437
A-204,9911830,-3.308014491584552
SUIT-2,12003241,-0.3419407469483631
CAL-51,JQ-1-carboplatin (1-1 mol-mol),2.422524169436591
Hs 688(A).T,135423438,1.627421563855232
Kuramochi,135875424,3.969220594462324
MCF-7,JQ-1-carboplatin (1-1 mol-mol),-0.3789372065214004
BEN,46943432,2.875871955716667
NCI-H2196,tanespimycin-bortezomib (250-1 mol-mol),0.7510452056774047
BT 504,148198,-4.360319644130701
MCAS,sirolimus-bortezomib (250-1 mol-mol),0.8032325328072784
SNU-C1,12003241,0.2452706417287593
LXF 289,selumetinib-GDC-0941 (4-1 mol-mol),2.154352876327122
SCaBER,JQ-1-carboplatin (1-1 mol-mol),1.2535925980177334
Ku812,135875424,4.708872885868404
MJ,135423438,2.050663035644961
MDA-MB-231,54618164,4.06902412063099
SNG-M,sirolimus-bortezomib (250-1 mol-mol),0.843195777913948
HuP-T4,54618164,4.557554546423835
NOMO-1,sirolimus-bortezomib (250-1 mol-mol),-0.7938299836559928
PF-382,9927531,5.462558018035092
GSS,136227924,2.0459518542117983
OCI-AML-5,46943432,1.3940665878668066
TE-1,tanespimycin-bortezomib (250-1 mol-mol),-1.7455027047349927
HH [Human lymphoma],6505803,-0.1440406835782353
CCF-STTG1,9926054,1.9394922490252933
CHP-126,439501,-0.4236570710914729
GCT,8515,3.4172979303744175
OVCAR-5,24180125,3.2133850290549453
PE/CA-PJ34 (clone C12),262093,3.186494210920842
BT 164,100016,6.2228733531949505
Hs 683,3136844,4.024059328221529
NCI-H1650,136227924,4.84526698521074
SCaBER,26596,-1.7174475471543391
OE21,12003241,-2.4283256435660205
TE-14,148198,-4.134736941909179
YD-38,36462,2.856164296020876
BT-20,9936388,-7.739336729410493
NCI-H1581,148198,-2.796222248008704
KMS-20,11404337,-1.24048912938788
Granta-519,36462,-1.2340392932323463
HEC-151,262093,2.667137080366997
U-251MG,10296883,4.141522340635607
BxPC-3,9903786,2.126136875029704
OCI-Ly3,9927531,4.54855652960748
JVM-3,6505803,-1.4044558034159191
TE-14,136227924,3.1216716097465365
COR-L95,44491742,4.146782751375218
TCC-Pan2,9926054,2.315773971229038
Hs 294T,6610216,4.3443465389355715
SNU-1033,54618164,4.351406762339218
NCI-H889,136227924,2.7199111384597447
JVM-3,sirolimus-bortezomib (250-1 mol-mol),-5.712232327729444
SK-HEP-1,3136844,5.506062707172487
BICR 22,168313200,4.032164885313491
HCC1806,54618164,4.175335893823892
MDA-MB-415,9927531,4.701582574311918
JURL-MK1,6610216,3.8705017009241263
DU145,54618164,4.17145351900014
NCI-H2087,10322450,3.569680650808545
MHH-CALL-4,24180125,2.4020121607744653
HCC1833,54618164,3.937517250635008
Rh30,409805,5.11813479987097
NCI-H1581,6918878,2.7160427108687024
LS513,6610216,4.305930787985114
SiMa,136227924,1.9858625956320377
SNU-182,24180125,1.310847414241977
42-MG-BA,262093,4.0294491331177715
OVTOKO,136227924,4.392974848141837
HOS,148198,-4.398135238674327
HT115,3689413,1.0252939168322983
BT 232,24180125,3.864278163608165
SR,44493528,4.089009709270584
KE-37,3689413,-1.780022958661614
TE-15,3136844,3.713291500695178
IPC-298,tanespimycin-bortezomib (250-1 mol-mol),1.4855938894276637
ESS-1,148124,-6.743563487136813
RL95-2,12003241,-0.4521887729146946
BCP-1,selumetinib-GDC-0941 (4-1 mol-mol),1.866380650613888
EHEB,136227924,2.586993854279513
Hs 683,6610216,4.167851340670154
SCC-4,148124,-5.0837387423667515
Detroit 562,54618164,4.201054272091685
CAL-27,6505803,-0.9389361210216336
Becker,409805,5.716119591245028
MOLT-13,5460769,4.221123357906427
SK-MEL-31,24180125,2.52832402517647
Hs 294T,9927531,5.24007707651297
KMS-11,9903786,1.9090096011276083
UM-UC-1,9927531,4.732850009488004
BT 147,168313200,1.828641236275665
TE-8,selumetinib-GDC-0941 (4-1 mol-mol),2.5154311677987575
OVK18,11404337,-0.9122714237451722
COV362,439501,-2.4929175140704443
CMK,8515,3.756463629168832
NCI-H69,6918878,1.9450769167430224
NCI-H2141,6610216,4.157777487639752
LS513,135875424,4.138794062430469
NCI-H1573,JQ-1-carboplatin (1-1 mol-mol),-0.275309697042944
TE-11,136227924,3.028335758763499
KYSE-410,3689413,0.6720370091874901
GSS,100016,3.718199006522657
OV56,6505803,0.8040031173297286
J82,107985,-3.8389067423667615
BT 330,9926054,2.1336209959126253
MDA-MB-157,3689413,-1.567220624306923
MOLT-16,44491742,3.707485326024471
RPMI-6666,409805,3.46469330142704
WM266-4,148124,3.1567402822869006
THP-1,262093,2.4428888686996237
JHOC-5,6918878,2.802975496871594
DV-90,6918878,0.6799749830572155
LOU-NH91,168313200,3.810508485111527
HMCB,11404337,-1.2429546984634874
AGS,8515,4.67838267995859
BICR 56,6505803,-0.5151519512858532
T3M-10,36462,3.304739967460866
HCC4006,409805,5.92416136943095
NOMO-1,46943432,0.592792127892358
A2058,9926054,1.7529225868456957
Ci-1,10296883,4.053173965998694
Kelly,selumetinib-GDC-0941 (4-1 mol-mol),2.978588327990176
BT-12,136227924,2.3126118312621404
NCI-H441,9936388,1.8164232394185744
Hs 578Bst,168313200,1.6109769305505062
BT 359,439501,-2.266223118686084
SK-MM-2,100016,6.381158442456996
MOTN-1,9911830,1.9978990566511137
MM1.S,107985,-4.097612409872881
YD-15,8515,2.6919898843278105
PE/CA-PJ49,409805,3.747059655038111
SNU-C1,135398744,6.35894151615267
CFPAC-1,439501,-1.9750103172149232
SK-HEP-1,148198,-3.434194259121147
LUDLU-1,409805,5.791089657297664
SNU-213,136227924,3.1812992174761696
OV56,6610216,4.622532733616633
YD-38,12003241,-0.5056624439731239
LS513,409805,5.865921710016113
ES-2,262093,2.44906158082759
TE 441.T,10322450,2.5137861182837207
BT-549,3136844,5.53345832245052
HMC-1-8,409805,4.767028573995512
HeLa,26596,-2.0330393314508868
NCI-H810,409805,3.8950776421244377
KE-97,26596,-2.711610546447418
SNU-387,6505803,0.0715059334590081
NCI-H510A,26596,-3.9165599075217994
HD-MY-Z,selumetinib-vorinostat (8-1 mol-mol),2.8123718664727773
Mel JuSo,11404337,-0.8493423015678001
HCC2935,3136844,5.81203525796931
NCI-H526,sirolimus-bortezomib (250-1 mol-mol),1.536405299935234
OVK18,135875424,3.840132228822679
CML-T1,135875424,3.5304182343940935
NCI-H2444,44493528,4.4653307538151354
OCI-Ly3,5460769,0.7293331267323642
SNU-878,9926054,2.3591129664276194
OCI-Ly3,11404337,-1.6616072452432793
KMS-12-BM,262093,1.1865999929989532
PE/CA-PJ34 (clone C12),135875424,2.9771289784544934
SUIT-2,262093,4.049104877248936
BICR 16,148124,-4.759947113058055
AGS,44484440,3.472943739980985
BT 172,3689413,0.915101391559166
PE/CA-PJ41 (clone D2),5460769,2.5777137088305184
RL,100016,6.4335673885856135
SNU-182,3136844,3.7107120218316463
JHH-4,11485656,1.6774790555680354
U-CH1,selumetinib-vorinostat (8-1 mol-mol),3.4811968102545308
786-O,10296883,4.604694854621938
NCI-H1373,135875424,5.093925660594389
L-540,10296883,2.97370959547478
NB4,6610216,4.109528798583204
T98G,148198,-3.089381534593653
JHOC-5,12003241,-1.1087899100302334
SF539,12003241,-2.026733754371074
Hs 766T,6505803,-1.244402871615241
RVH-421,JQ-1-carboplatin (1-1 mol-mol),4.487330987841125
A2780,36462,-2.0824592368546893
SK-LMS-1,135875424,4.759949001069946
HCC95,36462,3.279798214232864
EPLC-272H,3689413,0.721701872436853
HLF,9903786,4.061487019079308
NCI-H1915,10322450,3.706063293985689
HEY A8,8515,3.710776284319144
NCI-H1573,44491742,3.554417916622067
NCI-H1563,11404337,1.575154147256652
KMS-28BM,24180125,1.7269497251160733
5637,12003241,-2.3897344760826775
NCI-H526,439501,-2.4772740458578983
A-549,11404337,-0.2898707579606809
KNS-62,6505803,0.1679251813007588
BT 245,11485656,1.931183051045247
FTC-133,246676,4.92384525208296
NCI-H23,107985,-4.988280245499153
KE-37,24180125,2.169434675284816
ST486,12003241,-0.1204499968223502
DoHH2,12003241,-3.729445034849217
HCC202,24180125,1.1972188242288753
CL-11,44491742,4.051585264115174
HCC1171,12003241,-1.936475523579036
BFTC-909,107985,-3.700699007813787
KCL-22,262093,2.312361441448963
LAMA-84,100016,4.28644111913654
TUHR4TKB,6610216,4.683546527875489
JVM-2,26596,-2.43180743148247
UACC-812,6505803,-4.59801553223132
Hep-G2,selumetinib-GDC-0941 (4-1 mol-mol),-0.4461378228189951
BT-12,3689413,-1.6226385767572318
PC-3,sirolimus-bortezomib (250-1 mol-mol),0.5730469414273184
RS4;11,12003241,-1.5224166820052676
KATO III,44491742,4.678429550063523
IGR-1,24180125,3.269696921536744
HDLM-2,36462,1.1917482107311113
DMS 114,3136844,4.527597221115842
Ki-JK,12003241,-1.478318359413444
L-363,6505803,-2.0442344992040837
OVCAR-5,sirolimus-bortezomib (250-1 mol-mol),0.9753915222823988
ALL-SIL,262093,0.6753795238054565
NCI-H1341,409805,3.659332889741384
Hs 688(A).T,3689413,-1.8044012386941577
NCI-H226,tanespimycin-bortezomib (250-1 mol-mol),2.419002105970759
LNCaP clone FGC,26596,-2.187376252798695
GP2d,148124,-6.606459612747149
NCI-H524,10296883,3.65691401974992
SF268,12003241,-2.0418893916572243
HCC1143,6610216,3.638345017281011
EHEB,9911830,3.0366000052999893
COLO 699,36462,3.424891097483833
TE-14,107985,-3.6830592516934697
REC-1,136227924,3.1866861789415855
LXF 289,sirolimus-bortezomib (250-1 mol-mol),0.6089213560806236
SKM-1,54618164,3.978394394327194
MES-SA,selumetinib-vorinostat (8-1 mol-mol),3.174242970755464
JURL-MK1,107985,-4.050737585877582
NCI-H522,136227924,2.2034936459857506
Kuramochi,54618164,4.340040712483917
DOV13,159324,3.690202624549136
SNU-626,5460769,3.7499472406611334
COR-L105,11485656,1.8131666015075352
SNU-46,9936388,3.201545334866413
DND-41,36462,0.0569290379615615
BHT-101,409805,5.910877889789324
HCC2218,24180125,2.93475065656583
RT-4,11485656,2.1371904728142
ACC-MESO-1,159324,5.7222118158510344
EC-GI-10,44491742,4.525033675313585
Namalwa,36462,-1.022429039126246
G-361,36462,1.8201725237050903
RT-4,9926054,1.7601963161522494
HSC-2,409805,5.8439599049225714
KMS-21-BM,3136844,3.136423422815638
A-253,11485656,0.5769754234687416
ONCO-DG-1,sirolimus-bortezomib (250-1 mol-mol),0.4937178485517417
SNU-C2A,11485656,2.2484892549692104
KMBC-2,9911830,3.153897570043922
NCI-H1184,selumetinib-GDC-0941 (4-1 mol-mol),2.1589965755168152
NCI-H1793,168313200,1.7961344835426234
CHP-212,9926054,1.886787046066781
KYO-1,100016,4.086276175586104
BV-173,159324,-1.7619985937899936
P31/FUJ,36462,-0.6599401629031103
SNU-398,168313200,2.6056728837341265
TUHR4TKB,409805,5.922934417095481
EN,9903786,3.730384858671513
OVISE,12003241,-0.8183931153803442
NH-6,24180125,1.2366902198749954
KMS-27,439501,-2.6111087383065597
DV-90,JQ-1-carboplatin (1-1 mol-mol),-0.681487288410465
LMSU,sirolimus-bortezomib (250-1 mol-mol),0.3355197835459403
NCI-H661,9911830,2.711917815790479
SK-N-MC,409805,3.444464894840386
RCC10RGB,9936388,2.3235560801623465
Hs 822.T,selumetinib-GDC-0941 (4-1 mol-mol),4.199779090816491
NCI-H2087,100016,6.366125554898137
SNU-761,3689413,-0.7506907427890448
JHH-6,439501,-0.5793275995059294
Mino,46943432,-0.4971400671027619
A-673,135875424,2.9734448822107886
SF268,168313200,1.683727721969487
MOTN-1,168313200,1.7556194121014388
RCH-ACV,9927531,3.1896486071629724
KU-19-19,6505803,0.0199416611110358
SW1353,3689413,-1.8577928934605696
NCI-H1563,11485656,2.498309340246036
OVK18,9926054,1.8068809708246223
OCI-M1,11404337,-0.1677571096937809
NCI-H211,46943432,0.2016973908222597
U-BLC1,9927531,5.132450103816796
NCI-H146,3689413,0.5626872136369616
JHOC-5,selumetinib-GDC-0941 (4-1 mol-mol),2.1101820766966832
TE-10,6918878,4.756932134879377
WSU-DLCL2,11404337,-1.1416325362941906
SNU-489,3136844,3.821746970257834
SUP-B15,9927531,5.1368052730530955
Sq-1,54618164,3.699819225246008
JHH-1,148198,-5.058972904251947
NCI-H1703,136227924,2.979921585365296
SK-OV-3,36462,2.5052417836250496
SH-4,9911830,2.4844641601514863
COLO 320,135398744,6.463011253269961
OV-90,44493528,4.327625554130725
VMRC-LCD,135398744,6.4569642970049
NCI-H441,159324,3.2801227887174
YD-10B,44493528,3.7407231951864497
CAMA-1,159324,3.8065405896449263
KU-19-19,6610216,4.876021689690227
BICR 22,selumetinib-vorinostat (8-1 mol-mol),2.1163342168700936
Ku812,49836020,4.574644913995472
RT-112,3689413,0.3015272221175239
KYSE-520,5460769,2.8497133103495713
SaOS-2,409805,5.764413924489168
L-428,11404337,-1.5944494988953837
Hs 839.T,136227924,4.248389123686858
PE/CA-PJ34 (clone C12),168313200,2.559397227720179
769-P,107985,-2.9874753130628418
697,selumetinib-GDC-0941 (4-1 mol-mol),0.5718014976116145
Panc 03.27,selumetinib-vorinostat (8-1 mol-mol),3.66722901648523
HEC-151,26596,-1.920762353069635
AGS,73707440,4.5504628850403
OCI-Ly19,selumetinib-GDC-0941 (4-1 mol-mol),-1.7363769217481064
MKN1,selumetinib-vorinostat (8-1 mol-mol),3.560075936672011
Aska-SS,24180125,2.481672199133219
FTC-238,tanespimycin-bortezomib (250-1 mol-mol),0.0088820138944574
BL-70,409805,3.720661860726631
NB1,selumetinib-vorinostat (8-1 mol-mol),2.4657686582204255
GA-10,26596,-3.772659675473913
OS-RC-2,409805,6.365104149544731
A3/Kawakami,9927531,2.786138883968946
EJM,9903786,2.5710642236856818
BT 231,439501,-3.8677572824685913
Hep 3B2.1-7,9911830,1.7769280634909912
ML-1 [Human thyroid carcinoma],409805,4.766723032315811
BEN,11485656,2.522824701097711
RPMI-8402,246676,4.500897758755647
TE-1,148198,-2.725381459547287
NCI-H1792,54618164,4.250571755822218
SNU-878,159324,3.1522028257412864
IM95,72199289,4.342442192219408
MKN45,148198,-2.2480188061666913
SF126,135398744,7.810596319596066
22Rv1,136227924,2.1207718843699
NCI-H2452,9927531,4.529523169776047
FU-OV-1,46943432,0.7627718951481175
COLO 320,409805,5.814717482714791
SEM,26596,-3.506968001766276
SNU-475,136227924,3.0898415955820715
BT 172,168313200,1.6859469241493503
MPP 89,3689413,-2.191379674666751
SNU-182,107985,-4.121441833862979
YD-10B,148198,-3.6118455313709186
NCI-H929,54639024,4.491044339124744
HuH-1,26596,4.2639260913768755
NCI-H520,6610216,3.9954490147026647
Mono-Mac-1,54618164,2.5791045372216703
PK-1,9926054,1.83429012816666
NCI-H2023,5460769,4.150302713550692
CAL-54,8515,3.577845304599322
HEC-1-A,9927531,4.872071430147468
WM115,11485656,3.738489726762909
K-562,135423438,0.8826240773524879
8305C,409805,4.694735989662373
SNU-1066,409805,6.103521485077888
SNU-410,6610216,4.607565323971714
NCI-H727,6610216,4.563405769903236
NCI-H522,135875424,3.5456342124976445
MDA-MB-231,sirolimus-bortezomib (250-1 mol-mol),1.1512355372843297
RCH-ACV,sirolimus-bortezomib (250-1 mol-mol),0.6092850769346084
SW1783,9936388,2.9056540363277796
SNU-407,107985,-4.40126942216499
SNU-245,9936388,-0.9809692402129652
LOX-IMVI,148124,3.752144785635508
SU.86.86,159324,3.460908276663124
Hs 888.T,9927531,5.625894406785977
OPM-2,9903786,2.6412283094975657
KMH-2,44484440,3.223340167755633
HPB-ALL,136227924,2.35435467065409
HCC1395,3689413,-0.620515875859175
TE 617.T,44493528,4.329408184341151
JL-1,100016,8.572446789328106
NCI-H1666,3689413,1.2654271755000104
LP-1,8515,3.897304365418543
DAN-G,selumetinib-vorinostat (8-1 mol-mol),3.226437568677093
JHH-4,100016,6.356907567320683
BT 159,3689413,0.7549791540054046
EM-2,9926054,0.5147420382885298
RVH-421,10296883,3.51018214130791
JHUEM-2,9911830,0.7349841579012222
DEL,6918878,1.4774015334429618
DLD-1,26596,0.8453725223634535
HCC2279,11485656,2.9593776026466756
KMS-34,36462,-0.9076906015398876
Mel Ho,148198,-2.080740439053791
SNU-840,148198,-2.353488885952442
MIA PaCa-2,tanespimycin-bortezomib (250-1 mol-mol),-3.0154822613403898
DMS 273,9926054,1.8030373867492464
EB1,135875424,2.5798652139486262
NCI-H1915,8515,4.43756010195983
LCLC-103H,262093,3.3068425344063326
CL-11,12003241,-0.9595086367475664
MOLM-6,3136844,3.4352964960681502
Rh41,107985,-4.1063623944843695
NCI-H810,9911830,1.0779216490046777
SNU-719,136227924,2.577096412948206
GSS,107985,-3.999302317591999
LXF 289,262093,3.4150141342974605
NCI-H716,6918878,3.809377355631782
JHOC-5,tanespimycin-bortezomib (250-1 mol-mol),0.5504047070747966
COR-L105,6610216,4.21117605455994
HCT 15,3689413,1.3698068653375808
DMS 53,6505803,0.1213526787251841
Peer,sirolimus-bortezomib (250-1 mol-mol),-1.139363807048106
P-STS,6918878,1.6561639440712272
BT 112,26596,-1.3919420546275056
ONCO-DG-1,11485656,2.8081349041133663
LMSU,11404337,0.046862413597458
NCI-H2085,262093,2.713548107137237
NU-DHL-1,10322450,3.582925513183909
P31/FUJ,262093,1.035147161622815
HCC1500,sirolimus-bortezomib (250-1 mol-mol),0.0140631270051885
HCT 8,8515,5.054538260051568
HMC-1-8,135875424,3.5952222830478364
MDA-MB-453,sirolimus-bortezomib (250-1 mol-mol),-2.416971902682566
VM-CUB-1,24180125,3.0164665959984505
JHUEM-7,tanespimycin-bortezomib (250-1 mol-mol),-0.0825179950707132
HuH-6,10322450,3.486001071319901
EN,6918878,4.293404077344305
Mel Ho,136227924,2.792099034627563
SW620,36462,2.219897715399993
LN-18,3689413,-0.4753252169993508
NCI-H2170,9903786,3.56987053348202
MeWo,11404337,-0.4455476930760103
HCT 15,36462,1.5260279602132691
MDA-MB-361,9936388,2.003587918290059
SUP-HD1,26596,-3.617348161498389
A3/Kawakami,11485656,1.2537678238706411
OE21,tanespimycin-bortezomib (250-1 mol-mol),-1.6225844369747413
NCI-H841,9926054,1.733938420008062
WM793,107985,-3.039809125194022
AML-193,tanespimycin-bortezomib (250-1 mol-mol),-1.641441169090329
Jurkat,46943432,1.5147475299254256
NCI-H2106,159324,1.7207732882351374
PL-21,54618164,3.670173179687308
COV434,9903786,2.975082903645508
VCaP,9936388,1.4949429315009104
PE/CA-PJ41 (clone D2),6505803,-0.4507500369158054
A-253,9903786,4.10726286628635
KMS-34,sirolimus-bortezomib (250-1 mol-mol),-7.371271931180508
U-118MG,168313200,2.145334385054909
A2780,100016,4.757543521992015
U-CH1,44491742,4.471385772399255
SK-MEL-5,selumetinib-GDC-0941 (4-1 mol-mol),2.1259535578143995
253J-BV,JQ-1-carboplatin (1-1 mol-mol),2.2786098419782403
SK-N-FI,3136844,4.422315801246329
LC-1/sq-SF,selumetinib-GDC-0941 (4-1 mol-mol),2.9597977830319935
JHUEM-7,135398744,6.411220982649173
A-375,24180125,3.577996774573621
Malme-3M,selumetinib-vorinostat (8-1 mol-mol),-1.6232213829827038
BT 333,148198,-2.763261808909799
22Rv1,11404337,0.9568158231901654
SK-N-MC,136227924,2.70298794492574
BT 139,selumetinib-vorinostat (8-1 mol-mol),4.048057418215767
HCT 8,9926054,1.7590637787808916
BT 440,12003241,-2.6320772698218793
GOS-3,6610216,4.739620593848468
HCC-56,107985,-4.037226887068548
697,6505803,0.3097004019947232
Sq-1,10322450,4.325633425734601
DB,3136844,2.8947032902339025
SaOS-2,9903786,2.3206358959344264
SNU-503,12003241,-0.772187364196845
KMRC-2,9927531,6.175340087469203
MKN45,409805,6.427379029102213
MOLT-13,148198,-2.9272995134597157
LOX-IMVI,sirolimus-bortezomib (250-1 mol-mol),0.6922186847217285
NU-DHL-1,246676,5.479524719053534
A-549,selumetinib-vorinostat (8-1 mol-mol),2.322163064753337
HeLa,9936388,2.2030969514797256
JeKo-1,9911830,1.55296695781185
Caki-2,11404337,2.178214779259819
NCI-H2087,135875424,3.0815246928264575
Rh41,159324,0.6982198047031537
BT 271,136227924,1.335352033885486
NCI-H1915,168313200,1.9344190672197936
JK-1,148198,-4.68047289678299
KMS-12-BM,46943432,-0.1840385129667849
BT 422,439501,-3.455801521940444
KYSE-410,11404337,-0.5095483106694066
BT 504,8515,3.6274381992503786
NCI-H2286,9903786,1.3981147995547691
SK-MEL-28,107985,-2.7940500151600296
HCC1195,selumetinib-vorinostat (8-1 mol-mol),1.6123669197012191
SK-OV-3,11485656,3.3782074628341894
SaOS-2,tanespimycin-bortezomib (250-1 mol-mol),-1.2470778221654188
Caki-2,135875424,5.110553141792517
Hs 746.T,100016,6.2249168538435
OVTOKO,tanespimycin-bortezomib (250-1 mol-mol),0.5504148489500027
RPMI-8226,sirolimus-bortezomib (250-1 mol-mol),-1.8682631606171884
HCC1419,11485656,3.3617833706326277
KG-1-C,148124,-2.4914776723153995
PLC/PRF/5,439501,-1.8160204684239925
TC-71,107985,-3.2735823603491987
U-BLC1,49836020,5.6845894274854585
BT 428,6610216,3.3816789870982547
NCI-H1944,100016,8.062523558454052
TF-1,6918878,0.5577783639703056
BEN,6918878,3.6226335161338623
RKN,3689413,-4.085525957083088
OCI-AML-5,10322450,3.661053822054087
IGROV-1,11485656,1.900409616013456
A2780,159324,-2.166969557176003
SW948,409805,5.995103866916248
Panc 08.13,sirolimus-bortezomib (250-1 mol-mol),0.500337549713312
SNU-869,9927531,5.42388661469149
Ishikawa (Heraklio) 02 ER-,selumetinib-vorinostat (8-1 mol-mol),2.5379736482823625
TALL-1 [Human adult T-ALL],49836020,4.412561834618748
PSN1,135875424,4.38320892941454
KMS-11,JQ-1-carboplatin (1-1 mol-mol),-1.3337682684641334
D283 Med,selumetinib-vorinostat (8-1 mol-mol),2.011575118738352
KMS-18,selumetinib-vorinostat (8-1 mol-mol),2.400685931534778
JHH-1,136227924,2.990976056622349
T3M-10,135875424,5.0182916898666
GCT,107985,-3.933588021223445
IM95,12003241,-0.6158272527459553
HCC1500,148124,1.3380754252474834
Peer,46943432,1.3270987251698654
SF539,9936388,-8.641778658087059
CAL-148,262093,2.3702009846471928
Hs 611.T,5460769,0.2348324565646969
A2058,107985,-2.639980801689558
LP-1,44491742,3.686326414227543
TE 441.T,9926054,1.7722508105545176
KP-N-SI9s,54618164,3.938128772569179
HuH-28,159324,2.8746957838350062
SK-N-AS,6505803,0.8631817321203803
NCI-H661,168313200,3.81404568417466
K029AX,262093,3.0004551512416957
Rh18,9926054,2.105597282648335
EC-GI-10,6505803,0.7736206761478788
BT 231,selumetinib-GDC-0941 (4-1 mol-mol),1.8101702553232384
HLF,409805,3.842162011075353
NCI-H1793,9936388,1.8612470505024563
COV644,148124,-1.3281170130186468
COR-L95,12003241,2.921570030601445
LN-18,136227924,2.6730717807576347
EJM,selumetinib-GDC-0941 (4-1 mol-mol),1.950719382616822
SNU-475,135875424,5.230711078177573
MV4-11,9911830,-0.0631549000021615
SNU-685,439501,-2.253643843124453
QGP-1,136227924,3.0535414774537424
SH-10-TC,9911830,2.2874215720180464
NCI-H1734,11404337,-1.6493245767646154
RCH-ACV,439501,-2.6930538101979575
TE-9,136227924,3.0742454984310825
NCI-H716,11404337,0.1274429986614186
SK-MEL-3,6505803,3.3435678878510817
LK-2,148198,-4.1754104163119505
MKN74,6610216,4.33380428824605
IGROV-1,46943432,4.105714883822214
NCI-H1581,159324,1.3429919034073754
NCI-H2444,9927531,4.993346804303282
Granta-519,262093,1.5974758737964725
SK-LMS-1,selumetinib-GDC-0941 (4-1 mol-mol),2.0421958472836335
MKN74,44491742,4.321441779997771
BT-12,9936388,1.0683866861493725
HOP-62,6505803,-0.0366684489798773
KMBC-2,tanespimycin-bortezomib (250-1 mol-mol),0.8255558863308646
TUHR10TKB,3689413,0.0025132381526345
PE/CA-PJ34 (clone C12),148198,-4.8428586798807265
CAMA-1,selumetinib-vorinostat (8-1 mol-mol),2.4457892828715746
CFPAC-1,46943432,3.316693908453427
HEC-59,11485656,2.515586983262965
Detroit 562,262093,3.439277279464399
LK-2,tanespimycin-bortezomib (250-1 mol-mol),-0.1134545910607498
UACC-257,135423438,1.9285683204106765
Ci-1,3136844,3.9819041974439657
MOLT-3,44493528,4.004612742567489
SNU-899,8515,3.345073920637004
SK-BR-3,tanespimycin-bortezomib (250-1 mol-mol),-1.1582465529639416
SNU-840,selumetinib-vorinostat (8-1 mol-mol),2.4340389670643345
COV434,sirolimus-bortezomib (250-1 mol-mol),-0.3799222121291876
TUHR10TKB,49836020,-1.137446729131538
NCI-H358,6918878,3.0377130681925877
CAL-51,12003241,-1.2189714227076325
RD-ES,12003241,-1.2305184687153958
OAW28,44491742,4.754653012158477
NB1,11485656,1.5825359819360478
CHP-126,3136844,4.025893384803395
NCI-H1155,135423438,2.3311426063926795
LS123,9926054,2.1967740903619934
CL-11,36462,2.482069407181084
CCF-STTG1,tanespimycin-bortezomib (250-1 mol-mol),-1.580978522433375
NCI-H1694,54618164,4.0611966209465065
Panc 10.05,12003241,0.2449442349226892
COV644,6505803,4.248640118534715
LP-1,46943432,-0.1218139199537091
TC-71,9911830,2.32382211110597
KMS-12-BM,11404337,-1.6165924780935808
KMS-18,9927531,3.9141727382936624
NCI-H1395,11404337,2.1973197619817832
SNU-216,36462,2.86106389441445
SNU-1079,6918878,-1.3866850537838704
BT 228,6505803,-0.8466206341020581
AMO1,9903786,2.4699152046705253
ONS-76,159324,2.5690437216419677
OV56,3689413,-0.2367136689985935
OV56,409805,6.100421280710762
U-BLC1,439501,-3.0504776234222035
NCI-H1385,6610216,3.477667677691411
JHUEM-1,54618164,3.7597599948507217
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
SKM-1,439501,-2.678240610691138
QGP-1,9926054,1.84722301836143
KYSE-140,selumetinib-vorinostat (8-1 mol-mol),3.686519594509002
HCC1438,26596,-1.656092804302775
BCP-1,107985,-4.375939376714335
TE-1,44493528,5.0979019635900364
CGTH-W-1,409805,4.778168346758229
OCI-Ly19,44491742,4.513227413160856
Rh18,JQ-1-carboplatin (1-1 mol-mol),2.2033827405363087
KATO III,6610216,4.590153428005395
SW1271,409805,4.993473873943069
Ri-1,168313200,2.421861912259082
8505C,6505803,0.879841655503536
TE-6,246676,4.234974035576642
KALS-1,11404337,0.5593043385497104
SNU-81,9926054,1.3093723678717843
SNB-75,11404337,0.4228386005556312
HCC202,409805,3.852512528644294
SNU-878,9903786,2.6270705473192644
Calu-6,9926054,1.940861811750295
KATO III,6918878,3.777521918150907
TM-31,135875424,4.624744892996729
HCC2279,9911830,2.3540320094713456
SaOS-2,9926054,1.5065280757428428
SNU-387,10296883,4.167941134769786
MKN1,136227924,3.2741698595271025
OUMS-23,44493528,4.557464457918189
SCC-9,9927531,5.254709651648818
KNS-81,36462,4.397643214325172
KP-N-SI9s,11404337,-0.8140726577630073
NCI-H1385,JQ-1-carboplatin (1-1 mol-mol),2.259608589109217
IGR-39,10296883,4.067420766140578
UACC-62,6610216,4.142739754949153
PE/CA-PJ49,148124,-8.481770349273331
Pfeiffer,12003241,-4.957665380544675
MHH-ES-1,36462,-0.1756976495711807
Panc 03.27,12003241,-0.3666669100111787
KMBC-2,9926054,2.0094384239747294
HCC827,9903786,1.5312362888468285
G-402,46943432,1.7574910832930757
IGR-39,9936388,0.7486960389852466
MDST8,12003241,0.3559193403256231
NCI-H661,439501,-2.903837615768139
OE33,9903786,4.225835285233996
NCI-H358,11485656,2.220633179446384
TOV-112D,107985,-3.748470845385748
SCC-25,5460769,1.2990848940221191
KMS-21-BM,36462,-0.9677921947133352
SW620,100016,5.873144490676751
MOLM-13,9903786,0.7109980532390177
BT 187,24180125,2.9040005790614183
D283 Med,439501,-4.70695325279779
NCI-H2009,selumetinib-vorinostat (8-1 mol-mol),-1.4945582225586194
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681
SH-10-TC,54618164,4.2209628595779005
HCC2218,100016,5.089450081937329
ME-1 [Human leukemia],44493528,4.9966517088046345
SNU-478,439501,-2.527106469117114
TE-14,44491742,4.678720015809428
SUIT-2,6610216,4.902807448612422
KMH-2,46943432,1.9293526492233928
PC-3,36462,3.8990725123276215
TUHR10TKB,159324,3.1816852978480927
NCI-H2170,9926054,1.935868452223027
LCLC-97TM1,6610216,4.478615539127516
COLO 668,3689413,-2.474838617448709
SK-N-BE(2),148124,-5.184083311017544
SK-ES-1,tanespimycin-bortezomib (250-1 mol-mol),-0.5276941672655032
SW1573,135875424,1.8143158468632437
NUGC-3,159324,2.9089691628310845
Detroit 562,439501,-2.3410897293820003
COLO 680N,54618164,4.295037295066884
SW1417,sirolimus-bortezomib (250-1 mol-mol),0.2535776257809292
ONCO-DG-1,44491742,4.983213967285157
NCI-H1915,tanespimycin-bortezomib (250-1 mol-mol),-3.029490834381303
RCH-ACV,49836020,-2.2684832321475774
RCM-1 [Human rectal adenocarcinoma],6610216,4.434175859871968
COR-L95,5460769,3.3963309413836815
SNU-407,selumetinib-vorinostat (8-1 mol-mol),0.751458580891734
NCI-H2009,tanespimycin-bortezomib (250-1 mol-mol),-0.207724504276561
EPLC-272H,9903786,1.2271384419186997
A-498,6610216,4.284288503720797
HSC-4,tanespimycin-bortezomib (250-1 mol-mol),0.4907221930959023
Rh18,11485656,2.5820801285945927
DAN-G,44493528,4.283490884814904
YKG-1,439501,-3.197548465236136
KNS-81,selumetinib-GDC-0941 (4-1 mol-mol),3.534657473122144
TE-4,6610216,4.0741132889098655
RL,135875424,2.9597814982763753
CAL-33,11404337,-1.8217571970645148
HuP-T3,9911830,2.533690069517969
EJM,6610216,4.116260512201503
HCT 8,6505803,0.5074441333519764
EoL-1,100016,3.3783759894754795
HCC366,tanespimycin-bortezomib (250-1 mol-mol),0.9918173547189246
MV4-11,24180125,3.615373705139622
ALL-SIL,9903786,1.532435199339551
LXF 289,54618164,3.0378434141224617
Mono-Mac-1,selumetinib-GDC-0941 (4-1 mol-mol),1.552083741866212
SW1271,24180125,2.511417012575286
BT 145,3689413,-2.1573583471040827
NB1,439501,-2.2993360738685604
LN-18,11485656,1.656863008716467
SHP-77,9926054,1.3761087450643723
A-375,selumetinib-GDC-0941 (4-1 mol-mol),1.473699633531409
WM793,12003241,-0.659721194491695
BT 498,selumetinib-vorinostat (8-1 mol-mol),4.296908663159793
NCI-H1373,9926054,1.8231885221159896
IMR-32,8515,1.8895636486981031
NUGC-4,6505803,-2.369150454841633
HCC1438,JQ-1-carboplatin (1-1 mol-mol),6.275002785263112
A-549,100016,7.181380121169662
TE-5,26596,-0.6674646083378311
A-673,9927531,4.216692000672551
KNS-62,107985,-3.5303048241663664
RPMI-6666,9903786,1.3063050389166864
COR-L105,107985,-4.244896937866387
EJM,168313200,3.7804211641471097
BT 145,168313200,2.3295884217970992
639V,9936388,1.6138439311041346
SEM,46943432,-1.9096552724661455
SK-CO-1,11485656,2.076616779710352
NCI-H1650,6505803,-1.2537158640702348
FTC-238,100016,6.441740826290021
BT-16,148124,-5.849919168450062
Yamato-SS,6505803,-0.8903036807486634
BT 286,tanespimycin-bortezomib (250-1 mol-mol),-2.64428689398821
NCI-H2286,8515,5.248584846283366
NCI-H2405,selumetinib-vorinostat (8-1 mol-mol),0.4232908864831333
NCI-H1693,100016,7.64063251702684
COLO 829,9927531,5.213552390265391
ChaGo-K-1,36462,1.940737547002896
NCI-H1838,107985,-2.652915947627781
MKN45,9936388,3.1179555468131235
NCI-H1573,107985,-3.560448544788339
NCI-H2444,9926054,0.9505376631945008
NCO2,5460769,1.276478801243687
DBTRG-05MG,11404337,1.1943390639472689
SK-MEL-24,9927531,5.248971858061216
PF-382,5460769,-0.5383889446594711
SNU-1066,36462,2.955428142789315
Ishikawa (Heraklio) 02 ER-,tanespimycin-bortezomib (250-1 mol-mol),-0.660556469573982
WM983B,5460769,5.3340527249808005
SET-2,107985,-4.483879722090849
YH-13,6610216,4.911134346587397
NCI-H650,36462,2.691387318972264
GP2d,439501,-1.2526235353612607
DEL,159324,1.0301611989714654
BT 187,44491742,4.194091483119568
SH-4,9903786,3.356674972156618
MPP 89,100016,6.902779011713528
Becker,6610216,4.575848391008017
T24,9926054,1.988465622132668
SH-10-TC,409805,5.166085352116196
EFO-21,selumetinib-vorinostat (8-1 mol-mol),2.792209112341651
OE19,selumetinib-vorinostat (8-1 mol-mol),4.06149932522275
CCK-81,3689413,0.410216547608945
NCI-H1105,11404337,-1.3453817375837114
SNU-1,168313200,3.5647189331529296
OCI-Ly10,135875424,5.106467369331284
ChaGo-K-1,135423438,3.972168514727344
Sq-1,6918878,3.4321916644304986
HCC2935,135875424,5.111767291831502
MEC-1,8515,2.108041369396499
SNU-738,9903786,3.5811355233288773
KYSE-180,54618164,4.682866725736199
NCI-H1184,44493528,4.250778003560126
RPMI-6666,54618164,3.989215345651126
Lu-99,9936388,-2.3280603077053317
CCK-81,409805,5.180549735133195
LN-229,36462,3.5635069108611024
BICR 18,135423438,2.266029017324442
MJ,107985,-2.8858164405295015
QGP-1,159324,3.569458401959675
KMS-18,136227924,4.439422503928272
NCI-H1703,3689413,-2.562471575946014
KYSE-180,6610216,4.857625528938267
NCI-H1869,9926054,1.781753958996035
CHP-212,6918878,-1.2295250328780245
QGP-1,9936388,-1.1142521734336477
SW1271,9936388,2.2656701786136315
HEL,6918878,-0.4197772532459504
LOX-IMVI,3689413,-4.023880524547255
CFPAC-1,9911830,2.8943763648289833
JM-1,409805,3.649428990507172
Panc 08.13,136227924,2.4171431229910265
MOTN-1,11485656,1.953778379439836
RKO,439501,-1.8401322759847645
BT 164,tanespimycin-bortezomib (250-1 mol-mol),-0.668704186369019
U-BLC1,6918878,1.4438083974668092
OV7,107985,-3.6267899251905606
HCC1569,36462,1.738183418675638
HEC-151,439501,-1.7100799573978192
ALL-SIL,107985,-3.6188373708521495
NCI-H358,sirolimus-bortezomib (250-1 mol-mol),1.7482633742638032
MFE-296,3136844,4.396577867876318
EFE-184,selumetinib-GDC-0941 (4-1 mol-mol),4.957759622991816
DEL,107985,-3.4805705994684293
786-O,3689413,-2.4095930887688546
NCI-H524,3689413,-3.856889937044058
HT,36462,1.6293065622755083
Karpas-620,9926054,3.72255119036043
SK-MES-1,tanespimycin-bortezomib (250-1 mol-mol),-2.706649698692507
ONCO-DG-1,6610216,4.49894571194037
23132/87,5460769,0.87100881863978
NCI-H460,100016,5.855223104671776
NCI-H292,9903786,2.498172259524573
SNU-5,9927531,5.646839183086857
BT 172,8515,3.555586253309452
HuCC-T1,36462,2.236186722853638
Daudi,3136844,3.4483363469146098
NCI-H322,439501,-2.585087913028924
HCC1588,148198,-2.081842945352174
BT-16,12003241,-1.8198494997272787
NCI-H841,3136844,3.855758239319034
MG-63,10296883,4.161966556004564
NCI-H1092,10296883,3.8260798051213376
UO-31,54618164,4.25959693646093
BT 333,11485656,2.747933389336241
P31/FUJ,54618164,3.783909273991047
NCI-H2444,439501,-0.8074653551260249
OCI-AML-2,sirolimus-bortezomib (250-1 mol-mol),0.9467040078581898
WM266-4,168313200,2.299042101542935
RCH-ACV,262093,0.7174466036111895
SNU-182,36462,2.799224357966921
NCI-H1838,3689413,1.1347617687317235
ONCO-DG-1,9911830,2.7128459203034105
DU4475,selumetinib-vorinostat (8-1 mol-mol),-2.7823531761956257
BT 187,9926054,3.0457893099703197
OVISE,439501,-2.343202219776273
HD-MY-Z,409805,3.913878546925476
8-MG-BA,24180125,3.2708550287441813
NCI-H1623,9903786,3.0418604220511436
OPM-2,107985,-4.911691484457119
P3HR-1,135875424,3.923960378133027
MOR/CPR,9911830,2.8520547891794945
NU-DHL-1,135398744,6.409233084142903
P31/FUJ,49836020,4.674155414221834
KYSE-510,262093,2.791157701495768
LNCaP clone FGC,44491742,3.7255423914895776
HCC44,3689413,2.49151375476088
SF268,262093,3.1286411170758113
GCT,148198,-3.923024510865304
SK-MM-2,6918878,-0.1370320977263215
JHH-5,36462,0.9315397136596794
NCI-H810,11485656,1.6227483490056236
SW620,selumetinib-GDC-0941 (4-1 mol-mol),-0.6864895325025141
HT-144,6505803,-0.5901763284760635
NCI-H1869,6918878,4.025973288995393
NCI-H2171,168313200,1.615164123973231
SW1417,selumetinib-vorinostat (8-1 mol-mol),1.0525400374551923
KMS-34,tanespimycin-bortezomib (250-1 mol-mol),0.6300462572492305
SW620,262093,2.830381572601645
HH [Human lymphoma],36462,1.6399321018536528
DU145,11404337,1.4411442495527176
SNU-466,9926054,2.420216987024882
DAN-G,107985,-3.9359563763245458
OAW28,54618164,4.207465894202405
HCC95,3689413,2.984270072976439
UACC-62,9911830,2.15398802425272
SNU-719,tanespimycin-bortezomib (250-1 mol-mol),-1.2568282299836298
NCI-H446,9903786,1.878824600883621
NCI-H2030,409805,6.26321786552448
NCI-H841,10296883,4.212542527018102
8505C,24180125,3.3007997702973797
WM88,3689413,-2.428480680194512
KMH-2,6918878,1.3262621039986062
Ci-1,11485656,1.9220141721466868
GCT,439501,-2.020397475807145
HCC2935,9926054,1.9348902152341665
EN,11485656,1.3924868534559591
HCC44,6918878,1.5317963092393276
JHOC-5,136227924,3.178485175637893
NCI-H1105,10296883,2.7167194577249947
RKN,107985,-3.0900461086436404
COR-L105,8515,4.561371818511258
P3HR-1,selumetinib-vorinostat (8-1 mol-mol),2.8609164673310907
COLO 684,selumetinib-GDC-0941 (4-1 mol-mol),1.3698128792946012
Peer,6610216,2.802806144642803
SU-DHL-6,26596,-1.882707371112463
Mono-Mac-6,100016,3.84240036835353
AML-193,9926054,0.8292500331421907
KO52,9903786,1.3206822748757847
HOP-92,6505803,0.7885009521193799
SNU-626,46943432,4.418446938895329
HCC44,selumetinib-vorinostat (8-1 mol-mol),0.804624946321419
HEC-151,12003241,-1.83751972949174
TYK-nu,100016,5.6630271022409495
SJSA-1,159324,3.80895338828845
OVCAR-4,3689413,-2.062187861989016
EC-GI-10,54618164,4.293079526845323
NCO2,439501,-2.4046294895536446
5637,3689413,-0.8929275995994026
HCT 116,159324,3.5390690046327573
NCI-H1666,409805,3.918123899724523
SUP-T11,9926054,1.9086268061731997
KO52,46943432,4.605559929302298
SW1271,44493528,4.286060334293371
BT-549,100016,6.139281322747303
KM12,135423438,-1.274556391505103
SK-UT-1,11404337,0.3155392200884543
SK-MEL-1,36462,2.966778719187199
MIA PaCa-2,6610216,4.225429520822784
KYSE-180,439501,-1.6605779697575254
SNU-719,sirolimus-bortezomib (250-1 mol-mol),2.0194347248370432
JHH-2,selumetinib-vorinostat (8-1 mol-mol),2.324010173009433
SNU-886,107985,-2.815059265270472
SNU-216,5460769,1.6923637113112366
HuH-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8646931377295993
NCI-H23,6505803,-3.94863940408712
EC-GI-10,107985,-2.914072916658783
IGR-37,148198,-3.2890285430700064
NCI-H2452,9936388,2.1806204942966803
VCaP,6505803,0.850097300385562
HCC1937,selumetinib-vorinostat (8-1 mol-mol),3.3139482335722787
HCC44,5460769,-1.4878647509683542
WT2-iPS,selumetinib-vorinostat (8-1 mol-mol),-0.2809222958468133
VMRC-LCD,11485656,1.8176321806721345
COV362,3136844,4.225995799803608
M059K,selumetinib-GDC-0941 (4-1 mol-mol),1.9371226079768809
FaDu,409805,5.757120599805432
CL-11,44493528,4.354621073890832
WM1799,selumetinib-GDC-0941 (4-1 mol-mol),0.0731579232599876
BT 232,6610216,3.928895495899257
KYSE-70,26596,-1.4453873864890578
NCI-H1666,5460769,-0.3925578984877662
SCaBER,6505803,-1.4253513809076774
769-P,6918878,2.779371893015349
NCI-H446,100016,4.920277084242614
SU-DHL-1,12003241,0.0778318253848937
OAW42,100016,6.607597097790758
BT 112,136227924,2.645928432247734
SK-N-BE(2),44491742,3.960613770840922
BT 187,11404337,1.604866987850638
NCI-H929,11404337,-0.6691193705825791
COR-L105,6918878,5.053406021852451
MM1.S,10296883,3.0108141042121246
CMK,9936388,-7.015739641414748
M059K,6918878,5.124348533380875
5637,tanespimycin-bortezomib (250-1 mol-mol),-0.6809849161541731
NCI-H2106,136227924,2.8262070038466955
DMS 454,262093,2.385432279101096
KMS-28BM,26596,-2.75100842761318
HCC2108,107985,-3.038738614535184
ES-2,JQ-1-carboplatin (1-1 mol-mol),4.854592360478168
DU145,148198,-3.066698935751989
253J,409805,5.259163480359584
786-O,9936388,-0.7628994518050997
SNU-1077,6505803,4.592101417459953
ONS-76,6505803,1.3937943977095182
ALL-SIL,6505803,0.7073572306495796
KNS-42,148198,-2.941932964829523
HOS,148124,-6.277253873597463
KMS-11,selumetinib-vorinostat (8-1 mol-mol),2.399749533932205
SNU-1272,3689413,0.1489687776606243
KMS-26,11485656,1.8786999049789332
TYK-nu,9926054,1.6864170114704335
SU.86.86,11485656,2.809673440388426
PaTu 8988s,11404337,-0.6739371473320328
SF126,3689413,-2.3760985230108584
SNU-216,9936388,0.9315958331188322
RERF-LC-Ad1,selumetinib-vorinostat (8-1 mol-mol),4.734189741537759
PE/CA-PJ49,54618164,4.029217614638186
JHUEM-1,148198,-4.791795021050916
JHUEM-7,136227924,2.4332957155572688
MHH-CALL-3,135875424,3.7440034297864258
BT 147,135398744,6.518001641470466
NCI-H1581,11404337,-0.7792985838470738
SNU-899,12003241,-1.150293591999144
UO-31,439501,-2.964555924947922
BT 440,10296883,3.8375846267667777
RCH-ACV,409805,3.911784107181204
NCI-H1573,6610216,3.8835594235884674
SR,6505803,-2.233743184339516
KLE,107985,-4.625155684647364
SK-CO-1,44491742,5.1736211152382285
CL-11,46943432,2.565067482985585
BxPC-3,6505803,-3.0514917868960767
JHUEM-1,9911830,1.6062370327593674
TE-5,10322450,3.7882454446327087
Detroit 562,5460769,3.1492937743842724
MSTO-211H,100016,4.243846732059744
IGR-37,107985,-4.09870344472461
UACC-812,439501,-1.4243957864326813
BL-70,11404337,-3.370287818653298
NALM-6,9936388,-6.74372502576803
BT 328,9903786,4.817171686681598
IMR-32,44491742,3.818890533402266
NCI-H292,12003241,-1.027467238096921
Mel Ho,26596,-0.5803801535189402
SW48,439501,-2.266376314928653
HD-MY-Z,36462,0.9002235780520323
MOLP-8,24180125,2.8280981087253605
CCF-STTG1,9936388,2.748356806633847
NCI-H2029,selumetinib-vorinostat (8-1 mol-mol),2.618172827263168
SNU-1076,262093,2.995826964829708
NCI-H1563,9927531,5.123884061924823
Karpas-299,135875424,2.3425369765707913
MHH-CALL-3,262093,1.7879800250632032
NCI-H2405,24180125,2.50085273368924
J82,54618164,3.775864459109127
HT-1080,44491742,3.909011022661936
KMS-27,selumetinib-GDC-0941 (4-1 mol-mol),-1.985163652094814
SW579,5460769,2.5889118142562197
BT 498,selumetinib-GDC-0941 (4-1 mol-mol),3.507638604673562
HEC-108,6610216,4.664785359409005
NCI-H2170,135423438,3.656006227697759
Panc 05.04,tanespimycin-bortezomib (250-1 mol-mol),-3.230060411523549
JVM-2,6918878,0.08404687599472
EFO-27,11485656,3.240498776862908
HT115,9927531,5.770411786358663
SU-DHL-8,9926054,1.545172236486763
SK-MEL-1,3689413,2.3373069635982495
HDLM-2,135875424,3.7112298908511017
SU-DHL-8,159324,-1.6239569487690224
KMS-26,262093,1.018601177342637
Ci-1,24180125,1.336206508417529
T3M-10,10322450,3.511254114346124
K029AX,135875424,4.978137125833805
KM12,159324,1.9877209753043628
SF268,6610216,3.7969186447018455
HSC-2,selumetinib-vorinostat (8-1 mol-mol),4.145527332979143
UM-UC-3,100016,5.625806405184742
HCC1937,136227924,3.58866664774513
NCI-H211,JQ-1-carboplatin (1-1 mol-mol),-0.6701581797936323
BT 232,9936388,1.379095675434134
Hep-G2,10296883,3.682570839684776
CJM [Human melanoma],12003241,-0.9609981142913676
JHOM-1,439501,-1.2372155535522604
CCK-81,159324,-1.287250290469648
SR,36462,-0.3109859295977757
HEC-265,439501,-2.385481236661946
U266B1,36462,0.6350126648002399
MOR/CPR,sirolimus-bortezomib (250-1 mol-mol),1.9515018462114049
NCI-H1341,100016,3.8327529210726903
SK-BR-3,135875424,2.976147465835477
UM-UC-3,36462,1.2074051726105934
KE-37,9936388,-6.941921188286439
LMSU,262093,3.167641110749879
SNU-840,54618164,4.366346173630273
KYSE-450,selumetinib-vorinostat (8-1 mol-mol),4.7047853515595515
L-540,36462,-0.279391918254195
NCI-H2405,3136844,6.340311687153713
PSN1,26596,-0.5365301326145567
KE-97,6505803,-0.1313893221516437
SNU-175,selumetinib-vorinostat (8-1 mol-mol),1.1144482658649129
EPLC-272H,selumetinib-vorinostat (8-1 mol-mol),0.8736900112568272
BT 216,6505803,-2.2402570422569905
42-MG-BA,136227924,3.1509029182486845
HCC366,5460769,-0.0088365115150554
EB1,12003241,-4.025525342770554
SUIT-2,54618164,5.030082257565933
MDST8,sirolimus-bortezomib (250-1 mol-mol),1.3453299631576727
JHH-6,11404337,1.87275396496971
EFO-21,8515,4.337691454144492
NCI-H1793,36462,1.7217915676129778
L-540,11404337,-2.0629027797963664
TOV-21G,11404337,1.0752571237200843
PE/CA-PJ49,6918878,0.932833861290764
KMS-21-BM,262093,1.4735879820093536
Hs 729.T,135423438,2.291077671494273
TTC-709,46943432,2.6440206287673513
KMRC-3,262093,3.093643058080816
Daoy,12003241,1.232177667394707
NCI-H716,8515,1.647950101342266
JHH-2,26596,-0.057413924712861
RD,JQ-1-carboplatin (1-1 mol-mol),1.5252268474537996
TE 617.T,10322450,3.863383234066746
DAN-G,9926054,1.747482520890968
TE-11,44491742,4.693263805058857
Detroit 562,9911830,2.4329173444372176
NCI-H1341,10322450,2.409871050091722
JL-1,54618164,6.423495302629067
JMSU-1,6918878,4.804292373730051
B-CPAP,6505803,1.185723298587951
SW1271,9927531,4.558020454092029
PK-45H,136227924,2.93841309707887
CAL-120,11404337,0.6916203737378318
SNU-61,JQ-1-carboplatin (1-1 mol-mol),3.4608261029865615
HSC-3,439501,-2.291291548686292
RL,46943432,1.3308901805339093
U-BLC1,9911830,2.345404263930682
NCI-H1703,6505803,-4.731386050574026
KCL-22,73707440,5.760609737483316
SK-N-DZ,selumetinib-GDC-0941 (4-1 mol-mol),1.1652159438027232
A-673,10296883,3.758044639987347
EBC-1,135875424,4.611810630126507
NCI-H1299,36462,2.6599488251356536
HEC-1-A,3136844,3.984927736134899
L-363,159324,3.0592398872090123
A-172,8515,4.30738582530966
Caov-3,selumetinib-vorinostat (8-1 mol-mol),2.3601771455204226
NUGC-3,262093,3.0230092898812484
HPB-ALL,135875424,3.2013409363750474
PE/CA-PJ34 (clone C12),44491742,3.733326745267952
OCI-M1,3689413,0.2396810105329112
Hs 294T,10296883,4.084911728329476
MHH-ES-1,159324,0.9353863537723508
SW1088,9926054,2.0788174328581515
SW620,6505803,-2.457729118039499
TOV-21G,tanespimycin-bortezomib (250-1 mol-mol),-2.720450448840342
COLO 205,sirolimus-bortezomib (250-1 mol-mol),2.1268339041997457
JHH-6,selumetinib-GDC-0941 (4-1 mol-mol),2.61874119121482
UACC-812,tanespimycin-bortezomib (250-1 mol-mol),-2.245399368845158
Karpas-422,10296883,3.4516705884612704
SK-MM-2,9927531,3.423086236737343
M-07e,12003241,-1.0456216878354962
HOP-62,100016,6.313498249886369
RKN,262093,2.5285063130840344
P12-Ichikawa,136227924,2.6176590952299477
CAL-51,selumetinib-vorinostat (8-1 mol-mol),2.7100607191382187
Pfeiffer,11485656,1.3826588653804326
HCC1171,3689413,-1.743559773321706
TOV-21G,135875424,3.093416550271537
BICR 31,148124,2.7085675831815292
VMRC-LCD,8515,3.6418627663613767
2004,107985,-3.884773360661375
A-204,9927531,4.116017775807866
NCI-H1373,44493528,4.762290588865201
SCC-9,262093,3.396257832039873
RT-112,selumetinib-GDC-0941 (4-1 mol-mol),2.1504291571764287
WM115,44491742,3.78432787650886
Hs 611.T,JQ-1-carboplatin (1-1 mol-mol),1.233772265287216
BT 504,11485656,1.8828721795315295
SNG-M,6505803,0.0045720591705094
PE/CA-PJ41 (clone D2),107985,-2.5138911601110254
SK-OV-3,9926054,2.1800400954819716
SNU-61,100016,6.106397388471953
PE/CA-PJ49,3689413,1.6027869787622069
PE/CA-PJ41 (clone D2),selumetinib-vorinostat (8-1 mol-mol),2.0198593804037475
NCI-H2023,54618164,3.138297226755115
SW1783,10322450,4.230470764848986
DU4475,11404337,-2.480961012408467
RL,10322450,3.279088357497389
MG-63,46943432,5.483589733735585
EFE-184,selumetinib-vorinostat (8-1 mol-mol),2.9021971847254893
LK-2,11485656,1.8402967364166432
Hep 3B2.1-7,6505803,-0.5491843508320539
COLO 680N,9936388,1.5299770165572488
QGP-1,246676,4.4119150603625785
ONS-76,135875424,3.856833286433643
DK-MG,9903786,4.148261806293546
WSU-DLCL2,54618164,3.925367757043136
NMC-G1,6505803,2.4700924205747827
THP-1,148198,-1.1701008098943837
BT 444,10296883,4.263096612755244
NCI-H28,11485656,1.9192630984441017
KP-3,100016,6.07483479536675
MCAS,6505803,-1.4160035963714128
NCI-H2291,selumetinib-vorinostat (8-1 mol-mol),1.0028755905319455
NCI-H526,36462,-0.2788107449556972
BHY,11485656,2.162098397654175
HuH-6,24180125,2.007302619499647
PC-14,135423438,1.1691167584744715
BT 187,107985,-2.5893459748283507
SNU-308,135875424,4.501679724510711
KMH-2,148198,-4.1260923744300015
KMS-18,sirolimus-bortezomib (250-1 mol-mol),0.6867934925830966
5637,9927531,3.46604374571058
HEC-1-A,tanespimycin-bortezomib (250-1 mol-mol),-0.4943806740107087
MeWo,135423438,3.135774621295312
TYK-nu,11485656,2.0591967948441665
MDA-MB-453,6505803,-3.8322805026755806
KMS-20,JQ-1-carboplatin (1-1 mol-mol),-1.0722659574284303
BT 112,3689413,-2.4519950955667764
SHP-77,100016,6.499498313563913
SYO-1,36462,-0.3821468106451705
NCI-H747,54618164,4.351605428759409
Hs 944.T,selumetinib-vorinostat (8-1 mol-mol),-0.0424227791856705
DV-90,168313200,1.844250299013333
SNU-1033,sirolimus-bortezomib (250-1 mol-mol),0.349990621506149
EPLC-272H,44491742,4.296380741364786
TYK-nu,JQ-1-carboplatin (1-1 mol-mol),2.875539349540035
MDA-MB-415,3136844,4.39396711031463
SW1573,159324,2.9705070550476274
EPLC-272H,JQ-1-carboplatin (1-1 mol-mol),0.1127668354525981
SNU-475,9903786,5.095134957133182
NCI-H446,135875424,2.863790721987945
LS123,100016,6.571994849278421
PL-21,6918878,0.9714665821060572
AU565,9926054,0.9817648939808896
KYSE-150,54618164,4.276823128617318
KMS-34,136227924,2.5847633588950147
WM1799,148198,-2.113504584612542
SNU-182,262093,0.4168376562229068
CJM [Human melanoma],3136844,4.159189084835467
OC 314,5460769,0.7455149919957782
SNU-C1,136227924,2.406947195401098
KP-4,100016,6.84348879863886
PaTu 8902,selumetinib-vorinostat (8-1 mol-mol),2.5580221704247403
TT,135875424,4.193021061621861
AN3-CA,10296883,3.730893077527662
GA-10,136227924,1.4612725021832749
NCI-H2171,439501,-3.0635131055453924
BT 172,9927531,4.926572000473132
OVCAR-4,9903786,4.586941705699431
BT 482,sirolimus-bortezomib (250-1 mol-mol),0.6907201532102293
OVTOKO,159324,4.080099664320937
NCI-H1838,selumetinib-vorinostat (8-1 mol-mol),-0.3496961442903177
SK-MEL-3,11485656,2.032350870448147
Capan-1,54618164,5.43601274442026
SNU-8,5460769,4.64495536055113
ST486,36462,0.4017650011004973
DEL,11485656,1.7732311398144052
A3/Kawakami,148124,-4.427555036012123
Hs 766T,36462,5.389792201057677
HCC15,6505803,-2.813846830430111
KALS-1,sirolimus-bortezomib (250-1 mol-mol),0.8201349521844062
HCC2279,9927531,4.656852539502924
JM-1,12003241,0.2073989775302392
JHOS-2,409805,4.008405308224089
NCI-H1184,selumetinib-vorinostat (8-1 mol-mol),2.335103631077057
SNU-840,9903786,4.945950711370254
Hs 294T,44491742,3.9125649468331383
MES-SA,8515,3.777635178770389
KMRC-20,11404337,0.8151706043014814
NCI-H2081,10296883,3.746053952557345
LNCaP clone FGC,6505803,-1.5170131166658098
SNU-387,3689413,-0.310852459101112
SW1417,9936388,1.1366395190949656
ESS-1,selumetinib-vorinostat (8-1 mol-mol),3.369239403980627
QGP-1,409805,3.7704201197308578
SUP-B15,11404337,-2.134584192149202
SK-N-DZ,36462,1.81042272439934
EN,24180125,3.337760459599765
BHT-101,9903786,3.039821260092269
SNG-M,44493528,4.902033087695682
SNU-869,9926054,1.9894355639340104
BT-549,selumetinib-vorinostat (8-1 mol-mol),4.066811248351909
KYSE-520,439501,-3.151478653175136
MSTO-211H,107985,-3.699787970340743
LOX-IMVI,9936388,0.4128358081832157
NCI-H1869,3689413,-0.7267032921286074
SK-MEL-30,24180125,3.411770720439659
Daoy,6610216,4.836083157079014
KMRC-2,tanespimycin-bortezomib (250-1 mol-mol),2.039285304893744
NCI-N87,5460769,3.352422042402732
RT-112,107985,-3.0957792723362134
PaTu 8988s,10296883,3.673245902839484
LXF 289,3689413,0.4542816941401804
SUP-HD1,136227924,3.4836971225000735
KMBC-2,49836020,0.1766293750985906
KMS-26,9926054,0.2958792952736858
NCI-H1385,11485656,1.967780346674157
Hs 729.T,5460769,4.220142900655458
Calu-3,9936388,1.0811796684163033
JIMT-1,439501,-2.416769885537428
IGROV-1,36462,2.313632721410001
OCI-Ly19,12003241,-2.2360327877915545
SNU-685,168313200,3.8994642144724105
MKN74,9911830,3.231160876799454
YKG-1,11404337,0.7038073229533129
SK-ES-1,24180125,2.2207898097627856
SK-BR-3,5460769,4.927732708716518
MDA-MB-361,262093,2.430209495289511
AsPC-1,3689413,-2.062701377390924
OS-RC-2,44491742,4.539389041576503
MHH-CALL-4,44491742,5.077124852247723
JHH-2,6505803,0.8669908144871188
UO-31,9936388,1.3141929110792994
KYSE-150,36462,2.2869489310806497
OVSAHO,11404337,0.0344009814781069
TE-8,3136844,4.121108783220859
HCC2218,44491742,3.8267338846087497
HCC15,44491742,4.47716804785037
NCI-H520,selumetinib-GDC-0941 (4-1 mol-mol),1.617810838341725
OCI-Ly3,6505803,0.3462361722784563
TCC-Pan2,6505803,-2.1340382600385035
HuH-6,159324,3.549059872612121
CAL-78,selumetinib-GDC-0941 (4-1 mol-mol),2.58322288214442
JVM-3,148198,-2.4779915493019646
BT 231,135875424,2.2081545391597728
OS-RC-2,24180125,2.296082351399407
JURL-MK1,439501,-2.5160318205813432
HT-1376,6610216,4.281490165857978
NOMO-1,100016,4.546215242968586
TM-31,9936388,3.1233644325895185
CAL-12T,24180125,3.1463232755179225
SNU-407,262093,2.588557756768625
SK-N-SH,3136844,3.72622002886312
SNU-410,8515,4.263852404046252
HCC1833,9903786,4.187003338939228
HuP-T3,409805,5.703463345532586
COV434,11404337,-1.4918185868147884
KP-4,selumetinib-GDC-0941 (4-1 mol-mol),0.6661339772202117
GCT,135398744,7.690422491741855
253J-BV,11404337,0.2786580160895149
Kasumi-2,262093,1.7604912977671856
NCI-H146,44493528,1.3818057906729433
HSC-3,6610216,4.3028162807700365
RT-112,6505803,-1.2171367776544837
8-MG-BA,262093,2.906826185305208
MOLM-13,6918878,-0.6248914400619264
LS1034,54618164,3.795976603744235
CAL-54,409805,5.955024791707747
KMS-34,9936388,-7.578544661125487
RERF-LC-MS,168313200,3.896073258981905
HT-1376,selumetinib-GDC-0941 (4-1 mol-mol),5.083732024121345
SNU-16,JQ-1-carboplatin (1-1 mol-mol),-0.5947193789750925
MDA-MB-231,107985,-2.831885179026934
COLO 678,3689413,0.0140701655611088
NMC-G1,9936388,2.483063894359811
VM-CUB-1,36462,1.410082358150048
Hs 944.T,selumetinib-GDC-0941 (4-1 mol-mol),0.0800181936999451
HEL 92.1.7,11404337,-1.5262741770805954
HEC-251,159324,3.582550547343554
BEN,selumetinib-vorinostat (8-1 mol-mol),4.272191912190305
NCI-H508,11404337,0.8891896977969643
SK-HEP-1,262093,3.158620019748703
HuP-T4,11404337,-0.0710006834514767
NCI-H2342,135875424,4.000102704356125
JMSU-1,12003241,-3.06340831413481
UM-UC-1,262093,3.285353873808155
HCC1195,6918878,1.9622901354442763
PF-382,selumetinib-vorinostat (8-1 mol-mol),2.136528432975779
IGR-1,JQ-1-carboplatin (1-1 mol-mol),-0.2178346273954091
BL-41,sirolimus-bortezomib (250-1 mol-mol),1.1503434998526136
HCC1806,9936388,-6.293878706667742
SK-N-MC,246676,4.732478125097426
SKM-1,26596,-4.237929506963809
SK-MEL-5,148198,-1.053859411744173
HCT 116,tanespimycin-bortezomib (250-1 mol-mol),0.9696018979872172
Hs 940.T,9926054,2.0266998753682324
NCI-H23,26596,-3.72229415651004
HCC366,9926054,2.0580421664352513
SNU-899,54618164,4.198848863293895
MDA-MB-361,135423438,1.6675255620633262
OVSAHO,selumetinib-GDC-0941 (4-1 mol-mol),2.882517977180431
KE-37,262093,1.3419761733864255
AGS,148198,-2.2056365427591307
JHH-2,6918878,4.513423921721543
Rh41,6610216,3.3674197793498455
COLO 320,JQ-1-carboplatin (1-1 mol-mol),2.160423517862895
TUHR4TKB,107985,-3.5922280994521407
ZR-75-1,262093,2.676837097800324
OAW42,tanespimycin-bortezomib (250-1 mol-mol),2.1968698973757257
MDA-MB-231,36462,3.2714270621849404
MPP 89,26596,0.6612538021834572
SK-N-MC,54618164,3.6876271141926926
JHUEM-2,46943432,1.9094756808376605
BT 159,selumetinib-GDC-0941 (4-1 mol-mol),1.265249520396083
Hs 822.T,409805,5.747938151507347
EM-2,409805,3.6085049629545543
NOMO-1,107985,-4.118574275669005
ST486,24180125,1.1737019727020874
HeLa,409805,3.8139652884767377
NCI-H2342,3689413,-0.4986291797575011
RL95-2,9903786,1.393609544351605
MeWo,tanespimycin-bortezomib (250-1 mol-mol),1.6748762379833977
SNU-8,6918878,1.8134579719269337
Hs 888.T,262093,2.531155754559327
HT-55,439501,3.0049152055175377
Mono-Mac-6,tanespimycin-bortezomib (250-1 mol-mol),4.2631567174447556
T3M-10,24180125,3.807594514191483
CAL-51,3136844,4.799885860604426
MHH-CALL-4,159324,2.2712057532386254
LOU-NH91,9911830,2.650870613913377
F-36P,9926054,1.445748070072179
NCI-H727,selumetinib-vorinostat (8-1 mol-mol),-1.6328295941141144
NU-DHL-1,26596,-3.470221600864271
NCI-H441,107985,-3.286782170083998
23132/87,3689413,0.7778055116853778
NCI-H647,44491742,3.8006488884614527
KM12,262093,3.385023533358405
NCI-H1703,9926054,1.7378583933423122
DOV13,6610216,4.6419084541016415
LOX-IMVI,11485656,1.9351920109561
2004,JQ-1-carboplatin (1-1 mol-mol),0.7466571410916254
MM1.S,100016,6.180279624553647
LMSU,5460769,3.9630418347665857
GSU,tanespimycin-bortezomib (250-1 mol-mol),-0.9312032825444012
Peer,49836020,4.240424721025454
EFM-192A,107985,-2.7346010401820595
SNU-423,9936388,-4.810408284387772
NCI-H650,262093,2.723348041118166
CAL-51,409805,3.8515087112009656
WM1799,8515,5.251103222363271
HDLM-2,439501,-2.3355243460723747
KMS-12-BM,26596,-3.7364157309734822
NCI-H2106,107985,-3.3293764267517645
BV-173,3136844,3.4150387033468115
SNU-1214,selumetinib-vorinostat (8-1 mol-mol),1.1139893258531253
NCI-H1341,439501,-2.6104164072221168
GP2d,100016,6.428285689025714
Hs 944.T,12003241,-1.584632945920027
L-428,54618164,4.086288112715587
Ku812,9911830,-2.227591069329418
SIG-M5,3689413,0.233032105010129
Hs 934.T,135423438,1.6511410830672884
SNU-C4,107985,-3.918027903558023
LCLC-97TM1,selumetinib-GDC-0941 (4-1 mol-mol),1.4589950943419845
OCI-AML-2,439501,-2.945157705835344
SNG-M,8515,4.053426121946113
Caki-2,6610216,4.487698471126339
NCI-H2029,9936388,-1.4677878209950324
Rh41,10322450,3.0581399607102773
HCT 15,9903786,1.9585182501172609
SNU-620,49836020,5.484424750861699
5637,36462,0.8736544346483371
NCI-H1651,135875424,3.2371114243146453
BDCM,36462,-1.2940643345656602
JHUEM-7,3136844,4.744963133957354
Hs 578T,selumetinib-GDC-0941 (4-1 mol-mol),1.92507246829287
NCI-H28,26596,-2.2516218144459508
JMSU-1,6505803,-3.090216312025297
HuH-6,JQ-1-carboplatin (1-1 mol-mol),1.9936450141574449
OE21,24180125,3.3854112835406625
NCI-H661,262093,3.4983141095274126
SNU-761,9927531,4.19360542314586
PL-21,100016,4.334695208074886
JHUEM-2,262093,2.369625461390079
HL-60,9903786,1.6430909188137364
Hs 611.T,46943432,2.371802595815265
CAL-54,JQ-1-carboplatin (1-1 mol-mol),-0.1626654882984976
Mono-Mac-1,46943432,0.6845329233652461
SET-2,262093,0.9752595476876692
SNU-761,136227924,3.0890701215325085
KMS-26,148198,-4.824995568216466
HMCB,6505803,-1.40903466994972
NCI-H1435,3689413,0.9860334604053864
BT 224,148198,-3.2746720257013813
BC-3C,54618164,4.2924903991284395
KE-39,3136844,4.342976017638663
U-251MG,3689413,0.7299892089467567
OV-90,selumetinib-GDC-0941 (4-1 mol-mol),0.0279948147357564
NOMO-1,5460769,4.769752092364765
BICR 16,9926054,1.5790536370066437
NCI-H1435,159324,3.0916076560214125
NCI-H1339,44491742,4.759108525431012
HT115,8515,3.1218327177521563
NCI-H1155,439501,-2.4258947741424572
639V,439501,-2.2821025832606083
OPM-2,46943432,-1.735277326796896
HT115,11485656,1.923791762912221
Karpas-422,6918878,0.8908244199335652
A3/Kawakami,6918878,-0.8008619766591237
JeKo-1,3689413,-2.4394197066593835
KYSE-410,6505803,-1.395116732641888
DMS 273,439501,-3.5888564067388633
HEC-151,10296883,3.675956149700743
LS513,11404337,-0.9008701596149395
SK-LU-1,49836020,-1.7403396635124715
MDA-MB-361,136227924,3.324084435927791
ACC-MESO-1,selumetinib-GDC-0941 (4-1 mol-mol),2.151335937805361
KYSE-410,409805,4.5262440773568
WM88,10296883,3.749160769987803
Mono-Mac-1,44493528,3.807460562047893
HT-29,selumetinib-GDC-0941 (4-1 mol-mol),2.4520768151927976
EB1,10322450,2.387875240843174
LAMA-84,73707440,4.880808269322907
NCI-H2122,9903786,2.7991091527294216
OAW42,26596,0.2521816339620648
SNU-5,11404337,-1.177028079516049
SiMa,9936388,-4.904679848632844
Hep-G2,11404337,0.9907256098180968
MOLM-13,10322450,2.9930800125873045
NCI-H28,44493528,4.782322739725782
PLC/PRF/5,100016,6.529147023700783
Karpas-422,54618164,3.784290437567208
MDA-MB-231,selumetinib-GDC-0941 (4-1 mol-mol),2.1561447118873383
HSC-2,100016,6.282703144403752
SCC-25,3689413,-0.8116745291609476
NCI-H1755,135423438,4.382002312871588
P31/FUJ,6918878,-0.2487475841908946
IA-LM,168313200,3.804941602819176
NCI-H196,9936388,-3.664647197542574
BICR 22,135875424,4.925705128316808
HSC-4,11404337,-0.2351979780524762
SK-MEL-1,54618164,4.203160521869226
Jurkat,12003241,-1.1785607025510931
NCI-H2172,selumetinib-GDC-0941 (4-1 mol-mol),3.58741960121688
SNU-175,11485656,1.332587487801819
IGR-39,24180125,3.339854178002294
A3/Kawakami,5460769,1.7157310456182762
EHEB,107985,-3.431566617096362
AN3-CA,9926054,1.8039265956503063
Kelly,sirolimus-bortezomib (250-1 mol-mol),0.1077150919065075
Rh18,135875424,2.011591688646641
KYSE-510,3136844,4.134498854805466
NCI-H1694,selumetinib-GDC-0941 (4-1 mol-mol),2.084938486650406
Peer,6918878,-0.5652263591151042
NCI-H1435,9926054,1.8918877697265553
HCC1569,9936388,1.7160045234798948
COLO 699,439501,-0.4708312711011941
NCI-H1869,JQ-1-carboplatin (1-1 mol-mol),3.1851237183291765
AU565,selumetinib-GDC-0941 (4-1 mol-mol),0.6894235176740465
JeKo-1,54618164,3.7993181207921127
SK-CO-1,159324,2.1120355222347738
HEL,44484440,3.2564839193688524
KMH-2,11404337,-1.9075326301634037
NCI-H1355,24180125,4.622759020325423
NCI-H647,135398744,6.542739498462596
OCI-Ly3,36462,-1.349949194465581
SJSA-1,148198,-2.7316697840866673
RPMI-8402,tanespimycin-bortezomib (250-1 mol-mol),0.8651644866846245
C2BBe1,12003241,-0.6014753337621667
EFM-192A,10296883,4.154655152723566
IGROV-1,6505803,-0.2382223795960626
NCI-H522,26596,-2.5500947066960276
GCT,tanespimycin-bortezomib (250-1 mol-mol),0.7186181372238337
SNU-1105,selumetinib-vorinostat (8-1 mol-mol),2.6742538037072854
JHH-1,11485656,1.826654230939741
MDA-MB-468,49836020,3.927183487044253
HCC44,9926054,1.5614419320460398
YH-13,3689413,-1.970237829798131
FTC-133,9911830,2.8814152307979946
NCO2,3136844,3.804678476116922
HT-55,148198,-2.6616245414762996
HEY A8,107985,-3.8703126786131463
KYSE-510,148124,-5.076093364813466
MES-SA,135875424,4.270871924895991
PE/CA-PJ15,36462,-0.1372192920508844
HOP-62,136227924,3.3249367186884564
BHT-101,6918878,1.4130033349529694
HDLM-2,107985,-3.6724604658720623
IGR-1,9926054,1.7421331192656782
CML-T1,24180125,2.207667320892802
Tm87-16,tanespimycin-bortezomib (250-1 mol-mol),-2.1995475163951217
NCI-H1703,sirolimus-bortezomib (250-1 mol-mol),-0.4256415561025075
VMRC-RCZ,168313200,2.5099927309584924
RT-4,5460769,0.3645225539442671
HCC4006,439501,-0.4255324495628316
SW1088,6610216,4.433022811362425
HT-55,5460769,6.100853443002961
BFTC-909,12003241,-0.8371396827795129
SR,11485656,1.4152988007368743
KMS-18,6610216,3.94026464586725
Aska-SS,11485656,2.660522165344914
JHH-2,JQ-1-carboplatin (1-1 mol-mol),3.497557537915234
Mino,36462,-1.1921094192987896
TE-1,selumetinib-vorinostat (8-1 mol-mol),2.3565359063634133
SNU-201,159324,4.275700676511976
A-673,3136844,3.9161258830055736
SK-N-MC,selumetinib-GDC-0941 (4-1 mol-mol),1.42335889342789
COLO 699,11404337,1.232943062942203
IGROV-1,selumetinib-vorinostat (8-1 mol-mol),2.2605882474472057
SK-MEL-30,selumetinib-GDC-0941 (4-1 mol-mol),-0.2410221738936931
HOS,9903786,4.58127571794388
SNU-1105,135875424,3.163533063025223
OCI-AML-2,12003241,-1.1091047572975106
697,6610216,3.629204031337067
Hs 895.T,sirolimus-bortezomib (250-1 mol-mol),2.0562146171637723
KM12,9926054,1.9213576714139085
UM-UC-3,3689413,2.922700003558909
SCC-4,selumetinib-vorinostat (8-1 mol-mol),1.0043202724846296
BT 145,8515,4.164809683477465
F-36P,selumetinib-GDC-0941 (4-1 mol-mol),-0.222152579559036
SNU-1041,11485656,2.4138197522707383
KMS-12-BM,11485656,1.287590694324435
NCI-H1869,148124,3.56569848819375
OV-90,6505803,-3.2294324705329576
LMSU,6610216,5.122726082721053
NCI-H211,10322450,3.046049170762013
Hep 3B2.1-7,tanespimycin-bortezomib (250-1 mol-mol),-0.3332537957884871
RT-112,148198,-2.2564798144286597
JK-1,136227924,1.8733417156502243
DEL,selumetinib-vorinostat (8-1 mol-mol),2.397935480215318
VMRC-RCZ,10296883,4.271473325203521
NU-DHL-1,262093,0.667372891927881
AML-193,9903786,0.8964959082150169
HuT 78,6918878,-1.0659334174257225
COLO 678,11404337,1.0934047446888793
NCI-H1299,107985,-2.368506308925934
NCI-H1299,9926054,1.7323284970245385
WM983B,3689413,0.8501817874784955
BT-12,9903786,4.28961947380918
EB1,tanespimycin-bortezomib (250-1 mol-mol),-0.3360954254075145
NCI-H2122,168313200,3.523081981483709
Aska-SS,262093,2.4925778805334975
TC-71,5460769,1.4458290097671247
HEC-251,44484440,3.444790213076555
PE/CA-PJ49,12003241,-1.496755728928347
MOLT-3,6610216,3.760595220298074
LOX-IMVI,11404337,-0.9085197853802874
253J,36462,1.5975956987115052
TALL-1 [Human adult T-ALL],409805,3.458170600954479
A-375,135875424,3.696378355879961
RERF-LC-A1,439501,-2.669244370935075
HCC1954,6610216,4.626340773067161
BICR 31,136227924,2.8140968842668923
MOLM-6,54618164,3.463736162611532
M059K,tanespimycin-bortezomib (250-1 mol-mol),0.2006380895510879
TE-11,439501,-2.6156568819541435
RS4;11,148198,-5.281642952931228
IMR-32,439501,-2.4799025778743884
SNU-869,262093,3.5484440490505738
KYSE-520,9936388,1.4275069153979305
DMS 454,6505803,3.432232665344106
SNU-C5,26596,3.4561899708021175
OPM-2,6918878,0.2719026340750923
NALM-6,9927531,3.382690661986343
SNU-466,5460769,0.9969525340042612
SEM,3689413,-0.1393923728957227
SNU-478,26596,-1.226862251098003
SYO-1,9936388,-7.327541769991975
MCAS,9926054,1.882674367902201
Kasumi-1,439501,-2.487116457098306
BT 428,10322450,4.171296655818114
SH-10-TC,10296883,4.6565479517394355
OCI-M1,10322450,4.213723369205614
Yamato-SS,409805,5.817097859197369
MOLT-16,6610216,3.5275636853369097
Ishikawa (Heraklio) 02 ER-,409805,6.059507379777802
MHH-ES-1,JQ-1-carboplatin (1-1 mol-mol),0.9828156633335828
VMRC-RCW,6918878,3.2753059143263012
BT 416,12003241,-2.2907483254938774
BT 245,148198,-4.884445563516914
KYSE-140,sirolimus-bortezomib (250-1 mol-mol),2.1276089770363265
NCI-H1299,12003241,-0.9760038754339474
SNU-1079,9903786,0.8372132722803839
JM-1,36462,-2.702351282209385
YAPC,107985,-3.02393363080246
Namalwa,9927531,3.1365070733929663
TE-1,262093,3.2367135010578134
COR-L105,12003241,-1.8759508779616432
KYSE-450,12003241,-0.0119879221972118
MV4-11,9936388,-6.825137915729416
OC 314,selumetinib-vorinostat (8-1 mol-mol),2.4307033935801505
NCI-H2122,135875424,3.891671536757885
HCC1143,3689413,0.0716522323698814
NCI-H1650,selumetinib-GDC-0941 (4-1 mol-mol),2.5973614834330965
COLO 699,409805,5.831593665999148
SNU-C1,9936388,1.0138657245137583
PE/CA-PJ15,3689413,2.6755130574722767
LN-18,100016,6.511039950794577
OVCAR-8,168313200,4.004773853109795
HEL,6505803,1.212867497705534
GOS-3,49836020,5.837697611269413
B-CPAP,12003241,-1.7111954205398938
GDM-1,46943432,2.962315005619514
AN3-CA,selumetinib-vorinostat (8-1 mol-mol),3.509818575986226
EFE-184,10296883,3.6509562081155167
BT 504,9903786,2.1257740171546717
BT 248,11404337,-1.3909400551472375
MHH-CALL-4,168313200,3.206527597863312
NCI-H1299,tanespimycin-bortezomib (250-1 mol-mol),0.405614896929535
HEY A8,6918878,3.1146430988442835
Hs 766T,9926054,1.7033769922015074
UACC-62,148124,3.975689175155842
RPMI-7951,439501,-2.4869379045692313
PF-382,409805,3.4085068464251997
SK-UT-1,44491742,5.121507877742128
SR,49836020,-3.5786730229489603
Hs 888.Lu,3136844,4.7854975972573595
ONCO-DG-1,selumetinib-GDC-0941 (4-1 mol-mol),1.679099331983427
C2BBe1,262093,2.5609927987470753
A-204,49836020,-1.292663609986573
WM793,selumetinib-GDC-0941 (4-1 mol-mol),1.528214563174997
KMS-21-BM,11485656,0.7331254638608181
SK-LU-1,selumetinib-GDC-0941 (4-1 mol-mol),2.1643494773787224
SNU-840,135423438,2.360395222844115
UO-31,6610216,3.3028377500780235
BHT-101,54618164,4.746159131791783
SJSA-1,9903786,3.6249544402257863
LCLC-103H,11485656,2.3573418350596644
RT-4,148198,-0.8360848986797086
MDA-MB-231,8515,5.450664059005112
NCI-H522,439501,-5.784929410118117
SK-MES-1,100016,6.467052003541006
SNU-182,26596,-1.9870021319207585
P12-Ichikawa,10322450,3.1626592716679376
NCI-H358,selumetinib-vorinostat (8-1 mol-mol),0.0207617613285498
SH-10-TC,3136844,4.490496906114953
NCI-H292,selumetinib-vorinostat (8-1 mol-mol),2.7823927532205546
DoHH2,9911830,0.7564656851720019
BT 416,136227924,3.4255307271180726
NCI-H1339,262093,3.4716839644219246
Hep-G2,148198,-2.3541136469085493
MOLP-8,135423438,1.7176055832456645
BT-12,439501,-3.217940129826054
TE 617.T,9926054,1.7506239081922086
OAW28,44493528,4.631141764792384
G-402,6610216,4.300869455279292
MDA-MB-468,168313200,3.682580404252184
DAN-G,168313200,3.898959212674069
HCC1954,5460769,3.202561874283659
KP-N-SI9s,10296883,3.538113469874099
JK-1,JQ-1-carboplatin (1-1 mol-mol),0.4843297170939055
HEC-151,148198,-1.7915860378087891
WM793,11404337,-0.7690985454206903
HuH-28,3689413,-1.8867540967033527
LS411N,49836020,4.501659667614969
GP2d,9926054,2.6461987815751096
YH-13,262093,3.0071094341497826
NCI-H1693,5460769,1.1417796185034783
BT 359,selumetinib-vorinostat (8-1 mol-mol),2.781469406851911
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725
SW620,135398744,6.387116600988426
BT 139,136227924,3.476406727957654
HuH-6,44493528,4.083061527046497
MOR/CPR,439501,-2.2142939555112484
SNB-75,136227924,3.131186635449868
NCI-H211,8515,3.6048650203419457
HCC78,11404337,1.202138123239975
SUP-B15,148198,-7.712554258926361
TE 617.T,135875424,2.9015039808938483
NCI-H650,selumetinib-vorinostat (8-1 mol-mol),2.643357651704564
P3HR-1,6918878,5.0960120957368
Hs 683,6505803,-1.9207933299910505
RL95-2,9926054,1.9942568161623715
MHH-ES-1,11485656,2.0026914663439648
ChaGo-K-1,10322450,2.8130717345361336
SNU-5,6610216,4.615422889349808
Li-7,11404337,-1.093112923264353
FU-OV-1,9911830,2.8434321082933773
ALL-SIL,46943432,1.7359798293614472
SNU-719,6505803,-1.6348433064714072
PC-3,409805,6.300814856028665
NCI-H647,36462,3.0130697946404874
NCI-H2110,10296883,4.192584749950301
SEM,selumetinib-GDC-0941 (4-1 mol-mol),0.0721321703925677
NCI-H446,148198,-3.559974715415813
HT-1376,36462,3.4187537470401654
22Rv1,439501,-2.2106497946316175
A-375,409805,5.425302340535218
JHUEM-1,sirolimus-bortezomib (250-1 mol-mol),0.1143622651277921
MIA PaCa-2,10322450,3.5979699373077585
HCT 8,5460769,4.645297134954857
ECC12,54618164,4.292399668156714
Mono-Mac-1,159324,1.4923395471491
RCC10RGB,10296883,4.350673741830848
NCI-H1341,selumetinib-GDC-0941 (4-1 mol-mol),0.3827497304694547
SHP-77,9911830,3.164376441687973
HuH-6,36462,4.673839664670026
KMRC-2,11404337,1.481375710238033
Detroit 562,11404337,-0.2286733429262966
HeLa,6505803,-0.0506022751267441
MCF-7,54618164,4.236362509172509
DLD-1,135875424,4.314785833755313
NCI-H2286,3689413,-2.1479799329428437
WM115,3136844,4.4781621433894925
G-402,3689413,-2.398883611420732
BT 239,9903786,2.77679173166366
NCI-H1568,49836020,3.1231470101883336
NCI-H146,168313200,1.5894074456272884
Aska-SS,100016,5.454856815374324
NCI-H2087,JQ-1-carboplatin (1-1 mol-mol),-1.3930122272626189
P3HR-1,9926054,1.7849212389607798
NCI-H460,100016,5.855223104671776
NCI-H2081,26596,-1.5856459484869678
RPMI-7951,26596,-1.730558618097036
COLO 684,10322450,3.614358100313302
SK-MEL-30,3689413,3.4376299216272685
BT-20,10322450,4.517270992352955
OC 314,135423438,1.699134190233343
LN-18,5460769,0.9939611818756712
VMRC-RCZ,JQ-1-carboplatin (1-1 mol-mol),3.747713311192417
KNS-42,3136844,4.598567009270827
T84,107985,-5.262211423380302
KYSE-70,12003241,-1.4257688129039825
BT 187,6610216,3.657952430063432
UO-31,136227924,2.530889708332206
OVCAR-4,409805,4.907357976433214
NCI-H2081,148124,-3.831662126446776
KNS-81,9936388,2.4620371956354834
A-673,selumetinib-GDC-0941 (4-1 mol-mol),0.7594316863977323
KYSE-180,9911830,2.764203258021631
MKN7,24180125,3.837837013146784
Kuramochi,262093,3.1885659706851026
Calu-6,439501,-0.8430638577007564
KLE,135875424,3.394401628511705
PLC/PRF/5,sirolimus-bortezomib (250-1 mol-mol),0.3197220965800605
SK-LMS-1,6918878,4.8128232448975705
DAN-G,6505803,-1.4113382946218047
SK-MEL-5,selumetinib-vorinostat (8-1 mol-mol),1.478441576802813
AsPC-1,6505803,-1.959385905579291
2004,24180125,-0.1305197339649844
NCI-H2081,9903786,1.5566694513779922
SUP-B15,11485656,1.8615959467984833
HuG1-N,44493528,4.884146273169327
TF-1,9936388,-7.588879673689913
LN-229,11485656,2.3407589435877187
NCI-H1573,11404337,-0.6417516749678569
PSN1,sirolimus-bortezomib (250-1 mol-mol),0.321817101338521
UO-31,12003241,-2.005680138773524
JK-1,439501,-2.3094568759097265
J82,3689413,2.7361853242444045
A4/Fukuda,26596,-3.7061252239164553
SNU-213,9911830,2.5887674571936827
SNU-119,9911830,2.5015276348474424
8505C,9927531,4.3206227244137745
Becker,262093,3.305929946624271
Rh41,tanespimycin-bortezomib (250-1 mol-mol),-0.5617508290284754
OAW42,12003241,1.2884936123543242
SUP-HD1,54618164,3.232914065474842
OCI-Ly3,9936388,-6.9188564775194035
HEC-108,selumetinib-GDC-0941 (4-1 mol-mol),4.231361891065658
MeWo,54618164,4.010085322974807
BT-474,11485656,2.39208559559141
SW1463,11485656,1.9271812519349985
NU-DHL-1,9927531,5.134600574788464
JM-1,6610216,3.7780643735318615
BT 232,439501,-1.8419260323239657
HCC2218,selumetinib-GDC-0941 (4-1 mol-mol),1.5702207772151422
GOS-3,409805,3.6304586799066967
IST-Mes1,tanespimycin-bortezomib (250-1 mol-mol),0.5343992581220592
SU-DHL-10,sirolimus-bortezomib (250-1 mol-mol),0.6200641507940263
CHP-126,135875424,3.887160554276878
CGTH-W-1,148198,-3.7862022669488
NCI-H1341,5460769,4.302850791572325
DU145,sirolimus-bortezomib (250-1 mol-mol),0.8074859592711968
JJN-3,148198,-4.237204763630457
SNU-1077,selumetinib-GDC-0941 (4-1 mol-mol),2.4598192677484163
PC-14,159324,4.972641562462416
KMRC-20,6610216,4.741983793565595
KMRC-3,11485656,2.7708610077746036
GB-1,11485656,2.586323751918647
LP-1,11485656,1.1058923195648849
SHP-77,148198,-3.620060060675933
EoL-1,6505803,-1.4779318620644195
Hs 611.T,262093,0.9776083871947168
SNU-213,9903786,2.2891232968098887
RL95-2,44493528,4.087337574657741
SJSA-1,9936388,-5.643627471351419
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
HT,9936388,-5.879912313959706
MOLM-13,9927531,3.44947203831576
HuH-28,5460769,2.112533024093989
SUP-HD1,9903786,1.2830576514216323
JeKo-1,3136844,3.7415146181524017
Reh,9903786,1.595846435725099
D283 Med,9903786,1.479416225891386
SU-DHL-4,11485656,1.626108094127111
A-172,3689413,-0.4114318334262174
NCI-H2087,44491742,3.6695473170739583
SK-ES-1,107985,-4.064224654159369
SNU-1066,selumetinib-GDC-0941 (4-1 mol-mol),1.622393970628324
639V,11404337,-0.9671981800309744
OV7,selumetinib-GDC-0941 (4-1 mol-mol),2.168494345054348
ALL-SIL,11404337,-1.8413362349398936
NCI-H1694,107985,-3.656333029767555
NCI-H69,3136844,4.497125999979969
HCC1419,selumetinib-vorinostat (8-1 mol-mol),2.8318655126254986
NB4,12003241,-0.9132683604987908
KMS-20,6505803,-0.2025622916563878
JHH-4,54618164,3.864214635175561
BT 239,3136844,3.711091726367837
NCI-H2110,3136844,5.069664376003593
Panc 10.05,44491742,3.75595275347319
HCC1500,6505803,-1.3038553273576796
SCC-25,409805,3.725109800952581
CAL-62,24180125,3.2577032157820547
NCI-H510A,9927531,4.438228286684184
BT 145,54618164,3.7075953123228538
OV7,44491742,4.062871601608624
BT 330,10322450,4.515837789997584
SW620,107985,-3.2092774586493245
MOLT-3,49836020,4.359982480668932
NCI-H2170,107985,-2.7098434494469443
A2780,136227924,2.141563547945887
HCC44,136227924,2.988750330313465
RKO,54618164,4.0326978900214705
UM-UC-1,10322450,4.765411515490737
CGTH-W-1,9926054,2.1439424725815814
KYSE-30,8515,5.061057481415257
SJSA-1,100016,7.674645652371816
HT-144,selumetinib-vorinostat (8-1 mol-mol),0.5530422914319657
LNCaP clone FGC,selumetinib-GDC-0941 (4-1 mol-mol),1.7020146925511015
HuH-28,262093,3.3718876693981175
SNU-C2A,36462,2.7016140630002714
HARA [Human squamous cell lung carcinoma],107985,-4.031127583701494
NCI-H1734,49836020,-1.214582633360451
GDM-1,5460769,2.283984174479844
SK-LU-1,9911830,2.3624970438658144
SNU-719,3689413,0.5380163789509392
NCI-H747,6918878,3.0727540234618895
MKN7,11485656,2.688559348237845
Rh18,12003241,-2.237967131461188
BICR 6,54618164,4.1919991620440245
LMSU,439501,-3.1304465735998153
23132/87,44491742,4.505625737535984
ALL-SIL,9927531,4.600523700119875
NCI-H1299,107985,-2.368506308925934
NCI-H1155,11485656,2.0166410350389885
PL-21,135875424,3.3109880797567595
KMS-21-BM,135875424,2.842121058769458
TE-4,107985,-2.609556719332766
BICR 16,168313200,3.664678330841195
NCI-H1650,9903786,2.8320144189469385
SK-ES-1,6505803,0.0582919065380463
LMSU,11485656,2.410376154528579
SNU-201,tanespimycin-bortezomib (250-1 mol-mol),1.2194348373634587
SK-MEL-3,439501,-0.9323794711246036
AN3-CA,246676,4.36497705352595
SHP-77,9903786,4.085318424686739
BT 231,44491742,3.9496827176131384
BICR 22,8515,4.348804794701894
SK-N-BE(2),6505803,3.424835431725291
NCI-H1651,148198,-3.460824501598599
HT115,9936388,-5.559170111556583
SNU-1033,135875424,3.081818614002125
NCI-H1694,409805,3.645232485938763
PE/CA-PJ15,135875424,3.5762101924458585
T84,10322450,3.7674280785024976
SK-N-DZ,44491742,3.9840069294663025
HCT 8,262093,3.680435821837603
NCI-H2081,9911830,1.4932773015429426
NCI-H1869,44493528,4.333760189181675
DU145,tanespimycin-bortezomib (250-1 mol-mol),-0.7432626565730119
BT 145,44491742,4.062519071433911
BT 145,9926054,1.693307076625488
NCI-H1339,409805,5.836206098158848
COLO 680N,159324,3.5471149133283113
NCI-H322,selumetinib-vorinostat (8-1 mol-mol),3.8122623010454264
IGROV-1,12003241,-2.0122972114546904
HMCB,9926054,1.939305093595803
HCC38,26596,-1.4255018531390269
NCI-H1944,selumetinib-GDC-0941 (4-1 mol-mol),0.8132454381958738
BT 416,135875424,2.581275175967605
PE/CA-PJ49,246676,4.881777870317724
HT-29,409805,6.035174315554334
MDST8,9903786,2.958137426904596
G-292 clone A141B1,135398744,6.65861915049708
OV56,148198,-3.008820928663164
NCI-H1694,11404337,-1.0250746048431445
BT 444,136227924,3.5279486847576886
NCI-H2122,selumetinib-vorinostat (8-1 mol-mol),2.447368686339531
639V,36462,1.8340665533004876
A-204,135423438,-4.574115498517721
SW1783,168313200,3.606419156743755
BHY,135423438,4.398718869974742
L-363,409805,4.62619872485341
ONCO-DG-1,409805,5.221820983759216
DBTRG-05MG,9903786,2.261180783210366
OVSAHO,6610216,4.836498712368914
SK-N-MC,135875424,2.366794730604702
JeKo-1,136227924,2.4041415853814687
NCI-H1105,9903786,2.2828684981562013
HuP-T3,168313200,4.289513738947004
Kuramochi,9936388,1.4592676990765918
Hs 746.T,148198,-2.6846160081126422
Hep 3B2.1-7,3689413,-0.8676280815745859
HCC-56,135875424,5.1003791094232085
A-172,9936388,-2.441923795647272
253J-BV,9927531,5.275278966830564
NCI-H1299,11485656,2.4848432250614843
HT-1080,11404337,0.3572929158559362
JM-1,44493528,3.997956862382446
K-562,54618164,3.946994253297547
SNG-M,5460769,2.9987935080013695
MG-63,44491742,4.049642181579157
Granta-519,135875424,2.983761714085865
GB-1,24180125,3.6098905921033015
AML-193,9911830,1.9616986118151176
HuNS1,439501,-3.2381997907918447
IGR-37,135423438,1.6806022412705843
TE-8,selumetinib-vorinostat (8-1 mol-mol),1.8671517519131735
KYSE-510,12003241,-0.1961434673469709
NCI-H1666,54618164,4.069380954979025
PaTu 8902,9903786,4.041497343746548
BT 159,135875424,2.5273091114985777
PC-3,9927531,5.366538449676758
DU4475,54618164,3.720163464604322
OCI-M1,6505803,0.7665872263269772
KYSE-150,selumetinib-GDC-0941 (4-1 mol-mol),2.603924706865474
TCC-Pan2,selumetinib-GDC-0941 (4-1 mol-mol),0.1470991216405226
SNU-685,100016,6.855109756647912
SKM-1,sirolimus-bortezomib (250-1 mol-mol),0.3833247137434921
DAN-G,135875424,4.48447178949668
SEM,8515,3.1734533469366064
LS411N,262093,3.2594677855419456
NUGC-4,JQ-1-carboplatin (1-1 mol-mol),-0.8477062663812829
SNU-601,JQ-1-carboplatin (1-1 mol-mol),1.969115182185286
Hs 729.T,136227924,2.3598946894515014
SNU-213,9936388,2.0534039631402994
SW1271,6505803,0.8186340021888412
SU.86.86,409805,3.5437466689981676
Mel JuSo,3689413,1.1230560004280308
HT-55,409805,6.000222439376886
SNU-119,135423438,2.0179604003543288
Mel Ho,6610216,4.549497934194354
CA46,9927531,3.0223750820915978
LCLC-97TM1,selumetinib-vorinostat (8-1 mol-mol),2.6249327644586153
MKN1,10322450,5.563545254073129
LS411N,9903786,3.6806866285220017
EFE-184,6610216,4.606537612273475
SNU-601,12003241,-1.174156148938379
KMS-12-BM,12003241,-2.27657533610394
NCO2,6918878,-0.348225123723106
NCI-H1581,44491742,3.702285088658523
NCI-H1568,54618164,3.652866089784218
Ki-JK,11404337,-1.0273669041089517
SCC-4,409805,6.015616083217262
SYO-1,148124,3.7376682623632966
SIG-M5,tanespimycin-bortezomib (250-1 mol-mol),-0.3458205812117419
SaOS-2,100016,6.565789067704999
ALL-SIL,24180125,1.6553840753953686
CAL-12T,9911830,2.1862745450172576
Kasumi-2,6610216,3.59110037414398
IGR-1,tanespimycin-bortezomib (250-1 mol-mol),1.1267581666470343
MHH-ES-1,tanespimycin-bortezomib (250-1 mol-mol),-0.6292839894036704
HOS,12003241,-0.4852200240623472
SW48,tanespimycin-bortezomib (250-1 mol-mol),-3.595985811968766
MOTN-1,6918878,0.0674192948625932
NCI-H2172,9903786,4.970438346504575
HCC1143,44493528,4.485488370266477
ECC12,107985,-2.5253216616442047
UO-31,135423438,1.1750437401104377
NCI-H2170,3136844,4.204334385067317
NCI-H211,11485656,1.3378939159503729
CAL-120,439501,-2.2295565318957955
JHUEM-1,9927531,4.870867049217503
RT-4,selumetinib-vorinostat (8-1 mol-mol),2.4962461169474084
EFO-21,9927531,5.470218663007946
SK-MEL-24,6505803,-0.5263584853555022
SW579,6610216,4.132063529234779
Becker,6918878,4.133877014709684
BICR 22,11404337,-1.5250786338229352
SUP-T1,44493528,4.4942343110915655
NCI-H2171,136227924,2.167829841056951
NCI-H2122,6918878,3.1347759203186127
SNU-423,3689413,-2.448438848320713
LOX-IMVI,12003241,-2.813518393614124
SNU-407,6610216,3.823355426817763
Hep 3B2.1-7,409805,6.120261984134354
SNU-1076,3689413,-0.3890418815015654
HDQ-P1,9911830,3.444043244952707
LN-229,409805,3.62654797699027
A-253,10296883,4.076083585934383
MOLP-8,JQ-1-carboplatin (1-1 mol-mol),-0.7588683882378918
BT 112,selumetinib-vorinostat (8-1 mol-mol),2.3775465177087063
CA46,44491742,3.801952242992866
EFO-27,11404337,1.0583908830182924
KNS-81,409805,3.4402496487682788
SJSA-1,9926054,1.739207886020936
SK-BR-3,selumetinib-GDC-0941 (4-1 mol-mol),-0.2707280025522744
BICR 6,100016,5.983099357165641
ST486,135398744,6.173673764709001
5637,262093,4.0544390012856235
DU4475,3136844,4.00884158736482
RVH-421,8515,4.612413055321368
SK-N-MC,8515,2.9723089928083577
JK-1,100016,6.141145240463154
VMRC-LCD,54618164,3.9757148680155887
DV-90,9911830,-0.2837927843427922
VMRC-LCD,100016,6.5149453048399515
SNU-475,3689413,0.7678171361213897
A101D,11485656,3.576115374437905
SK-UT-1,26596,0.4182972999713699
PLC/PRF/5,9911830,2.188550604148889
Aska-SS,135875424,5.860449274469886
LUDLU-1,439501,-1.4236131557498473
NCI-H1568,11485656,1.8106242285910237
KO52,148124,-8.023122181205325
SNU-201,24180125,3.798087696111674
COLO 684,11404337,-0.4632176529743375
F-36P,11404337,-0.3828282129667895
SW1710,168313200,3.54622842973123
KMS-12-BM,10296883,2.976049270226853
KE-37,44491742,3.673383181125235
EFO-27,100016,6.711163327148508
NCI-H1623,10296883,4.489600285768525
SNU-668,9911830,2.5629729195971955
BT 216,100016,6.740671439747835
Pfeiffer,36462,0.9316278821467424
BT 131,selumetinib-GDC-0941 (4-1 mol-mol),2.219067508706083
NB4,selumetinib-GDC-0941 (4-1 mol-mol),-0.8849476640562556
TE-8,135423438,0.3747901099487811
AGS,100016,6.525427767108566
HT115,54618164,4.046748219175573
HCC78,9926054,2.494370122209171
VMRC-LCD,135875424,4.154555639991533
KU-19-19,73707440,5.592820593626321
SNU-489,9911830,2.9687601637923104
DMS 79,3136844,3.956839195559304
GCT,136227924,3.024645180957839
RPMI-8402,JQ-1-carboplatin (1-1 mol-mol),0.3952055511625851
KO52,9926054,1.7676529122170044
SU-DHL-8,9903786,1.70511202729143
Karpas-620,168313200,4.02321934640799
LS123,tanespimycin-bortezomib (250-1 mol-mol),0.0311387625429896
NCI-H2126,159324,3.545755917138017
HuG1-N,selumetinib-vorinostat (8-1 mol-mol),3.312476011895398
Hs 746.T,3689413,-1.6439550226846966
GA-10,9927531,2.891443375149746
JHH-1,409805,5.920363605270019
SNU-213,11404337,0.895138111314107
NCI-H1666,136227924,2.19834773760599
HEC-108,11485656,3.338600175698492
SEM,9903786,1.5227669871926164
KMS-28BM,3689413,-2.3321976244932134
SW620,44491742,4.4130085164157125
HH [Human lymphoma],49836020,3.7105679750249663
NCI-H1341,12003241,-1.9101542939935303
A-204,148124,-4.816977213952127
KMS-34,selumetinib-GDC-0941 (4-1 mol-mol),0.0635053645557878
NCI-H508,439501,-0.5256588079382335
PK-1,3689413,-0.025358625846968
SNU-201,11404337,0.8622736318146181
NCI-H1435,148198,-2.750299073281892
BT 330,11485656,2.0154555749445486
SK-OV-3,107985,-2.353051363092625
KYSE-180,6505803,-2.0087833017185264
HT-1197,135423438,4.472256481601468
BV-173,selumetinib-GDC-0941 (4-1 mol-mol),0.1025224911363418
EFE-184,44493528,4.48158845578013
Hep 3B2.1-7,12003241,-1.3373877223864783
DU145,44491742,3.929497920305024
MFE-296,tanespimycin-bortezomib (250-1 mol-mol),-0.069191081241384
SK-N-FI,136227924,2.3066593011882084
HDQ-P1,136227924,3.063540067223108
IA-LM,148198,-11.384967135346804
L-540,10322450,3.2951827838559895
TE-15,selumetinib-GDC-0941 (4-1 mol-mol),1.395228567811366
SW1990,11485656,1.987828191145096
AML-193,selumetinib-GDC-0941 (4-1 mol-mol),-1.3342329805744104
WSU-DLCL2,246676,4.362117975883253
Ishikawa (Heraklio) 02 ER-,135875424,3.942443711237878
SK-LU-1,6505803,-1.477995420791017
HL-60,11485656,2.725132337131944
SEM,tanespimycin-bortezomib (250-1 mol-mol),-2.121594680168012
HEC-108,148198,-2.2464200337513587
Ci-1,sirolimus-bortezomib (250-1 mol-mol),0.4066762870237297
PANC-1,11485656,2.097269968494983
Hs 944.T,136227924,3.55320847384718
BT 333,selumetinib-GDC-0941 (4-1 mol-mol),3.256611594261358
NCI-H1341,44493528,3.962775176370478
JL-1,439501,-1.5766228751230973
Hs 936.T,439501,-0.3006494435216346
SNU-216,11404337,-0.7436610925810526
HuH-1,selumetinib-GDC-0941 (4-1 mol-mol),1.7373904451201925
KATO III,9927531,6.301212923475331
NCI-H1703,9903786,2.5255687748265903
NCI-H838,46943432,5.187493822997753
BT-16,100016,4.275534033025709
LP-1,JQ-1-carboplatin (1-1 mol-mol),-0.8126599405302602
NCI-H1755,9926054,2.18101646942672
SNU-119,26596,2.579410873890194
NCI-H520,262093,2.5616079053074787
BT-474,24180125,2.5464678025826077
Hs 895.T,439501,-3.8668511324468664
JHH-1,9903786,3.3314474186941987
IST-Mes1,sirolimus-bortezomib (250-1 mol-mol),2.2264590257726704
COR-L88,5460769,4.328731747643338
OCI-Ly10,36462,1.511328691216577
DAN-G,selumetinib-GDC-0941 (4-1 mol-mol),0.9464172392973902
BT 179,9911830,2.311189147842498
KNS-42,10296883,4.193671249081411
HCC2108,100016,5.291323338255078
SU-DHL-4,26596,-1.8970615023372663
ML-1 [Human thyroid carcinoma],12003241,-1.866080903179476
KYSE-140,tanespimycin-bortezomib (250-1 mol-mol),1.07256809549566
253J-BV,136227924,2.6085874458601066
NCI-H28,3136844,3.6151068571090903
BT 231,9926054,1.8669465776815437
MOLP-8,11485656,1.8270206697288176
Detroit 562,26596,-2.098444949143179
NCI-H1651,136227924,3.2782738852919966
NMC-G1,107985,-11.863849928065331
LK-2,135875424,3.2650387901291844
NCI-H1184,107985,-3.039102604454098
JHOM-1,6505803,1.4741173976655575
DB,8515,3.587281153546521
DAN-G,148124,-7.819033791803524
SNU-475,11404337,1.9630553602139893
KMRC-20,11485656,3.1191450490376673
SF268,9936388,0.7736528995107874
TE-14,JQ-1-carboplatin (1-1 mol-mol),0.3658378251951246
GDM-1,11404337,-0.1697685825330185
A-673,409805,3.491559756034339
K029AX,selumetinib-vorinostat (8-1 mol-mol),1.1162865494323109
KYSE-450,439501,-3.185322034462323
TYK-nu,246676,5.58650577200375
MDA-MB-157,9927531,5.35009923211275
KMS-18,24180125,2.507330316138634
OCI-Ly19,54618164,3.8908263095875775
BxPC-3,11485656,2.0481416814216375
SUP-B15,49836020,5.289684304949365
2004,12003241,-2.052412032835344
BT-16,9926054,1.298876500503981
GB-1,8515,2.0817327555549436
NCI-H747,selumetinib-vorinostat (8-1 mol-mol),-1.4900573400803985
NCI-H2452,9903786,2.1501841215173396
K-562,439501,-2.3563528898814905
PL-21,168313200,3.805742072358513
NCI-H661,12003241,-1.8871798966926587
697,44491742,3.706087965098128
SNU-668,3689413,0.4740443403911467
SNU-886,11404337,1.5055907567781088
MKN74,9926054,2.8513802079001844
DEL,JQ-1-carboplatin (1-1 mol-mol),1.3960837973555382
SW982,262093,3.11351394040104
CAL-62,tanespimycin-bortezomib (250-1 mol-mol),1.0619884321927937
PE/CA-PJ49,selumetinib-GDC-0941 (4-1 mol-mol),0.8657642866761842
HEC-1-B,selumetinib-GDC-0941 (4-1 mol-mol),1.120792302253412
SW620,9903786,1.7872370567942188
NCI-H1944,44491742,3.732177387700191
KYSE-140,3689413,0.0626395685413909
Kasumi-1,9903786,0.9129411943023928
NCI-H2029,selumetinib-GDC-0941 (4-1 mol-mol),3.389084232117775
MSTO-211H,439501,-1.1644309958543906
OVCAR-8,9911830,3.0266621981898307
NCI-H2052,9903786,2.0027287626066297
Sq-1,3136844,5.374615795557544
ESS-1,5460769,-0.3251379363550979
MKN74,11485656,1.8439400608742984
DU145,135875424,4.588838795967896
GCT,5460769,3.4482432173572644
GSS,sirolimus-bortezomib (250-1 mol-mol),-2.7575012848094147
GDM-1,135398744,6.258827934702185
YD-38,selumetinib-vorinostat (8-1 mol-mol),0.9831282675647876
GSU,12003241,-0.2864311193180854
IGROV-1,6610216,4.310938387105607
SET-2,168313200,1.9017333660597997
NCI-H358,9936388,-5.546440676880145
OUMS-23,6505803,0.855156690272806
U-118MG,11404337,-0.8562943449328914
PaTu 8988s,9936388,0.6570193749634515
BICR 6,44493528,4.427648512148668
BT 187,sirolimus-bortezomib (250-1 mol-mol),0.4911829416060825
JHUEM-7,409805,3.8541488067969785
SNU-16,5460769,1.4244737217539871
8-MG-BA,selumetinib-vorinostat (8-1 mol-mol),4.658007883531654
Yamato-SS,10296883,4.303641626861945
JHUEM-1,10322450,3.3656679927658213
Mono-Mac-6,10296883,5.539962555703235
OCI-Ly10,3689413,2.738747600587094
HT-144,44493528,4.6392793264326
CGTH-W-1,6505803,-0.523636813552918
Malme-3M,135875424,3.120735979829605
RPMI-7951,409805,3.607253520959431
SK-MM-2,9936388,-2.43514787246578
SUP-T1,10296883,3.2156381873423725
HPAC,9926054,1.8309217170446392
SK-MEL-2,409805,5.943118564665864
NCI-H520,9936388,-7.179601192363118
SNU-738,sirolimus-bortezomib (250-1 mol-mol),1.9846643128257275
BT 428,439501,-3.4900182991978936
KE-37,246676,4.808811994794393
SH-10-TC,sirolimus-bortezomib (250-1 mol-mol),0.4964962482728405
OVSAHO,136227924,3.9451154225840783
769-P,159324,3.698580047376789
DOV13,11485656,2.572121506597987
HEC-1-A,selumetinib-vorinostat (8-1 mol-mol),2.344183978160483
NCI-H2030,136227924,3.923759704530775
JHH-6,tanespimycin-bortezomib (250-1 mol-mol),2.875959809379233
DLD-1,44491742,4.025001948780805
CAMA-1,262093,3.184417935809398
OC 314,3136844,3.812126244969926
SNU-466,262093,-0.0016542197274145
RMG-I,5460769,4.854195851393806
HuP-T3,5460769,4.291069487745317
TE-1,6918878,1.81591893552176
NCI-H2110,6505803,-2.3425437188382587
HeLa,selumetinib-vorinostat (8-1 mol-mol),2.818630942725572
NCI-H1395,3689413,-2.5246792207692073
WM88,136227924,2.639448330236639
SK-MM-2,409805,3.1176890725154403
HEC-151,6610216,4.488226027984822
EJM,selumetinib-vorinostat (8-1 mol-mol),1.9565276246961512
NCI-H1581,262093,2.2413159684739905
MKN74,44493528,4.689150119305487
VCaP,9911830,1.9599655969154228
CCK-81,439501,-0.4641982207624705
SNU-61,44491742,3.859456688826312
P12-Ichikawa,9926054,1.82657661814102
SUIT-2,159324,3.729714900714809
SK-MEL-24,168313200,1.6999821233302863
PC-14,107985,-3.662594404968572
NCI-H1694,24180125,1.3513315872671017
RD,3136844,4.047381970292905
SNU-81,9936388,-6.314751034125396
22Rv1,11485656,2.087552873694697
BT 320,168313200,3.0477072720221936
EoL-1,sirolimus-bortezomib (250-1 mol-mol),-9.043460932568856
HT115,9926054,3.740593425047279
SK-UT-1,tanespimycin-bortezomib (250-1 mol-mol),-0.7154967018113316
BT 159,sirolimus-bortezomib (250-1 mol-mol),0.8786451932311966
CML-T1,10322450,3.1347292789416934
EFO-21,sirolimus-bortezomib (250-1 mol-mol),2.2010900590086595
T-47D,9936388,1.741664063669155
HGC-27,tanespimycin-bortezomib (250-1 mol-mol),-1.4262734798711498
ONS-76,107985,-3.307412021608342
HT-55,44493528,4.268967793319167
SNU-1,148124,3.4248639616282777
HCC1806,9903786,3.5202039340354636
SNU-899,262093,2.8321925614753116
DB,135398744,6.337933152850909
EFO-27,135423438,3.7049046399150134
IGROV-1,6918878,1.6706182189896102
PE/CA-PJ41 (clone D2),6610216,4.420679698302765
VM-CUB-1,100016,6.234028822794693
HGC-27,11485656,1.9674233775632803
WM983B,44491742,4.283339353588083
COV362,9927531,5.782280660469085
KYSE-450,168313200,3.958386537902572
BT 422,11485656,2.164930986451698
KP-2,10296883,4.2919996415348125
Daudi,6610216,3.2134188501838494
EBC-1,3136844,6.244258207340203
HCC15,6610216,4.23435184261858
THP-1,100016,3.892329450898836
PaTu 8988t,selumetinib-GDC-0941 (4-1 mol-mol),1.0326932423441333
TE-14,36462,2.704845630868705
NCI-H446,10296883,3.7190585184043337
REC-1,6610216,3.8618283441811054
NCI-H460,136227924,3.925006850615035
IM95,409805,3.0284859777571955
KYO-1,46943432,0.7907971392982073
HEY A8,3689413,-2.2125181580464592
NCI-H2228,262093,3.7725646248304447
ECC10,10296883,3.344976615043335
Kelly,9927531,6.376471657693257
RCH-ACV,159324,1.0284560082881151
T84,6610216,3.707288952645697
Rh30,148198,-2.9975267063849507
NCI-H196,6610216,4.943661751084643
Panc 03.27,148124,-5.205294633058992
KMS-27,148198,-3.735247787675698
Capan-1,9926054,1.8783300658857656
SW1990,36462,1.719748778334474
DEL,439501,-2.407341543091591
5637,107985,-3.0961708485715667
B-CPAP,136227924,3.258845757188781
SNU-423,439501,-3.458666497477645
ECC10,262093,1.4663563613449744
B-CPAP,44493528,4.579013970980452
NCI-H2081,10322450,4.110472568642291
Karpas-422,selumetinib-vorinostat (8-1 mol-mol),1.6918556367520698
NCI-H727,439501,-2.2848783314382133
KMS-20,11485656,2.050412836201762
HOP-92,9911830,1.5727433833284383
TUHR4TKB,3689413,-1.6587483895037962
DOV13,262093,2.5740309324045327
8305C,46943432,1.2980844168012595
Granta-519,11404337,-2.8078628280004048
CAL-85-1,262093,2.917494988411318
HCC1419,selumetinib-GDC-0941 (4-1 mol-mol),1.9715069787616553
LNCaP clone FGC,46943432,1.061880867154241
MOLT-16,135875424,2.8305217651964463
A2780,24180125,2.723679145549484
NCI-H146,148124,-0.9007997951548676
KYSE-140,9936388,1.9603983153875792
RL95-2,11485656,2.119003838335733
SK-MEL-3,9911830,2.957131772222056
A-673,148198,-7.755828732328633
Hs 936.T,36462,2.938435716058904
MHH-CALL-4,6505803,0.4342437692072871
Mono-Mac-1,36462,0.1065012305215149
PF-382,3136844,3.510785171533077
NCI-H292,selumetinib-GDC-0941 (4-1 mol-mol),-0.4502449233555984
A-375,107985,-3.1836628445194592
BICR 22,sirolimus-bortezomib (250-1 mol-mol),4.6715609696805505
KYSE-30,9911830,3.463728225083358
B-CPAP,6610216,4.017338863517876
RERF-LC-Ad1,9936388,2.559895364863056
TE-8,11404337,-0.0552230225351692
SF126,24180125,3.7130980524835233
NCI-H520,9927531,5.647411307076465
K-562,10296883,3.719487542859837
HCT 8,148124,0.3582614048757344
SNU-1079,JQ-1-carboplatin (1-1 mol-mol),-1.464930217070614
SH-4,selumetinib-GDC-0941 (4-1 mol-mol),-0.2287581368829222
NCI-H1355,26596,0.1615668606609613
KE-37,26596,-2.2525665271951527
MIA PaCa-2,409805,3.7490389776997466
B-CPAP,148198,-2.876725444252461
CAL-78,JQ-1-carboplatin (1-1 mol-mol),0.9735097666189562
YD-10B,selumetinib-GDC-0941 (4-1 mol-mol),-2.4124074693543887
F-36P,5460769,6.312488647887553
U-118MG,54618164,4.155330932675476
Panc 03.27,100016,6.730276002902577
GaMG,selumetinib-vorinostat (8-1 mol-mol),3.41853760080223
EFO-27,9936388,3.039710224097925
BT 271,9927531,5.398706995408204
NB1,168313200,2.740392825488863
COLO 668,44493528,4.28656407628961
WM266-4,3689413,-0.1379446477721048
SYO-1,6918878,0.9897904291016092
RT-112,6918878,3.392592035532556
LS411N,136227924,3.1900427132689724
Hs 683,10296883,3.967060059444981
SK-BR-3,148124,-5.1305926925012235
Panc 10.05,5460769,2.1730903163441444
Jurkat,9903786,1.902939896932713
NCI-H889,168313200,2.633845785204046
SK-MES-1,26596,-0.6489352140411898
SW1088,44491742,4.15883159123132
PC-14,sirolimus-bortezomib (250-1 mol-mol),1.4531465186128956
SBC-5,3136844,4.085952663076754
DEL,100016,3.851368536137221
SCC-4,26596,-2.628163319920325
SUP-T1,54618164,4.107914943294929
HCT 15,6505803,0.2162599595018707
SNU-16,409805,3.8567661793390826
OCI-Ly19,262093,1.0490468502028176
MOLT-16,12003241,-1.273061825596023
COV644,selumetinib-vorinostat (8-1 mol-mol),1.2714620480734766
Hs 888.T,11404337,-1.3976008238381223
EFO-21,135875424,5.187448577491803
SNU-886,6505803,-0.0303295506780238
2004,26596,-1.025080107658215
FTC-238,409805,3.813014825552704
HMC-1-8,44484440,3.259078780755174
MV4-11,6918878,-0.8253678410508817
Hs 611.T,24180125,0.9846355561262036
LK-2,selumetinib-GDC-0941 (4-1 mol-mol),2.476952398707666
COR-L51,168313200,2.5521907876771848
AsPC-1,409805,5.083096669481897
Hs 888.Lu,11485656,2.9342163037973563
Li-7,selumetinib-vorinostat (8-1 mol-mol),2.389251395528668
KYO-1,3689413,-0.0705408923087068
SBC-5,selumetinib-GDC-0941 (4-1 mol-mol),2.377221196755023
P3HR-1,9911830,3.3679619343165452
BT 271,135875424,3.267528631727611
HARA [Human squamous cell lung carcinoma],439501,-2.358364257130844
CCF-STTG1,selumetinib-vorinostat (8-1 mol-mol),4.379403579151937
SNU-C4,11404337,1.6015292344690046
TE-11,JQ-1-carboplatin (1-1 mol-mol),3.4932129749903984
LoVo,135398744,6.330186357549225
MFE-319,6610216,4.57557190347099
LXF 289,9903786,1.8485652979864533
2004,262093,1.3904438006170303
YD-15,148198,-2.3396960553231456
TT2609-C02,selumetinib-vorinostat (8-1 mol-mol),3.0555400293407313
RL95-2,262093,3.494468986300009
BHY,107985,-3.391565745275974
NCI-H520,26596,-1.7163548151943342
BT 340,11485656,3.382353579781301
NCI-H28,11404337,-2.031510536668559
TTC-709,9903786,2.3304378522453866
SNU-503,409805,5.9383917645195075
CAL-51,5460769,1.3780575552768597
U2OS,135875424,4.905688284770679
CAL-85-1,5460769,4.15135857015067
VMRC-RCW,409805,5.902795568168737
BT 328,262093,2.379096363022233
Calu-1,107985,-3.5408503665357385
JMSU-1,107985,-3.68348103798744
RCM-1 [Human rectal adenocarcinoma],148198,-3.91492317301152
SNU-C4,136227924,2.9928621999202467
SNU-410,11485656,3.512018724098686
COV434,6505803,-0.6125824697560679
BICR 16,11404337,-0.0303488744380645
DU4475,10322450,2.3984430458592385
Panc 08.13,46943432,1.4716775334108003
LCLC-97TM1,439501,-2.367039612081251
OPM-2,9911830,2.101419447334853
HCC15,12003241,-1.0460858766179792
VCaP,6610216,4.200351361755344
5637,26596,-2.698358850803536
TE-8,3689413,-1.695063922582594
YAPC,11404337,0.4717703732171429
SK-HEP-1,107985,-2.2891993358893856
TM-31,44491742,6.007028920174117
SK-LMS-1,sirolimus-bortezomib (250-1 mol-mol),0.2757332914045335
HCC202,439501,-1.9855042257832605
TUHR10TKB,tanespimycin-bortezomib (250-1 mol-mol),1.8838456132179628
SK-N-BE(2),409805,6.030364994346273
Calu-1,9927531,5.244935764908175
SNU-626,11485656,3.731914296666243
Hs 888.T,439501,-5.801037223256167
COLO 201,44493528,5.016521655582729
JHH-5,135875424,3.15748575614029
NCI-H146,107985,-3.379993708562796
NU-DUL-1,36462,-1.877117130563615
CCK-81,54618164,3.3848592461901235
BT 416,6610216,3.4319544702554405
HCC1143,JQ-1-carboplatin (1-1 mol-mol),2.533079655753226
VMRC-RCZ,44491742,4.2386816825846285
BT 504,sirolimus-bortezomib (250-1 mol-mol),1.7161873277095432
NCI-H2196,409805,3.7550378026386104
BT 320,selumetinib-vorinostat (8-1 mol-mol),4.325017392219319
HSC-4,selumetinib-GDC-0941 (4-1 mol-mol),1.9348378913345816
BT 228,sirolimus-bortezomib (250-1 mol-mol),-0.6325726268478239
NCI-H460,6505803,-0.4074860596498978
NCO2,100016,5.1199760357582385
KMM-1,159324,3.5302445875104365
A4/Fukuda,5460769,3.0365194168079572
HCC95,tanespimycin-bortezomib (250-1 mol-mol),-0.0613788307173083
HCC44,9927531,3.2754168004895328
Raji,148198,-3.0979012911214077
LK-2,10322450,2.8029884793598177
HSC-2,24180125,3.69212808406266
NCI-H929,44491742,4.424394304638718
LUDLU-1,9926054,1.8617120828735427
MHH-ES-1,3136844,5.32653269194897
AsPC-1,168313200,3.2842521999758523
LS513,49836020,4.383197758831643
BICR 56,9936388,-4.960855402776582
Hs 822.T,3689413,-2.285857937794557
NCI-H1105,11485656,1.7078200129444954
ZR-75-30,selumetinib-GDC-0941 (4-1 mol-mol),2.2960611598253178
BHY,159324,3.6191013988599297
SW1573,12003241,-0.6702221198842615
MOLT-13,107985,-3.8104926329516857
NCI-H727,11485656,2.2939690780404423
LS513,107985,-2.540628881225553
MeWo,100016,6.619977613887792
BICR 18,3689413,0.5803768983412222
T98G,JQ-1-carboplatin (1-1 mol-mol),2.716924678196497
NCI-H2126,9911830,2.4864005451988787
BFTC-905,6505803,1.2859108596962958
LP-1,26596,-1.5638632087078823
WM983B,6610216,4.015594712233716
MDA-MB-468,409805,3.012784504091546
Kasumi-1,135875424,2.9305214666609904
HCT 8,tanespimycin-bortezomib (250-1 mol-mol),0.9236703838462946
TE-5,6505803,0.1996396814401048
HEC-151,135423438,1.588330635557561
NCI-H1869,6610216,4.465976467686126
C2BBe1,409805,3.7621977562133178
NCI-H522,409805,3.737006742854017
NCI-H660,148198,-5.84244418437934
Detroit 562,12003241,-1.0092858141729106
IGROV-1,9936388,2.10108466287406
NCI-H838,135875424,4.377927908580301
SNU-407,9903786,2.2079678485918977
IA-LM,10296883,4.25848729020474
BT 245,selumetinib-GDC-0941 (4-1 mol-mol),1.6158024411915433
DU145,262093,3.2967412726475187
OCI-AML-2,73707440,3.915095713182096
SW1573,409805,6.568626512075582
OCI-Ly3,tanespimycin-bortezomib (250-1 mol-mol),-0.0739277067008881
MDST8,selumetinib-vorinostat (8-1 mol-mol),1.0590621941896752
ML-1 [Human thyroid carcinoma],9911830,3.383108057822615
KE-39,159324,3.584614004631027
HCC1143,49836020,2.702530837822698
COLO 320,262093,2.003306505705094
NCI-H2171,107985,-3.896160678794096
SW48,409805,3.4729287041870127
FTC-238,JQ-1-carboplatin (1-1 mol-mol),3.2551841017728083
SU-DHL-1,11404337,-0.9851913382580488
NCI-H1092,36462,1.746172568826328
MES-SA,11485656,1.9187947649537451
TUHR14TKB,136227924,3.4575547117836836
YAPC,selumetinib-GDC-0941 (4-1 mol-mol),2.7150403374869856
TE-6,107985,-2.7595126559033454
AU565,10296883,3.47614106437246
RPMI-8226,selumetinib-GDC-0941 (4-1 mol-mol),1.6638240545531544
NCI-H1581,selumetinib-vorinostat (8-1 mol-mol),2.561236854042443
MKN7,selumetinib-GDC-0941 (4-1 mol-mol),2.574249068911848
Lu-65,54618164,4.000249960497271
SK-MEL-1,sirolimus-bortezomib (250-1 mol-mol),1.7691939182804728
NCI-H2106,JQ-1-carboplatin (1-1 mol-mol),3.821123323467481
SaOS-2,5460769,2.263492155098724
TALL-1 [Human adult T-ALL],selumetinib-GDC-0941 (4-1 mol-mol),0.2604149322081276
DMS 79,JQ-1-carboplatin (1-1 mol-mol),2.1232478586327215
LMSU,168313200,4.186982561512388
22Rv1,sirolimus-bortezomib (250-1 mol-mol),-5.664247196474798
Raji,107985,-3.425855595457866
TF-1,selumetinib-GDC-0941 (4-1 mol-mol),1.467323615098958
IST-Mes1,136227924,2.313131576565863
COLO 829,12003241,-1.833925982592443
SNU-1,54618164,3.71429087796208
KP-2,44491742,3.9373322425213138
ESS-1,9926054,1.828443058535804
NCI-H1155,9903786,2.7353298872083984
ECC10,10322450,3.1238725703849988
LOX-IMVI,selumetinib-vorinostat (8-1 mol-mol),2.269667540856765
NCI-H747,3136844,4.409113692665309
GCT,148124,-5.863408209006589
SIG-M5,135875424,3.9161233057534584
JHOM-1,107985,-3.070831769435884
SNU-201,135875424,3.4476242027363715
DV-90,10296883,3.593064780015178
A2058,135875424,4.909286996355865
TCC-Pan2,12003241,-0.2350019856779653
LMSU,26596,2.3008598244356935
IGR-1,135875424,5.003318891233818
ME-1 [Human leukemia],11485656,2.505616015022391
HuH-6,tanespimycin-bortezomib (250-1 mol-mol),0.4881830883702249
RD,136227924,2.2627633289805424
GI-1,11485656,2.981503140786654
KMS-34,10296883,3.0941719737889515
KYSE-510,10322450,3.90855044095945
Granta-519,tanespimycin-bortezomib (250-1 mol-mol),-0.1680583743842791
AsPC-1,54618164,4.187549957668634
OVTOKO,11404337,0.3114289672372418
NCI-H2087,8515,3.0210679259054003
SK-N-FI,148198,-6.001619008319419
HEC-1-B,11485656,2.1491894336103123
SK-MEL-1,9936388,1.368356716964437
SNU-620,36462,1.92809998402212
HT-1197,262093,2.0088485136907575
NU-DHL-1,5460769,0.1990382783266381
BT 228,selumetinib-vorinostat (8-1 mol-mol),3.923422561678695
BT 224,tanespimycin-bortezomib (250-1 mol-mol),-3.111223300831193
SNU-410,262093,2.9879613961382363
IGR-37,10322450,5.040348991848962
NCI-H2087,49836020,4.38375865979883
IGROV-1,9936388,2.10108466287406
TE 617.T,12003241,-2.151805000440827
SNU-C2A,JQ-1-carboplatin (1-1 mol-mol),1.666650905200112
M-07e,JQ-1-carboplatin (1-1 mol-mol),-0.796008398970337
NCI-H1838,9926054,1.7507639405240023
CCF-STTG1,409805,5.227575027972168
NCI-H1944,6610216,3.869359165778001
SNU-C5,selumetinib-GDC-0941 (4-1 mol-mol),1.7590235463431136
SW1783,11485656,3.310538702987134
Hs 936.T,54618164,4.395374360312425
TE 617.T,tanespimycin-bortezomib (250-1 mol-mol),-1.7403863885968738
Hs 839.T,3689413,-2.374647409552807
PL-21,439501,-2.414753232425099
MKN7,10296883,4.147888797827488
TUHR14TKB,148124,4.386073638804714
LS1034,9903786,3.887461634575776
IGROV-1,135398744,6.402844237905131
BC-3C,11404337,0.8699913882296267
NCI-H520,439501,-2.5978412941351405
PK-59,6505803,-0.3559678115713951
LUDLU-1,selumetinib-GDC-0941 (4-1 mol-mol),1.599632203402907
HDLM-2,3689413,0.2567400255605154
TCC-Pan2,3689413,-0.1350455546392483
JM-1,54618164,3.458143614246244
NCI-H1693,409805,4.770245399026225
G-401,46943432,1.6295589064479152
OVK18,3689413,-2.4624871166851965
MeWo,6610216,3.8113300714365126
HCC1937,409805,5.257165815525836
KMS-18,11404337,-2.191729984555339
Rh30,9926054,2.2159405572329143
Hs 578T,10296883,3.7096057485466223
SNU-899,9911830,2.8044737059102474
A-673,5460769,1.3883868162718005
CHP-212,135423438,1.6303147778889178
8305C,6505803,0.0695536722094139
COR-L47,148124,1.2838207358762983
NCI-H716,9936388,-4.976580043871955
RPMI-8402,9903786,1.556072952295762
SW1353,36462,4.974473156128621
HCC827,9911830,0.6669309541853267
NCI-H810,135398744,5.260119762115652
HCC1143,11485656,1.8564802256291268
RPMI-8402,24180125,2.381809209442335
LN-229,11404337,0.1730765836405472
NCI-H1755,10296883,4.225143740358611
KMS-21-BM,10322450,3.0637099399177936
KO52,148198,-6.726627358418003
KYSE-180,409805,5.709174911109602
HCC1806,24180125,3.752298638781302
BICR 22,72199289,4.441607504718354
A-204,54618164,4.119063693275809
SW579,6918878,5.446818694952154
AsPC-1,8515,4.986545700595871
P31/FUJ,148198,-3.664233852608881
OCI-AML-5,26596,-1.736130608355082
NCI-H2122,5460769,2.4268150631675067
SNU-5,54618164,3.8244213161134497
SNU-1,100016,5.685360721271126
Panc 05.04,3689413,-0.0862100916213441
SNU-1,44491742,4.0790825455255195
BT 245,11404337,-1.7449999203479594
EJM,49836020,4.362565190709962
CAL-51,148198,-3.728190383000159
KMS-18,44491742,4.313842675965846
SNU-245,selumetinib-vorinostat (8-1 mol-mol),0.3021660304268694
HCC1937,9911830,3.374692037294104
BT 172,439501,-3.021522386524776
HCT 15,44491742,3.7262724808810295
SK-UT-1,9926054,1.807396230777958
A4/Fukuda,107985,-4.34456564276242
PE/CA-PJ15,44491742,3.9025986426144934
BT 224,9927531,6.091778203420535
CHP-212,sirolimus-bortezomib (250-1 mol-mol),-0.2954884064996527
EKVX,3136844,4.5895063245751615
SK-BR-3,JQ-1-carboplatin (1-1 mol-mol),3.127240758828175
KYSE-30,tanespimycin-bortezomib (250-1 mol-mol),0.3165609096596899
SNU-308,36462,4.516059663616316
HOP-62,439501,-3.0300699988747333
MEC-1,9903786,1.8402940604427764
RPMI-8226,11404337,-0.8965265864586413
CAL-54,44491742,4.012557158379019
ESS-1,6505803,-2.0071033756271106
KCL-22,439501,-2.3189522381647194
DMS 53,9936388,-3.9040655164911686
WT2-iPS,9926054,1.80219025961501
RCH-ACV,246676,4.239213024568716
SH-10-TC,100016,6.555483038363527
SW1783,135875424,4.794068332474245
CAL-54,5460769,-0.0866419988438866
VMRC-RCZ,135875424,4.757952332015436
RT-4,9936388,-6.517969541343547
SK-N-BE(2),6610216,3.968848166238241
NCI-H1869,selumetinib-vorinostat (8-1 mol-mol),2.952305626055488
NU-DHL-1,107985,-5.852649208769622
BT-20,11485656,1.799713509383809
PLC/PRF/5,selumetinib-GDC-0941 (4-1 mol-mol),2.3628622666013683
SCC-9,JQ-1-carboplatin (1-1 mol-mol),3.612051093214818
KMRC-20,3689413,-2.0293333018936877
FTC-133,sirolimus-bortezomib (250-1 mol-mol),1.8639176688857977
BV-173,9936388,-7.205824957487243
MOLT-16,3136844,3.3587931874190704
NCI-H1184,9903786,1.9169497440885477
BT 232,148198,-4.3155726249188
SW1710,26596,-1.5930178898936072
EJM,107985,-4.84255557894517
HuCC-T1,12003241,-1.0945393222434805
SK-N-AS,10322450,4.76025598295129
U2OS,100016,5.485609538675787
OVCAR-5,selumetinib-vorinostat (8-1 mol-mol),0.2015701638150661
KP-N-YN,409805,3.805476541257568
EFO-21,9936388,3.018454857449296
DOV13,409805,5.824694231108339
Sq-1,262093,2.8908130105513856
HOS,409805,5.854955980569708
Kasumi-1,107985,-4.35650494929647
Hs 294T,JQ-1-carboplatin (1-1 mol-mol),4.214438557750139
SNU-878,262093,4.410693672921156
KCL-22,9911830,-0.7546255295012573
BV-173,44491742,2.039629297457472
Kelly,136227924,2.280835674454857
MFE-319,10296883,4.228563171543355
DMS 53,selumetinib-vorinostat (8-1 mol-mol),2.453431663164935
DK-MG,44493528,4.356107772315373
PE/CA-PJ49,439501,-2.9475727314168174
BT 333,107985,-1.308331021854272
RERF-LC-A1,sirolimus-bortezomib (250-1 mol-mol),0.1484412834683056
Namalwa,26596,-3.71974803891978
COV434,12003241,-2.0451557846060537
SCaBER,9911830,3.3117474506944253
JHUEM-3,24180125,3.5826346710476256
NCI-H526,26596,-1.5534394961181943
SU-DHL-8,5460769,1.8345696055083096
TYK-nu,159324,2.671430187813448
TE-10,sirolimus-bortezomib (250-1 mol-mol),0.6005656385189257
HPB-ALL,8515,4.035374798889955
JHUEM-2,sirolimus-bortezomib (250-1 mol-mol),-3.6728570307591686
Ishikawa (Heraklio) 02 ER-,6505803,-0.7712031048650526
L-363,100016,4.553463106890726
EJM,44493528,4.28788220416213
SH-4,135875424,4.59145070139426
KATO III,10322450,4.372347394636034
TYK-nu,3689413,-0.8961723591289054
OPM-2,148124,-6.3849256320012575
P12-Ichikawa,5460769,2.2031078708702196
DBTRG-05MG,439501,-1.6362214385175518
BT-474,135875424,5.915453425364125
BICR 31,5460769,3.9433617709959696
U-118MG,8515,5.012125879248694
SNU-449,6505803,1.2866498789511422
CCK-81,9911830,2.89026136478977
IM95,tanespimycin-bortezomib (250-1 mol-mol),-3.0654337981747273
SK-N-MC,36462,-0.6057353178382218
TYK-nu,8515,5.680791185105499
TALL-1 [Human adult T-ALL],6918878,-0.5475107526958405
DOV13,tanespimycin-bortezomib (250-1 mol-mol),0.5750258227871521
SNU-8,sirolimus-bortezomib (250-1 mol-mol),0.5784576721065883
GA-10,selumetinib-vorinostat (8-1 mol-mol),1.5334838453135928
SNU-478,5460769,1.0103147308873888
GP2d,selumetinib-GDC-0941 (4-1 mol-mol),-1.1591880613582235
TTC-709,tanespimycin-bortezomib (250-1 mol-mol),0.5220611379237968
KMH-2,tanespimycin-bortezomib (250-1 mol-mol),-0.7573218655291942
A-549,136227924,3.1395144761786486
SNU-899,9926054,2.026075556253581
PSN1,9926054,1.7845816919346065
SW1088,11404337,0.4126276779889334
HSC-4,10296883,4.12801319058873
HT-1376,135875424,3.6702822969792193
HCC1569,107985,-2.9750377581153353
HGC-27,12003241,-2.439316929165163
COLO 792,44493528,4.179590114468014
COLO 668,44491742,3.890577146633183
EoL-1,11485656,-6.598388814450544
JURL-MK1,26596,-1.965499498470982
OPM-2,136227924,1.7425170628423947
MDST8,9911830,3.786562744766562
MDA-MB-435S,262093,2.2230696932896
SF268,135875424,2.548556170220251
SK-MES-1,136227924,2.193847007439744
Rh18,159324,2.379884885928139
RPMI-7951,3136844,3.4252156043373945
U2OS,3689413,0.3310874452746708
8505C,49836020,5.7227071797800235
SK-MM-2,24180125,2.1802693421852943
NUGC-4,26596,-1.113746804335536
NCI-H1105,sirolimus-bortezomib (250-1 mol-mol),0.3147728445720161
CAL-27,10296883,4.057207739356728
COLO 678,439501,-1.1365168855313783
Caki-1,136227924,3.8203162456228417
JHH-4,262093,3.0993355303406305
GI-1,10296883,3.999407360262004
Hs 746.T,24180125,3.39079368613673
SNU-869,9903786,4.230852859752073
OV56,9926054,1.8437049272321575
Rh18,49836020,4.886485383707075
DU145,9936388,-2.7050109048591287
SNU-1041,136227924,4.256354114890169
Hs 822.T,6610216,4.486963526445925
SW1116,3136844,4.749108435900641
IM95,11404337,-0.2020778805418927
BT 330,8515,4.407994026323292
HCC44,sirolimus-bortezomib (250-1 mol-mol),1.406227075762608
SCC-25,148198,-2.3874045507068895
BT 147,135875424,2.90044056464114
TT2609-C02,10296883,5.629000446872017
CAS-1,135875424,5.317066072752183
Capan-1,selumetinib-GDC-0941 (4-1 mol-mol),1.801614812477531
LUDLU-1,148124,-7.004374520301572
SKM-1,44493528,3.979629908351757
UM-UC-3,135875424,2.7438914646322106
NUGC-3,54618164,3.5634318473860658
GCT,sirolimus-bortezomib (250-1 mol-mol),1.1354554226801
U-BLC1,11404337,-1.495782153452068
HCC2108,24180125,3.362517679132719
IGR-37,26596,-1.7212662992488197
HEC-251,5460769,6.090602801092177
KYSE-520,136227924,3.1208401396418592
SUP-M2,3136844,3.930281517713076
HPB-ALL,10322450,3.7687188105178206
5637,9911830,2.7400256251979704
OC 314,11485656,2.060949002481836
SNU-761,11404337,-2.3232289106427695
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
U-251MG,selumetinib-GDC-0941 (4-1 mol-mol),1.876710388033308
RD,168313200,3.695848535571739
TALL-1 [Human adult T-ALL],9927531,3.369458546084366
Hs 888.T,3689413,-2.4304159299205215
GaMG,159324,3.8399876349206634
LC-1/sq-SF,sirolimus-bortezomib (250-1 mol-mol),0.7549261124626822
CA46,107985,-3.181693098398671
SNU-886,selumetinib-vorinostat (8-1 mol-mol),0.3326918028445991
TE-5,12003241,-1.2234174090075007
BT 131,262093,2.390336920502222
BFTC-909,148198,-2.03933057080943
U266B1,6505803,-0.3564252706563441
SNG-M,6610216,4.501978621447079
TUHR4TKB,9903786,3.6038306258320425
HCC366,159324,3.430182711772013
NCI-H2030,9926054,2.071654789099982
MHH-NB-11,6918878,0.0062220420470276
8305C,selumetinib-GDC-0941 (4-1 mol-mol),-0.5953379888353332
KYO-1,9903786,1.1587901811719317
JVM-3,439501,-2.5078633176007803
JHUEM-7,9926054,1.641999407547345
OVSAHO,24180125,2.408510590249746
KM12,5460769,1.9442092441204395
Hs 936.T,6918878,1.8534972681438395
BT 112,sirolimus-bortezomib (250-1 mol-mol),0.0905666857071608
DU145,409805,7.850532015731276
Hs 766T,107985,-4.370036602649094
SK-N-SH,selumetinib-vorinostat (8-1 mol-mol),2.237833901076091
OVSAHO,135875424,4.354044130900052
Karpas-299,12003241,-0.4647539333721411
647V,262093,3.044497646509944
SW982,3689413,-0.7945580289517821
NCI-H2081,6505803,1.279924414831301
KHM-1B,5460769,1.8331932839616616
Kasumi-1,JQ-1-carboplatin (1-1 mol-mol),-1.0248552118786003
COR-L95,136227924,2.879022500990784
KE-39,24180125,2.8951506389407053
LoVo,9936388,-7.372990206557469
HCC1143,9926054,1.808099247882512
CAL-62,100016,6.567555445612565
SK-LMS-1,6610216,4.4083288999249
TE-15,24180125,5.117300850152298
JHH-5,262093,2.961551350403051
PF-382,73707440,6.113676619987129
AML-193,107985,-4.640089928252453
EKVX,136227924,3.396888883126824
NU-DUL-1,8515,2.6851290714182543
COLO 678,12003241,-1.07618054300688
SW1353,11404337,0.8555790619059997
KYO-1,6505803,0.8445463549156219
KYM-1,9903786,3.7679848907863738
EB1,46943432,5.750857255240241
HEY A8,9936388,2.7984735931283153
PL-21,159324,0.5268160005724882
KP-N-YN,11485656,3.2850291914647345
NCI-H716,12003241,-5.132639925352329
SKM-1,3689413,-2.418262014134033
Kelly,54618164,3.6776094025388586
SK-MEL-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.7049789212673134
KP-3,JQ-1-carboplatin (1-1 mol-mol),5.58247855672367
Fu97,6505803,-2.9243122575537552
BT 179,11485656,3.2813483165810218
NCI-H460,9911830,3.1326305509826824
NUGC-4,sirolimus-bortezomib (250-1 mol-mol),-0.7003911185233305
NCI-H1568,262093,2.8880881470868585
NCI-H661,6610216,4.875851858170822
OVCAR-5,9911830,2.2712250942356143
RS4;11,36462,-2.0562478035325698
DV-90,36462,-0.1530229688681401
SNU-245,44491742,4.301989616183203
ACHN,sirolimus-bortezomib (250-1 mol-mol),2.4619171301455736
A-549,439501,-2.483005959928592
LN-18,159324,3.14866398912549
NCI-H1869,439501,-1.575584272947446
HCC1806,3689413,2.70275971282259
CHP-126,107985,-3.8801620613703087
Li-7,136227924,3.3307357238068818
DMS 79,tanespimycin-bortezomib (250-1 mol-mol),0.386728913048693
Capan-1,9936388,2.896402107939059
TT2609-C02,54618164,4.21791188620747
HH [Human lymphoma],3689413,-2.48685445642347
EBC-1,24180125,2.7534112587240194
LS513,8515,3.476923089541429
NCI-H524,135875424,1.583285673103297
SNU-878,26596,-1.9589890224119235
SW1353,11485656,2.8326664945571585
P31/FUJ,107985,-4.114404549725097
PC-14,6505803,-1.6585666949761726
SNU-489,409805,3.7956139980045225
HCC366,262093,3.5189758741975905
COLO 800,54618164,4.241548358407708
SNU-1076,sirolimus-bortezomib (250-1 mol-mol),0.4980535505825825
OAW42,3689413,0.5201903722679624
NCI-H322,tanespimycin-bortezomib (250-1 mol-mol),-2.794682738050535
TE-5,136227924,2.0128832307516715
NCI-H446,3136844,3.0889204745358243
BT 504,6610216,4.285733774392814
Hs 746.T,selumetinib-vorinostat (8-1 mol-mol),2.6877277725717357
Hs 940.T,44491742,4.308619589326881
P12-Ichikawa,36462,-2.2820035892706345
COLO 205,439501,-0.8424951249003566
COR-L105,136227924,2.729950058152846
SEM,36462,-2.7360640601525845
NCI-H1105,439501,-2.509690538840725
A-204,100016,6.602223097366851
SK-UT-1,6610216,4.443950873518219
T98G,9903786,3.9737183240681153
U-937,9926054,1.4281376565753103
COR-L95,168313200,1.9910859109269063
SK-ES-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4310498502666769
CAL-120,9926054,3.430797555245233
253J,46943432,4.809748990223763
ONS-76,10322450,3.321198163736043
HCC1428,439501,-1.870619220326862
Mono-Mac-1,10296883,2.780550097818586
QGP-1,100016,6.909688760762285
BICR 6,5460769,0.6237785323656337
ONS-76,9936388,2.029236983033262
CA46,6610216,4.017162804005507
GSU,3689413,3.217966232949248
Hs 934.T,11404337,-0.0491167451592997
BT 139,9926054,3.0317650629280717
HCC2218,26596,-0.1880453521462128
NCI-H1373,46943432,2.6710701637629684
CAL-78,9936388,2.7062290727666816
SK-LMS-1,3689413,-2.0473825870324935
CMK,409805,5.884748544483751
Daudi,selumetinib-vorinostat (8-1 mol-mol),1.8930359660265372
NALM-6,selumetinib-vorinostat (8-1 mol-mol),1.444675581802376
SK-HEP-1,136227924,3.6301481247272287
LS123,12003241,0.0406446748290718
ZR-75-30,10296883,3.903831871588827
5637,439501,-2.4129442020826697
TM-31,107985,-3.4988477305101857
TE-15,11485656,1.960576997256463
UM-UC-1,36462,0.7932866865942573
KE-39,selumetinib-GDC-0941 (4-1 mol-mol),2.2885736306774076
Ishikawa (Heraklio) 02 ER-,sirolimus-bortezomib (250-1 mol-mol),0.8957919072189129
TM-31,439501,-2.1329770748027426
HCC2218,6918878,2.7353588630987686
HCC1806,11485656,2.35396149601903
SNU-1041,135875424,4.844300116851518
MOLT-16,6505803,0.4764435531440419
TALL-1 [Human adult T-ALL],107985,-3.66791594276573
BxPC-3,49836020,-2.380895293574403
MOLT-3,5460769,-0.5989426440895276
HOP-92,sirolimus-bortezomib (250-1 mol-mol),1.0049376292822905
NCI-H1975,9903786,1.3990648437170825
NUGC-3,409805,4.126577550423276
SU-DHL-8,6918878,-0.5624575718237048
WM793,6505803,-1.695252066312567
253J,136227924,2.473625062581448
Aska-SS,selumetinib-GDC-0941 (4-1 mol-mol),-0.3966051454003071
HSC-2,8515,3.770008719257322
SiMa,36462,0.1829414877953918
KMS-12-BM,44493528,3.477782404349953
TE-8,159324,3.1716058711532833
647V,6505803,0.3251392573539524
U2OS,11485656,2.250878225413065
CAL-120,136227924,2.519967645750226
HuP-T3,136227924,2.888640375816574
DMS 454,3689413,-0.1217907891040976
Li-7,159324,3.1204100188155777
DMS 53,sirolimus-bortezomib (250-1 mol-mol),0.155507409478016
TOV-21G,11485656,3.507052738885456
OCI-AML-5,11485656,1.9457799090606884
BC-3C,12003241,-1.7584420473179934
KP-N-YN,262093,1.320292146111092
MPP 89,168313200,2.3014494159332815
MDA-MB-415,135875424,2.557894559104866
CHP-126,10296883,3.566759468815065
KNS-60,49836020,-2.408070727278554
LK-2,136227924,2.893153940116167
SF539,6505803,-2.26727491960267
TE-5,9911830,2.198323188623282
G-401,3136844,3.887156631896907
KYSE-410,135875424,4.192963545953549
SUIT-2,12003241,-0.3419407469483631
SK-N-BE(2),11485656,1.869214340930476
42-MG-BA,54618164,4.748966757965469
K-562,9927531,3.3022164605184763
MOR/CPR,409805,5.7867477385029815
SNU-1214,6610216,3.72445074492986
NB4,6918878,0.0231800425939129
253J,246676,2.022290784770066
A4/Fukuda,11485656,1.5130746228374388
SF539,46943432,2.0271543904998746
P31/FUJ,3136844,4.357504973194935
OCI-Ly19,11404337,-3.477649976578423
Hs 888.T,selumetinib-vorinostat (8-1 mol-mol),3.55147943154118
U-251MG,sirolimus-bortezomib (250-1 mol-mol),1.1740336487454477
GSU,6610216,4.620250876462257
UACC-257,10322450,5.085942175181601
NCI-H1341,44491742,2.77003350871112
Lu-99,135875424,3.620221919582757
HCC366,8515,6.197083268003746
MDA-MB-157,sirolimus-bortezomib (250-1 mol-mol),1.4679701866850798
NCI-H1105,12003241,2.305570238632079
SNU-503,9927531,6.946018069076572
NCI-H1693,49836020,4.720041053935088
BT-12,tanespimycin-bortezomib (250-1 mol-mol),0.4298883528890555
SUIT-2,9936388,2.2499280975506393
SU.86.86,36462,3.59253947895057
8505C,11404337,-1.4016142280742767
Hs 729.T,11485656,2.9602548110779145
FU-OV-1,10296883,4.259179003182187
NCI-H2009,54618164,4.160237516111787
HDQ-P1,9926054,2.660031643800519
TE-15,168313200,2.769784502897391
Mono-Mac-6,135875424,2.7965119530378906
Hs 852.T,54618164,3.172900105103994
DU4475,6610216,3.725870143122914
KMRC-1,409805,5.852991634240623
TE 441.T,3136844,3.779446579435195
TE-9,6610216,4.485470919587612
LoVo,sirolimus-bortezomib (250-1 mol-mol),0.1095810263563626
BICR 22,6505803,-0.8504421983690468
KP-3,54618164,4.648325993327064
PF-382,6918878,-0.2369499162228823
T-47D,3689413,-1.6434373642176223
OV56,100016,6.603582199202106
MOLT-13,9903786,1.350785557130732
BT 131,36462,2.7060964215405043
G-402,9903786,2.6546356785146084
TE-10,107985,-3.1810326059958585
HCC2218,136227924,2.978872567688762
Karpas-620,100016,5.312019885835398
HEC-1-B,12003241,-1.9447585975595445
VMRC-RCW,selumetinib-vorinostat (8-1 mol-mol),2.6578648618984526
SNU-81,8515,4.116210915577815
NCI-H2106,44491742,3.3894720811903976
CHP-212,JQ-1-carboplatin (1-1 mol-mol),-0.8333787356849307
JeKo-1,6610216,5.101386243640172
BT 444,135875424,3.072023667711102
CCF-STTG1,sirolimus-bortezomib (250-1 mol-mol),2.0360820241023876
HT,11404337,-1.0705366474134053
MHH-CALL-3,5460769,1.3871224464271157
GB-1,136227924,3.951727784027331
THP-1,9911830,3.0400846204578262
LOX-IMVI,135875424,4.258043031810949
CHP-126,tanespimycin-bortezomib (250-1 mol-mol),1.029486462123943
OC 314,148124,-5.275997135374238
BT-20,9903786,4.2067479925704925
PE/CA-PJ15,10322450,4.3579745096101075
MHH-CALL-3,9926054,1.9964305651779948
HT-29,sirolimus-bortezomib (250-1 mol-mol),1.8819281446300895
EPLC-272H,10296883,4.153935511243516
SNU-407,46943432,1.5271600155892695
KYSE-30,136227924,3.298083829392356
COR-L51,11485656,1.4536828113034417
5637,11485656,2.17002066337147
SNU-1196,3689413,-1.8376731206647552
HCC366,selumetinib-GDC-0941 (4-1 mol-mol),2.581638032416284
JL-1,9926054,1.8045722808491491
CW-2,409805,5.860844498475822
Lu-99,439501,-2.3036425217634395
LMSU,148198,-4.18626130759339
TE 441.T,selumetinib-GDC-0941 (4-1 mol-mol),1.683399232345051
MOTN-1,439501,-3.3199671011375913
CHP-212,26596,-3.74720846369554
SUP-T11,8515,4.480563126453878
IST-Mes1,11404337,-0.5180157624887997
KYSE-30,100016,6.190453384433256
BFTC-909,tanespimycin-bortezomib (250-1 mol-mol),0.7192435114334943
K-562,262093,3.1056763935044813
NCI-H2009,26596,-1.5885219134108934
HeLa,8515,1.8792207243719483
A2058,46943432,5.180107767391253
NCI-H1915,12003241,-2.138789855422618
TF-1,100016,6.442708110888471
HT-1080,409805,5.848431740020943
OC 314,9926054,1.7783261777640869
SW1271,262093,2.7991981503454495
NCI-H2141,3689413,-3.646913366295815
CFPAC-1,100016,6.545938487461667
NU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),-0.7283867124282789
SU-DHL-8,11485656,1.738295367016229
LS1034,selumetinib-vorinostat (8-1 mol-mol),0.4760250390753199
KMRC-1,selumetinib-GDC-0941 (4-1 mol-mol),1.816727012202974
COV362,135875424,4.673498463439342
JIMT-1,6610216,4.8659942522490365
IGROV-1,6505803,-0.2382223795960626
KMS-12-BM,sirolimus-bortezomib (250-1 mol-mol),-0.0125868994295277
HCC1569,46943432,3.698021495912772
NCI-H1355,3689413,0.7312644846226123
SNU-61,6610216,4.086517799339023
JHOM-1,11485656,1.6870772577759805
LS411N,46943432,5.879073426568822
Granta-519,168313200,2.290121636997186
MDA-MB-435S,409805,3.705135997804818
SCC-25,44491742,4.077227537084196
BT 172,26596,1.567138444115151
HDLM-2,9903786,0.9941602221273084
TT2609-C02,36462,0.8008481405878352
HCT 15,10296883,4.151348683553031
Hs 578Bst,24180125,2.67706598994645
MHH-ES-1,3689413,-2.44734032949193
BT-474,148124,-3.6450938662304457
A-204,11485656,-0.4332502433044572
DND-41,26596,-1.3202555430270588
MOTN-1,11404337,-2.499451139937234
Hs 852.T,107985,-4.821135599843027
KM12,26596,0.910782273652732
IGR-39,54618164,4.233555537459641
G-401,107985,-4.394015959361378
UACC-62,9936388,3.097569174421774
MDA-MB-157,44491742,3.772080854170876
MPP 89,selumetinib-GDC-0941 (4-1 mol-mol),2.3167615576876734
VMRC-RCW,246676,3.8050193333668463
PF-382,9926054,1.6899693166343082
HCC366,6505803,3.392526655908561
NCI-H1694,36462,-0.7254541172270241
KP-N-SI9s,135398744,6.4391278360731246
ALL-SIL,8515,1.9161675301812888
NCI-H716,11485656,1.4384613287076216
HCT 116,409805,6.026395844071452
JHH-2,11404337,-0.6360298022443034
A-172,148198,-5.088269215681032
HCT 15,11485656,1.8077127542489733
NCI-H1703,135423438,-3.3255405313096733
Lu-99,36462,0.6677201445831182
HMC-1-8,tanespimycin-bortezomib (250-1 mol-mol),-0.5086629381230219
BT 112,262093,1.8523945417932268
CL-11,107985,-3.0176631781990313
F-36P,136227924,2.476842028434826
HuH-28,44491742,4.601953674704061
LCLC-103H,3689413,1.9966381223526644
JM-1,148198,-6.864264453079388
PaTu 8988s,selumetinib-vorinostat (8-1 mol-mol),2.3854275000826592
697,439501,-3.82474204489092
CAL-54,439501,-3.2230187997856308
JHOC-5,262093,3.0668349870794542
P3HR-1,selumetinib-vorinostat (8-1 mol-mol),2.8609164673310907
GSS,159324,1.2139166709223652
SF126,107985,-2.3534932872641803
CHP-212,10322450,3.626434944218361
COLO 320,3689413,-1.9916072658639432
KP-2,409805,5.00023719878481
WM115,262093,2.5199436905866905
HCC1428,8515,5.291455907802894
SiMa,5460769,0.4503719492820418
FU-OV-1,168313200,1.721890351327649
UACC-257,9903786,4.920300978966239
HH [Human lymphoma],46943432,-1.3973827152305456
DU145,10322450,6.851968050616261
IM95,3689413,0.7350625809131119
KHM-1B,JQ-1-carboplatin (1-1 mol-mol),-0.2133455800101861
YD-15,5460769,-2.912025087128814
RERF-LC-MS,10296883,4.230661493555322
HCC1937,9936388,1.6949856124341256
Ki-JK,11485656,1.8508993883264373
HSC-3,5460769,0.5796773846600773
MHH-ES-1,sirolimus-bortezomib (250-1 mol-mol),0.9882924076413532
A-375,159324,3.1651524914786333
MOLT-3,409805,3.005730430773921
HCC366,44493528,4.3832061934270445
HCC1500,44493528,4.240662848371031
OCI-Ly10,selumetinib-GDC-0941 (4-1 mol-mol),1.0181444461611715
KYSE-520,tanespimycin-bortezomib (250-1 mol-mol),-1.1109729915268285
NCI-H2444,409805,4.152431794667637
SNU-886,12003241,-3.694795257520175
YAPC,135875424,4.215334227700636
DMS 114,148124,-6.476256055928947
Raji,26596,-2.574302974428465
G-361,9903786,2.8296470400432296
DMS 53,409805,5.806403713845953
RVH-421,5460769,4.814862206766451
SNU-16,54618164,3.5842381712580367
GDM-1,12003241,-2.0828988572069487
SEM,11404337,-1.9668178292815095
BCP-1,46943432,1.2230336269713535
YH-13,10296883,4.196539709790054
HCT 15,sirolimus-bortezomib (250-1 mol-mol),0.2078755227007766
NCI-H1385,439501,-0.294435314613152
CGTH-W-1,100016,5.226111530095554
CML-T1,36462,-1.7431711247812498
COLO 320,sirolimus-bortezomib (250-1 mol-mol),0.8564336763022389
JHOM-1,12003241,-1.2744243269669069
LXF 289,5460769,3.06478422280727
NCI-H1581,9903786,1.8918310652044057
NCI-H2126,107985,-2.5508062145194264
NCI-H2452,36462,2.3648017756260327
DMS 454,6610216,3.227176343293299
Hs 888.Lu,9926054,2.118592716385535
NCI-H211,26596,-3.016523907085459
BDCM,8515,3.1088597237934423
NCI-H23,5460769,-1.0672070635340756
SW948,6505803,-1.4287073835677784
NCI-H716,46943432,2.344580529763938
Hs 611.T,168313200,3.4582352812742516
253J-BV,439501,-2.3122827098315515
TT,selumetinib-GDC-0941 (4-1 mol-mol),2.303935736572117
G-402,tanespimycin-bortezomib (250-1 mol-mol),-2.2331450772750285
NCI-H460,6505803,-0.4074860596498978
Pfeiffer,10296883,1.0462803777158507
NCI-H1651,11485656,2.5009504795873516
KATO III,JQ-1-carboplatin (1-1 mol-mol),1.5255725604391266
L-428,136227924,2.9759698761374795
HCC1438,3689413,-0.4859764672187859
PLC/PRF/5,6610216,3.842648408877997
TT2609-C02,5460769,3.053476613598646
SaOS-2,3689413,0.0712794264513353
RPMI-6666,262093,3.187153978804494
Karpas-299,10296883,3.126285958642229
MJ,tanespimycin-bortezomib (250-1 mol-mol),-0.74419356352866
Aska-SS,11404337,-0.8839501993376483
PL-21,8515,3.0959710718642044
ACC-MESO-1,9936388,3.1205070846652374
VCaP,44493528,4.161690845377168
AN3-CA,11404337,1.5621280335523782
AsPC-1,9936388,-0.8199656713038528
LOX-IMVI,439501,-2.207275092585139
U-CH1,11404337,0.9399047306468424
SNU-387,tanespimycin-bortezomib (250-1 mol-mol),0.93646564215711
NCI-H146,11404337,-1.5914515878545687
NCI-H1623,sirolimus-bortezomib (250-1 mol-mol),0.487688387449291
NCI-H1355,5460769,3.1635335423218907
Mel Ho,36462,3.5703976572231557
NALM-6,136227924,1.937403591420271
Namalwa,6918878,-0.0380235771387645
MKN7,262093,2.224966476841938
Mono-Mac-6,selumetinib-GDC-0941 (4-1 mol-mol),2.3199178680358683
F-36P,135398744,6.4039586130062505
23132/87,100016,5.572734576179291
IST-Mes1,8515,4.272788297141445
SF126,9903786,3.79320485000813
BT 112,439501,-2.896282798681624
ME-1 [Human leukemia],262093,1.5767156474221262
BT 359,409805,5.267313408202177
NCI-H1793,49836020,4.8036601506688275
Hs 578T,sirolimus-bortezomib (250-1 mol-mol),0.4812309444002518
KMS-28BM,6505803,0.5045053527572001
Hs 611.T,26596,-1.6290206215335707
SH-4,sirolimus-bortezomib (250-1 mol-mol),0.5100564849810528
SaOS-2,148124,-5.379251304292956
JL-1,262093,4.749807355253156
OC 314,36462,0.0152019987062778
CHP-126,54618164,6.478655654296826
PC-3,11404337,1.6869548437610449
NCI-H1915,11485656,1.946470366394693
OVISE,54618164,4.29678583267412
Malme-3M,49836020,-0.4276181558524726
HMCB,6610216,4.4861904027359145
MeWo,sirolimus-bortezomib (250-1 mol-mol),0.5468033899342802
GDM-1,11485656,-1.9414124993158248
NCI-H1944,JQ-1-carboplatin (1-1 mol-mol),2.139349165329713
SU-DHL-10,168313200,3.8517286241032327
KNS-60,9911830,2.602703450863029
KATO III,148124,2.7785183378157434
LS513,26596,-1.0957721063054122
Hs 294T,9926054,1.7844528476619044
SW1710,sirolimus-bortezomib (250-1 mol-mol),0.811654459506224
JHOS-2,11404337,1.6734890105758244
PF-382,159324,-2.108239526563577
A-549,54618164,4.216271974260082
KMS-28BM,9911830,2.6443818956107696
RPMI-8402,9926054,1.3971414667672897
CAL-29,9936388,1.3417151621152168
GDM-1,9926054,1.958570414824769
NH-6,9927531,5.219237358239311
KP-4,135423438,2.950077613704309
SNU-1,selumetinib-vorinostat (8-1 mol-mol),2.376035951172743
Panc 03.27,sirolimus-bortezomib (250-1 mol-mol),0.6121410442614872
BT 248,6505803,-0.8385222866943476
DK-MG,135398744,6.3715043377255665
RKN,159324,4.081844329649501
HPAC,selumetinib-GDC-0941 (4-1 mol-mol),0.9383091275833384
Reh,54618164,3.699236852109201
TE-6,tanespimycin-bortezomib (250-1 mol-mol),-0.454134198851735
Lu-99,9927531,4.1215148534256105
DB,6610216,3.677102937964002
SNU-620,11485656,1.82591162033248
MJ,26596,-3.924273415415616
ChaGo-K-1,11404337,1.1508536619225571
RPMI-8226,9936388,-6.980714667404577
SH-10-TC,168313200,3.5833535240153225
NCI-H460,135875424,3.211754300989152
MKN45,sirolimus-bortezomib (250-1 mol-mol),2.222344728894145
Rh30,selumetinib-GDC-0941 (4-1 mol-mol),1.4659883817366972
KE-97,3136844,4.073039312215867
CAL-51,9911830,2.6702149728757343
HOP-62,11404337,-1.0489074115392232
SNU-1079,46943432,-0.9154654720433444
YD-8,107985,-2.331165064329628
KMS-27,159324,1.3693882554650931
HT-144,3136844,4.390659372957952
Panc 10.05,tanespimycin-bortezomib (250-1 mol-mol),-0.5396853932122618
LN-18,9911830,2.2683333599151254
SNU-685,10296883,4.374649581801884
RPMI-6666,6918878,0.5474521682952321
Hs 294T,3136844,4.088065037649113
MDA-MB-157,selumetinib-GDC-0941 (4-1 mol-mol),2.2510493382113155
HuH-1,135875424,4.883016404001769
LCLC-97TM1,135875424,3.9585615026829823
HT-144,6918878,3.205794089065829
MCF-7,9936388,1.4763358152049189
JHUEM-7,sirolimus-bortezomib (250-1 mol-mol),-6.320695454237984
BV-173,6505803,-0.0472737333369297
BICR 56,136227924,3.153782585129781
BC-3C,tanespimycin-bortezomib (250-1 mol-mol),1.3285525848592783
SNU-475,100016,7.606290519099935
U-BLC1,262093,2.6001367621084306
JHH-1,tanespimycin-bortezomib (250-1 mol-mol),1.1160802698150678
BT 416,selumetinib-GDC-0941 (4-1 mol-mol),1.4242599676579912
U-937,44493528,4.3838606909350055
OCI-AML-3,409805,3.723467633820993
CAL-12T,selumetinib-GDC-0941 (4-1 mol-mol),2.008414160334409
KO52,168313200,1.5421636413024
MPP 89,9926054,1.8831902537321672
KYSE-150,tanespimycin-bortezomib (250-1 mol-mol),-0.0451263891138861
HCC1833,9911830,3.390320046455881
YH-13,sirolimus-bortezomib (250-1 mol-mol),0.2727627020521754
Ci-1,JQ-1-carboplatin (1-1 mol-mol),1.531401836561634
RS4;11,JQ-1-carboplatin (1-1 mol-mol),-0.1933675643740757
OE19,12003241,0.3915460727280876
PC-14,11404337,-0.86699452338107
NCI-H1734,9936388,-4.869160721724045
Fu97,159324,2.7232800930597367
KE-97,9926054,0.8495096752282992
IM95,100016,6.474511795509729
BICR 6,168313200,2.895523161821981
NALM-6,JQ-1-carboplatin (1-1 mol-mol),-1.4954941357174671
BICR 22,9903786,3.2901982519836213
HDQ-P1,tanespimycin-bortezomib (250-1 mol-mol),3.130731084653335
NCI-H2029,135875424,4.350194062307378
LS123,11404337,0.6660636167955499
Calu-1,11404337,1.1287217214353569
BT 145,409805,4.038584920935172
A2780,135423438,1.4521240670524396
AsPC-1,9926054,1.8957621767397328
PaTu 8988t,46943432,6.478561461465468
Ki-JK,6918878,-0.708873883906706
HEC-251,26596,-1.8718311463988424
HCC1195,159324,3.4692745079061997
EoL-1,11404337,-2.4489617476913432
REC-1,44491742,3.8136752597353953
TCCSUP,3689413,0.6301346851622357
HuT 78,selumetinib-vorinostat (8-1 mol-mol),-4.277294994055841
OAW28,10296883,4.314409366833216
BT-12,24180125,2.7437053891950636
LC-1/sq-SF,6610216,4.211537724220602
FaDu,148124,3.760375102860639
MDA-MB-435S,100016,6.42664314163943
BFTC-909,9936388,1.702123766125507
SNU-899,11485656,2.609975330684587
NCI-H929,24180125,2.4641763284453795
SF539,24180125,3.915045335194428
Kuramochi,148198,-1.655835644166272
NCI-H1341,26596,-1.5435661996164969
DV-90,10322450,2.5684087153895447
COR-L105,sirolimus-bortezomib (250-1 mol-mol),-3.794916830429034
MFE-296,24180125,3.541536211927579
Hs 294T,26596,-0.6328702993813093
HT,8515,3.745952882940517
HMCB,135423438,4.419625220654583
ACHN,5460769,0.8804471145118281
WT2-iPS,24180125,3.3778109257931086
KMS-28BM,36462,0.1305397549429897
NCI-H1694,262093,1.281080897473335
NCI-H460,44484440,3.757520830720006
TE-10,46943432,3.9363265037788087
HCC827,44491742,3.1413058075131746
42-MG-BA,9926054,1.7568260355296932
SNU-398,5460769,0.8679915096242241
BT 340,135875424,2.9922583399282163
Panc 03.27,9926054,1.7808185952102251
SF126,54618164,4.040751371978287
Jurkat,439501,-2.365566126578654
NCI-H2170,tanespimycin-bortezomib (250-1 mol-mol),-1.8178915881298592
KP-4,tanespimycin-bortezomib (250-1 mol-mol),-2.4280197504959107
MeWo,262093,2.898334268827345
RS4;11,46943432,0.8873668364178348
VCaP,262093,1.994503008869617
GB-1,12003241,-0.733058723008687
SW1417,54618164,4.206542858646136
HuG1-N,54618164,3.8770793996245345
SK-LU-1,44491742,5.866940990531296
NCI-H1299,24180125,3.786842850309645
NCI-H2122,6505803,-2.4477843500675207
EFO-21,tanespimycin-bortezomib (250-1 mol-mol),0.1444768142311704
YD-8,selumetinib-GDC-0941 (4-1 mol-mol),2.360092412498975
MDA-MB-157,439501,-3.062684000428755
KYSE-140,135875424,3.5989722346209927
LK-2,36462,2.1867677758587405
PK-1,5460769,3.319049240944118
BT 328,selumetinib-vorinostat (8-1 mol-mol),3.560914687145029
SNU-423,9926054,1.7894708985292902
JHOS-2,10296883,4.146882384876985
U-BLC1,9926054,1.6248687315541563
MDA-MB-468,148198,-4.179391115817734
KE-97,107985,-4.681691793558965
BT-12,36462,3.2397163088580103
COLO 668,11404337,-0.9260086161567648
NCI-H1395,selumetinib-GDC-0941 (4-1 mol-mol),2.3368578075304463
COR-L95,135875424,3.0866900102445816
BT 416,168313200,1.511876706612717
U-BLC1,148198,-4.602164076011155
NCI-H1666,9936388,0.7507462468701122
AM-38,9936388,-6.913644192260965
BEN,439501,-2.2680431594189727
GA-10,9911830,0.6286737251156136
NCI-H1734,11485656,2.0530229474698194
KMS-12-BM,44491742,3.489197811217823
MDA-MB-453,44491742,4.088527945953042
OCI-Ly3,12003241,-1.5890645032871102
HEL,9936388,-3.337900467930123
BICR 22,10322450,4.612637955736889
SNU-1041,3689413,2.0809742429378133
HSC-4,9936388,2.361545024779824
HCT 116,6610216,4.8185648619977295
MDST8,selumetinib-GDC-0941 (4-1 mol-mol),0.8218915121525238
Detroit 562,6610216,4.0643326669057505
Calu-3,159324,1.8349438271720837
KNS-60,409805,3.248100992650401
SK-MEL-5,159324,3.0838844609903355
LP-1,262093,1.1866363383040155
VMRC-RCW,159324,3.6824970215019697
MDA-MB-435S,159324,2.5157696151622413
SUIT-2,11485656,3.4408604141627763
A101D,8515,4.373950298019086
YD-10B,9911830,1.8444860220568733
RMG-I,36462,2.9909817181283556
HCC1419,3136844,5.446603940608748
NCI-H211,135423438,1.3338851322165923
TUHR4TKB,9926054,1.808622022375876
SNU-1076,100016,6.986031941643801
KMH-2,107985,-4.440693549832868
HGC-27,6505803,-2.0578617298265787
HPAF-II,tanespimycin-bortezomib (250-1 mol-mol),0.3261912422307886
EoL-1,168313200,1.1681418802699055
8505C,262093,2.08540105499643
HEC-1-A,11404337,0.0023043827287881
HCT 15,439501,-2.431117301372995
Hs 578T,12003241,-1.9219753364875385
AN3-CA,11485656,-0.8274044857319752
KE-39,24180125,2.8951506389407053
CA46,tanespimycin-bortezomib (250-1 mol-mol),0.4718837425399894
BV-173,148198,-4.631322243168152
HEC-151,6505803,0.2052514279790806
MOLP-2,3689413,-0.0389139812968664
Hs 936.T,9936388,-4.507745146359587
Hs 766T,12003241,-1.434019858151168
HCC2935,11404337,1.520718137800647
TE 617.T,selumetinib-GDC-0941 (4-1 mol-mol),0.2172055936678418
SNU-475,6610216,4.19198835261524
NCI-H524,9936388,-8.40858165815813
SK-MM-2,9903786,2.9629309693480983
Ki-JK,44493528,3.660755145624423
KYM-1,107985,-4.451776269961161
JHH-5,JQ-1-carboplatin (1-1 mol-mol),1.839630269464315
NCI-H2052,12003241,-1.5616837194527835
RKN,selumetinib-GDC-0941 (4-1 mol-mol),1.8547441727402172
UACC-257,9927531,4.918712273550195
MFE-319,9936388,3.279926844383342
NCI-H1092,9911830,2.3624309911243313
SK-N-AS,148198,-4.149694989731526
SET-2,10296883,3.6220267482667943
NCI-H838,100016,5.521581837907123
Panc 02.03,5460769,1.6540560754425335
BT 172,selumetinib-GDC-0941 (4-1 mol-mol),1.268434466812915
DU4475,9903786,2.594571624962549
Mono-Mac-1,9911830,2.1868049767694044
SNU-182,54618164,3.7450225513985753
KP-N-YN,9911830,1.0744667275955389
SNU-869,6610216,4.335710435048634
HCC4006,11404337,0.6477756071897834
NCI-H2405,262093,3.3162860948220714
MHH-NB-11,136227924,1.3020282745517038
KMM-1,selumetinib-GDC-0941 (4-1 mol-mol),3.455450229836309
NCI-H1694,26596,-2.376634499212247
LK-2,3136844,3.931711044879019
VMRC-RCW,135398744,6.359457324257638
DEL,selumetinib-GDC-0941 (4-1 mol-mol),2.6612594732504475
Yamato-SS,selumetinib-GDC-0941 (4-1 mol-mol),-1.5672740621691217
YD-38,5460769,0.587016845611175
PE/CA-PJ41 (clone D2),136227924,3.7691635351021855
KYSE-520,107985,-2.3636087010870392
8305C,tanespimycin-bortezomib (250-1 mol-mol),1.1491228196694627
LS123,107985,-4.283414364428649
BT 145,JQ-1-carboplatin (1-1 mol-mol),4.281045912366545
SNU-1079,6610216,3.35756036881602
NCI-H2141,8515,4.27499486698666
SNU-1196,selumetinib-vorinostat (8-1 mol-mol),2.510516391643449
PaTu 8988t,9903786,4.140175125497243
NCI-H446,6918878,2.737683671471643
SK-MEL-30,159324,3.913782047256045
NCI-H1793,262093,3.818681600610628
MEC-1,36462,-0.6422980977317088
RT-4,24180125,3.633157370927589
VCaP,8515,3.1878682585900258
A-673,36462,-0.225010248526114
NCI-H2444,6610216,4.694771975747221
MOLT-13,sirolimus-bortezomib (250-1 mol-mol),-0.8755495405790606
MHH-NB-11,439501,-2.5352340677709404
NCI-H1703,26596,-2.7803694480879857
COLO 668,JQ-1-carboplatin (1-1 mol-mol),3.106273678335465
NCI-H1105,148124,-3.080281083040765
BT 440,9903786,3.1498376271679533
NCI-H1355,9926054,1.8192914468713284
UO-31,selumetinib-vorinostat (8-1 mol-mol),1.996213021898257
BHY,439501,-2.5036111867595823
TE-15,36462,0.8303129579402212
Hep-G2,9911830,2.4259359362723147
PSN1,3689413,-0.2980036400640658
JHUEM-2,135875424,3.27601343648584
ES-2,9911830,3.057885215196293
MDA-MB-453,409805,5.496183153122164
Karpas-620,9903786,4.2683089971609265
CMK,9926054,1.7941257572629667
DU4475,100016,3.3182611876021157
42-MG-BA,9911830,3.146515897881783
HCT 8,54618164,4.218038509865035
SNU-1196,409805,5.507491068612232
OCI-Ly3,9903786,0.6513092256101434
NCI-H1869,5460769,3.405523512527605
COLO 792,selumetinib-GDC-0941 (4-1 mol-mol),-1.2874205422493403
NCI-H23,148198,-4.855451387960017
Jurkat,tanespimycin-bortezomib (250-1 mol-mol),0.7517275719467844
Hs 766T,11485656,2.6459826736539376
BxPC-3,107985,-2.51349631829315
MOLP-8,3689413,-2.303477592076259
RERF-LC-MS,tanespimycin-bortezomib (250-1 mol-mol),-0.8960063928147526
DMS 454,36462,2.270934530908605
P31/FUJ,100016,5.4217002529902185
CJM [Human melanoma],tanespimycin-bortezomib (250-1 mol-mol),0.2668516284110745
OVCAR-5,44491742,4.010152953024954
KMRC-2,12003241,-1.7913952791170802
KMS-34,12003241,-3.0064029669480528
RCM-1 [Human rectal adenocarcinoma],136227924,3.314624698864007
SK-MEL-24,439501,0.5144696508733063
DV-90,148124,-8.414781683507076
LC-1/sq-SF,54618164,4.300046156194216
EN,11404337,1.8995795363110224
SK-MEL-2,262093,3.2801506390546225
Panc 03.27,54618164,4.198880096494509
Daudi,135875424,2.734623655159311
NU-DUL-1,9903786,0.8090083924855098
HCC2108,135423438,4.347791872690299
JMSU-1,44491742,4.046305015990271
NCI-H69,6505803,2.592784813804099
UO-31,26596,0.4742942530113579
HCC1937,24180125,2.538066880036907
KG-1-C,135875424,3.0761511771820573
VCaP,49836020,3.7297112197262337
SK-MEL-1,8515,3.632622061872653
TALL-1 [Human adult T-ALL],135875424,3.2199979097840905
SNU-685,11404337,-1.4693578983295623
COLO 829,9903786,4.931323632089431
NUGC-3,11485656,2.456489968727232
HCC1954,107985,-2.6910396839606743
SNU-685,136227924,3.487679457544809
EBC-1,49836020,4.041761576127936
Karpas-422,168313200,3.637067495296451
IPC-298,107985,-3.141608665259132
RT-112,11404337,0.3024597530600803
U-CH1,tanespimycin-bortezomib (250-1 mol-mol),-2.1423466451005524
SR,6610216,4.010987064969844
KE-37,5460769,2.542918791182312
KP-N-SI9s,409805,3.6251119237162177
NCI-H522,8515,4.67214972936148
Caov-3,9926054,2.84814467099178
OV7,sirolimus-bortezomib (250-1 mol-mol),0.4269208814409986
KMS-18,107985,-4.362262609163058
SK-MEL-5,9926054,2.75949424585879
SNU-503,selumetinib-vorinostat (8-1 mol-mol),0.2887202036830235
HL-60,6610216,4.340783872079224
KMRC-3,9936388,-1.673858974154645
KYSE-30,9903786,5.462463083669851
SK-MEL-30,107985,-2.8355953355058205
OCI-AML-5,148124,-5.059033950577293
Hs 294T,107985,-3.5780163636392768
MDA-MB-468,107985,-2.837120090613579
MOLM-6,sirolimus-bortezomib (250-1 mol-mol),0.6452652216759648
ONS-76,6610216,4.821554065133985
NCI-H2171,selumetinib-GDC-0941 (4-1 mol-mol),2.15287144597935
SU-DHL-10,11404337,-3.1168849698273404
MFE-319,9903786,4.166499809230756
RVH-421,3689413,0.478404210346996
HH [Human lymphoma],11404337,-1.3544677406632493
SK-MEL-24,3136844,4.855790212026112
SNU-308,tanespimycin-bortezomib (250-1 mol-mol),-1.0172716653448413
Hs 895.T,262093,3.3540332653039195
JVM-2,44484440,3.157331197956859
NCI-H1395,10296883,4.692616973111803
COV644,5460769,6.215803603541286
OCI-M1,9926054,1.747333325747777
OVK18,6610216,4.184858807398399
A-375,107985,-3.1836628445194592
CAL-148,selumetinib-vorinostat (8-1 mol-mol),2.102120604451704
KU-19-19,3689413,0.155027117273248
NCI-H841,selumetinib-GDC-0941 (4-1 mol-mol),1.7546401329299928
KNS-42,tanespimycin-bortezomib (250-1 mol-mol),0.1852378636050138
NCI-H1703,selumetinib-vorinostat (8-1 mol-mol),4.45362073786032
BT 245,6505803,1.0921416598826974
KE-37,148198,-3.992364419056407
KYSE-30,107985,-4.08037761036898
SK-MEL-2,168313200,3.8202183973722144
LN-18,selumetinib-vorinostat (8-1 mol-mol),2.5778552693541052
RERF-LC-Ad2,136227924,3.207411157267862
SW1573,24180125,4.83914798243841
NCI-H2122,9926054,1.7352659466482192
SNU-C1,26596,-0.0671330439663034
LAMA-84,12003241,-5.010316876482206
BICR 6,10296883,4.111164180583034
CAL-120,262093,3.3293434401415847
Hs 688(A).T,262093,2.411815084878299
T84,148198,-4.2219788227955855
MOTN-1,135875424,3.06502770536401
HCC1806,tanespimycin-bortezomib (250-1 mol-mol),-1.018724698872974
BT-20,54618164,4.2305342335962175
COR-L51,12003241,-0.3418570343381517
ESS-1,49836020,-4.193111027878734
G-402,9926054,1.7683002714551472
Hs 944.T,54618164,3.859613969928264
U-118MG,36462,3.4030913750354563
KE-37,159324,0.190528965424999
PE/CA-PJ34 (clone C12),11485656,1.7983954039931191
SNU-119,54618164,3.949548457526877
Hs 729.T,26596,0.627655143965394
NB4,409805,3.793938928834636
TE-15,sirolimus-bortezomib (250-1 mol-mol),0.9127775689721958
T98G,135875424,5.101346341382456
Karpas-422,3689413,0.6826110279753447
BT 286,135423438,1.7051552017965996
SNU-175,selumetinib-GDC-0941 (4-1 mol-mol),0.0356628717912123
A101D,439501,-0.9695989482214274
MHH-NB-11,selumetinib-GDC-0941 (4-1 mol-mol),0.4891965075201672
SNU-620,100016,4.241219903285237
RPMI-7951,sirolimus-bortezomib (250-1 mol-mol),1.5520674857207382
22Rv1,9911830,3.385129780644084
RKO,10296883,4.075814636405189
Hs 688(A).T,409805,5.195577120542783
NCI-H69,24180125,1.624121163280204
NCI-H460,6610216,4.838717363885395
SK-N-DZ,selumetinib-vorinostat (8-1 mol-mol),1.2861910244827397
HEL,46943432,0.8947528664895825
MJ,24180125,3.2687573062983484
JJN-3,9903786,1.1978093816271655
LC-1/sq-SF,9911830,2.3973798476022985
NCI-H2228,107985,-3.27582791857513
BT 359,9926054,3.2726911092773223
SNU-1196,159324,3.4693899047563512
CAL-85-1,439501,-2.788056668623063
CAL-51,6918878,3.0110486558166274
HOP-62,selumetinib-GDC-0941 (4-1 mol-mol),0.8398551306230168
SK-MM-2,159324,1.4791508543366414
MM1.S,136227924,2.5395832269167027
Caki-1,148198,-2.50080081476661
HCC2108,44484440,3.875901941244504
Calu-3,6505803,0.3203856441914136
HuP-T4,9936388,-6.160630678520688
IGROV-1,135423438,0.764137689665023
NCI-H1341,selumetinib-vorinostat (8-1 mol-mol),2.1937405592406884
DEL,135875424,3.00477413293185
MEC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4728620848599026
COLO 668,135398744,8.327897360354253
TOV-21G,168313200,3.7401235687507226
BT 271,9911830,2.9198320046580952
MES-SA,148198,-4.473330928142554
KMS-27,9911830,2.432969269856635
BT 440,262093,2.750742554492899
SNU-886,135398744,6.3424886084429435
NCI-H446,3689413,-2.437056347343706
HCC827,5460769,2.7975928374001104
KMBC-2,sirolimus-bortezomib (250-1 mol-mol),0.4292158066242218
MHH-CALL-3,9911830,3.1939579003268133
NB1,100016,5.984902151942781
NCI-H716,3136844,5.367852821729496
EFE-184,12003241,-0.5797348651994826
KMRC-1,439501,-2.7889227637684773
8-MG-BA,107985,-2.2660198800752793
Capan-1,sirolimus-bortezomib (250-1 mol-mol),0.7071415431289269
JHH-4,10296883,4.085569000531024
Karpas-620,159324,3.63089099947116
OCI-AML-3,135423438,2.310750023126374
SNU-213,sirolimus-bortezomib (250-1 mol-mol),1.705548716075845
CA46,168313200,1.9493207867170304
BV-173,136227924,2.1412277594985816
FU-OV-1,159324,3.7929038817112746
JHUEM-3,JQ-1-carboplatin (1-1 mol-mol),0.1044516957131188
SK-N-SH,262093,1.5021437515873324
RPMI-8402,selumetinib-vorinostat (8-1 mol-mol),2.302380796643318
Hs 683,54618164,4.101275609218899
HT115,9911830,2.3719194937966583
HSC-3,24180125,3.0095192248544897
SU-DHL-1,24180125,2.3898229933344193
KMS-12-BM,selumetinib-GDC-0941 (4-1 mol-mol),1.197952693783939
SNU-869,selumetinib-vorinostat (8-1 mol-mol),3.0867433449606123
Hs 934.T,409805,5.721934448582198
YKG-1,selumetinib-GDC-0941 (4-1 mol-mol),1.6719516399203749
SNB-75,36462,2.650946261934248
HT-1376,9926054,2.913590047827676
SNU-C5,409805,4.287269505497504
KM12,10322450,3.9627058318193495
U-251MG,262093,3.13898838464472
SET-2,6505803,0.5122894661821437
OCI-Ly10,10296883,3.528234094962338
LAMA-84,selumetinib-GDC-0941 (4-1 mol-mol),-0.0298835136014615
Panc 04.03,168313200,2.993774278353398
RT-112,439501,-0.757801709231946
NCI-H446,26596,-3.841011502431018
A-253,9911830,3.0996294325120464
NCI-H889,6505803,4.205027761053593
PE/CA-PJ49,24180125,3.249476496714235
Namalwa,11404337,-2.5348333703062575
JHH-1,selumetinib-GDC-0941 (4-1 mol-mol),2.043129184310282
SK-N-MC,148198,-7.75937089514698
LC-1/sq-SF,selumetinib-vorinostat (8-1 mol-mol),3.9506285089296513
HCC1419,12003241,0.329008083865116
HCC15,6918878,1.2461206152093485
BT 164,10296883,4.081572415093264
253J-BV,5460769,4.4338655315193325
NCI-H1092,9936388,1.337118908669493
Mino,6505803,-0.2823157410063563
SW1417,9926054,1.9097255829508144
TYK-nu,sirolimus-bortezomib (250-1 mol-mol),0.7718318576607361
CAL-29,11404337,-0.7991299862488138
NCI-H1373,168313200,3.9826413133900544
CL-11,11404337,-0.8805356384482084
TOV-112D,9926054,1.7834686388264986
Calu-3,26596,0.6204289833771246
KP-N-YN,5460769,4.0809724038992705
NCI-H1703,439501,-1.5312988936027676
MDA-MB-231,selumetinib-vorinostat (8-1 mol-mol),2.4295694079712433
NCI-H2141,selumetinib-GDC-0941 (4-1 mol-mol),1.801687772031887
HEC-108,9926054,2.177226179063823
HCC1171,6610216,4.662809555111892
BT-16,9911830,1.9516077226292512
Panc 02.03,100016,6.582809568040202
KMS-20,439501,-3.5751856752548985
NCI-H1355,9927531,4.199887735428921
EFO-21,3689413,0.1102098212077115
A2780,246676,4.314588687253318
WM115,3689413,-0.1044392328624619
OC 314,148198,-4.2730667463972285
SNU-869,11485656,2.9373298298731463
NCI-H460,54618164,4.49670945938676
RKO,262093,2.7220373961576834
NCI-H1563,9903786,2.6215320097996684
SK-MES-1,3689413,0.2897315368024132
NCI-H1573,8515,6.25434864786871
MDA-MB-231,12003241,-1.774974219486486
GI-1,sirolimus-bortezomib (250-1 mol-mol),0.2030703478127671
23132/87,148198,-2.6574855185514816
CMK,selumetinib-GDC-0941 (4-1 mol-mol),2.84334284857712
TALL-1 [Human adult T-ALL],54618164,3.238906598306848
LXF 289,10296883,3.609856485747645
U-BLC1,3689413,-0.8991596677439855
RCH-ACV,JQ-1-carboplatin (1-1 mol-mol),-0.5668300449210979
EFO-21,11404337,0.1948042890750945
BT 179,24180125,5.244229269731757
MOLP-8,6918878,0.495059053850733
HMC-1-8,JQ-1-carboplatin (1-1 mol-mol),2.246629703835433
OAW28,107985,-3.5497769626209217
HuNS1,3136844,3.9455894296569487
NCI-H2342,44493528,4.387491480960399
Hep-G2,12003241,-0.7040118985216451
JHH-2,selumetinib-GDC-0941 (4-1 mol-mol),1.7984148033328824
Kasumi-2,135423438,1.5853456579896534
SNU-601,10322450,3.697276990394465
Mel JuSo,148198,-2.598455094519584
NH-6,12003241,-1.8219752869317325
T3M-10,439501,-3.538112606826756
MV4-11,107985,-4.336594623751159
OCI-AML-3,262093,2.331975538333622
RERF-LC-Ad2,sirolimus-bortezomib (250-1 mol-mol),2.075251911083675
TT,409805,5.07026702775905
KO52,100016,6.24417827042609
RT-4,12003241,-1.8542714118634884
NCI-H28,9927531,4.6016482528028515
SUP-M2,9903786,1.0371489832457852
RPMI-7951,107985,-3.3094239868135467
CAL-120,148198,-2.0212341580767283
8-MG-BA,sirolimus-bortezomib (250-1 mol-mol),0.8530432118926453
TYK-nu,9936388,2.2854724724454254
MOLP-2,tanespimycin-bortezomib (250-1 mol-mol),0.214791737845908
ECC12,selumetinib-GDC-0941 (4-1 mol-mol),2.781694050737888
L-540,168313200,3.887437294203427
NCI-H1184,11404337,-0.3594338062101045
NCI-H522,11485656,1.866098793785005
SYO-1,100016,3.831378840669671
WM1799,9936388,-1.7027793320208122
RCH-ACV,9911830,2.531185888082776
253J-BV,9936388,1.8223967711781484
BT-20,9926054,1.9620105743223175
Caov-3,100016,5.7781449283056645
NB1,6505803,-2.349165224527604
SK-MM-2,26596,0.072150738405161
Capan-1,107985,-4.358554315773558
MHH-CALL-4,46943432,0.4587577146987904
GB-1,sirolimus-bortezomib (250-1 mol-mol),0.3465048040128788
NCI-H460,9926054,2.081701465030928
HGC-27,11404337,-1.4323340614808602
HD-MY-Z,9927531,4.2813620085195625
KYSE-450,9926054,1.8553044985655331
KNS-81,tanespimycin-bortezomib (250-1 mol-mol),2.206166956375568
PF-382,136227924,2.0859082008018084
CAL-51,9936388,-5.638746232401389
OVTOKO,3689413,-2.3162270386238735
CAL-29,159324,3.720645478916591
Hs 944.T,44491742,4.471544496147254
WM266-4,148198,-3.639294781182272
LS513,11485656,2.48053451645545
Granta-519,148198,-4.763660659469611
Lu-99,9911830,2.0700119767872285
A4/Fukuda,409805,3.596796639089143
SK-MEL-5,44491742,4.058095878540579
GDM-1,100016,5.649529454604957
Mel Ho,44484440,3.3175819399600215
ZR-75-30,6610216,4.132835515037586
HuH-28,6610216,3.8460491643808727
KMRC-20,24180125,2.1292230700197874
HGC-27,selumetinib-vorinostat (8-1 mol-mol),2.872290349693273
SNU-216,10322450,3.800791101615317
KNS-60,136227924,2.463930704521007
U-251MG,9936388,1.7501129357253542
HOP-62,tanespimycin-bortezomib (250-1 mol-mol),-2.1315828929129332
MPP 89,409805,3.849347352715293
Caki-1,10322450,6.689578466604137
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076
CAL-51,44491742,5.152478206660974
NB4,439501,-2.5545682554076805
HCC2935,409805,5.908480125054504
LS1034,6918878,4.9751674683459
NCI-H2291,54618164,5.760703880265436
KNS-81,439501,-1.422452321432204
DU145,168313200,3.1229023319588363
A2058,tanespimycin-bortezomib (250-1 mol-mol),-0.4864507990371403
HCC2108,9936388,-4.897775231329417
DU145,11485656,2.5427151524786993
HCT 8,JQ-1-carboplatin (1-1 mol-mol),1.4638248293100051
SUIT-2,439501,0.993663636668041
JHH-2,10296883,4.160944892429831
DK-MG,11404337,-0.0389749694048802
NCI-H358,36462,2.0858276419608166
HSC-2,168313200,3.029663410726755
KE-39,JQ-1-carboplatin (1-1 mol-mol),1.0085240512621525
Hs 611.T,6505803,0.4096396664447451
BHT-101,11404337,-0.8780725416326395
NCI-H520,JQ-1-carboplatin (1-1 mol-mol),1.1909006472445542
COV362,JQ-1-carboplatin (1-1 mol-mol),5.952007792704957
SU-DHL-1,246676,5.693727803678488
TC-71,135875424,2.7755794314588105
SNU-1033,409805,7.650675265058521
TALL-1 [Human adult T-ALL],9911830,2.2392612574573865
HCC366,107985,-3.089581015877287
SNU-1033,9936388,0.9211545103072076
HH [Human lymphoma],JQ-1-carboplatin (1-1 mol-mol),-1.6749963255545115
IPC-298,148198,-2.1157958847718237
DU145,3689413,-1.3535401671184424
Panc 04.03,11485656,3.4698409381110435
THP-1,sirolimus-bortezomib (250-1 mol-mol),0.3217250845673337
CML-T1,5460769,1.000954417912476
RKN,5460769,5.79272629497122
COLO 680N,selumetinib-GDC-0941 (4-1 mol-mol),2.523373252620712
SKM-1,9936388,-5.746280121163761
CAL-27,tanespimycin-bortezomib (250-1 mol-mol),-0.409380186496711
DMS 454,135423438,1.477667151193616
ALL-SIL,54618164,3.625474128679928
BT 482,10296883,4.136673129402408
JVM-3,100016,3.63486720200834
BT 139,107985,-2.6737543341342316
IA-LM,selumetinib-GDC-0941 (4-1 mol-mol),3.6293192218894017
SUIT-2,44484440,3.710182665930374
MG-63,148198,-4.931736282287541
NU-DUL-1,6918878,-1.779997247121914
Lu-99,6505803,-2.9740342250772644
EHEB,26596,-2.0876334457911727
RS4;11,44493528,4.150848985906847
UM-UC-1,11485656,1.563439328929869
CL-11,24180125,2.5016118150307305
SNU-182,selumetinib-GDC-0941 (4-1 mol-mol),-0.56211795944893
ESS-1,439501,-2.0978778954241215
LCLC-97TM1,409805,4.11204743963536
TE-14,5460769,2.4898485363417917
NCI-H1734,159324,1.6131666092145154
EFO-27,107985,-2.474640150808475
IM95,JQ-1-carboplatin (1-1 mol-mol),0.9463817139870012
MHH-ES-1,49836020,5.438630069429388
DND-41,409805,3.476288751598273
Panc 08.13,9903786,3.5519515597880646
ZR-75-30,9926054,1.848847204207402
RPMI-8226,6610216,3.804422876207064
SNU-46,9926054,2.489766142928295
DMS 53,8515,3.81092171327107
639V,6610216,4.900491657762806
A-673,9926054,1.7717409858597033
SJSA-1,11404337,-1.5700525200999282
COLO 829,9926054,1.880005790170633
COLO 205,9936388,-5.293351176311716
Mono-Mac-6,11485656,1.0261248575156627
SBC-5,9927531,4.452264212548339
GB-1,54618164,4.489453248455872
MHH-ES-1,11404337,-1.1882712301989995
Daudi,11404337,-3.064654238522792
MFE-296,12003241,-1.246731028560956
BT 232,262093,2.843383638859083
697,9936388,-7.51713340803998
LoVo,3689413,-0.0015328635235731
T24,selumetinib-GDC-0941 (4-1 mol-mol),2.57595628877945
LUDLU-1,107985,-2.7518759622190463
MHH-ES-1,148198,-5.108564856367707
HCC78,9911830,2.672892482708517
SW1990,168313200,2.994110056013303
KYSE-410,54618164,4.094546226578619
T98G,9926054,1.93846990860498
SNU-685,107985,-3.2050759373927953
NCI-H1755,selumetinib-GDC-0941 (4-1 mol-mol),0.8235666459967586
RCH-ACV,9903786,1.555646026251057
SW1417,6610216,4.3263936017007225
SNU-1272,54618164,4.215546778710406
Peer,10322450,2.772201791811034
SK-N-FI,439501,-4.082548455414269
OVCAR-4,46943432,4.3382167265111935
ALL-SIL,12003241,-5.746631994241774
MSTO-211H,168313200,3.954855187852925
NCI-H1915,selumetinib-vorinostat (8-1 mol-mol),2.1526268159946156
SK-MEL-3,36462,3.2398359693189622
SU-DHL-4,9903786,1.90197998733756
SH-4,44493528,4.462421273683891
KMS-11,6610216,3.796053268478964
PSN1,9911830,2.6200300963649035
A-549,54618164,4.216271974260082
L-428,6610216,3.9920108953728
BT 330,11404337,-0.3310722205999429
TOV-112D,26596,-2.3004297516066927
HeLa,135875424,4.463353648372455
NCI-H28,9911830,2.204330269310846
NU-DUL-1,46943432,0.4481984329414775
SU-DHL-10,54618164,3.9853572378848927
LS123,3136844,4.470373535882854
Ri-1,26596,-3.083821338619051
EoL-1,9903786,-0.1437472034571408
RMG-I,54618164,3.80773173127852
HuCC-T1,11485656,1.9622878399892336
SK-BR-3,136227924,2.8779705448471975
HOS,tanespimycin-bortezomib (250-1 mol-mol),0.2321152572283642
MOLT-3,6918878,0.0223251439281453
Rh30,3689413,-2.408934939466004
NCI-H1155,135875424,3.2409208598380466
MKN1,selumetinib-GDC-0941 (4-1 mol-mol),2.452796078251995
HEC-151,107985,-5.149498087919081
RPMI-8402,selumetinib-GDC-0941 (4-1 mol-mol),2.2206105962068645
AM-38,107985,-6.423033763358534
SNU-423,409805,5.272007162134597
C2BBe1,168313200,1.8322203589058017
EC-GI-10,11404337,-0.7610557200028516
TF-1,8515,2.99414039942182
AGS,selumetinib-vorinostat (8-1 mol-mol),2.398857545176039
SU-DHL-1,3136844,3.883215489826005
KMH-2,44493528,4.009016955634305
CMK,JQ-1-carboplatin (1-1 mol-mol),-0.2458956642529063
SU-DHL-8,136227924,2.244700910858823
NCI-H520,8515,4.614929200779132
LNCaP clone FGC,11485656,1.8681426570872277
NCI-H1793,9927531,3.368036257397712
QGP-1,sirolimus-bortezomib (250-1 mol-mol),1.0320237802548329
LS411N,sirolimus-bortezomib (250-1 mol-mol),1.8501035907850776
CJM [Human melanoma],107985,-2.937279558730933
SUP-B15,46943432,1.3299933032827167
SU-DHL-1,9911830,2.4926956672938543
AN3-CA,9936388,-6.467722299824651
LNCaP clone FGC,54618164,3.473617920574014
NCI-H841,8515,3.715015096758455
MCF-7,24180125,2.9305572287480466
SNU-81,26596,-2.2143193215677925
MHH-ES-1,24180125,2.2198565259892775
CJM [Human melanoma],6505803,0.8455714648191155
KE-37,10322450,3.174319565832949
BT 333,9926054,3.6254500020575366
NCI-H1184,49836020,5.907287846852096
MDA-MB-435S,selumetinib-vorinostat (8-1 mol-mol),2.4592117826855193
NCI-H460,168313200,3.91056508525232
NCI-H2196,3136844,4.700396199483259
NCI-H2030,107985,-3.4072882201526515
BT 216,5460769,4.97858517740557
COLO 680N,11404337,-0.1735930732643658
RERF-LC-Ad1,136227924,3.427007002266959
CHP-126,9911830,2.5647606386705566
22Rv1,selumetinib-vorinostat (8-1 mol-mol),2.372409172383956
HEC-265,135875424,3.9538578477076136
OVSAHO,262093,2.313375156215166
K029AX,136227924,2.929460109593454
23132/87,9903786,3.7145887754512414
MKN74,439501,-1.7547166912858625
SNU-1079,11404337,-1.3798089381866616
IGROV-1,246676,4.485924799339535
Hs 852.T,tanespimycin-bortezomib (250-1 mol-mol),-1.155351108191556
PSN1,44493528,4.302980688159976
Detroit 562,135875424,3.611999355056841
SHP-77,24180125,3.776210546228356
NCI-H358,54618164,3.951567695583077
SNU-387,11485656,1.781894419315086
SW1271,sirolimus-bortezomib (250-1 mol-mol),1.1899864031488736
MOLT-16,9911830,2.5212447547414696
CAL-120,44491742,4.283004570772673
WM983B,11404337,0.2030951424899205
EM-2,159324,-0.2491393012788013
BT-20,100016,6.680150665921765
TYK-nu,44491742,3.839739340970965
DMS 114,439501,-3.85283118857385
HuG1-N,36462,3.53181824317366
SU-DHL-8,3136844,3.5070092776457713
CCF-STTG1,409805,5.227575027972168
639V,409805,4.766769703110161
NALM-6,tanespimycin-bortezomib (250-1 mol-mol),0.0910863571713514
MOLM-6,44493528,4.505995981059325
HPB-ALL,selumetinib-vorinostat (8-1 mol-mol),2.369639737776143
SKM-1,9911830,2.174138233230932
SK-N-FI,9903786,1.217997719739724
MOLP-8,44491742,4.067907034019371
NCI-H2087,36462,0.787608907647275
MV4-11,9927531,4.708512628737502
OS-RC-2,12003241,-1.2099466565873536
HOP-62,6918878,4.215530396127894
NCI-H2009,439501,-2.087429471182781
IST-Mes1,36462,4.9786696220654845
ChaGo-K-1,9911830,2.4299534095194084
NCI-H1435,107985,-4.254574866171067
NCI-H2029,9926054,1.852947583651784
T24,36462,3.7115537308708313
EBC-1,9903786,3.237672392939453
KYSE-510,409805,5.991865357716927
ECC12,24180125,3.733466398448284
L-428,24180125,3.211915408201291
DoHH2,439501,-2.792554896141067
MHH-CALL-3,135398744,6.205129646453742
KMS-28BM,JQ-1-carboplatin (1-1 mol-mol),-0.0604179663950409
UO-31,10322450,3.2206425207996268
KYSE-510,246676,4.677306022279273
MeWo,6505803,3.0730315194784947
Caov-3,3689413,1.9135377903432256
WT2-iPS,107985,-3.785373915846311
Calu-1,9936388,2.4202012833379016
SF539,11404337,-0.0923032150573938
CW-2,168313200,2.811372219498715
KYSE-150,12003241,-0.8115897611031261
MEC-1,54618164,3.764189598819816
P12-Ichikawa,6918878,-0.7315894223952625
BFTC-909,6505803,-2.7076869289136147
Hep-G2,9926054,1.3870503906392218
8305C,12003241,-1.8647493707838596
LAMA-84,44484440,3.2471143883660956
G-401,10296883,3.7583450228982342
SW579,9911830,-0.5656560030072354
MG-63,9926054,3.1754047574180815
Kasumi-2,12003241,-2.245419673861097
RD,49836020,4.595069513532316
SUP-M2,46943432,0.7437665955481163
YD-38,selumetinib-GDC-0941 (4-1 mol-mol),-0.5949225463432135
BT 232,6505803,-2.078004846595285
BICR 31,9911830,2.2138272662609064
TF-1,tanespimycin-bortezomib (250-1 mol-mol),0.3682708588950815
ONS-76,44491742,4.314760532803232
NCI-H2029,100016,6.638892611020326
KE-97,24180125,2.577843918420162
NCI-H650,9926054,2.0416939641657175
TE-4,6505803,-1.521875186657464
SNU-886,9926054,2.2284003182480774
HCC1171,9911830,3.390740346398818
DND-41,9936388,0.9439294041019026
IGROV-1,11485656,1.900409616013456
MG-63,selumetinib-GDC-0941 (4-1 mol-mol),2.7889103104471227
COLO 201,11485656,2.5416615004104237
G-361,selumetinib-vorinostat (8-1 mol-mol),-0.6405428240281378
LCLC-97TM1,9911830,3.2250615193472085
KMS-28BM,262093,1.4261672899079032
A3/Kawakami,6610216,4.023576597985235
T24,100016,6.183675550900896
Becker,3689413,0.4493271202500121
P12-Ichikawa,3136844,3.62185386466116
NB1,26596,-1.7417489155233454
EJM,JQ-1-carboplatin (1-1 mol-mol),0.7172378388996342
CML-T1,9936388,-6.3994005254305995
SW1990,selumetinib-vorinostat (8-1 mol-mol),3.2800234723001016
RPMI-8226,36462,0.6867842067888891
786-O,100016,5.342252836782742
SK-MEL-3,3136844,4.68445729807332
PC-14,8515,3.8030363012759327
Hs 683,135875424,4.08610069423659
HT-1197,sirolimus-bortezomib (250-1 mol-mol),0.4279936775188873
Daoy,tanespimycin-bortezomib (250-1 mol-mol),-0.2871492230613796
Granta-519,439501,-6.00499370561019
NCI-H2106,9936388,1.6529338103280846
BC-3C,439501,-3.6854661122428896
NCI-H1385,12003241,1.7057998630948272
NCI-H520,3689413,0.9100551461140616
BT 231,JQ-1-carboplatin (1-1 mol-mol),2.3175217406535156
OV7,5460769,0.8621725528933663
KYSE-30,9936388,2.2895828136918785
SNU-119,148198,-2.509458516530883
LXF 289,44493528,4.295099384269069
HARA [Human squamous cell lung carcinoma],262093,3.694607099499911
SR,11404337,-0.9358789780848294
NCO2,JQ-1-carboplatin (1-1 mol-mol),-0.8378761962661548
BT 179,5460769,5.470437683574026
KYO-1,JQ-1-carboplatin (1-1 mol-mol),0.7001099842135994
Ki-JK,sirolimus-bortezomib (250-1 mol-mol),-5.576010633092176
DB,24180125,1.2652524681153203
NCI-H1339,148198,-2.9438729710882963
KHM-1B,44491742,4.066156285625521
DBTRG-05MG,selumetinib-GDC-0941 (4-1 mol-mol),1.9211216865971592
HCC2279,262093,2.5944321390006397
SK-HEP-1,selumetinib-vorinostat (8-1 mol-mol),2.40344777828312
WM266-4,107985,-2.683759376298984
SK-MEL-30,9911830,3.8203238322037874
HuH-1,10296883,4.280217513091765
HCC1438,11404337,0.7174449174884908
OPM-2,54618164,3.637238343412542
DU145,5460769,5.167808415466422
CMK,107985,-5.004387874790032
JK-1,26596,-2.9056009254184247
DAN-G,409805,3.9735319479780618
NH-6,168313200,1.6877159521030758
THP-1,409805,3.587964257219881
BT 286,148198,-5.76188834046235
G-402,54618164,3.969442190636606
MeWo,24180125,3.515144215556771
ALL-SIL,44491742,3.700418914769662
23132/87,11485656,1.6570697759405837
ACHN,409805,6.312119487325195
RPMI-8226,9911830,2.9345050444494696
EKVX,11404337,-1.1482953673467733
FU-OV-1,11485656,3.4521578130267336
697,11404337,-3.514095221219387
NCI-H889,11404337,-0.9688065890654572
MKN1,3689413,-2.0686117581954537
TC-71,3689413,0.4216372127873143
RD,135875424,4.367894980695875
LUDLU-1,168313200,3.000777530927683
Rh30,36462,1.3156470813708137
EHEB,159324,2.208250970812642
AML-193,8515,4.304311331712035
Granta-519,3689413,-2.6080640580656977
OV-90,sirolimus-bortezomib (250-1 mol-mol),0.2139978702426217
OCUM-1,49836020,-0.6781383792077297
Granta-519,107985,-5.079154139769343
Hs 936.T,sirolimus-bortezomib (250-1 mol-mol),1.4470879407729986
A2058,3689413,3.023224690588694
KE-37,11404337,-3.142013141834162
769-P,3689413,-0.2029622109765157
KE-97,8515,2.5331907619060603
Granta-519,JQ-1-carboplatin (1-1 mol-mol),-0.0687085528306087
SUP-T1,36462,-0.1805467194258707
Hs 839.T,11404337,1.04111897538683
NCI-H2087,24180125,3.4986995074600356
A3/Kawakami,26596,-1.4802505010126563
NCC-StC-K140,107985,-3.758364572200111
KP-N-SI9s,9936388,-6.7356563717129925
LXF 289,24180125,2.8590757937383517
SNU-1077,11404337,-0.4720370259421129
BT 359,10296883,4.315166062972002
WM983B,262093,4.372812176554698
HDQ-P1,sirolimus-bortezomib (250-1 mol-mol),1.8478988823662197
HuH-1,6610216,4.319132810982458
U-937,107985,-4.172637526463277
OV-90,6918878,3.975776298884749
COV362,12003241,-1.5516185540299623
T24,168313200,2.990559857289937
BT 271,JQ-1-carboplatin (1-1 mol-mol),4.042067647182753
HuP-T4,3689413,-0.6711491165828569
Hs 746.T,44493528,3.791108114559063
KE-97,JQ-1-carboplatin (1-1 mol-mol),-0.8780333698313584
EBC-1,148198,-1.529856681948531
NU-DHL-1,100016,6.7557445252971355
GCT,26596,-0.460153915776305
BT 330,409805,3.8422840862788386
CA46,135875424,2.985562686352135
SCC-4,5460769,3.1702887923440466
ES-2,tanespimycin-bortezomib (250-1 mol-mol),0.7819342630175604
MHH-NB-11,9903786,1.7813974868905205
HMCB,24180125,3.3063760805557054
HCC1806,5460769,-0.192100809913994
BT 179,26596,-0.8233770737136159
OV7,3136844,4.305807131192211
BT-474,54618164,4.811471489444681
BT 498,9926054,3.200560952387037
BxPC-3,148198,-2.171424706341701
BICR 31,6610216,4.499990209090508
SNU-601,107985,-3.781462063304301
COLO 680N,11485656,2.5082408058849945
CAL-148,46943432,1.3946805830156972
EBC-1,JQ-1-carboplatin (1-1 mol-mol),0.4045548074723116
IM95,10296883,2.4504094731139676
Reh,12003241,0.0982187894519585
22Rv1,tanespimycin-bortezomib (250-1 mol-mol),0.2637398344293039
MKN74,135875424,3.2262010711942484
TCC-Pan2,54618164,4.990459114460208
MOR/CPR,44484440,3.6417957606355142
EJM,sirolimus-bortezomib (250-1 mol-mol),0.0278018018083393
L-363,9903786,1.2649504106242235
IPC-298,6610216,4.490869221617785
M-07e,136227924,2.437184343955499
KMS-26,9903786,0.9658613723306017
K-562,tanespimycin-bortezomib (250-1 mol-mol),-0.7275623889359331
WM266-4,9926054,1.9241350180859695
KMRC-20,36462,3.67134556506655
MeWo,JQ-1-carboplatin (1-1 mol-mol),2.4504069963497463
NCI-N87,sirolimus-bortezomib (250-1 mol-mol),-1.2024587113239409
T98G,148124,3.910493124351062
NCI-H2228,135875424,4.666656797632995
HCC4006,107985,-2.654507490141286
SNU-1,9926054,1.7218155896190992
SK-MEL-1,9911830,3.4534417148400145
EJM,100016,6.634092198961092
DK-MG,9911830,1.6041327482191914
OE21,9911830,2.128262086485743
SUIT-2,selumetinib-vorinostat (8-1 mol-mol),2.64771661765404
SK-N-MC,6505803,0.6222225816137853
LS513,9936388,-5.267981088058912
FTC-238,262093,2.848255562611525
TUHR10TKB,135875424,4.420218264862005
PC-3,9926054,2.02880432108919
TM-31,262093,3.077046279014693
SF126,9926054,2.7905707570317686
SW1783,5460769,4.078393209152703
HT-1080,8515,3.909948065157196
HPAF-II,409805,6.320045769749623
COR-L95,3689413,-1.01311028513846
SW1783,6610216,4.1970131352388265
NCI-H1792,439501,0.6605330204311965
NCI-H358,46943432,1.7093173589972348
OE33,9926054,1.932041644306032
HPAC,6505803,-1.845067175670312
MHH-CALL-3,10296883,3.858328954118167
PLC/PRF/5,6918878,3.7165774660165023
HMC-1-8,36462,2.02540653166462
J82,168313200,3.8217993883294903
MOLP-8,439501,-2.9296652389863267
HuH-28,439501,-2.3734651091068693
P-STS,36462,-0.5821459330594502
OUMS-23,11404337,-1.4377112711513047
NCI-H1734,148198,-1.222978862296857
NCI-H838,44493528,4.484447335433128
KHM-1B,3136844,3.849321357179878
BHY,148198,-2.089764447227438
NCI-H1755,8515,2.8473258016948777
ZR-75-30,439501,0.5523338496996666
KYSE-510,9911830,3.344308722430599
MDA-MB-361,11404337,1.0134082132616506
OAW42,168313200,2.5927841071629407
SU-DHL-10,9936388,-7.075176092444515
TE-5,10296883,3.820447093434926
NCI-H69,3689413,-1.5363030352959728
BT-20,439501,-1.326762104121763
L-540,selumetinib-GDC-0941 (4-1 mol-mol),4.246283194196457
HEC-108,9936388,-4.887528080420867
SIG-M5,9926054,1.755465184389032
NCI-H1694,9926054,1.45656685953477
HEC-59,36462,2.2040301999677965
BEN,selumetinib-GDC-0941 (4-1 mol-mol),4.689872875355836
OE21,44493528,4.16320367055504
L3.3,9926054,1.9335911906728165
SW1417,3689413,1.8157284329768
G-292 clone A141B1,9936388,-5.3493608745804515
Kuramochi,6505803,3.382467599706822
COLO 829,6918878,4.285792657291509
Karpas-299,9936388,-6.586031756730676
TTC-709,168313200,2.5540587155219385
NCI-H841,12003241,-1.6250883775981226
Panc 03.27,9927531,5.182143526242967
RT-4,262093,3.3301279648450985
SNU-886,3689413,-0.3695618539773043
HT-1080,9927531,5.0886456677015595
SNU-1041,409805,6.796428886349938
HuH-28,selumetinib-vorinostat (8-1 mol-mol),2.5161900130942176
SK-MES-1,107985,-3.478483308855868
NCI-H1734,5460769,-3.3513439751679983
Kasumi-2,selumetinib-vorinostat (8-1 mol-mol),0.9890334474484956
SNU-1196,11485656,2.2971817788007183
U-CH1,262093,3.1428300622202014
SNU-489,159324,3.7813842942666382
COV434,26596,-1.4572205446145876
BHY,100016,6.773898116669002
SNU-C1,3689413,-0.1776191587992591
LC-1F,tanespimycin-bortezomib (250-1 mol-mol),1.261925234920199
CGTH-W-1,8515,3.401940014880097
AN3-CA,168313200,3.821120909855463
TE 441.T,9927531,5.546705362793043
Rh30,11404337,-0.0362683068466765
PaTu 8988t,6610216,5.064895456595333
SW1990,54618164,4.162528357630221
Li-7,409805,6.263511622178945
Ri-1,6505803,0.1421500129584279
JM-1,sirolimus-bortezomib (250-1 mol-mol),-0.3513681100208012
MOLM-6,107985,-3.6633646803559183
BT 422,44491742,4.87231922177064
CHP-212,44491742,3.750067652008212
SNU-899,sirolimus-bortezomib (250-1 mol-mol),1.691778664572397
MDA-MB-361,3689413,-1.8803084883549792
KMS-27,107985,-3.725151900067263
NCI-H1299,135875424,3.7950147310792257
HMCB,tanespimycin-bortezomib (250-1 mol-mol),1.0972296557807748
BT 359,54618164,4.243296371952982
KMRC-3,10322450,5.943320377485073
NCI-H441,11404337,1.4464911476472675
Karpas-422,36462,0.1497993293193704
HCC1395,9926054,1.865398038154908
EFE-184,135423438,1.8647999692760415
BFTC-909,6610216,4.898578232775107
TE 617.T,3689413,-0.0312016851133043
Mino,3689413,-3.624730843514525
NCI-H2110,439501,-2.2349143195011583
SK-LU-1,409805,5.4476736017437135
UACC-62,136227924,3.255935919058072
Panc 03.27,44491742,4.225898186806888
U-BLC1,107985,-3.242236083428716
NCI-H1385,135423438,1.627035115180022
L-428,10296883,3.2610580713690944
TE-5,5460769,-0.4523281217111792
HT-144,36462,4.669629516323279
VMRC-LCD,36462,3.4209043337731475
VMRC-LCD,44493528,5.517080304343614
PL-21,36462,0.4732785028115152
MDA-MB-468,6505803,0.9541010396346138
SNU-1272,6610216,4.610007140028073
U2OS,12003241,-1.2814871357228934
NCI-H1869,11404337,1.2362831155289085
HCC366,409805,5.5100661130237105
639V,136227924,2.8924456476929605
HuH-28,12003241,-1.746609784805712
UACC-257,148198,-2.410232304331187
GOS-3,26596,5.630360863540023
786-O,9903786,3.782252181935989
RCM-1 [Human rectal adenocarcinoma],selumetinib-GDC-0941 (4-1 mol-mol),1.7782951057156742
JHOS-2,136227924,2.6850771580880783
SaOS-2,26596,-1.8442798913702467
RPMI-8402,49836020,4.366358527241826
NALM-6,24180125,1.7332354696580263
SK-MES-1,9903786,1.5074557756101594
RCM-1 [Human rectal adenocarcinoma],11485656,1.8807064812530925
HPAC,9911830,2.828349444827891
NCI-H209,9927531,3.5477571143466156
DB,148198,-4.69635746988682
PK-1,262093,3.4724760266373087
ONCO-DG-1,100016,7.582922943410799
NB1,12003241,1.4891548799263434
CCF-STTG1,selumetinib-vorinostat (8-1 mol-mol),4.379403579151937
KNS-81,49836020,5.788020143086265
Tm87-16,selumetinib-vorinostat (8-1 mol-mol),2.472623169855902
BT 228,107985,-1.863382776783745
P31/FUJ,159324,1.227532336429348
HuP-T3,selumetinib-GDC-0941 (4-1 mol-mol),0.9673243203252392
SNU-1214,439501,-2.3459859921965793
TT2609-C02,26596,5.442135867718664
MDA-MB-157,36462,0.1516360669313773
FTC-238,9926054,1.7889944253526169
TALL-1 [Human adult T-ALL],44493528,3.717855911159704
NCI-H1693,3136844,2.8254477295191354
YD-38,107985,-3.704885076305192
TUHR4TKB,selumetinib-GDC-0941 (4-1 mol-mol),2.368524394039708
SNU-216,JQ-1-carboplatin (1-1 mol-mol),3.8633664512106622
JHH-5,3136844,4.194510353529198
A2780,3689413,0.5219259729031659
BT 159,54618164,4.278849354727367
JHH-6,6610216,5.06991273615497
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
MV4-11,9903786,0.7441932169203459
PK-1,409805,3.919077042185541
SNU-8,26596,-0.6710039843025739
CGTH-W-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1580124006071881
G-401,12003241,-2.103305079214356
T3M-10,sirolimus-bortezomib (250-1 mol-mol),0.4109261861139289
HuP-T4,JQ-1-carboplatin (1-1 mol-mol),-0.0362149836695267
CCF-STTG1,148198,-4.129311374884182
JHOS-2,148124,3.8692644642066023
Hs 729.T,107985,-3.631652767547101
WSU-DLCL2,9903786,-0.2732990105431844
UACC-257,9936388,2.2230563753853754
COLO 668,10322450,3.302091291225127
WM88,54618164,3.999670280417755
PC-3,selumetinib-GDC-0941 (4-1 mol-mol),2.4972652387658174
Malme-3M,11404337,-1.1089721048886994
JHH-4,9936388,-5.466111968240916
VCaP,135423438,2.0671137172311305
SW1271,8515,5.208985199998064
Yamato-SS,6918878,2.1080030635212257
JHUEM-2,36462,-2.2677125501048176
TOV-21G,6610216,4.421232020851441
SNU-410,409805,5.168065352202116
LCLC-97TM1,9926054,1.7367616025320842
SNU-C5,6610216,4.499193869483049
JHUEM-3,9911830,1.9490536022519651
VM-CUB-1,107985,-2.186887836117853
SK-UT-1,107985,-4.193387591911345
BT 330,262093,1.7469148441543585
MHH-ES-1,9903786,1.586022951185602
SK-MES-1,5460769,2.678686049759102
Panc 04.03,5460769,2.0457621674825224
SNU-46,136227924,3.2751090842747637
RERF-LC-MS,11404337,1.609147033115388
Pfeiffer,135875424,2.9223731979657206
MKN1,JQ-1-carboplatin (1-1 mol-mol),4.3566594896883934
LS513,159324,2.72198596150407
DEL,44493528,3.9686709959238833
KM12,10296883,3.701493082192586
NCI-H2106,8515,4.750503875422281
SNU-503,9936388,-4.768623005936061
MHH-ES-1,6505803,-0.7832039030153297
Hs 940.T,sirolimus-bortezomib (250-1 mol-mol),2.1873747359763613
GCT,6505803,2.0457782939841667
RKO,9903786,4.184024439899693
T24,tanespimycin-bortezomib (250-1 mol-mol),0.0189711730076056
NCI-H1299,6505803,-0.2534280947368875
VMRC-RCZ,439501,0.1982663120150432
NCI-H2228,11485656,2.3007848748427184
NCC-StC-K140,6505803,1.225711680594439
CAS-1,107985,-2.532317162545706
MOTN-1,148198,-6.162698623617939
P12-Ichikawa,44491742,4.234271740927445
MV4-11,6505803,-4.621529690475533
LMSU,44491742,4.063120482610564
TE-11,9926054,1.7898768600573436
Fu97,9936388,-0.0217982395537123
SNU-213,159324,3.5982392765945344
CAL-12T,439501,-3.605636550997873
KCL-22,100016,3.971728515649248
HT-1376,44493528,4.459541638540956
Hs 839.T,selumetinib-vorinostat (8-1 mol-mol),5.039190007116338
SW1710,12003241,-1.2750404815852618
MOLT-16,10296883,2.3695958656227782
UM-UC-1,JQ-1-carboplatin (1-1 mol-mol),1.521072888434132
Lu-65,selumetinib-vorinostat (8-1 mol-mol),0.948619360922771
DEL,9926054,1.477463428719593
Mono-Mac-1,12003241,-3.167077714646063
SK-BR-3,26596,-2.188814054378237
TUHR14TKB,JQ-1-carboplatin (1-1 mol-mol),-0.4661242690765318
EFO-27,sirolimus-bortezomib (250-1 mol-mol),2.1280256093524264
HEL 92.1.7,168313200,5.297199343733881
EHEB,6918878,1.3489098367208612
PL-21,148198,-2.77177529672749
786-O,262093,3.537658086729407
BICR 56,135875424,5.509002498442888
SW48,JQ-1-carboplatin (1-1 mol-mol),0.1401684728057108
DMS 53,262093,1.90510022371224
SNU-407,sirolimus-bortezomib (250-1 mol-mol),0.8562288670922468
SW48,6610216,4.461301788418361
NCI-H650,44493528,4.3603009222588645
TE-5,3689413,-3.902523210420284
ECC10,9903786,0.6869958735378703
NCI-H1944,10296883,4.093574875483821
OVISE,6918878,5.066606594706477
JHOC-5,100016,4.009706795291197
CAL-78,135875424,3.436960606583848
TE 441.T,6505803,-1.628255920679656
SK-OV-3,8515,5.143916520422132
COV644,sirolimus-bortezomib (250-1 mol-mol),0.1029805647741307
IGR-39,136227924,2.6355333557661167
G-401,44493528,4.310857122389352
HT-55,36462,2.885692973431166
A-673,selumetinib-vorinostat (8-1 mol-mol),2.071525628595549
OC 314,168313200,2.155060879424653
Karpas-620,6610216,5.001310944068096
Hs 746.T,selumetinib-GDC-0941 (4-1 mol-mol),0.5116122127806854
KMBC-2,439501,-3.686477603107828
Hs 888.T,409805,4.018843136639201
COLO 320,9903786,-0.1996043978745841
BT 187,12003241,-0.5243066739913107
BT 231,selumetinib-vorinostat (8-1 mol-mol),2.946498999717448
LK-2,6610216,4.2207982837864275
LOU-NH91,9926054,3.1176474597994908
BT 422,3689413,0.8456322118691856
BHT-101,selumetinib-GDC-0941 (4-1 mol-mol),-0.4263486280129431
TT,3136844,6.442417700047041
HARA [Human squamous cell lung carcinoma],9903786,2.5216559880194263
KMS-18,11485656,2.411593279183438
SNU-213,selumetinib-vorinostat (8-1 mol-mol),1.4256342092692729
COLO 800,6610216,4.2049381477581
HCC1833,6918878,2.6315946463231277
BT 164,439501,-4.366983118458045
SUIT-2,selumetinib-vorinostat (8-1 mol-mol),2.64771661765404
K-562,6610216,3.734328570580528
U266B1,selumetinib-GDC-0941 (4-1 mol-mol),1.5301935614482745
NCI-H2029,9927531,4.454841105841318
SCaBER,262093,3.0352387860556824
COLO 668,439501,-2.739607891151669
KYSE-520,72199289,5.964996237473484
TF-1,54618164,3.846409776212563
EFM-192A,136227924,3.313769329286525
NUGC-4,tanespimycin-bortezomib (250-1 mol-mol),-1.8387633895820632
NCI-N87,9911830,2.159086109533926
SNU-C5,36462,2.1753757989582923
NCI-H1666,JQ-1-carboplatin (1-1 mol-mol),-1.0019835803629806
BT 504,selumetinib-GDC-0941 (4-1 mol-mol),0.4660055972927751
LC-1/sq-SF,JQ-1-carboplatin (1-1 mol-mol),2.338357576071754
BT-20,sirolimus-bortezomib (250-1 mol-mol),0.9050670682088444
M059K,36462,3.1426101410832623
MIA PaCa-2,148198,-3.7289909178632383
JHOM-1,135875424,4.80614919695595
TT,9903786,2.2571281683889253
KMS-18,135875424,3.1558215727233208
NCI-H522,11404337,-1.4542746262182442
SU-DHL-10,159324,0.0335286607858622
LS411N,107985,-2.091782559178726
BCP-1,439501,-3.5020472552151904
BT 416,26596,-1.7367305778393065
COLO 678,148124,5.974841779410185
NCI-H661,sirolimus-bortezomib (250-1 mol-mol),0.684217370363433
HEC-59,44484440,3.6083291111938416
YD-38,tanespimycin-bortezomib (250-1 mol-mol),-0.8254079071300491
SF539,246676,6.084250396214504
NCI-H841,6505803,-2.206212090567919
DK-MG,5460769,1.2841485986218522
JHUEM-3,36462,1.2759724443128675
JL-1,168313200,4.033515228256602
SR,9903786,1.863499016732126
22Rv1,246676,2.324287060158596
EFO-27,54618164,4.628305371415217
NCI-H2170,100016,6.477443817994488
MOLM-6,409805,3.963738362596128
SNU-761,6610216,3.8236120023734497
SK-MEL-31,107985,-2.2802285323914213
KP-N-SI9s,168313200,4.331383268876979
SBC-5,9911830,3.21689826570876
CAL-51,6610216,4.7761200098267365
RKO,sirolimus-bortezomib (250-1 mol-mol),1.0887451358800992
KMS-28BM,selumetinib-GDC-0941 (4-1 mol-mol),1.2761888843371896
TM-31,6610216,4.436147332902249
HCC4006,JQ-1-carboplatin (1-1 mol-mol),4.481735519200737
IGR-37,439501,-2.841973609481132
NCI-H2009,9926054,2.181635437582939
SYO-1,9911830,2.926835859906529
HT-1376,409805,6.134546024517547
THP-1,6505803,-1.3271534570910488
U-937,sirolimus-bortezomib (250-1 mol-mol),0.5850227728036819
ME-1 [Human leukemia],10296883,3.2444666645650675
K029AX,246676,5.307982399914677
NCI-H810,46943432,2.958355821936664
WM115,tanespimycin-bortezomib (250-1 mol-mol),-3.082960536086858
SNU-16,9911830,-1.4367424571286636
CJM [Human melanoma],5460769,2.7678000793867077
HCC366,100016,6.086233690393214
MDA-MB-231,3689413,-0.2652306492331258
HSC-2,11404337,-1.7488575927200145
Ki-JK,36462,-1.561717559675625
JMSU-1,selumetinib-vorinostat (8-1 mol-mol),2.3406904931318566
BT 271,36462,1.9954282482695451
B-CPAP,36462,2.9049699830233733
NCI-H2228,44491742,4.2440053782675555
SUP-T1,selumetinib-GDC-0941 (4-1 mol-mol),2.5812487961986226
NCI-H1693,3689413,-3.280819080207211
KYSE-70,9903786,2.353212274658888
WM793,sirolimus-bortezomib (250-1 mol-mol),1.012836657947069
K029AX,107985,-3.0173775457381917
MOLT-16,54618164,3.317019420322426
OCI-AML-5,6918878,0.1560698403777357
BT 271,9936388,0.913255428649528
COR-L105,9903786,2.948812050867326
BFTC-909,sirolimus-bortezomib (250-1 mol-mol),1.9272227302236649
BT 228,3136844,3.8510652049111327
NCI-H1734,6610216,4.006473100907771
LN-18,6610216,4.459676529320986
HuH-1,selumetinib-vorinostat (8-1 mol-mol),2.367798014443328
AM-38,9926054,1.7644212109272557
HCC2108,135875424,3.411556630339189
Mel JuSo,sirolimus-bortezomib (250-1 mol-mol),1.422716190739553
COLO 699,tanespimycin-bortezomib (250-1 mol-mol),0.6482920125737269
NCI-H1693,6918878,5.485915607926496
BT-16,11485656,2.0917795824799787
BT 328,107985,-2.461939045328001
SW579,9927531,5.20286248500357
FaDu,11404337,0.6518309370028597
NCI-H1623,135875424,3.67415188779786
BC-3C,10296883,3.936118595707102
JHH-1,107985,-3.0623416548282516
SK-MEL-2,9926054,1.8796163413954976
SW1710,9903786,3.726951851848614
SNU-626,sirolimus-bortezomib (250-1 mol-mol),0.2861431467696579
UM-UC-3,selumetinib-vorinostat (8-1 mol-mol),4.277445444212211
NCI-H1693,10296883,3.9815475003033143
COLO 668,3136844,3.558686679878352
NCI-H508,10296883,3.4644363543099312
F-36P,10322450,3.2432615470800883
KYSE-70,6918878,2.8589087884624673
BT 498,409805,5.970409290821295
SW1271,9911830,2.7072275961126997
SK-ES-1,5460769,0.8929417744322142
MOLM-16,11485656,1.7000856268128752
HCC1428,107985,-3.631274120999778
HT-1197,JQ-1-carboplatin (1-1 mol-mol),3.4670046988259675
Becker,11404337,1.8814700373648592
LS180,selumetinib-vorinostat (8-1 mol-mol),0.5678514609289822
MOLM-13,11404337,-1.791363376051536
MDA-MB-361,9903786,4.233301337396568
SF539,3689413,-2.2250008276513107
HLF,10296883,4.080114065573622
CAMA-1,selumetinib-GDC-0941 (4-1 mol-mol),2.627092897381015
SaOS-2,439501,-2.8243657156627724
BT 498,9936388,2.0435440687928614
RERF-LC-A1,159324,3.1171864929596977
OPM-2,selumetinib-vorinostat (8-1 mol-mol),1.6127891772049152
MDA-MB-435S,135875424,4.677381950528883
BT 416,107985,-3.986056469995941
NCI-H2087,3689413,-1.4883160931257695
BT 139,24180125,3.745397640720988
SNU-1077,9926054,3.1436307505327123
SNU-449,262093,3.0394524195162766
MDA-MB-468,selumetinib-GDC-0941 (4-1 mol-mol),2.2484170521033437
Lu-99,409805,5.898617863060202
T84,selumetinib-vorinostat (8-1 mol-mol),0.4047942108328854
GSU,148198,-2.846893382841785
NCI-H211,9927531,3.644928626875117
Caki-1,11404337,2.102506471634507
DOV13,12003241,2.698298225737835
Mino,135875424,2.8874232883749578
BT 416,9927531,5.009885250018842
COLO 320,9926054,1.5350415050718291
BHY,11404337,-1.9155741795554864
ST486,10322450,2.677792904621428
ChaGo-K-1,135875424,3.8110724271208656
PF-382,36462,-0.7112012842580974
HuG1-N,135875424,4.4582955762312055
YD-15,6918878,3.100550028921635
SNU-668,tanespimycin-bortezomib (250-1 mol-mol),-0.1123433935372655
SW1573,JQ-1-carboplatin (1-1 mol-mol),2.7673375122522
LS123,3689413,-2.2814901809462467
COLO 201,9911830,2.293891105725039
NCI-H520,11485656,2.0255953186148674
Raji,100016,6.465762715187829
P-STS,46943432,3.5979035534915833
SIG-M5,JQ-1-carboplatin (1-1 mol-mol),-0.4990095627989978
CJM [Human melanoma],409805,5.948377664787024
PE/CA-PJ41 (clone D2),148198,-3.3597343554635652
NCI-H716,135875424,3.9271515423817047
KU-19-19,tanespimycin-bortezomib (250-1 mol-mol),0.8089732350000719
NU-DUL-1,11404337,-3.806861406156987
SNU-C4,sirolimus-bortezomib (250-1 mol-mol),0.5711150121168962
MFE-319,11485656,1.6496792677763226
COLO 668,36462,0.6333115343562025
SK-N-BE(2),46943432,2.3862382436812215
COLO 792,6610216,3.916017741536628
OE21,135875424,4.2322811376256
HCC-56,54618164,4.385422668938835
MeWo,26596,2.4666205413872953
42-MG-BA,9936388,2.1836082954328644
NH-6,44491742,4.075747370877145
HCC78,6505803,3.403944957250862
NCI-H716,6610216,4.204233875034661
EFO-21,9911830,2.599153404560511
MPP 89,9903786,4.435706117930943
LoVo,8515,2.0502092932288543
SET-2,8515,2.781692301096623
NCI-H1581,36462,2.0643710775083894
L3.3,5460769,1.7814582708772182
CAL-51,9877608,5.917079709597661
HDLM-2,54618164,3.4787631819448546
BT 239,selumetinib-GDC-0941 (4-1 mol-mol),-0.9250239368821744
Detroit 562,JQ-1-carboplatin (1-1 mol-mol),0.26349976511481
A-498,sirolimus-bortezomib (250-1 mol-mol),0.4701899983837266
GOS-3,11404337,1.2142789078350222
SNU-175,9936388,-6.345283130310661
IGR-1,148124,0.9085011917115766
SK-N-SH,136227924,2.487245372945198
SNU-407,10322450,3.446523216641638
RERF-LC-A1,9926054,2.5963235420247965
RL95-2,36462,1.5615779458309782
BT 239,6610216,3.2848009151202113
OUMS-23,selumetinib-GDC-0941 (4-1 mol-mol),1.2093335289094016
NCI-H747,136227924,2.5739387589966265
HCC2279,12003241,-1.0560673565017786
IGROV-1,46943432,4.105714883822214
CAL-51,54618164,4.021329289838694
YD-8,148198,-3.6074550947406863
JJN-3,100016,3.8434142095984303
HEC-265,100016,5.251492285111922
IGROV-1,159324,2.8766947154825044
LK-2,44491742,3.8692951916642353
CAL-51,262093,2.862241975448649
Hs 766T,148198,-4.268636450980236
WT2-iPS,tanespimycin-bortezomib (250-1 mol-mol),-2.960139188693383
EFM-192A,9903786,5.377742197319564
SK-CO-1,9926054,2.0008566323964576
TC-71,9926054,1.5758673536433587
DMS 454,selumetinib-GDC-0941 (4-1 mol-mol),0.8231378505894382
TC-71,6610216,4.613001823007589
NCI-H2009,JQ-1-carboplatin (1-1 mol-mol),0.1059252519818266
HDLM-2,5460769,4.226839303780804
Granta-519,6505803,0.3707466177802866
HT,6610216,4.522772185536218
HPB-ALL,36462,0.3626764904924543
MDST8,159324,4.143261975826356
HT-55,262093,2.6396601461162588
BT 422,262093,2.50169329189886
COV362,5460769,5.303432014507575
NCI-H838,9926054,1.8305885270474245
Jurkat,54639024,4.525209760597627
KHM-1B,107985,-4.92843539421015
Hs 895.T,9911830,2.789284500785935
HD-MY-Z,9911830,2.287012187948462
23132/87,439501,-2.5239735825770797
BICR 18,sirolimus-bortezomib (250-1 mol-mol),2.192378588292802
BV-173,6610216,3.640744959880511
BT 440,11404337,-1.269417175966202
DK-MG,11485656,3.787510091339842
SiMa,12003241,-0.7003588791224504
Rh41,46943432,0.9288175147210126
BT 245,9911830,3.123552720106954
HGC-27,26596,-3.243081069551806
AN3-CA,36462,2.7690899161359774
G-401,44491742,3.951665256591854
EFO-27,9926054,1.857839666788878
SK-HEP-1,135875424,4.97106166770821
A4/Fukuda,6918878,-0.3411937140873722
GB-1,148198,-2.999255289786891
NCI-H1299,148198,-1.8449433288311332
TYK-nu,26596,1.1864585547757855
JHOS-2,3136844,4.44829296310888
PL-21,JQ-1-carboplatin (1-1 mol-mol),-0.1767086466705203
Mino,10322450,2.499731281895077
TF-1,10296883,3.653157078260328
TALL-1 [Human adult T-ALL],26596,-1.974209938729662
MEC-1,10322450,2.616136352285943
NCI-H1792,9936388,2.616597511132069
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434
EFM-192A,selumetinib-vorinostat (8-1 mol-mol),2.534370375575117
KM12,6610216,4.513163589835474
NCI-H1581,24180125,2.253474610987822
MDA-MB-468,100016,5.725845417349072
SK-MEL-5,3689413,3.463644790263917
NU-DHL-1,6918878,-0.9557667101081658
CAS-1,9911830,2.812931698425885
Hs 746.T,262093,3.2071255403244097
BT 239,3689413,-0.6991113979789645
P31/FUJ,5460769,2.718083541162644
RPMI-6666,148198,-3.3774260453354015
WM115,8515,4.149615392892544
BFTC-905,11485656,2.1700639053341666
DOV13,148198,-3.763867663702191
NCI-H1155,46943432,1.3010281013857317
CHP-212,11485656,1.772260285582149
HPAF-II,5460769,4.759612134982938
DB,107985,-5.7298347238370795
Panc 08.13,11404337,-0.6282112311194213
B-CPAP,9926054,2.1103473685311043
GMS-10,409805,5.760322629357072
A-549,54618164,4.216271974260082
CA46,6505803,0.7805822725654986
MDA-MB-468,9926054,1.8087827398846443
MKN7,10322450,4.432955441296817
Hs 852.T,262093,1.3766639413412267
NB4,168313200,3.5232840402565104
T24,9927531,4.8353414036700615
KYSE-510,135875424,3.1467699489442182
SR,159324,2.6135427463918885
MOLM-13,sirolimus-bortezomib (250-1 mol-mol),0.2337551440217556
LNCaP clone FGC,5460769,1.4769173176739367
CAL-78,8515,4.135140304520332
IGROV-1,439501,-2.1510551928674557
L3.3,107985,-3.199791523822717
A2058,12003241,1.9511247747481215
LCLC-97TM1,10322450,3.85878970197106
HCC1833,11485656,2.071891952669738
SW579,135423438,-1.0918455211139204
769-P,tanespimycin-bortezomib (250-1 mol-mol),0.3785474363326266
NCI-H1944,11404337,1.0777396024830528
HCC4006,100016,6.421907923076987
HD-MY-Z,3689413,-2.31640912661536
BT 504,262093,2.380431698547906
EFO-21,5460769,5.67589124107342
OE33,100016,6.493432597771833
DMS 79,8515,4.333974511399787
COLO 205,6610216,5.036861870134594
L-428,6505803,0.937044713122246
SW982,168313200,3.252090363192236
KMS-27,6918878,3.015060659774869
NCI-H2444,136227924,3.2293818919988153
NCI-H322,168313200,2.9385162240660483
VM-CUB-1,8515,3.53886241208846
Karpas-620,136227924,3.0310478312116467
NCI-H1341,8515,3.70555816086862
A-549,3689413,0.7236603744186211
BT 333,439501,-2.413365908020449
HEC-59,439501,-0.4694388725326887
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905
LXF 289,11485656,2.2610473771175847
KMRC-20,9926054,2.16526453404653
KMRC-2,8515,5.486198436058084
KYO-1,107985,-4.0986784850985565
SH-10-TC,148198,-3.7737897444404993
TC-71,tanespimycin-bortezomib (250-1 mol-mol),0.107717273209992
A2780,54618164,3.641335469190071
HSC-2,9927531,4.076262005833891
DMS 53,9927531,3.323341915494568
Sq-1,selumetinib-vorinostat (8-1 mol-mol),2.350813570544066
KMS-11,9926054,1.1489638287123365
Calu-3,107985,-4.172207821327108
MOLP-8,6610216,4.187822370904977
OS-RC-2,107985,-2.111710402162911
JHH-1,6610216,4.205222984762599
Granta-519,12003241,-2.1147517064841925
HuH-28,sirolimus-bortezomib (250-1 mol-mol),0.2799415361995808
SUP-HD1,262093,1.1594795274119565
DV-90,44491742,3.389036842154366
COLO 829,44491742,4.1867442642539725
TE-11,148198,-3.0538183571053183
BT 359,6610216,4.170909037500597
GaMG,44491742,3.8685046453697383
DU145,3136844,4.310051670074563
HT115,6610216,4.006110298161749
SW48,100016,6.031440310304127
Sq-1,409805,5.517276398336014
NCI-H1373,3689413,-0.1033910947263759
HEC-1-A,9911830,2.9415015270085254
LN-18,JQ-1-carboplatin (1-1 mol-mol),2.2157134511008927
BHT-101,selumetinib-vorinostat (8-1 mol-mol),0.3729037272415222
JHH-6,135875424,5.397184820434736
KE-37,6505803,-0.078936185166994
SW1353,26596,-1.2000741302841849
BT 164,54618164,3.5882356128871913
KNS-81,11485656,3.966409180746404
HCC2279,selumetinib-GDC-0941 (4-1 mol-mol),1.829926030012146
SNU-182,49836020,5.156218287298631
DU145,6918878,5.332800992773371
SUP-B15,100016,6.907261874504965
NCI-H358,24180125,2.9959066083616
HuT 78,148124,-4.9142161440271135
A101D,24180125,2.7039616559486706
MKN74,409805,5.7612246650948356
EM-2,3689413,-2.767286284866434
CCK-81,44493528,2.4329753489883106
SNG-M,9911830,3.1900089255378865
Jurkat,5460769,1.807388363251775
SK-N-BE(2),26596,-1.6881701599106194
IGR-1,148198,-3.4768573180396496
Hs 822.T,8515,4.8347087726536815
OV-90,49836020,4.456425733691278
HuG1-N,9926054,1.9171272639265269
NCI-H520,54618164,4.0316677264685135
GSU,159324,3.570193385076479
NCI-H2291,9936388,1.6916444639385806
Hs 611.T,44491742,3.458740390209698
TTC-709,8515,2.8339402756906735
Hs 611.T,44493528,4.184302816514897
Kasumi-2,135875424,2.5938758238859494
KG-1-C,46943432,5.204516853454411
GI-1,54618164,3.901626722229882
NCI-H841,tanespimycin-bortezomib (250-1 mol-mol),-1.639550345576176
NCI-H2052,36462,1.2640077105319876
K-562,44491742,3.373435641850853
NCI-H1694,6918878,0.7286106824194027
BT 232,11404337,-0.4479930144977115
SU.86.86,3136844,4.583009658758261
UM-UC-1,9903786,1.5514700820318568
EB1,36462,-1.26198957190765
OCI-M1,107985,-4.64577499507645
A-549,6610216,4.4512033607640475
GP2d,107985,-4.252296994603502
NCI-H661,JQ-1-carboplatin (1-1 mol-mol),3.6496372437464992
NCI-H526,262093,1.015946009419874
HPAC,6918878,3.2093475857065035
RPMI-8402,54618164,3.265888368810329
HCC1438,11485656,3.297814060039802
Hs 746.T,tanespimycin-bortezomib (250-1 mol-mol),-0.2857851889987055
NCI-H69,409805,4.432674324966018
HCC1419,44491742,3.720252057260251
HT-144,9903786,5.3539912005761705
Mono-Mac-1,409805,3.1107516004642406
MKN74,24180125,3.4034235920876648
OCI-M1,54618164,3.810802357546973
NUGC-3,6610216,4.213897022791766
NALM-6,49836020,4.594148282336944
HCC1395,24180125,2.442140570538284
LN-18,sirolimus-bortezomib (250-1 mol-mol),1.6485166407126024
BT 179,tanespimycin-bortezomib (250-1 mol-mol),-3.1981676947705564
BT 216,168313200,1.9085884214210995
CA46,selumetinib-GDC-0941 (4-1 mol-mol),2.557872196645032
ECC10,8515,1.9738672443997605
MKN74,54618164,4.583505133133128
HCC1171,11404337,-0.0693231628102016
SNU-1214,selumetinib-GDC-0941 (4-1 mol-mol),-0.7739258064747034
HOP-92,262093,2.340026978235907
BT 248,148198,-3.920391313180545
COR-L51,107985,-4.427716506009149
A4/Fukuda,9926054,1.7963505717751411
OVCAR-4,168313200,3.9529975480401784
Namalwa,selumetinib-GDC-0941 (4-1 mol-mol),2.0079218875345015
SNU-C5,11404337,-0.8246866486472284
BEN,409805,5.771182466366909
SR,selumetinib-vorinostat (8-1 mol-mol),2.722566868305421
A-253,135875424,3.168681324917889
K-562,9911830,-1.954559593888618
SNU-449,44491742,3.9284370838515903
IA-LM,sirolimus-bortezomib (250-1 mol-mol),1.6120597722062386
Rh18,9903786,2.6471801174141625
HCC4006,148124,-6.171218423439735
SU-DHL-8,135875424,3.290196738895973
NCI-H727,262093,2.950291125725139
WM115,5460769,2.9023963298546507
KP-4,439501,-3.618807292682963
YD-15,159324,3.5154662615579486
Malme-3M,107985,-3.617993222869164
KO52,6505803,1.22031024799857
MFE-319,9927531,5.194887870380863
B-CPAP,159324,2.672075580393903
Calu-1,11485656,3.860482320905327
Jurkat,159324,-0.2625759022362762
OVCAR-8,9936388,2.326713990957197
IGR-1,107985,-3.302323947887529
OE33,11485656,2.057023759496841
RMG-I,107985,-3.282472145872261
SKM-1,135875424,3.1648969740603095
K-562,3689413,1.0071697658281389
KYSE-520,3136844,4.482720789319933
BT-474,12003241,-0.1629967020972257
U-BLC1,10296883,3.798592374745875
AN3-CA,6505803,-3.3327049528719312
BT 330,5460769,2.587250000288721
MCAS,8515,4.589748627719716
IMR-32,11404337,-2.700681379951113
Hs 888.T,136227924,1.939793098771597
KMS-26,JQ-1-carboplatin (1-1 mol-mol),-2.004743944030579
U-BLC1,409805,3.947099920887272
RD,36462,3.5531092488775213
SW1990,148198,-3.981392088661051
NCI-H2405,136227924,3.1304062683146747
WM983B,168313200,2.0257774924558176
NUGC-3,6505803,-1.151304908691564
CMK,selumetinib-vorinostat (8-1 mol-mol),1.8342196975016083
MOLT-13,135875424,3.0994865086023125
NCI-H508,409805,5.189849293513136
769-P,11404337,1.353529745525745
GA-10,168313200,1.62244958697484
A-253,439501,-2.336084390723404
L-540,8515,3.762633351070898
Hs 895.T,135875424,4.928152538117819
TALL-1 [Human adult T-ALL],46943432,0.6516741568598718
MKN74,262093,3.405035629450505
FaDu,tanespimycin-bortezomib (250-1 mol-mol),-2.9915431159716603
HCT 15,5460769,3.425383237869742
EPLC-272H,6505803,-1.0769896118510445
GP2d,44491742,5.750365262572418
NCI-H1092,439501,-3.60207444945155
F-36P,12003241,-0.4333234421592413
GCT,409805,6.004543979788198
P3HR-1,136227924,2.9304577514896466
M-07e,9926054,1.1111810240373077
BT 228,3689413,-1.5659127438457598
IGR-1,136227924,2.467918205864833
MOLT-13,selumetinib-GDC-0941 (4-1 mol-mol),0.648080768379065
BL-70,262093,2.9607019791616387
SW1353,107985,-2.47114721264714
SW1417,5460769,5.65335320943634
MHH-CALL-4,107985,-3.8831394707718294
HT-55,54618164,4.13568733206581
NCI-H211,selumetinib-vorinostat (8-1 mol-mol),1.6355902662267163
SU.86.86,8515,5.04236611979258
LUDLU-1,26596,-1.0531529741547596
LOX-IMVI,JQ-1-carboplatin (1-1 mol-mol),-0.0700406014025903
TE-5,100016,6.463093527046919
SNU-C2A,sirolimus-bortezomib (250-1 mol-mol),0.2009996133577312
KMS-12-BM,159324,-2.1850115101348
HuP-T4,selumetinib-vorinostat (8-1 mol-mol),-2.420119488886567
MPP 89,JQ-1-carboplatin (1-1 mol-mol),2.0529863800316
A-204,9936388,1.1921952776349394
NCI-H146,selumetinib-GDC-0941 (4-1 mol-mol),2.6749469012990525
MHH-CALL-4,262093,0.5666969129517823
Panc 08.13,9911830,3.187524729125814
SUP-M2,135423438,1.6419066239176594
HT-144,9911830,2.047294493227566
DB,168313200,1.5488809827223406
LC-1F,sirolimus-bortezomib (250-1 mol-mol),1.5648585655869938
8305C,262093,3.034489216194041
KMS-11,439501,-0.5953872178744132
HCC1438,sirolimus-bortezomib (250-1 mol-mol),0.8076549533300275
WSU-DLCL2,46943432,0.1082975695214752
LC-1/sq-SF,11404337,-0.155620091081562
TE-5,9926054,1.840497993611495
NCI-H292,3689413,1.7536313837601494
NU-DUL-1,409805,4.193403538182111
NCI-H1341,11485656,1.4261548687553274
HuT 78,9911830,2.253743254641726
SU-DHL-8,100016,4.106875584244309
HCT 15,11404337,-1.6671544641516778
DV-90,3689413,0.3888446743511712
KE-97,46943432,0.5632795363835643
JURL-MK1,12003241,-5.793080967465335
SK-MEL-3,3689413,0.509275079548213
PE/CA-PJ41 (clone D2),168313200,3.0210086537721574
HEL 92.1.7,9936388,-4.8155020562106525
NCI-H2228,136227924,2.998313400459559
GOS-3,sirolimus-bortezomib (250-1 mol-mol),0.3031881482046261
ST486,46943432,0.4282456426671725
A-549,9926054,1.8971220341716168
BT 239,6505803,-2.8170451599207733
Tm87-16,11485656,2.0934920623366784
NCI-H1755,135398744,6.361982871837632
VMRC-LCD,JQ-1-carboplatin (1-1 mol-mol),0.5789512547654533
OAW42,24180125,3.18113812065638
SCaBER,9903786,2.6079380846248568
NCI-H2030,9936388,0.4850325164954482
P12-Ichikawa,262093,1.3353925545837786
NCI-H520,11404337,-0.911000559838952
RERF-LC-A1,36462,1.7424004173726408
HEC-265,6505803,-2.0773679998805346
NCI-H2030,3689413,1.2400324738328432
DB,54618164,3.106803740802123
CMK,148124,-4.626446728846703
DOV13,10322450,3.678402258814296
L-540,9926054,1.766103135672326
T3M-10,selumetinib-GDC-0941 (4-1 mol-mol),0.2338392597437749
SNB-75,135875424,3.5358654963321556
TE 441.T,tanespimycin-bortezomib (250-1 mol-mol),-0.9090621811033658
BT 224,11485656,3.221483556518939
AU565,sirolimus-bortezomib (250-1 mol-mol),0.9370118878253954
HCT 8,135875424,4.984268823368111
LXF 289,36462,2.912637639845359
SNU-886,439501,-0.6078207224909147
OCI-M1,10296883,3.5292915322873255
OVCAR-8,135398744,6.524120777237468
SK-UT-1,9911830,2.8726761747893756
BICR 31,409805,3.7719372874267982
BT 216,135398744,6.476974321326381
SKM-1,9903786,0.91314187591027
NCI-H23,49836020,3.049554437236292
HD-MY-Z,9936388,-7.089387661668647
Pfeiffer,409805,1.9666886475443683
HCC1806,148198,-2.202923064459824
SNU-1079,409805,6.036263178854899
Namalwa,24180125,2.5255693450157697
JVM-3,5460769,-4.534057079586897
Reh,409805,3.28690682151102
CHP-126,26596,-2.268724327317824
G-292 clone A141B1,6505803,0.1616313040376176
NCI-H520,9936388,-7.179601192363118
UO-31,36462,3.819646793717455
NCI-H747,148198,-4.03542032091069
NCI-H2023,6505803,-0.0935545329611447
PK-59,159324,2.910821247421296
NCI-H1693,JQ-1-carboplatin (1-1 mol-mol),-1.0867749942115603
KP-3,selumetinib-vorinostat (8-1 mol-mol),2.7675803183632155
JHUEM-3,439501,-2.1632963006772075
C2BBe1,439501,-3.497031397635042
SW948,9903786,1.6902329933335576
SK-N-AS,148124,-5.963448683076425
HD-MY-Z,148198,-4.870979577806884
SNU-407,selumetinib-GDC-0941 (4-1 mol-mol),0.3272948267945177
DoHH2,selumetinib-vorinostat (8-1 mol-mol),1.073205965733501
SK-MES-1,9936388,1.0310687201713455
KHM-1B,9936388,-7.3262126051433425
NCI-H650,409805,3.6301362356627886
UO-31,148124,-2.8322592718949178
Hs 294T,135875424,4.177071063974562
BV-173,12003241,-5.971697113356734
BT 216,54618164,4.238322726276742
SYO-1,107985,-3.867738791331657
OVSAHO,11485656,2.294193584233593
NCI-H1623,26596,-1.1542368606327895
BT 248,12003241,-0.5635987052840526
T3M-10,148198,-1.9174912256431331
MOLP-2,36462,0.3007891095090442
Hs 578Bst,11485656,3.9030782427040247
DMS 273,44493528,4.2569430545307725
Rh30,tanespimycin-bortezomib (250-1 mol-mol),0.9800677460463127
Kuramochi,136227924,3.2782581577037964
LP-1,selumetinib-GDC-0941 (4-1 mol-mol),0.6666027580739052
EoL-1,409805,2.9629225339184595
TE-5,36462,0.7154443377977948
KPL-1,6610216,4.881878965578164
OVCAR-8,135875424,3.0307558865901285
COLO 205,100016,5.963233409359241
Mino,136227924,1.7493984310197022
OVK18,sirolimus-bortezomib (250-1 mol-mol),-3.215952535759779
NCI-H1563,409805,5.970262971726849
NCI-H526,6610216,4.727896763820283
OCI-AML-3,46943432,-2.0174912276907637
LOU-NH91,6918878,5.623996708869271
KM12,9936388,-6.571860760975573
Ishikawa (Heraklio) 02 ER-,44484440,3.323935553013314
GI-1,409805,3.4701849775585902
Calu-1,tanespimycin-bortezomib (250-1 mol-mol),-0.0246421056522193
CAL-62,11485656,2.1726256294721167
KP-N-YN,72199289,5.448053701160584
SW1990,9903786,3.346032701157222
SK-UT-1,10296883,3.957718672541511
COLO 829,3689413,0.7694296944480054
SNU-8,9903786,3.356408381726989
BT 504,54618164,4.1210357013114365
HT-55,107985,-2.548300966518349
RPMI-8402,9936388,-6.946099895647247
ESS-1,136227924,3.049003867547222
CMK,tanespimycin-bortezomib (250-1 mol-mol),0.1761627875965655
SNU-5,36462,1.2095773487529122
KMRC-1,9911830,2.7576147713752532
KO52,selumetinib-vorinostat (8-1 mol-mol),-0.9100667251350252
HT-1197,11404337,0.4511848825128766
Calu-6,54618164,3.923286506483291
SW982,136227924,1.7454954285641082
NCI-H1650,262093,3.0085408028309786
SKM-1,12003241,-1.1629643414911237
LoVo,54618164,3.038824107117225
HSC-3,selumetinib-GDC-0941 (4-1 mol-mol),2.0477994857059647
Daudi,168313200,1.4988300519601074
MIA PaCa-2,9926054,1.823118001934022
SW1353,6918878,1.0541631026362632
NCI-H2171,135875424,2.950178944342904
BT 271,10322450,5.076233079663244
CW-2,3689413,0.3628565855877684
GSS,11404337,-1.198572034455594
786-O,selumetinib-vorinostat (8-1 mol-mol),3.923964737864286
CAL-120,sirolimus-bortezomib (250-1 mol-mol),1.988882229228272
ME-1 [Human leukemia],135875424,3.754856170927667
NCI-H1155,44491742,3.896429855213272
KMS-20,10322450,3.2597318465423353
YD-10B,sirolimus-bortezomib (250-1 mol-mol),0.8194985120964778
MOTN-1,5460769,0.7518419346698605
SK-BR-3,36462,-0.4893529517615315
TE-15,8515,2.4630178987516564
HeLa,9926054,1.7615972318293558
BICR 31,8515,4.104799625743522
A2058,11404337,-0.7992092997258325
NCI-H716,10296883,2.894605704782392
NCI-H1651,6505803,-0.3819158515130707
BFTC-905,12003241,-0.5086689742708943
SUP-HD1,44493528,3.885514545819132
NCI-H2029,tanespimycin-bortezomib (250-1 mol-mol),1.6756703480673036
BHY,3689413,1.273700268174745
AN3-CA,8515,3.3149085250291632
HCT 116,8515,4.318498680671023
HT-144,6610216,3.8777683523486544
SNU-387,262093,3.304396146111304
647V,JQ-1-carboplatin (1-1 mol-mol),0.8897727111065127
TE 617.T,439501,-4.266247423790402
MOLT-16,24180125,2.1628901306704833
HeLa,6610216,4.731171636127949
K-562,168313200,4.769830643466651
NCI-H1385,44491742,3.386868498663753
NCI-H1573,9936388,0.6973837947866425
PC-14,6610216,4.542252614030989
Kuramochi,10322450,3.6258037590655383
Ishikawa (Heraklio) 02 ER-,selumetinib-GDC-0941 (4-1 mol-mol),4.857183586946226
CAL-62,9927531,5.042893811802322
COLO 678,selumetinib-GDC-0941 (4-1 mol-mol),0.6470701140991139
SK-LU-1,135875424,4.823970968633346
NH-6,54618164,4.061108771946247
Mono-Mac-6,11404337,-0.9088442855658504
NCI-H1838,44493528,4.677704143001884
ST486,9911830,1.5676247278610147
KCL-22,3689413,0.1679864473503304
NB4,9903786,1.7786072365174606
OAW28,6918878,3.220005605820797
HEC-251,409805,6.031835667467917
Caov-3,262093,3.252230981856776
DV-90,439501,-2.858386639088026
EBC-1,6610216,4.132089283309266
NU-DUL-1,24180125,2.788711571629837
KYM-1,409805,5.989098964780094
NCI-H2106,tanespimycin-bortezomib (250-1 mol-mol),0.3731532829488707
SNU-1105,9903786,3.6171667561714056
M059K,135875424,4.531925541014952
HPB-ALL,11485656,3.05569165174981
HEY A8,54618164,4.2562410022928105
U266B1,136227924,2.814695997301776
BT-20,148124,-6.2975852770754015
GI-1,148124,-7.051514265549868
YD-38,9903786,2.8631306213752103
OCI-Ly10,409805,3.0484077961681773
A2058,6918878,2.6898546456864447
TE-15,6505803,-1.869936847714552
Calu-6,26596,-4.0671398242119965
MHH-ES-1,439501,-2.339727963154972
HCC1500,11485656,2.6610961572019103
COV434,136227924,1.351853150285656
COLO 792,136227924,2.7402829929938908
MOTN-1,100016,6.2802968176710445
Kuramochi,9911830,3.644451314699112
AN3-CA,107985,-2.3733374503146414
NCI-H1703,409805,3.824185286554961
SNU-C5,5460769,3.868586295292914
SNU-668,36462,2.9048047671619877
Sq-1,439501,0.4738250943054584
SNU-216,26596,-1.178501170162628
CAL-148,5460769,1.0209449875435856
KYSE-150,3136844,5.012906100108251
MHH-CALL-4,selumetinib-vorinostat (8-1 mol-mol),1.0890030142935403
KMS-26,44491742,3.93722038391691
CAL-27,8515,2.199074153497869
YH-13,36462,2.0221735206643743
NCI-H526,100016,5.298819017471169
KE-97,tanespimycin-bortezomib (250-1 mol-mol),-0.1953255566925064
NCI-H2286,11485656,2.9598645626124576
COR-L88,3689413,0.2810588861379679
Hs 611.T,11404337,-3.0246332650270777
SNU-213,6610216,4.06770286109328
RKO,135875424,3.829354185480349
SNU-620,6610216,3.664265163527259
Rh30,135398744,6.322590827161508
PK-45H,selumetinib-vorinostat (8-1 mol-mol),1.281652325813519
NCC-StC-K140,439501,-3.4454248624947437
BT 147,10296883,4.22717301234077
RCC10RGB,135875424,5.859031260595621
SK-UT-1,54618164,4.334674071191232
HPAC,3689413,3.007667333136724
JHH-4,6610216,4.057898484611385
U2OS,sirolimus-bortezomib (250-1 mol-mol),1.3880787640011472
JHUEM-2,246676,4.384067932362518
BT 187,6505803,-2.6159963341734613
A3/Kawakami,sirolimus-bortezomib (250-1 mol-mol),-6.300755370161075
HL-60,44493528,4.339853474381488
NCI-H2228,24180125,3.874762133754576
NCI-H2052,136227924,3.050038230910341
IPC-298,262093,3.133705488563506
TCC-Pan2,439501,-0.269334901836468
Hs 940.T,12003241,-1.8353600585061816
NCI-H2444,9911830,3.5265930099912017
KMS-27,49836020,5.305149991763679
IPC-298,100016,6.58023685235314
HCC1195,439501,-1.494120316453499
J82,439501,-1.5072353700594
QGP-1,24180125,2.573216603875163
K-562,26596,-3.6076758496321832
HMC-1-8,6505803,-1.2276193463288383
KMRC-1,100016,6.458679548763862
SNU-466,409805,4.306373877119286
NCI-H441,439501,1.4166866147967416
A2780,26596,-4.32263985415392
OVCAR-8,6505803,-0.7401549831867192
HH [Human lymphoma],6918878,-0.1416426895678318
KYSE-30,12003241,-0.1095696990749684
BICR 22,9927531,5.395078942533075
OCI-Ly19,26596,-2.6757237263114875
YH-13,6505803,-0.6394660445903715
MDA-MB-231,44493528,4.662027918960356
Mel Ho,selumetinib-GDC-0941 (4-1 mol-mol),-1.3923525506877812
F-36P,JQ-1-carboplatin (1-1 mol-mol),-0.2067996802850356
HCC78,6918878,-0.1466514209990675
CAL-54,11404337,-0.6827741736439762
RVH-421,135423438,4.562658125390885
SW620,tanespimycin-bortezomib (250-1 mol-mol),-2.1840810190060287
Rh18,sirolimus-bortezomib (250-1 mol-mol),0.7964593742547511
A-673,44491742,3.844993574977925
BT 422,6505803,-0.9027311495147816
CADO-ES1,3136844,3.1939853106086264
BT 232,selumetinib-vorinostat (8-1 mol-mol),2.9524508630620554
BT-20,11404337,0.6443596092093807
RCM-1 [Human rectal adenocarcinoma],9926054,2.0094388483046757
COV644,tanespimycin-bortezomib (250-1 mol-mol),2.484857024985863
SNU-C2A,136227924,3.0438027551295352
BT 428,tanespimycin-bortezomib (250-1 mol-mol),-1.9102610894463772
FTC-238,135875424,3.1896552091997603
BT 131,9936388,0.7125118165046622
JHOS-2,9936388,2.4979733354975773
BT 482,9911830,3.0772009625144325
OCI-Ly19,148198,-5.638964397793588
LK-2,6918878,3.576863026149854
NCI-H446,9926054,1.7959327761623658
NCI-H2405,36462,2.5920366371132295
BICR 18,44491742,4.057400353675569
YD-10B,26596,-1.4003119054370567
DV-90,6610216,3.9781363588857888
HCT 8,136227924,3.7452024891634785
AsPC-1,135875424,4.124114476494282
EC-GI-10,262093,3.0638768709018795
MV4-11,135875424,2.3295422515214717
SNU-119,159324,3.0008353242690045
PSN1,107985,-4.750149714277217
SU-DHL-8,6505803,-0.9881094595359692
SNU-886,26596,-1.4881272997493236
JM-1,100016,5.094244415703564
OVSAHO,9903786,3.817356196338304
MOLP-8,100016,7.090961588333011
NCI-H322,9926054,1.834077312686318
SNU-1033,439501,-2.7458935942411085
K-562,6918878,0.8571724386049573
EM-2,12003241,-5.8745734353402534
WM1799,selumetinib-vorinostat (8-1 mol-mol),-0.9356643897041474
PK-59,36462,2.3986313317590384
BL-70,9911830,1.8003743616060963
BICR 31,46943432,4.176233154169203
NCI-H1703,tanespimycin-bortezomib (250-1 mol-mol),-3.1681297716810692
SNU-61,11485656,2.115016827038527
WM266-4,6505803,-3.5137777685434384
CAL-85-1,148198,-3.2727903710905744
SNU-869,sirolimus-bortezomib (250-1 mol-mol),1.7458276464025495
SW1353,24180125,2.9527880744197708
KM12,9911830,-0.4437946129171659
MOLM-13,JQ-1-carboplatin (1-1 mol-mol),-1.1937671788026978
Li-7,JQ-1-carboplatin (1-1 mol-mol),-0.1092601408867035
GI-1,26596,-0.9174030047278064
NCI-H1563,5460769,4.309223313184859
CMK,11485656,1.9879747340083027
CAL-27,selumetinib-GDC-0941 (4-1 mol-mol),-1.559817490656083
NCI-H1666,6505803,-3.0985953637534354
Jurkat,135875424,3.3200547810241496
KMS-12-BM,10322450,2.7501974340219575
M-07e,148124,-5.941925680697441
23132/87,sirolimus-bortezomib (250-1 mol-mol),0.0673890059049479
HEC-1-A,135423438,1.6269697099453948
COLO 201,148198,-3.731044907420304
MOTN-1,9927531,4.434768269129304
DU145,54618164,4.17145351900014
BT 172,12003241,-0.4866452668331515
A-673,26596,-3.820628112159822
LCLC-103H,439501,-2.3624899744714956
HCT 116,44484440,3.359759358321295
RL95-2,9911830,2.3107530510389016
HuT 78,26596,-1.9929249611117947
SNU-761,9911830,2.50367716238648
OCI-Ly3,168313200,3.770083870930309
A101D,262093,3.196770029367663
CAL-78,44493528,4.952058712183874
COV362,6610216,4.265894841411048
BT 139,3689413,1.1435542954681734
BICR 6,107985,-4.058328125828726
OCUM-1,9936388,0.7309150474030258
SNU-61,136227924,2.341371828887226
SNU-719,9926054,1.5286214740335768
Ci-1,9903786,3.745611899218518
HCC2279,9903786,3.291578502930839
BICR 18,148198,-1.2308146568318987
NCI-H520,6610216,3.9954490147026647
TM-31,selumetinib-vorinostat (8-1 mol-mol),3.0229766520782095
NCI-H2085,409805,4.930961778179055
SK-CO-1,148198,-1.1611262776602205
SCaBER,selumetinib-GDC-0941 (4-1 mol-mol),-0.4937512054243923
SNB-75,11485656,3.1834770923218065
CMK,12003241,0.0052049395185332
NCI-H2286,9936388,-4.7248658959842
VCaP,3689413,-1.1358537127375183
Detroit 562,9903786,2.622976915424344
EHEB,11485656,2.717011543878295
EoL-1,10322450,2.2148801830684097
BICR 56,12003241,-1.3308187474558526
KYO-1,136227924,2.5889716651569614
OVSAHO,sirolimus-bortezomib (250-1 mol-mol),1.2333727480896128
CFPAC-1,148198,-1.2933950729349923
MOLT-13,439501,-2.4259548935745348
SNU-C1,selumetinib-GDC-0941 (4-1 mol-mol),-7.034120569721028
NCI-H2087,159324,1.2033860013078608
TALL-1 [Human adult T-ALL],100016,4.020437007073488
SH-4,12003241,-2.3432697923698083
UACC-257,44491742,4.3075324328228275
KMS-34,107985,-4.800473220860728
HuH-28,11485656,3.308019517544549
OCI-AML-5,tanespimycin-bortezomib (250-1 mol-mol),-0.6942997118623143
CADO-ES1,6918878,0.0890990446201022
KU-19-19,136227924,3.1447471190609217
BT 340,6505803,0.8782913115261707
L-428,9927531,4.649182566177492
MDA-MB-157,11404337,0.0143481506183785
LCLC-103H,9903786,3.9967722976793696
JHUEM-2,selumetinib-GDC-0941 (4-1 mol-mol),0.855828928912332
HuH-1,11404337,-0.1897413514588927
NCI-H446,selumetinib-GDC-0941 (4-1 mol-mol),2.0638797586373263
OCI-AML-3,10296883,3.1586909460466455
KYSE-180,11485656,1.9289585779871232
CAL-54,100016,6.472919480601912
Becker,10296883,4.31752254310815
BT 440,49836020,4.914023334980662
SW620,8515,3.5759588402103137
KMS-21-BM,409805,3.562482933732855
VMRC-RCZ,3136844,4.32021167133106
Jurkat,246676,4.546018962680684
MDA-MB-157,135875424,2.7117106005077276
SW1990,3689413,-1.271257676680656
SK-ES-1,8515,2.7531864061025013
FaDu,148198,-4.955627855681465
CAL-51,44491742,5.152478206660974
SET-2,54618164,3.897456065397519
PK-45H,107985,-2.8676088272844047
SaOS-2,12003241,-0.699813042979073
Rh41,6918878,0.4255550700374532
Jurkat,44491742,-1.1697965410945943
DEL,9911830,1.9134272494312208
J82,9903786,4.0002373465355054
EFO-27,10322450,4.618987367546035
T98G,9911830,1.7364710964395085
Calu-1,6610216,4.821045384716902
HEC-251,135875424,3.4387509729179913
TUHR4TKB,12003241,-0.5778416487283387
SNU-1,6610216,3.805786974362891
COLO 680N,107985,-1.189155361561619
BICR 18,11404337,0.2486496925996474
TF-1,sirolimus-bortezomib (250-1 mol-mol),0.3198417316245446
SH-10-TC,107985,-2.836230887151265
HMCB,100016,6.123582467992384
P3HR-1,11404337,-1.4937921094684845
22Rv1,5460769,4.1007004291064675
NCI-H1339,36462,1.5499539192290197
KYO-1,6610216,4.320602748188163
IPC-298,24180125,3.708538473010715
WM115,9926054,3.0880179510914454
U-87MG ATCC,262093,2.7764008714475317
A-673,24180125,1.1732098097274752
NCI-H2141,3136844,3.528867669857209
BT 359,9936388,-7.804167889982691
SNU-761,409805,5.079172606794191
HCC1954,26596,-1.6295363665710343
A-549,136227924,3.1395144761786486
SNU-668,9927531,6.94205854979306
U-251MG,9926054,2.2647834350690483
NB1,9926054,1.7584183979270531
UACC-62,44491742,4.3464910230211755
TE-14,439501,-3.001573063863178
G-292 clone A141B1,439501,-3.0998279845902723
A-673,6610216,4.190818336865809
BT 498,135875424,3.150429417088691
HCC202,107985,-1.8930247098179032
NCI-H2405,100016,6.531050125500204
SF126,73707440,4.55142805783094
LP-1,107985,-4.335772464221896
KP-N-SI9s,148198,-2.8651089609704283
HT-1080,5460769,3.028756475221219
SW982,tanespimycin-bortezomib (250-1 mol-mol),-1.8662349479314355
SK-N-DZ,9927531,3.3336857807362392
SK-ES-1,246676,6.206745799744681
L3.3,36462,1.8942720792997911
HEY A8,409805,6.361022434808549
RL,439501,-3.24492764026673
BICR 22,136227924,2.105383482893856
LS411N,11404337,-0.9351547419605356
Hs 944.T,11404337,-1.616812668410186
RPMI-6666,tanespimycin-bortezomib (250-1 mol-mol),-0.2887832089561175
A2780,11404337,-0.8981705286722745
YKG-1,26596,0.9408189524000934
F-36P,3136844,2.947834525735439
KATO III,11485656,1.9735561216219804
OCI-AML-2,selumetinib-GDC-0941 (4-1 mol-mol),-2.789265040727208
MDA-MB-361,selumetinib-vorinostat (8-1 mol-mol),1.866211608168264
BT 147,136227924,1.9245142249128984
KMRC-20,100016,7.210629640241846
COLO 829,262093,3.4773152453847715
JHUEM-7,100016,7.782886537779513
PK-45H,10296883,4.020299525080379
BT 340,10322450,6.150676634502763
NCO2,selumetinib-GDC-0941 (4-1 mol-mol),-0.0014559865533413
IGROV-1,9903786,1.7387584479757865
Namalwa,54618164,3.970816819204835
LS1034,136227924,1.69162800732405
ECC10,44491742,3.5514188140431644
KMS-12-BM,24180125,1.472923036280714
SNU-1,11404337,-1.6591941972461035
OCI-Ly19,11485656,1.5733827974679646
NCI-H2110,148198,-2.105563861688736
HuH-28,9936388,2.0438791197733632
OVK18,5460769,2.4178106376045516
NCI-H23,tanespimycin-bortezomib (250-1 mol-mol),-3.070808400033709
NCI-H358,136227924,2.8821870791202873
Hs 294T,6505803,0.4155965097555305
TC-71,11404337,-2.7316229346528145
TCC-Pan2,11404337,0.04940510816565
DB,6918878,0.4040297539819066
Kasumi-2,3136844,3.733604332390159
BT 328,3689413,2.3836323832860673
TOV-112D,3136844,3.915862706699143
SK-MEL-5,409805,5.871261975473595
Mel Ho,JQ-1-carboplatin (1-1 mol-mol),1.3630461698598746
NCI-H2405,sirolimus-bortezomib (250-1 mol-mol),-0.6741915043369825
MCF-7,11485656,1.7556597591503045
HEL,100016,4.260371486080393
HCC4006,3689413,-2.273135078427732
HT-55,9911830,2.2687897091778138
Hs 611.T,135875424,2.7263445003410536
DBTRG-05MG,262093,3.4066291906537645
KNS-60,selumetinib-vorinostat (8-1 mol-mol),1.8359205903687537
SUP-HD1,12003241,0.3285815834035863
SNU-475,12003241,0.1195420556659512
Hs 766T,9936388,1.7778445616458998
JK-1,selumetinib-vorinostat (8-1 mol-mol),-0.0051710372018302
SUP-HD1,9926054,1.7829346209502994
NCI-H460,selumetinib-vorinostat (8-1 mol-mol),4.393726513412324
NCI-H2085,sirolimus-bortezomib (250-1 mol-mol),0.8300546394702069
BT-16,148198,-6.229115557962731
KG-1-C,9936388,2.2222312234871957
JeKo-1,tanespimycin-bortezomib (250-1 mol-mol),0.4974732421347879
SF295,11485656,3.5430104374180806
LOX-IMVI,46943432,0.8500052465051992
MDA-MB-361,12003241,-1.091645986643679
T-47D,selumetinib-vorinostat (8-1 mol-mol),3.20123924318934
Tm87-16,9903786,3.2568482334104587
IGR-39,36462,0.7712371318565482
MHH-NB-11,12003241,-1.5354599516868075
GI-1,tanespimycin-bortezomib (250-1 mol-mol),0.3009698031973534
JHH-4,selumetinib-vorinostat (8-1 mol-mol),2.0641916826842963
BICR 31,11485656,2.9684140094972387
OVK18,439501,-1.6105511378028463
OAW42,135875424,4.816412015133948
LUDLU-1,8515,4.620878696519872
647V,9903786,2.919786568637495
PF-382,11404337,-1.5613133934389778
HCC44,439501,-2.457856090784354
NCI-H1651,11404337,0.2113643612214112
SNU-478,107985,-3.774597875845584
HCC78,5460769,-0.5347925527973022
697,36462,-2.3548422170765946
NCI-H2009,8515,4.894015987740437
NCI-H1694,168313200,1.7110744795628887
D283 Med,168313200,1.8321011656642825
TOV-112D,11404337,0.1450388001924293
647V,100016,6.109475002217934
769-P,11485656,3.1520053079529955
OCI-Ly10,54618164,4.491918084820433
NCO2,11404337,-0.941549986556875
SH-4,409805,3.579343457445403
Li-7,44491742,3.4427957124518325
U-937,8515,3.244318926695943
697,148198,-7.764222661633608
COLO 668,selumetinib-GDC-0941 (4-1 mol-mol),1.3136339769423369
HuNS1,selumetinib-GDC-0941 (4-1 mol-mol),2.547850957341402
RL95-2,100016,4.898266673475204
BHY,9926054,1.5277493877995152
MDA-MB-361,135875424,3.2859719831181176
LUDLU-1,262093,4.588998578428556
NCI-H1703,36462,0.3978809635850562
DMS 114,24180125,2.571127008152471
Peer,44493528,3.441371603588331
J82,6610216,4.454251017755925
SW1573,selumetinib-vorinostat (8-1 mol-mol),4.856763743237327
CAL-33,9936388,-7.915687157978736
Caki-1,135875424,5.125575206992357
OVCAR-5,9927531,5.160514110518488
HOP-62,3136844,3.524389287742587
EFO-21,12003241,-0.6894261883426276
HCC38,selumetinib-vorinostat (8-1 mol-mol),3.9868927828285594
TE-14,12003241,-0.291419040743519
MHH-CALL-4,11404337,-1.4992681274735582
OPM-2,135875424,2.796643273298537
HuT 78,8515,3.8606402282287657
SK-N-DZ,54618164,3.925658631288567
NCI-H1650,sirolimus-bortezomib (250-1 mol-mol),1.0715909350533408
BFTC-905,159324,3.4792203482378117
KYO-1,44491742,4.154466430935869
TE-11,409805,3.950672349574134
NCI-H520,tanespimycin-bortezomib (250-1 mol-mol),0.1006968831130432
AU565,24180125,2.1910645714042634
NCI-H841,5460769,2.2001101436907984
Tm87-16,168313200,3.0949876712428224
Kuramochi,tanespimycin-bortezomib (250-1 mol-mol),2.338671099156103
ME-1 [Human leukemia],439501,-0.373146825712067
CML-T1,262093,1.3151134240668207
HeLa,11485656,1.8522393336584817
PC-3,tanespimycin-bortezomib (250-1 mol-mol),1.8125784159372291
JHH-1,262093,3.2882358665123426
AsPC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.9679789776412068
NCI-H1339,12003241,0.6707609457385758
BT 187,10322450,6.076847615310279
SUIT-2,11485656,3.4408604141627763
NCI-H2141,tanespimycin-bortezomib (250-1 mol-mol),0.6080837341051074
EBC-1,409805,4.585447738175281
SU-DHL-8,107985,-4.356610955775537
UACC-257,tanespimycin-bortezomib (250-1 mol-mol),0.2764764402822645
HL-60,6918878,0.153982962801108
EBC-1,439501,-0.4192565995990754
SW1271,11485656,2.5257448561020053
ZR-75-30,100016,8.126082181881081
Becker,148198,-3.822753548425191
HH [Human lymphoma],44491742,2.6350452695028888
WT2-iPS,262093,1.0416118497469489
SNU-899,6610216,4.41972312079981
OVK18,6505803,-0.991074322239109
SNU-175,6505803,-3.2820452967658778
CAL-51,159324,3.1794720270506307
IGROV-1,9911830,1.9130562323799436
SNU-1076,44491742,5.119632622149795
SK-LMS-1,409805,6.056363964674445
MOR/CPR,3689413,3.3711926349807797
SCC-9,36462,2.4622585602605493
NCI-H292,9927531,4.942242070848643
DMS 53,26596,-0.0361883728556599
Kasumi-1,9936388,-5.775038458721337
MHH-CALL-3,tanespimycin-bortezomib (250-1 mol-mol),0.530639980340651
Reh,sirolimus-bortezomib (250-1 mol-mol),0.0012430835565731
DMS 273,409805,3.6932334728164826
Hs 888.Lu,tanespimycin-bortezomib (250-1 mol-mol),0.5097438432490347
NCI-H841,24180125,3.3524098176171835
Rh41,12003241,-2.564539347057637
Mono-Mac-1,26596,-2.0508737654950036
Pfeiffer,9903786,-0.8773679724419216
SNU-8,selumetinib-vorinostat (8-1 mol-mol),1.098702489226645
SK-MEL-5,10296883,3.4956550108222775
8305C,107985,-3.674181215647319
DU4475,selumetinib-GDC-0941 (4-1 mol-mol),-4.053577940845995
LS411N,6610216,4.962940577428159
MM1.S,24180125,2.972534828152793
CAL-33,selumetinib-GDC-0941 (4-1 mol-mol),-0.2245005212599697
Ri-1,24180125,1.2545611778962542
SW982,11485656,3.4639453633875985
WM88,9911830,1.6479325280433286
BICR 18,409805,5.834842902034196
NCC-StC-K140,168313200,1.6105934418436303
PSN1,54618164,4.143205151056231
BT 216,24180125,3.180911613417136
KYM-1,5460769,0.1657624677468328
SNU-503,100016,6.601678520618542
SYO-1,11404337,-1.0421940088856276
HCC1588,159324,2.919673795321196
OVCAR-8,409805,6.24723950775959
HCC1500,246676,4.424448695399937
BT 498,3689413,1.8744771197995864
NCI-N87,26596,-0.8687464208841552
BxPC-3,262093,3.443903516481154
MSTO-211H,136227924,2.717505566177341
SF268,100016,6.377468220379779
JHUEM-3,148124,-5.835498657888768
RERF-LC-A1,9927531,4.243256542635893
HL-60,44491742,3.945358906065035
JL-1,11404337,1.0856357490679192
HCC1500,11404337,-1.1638452247583002
COR-L88,9936388,-7.008316023847794
KE-39,9927531,6.019185228760376
SNU-213,100016,6.954868306659309
OAW28,12003241,-0.542287488877267
GaMG,9911830,2.2746668067781486
HCC1806,sirolimus-bortezomib (250-1 mol-mol),1.669162775720282
COV362,sirolimus-bortezomib (250-1 mol-mol),0.7278420573421237
NCI-H1734,46943432,1.3526453499379931
EKVX,11485656,2.7917254369423055
SUP-M2,9927531,2.443296482682693
TE-1,9911830,3.113760912947507
EBC-1,tanespimycin-bortezomib (250-1 mol-mol),-3.429772106953884
NCI-H460,159324,4.0462841352482855
IA-LM,JQ-1-carboplatin (1-1 mol-mol),4.993034474620053
LN-229,12003241,-0.983315383516156
LN-18,selumetinib-GDC-0941 (4-1 mol-mol),2.471662791203074
NCI-H322,9936388,3.3425282984485656
A-204,46943432,2.665226658704685
L-363,6610216,4.393739110734271
SNU-407,tanespimycin-bortezomib (250-1 mol-mol),0.2441686883353643
TE-9,9903786,2.6320007696302894
JHH-1,6505803,1.4428022461389338
OVCAR-5,JQ-1-carboplatin (1-1 mol-mol),2.2287915879849116
MCAS,selumetinib-GDC-0941 (4-1 mol-mol),0.6896207239253057
OVTOKO,148198,-1.8970821230832648
NCI-H1355,11404337,-0.5901548623910822
TT2609-C02,tanespimycin-bortezomib (250-1 mol-mol),-2.374986906427309
HEC-1-B,100016,7.817681002018073
L-363,49836020,4.471751893617592
SNU-719,439501,-0.6056911297010781
786-O,44493528,4.535672196429034
SNU-182,439501,-3.0072363734756173
DMS 114,5460769,0.4207237171136718
NCI-H661,26596,-0.5563822784391794
Hs 944.T,107985,-4.037293595068503
SUIT-2,409805,6.22384099753819
A-204,3136844,3.9842157642785256
KP-N-SI9s,3136844,6.169807244161062
SNU-61,8515,5.6731171982359365
NOMO-1,9927531,5.049638663441057
NCI-H358,159324,1.810337922367244
FU-OV-1,9926054,2.079351745951841
Mino,135423438,1.6490290727182615
CFPAC-1,107985,-2.993539279710045
SK-MEL-3,44493528,4.418694031341945
TALL-1 [Human adult T-ALL],6505803,1.3130685662142687
HCC366,sirolimus-bortezomib (250-1 mol-mol),1.704813233293803
SH-10-TC,262093,3.640204599057082
BT 112,11404337,-0.2767075951827175
PaTu 8988s,3689413,2.020164099747706
Panc 05.04,12003241,-1.2094626899686458
NCI-H1755,9936388,2.296070393599244
KMS-27,8515,4.078018494843081
AN3-CA,54618164,3.8831604834020688
COLO 699,11485656,2.4382594148828995
NCI-H2452,selumetinib-GDC-0941 (4-1 mol-mol),2.2378905262634343
RERF-LC-MS,107985,-3.0933260647006215
GaMG,54618164,4.23185750242406
KYSE-410,44491742,3.6208474241241473
TE-9,9926054,2.1843594630677674
HCC1143,selumetinib-vorinostat (8-1 mol-mol),1.9962314127216017
OE33,107985,-4.064645418730777
SBC-5,148198,-1.371938553790338
A-375,6610216,4.632433700861142
Daoy,9936388,-5.3939036036909656
OCI-AML-3,9927531,5.116735976562035
EC-GI-10,selumetinib-vorinostat (8-1 mol-mol),3.7752462789918697
TM-31,26596,-0.9336571735173056
CW-2,135875424,-5.260207779048425
BT 416,9903786,2.244954394725016
Karpas-422,246676,4.416007405024325
KMS-27,10322450,3.3921429038631707
G-402,12003241,-1.3833657940583168
SNU-16,6610216,3.5792098675105075
MOLM-6,6505803,0.3209765108224145
NCI-H526,9936388,-5.702236125397588
MHH-CALL-4,11485656,2.372182753461333
BT 187,selumetinib-GDC-0941 (4-1 mol-mol),2.194213096235158
OAW42,10296883,4.103500664094552
NCI-H522,44493528,4.173254194812623
NCI-H1755,11404337,-0.8825666312095473
GDM-1,6505803,0.9886277472188528
NCI-H661,136227924,2.7818959309662183
NCI-H2009,selumetinib-GDC-0941 (4-1 mol-mol),-2.07577936678547
COLO 201,159324,3.0318609324112087
HSC-3,11485656,2.2428743548360863
NCI-H2228,12003241,-0.7511130172017173
NCI-H292,136227924,3.1886204590132654
Panc 04.03,selumetinib-GDC-0941 (4-1 mol-mol),1.425782410580866
NCI-H1299,selumetinib-vorinostat (8-1 mol-mol),3.816207733314422
HDLM-2,46943432,3.238903302333344
Rh41,439501,-3.728538784636516
GCT,10296883,3.718708218585829
CAL-85-1,sirolimus-bortezomib (250-1 mol-mol),-0.0188849543206935
Daoy,262093,1.456980228501706
Lu-65,tanespimycin-bortezomib (250-1 mol-mol),-1.7851341397947351
CCF-STTG1,6610216,4.787403157480984
NCI-H1568,36462,0.6787379731584755
KMBC-2,5460769,1.880103554481412
LN-18,439501,-2.51749540441962
VMRC-RCW,9903786,3.331782716085826
Panc 03.27,11485656,1.610276290455132
HuP-T3,9936388,0.6940852338085793
THP-1,36462,-0.696245024899833
HCC-56,5460769,4.347795399558133
EM-2,262093,0.7558915053093321
NCI-H1650,selumetinib-vorinostat (8-1 mol-mol),3.5739205665134466
UACC-257,107985,-2.6812388273080416
HEC-151,46943432,3.433057061661308
A-498,135875424,4.978423270774445
SF268,26596,0.6172202345506846
NCI-H1299,9936388,-0.1781231784373126
KP-3,3689413,-2.21572351958202
HuCC-T1,9926054,1.7884670483643574
T84,selumetinib-GDC-0941 (4-1 mol-mol),-1.055880319299995
RPMI-8226,44493528,3.728684145979083
A-204,3689413,-1.831192826185156
RVH-421,12003241,-1.8374248826372317
HCC1143,12003241,-0.0421467164139253
Hs 746.T,11404337,-0.7817772551225204
BT 320,selumetinib-GDC-0941 (4-1 mol-mol),2.4654879652784447
LOX-IMVI,135398744,6.429324407359154
Panc 05.04,9926054,1.8029787074876424
SNU-46,54618164,4.1308083358552246
NCI-H522,148124,-6.241132033807486
COR-L51,3689413,-2.4511139859333526
NCI-H524,sirolimus-bortezomib (250-1 mol-mol),0.5181816489165546
GA-10,6505803,-0.6934451176376895
NCI-H2196,439501,-1.9043844138508108
BT 333,409805,5.361000728406263
BT 216,9926054,2.3183160666654783
T24,3136844,4.832239376658648
TYK-nu,9927531,4.342224808335168
HuT 78,9926054,1.4431118641564118
IGR-1,10296883,3.2349676961668083
NCI-H1693,135875424,2.849397745802666
Ci-1,439501,-2.567904110965142
AML-193,JQ-1-carboplatin (1-1 mol-mol),0.2220532745153866
SNU-601,262093,2.665583006952994
Hs 944.T,sirolimus-bortezomib (250-1 mol-mol),1.3396818337224137
COLO 792,tanespimycin-bortezomib (250-1 mol-mol),-2.234001402971202
MSTO-211H,9911830,2.3480580098381747
LUDLU-1,9911830,2.1966438359182767
OVSAHO,159324,3.32268951699503
OCI-AML-3,8515,2.0861016142229705
L3.3,8515,4.3523389716154455
BICR 31,9927531,5.661036072082279
BT 147,selumetinib-vorinostat (8-1 mol-mol),2.9014977587834374
HPB-ALL,9903786,2.3044154759834847
COLO 320,selumetinib-vorinostat (8-1 mol-mol),2.1116908992228702
DMS 53,11485656,2.0694415183010317
RKN,11485656,2.343665915939472
HuH-6,148198,-4.2090148459879275
Peer,159324,-2.537523306303502
SU-DHL-1,135875424,2.8587183873170847
MHH-CALL-3,136227924,2.519521666896543
MV4-11,selumetinib-GDC-0941 (4-1 mol-mol),-2.1623049126826372
KP-N-SI9s,107985,-2.511989940136039
NCI-H1944,3689413,3.2556823925737395
BT 422,11404337,-0.0607028130466723
OCI-M1,135875424,3.745039628073017
CAL-29,262093,2.679093479440611
Tm87-16,262093,2.22528250793553
22Rv1,100016,5.084356097831624
UM-UC-1,148198,-3.090298410357246
Li-7,12003241,-1.919504874807884
NCI-H1299,6505803,-0.2534280947368875
NCI-H1299,12003241,-0.9760038754339474
TOV-112D,409805,5.782770805049322
Mono-Mac-1,439501,-2.692243954974466
SW1417,9927531,5.165268920139929
LOX-IMVI,107985,-4.647027352160178
SNU-503,tanespimycin-bortezomib (250-1 mol-mol),2.9801728047374527
SUP-T1,148198,-4.331447588752824
A2780,selumetinib-GDC-0941 (4-1 mol-mol),-0.1378336599124344
SK-ES-1,26596,-2.5080764618558775
HCC2935,148198,-1.8652602121018471
NCI-H1869,sirolimus-bortezomib (250-1 mol-mol),0.1597527928454194
VMRC-LCD,6918878,0.611810657347729
BT 428,9927531,4.812195201637174
KYSE-520,sirolimus-bortezomib (250-1 mol-mol),0.4067313196424638
COLO 829,selumetinib-GDC-0941 (4-1 mol-mol),-1.0343545456738177
OCI-Ly10,44491742,5.232515428740167
Kuramochi,6610216,4.865432129789608
HCC1428,3689413,0.0072798037629334
Mino,262093,1.013010854269816
YD-8,10296883,4.26925641885348
GDM-1,439501,-2.0864895468216846
COLO 699,selumetinib-GDC-0941 (4-1 mol-mol),0.865445033104183
CW-2,10322450,3.213941293379877
Hs 746.T,3136844,4.217176926190934
KYSE-150,selumetinib-vorinostat (8-1 mol-mol),3.39838636509464
PaTu 8988s,136227924,2.43354349220747
AML-193,6610216,3.825540267355674
Mono-Mac-6,3689413,-1.766017033423464
L-363,10296883,3.350566136289887
SNU-478,409805,4.514239248818933
SW579,26596,-1.623870534815972
DOV13,439501,-2.3645646799051754
HOP-92,3136844,4.430942650818718
Lu-99,44491742,4.467729937048073
THP-1,44491742,3.722381012581274
SNU-719,44484440,3.623849068455505
JJN-3,262093,2.0717593866365847
Mel Ho,9926054,2.124486503190193
2004,6610216,3.877124276480686
G-292 clone A141B1,135875424,3.061063292473857
Tm87-16,10296883,3.860781577822318
MOTN-1,44491742,2.9342913777963555
BL-70,JQ-1-carboplatin (1-1 mol-mol),0.8530226058768635
DND-41,46943432,1.2374312030796195
ChaGo-K-1,9936388,-4.876543253304364
Hs 766T,262093,3.5846417811943514
NU-DHL-1,9911830,2.5877421671517578
ONCO-DG-1,5460769,1.9256836095204335
MIA PaCa-2,24180125,2.6361206455792066
BT 187,9936388,1.2853309860246789
COLO 678,9926054,1.8882856749448629
DV-90,8515,2.3844270200135615
NCI-H1703,135875424,3.0256597823887725
Yamato-SS,439501,-2.9542074712794517
COR-L105,100016,7.1590039780101895
FaDu,12003241,-1.459997114195287
SNU-1105,9936388,-0.2458072651641521
Hs 611.T,36462,-1.281964415022038
GaMG,107985,-3.038820725669045
JHUEM-7,107985,-5.321387186988869
SNU-C4,262093,3.503220082312251
NCI-H889,10296883,3.661891434193148
LCLC-97TM1,8515,3.105500626842055
Kuramochi,9927531,6.027141313400392
MDA-MB-231,10296883,3.96898040107769
Panc 02.03,54618164,4.482290203520866
SK-N-DZ,46943432,5.457291961599217
PSN1,44491742,3.787418780270154
HARA [Human squamous cell lung carcinoma],409805,4.942295126142001
HEC-1-B,9903786,3.578370658582295
AM-38,439501,-2.2075146927882177
CJM [Human melanoma],11485656,2.6899904123540037
NCI-H1693,sirolimus-bortezomib (250-1 mol-mol),0.2355785626536786
Hs 578T,tanespimycin-bortezomib (250-1 mol-mol),0.2448774923200065
SW1271,12003241,-1.4062779923685875
LS411N,9926054,1.9376785020428349
MM1.S,selumetinib-vorinostat (8-1 mol-mol),1.8050138059594567
A3/Kawakami,100016,3.999978023882096
SNU-878,6505803,-0.5234937095696075
HCC1806,6610216,4.4100641961164415
G-401,9926054,1.744192331951833
BT 333,10296883,4.228869455795536
MG-63,136227924,3.2795436313273685
RERF-LC-Ad2,148198,-4.2716837580451825
HCC1143,9936388,-6.988875343339418
SCaBER,409805,5.759469281447201
SW579,9926054,1.761228342294705
SW48,54618164,3.7830586534540616
NCI-H1373,148198,-1.3691101479869838
TUHR4TKB,9927531,4.964100941716243
NCO2,6610216,3.0387992514470663
NCI-H2228,9936388,2.203953103351002
RPMI-6666,100016,5.822007631719843
GMS-10,262093,2.9524447590849063
IGR-37,sirolimus-bortezomib (250-1 mol-mol),0.8968777908953848
PC-3,9911830,2.771725932038049
L-1236,sirolimus-bortezomib (250-1 mol-mol),1.403422736729983
NCI-H810,11404337,-1.324114158027616
PL-21,6505803,-0.5329499578695445
COLO 201,9936388,0.7010349840122784
VMRC-LCD,selumetinib-GDC-0941 (4-1 mol-mol),3.316694263206271
Hs 839.T,10296883,4.248587708803948
SK-MES-1,6610216,3.4550348226980536
PE/CA-PJ41 (clone D2),36462,2.2016180933991594
HCC78,3689413,0.9109498190296136
VMRC-LCD,9926054,1.8620502952585032
HEC-151,8515,4.452182396163437
CAL-51,9903786,2.1849161121493847
Lu-65,12003241,0.1595843887204832
EKVX,3689413,-1.7429314171810966
BxPC-3,9911830,2.611582201474507
TE-5,439501,-3.2949389532726867
RPMI-6666,136227924,2.5880592922669097
U-937,9936388,-6.425883937752082
BT-16,46943432,4.318717641296422
NCI-H2052,262093,2.885672555371676
RERF-LC-Ad2,10296883,4.240676300513298
HCC1937,54618164,4.424914641372808
RPMI-8226,3136844,3.882792460080041
NCI-H716,selumetinib-GDC-0941 (4-1 mol-mol),0.5800821260708712
SHP-77,11404337,-0.9564004867270302
NU-DUL-1,3689413,-2.4087699464815664
Detroit 562,3689413,-1.858060179976838
ONS-76,9926054,2.5108803232151304
U-CH1,439501,-1.675454590298179
SNU-46,107985,-3.76796629724838
SNU-761,135875424,3.262050115513109
JHH-6,selumetinib-vorinostat (8-1 mol-mol),4.827316742876486
SK-BR-3,24180125,2.453332615132994
KMS-21-BM,26596,-2.3391795645360403
BT 172,100016,6.450201924949107
JMSU-1,409805,5.116602138696932
BxPC-3,12003241,-1.7282705692868598
COLO 320,9936388,-1.5439590773342686
TE-14,54618164,4.303760954268937
MOTN-1,12003241,-0.0935669928398487
HCC2279,11404337,1.1407968347244497
SNB-75,107985,-3.636454982238337
EHEB,9936388,-5.642934540589324
BT 164,selumetinib-vorinostat (8-1 mol-mol),2.2572837583830068
LXF 289,409805,5.2068809837223435
CAS-1,135423438,2.545447966463113
HGC-27,JQ-1-carboplatin (1-1 mol-mol),1.0978980363153934
CCF-STTG1,136227924,3.7108552267199504
NCI-H2122,12003241,-0.1228144224546952
SK-MEL-31,10322450,4.01395205895819
Li-7,11485656,1.4880931297803832
KYM-1,9926054,1.655871413890737
KM12,8515,1.6366887963761436
NCI-H1184,9926054,1.8119934997453773
HEL 92.1.7,sirolimus-bortezomib (250-1 mol-mol),0.1862867514845364
DLD-1,selumetinib-vorinostat (8-1 mol-mol),2.6727552723054755
PK-45H,11485656,3.836496845860948
KE-39,44491742,3.945663107977575
SNU-387,168313200,2.350990490549559
HOP-92,10322450,5.279706344713567
HARA [Human squamous cell lung carcinoma],11485656,2.214748392282881
PaTu 8902,sirolimus-bortezomib (250-1 mol-mol),1.4421927553258482
VM-CUB-1,439501,-2.2859816602677077
NCI-H358,selumetinib-GDC-0941 (4-1 mol-mol),-1.5970203411339507
DAN-G,3136844,4.27893519297169
697,3136844,3.0775250843486757
NCI-H524,439501,-1.5131923813940935
EHEB,262093,2.39806678929768
COLO 205,54618164,4.3534025935886955
LUDLU-1,6610216,4.136129854061651
HCC1195,9926054,3.439884423988142
KE-39,6610216,4.077734835238396
IGR-37,3136844,4.235582061446334
NCI-H2052,100016,6.8923960055757805
BT-549,12003241,-0.9663956127583828
EFO-27,tanespimycin-bortezomib (250-1 mol-mol),1.741135148136739
BT 416,5460769,1.3706696040691966
OVCAR-5,439501,-2.798423639950905
DMS 114,9926054,1.677325946401266
HCC95,6505803,-0.8812410115134491
TOV-112D,262093,2.6540269134796213
KNS-62,3689413,1.1853258222695242
HGC-27,selumetinib-GDC-0941 (4-1 mol-mol),-0.8359606589249554
KM12,44491742,3.983947326566667
LOX-IMVI,JQ-1-carboplatin (1-1 mol-mol),-0.0700406014025903
HEC-6,9936388,1.177360441508745
NCI-H146,135875424,2.9115600315347057
ALL-SIL,409805,3.511042482554543
RL,26596,-2.6100801443617336
BT 145,6505803,-1.6156517406127768
NCI-H1299,3689413,-0.9598507897960026
DB,3689413,-2.3561309099852448
HT115,selumetinib-GDC-0941 (4-1 mol-mol),-0.4177192932655061
MKN1,148198,-2.187340578141158
KYSE-450,148198,-3.4919685284150876
PL-21,10296883,3.1495852903666623
Kasumi-2,148124,-6.270957848916609
HCC44,6505803,-2.265511821723746
SNU-5,46943432,1.3354145069427903
NCI-H2196,9936388,1.3718542945695429
SW579,409805,3.672611404001125
Capan-1,148198,-2.3520537722391075
BT 440,9936388,1.094365580931073
NCI-H526,9926054,1.8580444014969677
MDA-MB-231,6610216,5.495041065534818
IGR-1,9936388,-6.544031744867033
HuP-T4,159324,3.287131354646656
SK-N-AS,11404337,-1.03684068328029
VM-CUB-1,3689413,3.0900699567187013
NCI-H520,9926054,1.793691213544428
BT 131,6610216,4.128330382659673
NCI-H647,6610216,4.146662237643
GMS-10,49836020,0.0918808601925
T-47D,168313200,4.207994200595196
HDLM-2,6918878,0.8195302952779613
NCI-H1694,tanespimycin-bortezomib (250-1 mol-mol),-0.386320713281567
Mel JuSo,10296883,4.305095904574399
SYO-1,3689413,0.2165411688819273
HT-144,168313200,2.154847170471374
RKN,6505803,1.4092626649390017
MCAS,11485656,2.57416789640687
SNU-899,5460769,1.25373521066823
NCI-H526,136227924,1.9152739000663332
G-402,11404337,-0.2966965164109829
NCI-H441,100016,5.015174861435744
Hs 688(A).T,6505803,2.8960604198469206
COR-L105,9911830,1.908645944756667
Karpas-299,5460769,1.8174425760442317
Hs 888.T,100016,7.920695284419831
Ri-1,9936388,-7.695738985409057
EB1,9903786,1.1512361945239595
IGROV-1,8515,2.1861539315976053
SW1353,6505803,0.3759495055091644
SW620,439501,-1.8970460757593473
WM983B,10296883,3.9280678477622857
LK-2,9927531,4.895223263990893
MOTN-1,3689413,-2.530735206047899
KM12,12003241,1.1245278791827416
HuH-6,12003241,-0.3879852820159472
SJSA-1,9911830,3.7897570327927994
Kuramochi,sirolimus-bortezomib (250-1 mol-mol),2.121194092694626
SW982,36462,3.200595192366945
BT 333,168313200,2.125969547052707
NUGC-3,439501,-0.8687930764506365
SK-MEL-5,5460769,5.96903783579764
OS-RC-2,selumetinib-vorinostat (8-1 mol-mol),3.5044283188137504
BT 422,107985,-3.238764101436753
FTC-133,11404337,1.1811341910019733
RS4;11,135423438,1.0348635952337828
JHUEM-7,10296883,3.9492602271456065
IGR-37,168313200,1.7746354442745738
NCI-H1792,11404337,0.0016171974821283
HDLM-2,9926054,1.2404831446966105
OVISE,11404337,1.793635825025173
WSU-DLCL2,36462,-1.1890066512244994
Pfeiffer,tanespimycin-bortezomib (250-1 mol-mol),-0.0267896609776724
Rh41,11404337,-1.1237512240479817
ACC-MESO-1,9926054,4.037988480167424
A-375,409805,5.425302340535218
NCI-H1105,6610216,3.9896940586216663
Ri-1,159324,0.7122942359336857
L-540,JQ-1-carboplatin (1-1 mol-mol),0.3906962491825653
SNU-119,selumetinib-GDC-0941 (4-1 mol-mol),1.3564529496454796
BT 286,49836020,4.709879888093613
KYSE-410,11485656,2.2435649092934775
VM-CUB-1,selumetinib-vorinostat (8-1 mol-mol),2.483062987600528
CMK,44491742,6.009937952525146
KYSE-30,11404337,-1.4511722042502642
BT 328,6505803,-1.1568571975604598
SNU-16,107985,-5.277922842237505
LC-1/sq-SF,3689413,0.5159232922556106
HEL 92.1.7,tanespimycin-bortezomib (250-1 mol-mol),0.3488899515335228
BT 228,135875424,2.3307111472907263
JVM-3,135875424,3.424449119356365
EN,54618164,4.025046535764669
ECC10,9927531,3.415986585333862
EHEB,24180125,1.8891722665908557
ZR-75-30,107985,-3.64211446272769
K-562,11404337,1.5978316825317844
HEC-251,11485656,3.0067875712953
KCL-22,46943432,1.9547601965976713
CAL-27,36462,0.179567917898061
NCI-H2342,168313200,3.849648690300757
BT 444,tanespimycin-bortezomib (250-1 mol-mol),-3.2528888157944684
MFE-296,9927531,4.364597960371392
HT,262093,2.3474073826292265
NCI-H292,5460769,0.0770188109309223
HCC95,46943432,1.698230106706683
PE/CA-PJ15,100016,6.230779358531284
ML-1 [Human thyroid carcinoma],9903786,1.6234934744716731
TCC-Pan2,sirolimus-bortezomib (250-1 mol-mol),2.6812327412010095
GP2d,sirolimus-bortezomib (250-1 mol-mol),1.47869263930016
CA46,100016,3.773189878640827
SNU-213,107985,-3.586157663071436
NB4,9936388,-6.659724835082886
KYSE-520,44493528,4.570249805498521
SCC-25,9911830,2.7876324164703736
NCI-H1573,9911830,2.169886437603078
VM-CUB-1,12003241,-0.6809659848466374
Becker,selumetinib-GDC-0941 (4-1 mol-mol),1.91048456037032
GaMG,3689413,4.2258406300802145
NCI-H2122,11485656,1.6231046249934602
CL-11,409805,5.877907477859192
Li-7,9903786,1.4917500852360135
Hs 888.T,9936388,1.4712772927415676
ChaGo-K-1,44491742,3.5931231049771126
NALM-6,11404337,-2.6750966527549855
GDM-1,107985,-3.5655662654697284
TE-11,selumetinib-GDC-0941 (4-1 mol-mol),0.8389295990054343
GI-1,44491742,3.8147677768435497
DAN-G,44491742,4.1375495021288
KYSE-410,selumetinib-GDC-0941 (4-1 mol-mol),1.4678317054050969
KYSE-450,9911830,2.46681001783931
BT-474,10322450,2.780600319023071
NCI-H1435,409805,4.495961033647919
CML-T1,selumetinib-GDC-0941 (4-1 mol-mol),2.3571897890829323
KP-4,9927531,4.133132471869078
DV-90,46943432,2.0897997474065484
SW1417,148198,-3.336621640572291
OS-RC-2,9936388,2.9973803425590733
DV-90,selumetinib-GDC-0941 (4-1 mol-mol),-0.7506307924929138
HCC1954,12003241,-0.7991546925756471
CGTH-W-1,44493528,5.078721913165128
BT 145,10322450,2.778545625329855
KYSE-520,148198,-3.940360591916268
DU145,107985,-2.6553199343257483
SNU-620,107985,-2.9200019324951483
U-937,262093,2.270631541359052
TE-4,9926054,1.7320967547040995
SNU-1,8515,3.60368190777916
Panc 03.27,9936388,-5.075789023716421
KP-3,409805,5.570202879037171
LC-1/sq-SF,168313200,4.088253469827713
HEL 92.1.7,11485656,1.7969731884547977
NCI-H1975,tanespimycin-bortezomib (250-1 mol-mol),-1.468609028011694
SNU-5,262093,3.3115328447566723
TC-71,9927531,4.177938465440418
TT2609-C02,6610216,4.56614833018797
KYSE-520,148124,0.6862121689494067
TTC-709,9911830,1.1400887698585542
Hs 888.Lu,6505803,0.1464853570019931
JHH-1,54618164,3.8675979353658496
LS513,136227924,2.4637797835127793
BT-16,135875424,3.384825931248148
BT-549,262093,3.1295246575488354
Jurkat,54618164,1.967118142382213
NCI-H2023,439501,-1.9243866702684376
HCC1438,9903786,3.876774477069639
BDCM,selumetinib-GDC-0941 (4-1 mol-mol),0.2374601063606183
SNU-1196,439501,-2.3352671282254303
HT115,100016,5.804685245268015
KALS-1,9936388,2.309164316423604
D283 Med,3136844,3.2984572039507274
NU-DHL-1,24180125,2.343403566122717
TE-5,selumetinib-GDC-0941 (4-1 mol-mol),0.92004648470689
HLF,54618164,3.959273462123582
DB,9926054,1.795775748692003
OC 314,11404337,-1.3108205145467993
COLO 829,5460769,5.712006369948703
SK-MES-1,12003241,-1.463616091527542
NCI-H2023,100016,7.201065180404722
BICR 6,6610216,4.773782205197453
MFE-319,54618164,4.567083420097771
RERF-LC-A1,6505803,-1.6574767095757488
CL-11,5460769,2.817673582837802
NCI-H1573,46943432,4.3322940998633985
OCI-Ly19,439501,-4.390923092151438
BT 187,54618164,3.97391253184756
NCI-H2085,36462,4.466396535558883
HCC1954,tanespimycin-bortezomib (250-1 mol-mol),-2.182183839668862
DB,135875424,2.935208390580705
NCI-H358,262093,2.755416882784921
TT2609-C02,24180125,3.81784594908871
HCT 15,9911830,2.1047581294731277
SU.86.86,9936388,2.2696796585655
MES-SA,sirolimus-bortezomib (250-1 mol-mol),0.1069072940558757
P31/FUJ,selumetinib-vorinostat (8-1 mol-mol),0.1511350548351421
SK-MM-2,136227924,3.42367167276636
SBC-5,tanespimycin-bortezomib (250-1 mol-mol),1.6745298572430678
SUP-M2,148198,-0.2011306598462228
OAW28,135875424,4.470041991889524
Rh30,107985,-3.1857089602300563
G-361,6918878,1.9032396072330793
BICR 18,136227924,3.2249717702756486
Daudi,9903786,1.3988461789185107
KMS-12-BM,49836020,4.363885927749537
HuNS1,11404337,-3.482184142703688
PSN1,9903786,4.143013374018909
HMCB,439501,-1.1140754693945072
NCI-H1184,36462,-0.6681972686085113
TE-4,46943432,1.546828329811108
WSU-DLCL2,26596,-2.173424611684264
COLO 800,10296883,3.791440473177963
HEL 92.1.7,36462,0.1283658129204001
YD-8,135875424,4.059859189077627
SW1417,168313200,4.158512973048199
Ki-JK,439501,-2.4258748646441624
SCC-4,6918878,2.253689794439771
Ishikawa (Heraklio) 02 ER-,135423438,4.463987581910629
SUP-T1,JQ-1-carboplatin (1-1 mol-mol),-0.4695857122816443
BT 131,sirolimus-bortezomib (250-1 mol-mol),-0.1353843120079282
YH-13,135875424,4.585935280505426
Hs 895.T,6610216,4.546912448476249
BT 286,9911830,2.3367947096317927
EKVX,49836020,5.428301745137177
Hs 936.T,selumetinib-vorinostat (8-1 mol-mol),0.3450165973720776
LS1034,9936388,-2.448497321625194
HCC366,36462,1.9549292972241572
HSC-2,26596,0.6802273350911279
JMSU-1,tanespimycin-bortezomib (250-1 mol-mol),-2.9678894652146584
TT,439501,-2.411064207621025
SUP-HD1,44491742,5.1977387021810255
HEC-151,54618164,3.8374774746461706
NCI-H1755,46943432,1.8074214413650171
KMRC-2,439501,-1.138228475309333
CW-2,136227924,3.283467391951437
SK-MES-1,409805,3.68215710914594
A-375,148198,-2.551882325467432
NCI-H211,24180125,1.6586707471398143
KNS-60,10322450,5.014085797692543
8505C,148198,-2.1728643040186237
RL,3689413,-2.4285945149334185
KMS-18,10296883,2.8324410966365985
L-363,135875424,3.938515519737711
MHH-ES-1,selumetinib-vorinostat (8-1 mol-mol),2.4304170716272813
SF126,selumetinib-vorinostat (8-1 mol-mol),2.6989526919187012
HCC1143,409805,4.31745443409651
KATO III,selumetinib-GDC-0941 (4-1 mol-mol),2.4282234364089863
Lu-99,tanespimycin-bortezomib (250-1 mol-mol),-2.7467052265090723
DLD-1,12003241,-0.215038024432674
HEC-1-A,JQ-1-carboplatin (1-1 mol-mol),2.5106263332941308
FTC-133,tanespimycin-bortezomib (250-1 mol-mol),2.589157052333849
CAL-62,262093,2.299935005581277
KMRC-1,148124,2.1112012667960656
ESS-1,26596,-1.5335330182559344
CA46,54618164,3.845436645537388
SK-OV-3,6610216,4.5015440272840275
MKN1,44491742,4.1588945650125355
TUHR14TKB,selumetinib-vorinostat (8-1 mol-mol),2.7160873557760024
NCI-H69,8515,3.637799232844521
HH [Human lymphoma],54618164,2.9270787065962733
JMSU-1,262093,2.8828462460891444
RT-112,5460769,3.4890381868117712
HPAC,12003241,0.9185778330779416
RPMI-8226,3689413,-0.772061371238599
VMRC-LCD,46943432,3.939748255334783
MKN7,3136844,4.771911277905907
KMS-21-BM,tanespimycin-bortezomib (250-1 mol-mol),-3.1292569725831796
OVCAR-5,100016,6.797399029850292
JHUEM-1,26596,-1.2940313289426515
MDA-MB-453,136227924,2.410345496671846
NCI-H2081,54618164,3.631207373775394
LS411N,159324,3.2133975478450005
RT-4,3689413,0.3652230576391069
SNG-M,selumetinib-GDC-0941 (4-1 mol-mol),2.713078980516464
Kelly,409805,4.86847544408602
MOLM-6,159324,-0.3631540608942797
BICR 56,11485656,3.1292110693028237
YD-38,439501,-2.4363640234681347
HCC1428,9927531,5.49162668491902
KALS-1,54618164,4.429142679036427
BFTC-909,8515,4.73152093133166
SNU-5,26596,-1.206984929364511
RS4;11,selumetinib-GDC-0941 (4-1 mol-mol),0.8544814441739125
OCI-M1,148198,-4.87600979079706
SNU-16,11485656,1.507998082337787
WSU-DLCL2,409805,3.8476512869273143
RVH-421,9911830,2.458490224402164
MOLT-16,49836020,4.026167262908274
BT 440,100016,6.480442369798277
Hs 294T,tanespimycin-bortezomib (250-1 mol-mol),0.0201287487075006
NCI-H1341,9927531,3.217953728153189
COR-L47,36462,2.2585051399915934
CAL-51,12003241,-1.2189714227076325
MOLP-2,54618164,4.374715103779399
EoL-1,9927531,2.893857253769426
SNU-1214,9926054,3.9057313084396656
RCM-1 [Human rectal adenocarcinoma],6505803,-0.0377469333531859
DMS 273,9903786,1.811418424711566
VMRC-RCZ,409805,6.1071177447924025
U-251MG,44491742,4.097928635737581
TOV-112D,9911830,1.959668803130746
A-375,135398744,6.486116496095493
JURL-MK1,36462,0.5090018133918662
Karpas-620,8515,3.795596892904238
Hs 940.T,409805,3.704694505958849
NCI-H446,107985,-2.6399259174122145
NCI-H1869,148198,-2.251684124095355
GB-1,selumetinib-GDC-0941 (4-1 mol-mol),1.0997063493321384
639V,3136844,5.736106454152649
Lu-99,5460769,-0.1107532404571854
F-36P,3689413,-1.7757563129439584
LoVo,5460769,-2.1468642890382412
BICR 16,6505803,-1.4833128134740765
Lu-65,148198,-3.5921377356072397
SIG-M5,10296883,3.681364440246351
T84,439501,-3.2363484717371964
Kasumi-1,44493528,3.994031742837349
HD-MY-Z,tanespimycin-bortezomib (250-1 mol-mol),-0.5200948586273125
CHP-212,100016,6.525746829388361
KYO-1,9936388,-6.33783178095698
WSU-DLCL2,49836020,-5.951866834778445
MHH-NB-11,11404337,-1.8746153403956665
Kasumi-1,11485656,-2.0824070606449534
NCI-H1155,5460769,2.4022459790155413
NCI-H211,148198,-5.011927941581449
SUP-B15,sirolimus-bortezomib (250-1 mol-mol),-0.2788872316489693
CAL-33,107985,-3.788445171000951
HEC-6,6610216,4.405730732858135
U-CH1,sirolimus-bortezomib (250-1 mol-mol),-0.0071193636307831
SK-N-SH,12003241,-0.1782836435040178
CADO-ES1,159324,-1.4511857186718804
KYSE-70,6505803,-1.025033993677824
KYSE-70,439501,-1.7979650249976522
OVCAR-4,262093,2.934935020789089
SNU-119,6610216,4.326307589827554
JHUEM-2,9926054,1.5571026590008097
IGR-37,3689413,2.8374772536506407
253J,54618164,4.056107548266079
SNU-C2A,6610216,4.343391029884027
Hs 852.T,26596,-1.3645726938327003
CAL-33,6505803,1.0338529577109443
SK-MEL-30,selumetinib-vorinostat (8-1 mol-mol),-1.2228200130489273
TUHR14TKB,selumetinib-GDC-0941 (4-1 mol-mol),2.1009270469043897
SU-DHL-1,9903786,2.5464454731205777
KMRC-1,9926054,1.768451409600443
F-36P,46943432,1.5782924322919043
G-402,107985,-3.5863491011783517
DND-41,5460769,0.7297318325246287
BV-173,100016,4.070459829867503
HT-144,439501,-0.7742465567172142
WM983B,3136844,5.448921350485804
SK-UT-1,6505803,-1.8087484782267416
SW948,262093,3.1804911198162036
BT 164,135875424,2.686622551466718
Panc 10.05,135875424,4.82827544995575
GSU,409805,5.755802270178732
OS-RC-2,159324,5.727505196407322
T84,JQ-1-carboplatin (1-1 mol-mol),2.264364679539306
HCC1428,10296883,4.338608751562579
SNU-16,26596,-3.716787103027543
Mono-Mac-1,tanespimycin-bortezomib (250-1 mol-mol),-1.759960835446177
J82,3136844,5.547470037642463
GMS-10,12003241,-0.439124949180571
Hs 839.T,11485656,3.884634476915026
Panc 05.04,6505803,-2.723455605097511
KMS-20,12003241,-1.6984779188581272
BT-20,168313200,2.4651891211897734
SNU-119,3136844,3.853712010646443
HOS,9936388,3.3848022689257387
EFO-21,409805,6.083434426266822
HEC-1-A,135875424,2.7872654410751148
JHH-6,10296883,4.397827548560224
HSC-4,136227924,4.2199200707906845
OE19,11404337,2.1559744659791975
FaDu,selumetinib-vorinostat (8-1 mol-mol),3.771184293371853
A-204,tanespimycin-bortezomib (250-1 mol-mol),-2.803355347845335
AsPC-1,selumetinib-vorinostat (8-1 mol-mol),2.1619817893004805
NCI-H810,3689413,-2.3374294855019566
SW579,3689413,-0.123080329876746
BT 131,3136844,4.0366594462893985
TM-31,6918878,5.116340959952099
D283 Med,selumetinib-GDC-0941 (4-1 mol-mol),1.1541990578163812
JHH-5,9903786,3.1481910076888684
SNU-869,selumetinib-GDC-0941 (4-1 mol-mol),1.3245686314727811
GB-1,JQ-1-carboplatin (1-1 mol-mol),3.1926244646475
SNU-840,9926054,2.11865142604258
Rh18,9936388,1.9794921916079815
EFO-21,6505803,0.6098596142059811
OPM-2,135423438,0.9866001177758746
HT,sirolimus-bortezomib (250-1 mol-mol),-1.783381881062306
PC-3,148198,-4.170321827302026
JMSU-1,439501,-3.223216777280016
LUDLU-1,JQ-1-carboplatin (1-1 mol-mol),0.2520834188708127
HCC1143,sirolimus-bortezomib (250-1 mol-mol),-0.8248046184342958
HCC1143,6918878,5.533567107436573
NCI-H2452,6610216,4.12804282735119
PF-382,6610216,3.7963864090602737
SK-MES-1,selumetinib-vorinostat (8-1 mol-mol),2.706535329304162
KYM-1,148198,-4.868238794811474
Mono-Mac-1,6610216,3.235922016233304
KMS-34,9911830,1.4656867224439092
OE33,136227924,2.987067512543954
BT 416,54618164,3.776512207378467
PK-1,sirolimus-bortezomib (250-1 mol-mol),1.545806469698299
A2058,10296883,3.853282697194753
EFO-27,9927531,5.387402639259967
Caov-3,49836020,-0.0609342715049496
SW579,49836020,3.73786460957764
SW579,10296883,3.762097839369787
BT 179,9903786,4.337350994333445
MDA-MB-468,12003241,1.1497525105309832
Ki-JK,49836020,-3.31096865556518
Ku812,tanespimycin-bortezomib (250-1 mol-mol),-1.4793309547353497
A-204,24180125,5.792095309981467
NCI-H661,54618164,4.023349318575714
DB,262093,1.243928535741269
KP-2,44493528,4.335007894737588
KE-39,100016,6.665188081944046
HCC1395,11404337,-0.1331965245654414
KP-N-YN,168313200,3.2829506752497415
Hs 683,136227924,2.524769704566026
DLD-1,6918878,5.1268525240877105
PaTu 8988t,54618164,4.622822732421989
SW48,135875424,3.469184081134181
A-204,6505803,-3.259421100625582
Karpas-422,sirolimus-bortezomib (250-1 mol-mol),-8.407469772088508
Lu-99,6610216,4.764177880919915
RL,36462,0.1375591629555872
NCI-H1869,107985,-2.86385536497776
NB1,sirolimus-bortezomib (250-1 mol-mol),-0.0795560213748125
Caki-2,9936388,-5.25151724619499
VMRC-RCW,JQ-1-carboplatin (1-1 mol-mol),1.9272630806826467
MIA PaCa-2,136227924,2.1731844460154743
RERF-LC-MS,9936388,-8.273067767637817
ZR-75-1,148198,-2.6538383263533674
HCC44,11404337,-1.974038980762408
SU-DHL-10,6918878,-1.1314089472233464
PE/CA-PJ49,135875424,3.843300837205347
KM12,100016,6.486077549174115
KM12,11485656,1.3721990605630514
TE-8,9927531,4.6696791278322625
NCI-H1155,10322450,3.1814270570709766
CAL-33,148124,-5.466499230660003
LS123,148198,-1.1889670275766562
YD-38,3689413,0.3954861349850884
CAL-51,159324,3.1794720270506307
SJSA-1,tanespimycin-bortezomib (250-1 mol-mol),0.871032127395642
HD-MY-Z,44491742,3.754375539988437
COV434,selumetinib-vorinostat (8-1 mol-mol),1.8163098139826408
HCC366,3689413,-0.7247636162337553
HPAF-II,11404337,1.4025289203850997
TE-14,11404337,-0.8774681002045693
GDM-1,159324,-0.8409478858181092
8-MG-BA,11485656,3.634324102236689
Hep-G2,439501,-0.8010222698535624
PE/CA-PJ34 (clone C12),439501,-1.4242244228812553
Hs 746.T,148124,-1.248919853815242
EB1,107985,-4.010764763700101
NCI-H2444,11404337,-1.49307136407969
G-401,262093,2.911602765721858
P12-Ichikawa,9927531,3.8027198390435792
EC-GI-10,8515,2.8034116636933137
SNU-478,9927531,5.143977185818116
KE-37,12003241,-1.2024354482149269
COR-L51,8515,1.8792206140077008
SNU-C4,6610216,4.670910491319602
PaTu 8988s,6505803,-2.1809975101024417
RPMI-7951,136227924,2.219680452566263
Hs 895.T,6505803,1.07500421429109
HPAF-II,136227924,3.1547615754637
BT 340,9927531,6.379921104021661
NCI-H838,sirolimus-bortezomib (250-1 mol-mol),0.8112840650122598
BV-173,9926054,1.6102872074476016
A2058,6505803,-1.8574702030952697
NCC-StC-K140,3689413,-1.9001520150301452
SK-MES-1,135423438,2.7133393164015027
WT2-iPS,9903786,4.00311264543886
HCC827,3689413,-1.9670372316713456
HCC1395,9911830,2.556253460545972
DK-MG,107985,-2.9987178051865593
TE 441.T,135423438,2.5250342402764816
KYSE-70,9926054,2.326174845830733
JMSU-1,JQ-1-carboplatin (1-1 mol-mol),2.6355388254924517
SNU-1272,9903786,4.921324329124853
SNU-1,46943432,1.799656324239712
Calu-1,sirolimus-bortezomib (250-1 mol-mol),1.450698493515476
Yamato-SS,sirolimus-bortezomib (250-1 mol-mol),1.899815056583121
KYSE-450,sirolimus-bortezomib (250-1 mol-mol),1.472196995185456
SUP-T11,24180125,1.2702519400611516
Ku812,11404337,-0.6784609129861706
COV644,12003241,0.3541041054737522
SNU-1196,6610216,4.695877765522031
SNU-668,3136844,4.5022208486129385
TE-9,11485656,2.3565091821731903
EM-2,24180125,3.3243546283066836
TE-11,135875424,3.5127349276031996
SNU-878,tanespimycin-bortezomib (250-1 mol-mol),-0.1499782135858746
HuG1-N,11404337,-0.1697567004462442
ES-2,selumetinib-vorinostat (8-1 mol-mol),2.4176750496579524
CML-T1,107985,-4.139753917879256
NCI-H1299,3689413,-0.9598507897960026
G-401,3689413,-2.428789331956376
NCI-H1155,tanespimycin-bortezomib (250-1 mol-mol),-1.3476430950240228
OE21,9903786,3.8183922804943298
A-549,11485656,2.1977599259975764
BV-173,10296883,3.0067160543994045
TE-15,49836020,0.684840592082847
VMRC-LCD,148198,-4.056335514777046
WM983B,12003241,-2.729936813041864
SK-MEL-5,54618164,3.941567949618183
IGR-39,selumetinib-GDC-0941 (4-1 mol-mol),2.3690668734503415
LAMA-84,26596,-2.1995969037049936
NCI-H2342,11485656,3.078820685414162
WM266-4,8515,5.000160733889161
DMS 53,10322450,3.0772263685237062
EJM,11404337,-0.4702991542329423
LoVo,49836020,1.6927786584323
MV4-11,sirolimus-bortezomib (250-1 mol-mol),-0.4533727146594301
42-MG-BA,selumetinib-vorinostat (8-1 mol-mol),3.737674590470835
Hs 766T,136227924,2.630952750368734
Rh41,9926054,1.5140566326622644
C2BBe1,24180125,3.074630364609225
WM88,11404337,0.2884415241135956
NCI-H2023,107985,-3.2164871324415816
PL-21,11485656,1.7729113112041155
NCI-H69,9903786,3.032908802365876
SNU-489,12003241,-0.3449149032803904
SNU-119,11404337,-0.1265251374759644
KHM-1B,sirolimus-bortezomib (250-1 mol-mol),0.0402110157809841
IST-Mes1,6610216,4.781215155625892
OAW28,9926054,1.976123345191561
LCLC-97TM1,135423438,1.8911988038183152
RPMI-8226,11485656,0.7927893823334488
LOX-IMVI,9903786,2.476339692878584
GCT,11485656,1.7878903123598318
KG-1-C,6610216,3.995568855023672
NB1,136227924,2.7984479768491335
JJN-3,24180125,2.8642596708213537
SK-LMS-1,24180125,3.932034764154328
NCI-H1869,10296883,4.447785026459559
Calu-1,3689413,-2.465191800637427
COLO 668,6610216,4.122924669530787
RCM-1 [Human rectal adenocarcinoma],100016,6.48277389223573
HCT 8,24180125,3.86603834239024
GP2d,262093,3.014356837300259
MHH-CALL-4,54618164,3.885057071185027
BICR 16,107985,-3.614400369733834
Hs 940.T,135875424,6.668178474722678
SNU-719,262093,3.356379511241945
GSS,44491742,4.082096433494501
P-STS,135423438,4.306983999338839
MM1.S,54618164,3.790511096311708
KMS-21-BM,9927531,3.894276575541364
T3M-10,6610216,4.111876884549565
HCT 8,9927531,4.796707314113722
BT 428,selumetinib-GDC-0941 (4-1 mol-mol),0.5287087065167606
SUP-T11,135875424,3.130261828756196
Sq-1,tanespimycin-bortezomib (250-1 mol-mol),0.5619260521481989
NH-6,JQ-1-carboplatin (1-1 mol-mol),3.51966216446804
ACC-MESO-1,selumetinib-vorinostat (8-1 mol-mol),3.6513542751877313
LS180,409805,6.164182483443964
NCC-StC-K140,148198,-5.392485338723143
EM-2,54618164,3.877558145692375
SK-ES-1,136227924,2.7143313352480143
Panc 10.05,262093,2.3686778047262327
SNU-620,5460769,0.532888566426305
MOR/CPR,tanespimycin-bortezomib (250-1 mol-mol),-0.9000697563150304
Hs 852.T,3689413,-1.1635573957116976
NCI-H1666,sirolimus-bortezomib (250-1 mol-mol),0.7779430535962837
HCC1588,6505803,-1.104009998130938
L-428,tanespimycin-bortezomib (250-1 mol-mol),0.8418435976707451
HT,409805,3.66117299534608
LOX-IMVI,3689413,-4.023880524547255
L3.3,148198,-4.142602322676729
LS1034,9926054,1.864667676562072
YD-10B,3136844,4.735029728767343
HEC-1-A,107985,-3.1197912471628126
COR-L105,135875424,4.584511127602178
HCC4006,12003241,-2.6394477245029355
PaTu 8902,136227924,3.2072125986231117
NCI-H889,sirolimus-bortezomib (250-1 mol-mol),0.2656480378384786
HPB-ALL,6918878,0.0135044314123005
TF-1,11404337,0.9992321487738164
MM1.S,6918878,-0.530970823966065
MKN7,135875424,3.97567031740838
THP-1,tanespimycin-bortezomib (250-1 mol-mol),-1.1093068334471472
BT 232,135875424,3.043961791838538
NCI-H1395,439501,0.2163751108150007
COR-L95,selumetinib-vorinostat (8-1 mol-mol),2.598334256861724
MJ,168313200,3.5794941200353514
COR-L95,9927531,5.207677506691081
ST486,54618164,2.876081696628776
BT 286,3689413,-0.1900658377643967
HCC1569,sirolimus-bortezomib (250-1 mol-mol),0.3856699137888855
ECC10,136227924,2.5549710603978366
OVCAR-8,11485656,1.8119689787001292
BICR 18,selumetinib-vorinostat (8-1 mol-mol),3.62095054613652
RL,6918878,0.6630449005124558
OVCAR-5,6610216,3.967689851217868
NCI-H1944,3136844,4.171527788418376
NCI-H508,159324,3.293159228488628
HEL,9911830,3.2406370139452134
Daudi,107985,-4.311158471957254
HCC366,54618164,4.237927167369724
IGROV-1,135423438,0.764137689665023
Ku812,selumetinib-vorinostat (8-1 mol-mol),-1.7038187664037243
SK-N-AS,168313200,1.823483037418336
CA46,26596,-3.5845712744961324
KMBC-2,9936388,2.279378439007598
SNU-1077,409805,6.04127283545163
RERF-LC-Ad2,100016,6.703705933143471
SCaBER,36462,1.9141331234054
HD-MY-Z,135423438,3.7471437497344713
LNCaP clone FGC,sirolimus-bortezomib (250-1 mol-mol),-6.240208819655782
BxPC-3,159324,1.5239234886257875
HeLa,3689413,0.6540693787829278
RPMI-7951,selumetinib-GDC-0941 (4-1 mol-mol),1.7374138302319462
NCI-H2405,6610216,4.7475909326553705
SNU-8,3689413,-3.353074674655615
A-204,selumetinib-GDC-0941 (4-1 mol-mol),0.2553877558733737
L-428,6918878,1.990001292893394
BT-12,148124,-4.138669937120045
EKVX,9926054,2.0075425899751513
BT 147,135423438,1.671229902583041
KO52,409805,5.182082476499644
TE-11,107985,-4.723022079982108
RCM-1 [Human rectal adenocarcinoma],12003241,-1.4246438063204208
NCI-H2342,9926054,1.8673615783954545
GMS-10,sirolimus-bortezomib (250-1 mol-mol),0.908148060868429
RKO,3689413,3.093382349703003
SNU-61,selumetinib-GDC-0941 (4-1 mol-mol),0.6805559460270842
BT 286,136227924,1.3356746395497436
NCI-H1793,3136844,4.498845122525131
A2780,107985,-4.859396565896689
HCT 116,11404337,-1.072028422937356
SK-N-AS,8515,4.55115290186792
JJN-3,selumetinib-GDC-0941 (4-1 mol-mol),1.20099577342293
EJM,9927531,5.060130602494636
SF539,11485656,1.8649737443723855
KP-N-SI9s,135875424,2.000984128197718
HEC-108,9903786,3.9980769668892706
COLO 800,168313200,3.886241443900116
COV644,54618164,3.7830759061699086
A-673,439501,-3.092013019617277
KYSE-70,sirolimus-bortezomib (250-1 mol-mol),0.1222740684138433
NCI-H28,5460769,-1.4379241893426098
COLO 800,24180125,2.8848784664507416
DoHH2,6505803,-1.0222007356583789
CAL-51,54618164,4.021329289838694
JHH-2,9911830,1.7687500662887066
786-O,6505803,0.1704415236348838
KATO III,9936388,1.2982183156620934
RERF-LC-MS,54618164,3.9158352593779377
PE/CA-PJ49,9903786,3.1609136015972847
SK-N-MC,11485656,1.4655490415518024
BT 224,135875424,2.9965213302921816
EJM,6505803,0.0546883993617254
OCI-M1,6610216,4.2941719628539925
COR-L88,10322450,4.2439806030503915
HCT 15,selumetinib-vorinostat (8-1 mol-mol),3.789257313413483
SNU-16,168313200,1.665996336027964
SK-MEL-3,selumetinib-GDC-0941 (4-1 mol-mol),0.6060957157966415
GDM-1,54618164,2.5636313167651883
TE-15,3689413,0.9912236496957668
DMS 454,54618164,3.941051216840159
Panc 10.05,36462,2.974503019627731
WM983B,107985,-4.2173502785895245
SNU-1214,11404337,-1.0088442164692528
SF268,selumetinib-vorinostat (8-1 mol-mol),2.7475433476572872
SU-DHL-1,100016,4.0163007651424945
OE19,6610216,4.442159691341868
TYK-nu,107985,-3.986066902554295
Kelly,36462,0.235895154836424
Hs 839.T,262093,3.079390898816523
SK-ES-1,439501,-3.332679382402903
NCI-H1623,148124,4.04127286799143
SNB-75,5460769,5.271808255832039
SUP-HD1,11485656,1.8294636044245336
A-673,JQ-1-carboplatin (1-1 mol-mol),1.1518421458333987
CAL-54,sirolimus-bortezomib (250-1 mol-mol),0.5891301092659956
TC-71,JQ-1-carboplatin (1-1 mol-mol),2.9266133797401617
A4/Fukuda,439501,-3.252400391503616
8505C,6610216,4.483516940856299
NCI-H211,159324,-0.4282240371333439
CAMA-1,107985,-3.014648742580285
BICR 56,148124,-4.641918027930953
H-STS,6505803,0.5486553702983976
HCC44,24180125,3.500627575266525
23132/87,9926054,1.8706773159839023
P12-Ichikawa,26596,-2.168612597742571
PSN1,6918878,0.7270198325461739
HOP-62,148198,-4.07466395157971
NCI-H1435,6918878,2.163922137646525
HeLa,148198,-3.5416719655217976
TE-4,selumetinib-GDC-0941 (4-1 mol-mol),0.9436267923396215
SCC-25,439501,-2.292727593069412
PC-3,6505803,3.983075773464378
HCC95,159324,3.4223994590460594
MHH-ES-1,selumetinib-GDC-0941 (4-1 mol-mol),1.820294732010153
SaOS-2,JQ-1-carboplatin (1-1 mol-mol),1.527244446829994
IGR-37,11485656,2.5244768295786697
TUHR14TKB,135875424,2.9544471921358944
BT 340,11404337,-1.0592377517699567
MFE-296,148124,-4.488467363744148
OVCAR-5,selumetinib-GDC-0941 (4-1 mol-mol),-0.7048742493039822
OUMS-23,sirolimus-bortezomib (250-1 mol-mol),1.7172624252600015
JHUEM-7,9903786,1.8726211891462523
HMCB,26596,-1.2966092010554455
MDA-MB-468,9911830,2.3908610927357876
LCLC-97TM1,6918878,3.384977217975284
TM-31,sirolimus-bortezomib (250-1 mol-mol),0.5260626662043751
HuT 78,6505803,-1.3012174270497974
Hs 729.T,9911830,2.3189735483487888
NCI-H1341,10296883,3.7188145345884407
SHP-77,JQ-1-carboplatin (1-1 mol-mol),1.995667602939756
F-36P,107985,-4.433418239536547
Daoy,107985,-2.3537821634376836
T3M-10,12003241,-1.1759997048612671
AGS,24180125,3.82406888235565
DU4475,3689413,0.1265439413603304
HOP-62,44491742,4.640090000896823
SEM,135398744,6.34358667151958
Kelly,135398744,7.079466503802849
EM-2,73707440,3.768751115811406
OAW28,11485656,3.2643123414600645
COR-L279,135423438,1.6988524729087828
SK-N-AS,sirolimus-bortezomib (250-1 mol-mol),0.1203472334672894
CAL-51,6918878,3.0110486558166274
HOP-62,11485656,2.83083000651899
MSTO-211H,409805,4.793476239157615
EJM,tanespimycin-bortezomib (250-1 mol-mol),-0.1920922307802734
TUHR10TKB,409805,5.937613129628935
NCI-H2110,26596,-0.8689069076907829
HCC1395,107985,-4.4491862214991595
SNU-601,6505803,1.2450249306670702
P31/FUJ,24180125,3.650250525491935
SNB-75,9911830,2.263725415615307
COLO 684,9911830,2.4510294564666513
ML-1 [Human thyroid carcinoma],136227924,2.8741817701449506
G-402,24180125,4.207130674742538
NCI-H2452,12003241,-1.7557808561862691
HT-29,6610216,4.713436573815237
TE 617.T,148198,-5.570836708197065
Rh30,9911830,2.2640217333409693
NCI-H1299,148198,-1.8449433288311332
IMR-32,100016,6.43791059275997
2004,8515,3.233137098345555
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569
NCI-H1694,11485656,1.9484050464829303
SU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),0.2178646036916351
KMS-27,6505803,-0.687237988201334
SNU-601,148124,-5.099737761263376
NCI-H292,6610216,4.846288432835765
PL-21,9911830,2.7327137399498302
PaTu 8902,44491742,4.263402068757711
647V,49836020,-1.4541135312501283
Becker,8515,4.701222217711314
D283 Med,135875424,3.0041212409823053
SNU-878,12003241,-0.6657900217683382
NCI-H2405,tanespimycin-bortezomib (250-1 mol-mol),-0.894001775676426
A4/Fukuda,46943432,-0.0927442133672991
A4/Fukuda,JQ-1-carboplatin (1-1 mol-mol),-0.863856573463552
RVH-421,24180125,3.4561148986253736
JHUEM-7,24180125,3.52789412824338
CAL-148,136227924,1.0972662327382037
SK-MEL-1,9927531,4.509159168037888
NCI-H716,148198,-5.232540582479685
HuP-T4,24180125,3.5257576180586976
SNU-878,54618164,4.41938540885837
MDST8,11404337,0.5498361952050128
KYSE-180,3689413,3.064535959483158
Hs 839.T,9927531,5.8565553238540655
NCI-H2122,11404337,0.2982247321371532
KG-1-C,3689413,-1.7465014908016088
SUP-M2,3689413,-3.139623723794694
BT 159,9936388,-6.930864213478757
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384
OS-RC-2,6610216,4.858225947192859
LP-1,6610216,3.563963398106019
SNU-478,54639024,4.476897438688029
Ci-1,409805,3.8967919389594554
HMC-1-8,9903786,2.873770542760651
Hs 888.Lu,100016,7.863224005148367
NCI-H2196,148198,-4.10304845693827
SNU-869,54618164,4.157538962924349
KE-97,sirolimus-bortezomib (250-1 mol-mol),0.1118131766190663
ONCO-DG-1,439501,-2.5478488812484015
NCI-H1703,107985,-4.063268775801852
SNU-878,107985,-2.055146714055888
NCI-H650,6505803,-0.3045816142319602
NCI-H2126,6918878,2.884258178702791
JVM-3,11485656,2.278775985482816
OC 314,3689413,-2.4202845950234466
KP-3,selumetinib-GDC-0941 (4-1 mol-mol),1.1487168771210745
MOLM-6,44491742,4.372818024610458
JHH-2,100016,7.043022520962564
SW1353,selumetinib-vorinostat (8-1 mol-mol),2.5043308707131673
KO52,6918878,1.008757664965314
Hep 3B2.1-7,selumetinib-GDC-0941 (4-1 mol-mol),1.4217677888938105
HCC1438,3136844,4.029991644724261
EFE-184,262093,3.462409565200508
8505C,8515,4.351335582705761
KG-1-C,11404337,-1.389816436065637
SH-4,24180125,3.014930921556756
BHT-101,tanespimycin-bortezomib (250-1 mol-mol),1.2601290483730383
KYSE-510,148198,-4.124050195334788
JHH-5,6610216,3.708865198652102
JK-1,36462,-1.2857255048045515
NCI-H2122,sirolimus-bortezomib (250-1 mol-mol),1.792709807177603
NCI-H1105,49836020,4.351413850540497
SNU-387,6610216,3.9381426749214743
RS4;11,159324,0.3176154003787351
KNS-60,tanespimycin-bortezomib (250-1 mol-mol),1.2079185483503194
KMS-34,9903786,0.5468687794140459
RL,148198,-4.279305385936642
DMS 273,6610216,4.172124776089646
BICR 56,9903786,4.170821075739504
OCI-AML-3,10322450,2.261433742122515
Aska-SS,46943432,0.9231523980754076
MHH-CALL-4,148198,-4.435182205055272
PC-3,10296883,5.2902434892598365
UO-31,11404337,-1.2748998268508818
COLO 800,135398744,6.478150217692287
DMS 273,tanespimycin-bortezomib (250-1 mol-mol),1.3026014961511128
HL-60,26596,-1.7556952568708522
AML-193,6505803,-1.7450029346129687
Granta-519,3136844,3.153984140395424
ONS-76,73707440,4.1934861569389845
ESS-1,24180125,3.331979674522133
SK-MEL-3,262093,2.386841982025131
Reh,3689413,-0.3766335135286286
MIA PaCa-2,148124,-8.04655725116999
BT-12,selumetinib-vorinostat (8-1 mol-mol),3.455129054550989
ME-1 [Human leukemia],11404337,1.0093638821614643
HT-1080,100016,6.676268064255503
CML-T1,44493528,3.9716542826771297
KYSE-410,12003241,-2.1155115062785805
HSC-2,selumetinib-GDC-0941 (4-1 mol-mol),0.8174688254253049
EFM-192A,9911830,2.136951075803696
8505C,100016,6.577733697234268
PE/CA-PJ34 (clone C12),sirolimus-bortezomib (250-1 mol-mol),0.9308222519351572
COV434,148124,-5.833905283054875
Panc 04.03,262093,3.918875507815306
CAS-1,sirolimus-bortezomib (250-1 mol-mol),2.076174664589587
SNU-685,sirolimus-bortezomib (250-1 mol-mol),0.4201840468382607
BT 328,11404337,1.5843001055688009
SNU-878,9911830,1.8816958115291476
BT 440,6610216,4.135662592287223
HCC2218,selumetinib-vorinostat (8-1 mol-mol),2.1332099474977455
OE21,11485656,1.707456262972337
EC-GI-10,26596,-3.5687172078755087
HPB-ALL,6610216,3.95852106841488
HCC44,409805,3.740964566470102
CAL-54,10322450,4.089763150244814
MOLT-16,159324,-1.742888303650328
MCAS,12003241,0.5308085719616568
BT 271,54618164,3.681074149846346
HCC2218,9926054,1.6047846197702569
Ri-1,3136844,3.150567247939398
Namalwa,sirolimus-bortezomib (250-1 mol-mol),-0.1415528846199467
DB,11485656,1.836409608032291
Hs 822.T,9936388,2.249829055538111
BFTC-909,9927531,5.31835549136936
SK-ES-1,135875424,2.8714720771033297
Becker,44493528,4.387044567791122
HT-144,44491742,3.9121735247647127
SNU-61,44493528,4.287806417412906
SNU-81,selumetinib-vorinostat (8-1 mol-mol),-1.2319110423527484
KP-N-SI9s,439501,-2.735040326022903
KLE,9927531,4.8057879583658405
RKO,100016,5.817852214634293
MKN1,135423438,3.025317436009671
OCI-Ly10,107985,-3.494379177576491
T98G,11485656,2.7510926894657977
BT-549,409805,3.826135579342285
Becker,148124,-6.351335533141373
P3HR-1,168313200,4.175609839213621
PC-3,168313200,3.1941153689733137
LN-18,262093,3.730786897618696
Pfeiffer,sirolimus-bortezomib (250-1 mol-mol),-8.074968240863114
SK-MEL-5,tanespimycin-bortezomib (250-1 mol-mol),1.5988116818939204
BT 139,selumetinib-GDC-0941 (4-1 mol-mol),0.4945119496988254
RPMI-6666,11404337,0.2298054354312977
VM-CUB-1,54618164,4.270222083286748
MEC-1,46943432,0.6531344978892847
HL-60,JQ-1-carboplatin (1-1 mol-mol),0.4804402451119697
FU-OV-1,selumetinib-vorinostat (8-1 mol-mol),1.6178932175124687
ESS-1,135875424,3.182582939188363
NCI-H1395,409805,5.969168563416671
SBC-5,135875424,3.947045576812926
SK-N-MC,49836020,5.673841333096494
8305C,11485656,2.5131422370464436
IGR-39,8515,5.35285474164026
GP2d,10296883,2.4344246529088163
TALL-1 [Human adult T-ALL],JQ-1-carboplatin (1-1 mol-mol),-0.5352778858852548
P12-Ichikawa,9911830,2.2372509617860414
NCI-H1838,36462,1.5494898748578776
SNU-719,selumetinib-GDC-0941 (4-1 mol-mol),-0.9974612802611444
HCC1419,107985,-4.0861920126491365
NCI-H2171,9927531,3.1501077196413783
Ri-1,6918878,0.3594446743212551
DOV13,135875424,3.915299469104102
NCI-H23,439501,-3.080706529891667
RT-112,36462,2.29619659218897
SW1271,49836020,-1.4027167140646708
Hs 683,26596,-1.91567083647516
TF-1,selumetinib-vorinostat (8-1 mol-mol),0.2373450390299108
NCI-H1694,3689413,-2.758320209596303
KMS-11,6505803,-3.448917575969749
SW1783,10296883,3.940377993774996
TC-71,10296883,3.4863812877107176
Lu-65,107985,-2.4100126884744015
SNB-75,6610216,4.527522920111379
EM-2,135875424,3.8606951218736287
OVK18,12003241,-0.5661348884613613
Ishikawa (Heraklio) 02 ER-,159324,3.630524948383921
J82,10296883,4.03825923249178
BT 228,148198,-4.966222395978798
MKN74,5460769,3.534639533895065
SNG-M,12003241,-1.3269427590967688
MOLT-3,107985,-4.863339213865672
SW948,8515,3.759025323790885
BT 179,136227924,3.760107948072088
BT 239,10322450,3.395640435178443
A-375,439501,-2.387181275139254
NCI-H1734,439501,-2.4852115396408436
786-O,6610216,4.251525959368826
F-36P,135875424,2.6086131482089363
UM-UC-1,24180125,4.853668448035656
JHUEM-1,246676,4.366062260954229
OVCAR-4,24180125,2.4780177997263304
5637,9903786,1.5217427141278097
MDA-MB-231,9911830,2.6293157507295746
HCC202,44493528,4.2464995661804235
Hs 888.T,168313200,1.7807079224736295
ECC12,8515,4.870326922262876
NCI-H2286,159324,5.184730957482079
MCF-7,3689413,0.894647662863142
HuNS1,9911830,1.8724721971945
BT 139,11404337,0.9723364970795382
RKN,148198,-1.0178445286580065
SUIT-2,selumetinib-GDC-0941 (4-1 mol-mol),2.4482295182309257
COLO 678,24180125,3.7441922268279297
SNU-869,11404337,1.139832869567116
SW579,9936388,-9.135357848638378
BHT-101,12003241,-0.6402723165837827
MOR/CPR,107985,-3.2493016535307073
G-402,26596,-0.4180942485240064
BT 444,12003241,-0.4351069615199688
NCI-H358,439501,-0.5524451893811123
Hs 578T,107985,-4.43048214511299
Hs 688(A).T,6610216,4.587540345511735
TTC-709,9926054,1.3747627831999318
BT 444,selumetinib-GDC-0941 (4-1 mol-mol),1.0784151115799612
BT 164,JQ-1-carboplatin (1-1 mol-mol),4.081532753647648
BHT-101,5460769,1.8781791917401816
CAL-29,11485656,2.151813126384455
JVM-3,3136844,3.2113000396100646
WM115,9911830,1.4636751787761997
NCI-H1105,6505803,1.9416219535122128
OCI-AML-2,9903786,1.7653976313293729
YD-10B,11404337,-1.441259923990304
TOV-112D,44491742,4.330645914345901
KM12,tanespimycin-bortezomib (250-1 mol-mol),-0.2034233372604618
L3.3,54618164,4.298111449535211
NCI-H1581,11485656,1.8332307875240343
DU4475,JQ-1-carboplatin (1-1 mol-mol),0.3822189062446061
HPB-ALL,24180125,2.353985646096143
CAL-120,107985,-3.2720552365961364
CHP-212,tanespimycin-bortezomib (250-1 mol-mol),-3.160295416618492
SNU-1079,5460769,0.9743779178913314
YD-15,9911830,2.5298238484943463
SK-MES-1,3136844,4.0902197826019995
SNU-C2A,26596,-0.6540146277819451
KMS-21-BM,9926054,0.3453207317075127
BT 239,selumetinib-vorinostat (8-1 mol-mol),0.2511204621924663
HGC-27,136227924,2.541882907814414
SK-LMS-1,262093,2.881429058515633
OE21,409805,3.7550255149690943
SNB-75,9936388,1.911669139874388
LMSU,selumetinib-vorinostat (8-1 mol-mol),4.672884739471154
NCI-H460,9911830,3.1326305509826824
NCI-H1435,135875424,4.380789148010153
COV644,9926054,1.7976744262803612
OVTOKO,12003241,-1.0973416897014734
PE/CA-PJ41 (clone D2),439501,-0.7748943226504631
NCI-H2444,11485656,3.180889910704459
KYSE-150,107985,-3.63550255760894
HCC1438,5460769,1.743757679133544
NCI-H2122,135398744,6.485849720689022
HL-60,8515,4.112946136291534
KP-2,9903786,4.272294010971456
SH-10-TC,selumetinib-GDC-0941 (4-1 mol-mol),2.294004150887064
OCI-Ly3,9911830,2.1983538699669394
KCL-22,136227924,2.6502010503693016
EB1,135423438,1.4973113179323292
KE-97,3689413,-2.1029735471074225
SNU-761,439501,-2.8080514994136
Hs 895.T,5460769,5.961347926985583
EPLC-272H,159324,3.9545582528533982
BT 271,107985,-1.88483870994594
L-540,3689413,0.298858834558217
PL-21,9903786,1.6725311379491856
CAL-78,9911830,2.1826660302701058
KYSE-180,107985,-3.532250408088534
SW1710,135398744,7.400823424142947
SJSA-1,135875424,4.854723891945684
Calu-3,selumetinib-vorinostat (8-1 mol-mol),0.3086361684190137
NCI-H1573,9903786,2.787588976876453
SW1271,9926054,1.9992649208496855
PaTu 8988s,54618164,4.048235772282788
MDA-MB-157,9903786,1.458865596348786
DMS 53,3136844,3.938571240701918
RERF-LC-A1,49836020,4.4326562717782005
PK-45H,148198,-3.448845301231553
NCI-H889,10322450,4.7831613013187
RCM-1 [Human rectal adenocarcinoma],11404337,-0.1256073852846617
PK-1,107985,-2.929309788812076
SK-MEL-28,11485656,3.743045528473451
OE21,6610216,4.168001578531245
NCI-H727,54618164,4.079418853402711
MOLM-13,9936388,-7.059788369591511
HuNS1,selumetinib-vorinostat (8-1 mol-mol),2.3159502101358225
TE-4,9936388,-6.469304697668828
SNU-C4,9926054,1.7359691760271532
RCH-ACV,26596,-2.407585357799557
F-36P,6505803,-0.1070428944453584
NCI-H1355,439501,-2.6186321377113955
P31/FUJ,26596,-2.2448149587984836
SK-MEL-31,439501,1.7901681191985463
TCCSUP,159324,3.967918889169363
SNU-C1,5460769,4.252440714424883
MDA-MB-157,tanespimycin-bortezomib (250-1 mol-mol),-1.1455809440560911
LNCaP clone FGC,100016,6.505127339133147
NCI-H838,9903786,3.3354692149309124
HEL 92.1.7,100016,4.201358504841771
HCC1428,135875424,3.1301464909874546
LS180,selumetinib-GDC-0941 (4-1 mol-mol),-1.227348326224306
LNCaP clone FGC,10322450,2.7673995360058954
COLO 829,136227924,3.354215786550203
BL-70,100016,3.880189960258483
WM793,262093,3.640026682877067
MOLT-13,6610216,3.560997479568521
HCC1588,3136844,4.438168668840028
MV4-11,439501,-2.384651174177473
BV-173,5460769,1.1539249163538905
L-540,tanespimycin-bortezomib (250-1 mol-mol),-0.491280358264631
SNU-46,159324,2.6204586444716784
Hs 611.T,148198,-3.7604102025742345
GSU,sirolimus-bortezomib (250-1 mol-mol),1.8357391099692455
NU-DHL-1,36462,-1.7187718695601946
HCC95,246676,5.0629416583220594
BFTC-905,262093,2.3947823917937017
KM12,9903786,1.2751766913602836
Raji,9903786,2.8365362494251394
MOLT-16,9926054,1.655760518642202
NCI-H196,selumetinib-vorinostat (8-1 mol-mol),2.502166357099755
JHOM-1,selumetinib-vorinostat (8-1 mol-mol),4.561392642602074
MOLT-16,439501,-2.6339721487362775
EHEB,selumetinib-GDC-0941 (4-1 mol-mol),0.6698070674262858
NCI-H2444,159324,3.226784094447535
SK-MES-1,JQ-1-carboplatin (1-1 mol-mol),2.3477622395388495
OCI-AML-5,107985,-4.549772728055964
HGC-27,24180125,3.8514022431268113
SNU-398,9926054,1.6383550213348652
T3M-10,44491742,3.8541069254264566
HCC1954,sirolimus-bortezomib (250-1 mol-mol),-8.401031472525755
DMS 114,selumetinib-vorinostat (8-1 mol-mol),3.139820854284445
COV362,selumetinib-GDC-0941 (4-1 mol-mol),2.9953812620195066
OVCAR-5,tanespimycin-bortezomib (250-1 mol-mol),0.8786451228856517
SK-MEL-1,selumetinib-vorinostat (8-1 mol-mol),-1.3399286249767557
ACHN,135875424,5.052014083171249
D283 Med,36462,-0.7003958685437419
NCI-H2405,44493528,5.716888607372898
BT 245,12003241,-0.4272477548788383
EoL-1,439501,-3.7702491221703145
PF-382,selumetinib-GDC-0941 (4-1 mol-mol),0.8543427357308107
YH-13,9911830,3.324457602349572
HuH-1,11485656,1.6610003065842192
NCI-H929,409805,3.661820790042666
NCI-H1299,9926054,1.7323284970245385
COV644,168313200,3.3351573798183876
OAW42,6610216,4.144894228463558
EB1,44491742,3.4704982889402545
AML-193,12003241,-1.5379973109398848
EFE-184,3136844,4.752678488624171
HT-1080,JQ-1-carboplatin (1-1 mol-mol),3.260374124157549
HCT 15,9936388,-4.893709722395259
VMRC-RCZ,selumetinib-vorinostat (8-1 mol-mol),3.888432832731119
TCCSUP,6505803,-2.3370703799020323
JIMT-1,100016,6.5721980857327935
KP-3,9936388,-3.794861235698215
ST486,107985,-3.099452908911552
SNU-1033,49836020,1.7840304926095434
CAL-148,3689413,0.1534272524825109
JHUEM-2,5460769,-3.615295030871829
Ishikawa (Heraklio) 02 ER-,9936388,-5.11124273822625
Rh18,10296883,3.770152183649725
HEC-59,6610216,4.527816739997527
VMRC-LCD,6610216,4.359775252992096
KP-4,135875424,3.69718795810946
NCI-H2196,24180125,2.6408442695810925
TC-71,168313200,3.674389674642696
KE-37,54618164,3.8582430054460337
RERF-LC-MS,262093,3.104487938727744
OVISE,9936388,2.6758567859836826
BT 232,168313200,1.7449359098138864
JURL-MK1,262093,2.648959979850121
RPMI-7951,24180125,2.9670273769283506
Panc 03.27,6918878,4.786533174573136
HuT 78,54618164,4.24138057284203
NCI-H889,54618164,3.8719653516337176
HuH-6,6610216,3.4772585756777357
HuP-T3,107985,-4.90392348596967
U-118MG,10296883,4.307423912677154
GOS-3,10296883,4.354871301885758
NCI-H1838,selumetinib-GDC-0941 (4-1 mol-mol),2.2361071015638445
Calu-1,262093,2.8993991941012704
SK-MM-2,sirolimus-bortezomib (250-1 mol-mol),1.09289711908984
YD-10B,6505803,-2.5898311798787774
J82,136227924,3.3108045260668564
HuH-28,46943432,1.6312961638133356
COLO 201,9903786,2.3732534001710426
HOP-92,11404337,-0.857854163470874
UO-31,3689413,-5.037713706278837
JJN-3,409805,3.7646023994786457
SF539,148198,-6.422680321892083
Panc 10.05,selumetinib-vorinostat (8-1 mol-mol),2.182952448913038
BT 422,sirolimus-bortezomib (250-1 mol-mol),0.5835017840972496
NCI-H1184,6505803,-0.2982079096547607
HuT 78,36462,0.7819646320410331
BT 147,9903786,1.444914560684451
OE19,tanespimycin-bortezomib (250-1 mol-mol),-3.057865430510972
MFE-296,107985,-4.0658320718780985
SNU-C4,selumetinib-vorinostat (8-1 mol-mol),3.654514117080656
COR-L105,10322450,4.112392966182136
Li-7,9911830,0.8718891387559716
A3/Kawakami,107985,-4.442532010928943
IGR-1,6505803,1.3637597658923408
Hs 944.T,409805,4.813634896528736
BT 440,sirolimus-bortezomib (250-1 mol-mol),2.4257327980261936
SUP-T1,44491742,3.5302085503569782
BT-549,9936388,-4.888200161073446
HEC-151,136227924,2.850288220591168
MSTO-211H,148198,-2.180219295506665
JK-1,107985,-3.996309073067597
NCI-H747,409805,5.162158430196502
WM88,9903786,2.087799458877892
GI-1,36462,2.374062012412674
M-07e,36462,-0.4519131345392329
SK-HEP-1,6610216,4.694225049802747
Panc 10.05,148198,-3.9084182720611618
HCT 15,100016,6.694419225032017
JJN-3,54618164,4.053175478908277
SK-MEL-30,135875424,4.398067233460652
COLO 668,selumetinib-vorinostat (8-1 mol-mol),2.26627274162314
697,8515,1.5898758887599602
Lu-99,JQ-1-carboplatin (1-1 mol-mol),0.8870442725111318
SNU-201,136227924,3.0451171975506903
BT 216,409805,5.658617795151575
TCCSUP,selumetinib-vorinostat (8-1 mol-mol),2.3847964981208305
C2BBe1,107985,-4.460375093006492
BT 147,148198,-4.643582632338319
MV4-11,10322450,2.830685267799283
TALL-1 [Human adult T-ALL],3689413,-2.1948693605087577
BT 131,409805,3.877386037090413
SH-10-TC,439501,0.97642019578469
Detroit 562,6505803,-1.754599489690224
SK-MEL-3,10322450,3.9048135305000624
SNU-410,159324,4.304183383322186
CCF-STTG1,100016,6.985278157575169
COR-L95,36462,-0.8944975018350346
CGTH-W-1,107985,-2.4076610868668293
RT-112,10296883,4.279082989999429
SNU-601,6918878,4.487529930908577
NCI-H520,11404337,-0.911000559838952
JL-1,9903786,5.3673726170242455
Hs 852.T,148198,-2.877314307810341
KYSE-180,159324,3.323934124765763
SNU-475,246676,5.352165829175543
IGR-39,selumetinib-vorinostat (8-1 mol-mol),2.363486431650059
IGR-39,12003241,-1.2962824425712205
IM95,148198,-3.3737610727905056
RD,409805,3.088380106022685
MOLT-16,148198,-4.088839016877876
2004,10296883,3.635468664105464
JMSU-1,136227924,3.0914793862161747
BICR 31,9926054,1.721382648019371
Karpas-422,11404337,-0.752603119365503
DMS 53,12003241,-1.7395700319118894
BT 147,6610216,4.32528553211185
HCC1588,sirolimus-bortezomib (250-1 mol-mol),0.5991119753615496
BT 416,3136844,3.733744252628085
ESS-1,10322450,4.730793151305824
LS1034,6610216,4.176781620186853
SNU-668,selumetinib-vorinostat (8-1 mol-mol),2.4332575717888303
WM266-4,439501,-0.5871270471596414
Caki-1,3136844,4.447978579962262
PC-14,36462,2.3416403863743125
IGR-37,selumetinib-vorinostat (8-1 mol-mol),0.5095178470220681
OAW28,44491742,4.754653012158477
HT115,136227924,1.4968152830691424
MDA-MB-435S,sirolimus-bortezomib (250-1 mol-mol),0.878398861878788
KNS-60,6918878,3.2567776197024996
MOLP-2,11404337,-2.275467470037822
Hs 839.T,100016,7.045878686884313
KNS-42,sirolimus-bortezomib (250-1 mol-mol),0.2435231832120803
WM793,36462,4.293096910683363
RT-4,selumetinib-GDC-0941 (4-1 mol-mol),2.7541316564382856
KP-N-SI9s,3689413,-0.3839516560951015
PF-382,11485656,2.17330616168877
AML-193,6918878,0.7016492064404843
WM88,3136844,5.917870427875155
U-251MG,tanespimycin-bortezomib (250-1 mol-mol),-1.2552870435525063
NCI-H1299,selumetinib-GDC-0941 (4-1 mol-mol),0.1290372531898008
MKN7,439501,-1.6768390868463443
NCI-H889,148198,-2.8403688866942804
DEL,6505803,-2.9749849917390763
NCI-H647,9903786,3.1378024767973827
SNU-1076,9926054,2.0143618167190493
NCI-H292,107985,-2.5053359043606043
DU145,136227924,5.593457102459236
Hs 944.T,JQ-1-carboplatin (1-1 mol-mol),2.5361847784795715
G-361,9926054,2.5235638278884687
MOLP-2,6918878,4.193587721348543
JM-1,9927531,4.0230036766634125
NCI-H1339,168313200,4.075069570376525
GP2d,selumetinib-vorinostat (8-1 mol-mol),0.6453511281872317
HCC1395,262093,3.7391779193808254
MES-SA,selumetinib-GDC-0941 (4-1 mol-mol),2.335158862320408
HL-60,36462,-0.0073332403258697
SK-MEL-3,9903786,4.6944360721993545
PK-59,6610216,4.292036954059538
EoL-1,3136844,3.326483406194643
A-375,6610216,4.632433700861142
RS4;11,135875424,3.0879856704694313
RT-4,9903786,1.1299984693284726
MKN74,sirolimus-bortezomib (250-1 mol-mol),2.5374597800168446
TUHR4TKB,sirolimus-bortezomib (250-1 mol-mol),1.666673224601644
HL-60,selumetinib-vorinostat (8-1 mol-mol),-1.0995278309678689
SNU-81,107985,-4.076050447844214
BHY,44493528,4.130126082796934
TT,11485656,1.9272227240338475
NCI-H1581,135875424,3.5038022021338415
OUMS-23,46943432,4.9765962498164855
MDA-MB-157,11485656,1.3019788320898549
NH-6,sirolimus-bortezomib (250-1 mol-mol),1.143169079314691
BT 147,9926054,1.807277739033318
A101D,selumetinib-vorinostat (8-1 mol-mol),3.608310140298691
L-1236,246676,2.905629045644303
BT 164,136227924,2.714674644422482
BT 245,10296883,3.705541909006873
CHP-212,107985,-3.762512577622678
LP-1,5460769,5.634254198515754
TE-1,246676,4.450819178803798
OPM-2,148198,-4.827513159673032
JVM-2,selumetinib-GDC-0941 (4-1 mol-mol),-4.259839678662807
HDLM-2,26596,-1.5696156753174118
L-540,100016,3.9234848652304097
42-MG-BA,246676,4.8928589872752335
RCM-1 [Human rectal adenocarcinoma],36462,2.9964453818745924
SW1271,selumetinib-GDC-0941 (4-1 mol-mol),0.8746912096343703
G-401,9903786,2.8038927126182327
J82,9936388,2.8537355622155536
SF539,135875424,2.4028504168317473
OVCAR-4,135398744,7.790531663529689
Hs 944.T,168313200,2.970577482583042
OVCAR-4,JQ-1-carboplatin (1-1 mol-mol),1.400504619073484
SU-DHL-10,24180125,2.65939444404047
SNU-668,11404337,0.2383012933548859
NCI-H2452,6918878,3.5446658281374277
KMS-26,26596,-2.3246210028506873
8505C,409805,5.335927763220102
SK-N-AS,24180125,1.1974349379888387
BT-549,11404337,-0.1293922368150601
FU-OV-1,JQ-1-carboplatin (1-1 mol-mol),0.7571969377872175
RCH-ACV,46943432,0.6634078457695299
Ki-JK,9926054,1.4842884582556586
F-36P,tanespimycin-bortezomib (250-1 mol-mol),-0.3225177069442169
HOS,44493528,5.3157890671440855
BT 428,148198,-5.072102147760655
Hs 822.T,168313200,2.754326247854747
HCC1428,11404337,-0.7676967113695158
AsPC-1,44491742,4.429887143828186
M-07e,49836020,-3.7990494796960337
U-937,54618164,3.75737767809936
MFE-296,11485656,2.443705584915375
MOLT-13,9936388,-7.171381917175865
COR-L88,sirolimus-bortezomib (250-1 mol-mol),1.8944526230025216
CAL-33,12003241,-0.8317301463564554
SCC-9,6610216,4.4695629784882795
CAL-27,11485656,1.6862238781390195
HCC202,10296883,4.070733059674107
Detroit 562,46943432,2.661178412320311
LCLC-103H,5460769,4.406822689547097
SK-ES-1,262093,1.8712503240297784
COR-L105,9926054,1.7310748902984938
YD-38,6505803,-1.6031716801172209
BT 340,9936388,1.2186667237232216
BICR 22,24180125,3.296229177015365
Mono-Mac-1,6505803,-1.0735015571845192
HOS,439501,-2.316181578495001
SU-DHL-10,JQ-1-carboplatin (1-1 mol-mol),-0.069963148884663
SK-ES-1,9903786,1.417242629772361
SNU-407,6505803,0.2782297431267146
SNU-182,6505803,1.4884406130314256
BFTC-909,54618164,4.281231487810877
HCC1143,6505803,-0.5233928936461414
ML-1 [Human thyroid carcinoma],135423438,1.332992654992983
HEL,5460769,3.63888115942649
HCC1195,6610216,4.922829824877741
SU.86.86,262093,3.327893877156399
SNU-719,12003241,0.0299382028109862
HCC1500,8515,5.3989297102528715
Toledo,148124,2.3723667360022085
CML-T1,8515,3.304453494146528
SNU-1105,24180125,2.926642387261466
HCC1833,409805,5.961157606825395
SCC-4,11485656,2.4110004255244153
SW1417,9903786,3.296338786408906
MFE-319,sirolimus-bortezomib (250-1 mol-mol),0.3475063070174586
OCI-AML-2,159324,-1.1992485255240457
A-172,54618164,3.734087150642515
SNU-466,3689413,-2.151085855485809
TE 441.T,selumetinib-vorinostat (8-1 mol-mol),3.7277184259028378
BT-16,9903786,2.8143760707131347
Ki-JK,selumetinib-vorinostat (8-1 mol-mol),1.702696595732736
BICR 22,selumetinib-GDC-0941 (4-1 mol-mol),0.9236459983080146
SKM-1,148198,-3.315233928127138
JHUEM-3,11485656,2.0558841747808776
LS1034,11485656,1.821657133822141
NCI-H1581,136227924,2.9082899651974734
KU-19-19,107985,-2.420790531142743
Hs 888.Lu,9927531,5.408720252144841
JVM-2,159324,0.4301215701176792
RT-4,439501,-1.136247834932354
697,10296883,1.236413600919532
PC-14,439501,-2.395737625467809
SUP-T11,6610216,4.082537730275983
L3.3,11485656,2.040790548836277
SNU-761,135423438,1.615583061665389
Toledo,sirolimus-bortezomib (250-1 mol-mol),2.5454023047541985
SUP-T11,26596,-3.766256771827544
NCI-H1339,8515,4.704049354821168
JHUEM-7,5460769,0.024222502884872
SaOS-2,11485656,2.155652122560971
U-BLC1,11485656,2.1961180988259086
MIA PaCa-2,JQ-1-carboplatin (1-1 mol-mol),-0.0764118739989751
Karpas-299,73707440,5.429383065350182
NCI-H2171,44493528,3.677120674941258
Tm87-16,9926054,1.142722518421256
F-36P,sirolimus-bortezomib (250-1 mol-mol),0.0498711406572633
LN-18,9936388,-1.1399684434607444
22Rv1,409805,3.669693952554832
Hs 746.T,135875424,4.375354252450309
ZR-75-1,11404337,1.062777047801886
EFM-192A,11485656,2.8514070088200527
JM-1,135875424,2.019666731209586
LN-18,9903786,3.1734737643120696
U-251MG,JQ-1-carboplatin (1-1 mol-mol),3.361706194293166
LXF 289,107985,-2.691798131563437
TE-14,tanespimycin-bortezomib (250-1 mol-mol),-1.657648162906329
SNU-C5,107985,-4.306903080015857
LP-1,9903786,3.180613462551036
SK-MEL-30,6610216,4.414310809394379
MDA-MB-415,sirolimus-bortezomib (250-1 mol-mol),2.5616194008456916
NCI-H2342,107985,-1.5657357451574807
PaTu 8988t,24180125,3.300808715406375
KMS-28BM,107985,-4.596587711336739
U-937,44491742,3.930782705930826
TCC-Pan2,tanespimycin-bortezomib (250-1 mol-mol),-1.7030002887525872
RCC10RGB,9903786,5.708919982977709
SNU-16,8515,1.85079439361957
HARA [Human squamous cell lung carcinoma],100016,5.315547253627084
PF-382,44491742,5.368678247108403
NCI-H446,12003241,-2.472170144252885
NUGC-3,6918878,0.8478164423084844
GCT,135875424,3.965319619265028
A-673,262093,2.1198375376891705
NCI-H2171,9903786,1.7901794952315444
PC-14,selumetinib-GDC-0941 (4-1 mol-mol),1.0786711406515603
JVM-3,8515,3.3975589624762472
EFM-192A,409805,5.233985235852892
SNG-M,54618164,4.091040607264855
MOLM-6,26596,-3.738191164501696
RPMI-8226,159324,-0.4184155328955503
HSC-2,439501,-2.499396675496898
HCC2108,159324,4.9915636231764005
SU-DHL-8,148198,-4.565516831047941
SNU-478,8515,3.3464395121012847
ESS-1,11404337,-0.7954778123034105
U-BLC1,136227924,2.288895160726179
SNU-1214,107985,-3.75427796779674
BxPC-3,135875424,4.118804534986376
Caki-1,409805,6.67721906325642
HMC-1-8,3689413,0.9110162890999955
NCI-H647,sirolimus-bortezomib (250-1 mol-mol),1.438565345282899
Capan-1,148124,-0.5288233157580327
SW620,9926054,2.9151394622237823
Detroit 562,148198,-1.4589401504544364
HPAC,5460769,1.6003677750846823
BT 328,selumetinib-GDC-0941 (4-1 mol-mol),2.0917542081125067
COR-L88,3136844,4.185958299031873
A-549,9936388,1.4749208650316612
MDA-MB-157,6918878,0.7604288199483474
NCI-H1944,9926054,1.887577830316648
DV-90,136227924,1.3959750608222408
HEY A8,selumetinib-vorinostat (8-1 mol-mol),2.236859595097947
JHH-1,JQ-1-carboplatin (1-1 mol-mol),3.3935500836468764
BICR 31,tanespimycin-bortezomib (250-1 mol-mol),0.0232172753211841
NCI-H1573,3689413,-0.5514389876644209
CJM [Human melanoma],135875424,3.3018695486578573
SK-MEL-1,6918878,2.5312683960728264
JHH-5,168313200,1.7531156599727438
P3HR-1,selumetinib-GDC-0941 (4-1 mol-mol),3.428071377165287
SNU-C1,selumetinib-vorinostat (8-1 mol-mol),-2.612030699102198
BT 248,9911830,3.0671224453630326
NCI-H1666,11404337,-2.6853606173229125
WSU-DLCL2,44491742,3.7672171779194983
BT 428,JQ-1-carboplatin (1-1 mol-mol),-0.3144310627215171
Hs 888.Lu,409805,5.27366905303051
NCI-H2087,3136844,3.748847469849269
CGTH-W-1,11404337,-0.3355456944915889
ESS-1,100016,6.502595194480242
L-540,54618164,3.5943387572444827
Panc 10.05,3689413,0.9531263048130152
Ki-JK,9903786,1.8002187553993072
NCI-H460,439501,-2.362377537788676
MOLT-16,262093,0.3053132271730923
LOX-IMVI,5460769,1.2475955137176375
NCI-H1395,6610216,4.652818435628847
BT 131,3689413,-1.953613680223501
TT,3689413,3.828584328493261
OAW28,148124,5.441417229348929
ZR-75-30,262093,3.223282782718559
KYSE-510,selumetinib-GDC-0941 (4-1 mol-mol),1.3541576401803423
LAMA-84,9936388,-4.994244165866005
GSU,9926054,2.0753432463220065
Tm87-16,136227924,1.7990989939748585
HCT 116,selumetinib-vorinostat (8-1 mol-mol),2.362007276438713
SIG-M5,6610216,4.287770419963318
MEC-1,44493528,4.02747139301686
HARA [Human squamous cell lung carcinoma],136227924,3.047223136335837
MSTO-211H,46943432,4.749068259324704
NCI-H1651,selumetinib-GDC-0941 (4-1 mol-mol),2.159962931758626
Daoy,136227924,3.329647267316264
SNU-719,9936388,-4.601692458666014
SNU-478,135875424,3.766557259457048
ECC10,11404337,0.1866316876880306
Hs 746.T,9927531,5.239357337613853
SK-MEL-31,selumetinib-GDC-0941 (4-1 mol-mol),3.550007018724769
GA-10,36462,-2.446264155422686
HDLM-2,409805,3.613104828003659
Kelly,46943432,3.8381762571789926
BT 440,107985,-3.431835776853905
J82,12003241,-0.1407716325694316
VCaP,11404337,1.1855429552753238
A-498,11404337,2.25955984981305
SHP-77,439501,-1.6083465101803276
BT 359,44491742,4.570849750938812
YH-13,selumetinib-GDC-0941 (4-1 mol-mol),2.117878884448022
CAL-29,49836020,4.434653881531219
RCC10RGB,24180125,2.398663234613943
CGTH-W-1,54618164,4.475524470506254
DMS 114,10296883,4.0850638557883165
DB,9911830,1.738432800307682
HCC1195,136227924,3.859466477996048
SUP-M2,6505803,-1.2925324333028148
NCI-H2009,107985,-3.3237358160703843
253J,135875424,3.6390829141774934
SET-2,46943432,0.0852924787187384
BT-16,246676,5.246852938804325
BT 112,selumetinib-GDC-0941 (4-1 mol-mol),3.393388864496841
BT 440,tanespimycin-bortezomib (250-1 mol-mol),-2.7167133192176394
8505C,selumetinib-GDC-0941 (4-1 mol-mol),0.125719667045265
NCI-H650,26596,-0.9939630725117288
GOS-3,107985,-2.049266528770901
DoHH2,5460769,1.245270036002789
LOX-IMVI,selumetinib-GDC-0941 (4-1 mol-mol),1.2506716089378382
ZR-75-30,44491742,3.706511746773907
PLC/PRF/5,JQ-1-carboplatin (1-1 mol-mol),5.5351057973107505
G-361,148198,-1.9326173225508625
EFO-21,107985,-3.293348677001705
HCC2108,5460769,1.78766929460534
HCC4006,10296883,4.182376901779113
NU-DUL-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.5711505169578749
NCI-H2052,11404337,-0.3501167429878626
SK-MEL-1,9926054,2.8910201246716403
KG-1-C,136227924,2.6958486075351944
COLO 741,sirolimus-bortezomib (250-1 mol-mol),1.7364314358901989
OC 314,262093,2.2402315645095054
NCI-H889,6610216,3.663657334895107
HeLa,409805,3.8139652884767377
PE/CA-PJ41 (clone D2),11404337,1.298340763398175
BT 159,6505803,-0.0386292738928562
NCI-H747,9927531,5.010482166224782
IGR-37,11404337,-0.93778882861888
BT-12,262093,3.0128893223100333
HCC78,148198,-2.104540151198766
Rh30,159324,2.8052037123345572
SU-DHL-1,54618164,3.660876980117255
Tm87-16,selumetinib-GDC-0941 (4-1 mol-mol),0.1421801276665628
T84,148124,-4.089534404816918
NCI-H2029,26596,-1.020700117051714
HuT 78,107985,-4.626222476681204
NCI-H2087,136227924,2.807670387816286
AGS,44493528,4.404376645123692
KMS-26,11404337,-1.1990569021181443
BT 340,5460769,6.248142012309782
RL,3136844,3.8863104855377055
MHH-CALL-4,3689413,-0.1881082259185382
G-292 clone A141B1,11404337,1.6382299378859118
NCI-H1703,6610216,3.962286374366853
BT 145,262093,2.5646715988074917
DU145,9927531,4.922928089289864
LS123,10296883,3.5438428207771495
NCI-H889,409805,5.162454720252358
KNS-42,44493528,4.291598351645838
8305C,24180125,2.6212256046987052
SNU-1,135875424,2.684613740830041
JHH-1,148124,-4.284532449604465
SNU-899,selumetinib-vorinostat (8-1 mol-mol),2.6583170354453047
HCC1588,tanespimycin-bortezomib (250-1 mol-mol),-0.9414361012739926
CAL-12T,159324,3.872891724538248
LS180,9903786,2.2166672873522857
TC-71,262093,3.008445971803391
RERF-LC-MS,9903786,2.6182355767545213
SK-N-BE(2),262093,1.809319637639724
KMS-12-BM,439501,-2.5993845366115016
HCC2108,selumetinib-GDC-0941 (4-1 mol-mol),1.612699878393228
IGR-37,9926054,1.73801540894826
HEC-1-B,sirolimus-bortezomib (250-1 mol-mol),1.0526143004361572
TUHR10TKB,54618164,4.212884900845848
COLO 829,107985,-3.859000290830783
GSS,3689413,-0.0459197992618788
HCC1419,10296883,3.973664807604541
RCH-ACV,selumetinib-GDC-0941 (4-1 mol-mol),0.9468989618385945
A-172,selumetinib-GDC-0941 (4-1 mol-mol),2.629230075004273
SNU-899,135875424,3.6622876573155336
HPB-ALL,54618164,3.7864801195183704
SNU-738,9936388,-4.72034190751593
ChaGo-K-1,3136844,3.608639859706436
U-937,tanespimycin-bortezomib (250-1 mol-mol),-0.8253884714136634
SNU-475,148124,2.975733678575542
Caki-2,54618164,4.240331615220768
LOX-IMVI,159324,2.6537923363600937
HuG1-N,136227924,2.3836679865505332
KMM-1,9936388,3.2700380564057543
BT 320,6610216,4.229919303269505
JHUEM-1,11485656,1.8254780068900092
NU-DUL-1,6610216,3.840354315421099
JeKo-1,JQ-1-carboplatin (1-1 mol-mol),1.2993795236120171
MIA PaCa-2,11485656,1.8953661577719088
NCI-H1869,135875424,4.489996634847175
D283 Med,44491742,3.738153910971064
KE-37,46943432,0.342927335586204
KYSE-30,409805,5.989157547538198
DU145,6505803,2.9308640693327126
YAPC,9926054,1.8358643335634888
CAL-12T,135875424,4.193322146667977
KYSE-180,148198,-3.2204698770091653
LoVo,9926054,1.9069881185353632
HARA [Human squamous cell lung carcinoma],3689413,3.203435099189031
LMSU,9927531,5.404187778104352
LCLC-103H,9926054,2.81223402195442
RPMI-7951,159324,3.4055874402556725
CAS-1,44491742,3.9814120844096386
EFM-192A,168313200,2.8329755718004845
CAL-54,9927531,5.326263652959217
HDQ-P1,439501,-2.3169119812080794
NCI-H1373,246676,4.432877121602685
TE-4,JQ-1-carboplatin (1-1 mol-mol),-0.4679949874900955
NCI-H522,262093,3.0660845932794656
SNU-466,46943432,0.8744733602203646
HMCB,3689413,1.1423939419443525
Peer,8515,2.413065162773513
SW1353,159324,5.365297966496093
OAW28,439501,-0.9322268226633188
SW1417,11404337,-1.4535869227082985
Rh30,JQ-1-carboplatin (1-1 mol-mol),0.2476583684107503
BT 172,selumetinib-vorinostat (8-1 mol-mol),1.8698207880631204
SK-HEP-1,409805,5.808157500863876
NCI-H526,3689413,-2.6230284067277725
SNU-61,9911830,2.7749851076050187
KMRC-1,9903786,4.024109374851969
YD-15,6505803,-2.549779097055298
KE-39,9911830,2.572250482212608
HMC-1-8,246676,4.4072237241276975
TE-15,12003241,-1.6215722433150963
HSC-3,sirolimus-bortezomib (250-1 mol-mol),1.8734787499367431
U-118MG,262093,3.0545033004696203
KYM-1,10322450,3.05782537023932
MG-63,100016,6.791496028485962
NCI-H727,selumetinib-GDC-0941 (4-1 mol-mol),-1.3460907005826803
NCI-H358,3136844,4.075159385416372
COLO 829,sirolimus-bortezomib (250-1 mol-mol),0.4169423726863133
RPMI-8402,107985,-3.808655830164077
AsPC-1,135875424,4.124114476494282
RCH-ACV,3136844,3.5130213724261647
DLD-1,136227924,3.626313463652563
HSC-3,6505803,-2.979370598270903
KMRC-20,6505803,2.060614018584274
CJM [Human melanoma],44491742,4.278888606986291
HCC38,5460769,2.8026336362460307
CHP-212,10296883,3.383005137854127
SNU-840,409805,5.492227436828679
A4/Fukuda,100016,4.8831896191852096
KYSE-180,24180125,4.03262772641334
HCC2935,sirolimus-bortezomib (250-1 mol-mol),0.5945661645124948
MPP 89,148124,-4.406901923278282
KYO-1,54618164,4.4035881094936125
TOV-112D,10296883,4.52965667337078
JURL-MK1,409805,3.64663874719319
IA-LM,9936388,2.150111055311291
NCI-H522,10322450,3.5945001970925787
IM95,11485656,1.1906630822338928
NCI-H1339,9911830,3.231454639260267
LAMA-84,9903786,1.7036046577565669
SF126,9927531,4.99089280929888
NCI-H1435,selumetinib-GDC-0941 (4-1 mol-mol),1.0023239879000474
SW982,135875424,6.1479470083270735
COV644,11404337,-1.0337314183791615
NCI-H1155,36462,0.801473469069013
BFTC-909,selumetinib-GDC-0941 (4-1 mol-mol),1.742559417066922
Ri-1,selumetinib-vorinostat (8-1 mol-mol),1.7453072919465344
SNU-8,12003241,-0.8120802877527198
SU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),2.071258944893258
JHUEM-3,selumetinib-vorinostat (8-1 mol-mol),1.9362671719924216
BT 422,135875424,2.9816233876655387
CCK-81,selumetinib-GDC-0941 (4-1 mol-mol),1.1249387686067662
NCI-H1651,3689413,1.2718647351965997
Sq-1,46943432,3.156596182557323
EJM,3689413,-2.394173462666658
SNU-245,11485656,2.4335561364098073
BT 428,9926054,1.9432227600739695
Hs 611.T,10296883,2.1070249605904574
KYSE-30,54618164,4.68504508642832
Rh41,148198,-4.585289739604842
KP-N-YN,9927531,3.406811023385209
SF268,54618164,4.349289633289385
Ri-1,10296883,1.1182456491009578
KMS-18,54618164,3.80046237886975
JeKo-1,148198,-5.137467449260085
NCI-H1435,5460769,2.24942337838163
SNU-668,sirolimus-bortezomib (250-1 mol-mol),1.8089907805416063
8305C,sirolimus-bortezomib (250-1 mol-mol),0.6983572372591207
COLO 668,168313200,1.8456785422114392
HCC2279,439501,-2.2925635815610006
SNU-685,6610216,4.175803994793872
NCI-H650,159324,3.050208255297658
BC-3C,107985,-3.218950986835144
EHEB,9926054,1.8810570858595552
SNU-216,10296883,4.064330575642344
Detroit 562,sirolimus-bortezomib (250-1 mol-mol),0.7815437350354109
BV-173,JQ-1-carboplatin (1-1 mol-mol),-0.3456077598653477
NCI-H2009,5460769,1.3316086312624285
KYSE-450,148124,3.78473118264584
Ishikawa (Heraklio) 02 ER-,246676,3.9831360741159463
HCC38,409805,3.899400540305636
TT,tanespimycin-bortezomib (250-1 mol-mol),-0.7119220274254645
BT 172,10322450,4.417951286359916
CAL-12T,11485656,1.8742108242710025
CL-11,11485656,2.5570502281521263
5637,9926054,2.1895240062195396
JURL-MK1,6505803,-3.009657758249373
LMSU,107985,-1.9062813049718328
MKN7,9903786,5.918197098229428
NU-DHL-1,6610216,3.849394820990355
VMRC-RCZ,11404337,1.035796097984766
SCC-9,9926054,1.898935947612019
RPMI-8226,409805,3.8617443671491847
G-292 clone A141B1,8515,4.326693177509201
A101D,selumetinib-GDC-0941 (4-1 mol-mol),0.5924729203046659
PaTu 8988s,44493528,4.319224054149941
HEC-265,159324,3.632221551836653
WSU-DLCL2,6505803,-0.444395871025773
NCI-H2405,148198,-1.980170877151075
CAL-33,9926054,1.6426139792956471
BT 245,100016,6.42627295768896
HCC1954,262093,2.719302502923702
SNU-601,selumetinib-GDC-0941 (4-1 mol-mol),-0.2622654032095929
CAL-85-1,409805,3.2736432155675983
Fu97,12003241,-1.5366115434948442
769-P,6610216,4.7962180972248385
NCI-H2141,148124,-3.613831420136023
PK-59,10296883,3.535365595306604
BT 504,9926054,1.7523750045888775
L3.3,135398744,6.452563021638662
SW1088,sirolimus-bortezomib (250-1 mol-mol),0.8011613247197977
KNS-42,6610216,4.822184289035433
OCI-AML-3,44493528,4.354469059332478
BT 333,9936388,1.082637149291879
Capan-1,439501,-1.7438578400457687
VMRC-RCW,11404337,-0.70484816503425
HPAF-II,262093,2.839576376925405
SNU-449,3689413,-2.168376107627999
QGP-1,107985,-2.5717210871655203
Panc 10.05,409805,4.8204171361213906
T3M-10,54618164,3.850562433335668
DMS 114,6610216,4.687724609368201
SW948,tanespimycin-bortezomib (250-1 mol-mol),-2.5529889563934693
IGROV-1,409805,5.990596261907717
HOP-62,selumetinib-vorinostat (8-1 mol-mol),1.8094917487163475
KM12,54618164,4.266874999580224
NCI-H1105,44491742,3.93837449237457
C2BBe1,44491742,3.6465315929226967
SU-DHL-1,44493528,3.922242735424854
SH-10-TC,10322450,5.299988243449435
LXF 289,439501,-1.653941874457911
LOX-IMVI,262093,3.0192087839524433
BT 179,148124,-4.247300823001868
MOLP-8,262093,0.615798330418347
NU-DHL-1,11404337,-3.826325924415509
JK-1,sirolimus-bortezomib (250-1 mol-mol),0.507486963529962
NCI-H810,136227924,1.6901408020045232
TE-11,selumetinib-vorinostat (8-1 mol-mol),3.801977692651704
M059K,9903786,3.785857349201863
SNU-685,6505803,1.7815345104431104
NCI-H2291,262093,3.0616783331233197
NUGC-3,9926054,1.9670154065403471
SNU-620,11404337,0.4407908814780362
MOTN-1,10322450,3.6897160275286343
OVCAR-4,selumetinib-GDC-0941 (4-1 mol-mol),3.050941054620586
JHOC-5,439501,-1.8314674512872349
MKN7,6918878,5.285486998011433
NH-6,8515,3.897866563890799
T24,5460769,2.1302621758873435
OAW28,11404337,-1.5682838378564492
AGS,136227924,3.766909782373439
CFPAC-1,6610216,4.540388472392638
NCI-H1373,100016,4.430083600999957
TE-6,6505803,-2.104083305056956
LXF 289,9936388,-5.793518221083613
JM-1,46943432,-0.1491870155181681
BT-549,11485656,2.9441987555380855
SW1088,6505803,-0.5883716848555307
MDA-MB-157,148124,-6.016678597172854
OE19,10296883,4.248743663804576
Hs 578T,6918878,0.8422560555688274
LS123,44491742,4.080361644542357
KHM-1B,12003241,-0.9345261470540068
OCI-Ly10,9911830,3.818058704017732
AU565,26596,-1.0644098452654434
GI-1,JQ-1-carboplatin (1-1 mol-mol),0.4755278036860928
TE 617.T,8515,3.600809985804118
RS4;11,262093,0.7375601612159237
BT-16,24180125,2.577165097149746
SNU-61,12003241,0.1572719330395487
BT 440,6505803,-2.620705612839711
SW620,selumetinib-vorinostat (8-1 mol-mol),2.4747661815342306
FTC-238,6918878,2.177284581444065
AU565,12003241,-0.6235660341918571
NCI-H661,selumetinib-GDC-0941 (4-1 mol-mol),1.8607941121872416
HCC2108,6505803,-0.7557590797286265
GP2d,135875424,3.142612243202518
DMS 53,135875424,3.815847763190564
HOS,8515,4.704557853558991
EPLC-272H,148198,-1.1949908417722128
MOLT-13,11404337,-0.8509497692060022
BT 164,3689413,-2.3779302902052444
SK-BR-3,100016,6.79119351825136
Rh41,100016,7.167579216403683
NCI-H1755,11485656,2.6347035901065654
HEC-6,24180125,2.2718626747698383
HCC1954,135875424,3.784549105915095
Capan-2,135875424,4.579171720877857
U-87MG ATCC,409805,6.211942294277447
A-375,12003241,-1.2978704743837648
HCC2279,26596,-1.3902688555824585
HSC-2,5460769,0.0073733744403826
BT 286,10322450,5.184244057340175
OC 314,6505803,-0.2710007878606607
SK-N-MC,tanespimycin-bortezomib (250-1 mol-mol),0.3614874661050979
SET-2,135875424,3.0388135878797833
KYSE-510,26596,-0.7866712659714874
A-172,49836020,6.443724072404216
SEM,107985,-4.245084684067336
HuNS1,tanespimycin-bortezomib (250-1 mol-mol),-0.352087837441777
SNU-213,tanespimycin-bortezomib (250-1 mol-mol),-0.03636038337738
SNU-410,26596,4.2924060391829935
GSU,100016,6.3262103117900805
HCC1419,44493528,4.295803201146447
JHH-1,168313200,3.802482776709686
BV-173,409805,3.938623385027597
KO52,8515,2.033649946407287
BT 416,44491742,4.3969888889672415
HPB-ALL,44491742,4.0686707496415835
H-STS,44493528,4.270078015163244
SUP-HD1,tanespimycin-bortezomib (250-1 mol-mol),-0.2470989811885863
UO-31,9927531,3.0316635123485693
HEC-50B,9903786,4.880358665703779
L-363,439501,-2.2383513664350394
DK-MG,selumetinib-vorinostat (8-1 mol-mol),3.2742327803422757
EB1,6610216,3.5568648182048523
SCC-4,168313200,1.7103812894013133
JVM-2,12003241,-4.468160768320854
SF539,168313200,1.6661816240555782
NCI-H1694,135875424,2.6288634269875075
SU-DHL-10,46943432,0.4674442611482768
Ri-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1783875799681585
Reh,159324,-2.447992261106491
DMS 53,24180125,3.220936237072825
RKO,409805,3.580644131410829
SK-OV-3,12003241,-1.2313805329375749
Hs 852.T,11404337,0.7011610270367453
IGROV-1,54618164,4.2184521751950115
NOMO-1,159324,1.6027654254866297
Karpas-422,148198,-3.5709854147128843
HCC827,12003241,-4.000089472829944
KNS-62,135875424,2.885043849551813
MCAS,409805,5.6817502143710685
LN-18,107985,-3.4646422995384283
SU.86.86,selumetinib-vorinostat (8-1 mol-mol),2.278542875052656
TF-1,136227924,2.8858592548660766
SNU-61,selumetinib-vorinostat (8-1 mol-mol),-0.9807970774294382
RCH-ACV,100016,4.052738843081589
JVM-2,36462,-2.228443710611506
FaDu,9936388,1.704724007289382
HCC2935,44491742,3.357572958697748
HOS,selumetinib-GDC-0941 (4-1 mol-mol),2.6717134852728264
COLO 678,6610216,4.078758372603592
BICR 22,439501,-2.4052901035443
NCI-H2170,12003241,-0.7011198558518746
SNU-423,6505803,0.7785757061169877
HCC1588,11404337,-1.2064927748047265
OE21,136227924,2.0991161235844404
VCaP,JQ-1-carboplatin (1-1 mol-mol),-0.2826597777645429
HuCC-T1,8515,3.548265730968943
KE-37,73707440,6.056087509809561
SCC-25,selumetinib-vorinostat (8-1 mol-mol),1.0923234996305136
HEL 92.1.7,selumetinib-GDC-0941 (4-1 mol-mol),3.657513004741347
LoVo,135875424,3.182508442374063
KMS-28BM,12003241,-1.6881209255451883
SNU-1272,selumetinib-GDC-0941 (4-1 mol-mol),3.373247687277942
SF539,10296883,3.7658288303305976
BT 444,11404337,0.6214326786633448
KP-4,sirolimus-bortezomib (250-1 mol-mol),1.5699611904925963
SK-N-SH,10296883,3.689781558622769
HCC2218,11485656,1.6045404853234653
CAL-51,3689413,0.5709426612715743
G-402,9936388,3.284430890401921
SU-DHL-1,6505803,-0.92520479323989
BFTC-909,24180125,2.699370118217823
SW1783,8515,3.491142478274941
KNS-81,9911830,4.481974457035793
U-118MG,9926054,1.9994289810495935
BHY,12003241,-1.9102935005607824
Calu-1,100016,7.639038839177244
GCT,9936388,-4.326749507903357
IM95,54618164,3.6786593466115063
KYSE-180,44491742,6.4799420322622305
HT-144,tanespimycin-bortezomib (250-1 mol-mol),-0.8683575179427937
Kuramochi,44491742,6.028956148879381
HPAC,409805,4.12816985614744
NCI-H1944,6505803,-2.861840554451695
TE-15,439501,-2.48025284068881
EBC-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.174699743525061
Hs 729.T,262093,3.080256577751834
OAW28,5460769,4.044755256654475
CAL-33,439501,-2.9579708224622423
SNU-1079,9936388,-2.1340211532610636
T98G,8515,4.706991436731757
HCC366,439501,-0.4382794174763856
ME-1 [Human leukemia],3689413,-2.217252079013703
SU-DHL-8,168313200,3.8526529776928498
NCI-H747,3689413,-2.2954703648292605
HCC1937,11404337,1.0839462166923302
KALS-1,135875424,3.665008490823154
SK-LMS-1,136227924,4.704854352606181
RL,168313200,3.374202089321372
A-375,JQ-1-carboplatin (1-1 mol-mol),5.457971854061129
REC-1,8515,2.9172768808189096
RKO,5460769,5.660789679983863
BT 428,262093,2.2051737857299547
NCI-H23,409805,3.610834753190227
KMS-34,3136844,3.024659898797926
Hs 578T,136227924,2.600789152961688
TM-31,6505803,1.056244562382091
DEL,tanespimycin-bortezomib (250-1 mol-mol),-1.3033090305095067
SK-N-BE(2),9926054,2.2939851330117413
HEC-59,selumetinib-GDC-0941 (4-1 mol-mol),2.1993787414132675
TCCSUP,107985,-3.010766846655704
OPM-2,26596,-3.75281027154887
MEC-1,26596,-1.4944057602934653
NCI-H1703,49836020,-2.068142260286603
NCI-H1694,3136844,3.753139581975466
OCI-Ly10,11404337,-0.1929706540387932
EFO-27,10296883,4.235346466258499
M059K,sirolimus-bortezomib (250-1 mol-mol),0.4105527890909189
T-47D,tanespimycin-bortezomib (250-1 mol-mol),1.663799380230643
Calu-1,44491742,5.4818200754646
UM-UC-3,11404337,0.461237449604962
KP-2,9936388,2.471423235540368
BT 139,12003241,-0.7824976089919207
NCI-H1869,9936388,1.425696213804551
G-361,24180125,4.598924085949766
PaTu 8988s,6610216,4.229616892314871
BT 328,409805,5.840944403536212
TT2609-C02,sirolimus-bortezomib (250-1 mol-mol),1.6449110161663607
MDA-MB-468,135875424,4.133730456333857
TE-11,9911830,1.9048813646783824
YKG-1,107985,-2.4631339535317993
L-428,439501,-3.0695670825388848
RVH-421,44493528,5.192740669556376
DMS 273,3136844,4.133948633698644
SUP-T11,selumetinib-GDC-0941 (4-1 mol-mol),2.192774933353548
OE33,12003241,0.2230817721074321
SR,sirolimus-bortezomib (250-1 mol-mol),-4.8079752577906625
MES-SA,3136844,4.166331272428966
OE21,10322450,4.259055597018236
MM1.S,sirolimus-bortezomib (250-1 mol-mol),-3.4112466986615475
KNS-42,11485656,3.6641636837314873
HCC2279,6610216,4.631099276458667
EoL-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.0548301208208537
NCI-H1915,6610216,4.005015250332215
HCC1438,9926054,1.860816529304143
COV644,246676,1.7961225471603073
BT 248,409805,5.374494739188799
KMS-20,9903786,1.7377090782754483
NCI-H2170,409805,5.700788165859039
GDM-1,selumetinib-GDC-0941 (4-1 mol-mol),1.4015630537734989
JHOS-2,439501,-1.7810659698963345
UACC-62,107985,-2.9026849237328056
NCI-H2141,9927531,4.975438094968349
DK-MG,9936388,-7.3302132848609665
Hs 936.T,100016,5.806135174623166
Hs 822.T,selumetinib-vorinostat (8-1 mol-mol),4.7546424855856175
HuH-6,9936388,0.7826739866684046
NCI-H196,409805,4.55561469724075
NCI-H2126,selumetinib-GDC-0941 (4-1 mol-mol),2.896687453534691
KP-4,107985,-3.0581190073780524
SF268,6505803,-0.4080835752334602
KMS-27,36462,-0.3122628984401899
MOTN-1,54618164,3.704812206069747
OVISE,159324,4.206537691518507
HCC1833,6610216,4.331535803824163
CAL-12T,9903786,2.474655504914218
BT 482,selumetinib-GDC-0941 (4-1 mol-mol),-0.4370874918517858
KMM-1,9911830,2.7075788823009006
KNS-62,selumetinib-vorinostat (8-1 mol-mol),2.7265872970297917
COLO 800,439501,-0.358926557493619
P12-Ichikawa,3689413,-1.803795844399087
KMH-2,26596,-2.508510760962814
TE-14,168313200,3.700677169997579
NCI-H322,5460769,4.726933223287107
HSC-3,262093,2.860040873457059
KHM-1B,tanespimycin-bortezomib (250-1 mol-mol),-0.3010055650508828
ESS-1,9927531,5.52249907084491
KP-4,148198,-2.7737316499717353
CL-11,54618164,4.087111044121258
Panc 02.03,262093,3.467425891303458
KMBC-2,135875424,3.177506278142116
NCI-H441,3689413,0.4936421850915237
COV362,3689413,0.2449279899544521
HOP-92,135875424,3.091462315962494
MEC-1,9927531,3.3122365402427816
KP-4,24180125,3.869043701331771
SK-N-MC,11404337,-1.4271046508781242
HCT 116,3689413,3.301731662910047
MEC-1,12003241,-2.6195126554486223
DOV13,9936388,-0.6150425956780249
OC 314,12003241,-2.177807668538587
Hs 294T,3689413,-2.200259258980444
SNU-1079,159324,1.9215483474213175
SK-LU-1,selumetinib-vorinostat (8-1 mol-mol),3.1775151004152327
U-118MG,9903786,4.127288494791117
Tm87-16,24180125,2.9564618948290255
JHOM-1,9911830,2.1522341035817685
HT,9926054,1.610418759813605
COLO 741,107985,-2.8349814512900062
253J,11485656,1.976874132149827
NCI-H1339,135875424,4.767141568633495
Sq-1,6610216,4.377642738532352
NCI-H1792,12003241,-0.2343490439085071
RCH-ACV,10322450,3.427971439759819
OCI-Ly19,9926054,1.6873576988098775
SK-MM-2,10322450,5.033500984762851
NCI-H2030,12003241,-1.1383124397984303
NCI-H647,JQ-1-carboplatin (1-1 mol-mol),2.369977920664563
NH-6,5460769,1.427769870137193
KE-39,3136844,4.342976017638663
TUHR4TKB,11485656,2.4946743864247467
NCI-H2196,6918878,4.601623274509383
HEL,148198,-3.399100076616297
SUP-T11,44491742,3.738526329456195
NCI-H841,54618164,3.9276782291967343
MM1.S,6505803,-0.1841114080814497
HCC1588,selumetinib-vorinostat (8-1 mol-mol),-0.2694546594396645
NCI-H2085,9911830,1.4316472600892705
COV362,262093,3.3118588999816008
SK-CO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.9815172513006872
NCI-H2196,selumetinib-GDC-0941 (4-1 mol-mol),2.5915120385322505
TE-11,100016,3.880053912311749
RCM-1 [Human rectal adenocarcinoma],selumetinib-vorinostat (8-1 mol-mol),2.2938712073349152
SCC-9,168313200,4.072126418899639
WSU-DLCL2,3689413,-4.959446620100962
T-47D,11485656,3.194758516284648
CAL-51,9903786,2.1849161121493847
COLO 668,5460769,2.9607897533404244
HuH-1,54618164,4.0584707784703635
SF268,10296883,3.944693282925585
Namalwa,5460769,2.4239066035753054
SKM-1,JQ-1-carboplatin (1-1 mol-mol),-0.9064446956996236
TE-1,439501,-0.5334953492440002
HCC15,8515,2.8931769079597767
LAMA-84,159324,1.313982035436444
JHH-2,9936388,-4.808151862711936
SW1783,9927531,4.46381053918724
HL-60,262093,1.12595796571635
SNU-1076,148198,-1.9796071848582624
AGS,159324,3.522997967735827
JHUEM-1,6505803,-0.0330531463180682
Peer,tanespimycin-bortezomib (250-1 mol-mol),-0.7923610578586646
NCI-H69,9911830,2.8600960756398868
SNU-16,262093,3.1289538389821248
TE-9,5460769,0.3621954570930285
A-549,439501,-2.483005959928592
OCI-Ly3,136227924,2.2750950031645885
Hs 944.T,3689413,0.6165521340275051
SK-MEL-3,107985,-3.869718224497346
RPMI-6666,selumetinib-GDC-0941 (4-1 mol-mol),0.4507229369642581
JJN-3,12003241,-0.0138977078234466
MOLP-8,36462,-1.3356090090333852
SNU-869,409805,5.023063229429615
NCI-H1339,6505803,-2.1203038529931857
BV-173,36462,-3.0716079120235147
KMS-26,54618164,3.749169095828711
TTC-709,11485656,2.1468859036039327
22Rv1,9936388,-6.447034824270601
WM88,409805,5.795816552441705
BT 504,168313200,1.7545727786068688
DU4475,135875424,3.0079145369477827
NCI-H23,9903786,3.588944874892838
COLO 741,49836020,-1.8257608892409716
NCI-H2286,12003241,-2.840007028807547
SNU-308,9926054,1.9749915644839853
YKG-1,168313200,2.942374611054984
Hs 578T,168313200,3.633474320966812
SNU-423,selumetinib-vorinostat (8-1 mol-mol),2.465169855614971
Calu-3,3136844,5.289717112263842
AsPC-1,107985,-4.227741895863185
NCI-H2081,8515,3.558797146048482
JURL-MK1,5460769,3.622430112813927
HT-1376,10296883,4.451130716286632
A2058,6610216,4.291634255564362
Peer,73707440,4.301856504216986
VM-CUB-1,tanespimycin-bortezomib (250-1 mol-mol),-0.9212762336148834
SF126,439501,-2.7774123769651315
CA46,3136844,3.7113001526336338
OPM-2,10296883,2.7550650350156474
Kasumi-2,10296883,1.6134498936175832
HEL 92.1.7,9903786,1.7249056875700772
HARA [Human squamous cell lung carcinoma],3136844,4.042885024123848
QGP-1,3689413,0.2348303758640308
MOLM-6,9903786,1.0024208305438098
LXF 289,46943432,1.4312531154305732
OVCAR-8,262093,3.292567047569706
NCO2,148198,-4.272732589139003
SH-4,49836020,4.187960947372796
ECC12,5460769,2.2219131741447913
SK-UT-1,36462,1.790037225485122
A3/Kawakami,12003241,0.0304416634107028
SNU-C5,10322450,3.582539499597872
NCI-H1944,135875424,3.314930841291418
KYM-1,6610216,3.835650941604875
PSN1,12003241,-0.8593243794123258
MOLM-13,44493528,3.9608078939228175
JHH-2,44491742,4.07921218281707
Reh,9911830,2.18019581180713
NH-6,3136844,4.082818005209051
OCI-Ly3,49836020,4.868556688555981
JHH-6,107985,-2.694167531262161
Kasumi-1,8515,2.586543049532785
NCI-H23,54618164,3.7047773278622778
COV434,262093,2.1356582362370897
Lu-65,6505803,-2.14133792645673
TE-10,26596,-0.9876255141372016
NCI-H747,135423438,1.6378864766896262
KE-39,100016,6.665188081944046
COLO 668,24180125,3.093687435572166
KU-19-19,12003241,-0.0608702413973226
KCL-22,6918878,1.136954815439872
RCH-ACV,136227924,2.5365542828193957
SNU-1,9903786,3.1259833622650315
253J,9903786,1.7805297403151377
JHH-2,3689413,-2.478608277030538
KCL-22,selumetinib-vorinostat (8-1 mol-mol),1.6515891446083002
HCC2935,9911830,2.2154288658991597
LAMA-84,JQ-1-carboplatin (1-1 mol-mol),0.9812608136784076
MOLP-2,selumetinib-vorinostat (8-1 mol-mol),2.2725522139570447
BT 504,148124,0.8340830795428085
NCI-H2126,9926054,2.0707718665056456
B-CPAP,11404337,-1.1633647036433346
RERF-LC-A1,107985,-2.1483108523550287
NCI-H889,12003241,4.506379405890452
SR,3689413,0.3714575249004426
PK-59,sirolimus-bortezomib (250-1 mol-mol),-0.7779015062858902
GCT,JQ-1-carboplatin (1-1 mol-mol),4.70217217207532
HEC-1-A,148124,-3.4679432039259392
SK-N-AS,10296883,4.111462357552098
NOMO-1,135398744,6.340708200805823
Namalwa,148124,-8.376959890675789
BT 179,409805,5.844677427581124
CMK,262093,3.0450317567550154
KMS-28BM,159324,2.1754109137768327
CCF-STTG1,tanespimycin-bortezomib (250-1 mol-mol),-1.580978522433375
Kelly,26596,-1.7791948075234636
CCF-STTG1,selumetinib-GDC-0941 (4-1 mol-mol),4.2264106032323445
786-O,439501,-3.5974319595711832
HL-60,sirolimus-bortezomib (250-1 mol-mol),-0.1037456225306153
RD,44491742,4.422595956491757
NCI-H1395,11485656,1.9214345391656065
KALS-1,168313200,3.0482766453888024
HPAF-II,107985,-3.421837559840437
PK-1,9927531,5.928994406522703
HSC-3,9926054,2.205728912393848
KYSE-70,148198,-2.193158047226166
SNU-398,JQ-1-carboplatin (1-1 mol-mol),3.701774883690344
OUMS-23,9926054,1.8521308155808696
HT-144,5460769,5.183826263672234
K-562,148198,-4.073315546446919
GSS,8515,3.1387042874632396
JHOC-5,9903786,4.996792602991681
KMS-18,439501,-2.5838956635173287
KMS-21-BM,JQ-1-carboplatin (1-1 mol-mol),-1.6939988291679535
HCC1500,9903786,4.21203406645071
JMSU-1,49836020,6.465700185404903
BT 286,54618164,4.321497968648174
Hs 578Bst,9926054,3.786469361001098
A2058,36462,0.7228445250033858
LOU-NH91,54618164,4.244208934703923
COLO 829,11404337,0.9914366451901834
NCI-H1755,54618164,3.712374543898709
DOV13,9911830,3.767973968860044
JVM-3,36462,-3.3738719116101743
A2780,8515,1.754639935244518
BICR 16,26596,-0.6914049107649834
MeWo,9936388,-4.455184723751584
Calu-6,49836020,4.336137767537177
HCC827,107985,-2.5128100299546574
KHM-1B,135875424,3.3101852288443276
SK-N-AS,135875424,4.067320794930689
DB,10322450,2.48234404234163
MDA-MB-453,10296883,4.2989687155614735
SNU-840,11404337,1.1450615228869434
NCI-H1975,9936388,-7.660165830996957
KP-2,148198,-4.1307782439966365
SK-MM-2,12003241,0.4022958113963022
ES-2,100016,6.579379467241575
HL-60,9927531,5.393037826630499
KU-19-19,selumetinib-vorinostat (8-1 mol-mol),1.3262473417693337
WM88,107985,-3.5954290536778526
KG-1-C,148198,-3.394740607582078
BT 172,107985,-3.8940786147439166
MOR/CPR,6918878,1.7665977976089409
Panc 10.05,9936388,0.6007373562986975
OVCAR-4,6505803,2.147472746643062
MEC-1,3136844,3.74208224738736
MDST8,tanespimycin-bortezomib (250-1 mol-mol),-0.1010970299548422
L3.3,26596,-0.871586326159775
SNU-869,JQ-1-carboplatin (1-1 mol-mol),5.110674906782879
DMS 79,136227924,2.929954381299975
TE-5,148198,-2.7916171681720567
SNB-75,JQ-1-carboplatin (1-1 mol-mol),6.178448608970183
Calu-3,9911830,2.7294588365608305
SNU-869,9911830,2.5314086207825635
OCI-Ly3,439501,-3.305238194936377
SK-CO-1,135875424,3.678629656731489
SF539,6610216,3.974614801985701
SNU-1272,409805,6.302573635067764
H-STS,5460769,1.2422964505231244
LUDLU-1,12003241,-0.5957791848083803
OPM-2,409805,3.1459770002319023
VMRC-RCZ,262093,3.1107535398689747
QGP-1,selumetinib-vorinostat (8-1 mol-mol),2.506831901126706
NCI-H1838,9911830,3.483637720340384
NCO2,3689413,-3.837216983883232
JHH-5,6505803,-2.587639781058575
697,9926054,1.6701290934346382
NCI-H1573,9927531,4.21902889327973
HCC15,44493528,4.34604946513687
SK-N-DZ,9903786,2.0344840639265787
SK-MEL-31,9926054,3.613636907383419
DLD-1,135423438,2.617658821195633
MPP 89,6505803,-0.6536237493754191
AsPC-1,12003241,0.1897400127907629
UM-UC-1,6610216,4.20419948705434
HCC15,135875424,4.57405525423842
NCI-H2170,36462,1.2877330572705072
PK-45H,135875424,5.088820558877691
KYO-1,135875424,2.9941253538881925
HCC1419,24180125,3.0714283426147913
HT-144,262093,3.242537447174441
WM88,6505803,-1.994136504003607
JL-1,10296883,4.327951566443025
HCC1171,262093,3.491139872179752
NCI-H2122,26596,-0.3703174924227287
RVH-421,439501,-0.8524727848852272
AML-193,selumetinib-vorinostat (8-1 mol-mol),0.1935247845364687
EoL-1,136227924,1.175653355009707
ZR-75-30,135875424,4.922735562927052
CAL-120,409805,5.416377125024685
SNU-466,tanespimycin-bortezomib (250-1 mol-mol),-4.621211093162312
NCI-H841,9927531,4.161760245261401
KE-97,12003241,-1.757079073884842
SK-CO-1,8515,5.207883928071115
HCC2279,54618164,3.781364659048129
MOLM-13,136227924,1.704251401840426
BT 416,409805,6.33771322760139
SYO-1,5460769,-0.8579503639796162
CL-11,439501,-1.1528361936308975
Mono-Mac-1,9926054,3.1061890381784187
T3M-10,9936388,1.68149243193284
HCC1954,44491742,3.88484853713588
OCI-AML-3,selumetinib-vorinostat (8-1 mol-mol),-2.4724160390070775
253J,9926054,1.3748639406347178
COLO 668,100016,7.809114037996309
D283 Med,sirolimus-bortezomib (250-1 mol-mol),0.1311503224086672
SNU-C4,44491742,4.387584080211158
SU-DHL-1,107985,-3.306496987383706
BT-12,11404337,-1.312123383148081
SNU-1214,46943432,1.6748160233466023
TE 617.T,49836020,3.775264114601375
HSC-2,sirolimus-bortezomib (250-1 mol-mol),0.058005047365845
BHT-101,3689413,0.1910629182476014
COR-L88,selumetinib-GDC-0941 (4-1 mol-mol),4.210918027029114
BT 440,148198,-3.676636651938413
LS513,54618164,4.0573753164291615
EBC-1,54618164,3.221465025886113
BT 359,tanespimycin-bortezomib (250-1 mol-mol),1.7721099348871308
769-P,9903786,3.979605140448373
NCI-H2172,9911830,3.117247767846657
KMRC-2,3689413,-1.0505298927618916
SNU-1214,JQ-1-carboplatin (1-1 mol-mol),3.0225618728899675
SNU-C2A,262093,2.4515351463373807
NCI-H1869,sirolimus-bortezomib (250-1 mol-mol),0.1597527928454194
22Rv1,6918878,2.1738033239270096
Hs 578Bst,11404337,-1.6472861367813505
EPLC-272H,selumetinib-GDC-0941 (4-1 mol-mol),-0.4942695564653549
LOX-IMVI,148198,-2.445772941232649
SJSA-1,439501,-2.834147074322405
SET-2,36462,0.7834835963268753
KYSE-450,107985,-2.5991622295290413
A-375,36462,2.2806967665334894
BT 147,8515,3.830553244560158
MIA PaCa-2,9903786,3.251255785633491
NCI-H446,sirolimus-bortezomib (250-1 mol-mol),0.5863083212438859
NCI-H1703,10296883,3.9122809054247054
NCI-H838,12003241,-1.6819169768090954
SK-N-SH,9926054,1.7311235151913027
SU-DHL-10,11485656,2.298266624508031
OVCAR-8,246676,4.456779412413474
NCI-H1105,409805,3.478082900897108
Hep 3B2.1-7,9936388,1.3594944323688356
MHH-CALL-3,44491742,4.228181381617403
SK-MEL-31,11404337,-0.7650509670659701
COLO 800,selumetinib-vorinostat (8-1 mol-mol),-0.4443681516533044
SNU-869,107985,-4.294928990441944
Daoy,3689413,-2.377724406680773
A101D,136227924,2.7929516463081123
769-P,12003241,-0.850847726914325
NCI-H2172,11404337,1.861894071580906
PF-382,8515,3.0389731440801224
HOS,3136844,3.972847722675054
UACC-257,54618164,4.3515064934854095
WM115,12003241,-3.303596686294694
Ishikawa (Heraklio) 02 ER-,6918878,3.724210290974002
Reh,26596,-2.983938152417055
SNU-1272,11485656,2.6947903691441795
RT-112,9926054,1.990332375678948
Hs 611.T,tanespimycin-bortezomib (250-1 mol-mol),0.1632190347218379
EFO-27,36462,3.079082429258617
KMS-26,6918878,-0.5863995655952686
NCI-H2405,11404337,0.6998100573495162
PE/CA-PJ49,44493528,4.271726954290608
HuNS1,12003241,-0.810335190638815
SW620,159324,2.851268234917908
NCI-H2444,9903786,4.235157669098579
DEL,136227924,2.1995562608544494
TE-6,8515,4.062611311857455
Tm87-16,49836020,-0.9947449056575012
T24,11404337,0.0422226925382746
Aska-SS,9926054,1.7306138768842658
Ri-1,5460769,1.1375471412538625
HCT 116,sirolimus-bortezomib (250-1 mol-mol),1.7104818148268468
HSC-4,36462,0.7755986988683452
NCI-H2170,6505803,-0.4260199985432408
DMS 273,100016,5.677769516399485
697,11485656,1.0677587184410018
TE-1,selumetinib-GDC-0941 (4-1 mol-mol),3.018112465414828
LOX-IMVI,12003241,-2.813518393614124
FaDu,9927531,4.819445610620238
CAL-78,selumetinib-vorinostat (8-1 mol-mol),2.749764405209418
BC-3C,3689413,4.931170730107947
U-87MG ATCC,11485656,3.26618514793835
Hs 944.T,26596,-1.3336328172357843
U2OS,136227924,2.232158663555595
COR-L105,tanespimycin-bortezomib (250-1 mol-mol),0.350179088814853
SHP-77,6505803,-0.6748725536499449
KE-39,44491742,3.945663107977575
HPB-ALL,3136844,3.5913479818101792
NCI-H810,107985,-3.977106637098994
SNU-61,439501,-1.3808373898758073
YD-8,9926054,2.068126295394322
SNU-840,135875424,4.211396947721992
Ci-1,9927531,4.406404304601132
JeKo-1,selumetinib-vorinostat (8-1 mol-mol),2.4453871376323955
KATO III,168313200,2.8684670433977293
SK-MEL-30,11404337,-1.0604812670426378
TOV-112D,12003241,-0.8504182456561812
ONCO-DG-1,12003241,-0.5849918543503058
ST486,sirolimus-bortezomib (250-1 mol-mol),-0.4662724333620547
SK-N-MC,168313200,3.837504051506091
NCI-H661,3689413,0.5447440822016135
GA-10,148198,-7.740276698759935
NB4,3689413,-2.3833174829698085
A-253,262093,2.9926889319530736
BT 232,3689413,-0.4723000491663335
NCI-H1915,135875424,4.440187270311882
COV644,24180125,2.7546946002955024
COR-L51,11404337,-0.9884929367070868
DOV13,selumetinib-GDC-0941 (4-1 mol-mol),3.389057426499923
NCI-H1869,10296883,4.447785026459559
COLO 668,12003241,0.007541298710802
OVCAR-5,46943432,6.399067985837115
HuCC-T1,54618164,4.328486254050945
BT 239,JQ-1-carboplatin (1-1 mol-mol),2.368101123229976
WM266-4,11485656,1.8350601891994096
NCI-H1341,54618164,2.6162570827682483
A3/Kawakami,3136844,4.207371856570791
NCI-H1915,136227924,2.449863082820113
LAMA-84,selumetinib-vorinostat (8-1 mol-mol),0.1963960485996854
LUDLU-1,10296883,3.7997906540073623
SCC-9,12003241,-1.125345709331217
NCI-H2405,selumetinib-GDC-0941 (4-1 mol-mol),-1.6328323472989523
TT2609-C02,3689413,0.4383684388125656
Hs 888.Lu,49836020,4.832752015410737
SW579,9903786,2.7100621017301516
CAL-54,3136844,4.481056684706584
SNU-81,439501,-1.707157001292212
HEC-59,262093,2.7698106992927007
ACHN,3689413,-2.388175172833965
Rh30,246676,4.974323438581708
BT 328,168313200,2.3539430397400523
Hs 294T,100016,6.337209257885702
LOU-NH91,36462,3.2256365983613677
A-172,6505803,0.7314329706083597
HL-60,46943432,1.262475604488991
SNU-1214,409805,4.003952928265266
NCI-H2196,9911830,2.2031508018887775
HCC95,409805,5.412444434020308
MKN74,6918878,3.272631722188731
SU.86.86,54618164,4.265820025060501
G-401,409805,3.720272745750916
KMS-12-BM,3689413,-2.359728446736426
LXF 289,6610216,3.700752852024682
BICR 22,tanespimycin-bortezomib (250-1 mol-mol),-0.7202446559484896
Hs 852.T,100016,3.86747930561629
SCC-4,9903786,2.916722616299938
EPLC-272H,262093,2.6585734964122576
NCI-H1395,8515,4.661084548760473
HSC-4,409805,5.399675964474335
SNU-503,3689413,0.9941235992839832
SNU-466,12003241,-1.792822949683991
Daoy,9903786,4.877795508066272
BFTC-909,44491742,4.0640318167931255
SNU-1079,136227924,2.5648904820695693
MFE-296,9926054,1.7629319837489352
KCL-22,26596,-1.6030605550543997
DU145,9926054,1.942219630113699
KMS-20,136227924,2.296093636743899
AN3-CA,135875424,2.655467292479818
HCC1428,54618164,3.90789130284992
HMCB,JQ-1-carboplatin (1-1 mol-mol),2.516859123575671
MPP 89,36462,2.681597486796125
Peer,107985,-3.546191160246613
HH [Human lymphoma],6610216,2.9617433337623256
MHH-CALL-4,26596,-1.7349356502662407
NOMO-1,439501,-2.35226533453039
Kasumi-2,168313200,3.5619242662151342
DEL,26596,-2.2766928538396916
BT 245,selumetinib-vorinostat (8-1 mol-mol),2.5548993263736235
RERF-LC-MS,6610216,4.063402980130349
GSU,11404337,1.2682774414342974
HuNS1,9903786,1.9338093787028072
MHH-CALL-4,selumetinib-GDC-0941 (4-1 mol-mol),0.3640668336330579
SF126,tanespimycin-bortezomib (250-1 mol-mol),0.701676185557571
AsPC-1,5460769,5.795061807453513
KMS-34,10322450,2.8971491774933553
KMS-18,6918878,3.5372333180175093
COLO 792,8515,3.901097239936766
OPM-2,36462,1.377546018006998
KMRC-3,26596,-1.545617580729079
EFO-21,168313200,3.134269131890617
IGR-37,409805,5.961933065604735
SNU-61,54618164,4.021673833793196
M059K,10296883,4.043900698661033
OCI-M1,9911830,2.240767531955393
Lu-99,9926054,1.653362823410905
OV-90,168313200,3.885761361931424
NCI-H727,11404337,0.8145711342672778
NCI-H446,6505803,2.330935427354621
LOX-IMVI,9903786,2.476339692878584
MOR/CPR,54618164,4.108199329752357
NCI-H358,9927531,4.779825407302033
NCI-H661,6918878,1.4921814323330362
Li-7,6610216,3.269081187832887
RERF-LC-Ad1,409805,6.089650612893954
NCI-H2170,44491742,4.021640872612266
DMS 53,107985,-3.9095415440862458
SNU-308,9903786,2.008516122429012
AGS,6918878,1.9630116013802144
CAL-12T,9936388,-2.4849922514623417
NCI-H211,tanespimycin-bortezomib (250-1 mol-mol),-2.6494968987318517
G-402,262093,2.972927806454912
MOR/CPR,136227924,3.350851412370925
EFE-184,3689413,0.8995807831619225
IGR-37,24180125,4.183476947530839
MDA-MB-361,8515,6.307213158315527
SW982,100016,3.947877721573723
YAPC,24180125,3.806846010722946
NCI-H1155,148198,-4.37557893691535
OCI-M1,sirolimus-bortezomib (250-1 mol-mol),0.0784730767185344
RVH-421,44491742,4.40169374936578
HMC-1-8,sirolimus-bortezomib (250-1 mol-mol),1.238114753866591
OVK18,54618164,4.037525377716131
JJN-3,10322450,3.7003001259189903
LAMA-84,sirolimus-bortezomib (250-1 mol-mol),0.5037633346566652
P12-Ichikawa,11485656,2.301138805430704
HSC-3,100016,6.558832951826536
LCLC-103H,9936388,2.1573494470182593
8305C,selumetinib-vorinostat (8-1 mol-mol),1.151504245037868
NCI-N87,11404337,-0.8803091706648726
WM115,24180125,3.7433275341391057
BV-173,26596,-4.295505465502321
MHH-CALL-3,24180125,2.697623286647445
ALL-SIL,JQ-1-carboplatin (1-1 mol-mol),0.1765424524035188
HeLa,168313200,4.248438421303553
Ki-JK,135875424,2.2623198423416255
SNU-1066,sirolimus-bortezomib (250-1 mol-mol),1.8149944261171216
HuCC-T1,9936388,2.1654759502470755
WM1799,11485656,2.91398377958601
SNU-407,36462,3.691403252799668
SNU-16,135423438,0.927911457885393
P-STS,107985,-4.020719010327622
KYM-1,JQ-1-carboplatin (1-1 mol-mol),-0.1526503740959246
T3M-10,11485656,3.630524872417795
BT 245,107985,-3.2343864047016706
TF-1,12003241,-0.8942649772523563
GP2d,168313200,3.749157716830288
EFO-27,9903786,4.039986452778869
Rh18,3689413,-2.3361578419795843
MIA PaCa-2,6918878,0.9930766335426112
MM1.S,5460769,2.129502129742311
REC-1,9926054,3.5400616992055847
SNU-1066,6610216,4.76095782121934
IPC-298,sirolimus-bortezomib (250-1 mol-mol),0.7212424962654913
A101D,10296883,3.721128272051271
Karpas-422,tanespimycin-bortezomib (250-1 mol-mol),-0.3820258248934754
5637,sirolimus-bortezomib (250-1 mol-mol),0.1813560942007127
SK-MEL-31,9911830,3.904454602522244
EBC-1,12003241,0.7952037321943549
SUP-T11,sirolimus-bortezomib (250-1 mol-mol),0.9294161353730758
HT-1197,5460769,3.9110228695560223
CCF-STTG1,9936388,2.748356806633847
EPLC-272H,135875424,3.5284269616389943
SNU-738,11404337,1.0077192926024503
A-549,6610216,4.4512033607640475
SK-N-SH,11485656,1.632835295559006
HuP-T3,3689413,-1.422602865458103
Hs 888.T,49836020,6.084092385452033
KMRC-3,148198,-3.839919535883422
KP-4,262093,2.717667187094357
HEC-151,11485656,2.368331048173754
KU-19-19,148198,-3.572091199224797
TE-14,135398744,6.394251875306054
WT2-iPS,135423438,3.753455715800744
SK-N-MC,46943432,3.956950856766089
CHP-212,168313200,1.911615856976856
SNU-119,136227924,3.0573258202750253
NCI-H1623,5460769,3.63452416726077
SNU-466,439501,-2.48566817429276
NCI-H1355,136227924,5.68794295830134
NCI-H1563,168313200,1.7986120411813236
SKM-1,36462,-0.9664350566951958
CHP-212,selumetinib-GDC-0941 (4-1 mol-mol),-3.8299169042442904
HDQ-P1,9927531,5.7159143296477115
HD-MY-Z,10296883,3.8983586745084033
HL-60,136227924,2.3594265520512447
SUP-M2,409805,3.348024044810787
HuP-T3,9927531,4.952379772704904
NCI-H1915,3136844,4.371601589694127
NCI-H2106,6610216,4.1015975696039035
2004,9926054,1.8081714609693849
HT,selumetinib-vorinostat (8-1 mol-mol),2.368663443065234
NCI-H1838,6505803,1.6268298993788928
NCI-H522,12003241,-1.5672925136718587
EHEB,46943432,1.4009693182531664
NCI-H322,148198,-4.812707384343781
KMS-27,100016,3.811410813700335
NCI-H1092,148124,4.484868615111272
Raji,sirolimus-bortezomib (250-1 mol-mol),0.8276284938593903
JHH-4,6918878,1.5239216815792305
HT,5460769,1.55908415219926
KMS-12-BM,409805,3.008136654369979
Hs 578T,135875424,3.578631345262118
Panc 08.13,5460769,-0.1924357520120825
HCC2279,409805,5.199241011512385
PSN1,168313200,2.63140160708384
HCC15,36462,0.276886424919507
TE-11,54618164,3.863333055844095
Namalwa,9926054,1.683884099727144
NUGC-4,439501,-0.6746997916086527
HuH-1,9936388,0.6905848957768463
NCI-H1623,selumetinib-GDC-0941 (4-1 mol-mol),0.8054769318526331
SNU-423,10322450,4.431866174300737
MHH-NB-11,159324,-2.228668051576579
Li-7,9927531,4.31523724383209
LCLC-97TM1,11404337,-1.4043223473519348
HuNS1,168313200,3.7440498292509257
HEC-1-B,24180125,3.5721659894435556
A4/Fukuda,9903786,0.7546004224414102
A-549,JQ-1-carboplatin (1-1 mol-mol),5.034765556590292
2004,135875424,2.8234839465542967
LMSU,409805,5.989527903576905
253J-BV,107985,-8.331736502582213
Malme-3M,JQ-1-carboplatin (1-1 mol-mol),-0.4541728562567664
SNU-1079,148198,-3.7175883561835295
MDA-MB-453,12003241,-0.9610578830621354
NUGC-3,12003241,-0.6366922027749422
RKO,9911830,2.9376280530386123
SUP-T1,6505803,-0.1872119927245122
HOP-62,9926054,1.899267170249981
NCI-H28,9926054,1.6125728317603996
IMR-32,46943432,1.660440908421779
SK-N-MC,3689413,-2.3816652298923873
TYK-nu,11404337,-1.0316748871481556
UM-UC-3,6505803,-0.1078533908221657
LK-2,sirolimus-bortezomib (250-1 mol-mol),0.5771573831788563
NCI-H1355,36462,2.9773846720161696
EC-GI-10,409805,6.0332797077156455
Granta-519,44491742,4.018752292224149
KYM-1,6918878,-0.0207796172360046
BT 286,5460769,1.8515527065353563
RT-112,9903786,2.0638797497197237
OE21,36462,4.517672973298236
SU-DHL-8,24180125,1.326767036294653
OCUM-1,9926054,1.1512095062885492
VM-CUB-1,148198,-2.29434239766537
MDA-MB-435S,10296883,4.225013123345449
GOS-3,6505803,2.171469842265414
MOLP-2,135875424,4.772032025808402
NCI-H322,3689413,3.1405279208224086
Raji,44493528,4.013963979075194
253J-BV,54618164,4.233946731936071
MOLM-16,26596,-3.9817084754511782
Hs 852.T,10296883,3.5270090388531883
Daudi,136227924,1.3476403322374937
SNU-8,6505803,0.4041272460627742
LS180,9911830,2.83226076921101
SNU-8,107985,-2.480678817312735
639V,11485656,2.1157835371974287
NCI-H1581,9926054,1.914442948452832
Capan-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.340534390124913
SK-MEL-30,168313200,4.435155789562201
VMRC-RCZ,3689413,-1.2845787687356065
BT 172,9903786,4.891040343072455
HuH-1,100016,6.427674645277276
HCC202,9936388,1.0165680238121546
JHUEM-2,11404337,-1.101426517745614
JK-1,46943432,0.8611878663113326
BT-20,10296883,4.2664147255542
YD-15,9936388,-5.281829985034155
TCCSUP,44493528,4.420877523389051
Panc 02.03,9926054,1.881153725115377
MKN74,54618164,4.583505133133128
BT 328,135875424,3.085389187382682
YAPC,439501,-1.3344819600707327
NCI-H28,135875424,3.040618130997964
PC-14,selumetinib-vorinostat (8-1 mol-mol),1.2532439157087734
Panc 05.04,6918878,2.171131145634899
Kelly,44493528,4.323987981167799
IM95,9926054,1.717853214717972
HT-144,10322450,4.703374814219381
SET-2,11485656,1.7886595096067897
EC-GI-10,3689413,0.4203199772849357
SK-MEL-24,8515,5.656474730619789
BT-549,54618164,4.423974096662665
MIA PaCa-2,36462,1.2671989611626788
YD-10B,9903786,0.9692609848682356
UM-UC-3,8515,5.210153711549927
G-401,36462,-0.1566510321668276
NCI-N87,9936388,-5.070095106907016
KALS-1,107985,-2.955854025233171
COV434,5460769,0.4340369587181126
KNS-60,44491742,4.18434599527296
LCLC-103H,148198,-1.3742012361346914
NCI-H1793,107985,-3.799152046715067
EFO-21,6610216,4.722092549752213
PE/CA-PJ49,3136844,3.894534312555505
JHUEM-2,26596,-3.440401418336309
TOV-112D,selumetinib-vorinostat (8-1 mol-mol),4.502433725059984
SK-N-MC,9903786,1.1605258193445984
HMCB,148198,-4.3449695976370055
SUP-T1,11404337,-1.5860390885647615
COR-L95,JQ-1-carboplatin (1-1 mol-mol),1.8062318254958765
NCI-H322,100016,6.362238943247445
BT 179,148198,-4.821830179812891
SNU-119,tanespimycin-bortezomib (250-1 mol-mol),0.9832561237476752
HLF,6610216,4.251232152723098
NCI-H2228,159324,3.317306961688271
NCI-H2342,JQ-1-carboplatin (1-1 mol-mol),1.5439939655053172
SCC-4,9926054,1.835519091908301
ChaGo-K-1,44493528,4.285653924871417
HL-60,5460769,4.053430435515514
BT 172,9936388,-4.290165173398555
CAL-148,159324,-1.9386881161550555
HOP-62,9936388,2.1829443174265997
TUHR10TKB,9926054,2.161946529406516
769-P,36462,4.933051347758078
NCI-H1734,9903786,1.4575898804478404
RERF-LC-MS,selumetinib-vorinostat (8-1 mol-mol),2.5829848762682865
HuH-28,selumetinib-GDC-0941 (4-1 mol-mol),1.7329089617670326
BT 145,10296883,3.987169762001794
A-375,262093,2.9970202931790046
COLO 829,439501,-1.3241633043003287
LOU-NH91,sirolimus-bortezomib (250-1 mol-mol),1.6256279429010452
SU.86.86,9926054,1.8736072532544432
LS180,44491742,4.531352051294965
NU-DUL-1,6505803,-0.4706315127513403
KP-2,36462,3.367817386344384
JeKo-1,44491742,3.7422814982420056
U-118MG,tanespimycin-bortezomib (250-1 mol-mol),0.2197944792007267
MIA PaCa-2,44491742,3.8709962970987464
TE-4,409805,4.857897884045195
A3/Kawakami,135423438,3.073341155380334
Rh41,54618164,3.138182443744225
BT 328,6610216,4.43822058219873
EM-2,9903786,1.526711348749508
OVTOKO,selumetinib-GDC-0941 (4-1 mol-mol),2.323282098150216
ALL-SIL,100016,4.099229681419155
NCI-H929,12003241,-1.2414676879861424
NCI-H520,9911830,1.0152339024945511
JMSU-1,8515,2.4008483201809776
HH [Human lymphoma],10322450,2.565345423842302
OCI-Ly10,sirolimus-bortezomib (250-1 mol-mol),-9.44158843717878
KMS-18,8515,4.2274985612472715
TC-71,3136844,3.85086680688821
U266B1,9903786,3.1119057024478094
TALL-1 [Human adult T-ALL],6610216,3.5711987866823933
HCC78,107985,-2.6460024224545493
IST-Mes1,49836020,4.276541253138442
WM1799,sirolimus-bortezomib (250-1 mol-mol),0.8718810301114039
HCC44,11485656,1.7726273089694435
KYM-1,12003241,1.54362271248318
SNU-308,11404337,1.2327957985917497
COR-L95,8515,4.297389552329342
5637,5460769,-1.549780285334619
A-172,tanespimycin-bortezomib (250-1 mol-mol),0.1851985294738919
KMS-34,9926054,1.6315221733896668
NCI-H2081,36462,-1.2215520528836945
MDA-MB-157,136227924,3.402219650297347
647V,11404337,-2.8105111103232985
DBTRG-05MG,6505803,0.4569026356625297
Peer,11404337,-1.6679589887046322
BEN,11404337,0.9203658173456966
MCAS,9936388,-6.436874065356807
COR-L51,tanespimycin-bortezomib (250-1 mol-mol),-1.1077118907846166
DU4475,168313200,1.634598375119855
8505C,135875424,3.698353328169634
ESS-1,44491742,4.277473074701454
Hs 936.T,107985,-3.1215732689718028
SW1271,135423438,1.1699634662635283
BT 482,168313200,1.7925441683039929
GaMG,10296883,3.750929990698749
RPMI-8402,8515,2.725548300733334
SNU-423,10296883,4.1095294295281795
CAL-54,148198,-3.3099024859791286
EM-2,3136844,3.483556500959754
SK-MEL-31,tanespimycin-bortezomib (250-1 mol-mol),2.560525845699468
GCT,100016,6.941224948418202
SK-CO-1,11404337,-0.5084033800481932
GB-1,selumetinib-vorinostat (8-1 mol-mol),3.3033356812645
CAL-33,9911830,2.6291235129166193
COLO 792,11485656,2.715792347654397
DB,9927531,3.16097275010185
JURL-MK1,11485656,1.8097714180338824
RL95-2,11404337,0.2119113216403357
Karpas-620,selumetinib-GDC-0941 (4-1 mol-mol),4.598341067647778
SK-MEL-1,100016,6.470813601542051
EM-2,148198,-3.744081167157371
SNU-1033,262093,2.351645391909522
RCC10RGB,11485656,3.364959979667133
Calu-6,148198,-2.2255623368633746
NCI-H661,9926054,1.7811448977738318
BT-474,JQ-1-carboplatin (1-1 mol-mol),5.214986891454346
K-562,409805,3.7514940654800064
Calu-3,36462,-0.1671565267971208
ST486,5460769,4.068144147085423
PE/CA-PJ41 (clone D2),10296883,4.236451814997899
COR-L95,439501,-1.1523844892623298
PK-59,12003241,-0.8874443449539482
IMR-32,136227924,2.2103917598606326
NCI-H647,3689413,0.6953623673111984
NCI-H211,3136844,3.180126085507952
Ci-1,44493528,4.267807025719403
JHOM-1,36462,3.754138858913095
NCI-H2030,36462,2.530734561122129
CAL-29,24180125,3.292703215341267
SUP-T1,11485656,1.1772627696716973
CMK,46943432,0.8826851376858325
A4/Fukuda,tanespimycin-bortezomib (250-1 mol-mol),-0.1272603681833176
SNU-308,6505803,-0.8731800664163156
UO-31,10296883,3.111389314005664
SNU-668,9936388,1.544401750271857
A-375,11404337,-0.2038231220320669
NCI-H1650,159324,3.40496590407731
OCI-Ly3,44493528,3.993360395088613
MHH-CALL-4,JQ-1-carboplatin (1-1 mol-mol),-0.223161875024046
JHH-2,107985,-3.242858350400616
HLF,6505803,-1.0701085003041886
SK-MEL-1,12003241,-1.7363712573149035
OE21,148198,-3.484738735179186
FaDu,5460769,4.852166639687207
TYK-nu,49836020,4.345378886251337
JURL-MK1,selumetinib-GDC-0941 (4-1 mol-mol),-1.4981298966453434
RPMI-8402,136227924,2.2526718879349694
HEC-151,9903786,2.765131251863377
BICR 6,12003241,-1.5069556465481264
RS4;11,439501,-2.445140752441031
LS513,6505803,-2.1765779470092332
HEC-59,107985,-3.77739031414332
NOMO-1,168313200,3.152434526133537
EPLC-272H,8515,2.6637644767045043
BT 187,11485656,2.779756722479281
KP-4,9926054,2.5953636784587877
YD-8,12003241,-1.7142863629727714
Karpas-299,9903786,1.3697827730065784
Hs 578T,9903786,3.085679401941195
HPB-ALL,44493528,4.688141259598365
MeWo,3689413,1.920191181250088
TM-31,54618164,4.481591418748458
Hs 895.T,tanespimycin-bortezomib (250-1 mol-mol),2.1359790138247674
CAL-148,10322450,5.795817783172109
OAW42,9911830,2.253682076539179
SNB-75,135423438,1.7474486526711988
CAL-78,11404337,0.3095011123947553
COR-L95,107985,-2.989419812710682
Caki-2,9926054,1.76147282411668
Hs 888.Lu,168313200,5.703757640857178
TCC-Pan2,262093,3.1215793064839903
SK-N-FI,tanespimycin-bortezomib (250-1 mol-mol),-0.0515208796010249
J82,409805,5.742622843413684
Pfeiffer,6610216,3.245133119862502
P12-Ichikawa,24180125,2.4423636001480156
OCI-Ly10,9926054,1.7793271735454907
KO52,12003241,-1.0632598943321483
M059K,409805,3.7462715716608943
HEC-6,9903786,3.848299658438586
JHUEM-3,3689413,-0.6367758327679763
CML-T1,11404337,-1.4571467715346416
HuH-6,135875424,3.823839910626804
HDQ-P1,11404337,1.6870707002815033
NCI-H838,44491742,4.734730430776703
Caki-1,9927531,5.587911994434885
BICR 6,selumetinib-vorinostat (8-1 mol-mol),2.3950298084345545
RCC10RGB,9911830,4.5526597563763795
HMC-1-8,100016,5.583587343649554
SNU-423,24180125,3.626785562106237
HT-144,11485656,1.9072618769680565
TT,6610216,4.542755453833215
A-375,sirolimus-bortezomib (250-1 mol-mol),2.0398206768525475
HuH-6,6918878,0.5148205874464938
LOU-NH91,26596,-0.8372049149458933
NCI-H292,11485656,2.2579953762585725
Sq-1,11404337,0.5164739159658084
MDA-MB-157,9926054,2.0716850398098368
SK-LMS-1,54618164,4.255927554001473
Hs 294T,36462,1.1730429194866945
T84,135423438,1.8548659324700536
BHY,73707440,3.8308297989049143
DAN-G,439501,-2.2705852872142236
BT 422,9926054,2.139061359959833
GSS,246676,4.2642843593675765
SNU-466,54618164,3.7908148329760585
TE-1,107985,-2.1441864894921587
MHH-CALL-3,439501,-2.5206189278952325
KP-3,107985,-4.13659757249414
NCI-H1944,9911830,1.980153865987294
CAL-78,6610216,4.387261995734319
RCM-1 [Human rectal adenocarcinoma],3689413,0.4564681386605935
MHH-NB-11,5460769,0.1822518013387546
NCI-H647,54618164,4.0719010175074475
647V,9926054,1.756736719694015
CAL-54,9936388,2.642816339395173
Rh41,8515,3.268186159654955
P-STS,tanespimycin-bortezomib (250-1 mol-mol),0.1209880905816519
Mino,107985,-5.05206384093963
PSN1,262093,2.941975220157323
A3/Kawakami,44491742,3.8621679307370953
NALM-6,sirolimus-bortezomib (250-1 mol-mol),0.084215684734826
NCI-H441,6610216,4.273182904143366
NCI-H526,11404337,-0.7565430519554945
GOS-3,100016,7.242262816552233
CAS-1,148198,-2.1391789652686324
KP-N-YN,9903786,5.5444671223667825
NCI-H1568,3136844,4.658915015928919
H-STS,148198,-3.664450029895992
PSN1,9927531,4.910271279543014
OCI-Ly10,49836020,3.5902164250425503
SNU-685,9903786,5.039547940758868
MOLT-16,100016,4.920795787487072
HEC-251,3689413,-0.622023028283223
Hs 683,100016,6.526692615081327
Pfeiffer,10322450,2.3368906147857693
SNG-M,selumetinib-vorinostat (8-1 mol-mol),3.700323618975828
CHP-212,3136844,3.658159698366908
KYSE-410,6918878,3.650985342430235
HCC1428,409805,3.849465032491537
CAL-85-1,6918878,3.7299769305113175
GCT,54618164,4.311053334920422
Lu-99,262093,3.013120554949913
COR-L105,selumetinib-vorinostat (8-1 mol-mol),2.277448874031188
SR,136227924,2.657612515566446
Ki-JK,JQ-1-carboplatin (1-1 mol-mol),-0.8899338497944629
SK-N-FI,6918878,1.3889833940468903
HEC-108,439501,-2.3418750446111347
TUHR14TKB,409805,6.116052032951237
CMK,439501,-2.5697505618969547
JHH-1,135875424,4.689279573138962
NCI-H292,9936388,-1.1579069678838152
KNS-42,439501,-0.277437282797495
SW1710,8515,4.438897883446972
MOLT-13,168313200,3.2034774165201236
TTC-709,10296883,3.6532150982477503
Kasumi-1,148198,-3.174700681388165
BICR 22,3689413,1.1307119933583345
G-361,409805,5.8363569704148714
Hs 688(A).T,9936388,2.197824687815799
HARA [Human squamous cell lung carcinoma],12003241,-0.2443339656532688
HCC2279,159324,2.7132779523720068
MOLP-8,135875424,3.0291075959050233
Fu97,selumetinib-vorinostat (8-1 mol-mol),1.744198071356546
KMRC-1,168313200,3.9547474801247455
ZR-75-30,11485656,1.735891499698879
RD,9903786,3.633793884549444
JHOS-2,9903786,4.753698085205414
PaTu 8988t,3689413,2.4784022576221836
HCC827,9926054,1.8610804670039272
HEC-108,tanespimycin-bortezomib (250-1 mol-mol),0.6287218196429517
L-1236,159324,2.5881501762218972
Karpas-422,44493528,4.27188958418413
COLO 792,24180125,3.327455807525018
KO52,24180125,3.3572012584638613
SUP-T11,selumetinib-vorinostat (8-1 mol-mol),2.479374773758299
NCI-H2171,11485656,1.3701169509015756
HeLa,11485656,1.8522393336584817
SK-MEL-1,11404337,-0.7875528095472949
SNU-478,11485656,1.921129079492399
8505C,135398744,7.128245503588914
Calu-3,409805,5.821032330735687
NCI-H1650,11485656,2.650722608935496
Aska-SS,3689413,-0.2828072846638814
UACC-62,439501,-0.4240195200695472
SF126,409805,6.434205859651259
DMS 454,10296883,3.765531757081873
MV4-11,100016,3.584878230644963
JHUEM-1,3689413,0.044302486666068
NMC-G1,11404337,-0.1784694384642232
DEL,36462,-1.0094557701318494
P31/FUJ,6505803,0.2535639265329721
NCI-H1915,9926054,1.8603630934731663
LNCaP clone FGC,tanespimycin-bortezomib (250-1 mol-mol),-2.6061183463030138
8305C,9926054,1.435515250555218
CAL-12T,409805,3.840728267752851
PaTu 8902,9936388,2.1491039356268966
NCI-H1573,100016,4.561614919470221
ML-1 [Human thyroid carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.142388159439524
OAW28,6918878,3.220005605820797
SiMa,11404337,-1.9067460076304843
LCLC-97TM1,148198,-1.8422045751990368
Hs 688(A).T,11485656,3.741191414447006
EoL-1,135875424,2.3813180528282416
U2OS,26596,-1.797685053172872
Hs 683,8515,4.507985509607111
A-549,11404337,-0.2898707579606809
PE/CA-PJ49,9927531,5.215467759359
NCI-H1734,54618164,3.6379129162989807
NCI-H226,136227924,3.4351319272724585
Kasumi-1,135398744,7.461687299190896
NCI-H2286,6610216,4.176129306068653
Ci-1,168313200,3.521334574329343
COLO 800,5460769,0.4868245753357603
EB1,9927531,2.850216647233053
TE-6,26596,0.4120128768036302
OV56,tanespimycin-bortezomib (250-1 mol-mol),1.0708573891285402
Hs 934.T,12003241,-1.701018905102148
NCI-H2052,9936388,2.267249027506278
EB1,100016,6.112181525197604
A-498,3689413,-0.327867250415736
LCLC-103H,36462,3.06746452433931
KNS-81,6610216,4.677287397778329
KMS-20,9926054,1.4765400556600523
COLO 320,6918878,3.5760969761257897
SF539,tanespimycin-bortezomib (250-1 mol-mol),-1.7404188546520216
COLO 668,10296883,4.05500534274126
Ishikawa (Heraklio) 02 ER-,26596,-0.9802171650937824
TYK-nu,9911830,2.956364674147038
SNU-1,44493528,4.533433840242425
647V,107985,-3.8456170953130977
SKM-1,8515,1.7539525603020008
Hs 822.T,262093,2.2664804620168693
EC-GI-10,439501,-3.666361132208791
ECC10,107985,-2.86450405382575
COV644,9911830,2.3933009993345156
SCC-9,sirolimus-bortezomib (250-1 mol-mol),0.9662100185478
LoVo,100016,6.001395250082881
SUP-M2,107985,-5.103168602095624
LoVo,44493528,4.114958638118981
MDA-MB-453,6610216,3.7821562137745217
SNU-878,11485656,1.7316943988807143
LOU-NH91,6610216,4.701575628194421
BT 271,11404337,-1.9578148063056395
SNG-M,107985,-2.904988920711604
TTC-709,6505803,0.8575358462555939
TYK-nu,409805,5.027177142631053
HOS,107985,-2.5585929292957466
Panc 10.05,107985,-4.4512341948004535
GP2d,3689413,0.2049378471192219
BT-12,49836020,2.972579306483729
HEL 92.1.7,selumetinib-vorinostat (8-1 mol-mol),2.302657261163946
BC-3C,135875424,4.794032428578798
Hs 822.T,24180125,2.973161880999435
PLC/PRF/5,11404337,0.67614932520098
HCC202,6610216,4.36654658645049
SNU-620,44491742,4.13195678155616
SNU-1,sirolimus-bortezomib (250-1 mol-mol),0.1110784277529242
NOMO-1,11404337,-0.1001889231988697
T24,44493528,4.3959417909273215
KYM-1,3136844,4.082416721394895
Ki-JK,tanespimycin-bortezomib (250-1 mol-mol),-1.1406777464208224
OCI-M1,409805,6.068123689034305
LS513,9927531,6.189167828595346
MeWo,148198,-4.218734376362087
NCI-H28,9936388,-6.07130459443066
SNU-1041,439501,-2.4187407213181085
8305C,36462,2.9479443430205565
SU.86.86,44491742,4.316349403220542
F-36P,49836020,5.768901368593018
KMS-20,135423438,1.13023072719564
8-MG-BA,12003241,-0.0474192028844215
HT-1376,262093,3.325962410010009
BHY,sirolimus-bortezomib (250-1 mol-mol),0.9100094711799346
U-937,6505803,-1.2409770185958264
HCC827,9936388,-1.46620375683839
RPMI-7951,44491742,3.876790810560562
PaTu 8988t,439501,-3.4446792284706347
BxPC-3,JQ-1-carboplatin (1-1 mol-mol),1.4385682837687654
KNS-42,9926054,3.077818601925372
Rh41,136227924,2.134040377876842
TE-8,12003241,-1.9101664586501004
MOLT-16,selumetinib-GDC-0941 (4-1 mol-mol),2.290963052000247
SKM-1,159324,-1.3530804275700197
PK-45H,262093,3.1651162159981765
Caki-2,selumetinib-GDC-0941 (4-1 mol-mol),1.5536102429563667
BT 482,3689413,0.1224003168777627
OVK18,9911830,3.2751037063298623
Aska-SS,selumetinib-vorinostat (8-1 mol-mol),2.5241370498286373
PSN1,439501,-2.156746892791343
U-251MG,3136844,4.29526103008082
RERF-LC-Ad1,12003241,-0.821513059069255
KYSE-520,selumetinib-GDC-0941 (4-1 mol-mol),2.0690481757247037
HSC-3,9903786,2.4966748748730025
OVCAR-8,9903786,3.64408364733759
NU-DHL-1,54618164,4.2613527063162895
Calu-6,136227924,5.658776934081175
HeLa,439501,-2.848382287027866
IGROV-1,54618164,4.2184521751950115
SNU-466,11404337,-0.8937710860512643
BT 504,409805,3.844578236593203
HT-29,9936388,1.7022736774811322
T24,44491742,4.439042191378119
C2BBe1,sirolimus-bortezomib (250-1 mol-mol),0.281617007338844
Caov-3,44491742,6.286074544034756
RCM-1 [Human rectal adenocarcinoma],148124,4.246203808599277
SUIT-2,136227924,3.4861054974924133
Panc 10.05,136227924,2.25248962667623
OVISE,selumetinib-vorinostat (8-1 mol-mol),2.514826548203033
AsPC-1,9911830,2.936776162598985
NCI-H28,JQ-1-carboplatin (1-1 mol-mol),0.6583342429642598
Hs 729.T,24180125,3.283852866352467
NCI-H2291,46943432,2.103514044788886
SNU-869,5460769,1.7157786407903552
KMS-27,9936388,-7.881651109846528
HT-144,9926054,1.741901669011513
EKVX,tanespimycin-bortezomib (250-1 mol-mol),1.3495515941174134
CL-11,9903786,2.342392371257784
T84,11404337,-0.6580973567556256
SNU-878,5460769,2.876812490154217
BT 340,selumetinib-GDC-0941 (4-1 mol-mol),2.751381864792414
BT 504,36462,3.8166909345932383
BT 164,107985,-3.1834960037296884
8-MG-BA,49836020,-4.019161217996327
MOR/CPR,6505803,-2.446657793445472
NH-6,36462,-0.7358252400441799
DAN-G,36462,1.1415877491353317
Capan-2,136227924,3.162135891621308
JURL-MK1,8515,2.887291129545749
JHH-6,409805,5.874382301544695
AU565,168313200,1.787588028354966
BT-20,5460769,5.85454688440853
HuG1-N,3136844,4.041535307710322
NCI-H727,9936388,1.6432072244848812
U-251MG,168313200,1.707119335082743
NCI-H2171,26596,-1.7584148860978708
LN-229,3689413,-2.3108318382356248
CAL-27,136227924,2.2169431722835324
GaMG,11485656,3.146169706850776
NCI-H1915,262093,3.400332041553307
Kelly,168313200,1.7675491424494791
TCCSUP,100016,6.5110410318476575
253J-BV,24180125,3.4609613429738455
RERF-LC-MS,8515,3.770178660744851
SNU-475,54618164,4.914308151118064
786-O,135875424,4.398795427398002
COV644,11485656,2.222554358198117
NCI-H2172,107985,-3.1793632305275836
Tm87-16,6610216,4.349326509918039
SiMa,439501,-2.281270120889317
KHM-1B,10322450,2.734741066135324
SEM,11485656,1.8495119352561953
GB-1,36462,2.476017326318834
CA46,11485656,1.2289823963881294
A-204,135398744,7.3650683487349236
PE/CA-PJ34 (clone C12),9927531,5.274687585125943
WSU-DLCL2,136227924,1.92257757824623
MES-SA,439501,-2.264210619464941
DU4475,148124,-4.703321943228874
Kuramochi,159324,3.3473872153511164
D283 Med,11404337,-0.900512184015852
TYK-nu,12003241,-2.574649573149326
KMRC-3,439501,-3.150982817952844
CGTH-W-1,12003241,-0.9249574155092228
SW620,44493528,4.454828902160922
TE 441.T,148198,-7.570550283496053
NCI-H2170,3689413,3.058757672919766
BT 504,24180125,2.722819243904145
Namalwa,46943432,0.650701651867592
FTC-238,sirolimus-bortezomib (250-1 mol-mol),0.2541232172189812
SEM,54618164,3.8944596685913138
Capan-1,36462,2.302180393835448
SNU-245,3689413,-1.9631171858613183
HD-MY-Z,9926054,1.8885520747906608
Daudi,6505803,0.7229387165377155
HuH-28,148198,-2.021570879292896
HCC2108,selumetinib-vorinostat (8-1 mol-mol),2.476774013379894
EHEB,JQ-1-carboplatin (1-1 mol-mol),0.4941102336804299
COR-L105,11404337,0.9270352493146456
UO-31,44491742,3.8837342350027377
U266B1,tanespimycin-bortezomib (250-1 mol-mol),-0.8017004823688043
OCI-Ly19,46943432,1.1319125471752869
BV-173,54618164,2.9660436540247903
SNU-308,9936388,-0.5886369856263455
KYSE-410,439501,-2.4284024166032365
PE/CA-PJ34 (clone C12),tanespimycin-bortezomib (250-1 mol-mol),-1.982258316980141
SNU-478,9936388,-5.768985040086462
FU-OV-1,11404337,-0.2130364442314083
NCI-H1563,8515,2.468674320283986
UM-UC-1,46943432,5.976790346070284
NCI-H508,9936388,-6.267876365775133
NCI-H460,11485656,2.6212830818798065
BT-12,135875424,5.671526751726921
HCC2108,11485656,2.4652137706419137
786-O,26596,-1.1841737668988108
HEC-6,439501,-1.45021451422316
CAL-148,JQ-1-carboplatin (1-1 mol-mol),1.5060433709656682
MDA-MB-157,49836020,-4.4611089332084335
ONS-76,136227924,2.542073211711186
Panc 08.13,24180125,3.7393311414493944
Rh30,168313200,3.8308139252747737
253J-BV,409805,3.806048297229197
FU-OV-1,12003241,-1.039273875540509
HuP-T3,148198,-3.5090934063696153
G-292 clone A141B1,26596,-0.9634124714344006
A3/Kawakami,168313200,2.7550323232462763
HD-MY-Z,107985,-4.509019468777268
HDLM-2,8515,3.3185322051747836
OCI-AML-3,6918878,-1.1888117332211317
NCI-H2030,439501,-1.2331748188079374
RPMI-7951,tanespimycin-bortezomib (250-1 mol-mol),-3.2107041108384524
EoL-1,135423438,-6.8618615828632565
CA46,246676,4.699933053014099
COLO 684,44491742,3.593536773011693
GA-10,409805,3.0075509696192397
NCI-H1395,3136844,4.616978313876093
KATO III,6505803,3.725568714877732
BT 428,5460769,2.5146871392563845
HPAC,148198,-2.210118845880014
SK-MEL-28,148198,-1.1695105826491254
BICR 16,sirolimus-bortezomib (250-1 mol-mol),-4.146745756723436
SNU-668,6505803,-2.4015311663396535
YD-8,sirolimus-bortezomib (250-1 mol-mol),1.3877197149953842
OCI-AML-5,5460769,2.0028479546764664
SIG-M5,26596,-1.691579811002482
TOV-21G,3689413,-2.863324096900296
BHY,24180125,2.855472953055454
U2OS,tanespimycin-bortezomib (250-1 mol-mol),-0.4956813125549447
COV434,439501,-6.307025719899454
HPB-ALL,10296883,3.0547886036343663
OCI-Ly3,135398744,6.408015135669225
PK-1,135875424,4.5989103647070655
F-36P,selumetinib-vorinostat (8-1 mol-mol),0.7634512600897306
MV4-11,44491742,3.928114355026535
KYSE-410,9911830,2.598803177921042
NCI-H1793,135875424,3.2087606409419087
BxPC-3,439501,-2.27553783948146
NCI-H1563,10322450,4.527770702811014
KMS-34,159324,0.2662861612259365
NCI-H196,11485656,3.8330163114503337
ECC10,6610216,4.114118365396388
NCI-H460,409805,5.4278006548731295
AsPC-1,12003241,0.1897400127907629
NCI-H1703,8515,3.787684444790488
KP-3,6918878,4.298092310764335
NCI-H1092,sirolimus-bortezomib (250-1 mol-mol),0.4958114346992872
KMS-20,44491742,3.719914001289463
SNU-407,24180125,3.709113643106665
HOS,6610216,4.706108734526838
SW1353,5460769,4.513460705614206
Kelly,107985,-2.874856101829992
SW1417,9911830,1.9711863745883549
HSC-3,12003241,-1.4285198417789524
SH-10-TC,9927531,5.280985634466932
A-172,44491742,3.879269865010821
NU-DUL-1,262093,1.0561136959498525
NCI-H1666,6610216,3.2218112987058207
OVCAR-8,12003241,-0.599857829959187
SNU-1196,selumetinib-GDC-0941 (4-1 mol-mol),2.312847943895299
A-172,26596,-0.1948539739463346
SF126,9936388,2.3000981317136433
LXF 289,100016,7.121965810949268
KMS-34,439501,-2.83193731194203
Calu-6,409805,5.233099124624357
Hs 944.T,9927531,3.41915171718772
Reh,44493528,4.04802880439871
HCT 8,3689413,3.2270836788045054
NCI-H1734,9877608,5.725584045619203
SNU-1272,9926054,2.4790221898932283
SNU-398,439501,-1.0670786880866563
P12-Ichikawa,409805,3.706415090956248
CAL-78,5460769,3.8399978594136193
Hs 746.T,409805,3.593124858795494
LP-1,136227924,2.2350423658008416
COLO 684,tanespimycin-bortezomib (250-1 mol-mol),-1.1171395210873645
A-204,12003241,-1.8688427044932845
LoVo,9903786,0.6551100591729495
G-401,selumetinib-GDC-0941 (4-1 mol-mol),0.5111362666668609
HCT 15,46943432,4.414742739807934
HuG1-N,9911830,2.161286986984273
HuG1-N,6610216,5.087045080663945
UACC-257,11485656,3.6556840450615065
A3/Kawakami,148198,-4.4977809283586865
NCI-H322,8515,5.55433033335456
SNU-61,262093,2.836545473910542
Hs 940.T,168313200,2.06590708272712
PLC/PRF/5,24180125,4.178076837557003
CL-11,159324,2.5736174893833046
JHH-4,9911830,1.3195614392380235
8-MG-BA,3689413,0.0230588346989354
K-562,49836020,4.414855158615189
PE/CA-PJ41 (clone D2),sirolimus-bortezomib (250-1 mol-mol),1.841699935420702
TT2609-C02,9936388,3.168099243698234
P31/FUJ,46943432,0.8368365469264624
COLO 678,136227924,3.6500617296173288
CAL-51,11485656,2.6541256228973773
KYO-1,sirolimus-bortezomib (250-1 mol-mol),0.6931512347685437
L-363,3689413,0.386026439105166
TE-4,sirolimus-bortezomib (250-1 mol-mol),1.0624472113387091
5637,100016,5.253062593048346
COLO 205,135875424,4.594078459695996
EKVX,selumetinib-GDC-0941 (4-1 mol-mol),0.6299385991814179
JHH-1,11404337,-0.8045754581071476
MM1.S,6610216,4.132453161575956
CCK-81,12003241,-0.505625792514721
HEC-265,11404337,-1.185290223880338
NCI-H1581,8515,3.165024241321023
U2OS,24180125,2.6546755923389527
Kasumi-2,11485656,1.64011250363507
KYO-1,3136844,3.989205872119856
BICR 18,54618164,4.250023654949769
NCI-H838,3689413,-2.1672294024388106
HT-1197,selumetinib-GDC-0941 (4-1 mol-mol),0.2261426645121145
T98G,selumetinib-GDC-0941 (4-1 mol-mol),2.822030636893018
BFTC-905,136227924,2.194418567728585
SW48,148198,-2.7635683141359277
Peer,100016,3.808596484759728
L-540,6505803,-0.3168506234020811
Raji,439501,-2.4044549184869872
SUP-HD1,49836020,4.390823916389519
DAN-G,9927531,4.82875872277198
OAW42,8515,4.937675036123391
EM-2,8515,3.0626946322597495
NCI-N87,100016,7.118039999797619
DMS 53,148124,-2.0065392154646537
NCI-H1623,107985,-2.7226564689550488
NCI-H2081,439501,-4.570953887500971
SNU-398,12003241,3.2060207303790924
GSS,46943432,0.9758869456663198
PaTu 8902,135423438,1.708930423466824
SNU-1,6505803,-3.5096009035536593
KMH-2,439501,-2.384989575251817
T84,136227924,2.5199027398538707
MPP 89,135875424,5.105268273979739
NCI-H1944,148124,-4.646184919447912
NCI-H524,6610216,3.735749352213653
HCC1937,sirolimus-bortezomib (250-1 mol-mol),0.6036989015606368
NCI-H661,selumetinib-vorinostat (8-1 mol-mol),2.6116020455446884
SNU-410,9911830,3.211976341536433
COR-L88,24180125,3.759046455796738
SW620,54618164,4.563373873734706
HCC366,9911830,3.120648620550164
Reh,439501,-2.4165922655956407
Hs 888.Lu,selumetinib-vorinostat (8-1 mol-mol),3.0889826196747685
A-204,11404337,-1.0491261061944723
SU-DHL-8,3689413,-0.1983897447219186
NCI-H460,36462,3.103581216464206
BT 271,9926054,1.6411198648288656
JHH-5,44491742,3.8169087988503705
LAMA-84,3136844,3.738856580812488
COR-L51,sirolimus-bortezomib (250-1 mol-mol),0.5050478913341053
KMBC-2,12003241,-0.070536665370705
OCI-AML-5,11404337,0.1912186748994763
UM-UC-3,44493528,4.3547377371063405
SK-MEL-5,sirolimus-bortezomib (250-1 mol-mol),0.9353591049866828
Caov-3,439501,-0.6475406712801833
LS513,3689413,-0.047571492296106
LoVo,6505803,-0.2027234925460443
JMSU-1,6610216,3.9610283464836047
WM1799,11404337,0.7575845894663391
COLO 668,9911830,2.596021506669569
L-363,8515,3.684456048259526
SK-N-FI,26596,-3.6176410664455374
SCC-9,136227924,3.721677265331546
NCI-H1339,JQ-1-carboplatin (1-1 mol-mol),3.0025540987138326
Caki-1,selumetinib-GDC-0941 (4-1 mol-mol),2.159609795753867
CW-2,6610216,3.647526913375138
TC-71,136227924,2.205314859996721
NCI-H460,selumetinib-vorinostat (8-1 mol-mol),4.393726513412324
ONCO-DG-1,3689413,-1.9285483999998865
Yamato-SS,54618164,4.292621514596885
TE-11,11404337,-0.8497822409936865
LP-1,24180125,3.144388402663548
HCC202,sirolimus-bortezomib (250-1 mol-mol),0.0889077055626295
L-1236,selumetinib-GDC-0941 (4-1 mol-mol),3.573145022328455
SW1116,11404337,-1.048062477762995
BT 224,100016,6.546386559669457
SHP-77,9936388,-4.866558294975543
NUGC-4,11404337,-1.0911037435760411
FTC-238,439501,-2.852234724495685
P31/FUJ,3689413,-2.495432751898851
KYM-1,148124,-5.892667990186819
Hep-G2,136227924,2.2133800896817304
BT 248,135875424,2.546043839111523
BL-70,44491742,3.343909693711406
NUGC-4,6610216,4.097960293460252
HEL,136227924,2.725456875957553
AM-38,262093,-6.35735494896705
CAS-1,3689413,-1.7594128574941137
BT 187,3136844,4.314268488797674
FU-OV-1,262093,2.4810055989466018
GSS,24180125,2.5429718088865503
G-361,3689413,0.7888420983212308
COLO 684,9903786,4.137443964220156
DMS 454,136227924,3.2899111891910424
SNU-1076,12003241,-1.173823716137647
BT 330,44491742,4.367748851083318
CCK-81,107985,-4.087159220561304
CJM [Human melanoma],6610216,5.096973872510674
SYO-1,12003241,-0.4468506697584958
Kasumi-1,9911830,-5.991531710448216
SK-N-BE(2),54618164,4.328131029932168
PF-382,107985,-3.9923551873687497
SNU-886,11485656,2.594845566887895
NCI-H2405,9936388,-0.650835223807707
BT 172,135875424,3.0485083904276933
KMRC-2,148198,-2.5062257311600753
SaOS-2,selumetinib-vorinostat (8-1 mol-mol),3.065255136374356
IGR-37,9936388,-3.744387709560832
NCI-H2106,selumetinib-vorinostat (8-1 mol-mol),2.254760596846594
NB4,sirolimus-bortezomib (250-1 mol-mol),0.8498736120929098
Hs 766T,46943432,3.2125671025540536
COLO 684,409805,3.735397320840961
IGR-1,409805,3.621837141721011
KCL-22,44484440,3.267287546101391
HDQ-P1,9936388,2.1962114210589134
SU-DHL-8,JQ-1-carboplatin (1-1 mol-mol),0.1071137470507251
A-549,6505803,-0.295425809550202
OVK18,6918878,1.6041460542540644
LAMA-84,135423438,-1.4093443238275885
NCI-H520,44491742,3.7897459257936057
Ku812,3689413,-1.935767376067546
HCC95,44491742,3.8054910800445994
U-251MG,409805,5.498064419607069
HuH-6,11485656,2.2399247025675084
SNU-719,409805,4.713440373446098
SF268,148198,-4.335293772909402
RPMI-8226,9926054,1.537898782638624
HuP-T4,9926054,2.1001790007483843
OCI-Ly3,135875424,3.008011320829632
LS123,selumetinib-GDC-0941 (4-1 mol-mol),1.252033053606901
OCI-Ly19,JQ-1-carboplatin (1-1 mol-mol),0.1428825624230537
KP-2,439501,-0.3502086047975351
EC-GI-10,sirolimus-bortezomib (250-1 mol-mol),2.282726808437879
NALM-6,135875424,2.687254524498793
SW1116,JQ-1-carboplatin (1-1 mol-mol),-0.0144510957041741
P12-Ichikawa,tanespimycin-bortezomib (250-1 mol-mol),0.3962036190597272
Hs 729.T,148124,-4.36637329405652
SU-DHL-1,5460769,-0.475427190707336
HEL 92.1.7,9927531,3.309303309112431
MV4-11,73707440,5.432484386170161
MG-63,9911830,1.9513563305490416
MDST8,6918878,1.145593411739036
JHOM-1,sirolimus-bortezomib (250-1 mol-mol),0.2834615362224199
NCI-H1651,sirolimus-bortezomib (250-1 mol-mol),1.0347909654714795
JHUEM-1,selumetinib-vorinostat (8-1 mol-mol),2.3736389824492035
KALS-1,36462,2.7301613620046803
SK-N-SH,24180125,3.172499964081901
YD-38,11404337,-1.21391516825444
OPM-2,6505803,-0.5489645461029444
BT-16,54618164,4.087299705518295
DU145,6610216,4.286029823589705
KP-3,262093,2.764663205540099
MKN74,409805,5.7612246650948356
LP-1,selumetinib-vorinostat (8-1 mol-mol),2.1103342223953243
PaTu 8988t,6505803,-0.6279165545759258
YD-10B,135875424,2.966969780143732
L-540,262093,1.75189061264014
NCI-H1693,54618164,3.6996601744635726
NCI-H209,439501,-3.220511958386942
MOLP-8,9926054,1.7939353525170396
JHH-5,9911830,1.7602427151080595
NCI-H1385,9936388,1.359050451063743
EC-GI-10,36462,1.6275747220843164
BT 422,selumetinib-GDC-0941 (4-1 mol-mol),3.332699583710218
P3HR-1,262093,1.7726417290278578
BHY,tanespimycin-bortezomib (250-1 mol-mol),-0.455078005089977
EJM,9936388,-8.624056137584708
KG-1-C,6505803,-0.4264272439200833
PaTu 8988t,sirolimus-bortezomib (250-1 mol-mol),0.5843474412149585
SKM-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.830110061350853
NCI-H1944,107985,-3.8930979106653183
YD-38,262093,2.9761292729070954
BT 245,36462,1.2671899599855267
NCI-H2029,12003241,2.5373322791001636
KYSE-140,11485656,2.138414918607982
NUGC-4,136227924,2.1432448607030308
TUHR4TKB,26596,-1.9685779873935287
NCI-H929,100016,3.8135603062591
G-292 clone A141B1,24180125,3.760295361832437
HT,9903786,3.804202680432086
Hs 895.T,10296883,4.2502082152330685
CAL-78,3689413,1.0903536033822472
SUP-T1,6918878,-0.6268463953057096
AsPC-1,36462,3.6552458214160506
NCI-H2228,3689413,-0.2908814661872257
UACC-62,44493528,4.51687103541405
TM-31,10296883,4.091171590398709
RPMI-8402,6505803,1.0273996849455458
647V,sirolimus-bortezomib (250-1 mol-mol),0.3544770314623594
Rh18,439501,-2.3237711161162102
HEC-6,262093,2.3423105964881414
OCI-AML-5,136227924,1.61818972770755
NCI-H23,135875424,3.011059427080452
Karpas-299,26596,-3.8097040773311246
OUMS-23,136227924,2.42742246798026
SNU-81,49836020,-3.195484765979539
BICR 56,107985,-3.799758605055094
LK-2,11404337,-2.7548250863089367
SK-BR-3,3689413,-0.6055139082378386
NCI-H1650,409805,5.641915285745506
L-363,JQ-1-carboplatin (1-1 mol-mol),0.6579201637920293
SNU-449,8515,3.796953450261519
BT 286,439501,-3.2145304071914844
SNU-449,JQ-1-carboplatin (1-1 mol-mol),4.503532877258194
EKVX,JQ-1-carboplatin (1-1 mol-mol),5.826710016487848
M059K,148198,-3.174973470049168
YD-10B,tanespimycin-bortezomib (250-1 mol-mol),-2.1326183945103807
BT-20,44493528,4.336473935891848
DAN-G,54618164,3.977352758546573
SK-UT-1,100016,6.311695779547894
BT 112,12003241,0.1954695576836523
NOMO-1,3689413,-2.5325178418163174
AsPC-1,439501,-1.6009280184427317
SUP-T11,9903786,1.3476542683573176
BT 159,9926054,3.0118614770860286
SNU-423,136227924,3.242018782370702
PC-14,54618164,4.181975842638425
SK-N-BE(2),100016,5.117046374692038
WT2-iPS,9911830,2.3630165212515917
SCC-4,135875424,3.69532319714556
SUP-T11,6918878,3.780858605030287
SNU-423,3136844,4.260601533804775
SaOS-2,36462,1.0480120523183942
Ku812,8515,2.860455557749638
COLO 792,6505803,-2.4277417436087294
VCaP,10296883,3.8501012850712137
MDST8,135875424,6.383148165610491
THP-1,9903786,3.0926145703043852
DMS 454,135875424,4.8848557327736115
MEC-1,5460769,1.3276972601062724
HCC4006,selumetinib-vorinostat (8-1 mol-mol),1.7233637217176108
SNU-8,36462,2.8022982828339957
MOLP-8,135398744,7.476327693514706
COV362,409805,3.5645157683747493
BT 224,6505803,-2.453220276677442
Hs 294T,168313200,1.8901423010477436
WM88,439501,-1.2543537382039465
NCI-H2087,46943432,0.8121400631384804
Hep 3B2.1-7,439501,-1.9738642324779276
SK-CO-1,5460769,-0.7722931098274061
MHH-CALL-3,9936388,-0.8161492964940873
BICR 56,11404337,1.611918044632369
KU-19-19,6918878,0.8609723302141853
MFE-296,409805,5.9865001584823405
ECC10,409805,3.5176729125359123
SET-2,12003241,-1.37504024910663
SK-MEL-3,9926054,1.7891311822278144
NCI-H2087,168313200,1.7599184921468192
ML-1 [Human thyroid carcinoma],135875424,5.514442636506433
NCI-H810,sirolimus-bortezomib (250-1 mol-mol),0.258624131959815
HT-144,8515,5.322157375138796
SNU-899,136227924,3.189426259363562
SNU-61,159324,1.5880493113453718
MM1.S,3689413,-0.3922685663675629
GB-1,135875424,3.7799523392029593
SK-MEL-24,54618164,4.106072127259134
SH-4,44491742,3.636684434382026
RS4;11,8515,2.057442259754831
SNU-5,159324,2.17123269045322
EPLC-272H,6610216,4.686916170256582
HGC-27,100016,3.78981980973908
KLE,136227924,3.154327848580928
KE-97,159324,0.6978324022921536
HT-144,24180125,3.3475527139348524
HCC1937,262093,4.048076592606387
OCI-Ly3,26596,-3.73515804460265
RS4;11,409805,2.991806460925903
SUP-HD1,135875424,2.9213239436654908
AsPC-1,262093,3.2992304028365926
OC 314,107985,-3.8109236792960863
Panc 08.13,3689413,2.756509749646428
SK-LMS-1,44491742,4.239159149665423
CCK-81,9903786,2.4008516567284848
OAW28,135875424,4.470041991889524
U-87MG ATCC,9936388,3.5467326028454087
OCI-AML-5,sirolimus-bortezomib (250-1 mol-mol),1.6444241054056523
OCI-Ly19,5460769,1.4066182919474557
AML-193,44491742,3.5122021187729184
SNU-478,3689413,0.4137881438833174
NCI-H1581,26596,-0.8859288398475073
NCI-H2122,54618164,4.161455181946263
HuH-6,26596,0.8914215652548961
YD-8,9936388,2.2646667902608724
NCI-H1693,148124,-1.129654365554156
Lu-65,168313200,3.8994737452267945
A-673,11485656,1.6006257465541904
IGROV-1,148198,-2.659972993252853
TE-4,135423438,2.180179409506435
NUGC-4,46943432,0.134646197138115
MIA PaCa-2,168313200,1.759366617697624
NCI-H841,44493528,4.365937622754757
HuG1-N,262093,3.534679932173412
Ishikawa (Heraklio) 02 ER-,11404337,-0.8066309120452816
NCI-H1734,9911830,1.9349371485534383
Ku812,5460769,3.1615206717567608
LOX-IMVI,36462,2.305207758034576
HCC827,44484440,3.373310239080704
SNU-16,10322450,2.297245339388599
HCC38,6610216,4.397537915498448
AN3-CA,24180125,3.116324501416526
RCM-1 [Human rectal adenocarcinoma],10296883,4.143855024915708
OCI-Ly19,24180125,3.0993607004682007
Panc 05.04,262093,3.3614710639297622
SKM-1,11404337,-1.0204518416697923
HDLM-2,262093,2.5590696667733908
NCI-H1563,9911830,3.05051820168894
JL-1,selumetinib-GDC-0941 (4-1 mol-mol),2.640014576160969
CA46,36462,0.0715644321871689
NCI-H2081,selumetinib-vorinostat (8-1 mol-mol),1.9423097889386416
KHM-1B,24180125,1.7183751461282626
LS1034,439501,-2.506043270280418
NCI-H1666,12003241,-2.860788946487449
EFO-21,262093,3.250428911213388
TE 617.T,262093,2.7005370454000004
NU-DUL-1,11485656,1.905169788673151
JHOM-1,9926054,2.608228459897926
NCI-H292,8515,4.694095877434875
A-549,8515,3.6622074868184464
42-MG-BA,tanespimycin-bortezomib (250-1 mol-mol),-2.385025804605588
SNU-308,12003241,0.0879961923245038
SK-MEL-31,159324,5.415671108450597
A4/Fukuda,3689413,-1.7998697854540155
VMRC-LCD,26596,-2.205960208364449
RL,49836020,3.855414326561088
AML-193,3689413,-0.2908308590674514
SNU-61,3689413,-2.128463404187725
TE-10,159324,2.9715130331129114
Calu-6,6918878,5.412778473153405
DMS 273,9936388,3.4086707637717883
A-549,JQ-1-carboplatin (1-1 mol-mol),5.034765556590292
SNU-466,11485656,2.57362986775831
COLO 800,11404337,0.0903366557424785
BT 286,6610216,4.050396966302166
SEM,49836020,0.2207243584754971
RERF-LC-MS,11485656,1.5190166417661397
FU-OV-1,3689413,-2.180005064661593
HuCC-T1,44493528,5.528865919674086
BFTC-905,9926054,1.624797844745876
MOLP-8,selumetinib-vorinostat (8-1 mol-mol),0.5192774432453199
JHUEM-3,6505803,0.6198707712073951
SNU-182,9911830,2.537024143397294
COR-L279,11404337,-2.7299136771765102
LoVo,9911830,1.9062113768292104
FTC-238,12003241,-0.6060695245587711
BT 245,sirolimus-bortezomib (250-1 mol-mol),0.5347503794304393
Capan-2,6505803,-2.2561135668737533
B-CPAP,135875424,3.307629887397838
MES-SA,6610216,4.191241749527869
BICR 6,3689413,-0.1381327952499849
Pfeiffer,46943432,0.0278801234257352
DOV13,246676,4.3974836150314145
COR-L105,44491742,4.003695029376484
CCF-STTG1,100016,6.985278157575169
SNU-601,6610216,4.325542610449876
NCI-H1623,11404337,1.3417738865788873
NCI-N87,439501,-2.2970478950560715
SCC-4,tanespimycin-bortezomib (250-1 mol-mol),-0.6950216335747628
JK-1,54618164,3.4300382631920425
ZR-75-1,9936388,2.1610264064405977
KYM-1,sirolimus-bortezomib (250-1 mol-mol),0.1122184014552232
CA46,12003241,-2.799565618947511
KYM-1,selumetinib-vorinostat (8-1 mol-mol),2.38379411541386
LS123,6505803,-0.3996553163472341
SNU-C1,135875424,3.0946795282474007
PK-45H,9936388,1.8966458551256495
HD-MY-Z,12003241,-2.342795911905131
NOMO-1,136227924,2.5449106490851263
Ki-JK,24180125,2.224495261698477
SYO-1,JQ-1-carboplatin (1-1 mol-mol),-0.7857384720647894
BV-173,246676,5.29399575682718
FaDu,135423438,3.89304152437962
B-CPAP,5460769,4.36425483182296
GCT,3136844,3.8657202286756456
NCI-H2087,11404337,-3.0287738757732585
COLO 699,selumetinib-vorinostat (8-1 mol-mol),3.340743888549838
HT-29,3689413,-0.0079740382830798
KYSE-150,9936388,0.0652021177968587
MEC-1,148198,-4.2599268822798955
AGS,JQ-1-carboplatin (1-1 mol-mol),3.380502968435776
IM95,107985,-4.271252977544848
COLO 678,selumetinib-vorinostat (8-1 mol-mol),0.9502383991002584
BICR 22,44493528,4.288893884195869
CAL-33,tanespimycin-bortezomib (250-1 mol-mol),0.6625956930764642
TCCSUP,5460769,3.7572024912117103
Hs 683,9911830,1.9641699230536744
NCI-H747,9911830,2.514395107340635
GI-1,selumetinib-vorinostat (8-1 mol-mol),2.2740495965317624
RMG-I,selumetinib-GDC-0941 (4-1 mol-mol),3.743143666757181
8505C,12003241,-1.423942083306862
T-47D,24180125,2.7686038082444258
EFE-184,9936388,2.4089760191608462
DAN-G,sirolimus-bortezomib (250-1 mol-mol),0.114309742904921
SF295,sirolimus-bortezomib (250-1 mol-mol),1.039702746506238
SNU-1,10296883,3.7174122839678336
REC-1,3689413,1.860618150322578
TE-10,6610216,4.592417655041801
NCI-H1755,12003241,-1.003418586049609
SK-MES-1,262093,3.241171035364572
NCI-H520,24180125,2.1608136415253334
HCC827,159324,3.279991136949679
TE-14,26596,-1.531582993203474
DOV13,selumetinib-vorinostat (8-1 mol-mol),4.285112015872766
COLO 792,107985,-3.7038898096904753
UM-UC-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8990264790704343
SUP-HD1,11404337,-0.4036873763873929
ST486,3689413,-2.784671548878338
ML-1 [Human thyroid carcinoma],24180125,2.9342502769836263
SET-2,135423438,1.6244153608303664
697,148124,-6.674056959330551
RKO,9936388,0.8183869926163714
EPLC-272H,439501,-1.68247015094151
WM983B,135398744,6.927047773444745
BHT-101,439501,-2.3771581779378828
MOLP-2,12003241,0.9753237716846912
Sq-1,49836020,-1.2584721229421645
HCC1143,11404337,-0.7051632820466462
JHUEM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.535997961075801
SEM,selumetinib-vorinostat (8-1 mol-mol),0.5449202862000408
HEL 92.1.7,JQ-1-carboplatin (1-1 mol-mol),0.0305344247994576
KLE,selumetinib-GDC-0941 (4-1 mol-mol),2.44507657684364
HCC827,262093,3.007487219518493
KYO-1,262093,2.3511585107741286
SNU-489,sirolimus-bortezomib (250-1 mol-mol),1.5186743345934282
SUP-HD1,JQ-1-carboplatin (1-1 mol-mol),1.2897139290826176
HPAC,107985,-3.4399957064086677
CA46,135423438,1.6657304721140649
H-STS,107985,-3.371812219101193
DB,46943432,1.5920279886281368
MFE-319,135875424,4.6574477212915015
AN3-CA,selumetinib-GDC-0941 (4-1 mol-mol),1.0170906897464025
OV7,6610216,4.457826030978553
WM793,10296883,3.657255931485473
NCI-H1651,selumetinib-vorinostat (8-1 mol-mol),2.389055853752904
FaDu,9911830,2.7395037864167446
NCI-H747,262093,2.550683117249541
BT 239,8515,3.59714906944717
BT-474,9926054,2.0382536553726207
SNU-601,135875424,2.726240370483818
U-BLC1,8515,3.4266677281329843
SNU-886,262093,3.428603865365944
THP-1,JQ-1-carboplatin (1-1 mol-mol),-1.7291574226431643
HT115,439501,-2.40828737906019
YD-8,73707440,4.452607469919264
BL-70,9903786,1.6201088809137068
HPAC,6610216,3.983150861287026
IGR-1,9927531,6.184289140362073
MHH-CALL-3,8515,3.3812196301764104
NCI-H2452,135423438,1.816833708086427
BT 440,9926054,3.075570735220903
SNU-601,136227924,3.114119824082727
KE-97,439501,-2.4280531684579896
CJM [Human melanoma],26596,-1.4087486748108544
NCI-H2110,168313200,2.986185729607549
BxPC-3,9936388,-5.112429278661846
YD-15,409805,3.695516943836326
JHOS-2,3689413,-2.497853898445669
Karpas-422,6505803,-0.6034425689167541
SW1710,9911830,2.762967184848754
F-36P,409805,3.912389253799608
HPAC,36462,3.2094999713867103
ML-1 [Human thyroid carcinoma],26596,-0.6105391992480588
THP-1,159324,-2.014853180774234
JK-1,3689413,-0.5403816328590246
COR-L95,6610216,4.601423414679649
BT 239,11404337,-1.7707193107124473
NCI-H1299,9911830,3.0840556106234653
ESS-1,148198,-4.109415572856481
A101D,6610216,4.171778403451026
U-118MG,439501,-2.7971615553970675
TYK-nu,439501,-2.468535707905716
OVTOKO,9911830,2.7891133715732983
G-402,168313200,3.4717706784897224
IGROV-1,148198,-2.659972993252853
HT-1376,148198,-2.6714995080003767
COLO 668,148198,-4.3418041773017135
Hep 3B2.1-7,9926054,2.8753203525792026
HL-60,9911830,2.2176306511968327
AML-193,168313200,1.5323685202636708
SK-CO-1,36462,0.7476665664464673
GaMG,26596,-1.3647461579215698
Hs 940.T,24180125,1.6425567786070054
IPC-298,159324,2.329841695256939
BT 248,sirolimus-bortezomib (250-1 mol-mol),0.4320618504093114
Hs 852.T,439501,-1.3990443453800825
RPMI-7951,JQ-1-carboplatin (1-1 mol-mol),3.054924141826928
CML-T1,9927531,3.1672020542525674
ZR-75-1,409805,4.246614706181892
23132/87,JQ-1-carboplatin (1-1 mol-mol),1.651339324624301
NUGC-4,9911830,2.666596193346337
OVCAR-8,159324,3.4796802978441614
Hs 936.T,159324,3.4620555818904473
Daoy,439501,-2.3347693323407195
LOX-IMVI,11404337,-0.9085197853802874
Hs 688(A).T,selumetinib-vorinostat (8-1 mol-mol),4.759563761908848
HuG1-N,409805,3.876200248719346
CCF-STTG1,12003241,0.9586959919868534
NCI-H2106,54618164,3.710847397109672
SNU-5,100016,6.769356825304223
Caov-3,tanespimycin-bortezomib (250-1 mol-mol),-1.0739653599444468
L-428,44491742,3.8287631756244944
SW579,12003241,-1.7693862144500747
LOU-NH91,3689413,0.742189593443008
SK-N-MC,selumetinib-vorinostat (8-1 mol-mol),2.156046762999695
Karpas-422,selumetinib-GDC-0941 (4-1 mol-mol),0.0851273385721037
Granta-519,26596,-3.6955660538224784
TE-8,10296883,3.8933893456121984
FaDu,3689413,2.633100488394503
U2OS,36462,0.572466421403533
SNU-423,262093,3.077382051759327
L-363,26596,-1.5549208071756957
MDA-MB-453,selumetinib-GDC-0941 (4-1 mol-mol),1.2517967202260842
Capan-2,selumetinib-vorinostat (8-1 mol-mol),3.1590069051625544
HCC1806,26596,-2.125787428122878
U-118MG,9936388,-3.83393648054696
NCI-H1838,100016,6.459213557236613
BFTC-905,24180125,2.4151686868886557
SH-10-TC,26596,-1.1215294696679303
SU-DHL-8,262093,1.173912345187794
BT-12,6610216,4.719873266038045
NCI-H1915,3689413,1.3727527679359948
NCI-H929,6505803,-1.240454682973536
NCI-H2172,9936388,1.8105409817982183
NCI-H196,9911830,5.051951455628038
LAMA-84,262093,2.21531989487936
MIA PaCa-2,135875424,3.180139545836177
HeLa,selumetinib-vorinostat (8-1 mol-mol),2.818630942725572
Tm87-16,148198,-4.741899128420961
SH-4,3136844,4.204194887260853
JJN-3,JQ-1-carboplatin (1-1 mol-mol),-0.9961051054382296
GMS-10,107985,-3.618834006022873
SK-MEL-5,9903786,4.335376265950657
LN-229,136227924,2.284287102346984
BT 482,tanespimycin-bortezomib (250-1 mol-mol),-0.9105363094795508
OCI-Ly19,8515,3.292375544216499
HuT 78,3136844,3.938412897897032
RPMI-8226,6918878,-0.0395443479153611
Hep 3B2.1-7,159324,3.436377788042606
TM-31,9926054,1.8520077619388624
GI-1,100016,6.475829804009189
NCI-H1792,26596,-3.036610435257371
MeWo,36462,1.633566585190807
NU-DUL-1,26596,-3.721309412327892
TT2609-C02,11404337,0.8244882242749442
KMS-21-BM,12003241,-1.038159466289584
RCC10RGB,11404337,1.763382313076518
NCI-H2405,439501,-2.240122833517123
EB1,6505803,0.7002035239944829
BICR 56,selumetinib-vorinostat (8-1 mol-mol),1.34351766962856
NCI-H2106,135423438,0.968781117866004
A-673,sirolimus-bortezomib (250-1 mol-mol),-6.228363606010268
A-375,selumetinib-vorinostat (8-1 mol-mol),1.9790131702817335
CCF-STTG1,3689413,0.3028996084806184
OE33,selumetinib-GDC-0941 (4-1 mol-mol),1.7622700953788215
IGROV-1,135398744,6.402844237905131
RERF-LC-A1,135423438,2.4770286699108857
M059K,9936388,1.0319872180787746
SIG-M5,9903786,1.9849552317824917
Caki-2,10296883,3.9921303819788574
CAL-51,262093,2.862241975448649
TUHR10TKB,selumetinib-vorinostat (8-1 mol-mol),2.947823569031478
NU-DHL-1,12003241,-2.4677988287748915
SNU-668,159324,3.408616564816967
MOLP-2,135423438,1.6947558908608933
NCI-H727,136227924,3.2179651731130585
HuT 78,9903786,-0.2471360619469426
IPC-298,12003241,-0.6695697613758284
OVTOKO,JQ-1-carboplatin (1-1 mol-mol),3.861822916435348
SK-MEL-1,49836020,3.8417397632517143
BT 248,24180125,1.9773901044414168
NCI-H2196,5460769,6.02637664184288
HCC1588,6610216,4.213759827124292
BL-70,135875424,1.380668609611053
COLO 680N,selumetinib-vorinostat (8-1 mol-mol),2.406461894687131
BT 131,12003241,0.8855020405936681
BICR 31,54618164,5.999146696375086
SUP-B15,6918878,1.8867040817956129
AsPC-1,11485656,3.206693439346989
Lu-99,100016,4.341210602126273
HGC-27,135423438,0.8474032670168677
CML-T1,409805,3.5817002644537683
NCI-H1693,168313200,1.14369624115849
NCI-H1373,107985,-3.7954259612019534
SNU-1076,26596,-1.989905852137358
A-375,8515,4.080476351747669
A4/Fukuda,selumetinib-vorinostat (8-1 mol-mol),0.52731023294293
BT 172,9926054,1.8062475080252252
NCI-H1573,10322450,3.3091904926766835
OCI-Ly19,36462,-1.4425476096855017
BL-70,26596,-3.7588271568583953
Capan-2,409805,6.718498972992748
Calu-6,8515,4.504386605976223
NCI-H716,sirolimus-bortezomib (250-1 mol-mol),0.1986169667929478
SNU-C5,44491742,3.683316121476328
RCH-ACV,6505803,0.7886152170301014
NCI-H1650,9926054,2.506807917571585
Panc 04.03,44493528,4.362737332857046
HEL 92.1.7,262093,2.5840863683898885
5637,6610216,4.322793648631034
SK-N-MC,6610216,3.936381871517216
Hs 895.T,9927531,5.651415148698969
SW982,9903786,2.8939777098979333
HT-144,135875424,4.403596226349448
KHM-1B,246676,1.870399937828377
KMH-2,9926054,1.558336314725876
KYSE-410,9903786,4.00816844948711
JHOC-5,JQ-1-carboplatin (1-1 mol-mol),1.4333459148204122
SK-MEL-24,selumetinib-GDC-0941 (4-1 mol-mol),-1.728607730118346
ECC12,11485656,3.0837599564309164
Caov-3,9936388,-6.651302664748808
SW1271,135875424,3.8663800475620542
L-428,36462,-0.2610095506512102
JHH-5,9927531,4.499670785521202
SNU-182,3689413,-3.9177675224777406
BT-20,12003241,1.693784137841815
BT 159,136227924,3.541986211057949
HCC2279,selumetinib-vorinostat (8-1 mol-mol),3.4821596775534167
B-CPAP,6918878,1.5397343685525162
NCI-H1105,36462,-0.2485041709419367
HCC1419,9911830,2.011265025097353
GDM-1,9903786,1.637599474321908
KMS-12-BM,JQ-1-carboplatin (1-1 mol-mol),-1.7231272416518306
LK-2,26596,-1.655987263184575
KNS-60,135875424,4.390614396621118
NCI-H2087,selumetinib-GDC-0941 (4-1 mol-mol),-1.1511446717874352
JJN-3,148124,-5.493027063423673
COLO 800,100016,6.663651406564157
Karpas-620,11404337,-0.9098676733651666
BT-474,selumetinib-vorinostat (8-1 mol-mol),2.752458488334215
Caov-3,9911830,2.8215627878948566
P3HR-1,168313200,4.175609839213621
MeWo,10296883,4.224617443246128
SK-N-AS,26596,-3.589406361417691
HCC1806,136227924,2.6306602850580387
U266B1,12003241,-0.5113173834247196
NOMO-1,9926054,1.6113291347040215
LMSU,12003241,-1.0531077396215482
A-253,sirolimus-bortezomib (250-1 mol-mol),0.2141066423714133
639V,selumetinib-vorinostat (8-1 mol-mol),4.333825603918846
OPM-2,8515,3.0418796641091226
P3HR-1,6610216,4.758792166812945
NCI-H1395,10322450,2.951434286433811
LCLC-103H,sirolimus-bortezomib (250-1 mol-mol),2.0296751829948683
KATO III,135875424,4.043779267428047
SNU-738,11485656,2.5933785348749243
TUHR10TKB,107985,-4.323692469229263
PK-59,409805,4.129578188717334
VMRC-RCZ,9936388,2.3109640343405418
MOTN-1,44493528,4.082381508431214
LNCaP clone FGC,24180125,4.5156786529947714
HT,11485656,2.2235968294792534
JHOM-1,3136844,5.151800248316799
NCI-H446,tanespimycin-bortezomib (250-1 mol-mol),0.8775659669348672
SK-N-AS,JQ-1-carboplatin (1-1 mol-mol),2.0637783416612767
NCI-H460,159324,4.0462841352482855
RERF-LC-Ad1,11404337,1.7320849295693297
RKO,12003241,-0.2410566552434749
JHH-4,26596,-1.5147419870530787
GaMG,6505803,-1.4041196242536171
Becker,11485656,3.616159279519061
HEL 92.1.7,44491742,4.540639923778426
COLO 678,54618164,4.04427262226164
DoHH2,3689413,-5.86508857802515
RERF-LC-Ad1,selumetinib-GDC-0941 (4-1 mol-mol),2.261809192633126
NMC-G1,409805,5.417486676360457
NCI-H1355,8515,3.3761756776550236
NH-6,10296883,3.372603292906397
OCI-AML-5,148198,-5.018972426044919
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683
BT 333,135875424,3.156129563480943
COLO 800,136227924,2.9949932078985437
BT 231,6610216,3.7441566513120863
RKO,11485656,2.16906736756012
EFE-184,409805,6.4504565549042665
SNU-C5,439501,-1.612847853644416
PE/CA-PJ15,24180125,3.914289437715523
LUDLU-1,10322450,1.9625689447261536
MOLT-3,JQ-1-carboplatin (1-1 mol-mol),-0.167608830947713
BT-12,148198,-4.094223347380762
SW579,36462,0.7742536602594905
Rh30,136227924,4.165333500464175
A3/Kawakami,46943432,-0.8824204154734967
SNB-75,148198,-3.914832369251688
PE/CA-PJ15,439501,-2.069757641280327
P-STS,262093,0.957741648186898
DU4475,26596,-2.6903175915045305
HuH-28,9911830,1.7583822057953695
NB1,11404337,-0.8321448133483081
SNU-1214,54618164,3.4998200252029257
NCI-H1373,9936388,2.083574695365507
NCI-H2196,10296883,4.157958831010532
MDA-MB-453,9911830,2.483477791354312
NCI-H1694,selumetinib-vorinostat (8-1 mol-mol),2.149311706676436
NCI-H1869,409805,5.751744182014799
HSC-2,11485656,1.6817242340457108
U2OS,107985,-5.01906931244061
COR-L105,409805,5.8843358134901775
Kelly,10296883,3.2053414181421265
L-428,100016,6.045371287660442
MOLT-3,36462,0.822802174642417
Hs 683,107985,-3.457154115132212
BICR 6,135875424,4.583907142773698
LC-1/sq-SF,148198,-3.4004768458616086
SNU-C1,44493528,4.07827245501809
DMS 79,6505803,3.896341959956276
PK-1,148198,-3.6704242534149296
RD,54618164,3.8582073092246394
GSS,135875424,3.760188013536636
JK-1,24180125,1.6438526742405235
CAL-85-1,54618164,4.01765600829776
BT-16,5460769,2.094030868827637
NCI-H929,9927531,5.740923779315927
DMS 273,11485656,2.8704893197930272
Kelly,9926054,1.469291049176786
Pfeiffer,5460769,3.50798965945468
NCI-H1339,selumetinib-GDC-0941 (4-1 mol-mol),1.2226355569779708
CAL-62,12003241,-1.1507806931187785
Peer,3689413,-2.558911360370697
KYO-1,10322450,3.690990391858763
NCI-H196,6918878,3.7948272154638825
EHEB,6610216,4.931191689693455
JMSU-1,10322450,3.467232689574709
ML-1 [Human thyroid carcinoma],8515,2.907082200923046
NCI-H2052,9926054,2.624833706657142
EN,sirolimus-bortezomib (250-1 mol-mol),1.0494581662942
HEC-251,9926054,2.414490090670839
KP-N-SI9s,9903786,1.8487391330719625
KE-39,262093,2.516325504276674
ONCO-DG-1,159324,3.5589671354196017
KMS-34,135875424,2.166327494960368
KO52,9927531,4.721929704585103
SK-LMS-1,11404337,0.6927873506119244
Rh18,8515,4.352254127140013
KMS-34,44491742,2.8856017326933965
LAMA-84,11485656,1.887389966808588
KMS-11,10296883,3.3073702256130693
HCC1833,11404337,0.2409381121234374
IGR-1,44491742,3.995353370886831
SNU-840,159324,3.351473356944552
KMS-20,46943432,0.2963080368709872
G-361,246676,0.6670896942083654
BT 245,24180125,3.7251003604929167
MDA-MB-435S,3689413,-2.4980053098555404
NCI-H1395,44493528,4.373197971838804
Toledo,10296883,3.728204772396323
DMS 273,9911830,2.0619640796568848
NCI-H1703,3136844,4.108137174406966
LS411N,9911830,3.118029057589745
HCC2279,tanespimycin-bortezomib (250-1 mol-mol),0.9868379448514812
TE-10,tanespimycin-bortezomib (250-1 mol-mol),0.6297749244951121
ONS-76,sirolimus-bortezomib (250-1 mol-mol),0.9944674218020764
P12-Ichikawa,12003241,0.1281153302005317
KE-39,10296883,3.8123665461282545
HD-MY-Z,6918878,3.564787070557489
SUP-M2,246676,3.894144452123606
NCI-H2141,148198,-5.2509826148997725
SK-MES-1,54618164,3.771541214581354
EKVX,44491742,4.084576713807475
769-P,409805,6.213929900185549
NCI-H1573,selumetinib-GDC-0941 (4-1 mol-mol),-0.038011367109904
WSU-DLCL2,5460769,0.924781789272552
YH-13,11485656,3.672447929172867
KMRC-1,136227924,2.9529226708788734
Kasumi-1,6610216,3.889187786361685
H-STS,135875424,3.212810522479317
ECC10,46943432,1.1549378530091958
NCI-H358,409805,4.640022804792819
MOLM-6,11404337,-1.8876803787246543
RERF-LC-MS,148198,-3.5927713028936834
Hs 746.T,54618164,4.0798704781496875
TE-5,selumetinib-vorinostat (8-1 mol-mol),2.572123660917941
U266B1,262093,2.320136156024279
TT2609-C02,10322450,4.933026976290495
PE/CA-PJ41 (clone D2),24180125,3.647059315463406
TE-1,409805,5.040342242889771
KMS-20,49836020,5.970121389426133
CAMA-1,sirolimus-bortezomib (250-1 mol-mol),0.4180423517556048
HCC202,135875424,3.830240155533794
DMS 53,136227924,2.35473496791988
HCC4006,9926054,1.7314546414063618
NCI-H2023,6610216,4.407320475070226
REC-1,6918878,4.654279043966399
RT-112,54618164,4.39788452790178
JHOM-1,9936388,-2.304365188363062
A-204,10296883,3.4330765827623617
EFO-27,6610216,4.772563131438148
SF539,44491742,4.105649274647132
SNU-423,JQ-1-carboplatin (1-1 mol-mol),4.402018355533478
KMS-11,3136844,3.564835240654414
HD-MY-Z,54618164,4.048037306322694
CAL-85-1,168313200,1.8264576279866271
KMS-11,107985,-4.8759119142247
HCC-56,439501,0.1637931010538502
COR-L88,44491742,3.2658502599700188
Ci-1,44491742,4.040597879597693
BC-3C,10322450,3.9889152923020537
SUP-B15,JQ-1-carboplatin (1-1 mol-mol),0.3674762383240116
LS513,9903786,1.9994254947829608
PaTu 8988s,9927531,5.1297297992623605
KMS-11,44493528,6.397457291534785
Kasumi-1,3689413,-0.2693105089834908
NCI-H23,selumetinib-GDC-0941 (4-1 mol-mol),-0.1629435385383226
CMK,10296883,3.7802056460582385
OUMS-23,107985,-3.0365791826627553
LS123,sirolimus-bortezomib (250-1 mol-mol),1.3187092506497549
SUP-HD1,24180125,2.93936623955847
PE/CA-PJ41 (clone D2),148124,5.794245590172473
HEC-50B,439501,-2.0612919893622084
GP2d,9911830,1.2685523875748046
OAW28,262093,2.853078829548121
PL-21,selumetinib-GDC-0941 (4-1 mol-mol),-0.6617204641483091
ACHN,10296883,4.360085471718373
EFM-192A,262093,3.3016365369190614
KCL-22,9936388,-5.415966351243413
MDA-MB-453,3136844,3.6967063162994114
HT,159324,0.5774269994513854
U266B1,439501,-2.1640561417805686
A-549,100016,7.181380121169662
COLO 678,44491742,3.8306560761300696
NU-DUL-1,9936388,-7.007510974926655
KMRC-20,12003241,-0.2043728031762648
NCI-H146,148198,-5.323171419653744
BICR 31,JQ-1-carboplatin (1-1 mol-mol),2.1121797103281876
SR,439501,-3.204976665793822
T3M-10,168313200,2.747390379796197
ALL-SIL,9936388,-6.364749169872344
SNU-5,136227924,2.8950932658181876
UO-31,tanespimycin-bortezomib (250-1 mol-mol),0.458183553535823
HSC-4,54618164,4.183236352259565
T3M-10,107985,-3.7399321689723872
KMRC-20,9936388,1.9781775187030703
AsPC-1,8515,4.986545700595871
HuP-T4,135875424,5.011521901574996
DEL,12003241,1.2715450206031036
A-375,12003241,-1.2978704743837648
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681
A-375,6918878,1.993858594678216
NCI-H226,262093,3.882477305073409
Yamato-SS,selumetinib-vorinostat (8-1 mol-mol),2.5138780111787424
NCI-H2170,135875424,4.845645858275147
GSU,9903786,4.148563338701872
MOTN-1,24180125,1.1072514712604145
A4/Fukuda,6505803,0.0348674492980193
FU-OV-1,136227924,3.2834953568281597
FTC-238,11485656,1.7631950190895933
Granta-519,9903786,1.2937892753152922
GMS-10,selumetinib-GDC-0941 (4-1 mol-mol),1.7760805254050829
NCI-H2405,107985,-4.119694758302467
OC 314,136227924,3.246361398875885
H-STS,36462,-1.1706487337003968
U-87MG ATCC,tanespimycin-bortezomib (250-1 mol-mol),0.7593284831518214
NCI-H747,11485656,1.912245155570418
NCI-H1341,6505803,-3.3380388018759772
MOLP-8,46943432,-0.8980695552897974
SNU-C2A,selumetinib-vorinostat (8-1 mol-mol),2.556346033839852
NCI-H2342,11404337,1.4757013589007744
Capan-1,9927531,5.621022347820903
GB-1,11404337,-0.6005799825323985
HD-MY-Z,168313200,2.256800856387925
BT 416,9926054,1.8827513028201357
NCI-H2052,sirolimus-bortezomib (250-1 mol-mol),3.0581569825638417
MFE-296,439501,-3.0642012902552
COLO 699,9911830,3.503135242779156
SH-4,selumetinib-vorinostat (8-1 mol-mol),0.851484479163358
KMRC-20,159324,3.723725061334236
Karpas-422,8515,3.8543440231436135
HOP-92,168313200,2.171997683243581
NCI-H2452,tanespimycin-bortezomib (250-1 mol-mol),1.699086924939448
HOP-62,6610216,4.033430969864694
MM1.S,148198,-3.54523038003387
2004,135398744,6.587609936981218
EM-2,11485656,1.7010188292526576
WM1799,107985,-2.5278242987340525
SNU-175,12003241,-1.252002444372071
OV7,6505803,-2.17823489191902
NCI-H1299,100016,6.953805951258825
NUGC-4,9936388,-5.886331938622264
IST-Mes1,135875424,5.039969018342982
LMSU,54618164,5.037763382519864
G-401,11404337,0.5096427987118028
UM-UC-3,262093,2.408651217666756
VMRC-RCZ,sirolimus-bortezomib (250-1 mol-mol),0.0993693702457471
TCCSUP,24180125,2.590806345958597
GB-1,409805,6.386301326274494
LS1034,10322450,3.783129685700755
DU145,148124,-5.577110103227381
SNU-175,100016,4.815284438481943
Panc 02.03,11404337,1.528571500956484
SW982,107985,-3.8739387991974303
JHOS-2,262093,3.1807395255548463
IGR-1,11485656,3.283043378063367
DU4475,6505803,-2.3168305657918156
NCI-H1666,9903786,3.302889272478758
EHEB,tanespimycin-bortezomib (250-1 mol-mol),-0.1449440337171298
BT 216,439501,-3.37474066613204
NCI-H226,409805,8.210178607703003
HT-1080,selumetinib-vorinostat (8-1 mol-mol),2.4518233128508418
EPLC-272H,24180125,2.4592552986941763
COLO 741,3136844,4.130175824257536
Pfeiffer,262093,0.9483544228261476
BT 416,439501,-5.114778373309692
CAL-148,439501,-2.3789265547219647
Daoy,9926054,2.457854765834399
IST-Mes1,262093,3.164571948045499
NCI-H28,54618164,4.110674659923601
IST-Mes1,9936388,2.2275468363886763
DV-90,135875424,3.100724148145735
HT-144,selumetinib-GDC-0941 (4-1 mol-mol),0.3357004293629391
NCI-H650,107985,-3.1029215971931645
IM95,148124,-7.38218571284071
22Rv1,selumetinib-GDC-0941 (4-1 mol-mol),-0.8202887961023889
SJSA-1,9927531,4.886165341408575
Jurkat,148198,-2.758721203845009
OCI-AML-5,9911830,2.11387543619275
SNU-46,12003241,-0.9132341104689335
LS180,6918878,3.4964027843545775
NCI-H1395,36462,4.192459813965937
NU-DHL-1,135875424,2.8057790902603665
LXF 289,tanespimycin-bortezomib (250-1 mol-mol),-1.4479595903244196
SNU-216,9927531,4.928854217015946
COLO 792,9926054,1.6988024802785178
Caov-3,12003241,-2.5094220970195136
KYSE-140,selumetinib-GDC-0941 (4-1 mol-mol),1.940040050969728
COR-L95,9911830,2.1813921058815553
BT 228,6610216,4.129545438534938
HEC-50B,246676,0.7337794677145143
JHH-4,11404337,-2.717621679177181
Tm87-16,11404337,-0.2481919010875855
JHUEM-7,262093,2.8461427698978197
NCI-H1573,6505803,-1.6898584234465963
ST486,409805,3.877677170131383
GOS-3,selumetinib-vorinostat (8-1 mol-mol),4.505292657728925
Li-7,148198,-2.409975630589331
SCC-25,9926054,1.6689856093207305
OC 314,tanespimycin-bortezomib (250-1 mol-mol),-1.1782334155710066
Rh30,6505803,0.7803145928661782
SW579,148198,-4.901581686812131
Jurkat,6918878,-0.0875481694256406
MFE-296,246676,4.375622879184601
IGROV-1,5460769,1.6083174601829917
HCC1806,11404337,0.4604274664094434
MDST8,JQ-1-carboplatin (1-1 mol-mol),1.720719180230483
GA-10,9903786,1.0626395044563215
MOTN-1,9903786,1.5262783813128549
DMS 273,selumetinib-GDC-0941 (4-1 mol-mol),1.852942012782467
KNS-62,sirolimus-bortezomib (250-1 mol-mol),1.3906693403770916
CAL-54,135875424,4.317349634986473
HCT 15,JQ-1-carboplatin (1-1 mol-mol),0.2733719637316636
SNU-C5,136227924,3.8791329718590264
Panc 08.13,JQ-1-carboplatin (1-1 mol-mol),-0.4380500096287519
NCI-H2023,9903786,4.254062749563359
NCI-H1299,136227924,3.5346618762414392
GCT,9926054,1.6553855879894792
NCI-H1299,JQ-1-carboplatin (1-1 mol-mol),3.860003872097341
LAMA-84,tanespimycin-bortezomib (250-1 mol-mol),-0.5777887932469495
Karpas-299,148198,-2.4560718310367604
NCI-H23,3136844,3.566150557931806
G-361,100016,5.501390716782531
YD-8,9911830,1.9962756690281929
MKN74,9911830,3.231160876799454
2004,46943432,1.6029430054361635
NCI-H1373,6918878,4.735410863186812
BHT-101,9936388,2.229649251743914
NCI-H441,12003241,-0.5712831750055372
NCI-H2052,selumetinib-vorinostat (8-1 mol-mol),0.3758764732322367
ECC12,136227924,3.114580380384796
KMH-2,262093,2.330746095077634
A2058,26596,-1.435799382276171
HT-1080,26596,-1.5262132269513464
SK-MEL-2,6610216,4.255505327986827
BT 228,10322450,4.52310265932876
SK-ES-1,36462,-0.9833921744862832
EHEB,5460769,-1.3281679410072365
KYSE-150,9926054,2.2758457773041645
SNU-466,JQ-1-carboplatin (1-1 mol-mol),1.650577111038187
CAL-85-1,44493528,4.246011079202567
SW1417,10296883,4.30591793322403
KMS-26,9936388,-7.293063549205381
DMS 454,168313200,1.494818405259989
NCI-H1650,tanespimycin-bortezomib (250-1 mol-mol),-0.4838646802432306
Fu97,10296883,3.8261692245769776
TE-15,148124,-8.056509685609365
HCC38,12003241,1.828137629090711
LOX-IMVI,24180125,3.3051299487129415
FTC-238,44491742,5.664145193267726
YKG-1,44491742,4.005192115909779
CAL-78,36462,2.4399344670231295
NCI-H1105,tanespimycin-bortezomib (250-1 mol-mol),0.6948185089061538
Hs 294T,136227924,2.369017342053728
NCI-H1792,10296883,4.349504038438606
SU-DHL-8,11404337,-3.4588929056554245
KE-39,409805,5.860910954246773
HuNS1,54618164,3.902045461689573
HPAF-II,6610216,4.592168242014849
SU-DHL-1,439501,-2.3864560258185916
T3M-10,9911830,2.185392352919696
HARA [Human squamous cell lung carcinoma],135875424,5.177992671051203
HMCB,36462,1.7096647665785494
KMBC-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.2152983894179389
SK-MEL-28,11404337,1.5828408993005263
RCM-1 [Human rectal adenocarcinoma],9936388,1.970083737001912
SK-ES-1,9927531,4.061932878113416
OPM-2,3136844,3.3377711403827783
OVCAR-8,selumetinib-GDC-0941 (4-1 mol-mol),3.698487260127977
P31/FUJ,11404337,-0.879305702132212
MM1.S,11485656,1.9684027845110144
HD-MY-Z,44493528,4.44799186118661
SW579,439501,-3.952222233094387
697,107985,-4.150889560119246
B-CPAP,54618164,4.142992093020013
UACC-62,9926054,3.2338645061682914
KYSE-70,135398744,6.338938630156892
WSU-DLCL2,selumetinib-GDC-0941 (4-1 mol-mol),-0.2724910625039847
TE 617.T,9903786,3.301651498076641
SaOS-2,sirolimus-bortezomib (250-1 mol-mol),1.8011935542733906
BT-12,10296883,3.911493297930768
SNU-410,439501,-1.2001719961376376
JHH-4,3689413,0.1617777803735524
KE-39,sirolimus-bortezomib (250-1 mol-mol),2.142327162680567
PK-1,36462,2.8123461467673954
SR,5460769,1.487017062685354
MIA PaCa-2,3689413,-2.455927464924985
IMR-32,6610216,4.098372993728488
TCC-Pan2,24180125,3.6360187099049424
AsPC-1,11404337,0.3809720735493328
SNU-119,262093,2.598697839644185
RL,tanespimycin-bortezomib (250-1 mol-mol),0.0166541585574005
HT,148198,-3.46019179150445
SK-CO-1,439501,-2.410857533331093
OCI-Ly19,sirolimus-bortezomib (250-1 mol-mol),0.0855079956722299
KP-3,9926054,1.9542215923866435
SK-MEL-24,135875424,4.490880969896708
BT 224,262093,3.775565066976983
WT2-iPS,6610216,4.234940774221
CGTH-W-1,439501,-2.6325140773837012
A-549,12003241,-1.903076073453771
OC 314,6918878,2.174058738008276
SCC-9,9911830,2.3699428367857145
Yamato-SS,148198,-5.276509118521361
Karpas-422,9911830,2.3048839894494653
D283 Med,26596,-3.592310964496019
JL-1,3689413,-0.3699196862305292
Karpas-422,46943432,0.9846326291416436
KMS-18,10322450,4.373704561545144
SUIT-2,3689413,0.4029780891432681
HGC-27,409805,5.82933383605485
SK-MEL-3,9936388,1.3818026560314072
BT 232,10296883,4.252681745204764
AsPC-1,11485656,3.206693439346989
EFE-184,439501,-0.6930526838136172
KNS-81,135423438,1.6796399573672585
NCI-H1573,135875424,3.6449998804885064
TE-5,262093,1.0368633823540545
HT-1376,selumetinib-vorinostat (8-1 mol-mol),2.644964050552289
CAL-29,9927531,5.397915625533194
HOP-92,8515,3.613790274585256
NCI-H1975,6505803,-1.9841603923716855
RPMI-8226,9903786,1.7655422214301637
WSU-DLCL2,JQ-1-carboplatin (1-1 mol-mol),-0.9568070052125086
L-363,46943432,0.9900841118632197
Hs 852.T,36462,0.4490530549542245
SK-MEL-3,135875424,4.254537076795971
P31/FUJ,8515,2.4023085754769133
EoL-1,6610216,2.588029624216937
NCI-H2228,135423438,0.7954817184322217
L-428,5460769,3.644532278593977
SNU-201,148198,-1.525453793244306
CAL-29,44493528,4.2702919799030035
BICR 31,3689413,0.760898743899782
EHEB,135875424,3.250653126047009
UM-UC-1,3136844,4.2164668568379655
TE-15,44493528,4.216402167585121
SNU-878,BRD-K16130065,4.3857850176988125
NCI-H2110,262093,4.10340668622513
Lu-65,135875424,4.016301544047221
G-402,10322450,4.125946909240017
Sq-1,135423438,3.0560767843125793
RL95-2,3689413,-1.8797416437850616
EB1,5460769,0.545957183213574
KMS-26,46943432,-1.993034671230462
OE33,439501,-1.244619642300935
EB1,selumetinib-vorinostat (8-1 mol-mol),1.9651507627888476
MHH-NB-11,3689413,1.2467762283849737
SNU-1105,439501,-2.4533098010215024
SUP-B15,409805,3.825124436171416
KMS-27,sirolimus-bortezomib (250-1 mol-mol),0.0328786954835015
Hep 3B2.1-7,11404337,0.0289427466491547
SNU-1076,tanespimycin-bortezomib (250-1 mol-mol),1.399348377657982
NCI-H810,135423438,2.2822714598344764
EN,148198,-4.716132059388744
NCI-H838,26596,-1.3070884520917134
P-STS,JQ-1-carboplatin (1-1 mol-mol),0.9856003461730172
RKN,selumetinib-vorinostat (8-1 mol-mol),2.829001792073934
SNU-46,409805,6.019654456375195
NCI-H1792,9903786,2.6645651408291227
RMG-I,JQ-1-carboplatin (1-1 mol-mol),2.4287881260338584
LS180,9926054,2.059729849775666
YKG-1,3136844,4.395647151601772
OV56,135875424,4.815096584327211
NCI-H1694,10296883,3.5236508455835116
TE 441.T,11404337,-0.8068289898007032
RD,11404337,-1.7858539381850014
HCC38,44493528,4.3442022500374815
KALS-1,selumetinib-GDC-0941 (4-1 mol-mol),1.963503577041432
YKG-1,11485656,3.6397536658143865
BxPC-3,selumetinib-vorinostat (8-1 mol-mol),-1.5896818639125374
MKN7,409805,5.725297157679611
GI-1,9911830,2.041005178400821
RKO,selumetinib-GDC-0941 (4-1 mol-mol),1.3988498652301435
T-47D,54618164,5.7219706086611515
RPMI-6666,439501,-2.7068928395348935
ACHN,11485656,3.39588605431362
HCC2218,6505803,-2.0723621071637788
LOU-NH91,100016,8.416108067142021
Hs 683,10322450,2.9588176453624766
HPB-ALL,409805,3.5963919308844283
JHUEM-2,tanespimycin-bortezomib (250-1 mol-mol),-2.8441025270456097
VMRC-RCW,46943432,3.328394132724634
ZR-75-30,9911830,2.006954783053178
JHH-5,selumetinib-vorinostat (8-1 mol-mol),1.604008416934301
EPLC-272H,11404337,-0.7906068386477291
JHH-5,9936388,-4.7805778905113705
CML-T1,439501,-2.361432010025089
HEC-1-A,168313200,1.7559556787527029
MDA-MB-157,selumetinib-vorinostat (8-1 mol-mol),2.3136990091285883
PLC/PRF/5,107985,-2.4767035195687304
UACC-62,9927531,5.07743176976165
BT 340,3689413,0.410444406671797
SNU-685,11485656,2.7967045381666877
HCC1143,262093,2.740628946324062
HT-29,135875424,4.223622397781982
KNS-60,11404337,-0.460790888098764
697,26596,-3.738264049294864
TCCSUP,439501,-2.3382973857263893
RKN,12003241,-0.3350096455718494
BT 231,3689413,-1.816097223149399
TE-10,12003241,-0.2960597839275556
NCI-H2052,tanespimycin-bortezomib (250-1 mol-mol),2.581253190791589
CL-11,10322450,3.8898071669578
Sq-1,36462,2.4167886575742505
NU-DUL-1,100016,4.060799847781438
NCI-H2029,107985,-4.717829684480381
KCL-22,JQ-1-carboplatin (1-1 mol-mol),0.9961294088187655
BICR 16,24180125,3.1205694926325034
BT 232,selumetinib-GDC-0941 (4-1 mol-mol),2.347635090849183
SNU-407,5460769,0.640220508180195
Fu97,9926054,1.5136567302830126
T3M-10,5460769,3.3157316369773926
TE-10,selumetinib-GDC-0941 (4-1 mol-mol),2.2597459184044593
BT 172,sirolimus-bortezomib (250-1 mol-mol),0.9880201722030184
NCI-H1184,sirolimus-bortezomib (250-1 mol-mol),-1.8985096784471465
KE-39,11404337,-0.6939323202576905
Panc 08.13,262093,2.9271884425048404
NCI-H69,selumetinib-GDC-0941 (4-1 mol-mol),3.077666934797567
DU4475,46943432,1.711697790565195
MIA PaCa-2,8515,4.279549136929449
SNU-5,11485656,2.318118129500767
SNU-119,36462,1.6001107706429532
SCC-9,selumetinib-GDC-0941 (4-1 mol-mol),0.7797361148156482
SH-4,9926054,1.7270263084889954
SK-MEL-30,6505803,3.705919925101854
TE 617.T,JQ-1-carboplatin (1-1 mol-mol),1.6979959142929375
HMC-1-8,9926054,1.7153047636867798
TE-15,10296883,4.422841947508094
TE-1,135875424,3.5778077934437658
SW948,36462,2.9711779559511604
OUMS-23,9936388,1.0481650973608996
LAMA-84,148198,-3.5414595786059886
DMS 53,JQ-1-carboplatin (1-1 mol-mol),-0.3265365150884423
ONS-76,262093,3.354802573562099
KMS-20,3136844,4.071065919144672
LS180,JQ-1-carboplatin (1-1 mol-mol),1.5137098822728978
HOP-62,409805,5.513075555987367
BICR 18,135875424,4.8231575753624645
CAL-78,46943432,3.7521594850871822
NH-6,262093,3.0659860570310995
G-402,44493528,4.750595450232596
BT 232,136227924,3.5495643934514223
BT 172,148198,-4.688822444710566
SNU-1079,36462,1.5004158593347587
HOS,168313200,3.7801043003963217
MDA-MB-468,11404337,1.423282205986455
SW1417,44491742,4.02538714893742
SUP-T11,3136844,3.20966238052388
KP-N-YN,selumetinib-GDC-0941 (4-1 mol-mol),4.501272647475443
EBC-1,135398744,6.3334705093468235
HCC1438,136227924,3.0530124683265725
Karpas-299,11404337,-0.9739899309482728
MM1.S,8515,6.088299107521539
COR-L95,selumetinib-GDC-0941 (4-1 mol-mol),2.521789990361809
SK-N-BE(2),11404337,-0.1394184505793084
AGS,439501,-2.3986338247622148
SNU-16,44491742,2.438228727906927
SNU-5,selumetinib-GDC-0941 (4-1 mol-mol),-0.1592396564326592
HCC1428,sirolimus-bortezomib (250-1 mol-mol),2.58650359596758
KCL-22,135875424,3.663318576460465
MV4-11,409805,3.572823269874292
HCC827,409805,5.870124087870235
COLO 201,135875424,3.4896254753557354
VCaP,9903786,1.7887289169146705
MEC-1,selumetinib-vorinostat (8-1 mol-mol),2.147486249621255
Aska-SS,9936388,1.048322458845263
Capan-1,135875424,5.030307204242131
Hs 895.T,107985,-2.292353641464491
NCC-StC-K140,100016,6.431860837963816
U-BLC1,5460769,1.2363713333826207
CAL-27,9903786,1.9830233496778105
EB1,136227924,2.1314721571590876
NCI-H522,3136844,3.3827652175643577
COV362,136227924,2.2847413829349947
HCC44,8515,2.31120341608701
OCI-M1,8515,3.8522238482171263
LOX-IMVI,262093,3.0192087839524433
NALM-6,5460769,0.3419650871663187
HSC-4,439501,-1.7709622187792924
Ri-1,100016,4.838113149785687
MOLM-6,tanespimycin-bortezomib (250-1 mol-mol),0.1329164696894222
TE-8,JQ-1-carboplatin (1-1 mol-mol),3.3318874034400885
NCI-H1105,5460769,2.617523266083722
BL-70,49836020,4.386780315181427
M-07e,selumetinib-vorinostat (8-1 mol-mol),1.3971239600856724
NCI-H1299,sirolimus-bortezomib (250-1 mol-mol),1.6380242614391785
TUHR4TKB,6918878,2.8581106667154623
HCC1438,148124,-5.1651120367888375
SNU-46,100016,6.6556000707540095
TE 617.T,409805,3.5642990209893024
OCI-AML-5,8515,3.17727630785645
Hs 944.T,100016,5.802201252997301
NCI-H2085,11485656,3.209743954630266
SK-UT-1,11485656,2.414217391257394
NCI-H1975,73707440,4.623007313356143
DLD-1,36462,3.118491670951203
CL-11,3689413,0.4065181450870009
SW48,6505803,-3.5264924347891897
Pfeiffer,11404337,-3.375841294616924
NCI-H2126,12003241,2.692479485403981
JM-1,10322450,2.576608882705072
SNU-213,24180125,3.139959624084286
Jurkat,6505803,0.70436685648012
U-118MG,3689413,-0.7349249104266066
HCC1500,9926054,1.7367797854287812
SNU-8,11485656,2.474151094807621
MG-63,9903786,3.648237948966595
COLO 320,54618164,4.252894112657086
MKN45,6610216,5.033385649834963
SNU-423,12003241,-1.4382544514663564
CAMA-1,24180125,2.8471894665186785
HCC1438,tanespimycin-bortezomib (250-1 mol-mol),-1.8197339175047005
JHH-6,36462,3.378771444296558
697,46943432,-0.4384533900138119
HuG1-N,44491742,3.596787790528333
ACHN,6610216,4.543816334940376
KM12,11404337,0.0188417949264162
CAS-1,6610216,4.732980040101764
OAW28,3689413,-1.4375749125930504
BICR 16,409805,3.7207804084193734
M-07e,44491742,3.818170293843834
MDA-MB-415,9911830,3.5900525948825943
NCI-H2106,9926054,3.0044250532123735
KYSE-140,262093,3.0131352463234906
AGS,12003241,-0.4936842382500208
SUP-T1,selumetinib-vorinostat (8-1 mol-mol),2.3626230933029375
SCaBER,6610216,4.252046489021801
SNU-5,9936388,-5.37483340979982
P31/FUJ,136227924,2.3905530687579497
BT 131,11485656,2.37569711489929
MFE-319,11404337,1.7191748497396555
SUP-T1,409805,3.665439994658061
SNU-475,selumetinib-vorinostat (8-1 mol-mol),4.539590497188421
DU145,136227924,5.593457102459236
Hs 895.T,9936388,3.096853408439268
HCC44,selumetinib-GDC-0941 (4-1 mol-mol),-1.5745455752339166
D283 Med,12003241,-3.4539176227720794
2004,11404337,-1.336940767900643
MFE-296,36462,0.8328013204585911
HCC1143,10296883,4.463772522749199
OVTOKO,sirolimus-bortezomib (250-1 mol-mol),1.6633585904908004
B-CPAP,9903786,2.2781712830719316
HEC-151,5460769,2.7656616945667
Hs 944.T,tanespimycin-bortezomib (250-1 mol-mol),0.6097209222741542
KP-3,135875424,4.114191182933948
LMSU,9903786,3.928631993031556
HOS,6505803,0.7785174414799726
BT 145,9903786,2.2676133006053965
HeLa,selumetinib-GDC-0941 (4-1 mol-mol),4.580619415349248
P-STS,44493528,4.057634229186882
EBC-1,44491742,3.57682955784604
BT-12,JQ-1-carboplatin (1-1 mol-mol),4.599252590032938
SK-LU-1,3689413,-0.1029638587908799
PLC/PRF/5,44491742,4.0953370325315355
HCT 15,107985,-3.3789999307881344
DMS 79,148198,-2.9658771448885197
OUMS-23,6918878,1.8305438408156625
PaTu 8902,36462,3.471634301287976
SNU-C4,6505803,0.4157286441200272
769-P,54618164,4.26283597987166
JVM-2,11404337,0.0691580331258648
UM-UC-3,107985,-2.89914501463289
TUHR10TKB,9936388,2.290376539920044
RS4;11,49836020,6.257665529441248
EFO-27,6505803,0.9411407576336728
HCC2218,5460769,-0.600250204778271
TT2609-C02,148198,-4.067682377200374
SH-4,tanespimycin-bortezomib (250-1 mol-mol),0.1503763926907838
Caov-3,11485656,1.8981464424658587
SNU-182,409805,3.346621636723639
HOS,11404337,-1.3499027331466464
JHH-1,6918878,0.1169026807347451
MCF-7,262093,3.511527860265079
NCI-H1944,5460769,2.8815728712933533
PLC/PRF/5,148124,-0.1119871124056631
NCI-H2444,sirolimus-bortezomib (250-1 mol-mol),0.8470480091874228
SW579,44491742,3.723441369263322
SUP-HD1,6610216,3.934832448864895
BT 359,3689413,-0.0229882443129298
HeLa,107985,-3.0123177853339262
P12-Ichikawa,100016,6.391056060940552
KYSE-510,5460769,1.9314900427321815
H-STS,100016,5.985929376611731
SCaBER,54618164,4.0199688029488705
Jurkat,107985,-3.461929084789121
G-401,135875424,3.147536590476696
NCI-H2172,6918878,5.33332551521151
YD-38,148198,-2.2054243046269044
NCI-H28,9903786,3.2913179081195776
THP-1,11485656,2.379664942460744
WM983B,tanespimycin-bortezomib (250-1 mol-mol),0.7695231376052774
SK-MES-1,148124,-3.591423335334301
G-292 clone A141B1,148124,-4.342355625050856
NCI-H1184,9911830,2.231711312227627
Detroit 562,24180125,2.391091053779096
786-O,5460769,2.250547826623791
YD-10B,3689413,2.253033530854965
OAW42,9926054,1.8927643653266228
TE-10,11404337,-0.3956055748669924
MHH-CALL-3,36462,-2.387414053634969
RPMI-8402,44491742,5.171904167752256
TE-11,12003241,-1.4991757511197057
HT-1376,107985,-2.5673845406867635
Ki-JK,262093,2.27215883158064
SNU-119,9936388,-1.2994148300283177
BV-173,439501,-2.3365000657543415
CMK,54618164,3.8956255903978607
DU145,12003241,-2.0135691280208876
RCC10RGB,135423438,4.4299924289236055
HuG1-N,100016,5.877444193140431
ML-1 [Human thyroid carcinoma],3689413,0.6725245747839163
Panc 02.03,168313200,4.226618217059218
BICR 18,11485656,2.3253115987118114
BICR 6,36462,2.804124260868763
NCI-H1975,8515,2.4112113946369824
BxPC-3,100016,6.453363473458683
SF268,selumetinib-GDC-0941 (4-1 mol-mol),2.7601032387039433
MDA-MB-453,26596,-1.0726693130426117
HCC95,JQ-1-carboplatin (1-1 mol-mol),-0.3599763977581854
NCI-H322,26596,-1.3562395131244265
RD,12003241,-0.8502341845781216
5637,9936388,-5.346129703335208
HuCC-T1,135875424,4.122331591088892
Daudi,5460769,0.2326576177581661
MCAS,10296883,3.979435703813419
YD-8,3689413,-2.153430400522153
CFPAC-1,9903786,2.8562781406669653
HDLM-2,3136844,3.1177830786590963
OCI-Ly3,selumetinib-GDC-0941 (4-1 mol-mol),1.725768146081181
MSTO-211H,6918878,2.3677965777112653
COV644,3689413,-1.4992872949818017
Caki-2,12003241,-1.799336945217181
A2058,11485656,1.8402668016957284
MDA-MB-361,tanespimycin-bortezomib (250-1 mol-mol),-3.253650081939563
KO52,135875424,3.01966044425059
CAL-29,5460769,2.8970816736671416
8-MG-BA,9936388,2.9775871054225256
LS513,12003241,-0.5342180043119649
OCI-Ly3,409805,3.465377623426226
BICR 22,36462,0.4717839486114671
LS1034,135875424,4.8820481204382995
NCI-H1339,tanespimycin-bortezomib (250-1 mol-mol),-2.1721885896548514
KMS-34,44493528,3.6227585741611
HT115,44491742,4.056949016282338
MOLT-16,73707440,4.869509830184637
A-253,tanespimycin-bortezomib (250-1 mol-mol),-0.0985571483289859
SNG-M,9903786,2.9432381601198427
HCC366,9903786,2.568010100247165
BT 224,36462,3.757538934765096
NU-DHL-1,439501,-3.591448694271343
CCF-STTG1,148124,-4.009391944909006
KALS-1,44491742,4.207872917974877
GSS,9903786,1.9234294660474929
TUHR10TKB,3136844,4.991730952233322
NCI-H660,3689413,-1.4753207784543096
NCI-H1703,11404337,0.332581718456744
JHOS-2,44491742,4.089494767364973
LK-2,409805,5.966172479711887
SNU-626,tanespimycin-bortezomib (250-1 mol-mol),0.974779826853052
CHP-212,8515,1.882954928641981
VMRC-RCW,6610216,3.7289316051742274
VMRC-LCD,136227924,2.9641387298533868
SH-4,11404337,0.8208570932203854
253J-BV,44493528,5.814016422877873
SNU-869,168313200,3.0083612902281778
THP-1,135423438,1.568931663958045
NCI-H1573,6918878,2.983687044852162
NCI-H889,11485656,2.9669952832356645
HT-1080,6610216,3.897305485410011
C2BBe1,10322450,3.982412687303459
UM-UC-1,439501,-2.7541191906970224
NOMO-1,6918878,0.4522523514749809
NCI-H526,9903786,2.628275304590264
VM-CUB-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2001367648558769
T24,148124,-4.481408537000778
YD-38,44493528,4.189502567524798
JHOS-2,selumetinib-GDC-0941 (4-1 mol-mol),1.3752490539264866
M059K,12003241,-0.3753342750649466
CAL-85-1,12003241,-1.401340141763049
SW1271,107985,-2.924919788256343
TCC-Pan2,159324,3.6009893052983406
SK-MES-1,8515,3.603504398534682
NCI-H520,409805,3.8213964278284953
BT-16,3689413,5.62862969112265
Hs 729.T,sirolimus-bortezomib (250-1 mol-mol),0.5283641874253757
22Rv1,9903786,3.2246012387786536
SIG-M5,12003241,-2.3044245068014826
HCT 15,9927531,3.5842922899079173
Peer,selumetinib-vorinostat (8-1 mol-mol),1.7833552737931586
RCC10RGB,262093,2.8343922904091134
P3HR-1,selumetinib-GDC-0941 (4-1 mol-mol),3.428071377165287
Hs 822.T,11485656,3.9087962472344744
SNU-5,439501,-2.355283147047071
SNU-899,107985,-2.968304260034228
CCF-STTG1,136227924,3.7108552267199504
SiMa,tanespimycin-bortezomib (250-1 mol-mol),0.5523677352528538
TT2609-C02,3136844,4.807800005077876
HPAF-II,9936388,2.7106140569939097
NB1,107985,-2.2681430923409405
OCI-Ly19,3689413,0.0585798733039559
HEL,selumetinib-vorinostat (8-1 mol-mol),2.406012225394231
MG-63,409805,5.820012776028697
NCI-H358,100016,4.0854531303861155
Caov-3,148198,-1.1153010896864872
EN,135875424,5.104378760772923
NCI-H28,44491742,4.1731257553412116
VMRC-LCD,9911830,2.082442328496714
EPLC-272H,49836020,-3.920805882597204
Panc 03.27,262093,3.23349895733636
MFE-296,selumetinib-vorinostat (8-1 mol-mol),3.5111137224314626
NCI-H1793,selumetinib-GDC-0941 (4-1 mol-mol),1.778228229757508
LMSU,8515,4.269991680871031
CAL-78,9926054,2.780134265811309
JJN-3,6505803,-0.5101554809068779
MDA-MB-435S,24180125,3.6420485522200505
SW1990,12003241,-1.6004272332343192
BICR 22,409805,3.8456212820768214
KALS-1,JQ-1-carboplatin (1-1 mol-mol),0.9205030835960966
HCC-56,12003241,-1.1028800957118954
BT 179,9926054,2.969670240545962
DMS 273,10296883,4.130929131041443
HCC38,9926054,1.7712684565891563
HEC-6,6918878,0.1731635382554392
CJM [Human melanoma],selumetinib-GDC-0941 (4-1 mol-mol),2.04616975422909
SNU-1076,selumetinib-GDC-0941 (4-1 mol-mol),-0.5128697942190128
NUGC-3,9936388,-6.309971467031446
MOLM-13,5460769,1.2989705913507943
COLO 792,9911830,3.1107031023609824
KHM-1B,439501,-2.4289183886287535
NCI-H520,sirolimus-bortezomib (250-1 mol-mol),-2.273461177298922
NCI-H2342,148124,3.3536352990429346
U-87MG ATCC,11404337,1.6069036214157395
KALS-1,159324,3.9170291523443126
CW-2,11404337,-0.6368156397090832
GP2d,409805,5.9524352500309545
HEC-108,sirolimus-bortezomib (250-1 mol-mol),0.3537850835558722
SNU-449,6610216,3.892858260461962
SiMa,selumetinib-vorinostat (8-1 mol-mol),0.6254332670939313
NH-6,11485656,1.6969072995394532
OV-90,9903786,3.9551127291738424
BT 239,sirolimus-bortezomib (250-1 mol-mol),0.5713357079761969
A2780,selumetinib-vorinostat (8-1 mol-mol),1.1370776925514063
NCI-H2029,11404337,0.5042736669587571
HT-1197,148124,5.0758471047510625
HGC-27,10296883,3.371644583045061
PSN1,JQ-1-carboplatin (1-1 mol-mol),4.6221791431053845
BT 179,selumetinib-GDC-0941 (4-1 mol-mol),2.518966795971957
HuNS1,5460769,0.1719707153677664
COR-L95,sirolimus-bortezomib (250-1 mol-mol),0.1452212598896528
RS4;11,10296883,2.9468024036762483
BT 172,3136844,4.230837263541708
SNU-213,12003241,-1.127561281071067
COLO 678,sirolimus-bortezomib (250-1 mol-mol),2.474512114208449
BT 224,selumetinib-GDC-0941 (4-1 mol-mol),3.286346759744933
BT 504,10296883,3.915758265808419
BT 422,6918878,3.7020710121656104
HCC1143,439501,-0.7374061663212956
UACC-812,JQ-1-carboplatin (1-1 mol-mol),1.7132070182589942
Caki-1,12003241,-1.8863162536101896
TE-11,246676,4.370161981630627
EHEB,12003241,-2.0597430880681062
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
SKM-1,100016,4.336407790429152
KMRC-3,3689413,-1.603340065722176
CAL-54,9926054,1.984720179187459
HCC2935,262093,3.2004499429644704
JJN-3,3136844,4.53827086104038
NCI-H1793,100016,7.252403961124031
SK-N-SH,11404337,-0.9981993214283256
COR-L105,9927531,5.197941564874311
PE/CA-PJ49,tanespimycin-bortezomib (250-1 mol-mol),-1.0553859212416536
KP-N-YN,9936388,1.912535006220544
SK-N-DZ,9926054,1.7056763451018535
NCI-H727,9911830,2.860892848593743
VCaP,136227924,2.2790218879563255
SK-CO-1,246676,3.87632071272349
T84,3689413,-1.5299599275494418
KP-2,sirolimus-bortezomib (250-1 mol-mol),1.2004115712626864
NCI-H650,100016,5.632760623979546
DK-MG,10296883,4.218475231126156
KE-39,168313200,1.6918255094583214
NUGC-3,148198,-1.9201503205114672
PaTu 8902,6918878,3.691618711508776
VMRC-RCW,selumetinib-GDC-0941 (4-1 mol-mol),3.3415688059991537
KLE,9936388,-3.639802417260702
GSS,6610216,2.9495192814585542
Calu-6,9911830,2.8671270572829153
KMRC-2,sirolimus-bortezomib (250-1 mol-mol),0.567306978247713
DB,6505803,0.2792419606143702
OV-90,148198,-2.8305147037841425
HEC-265,11485656,2.4370263560731926
BT 440,3689413,1.7448809021086664
NCI-H1734,6918878,-0.3170226674946561
LS123,selumetinib-vorinostat (8-1 mol-mol),1.989623849791832
HuP-T4,26596,-2.6464216672474783
HPAF-II,11485656,2.414916440294545
NCI-H661,5460769,1.0320957244219937
Daudi,6918878,-0.3078198284611306
VM-CUB-1,JQ-1-carboplatin (1-1 mol-mol),1.087386470094272
YH-13,8515,4.054803825976401
TE-6,3689413,3.2359405444130473
SNU-423,135875424,3.328445896940313
NUGC-3,selumetinib-vorinostat (8-1 mol-mol),2.91278989567709
SK-N-DZ,6918878,-1.190760391282929
BT 232,9926054,2.340014679513304
OAW28,168313200,4.298133692275281
COLO 678,107985,-2.812245296747932
HCC78,selumetinib-vorinostat (8-1 mol-mol),2.477042525751606
WSU-DLCL2,8515,2.8703139987768687
HGC-27,54618164,3.7690202033971416
EN,409805,3.3343826376053154
BT 328,12003241,0.43959296828198
SNU-387,selumetinib-vorinostat (8-1 mol-mol),1.7181520026261925
MES-SA,JQ-1-carboplatin (1-1 mol-mol),4.437075394990418
NCI-H810,24180125,1.2081946563304828
COLO 684,439501,-2.1381820034562944
UACC-62,11485656,3.7372530211489057
BT 172,10296883,4.205503162843324
T98G,10296883,3.86323730718366
U-251MG,54618164,4.511776015798793
CAL-85-1,9903786,2.154153676778314
PK-45H,sirolimus-bortezomib (250-1 mol-mol),2.3044458204241014
NCI-H358,26596,-1.6094838950604715
NCI-H1869,11404337,1.2362831155289085
KYM-1,tanespimycin-bortezomib (250-1 mol-mol),-2.3069485733891155
SNB-75,3136844,4.967100835246296
DBTRG-05MG,12003241,-1.7775035610862775
Caki-1,9911830,3.4330876709464904
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434
SNU-899,9903786,2.4739971743095497
L3.3,159324,3.32597872906173
NCI-H1568,8515,2.0721444777555327
Becker,9926054,2.0290907819284283
DMS 114,8515,4.5444932371015065
MHH-CALL-4,tanespimycin-bortezomib (250-1 mol-mol),0.3224433500782956
SK-N-SH,26596,-3.7665654883669664
NCI-H841,26596,-2.5240216748283393
UM-UC-1,selumetinib-vorinostat (8-1 mol-mol),1.0639259134064845
SK-MEL-31,sirolimus-bortezomib (250-1 mol-mol),1.406107901853138
OV7,49836020,5.356073606057271
NCI-H322,11404337,0.5054322511135948
HuT 78,409805,4.736359437343851
Peer,148198,-3.8508497827716264
SW1353,tanespimycin-bortezomib (250-1 mol-mol),-0.2663421154423994
IGROV-1,49836020,5.658436828096057
DU145,9911830,2.1364996794005395
BT 164,11485656,1.7708908189678425
KMS-28BM,136227924,3.12099798130619
U-CH1,54618164,4.479902968958697
SH-4,46943432,3.9453747221340207
PaTu 8988s,107985,-3.719022802572999
8305C,9903786,1.7590562865334185
SUIT-2,159324,3.729714900714809
SNU-119,9926054,2.3608984923700036
NCI-H1869,9903786,3.8309501172404734
RPMI-8226,168313200,3.781951804453522
HH [Human lymphoma],148198,-7.602984000747502
NCI-H209,11404337,0.938734555574242
LC-1/sq-SF,11485656,2.9810268276277267
SNU-61,409805,4.743067556302579
DEL,262093,1.2345626785360508
WM88,9927531,4.19876481787408
U-251MG,9927531,5.06166571476347
NCI-H1792,135398744,6.377997167001959
UM-UC-1,135875424,3.037930773608268
NCI-H1694,9911830,2.67356882591853
SW1990,136227924,4.2742525725591864
LP-1,54618164,3.411691931198772
SUP-HD1,selumetinib-vorinostat (8-1 mol-mol),1.5115268098946817
U2OS,9911830,1.6488004545095722
BT 248,5460769,4.810999932000391
KMRC-2,136227924,3.1141635996197183
ECC10,3136844,3.313352928274663
HPB-ALL,11404337,-2.5207664268075676
Rh18,6505803,-0.099361262112988
CAL-148,sirolimus-bortezomib (250-1 mol-mol),-6.661160669337239
MM1.S,9903786,2.841249590923514
HCC1569,10322450,3.661738408949136
Ki-JK,9911830,1.963510545330546
KYSE-510,6610216,4.6142103505031375
Caki-2,409805,6.325494049989893
Calu-3,5460769,-0.6817561012415637
KCL-22,24180125,3.6923950741905074
SK-MEL-3,sirolimus-bortezomib (250-1 mol-mol),0.3038157322659797
MOLM-6,10296883,2.5763077662070195
GB-1,9903786,2.9752485766111936
Mino,8515,3.2979107224105406
SNU-1214,136227924,2.9720785133706213
SNU-410,9926054,3.256884508245376
OV-90,24180125,3.901301919914901
OVCAR-8,tanespimycin-bortezomib (250-1 mol-mol),0.6249256155417496
KLE,9903786,3.130074514321622
KMS-18,9926054,1.804034237605838
EPLC-272H,54618164,4.238029382952188
NCI-H1792,262093,4.0169185554275915
OCI-AML-2,44493528,3.8960180300608345
SNU-685,9926054,1.8961816645578051
A-204,JQ-1-carboplatin (1-1 mol-mol),0.2793211134785925
G-402,10296883,4.070324886092359
YD-38,136227924,2.6123275605059075
SUP-M2,tanespimycin-bortezomib (250-1 mol-mol),-1.1687996119846569
HSC-3,36462,2.0858436100123847
PSN1,36462,1.208410017228589
KMRC-2,9911830,1.0904583461694266
SNU-719,11485656,-1.1383067501667237
HEC-108,107985,-3.7063937347849696
ACC-MESO-1,6505803,0.753585399472996
K029AX,6610216,4.396133565066132
DU145,409805,7.850532015731276
COLO 684,6505803,-1.3840458684273105
SNU-478,9903786,1.906264308135136
PK-1,selumetinib-GDC-0941 (4-1 mol-mol),1.3787528368135669
JK-1,262093,1.0085892511994845
Mono-Mac-1,3689413,-2.253738856829829
HCC-56,44491742,4.146730174017219
Jurkat,selumetinib-GDC-0941 (4-1 mol-mol),2.512422287113006
B-CPAP,107985,-3.233876642304658
SK-MM-2,6505803,0.930978545894494
EoL-1,36462,-3.6767399444136464
PK-1,439501,-1.8745947720441176
THP-1,439501,-2.363264407361294
FTC-133,36462,0.6793689394766376
HCC827,6505803,-1.7879054202576514
OCI-Ly3,107985,-6.510642065564684
TUHR10TKB,selumetinib-GDC-0941 (4-1 mol-mol),2.6041094312427258
P3HR-1,6918878,5.0960120957368
SU-DHL-8,selumetinib-vorinostat (8-1 mol-mol),2.6193351578085164
NCI-H1092,selumetinib-GDC-0941 (4-1 mol-mol),3.727074735978538
LCLC-97TM1,6505803,0.2281876141434561
BT 482,262093,2.2810025470588102
SK-BR-3,3136844,4.597763640921218
NCI-H1395,5460769,5.87662281780079
KMRC-3,54618164,4.408138675224867
CAL-54,tanespimycin-bortezomib (250-1 mol-mol),2.1097630424969593
NCI-H2141,107985,-3.815362487743321
SNU-C1,107985,-3.980380328262601
BT 159,100016,7.101052412805122
TE-6,409805,4.941088473523551
TE-6,262093,4.180478687873399
YAPC,6505803,-0.1975849276423945
KP-3,11485656,2.673409024797461
Rh30,8515,3.718568437073075
LN-18,54618164,3.805633117253899
HCC-56,selumetinib-vorinostat (8-1 mol-mol),0.9567492072878072
Hs 940.T,9903786,1.9949918440372123
HuH-1,JQ-1-carboplatin (1-1 mol-mol),3.110129386511311
NCI-H2087,9927531,4.212541441573842
IM95,selumetinib-GDC-0941 (4-1 mol-mol),-0.8100536248662729
EBC-1,9926054,1.6543051302548544
HH [Human lymphoma],12003241,0.3736289232405389
Reh,selumetinib-GDC-0941 (4-1 mol-mol),2.2162895945823093
CAS-1,439501,-3.1948113083897223
MKN74,JQ-1-carboplatin (1-1 mol-mol),1.391387927225722
MOLT-3,46943432,1.2471285566558974
KYM-1,262093,2.2176284666013366
NCI-H661,9903786,4.646166413465223
RERF-LC-A1,3689413,-2.1513750225162114
SNG-M,6918878,4.064970935927791
GB-1,3136844,4.65952323623653
MCAS,9911830,3.0082836124394214
RVH-421,107985,-3.4217512234536684
AML-193,10296883,0.366102504312359
22Rv1,3689413,0.3571323215452703
CAL-27,9911830,3.339248730221888
JMSU-1,9903786,1.2487858864951975
Lu-99,11404337,-1.2042664696883392
P12-Ichikawa,107985,-2.752664509679756
NCI-H2106,3689413,-2.547861084772001
TE-15,9926054,1.8189889434505215
HD-MY-Z,100016,6.5820470291511555
5637,11404337,-1.271939426582808
Lu-65,5460769,3.7972822070130494
KYSE-520,11404337,-0.584711234415048
HCC1937,11485656,3.1070041038533835
RS4;11,73707440,6.471067447631978
BT-16,6610216,4.321968186952469
NCI-H1299,36462,2.6599488251356536
Lu-65,9927531,5.027796470849251
CAL-27,107985,-3.8647010297285633
BT 286,135875424,2.624951262486574
EJM,439501,-2.5591027297640565
COLO 699,6610216,4.402616524797006
U-118MG,100016,6.712569444944465
SK-MEL-5,6918878,1.446817120772073
DK-MG,135875424,4.206439943890902
Hs 888.Lu,12003241,-2.029150250693523
ACC-MESO-1,409805,5.492965963250371
NCI-H1869,5460769,3.405523512527605
BC-3C,168313200,2.4495117116245786
SUIT-2,439501,0.993663636668041
BT 112,135875424,2.6326015677965087
OS-RC-2,135875424,4.485922096178854
SNU-886,sirolimus-bortezomib (250-1 mol-mol),1.314176922115052
NCI-H2291,12003241,-0.3481975958318299
SK-UT-1,24180125,3.450035886510637
NCI-H520,10296883,3.906496007421639
OC 314,JQ-1-carboplatin (1-1 mol-mol),-0.0943346801193366
KMS-11,tanespimycin-bortezomib (250-1 mol-mol),-4.691870791647551
HDQ-P1,409805,4.8501849426838435
T3M-10,selumetinib-vorinostat (8-1 mol-mol),1.7080840266936326
LNCaP clone FGC,136227924,2.6855023326383387
BxPC-3,9926054,1.7603137158224154
NCI-H460,136227924,3.925006850615035
NCI-H2023,11404337,1.2221631791218432
Lu-65,409805,4.990129571781812
CGTH-W-1,6610216,4.780150555279878
SNU-46,selumetinib-GDC-0941 (4-1 mol-mol),1.1203054933058916
CAL-54,36462,1.7881475166292906
786-O,3136844,5.410569940334138
Ku812,136227924,2.6493599225721742
HCC4006,54618164,4.128566350429528
PE/CA-PJ15,262093,3.193957949465754
BT 482,135423438,1.5025223732344029
NCI-H2122,selumetinib-GDC-0941 (4-1 mol-mol),2.3163159551655177
AML-193,3136844,2.3016102601438044
U-251MG,9911830,3.888182385382464
NCI-H1105,9927531,4.896971855718655
NCI-H1703,JQ-1-carboplatin (1-1 mol-mol),1.5748995560231345
EB1,26596,-3.5599614403908264
HuT 78,439501,-3.2848313932186315
BL-70,9927531,3.241092589782463
KATO III,9926054,1.9057208307143456
Panc 02.03,107985,-4.238430695688479
KE-97,9927531,3.606406667936729
BHY,54618164,4.089792459606202
SNU-410,selumetinib-vorinostat (8-1 mol-mol),3.953798700676283
REC-1,10296883,4.285765558435674
KO52,439501,-3.705469726802315
SK-MM-2,439501,-1.9347764023362728
COV644,10296883,4.09466699132534
HSC-2,6610216,4.150484676216286
TT2609-C02,439501,-1.3899506791900362
SNU-1196,262093,3.697852439265109
NCI-H522,148198,-5.538025476960186
CAL-51,107985,-4.126908547019261
NCI-H1568,6918878,3.5715267618547832
SW1783,136227924,2.7676121780420364
KYSE-140,36462,3.8546995001877176
BT 333,9911830,3.7396466566294126
SW48,26596,-2.356334812614481
OCI-AML-5,439501,-3.3473386459158583
SHP-77,sirolimus-bortezomib (250-1 mol-mol),1.6844110283136058
WSU-DLCL2,9911830,1.368165043083695
SEM,135423438,-3.9763751688577527
NCI-H716,135423438,0.7002351169719838
RKN,9926054,2.8101544562472056
RD-ES,36462,-0.4809008818897318
CAL-85-1,selumetinib-GDC-0941 (4-1 mol-mol),0.1820592337314743
NCI-H1355,6610216,4.163423166007809
J82,JQ-1-carboplatin (1-1 mol-mol),4.923162890410876
TE 441.T,44491742,3.759624787095016
8505C,439501,-2.435831139874658
BT-549,148124,3.591112191677911
NCI-H647,439501,-1.4518848962069395
BHT-101,36462,1.5384712003732817
SK-N-DZ,6505803,0.8525676742203174
MCF-7,246676,2.937501315455756
SK-MES-1,9927531,5.425786603716899
Calu-6,selumetinib-GDC-0941 (4-1 mol-mol),1.8439594255895029
KMH-2,selumetinib-GDC-0941 (4-1 mol-mol),1.8839311590073071
TTC-709,JQ-1-carboplatin (1-1 mol-mol),1.695991072597723
IGROV-1,9911830,1.9130562323799436
LS123,262093,2.2774181206163018
SNU-719,46943432,1.63856313223
BICR 6,6505803,-0.317492661903071
HEC-59,24180125,5.1543604770288525
Mono-Mac-6,54618164,3.3682959793737783
TCCSUP,11485656,2.4858219651419966
SNU-886,6610216,4.570931249301276
SNU-878,JQ-1-carboplatin (1-1 mol-mol),0.3987725595760565
BT 145,107985,-3.863476066500092
HEC-6,selumetinib-vorinostat (8-1 mol-mol),1.2683644389849238
L-428,148124,-3.3272903068622965
TE 441.T,36462,0.1000718625113496
P-STS,11404337,-0.4703645434055084
SNU-761,44493528,3.842181398457216
PLC/PRF/5,6505803,-1.356651808905463
HL-60,100016,6.415560767920564
NCI-H2172,3689413,0.3383001060602208
L-428,46943432,1.673068883218937
KYSE-30,439501,-2.11333824600192
COLO 684,148198,-5.116040428924247
HCC366,46943432,3.5432880564657667
A-549,44491742,4.437272986024
SH-4,135423438,4.390344914590639
HCC1806,409805,3.807575848238892
Kasumi-1,148124,-7.196205420916251
HEL,409805,5.92709656224454
Hs 888.Lu,11404337,0.6569012069034585
DLD-1,262093,2.7792650333384072
LCLC-97TM1,5460769,-2.8089441547625067
SNU-C1,8515,3.4568553627029552
CHP-212,409805,6.004594677417721
T-47D,5460769,6.397053715460356
HuP-T3,12003241,-0.2833744856936582
MOLM-6,136227924,2.6719988051227386
SF126,262093,2.7341205400396418
EN,selumetinib-GDC-0941 (4-1 mol-mol),3.4742194134426168
HCC2218,10322450,3.115665598848324
FTC-133,262093,3.024825063724614
HuH-1,sirolimus-bortezomib (250-1 mol-mol),2.2926354506042497
LMSU,135875424,4.495921610081383
SNU-245,selumetinib-GDC-0941 (4-1 mol-mol),-0.1076829246144878
SNU-387,selumetinib-GDC-0941 (4-1 mol-mol),1.4136760504697403
Kelly,6505803,1.0108033674457453
L3.3,9936388,-5.444309252993802
BT 328,9926054,3.720062864226824
RCH-ACV,24180125,3.0709250936055037
JHUEM-2,409805,3.9028131887521225
KP-N-SI9s,100016,6.171993249574907
PK-1,6610216,4.445941439691273
KNS-60,9926054,1.3283551370415152
MEC-1,439501,-3.41979967464108
ONCO-DG-1,49836020,4.455184005808947
SR,409805,3.9177412417250137
PaTu 8902,11404337,0.5155229173062875
KMS-18,12003241,-1.9143210957947092
WM266-4,54618164,3.8908549160673744
HGC-27,135875424,2.7794180683242575
NCI-H28,46943432,2.0555870948876147
KMRC-2,selumetinib-GDC-0941 (4-1 mol-mol),1.6802426748833608
FaDu,36462,0.6827369212753006
NCI-H1623,12003241,-0.4868602659209724
SW48,107985,-4.220376672084107
BL-70,5460769,4.3376670104082455
SNU-899,tanespimycin-bortezomib (250-1 mol-mol),0.5360677802944718
ST486,135875424,2.429416484956845
KYSE-30,sirolimus-bortezomib (250-1 mol-mol),0.2847397172348017
NCI-H716,9903786,1.532038090064473
JMSU-1,selumetinib-GDC-0941 (4-1 mol-mol),1.3740828564312233
KE-39,12003241,0.559414259019648
TALL-1 [Human adult T-ALL],36462,-1.67614091927168
SW1573,9926054,3.1618263718643513
Peer,262093,1.208995800009143
SiMa,3689413,-0.4508724532834644
JHUEM-2,107985,-3.927953160479623
RL95-2,409805,3.800799243361298
OCI-AML-5,selumetinib-GDC-0941 (4-1 mol-mol),0.4941119496058851
NU-DHL-1,3136844,3.805099216127406
ChaGo-K-1,9926054,1.8139091606673228
NCI-N87,6610216,4.734758596227503
IGR-1,439501,-2.7516642734120307
BT 328,9936388,2.1535847087745386
Rh41,9903786,2.3999141751709763
NCI-H2172,148198,-0.2534137859754289
TCC-Pan2,148198,-2.533769262654455
UACC-257,3689413,2.9773275321267945
SNU-620,439501,-2.3713510132267923
SNU-C1,10322450,2.683977813165255
Daoy,26596,-2.0962215675601024
YD-10B,6610216,3.129867810058842
PE/CA-PJ34 (clone C12),6610216,4.323795888758034
GaMG,135423438,1.57749164646486
BT 139,11485656,3.131336333287838
SNU-620,selumetinib-GDC-0941 (4-1 mol-mol),-2.4786489689796554
NCI-H2106,6918878,2.233285430397979
KMBC-2,107985,-4.329865422149039
FTC-238,3689413,-2.1600357182012493
NCI-H1155,selumetinib-vorinostat (8-1 mol-mol),2.411327156163
SU-DHL-10,3689413,-0.1067642786236739
LOX-IMVI,10296883,4.016923639720429
SW48,262093,2.726859331273406
BT-549,sirolimus-bortezomib (250-1 mol-mol),0.3371996014711167
Rh30,selumetinib-vorinostat (8-1 mol-mol),2.333625325238172
SIG-M5,sirolimus-bortezomib (250-1 mol-mol),0.1286056255448012
BT 131,24180125,2.5620481352252806
HCC78,159324,3.9487688063657505
TE-8,262093,2.355811133795261
BHY,135875424,4.814173497924925
NCI-H1355,135875424,3.7219654105807622
Rh30,6610216,4.152878640581398
TC-71,6505803,0.7879550085796516
THP-1,107985,-4.6582793969870755
Li-7,439501,-2.4815602749889005
TE-14,148124,-4.465123316500658
2004,44491742,4.273676019695118
BT 187,5460769,4.174601592946769
GMS-10,11485656,3.67523785200594
OVISE,148198,-3.4121309130102055
SNU-1079,selumetinib-GDC-0941 (4-1 mol-mol),-2.187846560815933
IGR-39,26596,-2.1240544281705955
NCI-H1792,100016,5.097619126157972
PE/CA-PJ49,6610216,4.338624993526508
BC-3C,9927531,5.131139518306293
ZR-75-1,5460769,4.241529452507845
Lu-65,9903786,2.0553359532496875
MES-SA,6918878,3.2337783445104593
NCI-H838,JQ-1-carboplatin (1-1 mol-mol),6.320973453370018
Jurkat,11485656,1.7204006951846988
MM1.S,135875424,3.0538620465615587
KMS-11,26596,-4.4422678730324465
NCI-H460,107985,-2.632533954936978
LNCaP clone FGC,6918878,1.6855471667539077
SNU-668,135875424,2.8972214679308084
KE-97,5460769,-1.2505802220316746
BFTC-909,JQ-1-carboplatin (1-1 mol-mol),5.2410563732595845
SaOS-2,136227924,4.496792726095474
MOLT-16,5460769,0.1124317409166702
NCI-H1581,tanespimycin-bortezomib (250-1 mol-mol),0.5752068727797862
HuG1-N,439501,-1.480081510168686
NCI-H2110,44491742,4.139827167651669
HEC-59,11404337,-0.8184180849969249
A-549,9926054,1.8971220341716168
TALL-1 [Human adult T-ALL],24180125,1.9711647389605609
SNU-738,selumetinib-vorinostat (8-1 mol-mol),3.5433152247780892
MEC-1,6918878,1.3810956851796827
FTC-238,26596,-1.757502878688391
BT 416,262093,2.6479795412008937
BT 228,54618164,3.930760792437564
SNU-216,8515,4.27176731188738
BT 333,6610216,4.264982488375611
ECC10,3689413,0.143670384150019
K-562,107985,-3.1543528536618175
SW579,6505803,-3.37113602004837
SNU-C4,9936388,-0.0983600900121806
Ri-1,44493528,4.227657049972306
SNU-245,JQ-1-carboplatin (1-1 mol-mol),1.4160097038546082
CAL-33,9927531,3.2885061744461273
IM95,5460769,5.308865140220459
CCF-STTG1,11485656,3.67410233042364
NCI-H2052,409805,6.16020441783884
HeLa,159324,2.7422361867154654
EM-2,136227924,2.1746228564853864
NCI-H810,44493528,3.9330833724433294
NCI-H747,12003241,-1.9291719472544329
2004,3689413,-2.0950734579660417
NCI-H1341,6610216,3.743623323763183
SNU-1066,136227924,3.4679855479635644
NCI-H2023,409805,5.555285179015439
B-CPAP,selumetinib-vorinostat (8-1 mol-mol),2.3348701814890904
SW982,148124,3.628082211575536
BT 179,sirolimus-bortezomib (250-1 mol-mol),0.6409612230554944
HCC1588,44493528,4.903297648657414
Daoy,11485656,1.6776877831097698
NCI-H647,135423438,3.3344215247990507
NCI-H716,262093,3.1268134242095735
LOX-IMVI,6918878,2.149981569146133
HOP-62,135423438,1.5837123025968611
SCLC-21H,439501,-2.4331226834497612
LMSU,9926054,1.9493229998791417
JHUEM-3,9926054,2.0122307954459004
HMCB,10296883,4.337758420607625
HEC-265,26596,-1.38176914424549
JK-1,5460769,-2.680332547756694
HuCC-T1,262093,2.7118122084105374
NCI-H28,selumetinib-GDC-0941 (4-1 mol-mol),0.00452428337889
SK-CO-1,selumetinib-vorinostat (8-1 mol-mol),-0.8201042282991368
EM-2,11404337,-1.9269330473502917
SUP-B15,10322450,4.034364888516056
IPC-298,8515,4.582627951903999
NCI-H2196,136227924,2.7386742576768643
BICR 16,5460769,4.333999441494942
Ri-1,3689413,-2.346816387466721
CMK,6505803,0.4799814546857159
BICR 56,sirolimus-bortezomib (250-1 mol-mol),1.89463967365671
AGS,11485656,1.9276189109477695
NCI-H2126,44493528,4.793880451858377
NCI-H1563,12003241,-2.3981612742304614
HCC15,135423438,2.37991378319322
NCI-H2196,9927531,4.117400803944708
TM-31,selumetinib-GDC-0941 (4-1 mol-mol),1.793600027043238
BT 112,409805,3.8696760433856774
TTC-709,136227924,1.406309539576174
SNU-308,8515,4.888482056700149
A-673,107985,-4.827881226135439
NCI-H661,148198,-4.235070372495308
KMS-20,26596,-2.568893435013116
MSTO-211H,9926054,1.9546831701161536
BT 239,44491742,3.7318422225870753
NCI-H1651,44491742,4.212944602241969
LCLC-103H,selumetinib-GDC-0941 (4-1 mol-mol),3.056154104463145
ST486,10296883,2.054791984575977
SK-LMS-1,148198,-3.2983357402975484
SNU-16,sirolimus-bortezomib (250-1 mol-mol),-0.2778167709338917
TE-15,selumetinib-vorinostat (8-1 mol-mol),2.423276654507223
BT 428,135398744,8.121810698450407
SNU-407,11485656,1.7989255802763466
KMS-28BM,selumetinib-vorinostat (8-1 mol-mol),1.8148707559723616
TOV-21G,selumetinib-GDC-0941 (4-1 mol-mol),3.592857274356158
COR-L51,439501,-3.194299942621501
MOR/CPR,11485656,1.924898920968698
BT 239,tanespimycin-bortezomib (250-1 mol-mol),-2.6769003708706594
COLO 678,11485656,1.706527066043961
HCC1438,9911830,3.0081308219016205
Ki-JK,136227924,2.2053195341815424
SNU-C4,5460769,4.699419094889071
CMK,6610216,4.646052839283286
BT 224,10296883,4.270908833872631
EPLC-272H,tanespimycin-bortezomib (250-1 mol-mol),-0.4152033872226455
DMS 273,11404337,-1.7233190830375906
SNU-1196,100016,6.169672174830197
DEL,6610216,4.0677868970779025
EHEB,54618164,4.264105290178519
ECC10,44493528,3.789717888225728
A-549,44491742,4.437272986024
ACC-MESO-1,11404337,0.4174226395883805
NCI-H1703,9911830,-4.3228308305897825
Calu-6,262093,3.3052566234761116
BL-41,9936388,3.270630647985179
IGROV-1,107985,-2.8971910842184516
ZR-75-30,9936388,2.0011388860463373
FaDu,262093,2.775295689369596
SNU-61,107985,-3.1587785808489297
KMBC-2,44491742,4.484748547607026
BT 359,6505803,3.620605516662926
HCC1438,262093,5.151605944522477
KYSE-150,409805,6.128139333480887
CAL-148,9926054,1.1690943917504333
Ku812,sirolimus-bortezomib (250-1 mol-mol),-4.706863759104448
SH-4,6610216,3.723529041441613
SNU-738,6610216,4.938178948183777
JIMT-1,6505803,0.7397672871240382
EFE-184,tanespimycin-bortezomib (250-1 mol-mol),1.3257452416243327
SK-LU-1,9926054,2.124586219371247
DB,tanespimycin-bortezomib (250-1 mol-mol),-0.1936867614029041
CAL-12T,3689413,0.6503456712736767
CCK-81,6505803,-1.799603519174377
KMBC-2,selumetinib-vorinostat (8-1 mol-mol),1.67831087866627
BT 216,sirolimus-bortezomib (250-1 mol-mol),0.2946031494778452
TE-15,JQ-1-carboplatin (1-1 mol-mol),0.1114942232553469
SK-N-FI,8515,4.830476271851616
NCI-H1869,100016,6.8338343579730285
BT 145,49836020,5.352704973250576
TALL-1 [Human adult T-ALL],44491742,3.807829450429648
CAL-148,9911830,3.4554633310507623
Kasumi-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.1995459699844852
DMS 454,12003241,-0.401739549188604
IPC-298,11404337,-0.8384519836472744
JHUEM-7,54618164,3.823825423336211
TE-4,10322450,4.2386221838106835
SNU-685,9911830,2.4915618314675783
PC-14,9926054,2.1919524814380846
J82,5460769,3.931927319993056
KYSE-70,11485656,2.2230455690794404
HEC-265,JQ-1-carboplatin (1-1 mol-mol),0.3590363949507987
HT-55,JQ-1-carboplatin (1-1 mol-mol),3.678098211673295
JIMT-1,selumetinib-vorinostat (8-1 mol-mol),2.6253101469518136
MHH-CALL-3,26596,-0.8027776235461769
Jurkat,44484440,3.4272914224596827
AM-38,3689413,-2.9608439081613387
SNU-899,44493528,4.57982118171392
LS513,262093,3.104156650593673
YD-8,11404337,-1.7651477779753342
A-498,409805,6.12415200666612
SF295,262093,3.7346493602329462
MKN7,107985,-2.3572369506787036
ME-1 [Human leukemia],selumetinib-vorinostat (8-1 mol-mol),0.9847489523071804
SK-N-MC,72199289,4.349528374595986
SNU-308,9911830,3.1003297251909845
KU-19-19,9936388,2.972521935644637
HD-MY-Z,sirolimus-bortezomib (250-1 mol-mol),0.1628834192986952
KMS-34,262093,1.7183791017447037
MDA-MB-361,JQ-1-carboplatin (1-1 mol-mol),1.1182697854337842
MHH-ES-1,26596,-2.3851189142163176
NCI-H1734,6505803,-1.047831457511852
RD,6505803,-1.3634143694838363
HT-1197,44491742,3.769562948559888
RPMI-8402,6610216,3.283119634553979
HSC-2,44493528,4.3031885175258475
NCI-H1563,JQ-1-carboplatin (1-1 mol-mol),4.5120553214981625
BICR 6,439501,-3.4433349442086234
OE19,6505803,-3.540605672493051
TALL-1 [Human adult T-ALL],10322450,3.187962745096946
LOX-IMVI,6505803,-1.7860593354464098
KYSE-70,10296883,3.691258417269261
MIA PaCa-2,9927531,4.662028210048159
NCI-H508,168313200,3.8956929305723618
HCC2108,54618164,5.127082823492277
HCC1500,168313200,1.6452616775244175
MPP 89,9927531,5.277486378374347
SHP-77,selumetinib-vorinostat (8-1 mol-mol),2.4257473125745275
HCC1569,135875424,2.981320238705361
HEC-6,selumetinib-GDC-0941 (4-1 mol-mol),2.6580781853062887
VMRC-RCZ,24180125,3.3518977322477084
SU-DHL-10,148198,-3.583469156036767
BC-3C,44491742,3.863176048034213
G-292 clone A141B1,54618164,5.2874340553249395
MDST8,8515,5.547245054967808
LOX-IMVI,36462,2.305207758034576
BT 422,12003241,1.9442582460098417
Li-7,tanespimycin-bortezomib (250-1 mol-mol),-1.0040061775367006
KYSE-70,262093,3.701785722517592
MDA-MB-361,9926054,1.9315814680305097
SK-N-SH,148198,-4.813749517608016
SW948,sirolimus-bortezomib (250-1 mol-mol),0.0443839489335638
MHH-NB-11,6505803,-0.1977325958086978
JHH-6,9927531,5.6306250844291075
ZR-75-30,sirolimus-bortezomib (250-1 mol-mol),1.7584870714322065
Toledo,168313200,1.788753632318655
NU-DUL-1,selumetinib-vorinostat (8-1 mol-mol),-0.8061860485308271
J82,36462,1.6839056752253356
Hs 746.T,9936388,2.9301322002426393
HT-1197,9903786,4.0222787047996915
RPMI-8402,5460769,1.919918299685469
A-549,11404337,-0.2898707579606809
HuCC-T1,6610216,4.873841301442745
JM-1,6918878,0.0294179493888284
HCC95,11485656,2.1465787672402104
NCI-H929,selumetinib-vorinostat (8-1 mol-mol),1.6351341952434315
BT 224,107985,-2.0427396938627993
NCI-H28,6610216,4.594899997318736
COV644,135875424,4.838301094582854
COLO 680N,262093,3.064075924679912
Ci-1,3689413,-2.5186366363641293
CAL-120,selumetinib-GDC-0941 (4-1 mol-mol),2.9364136017139932
BT 179,10296883,4.29112387952489
HCC95,439501,-2.2206191561813537
KMS-20,135398744,7.132407790781497
KMS-26,135875424,3.4699512465530713
NCI-H226,sirolimus-bortezomib (250-1 mol-mol),1.5737469522318486
KYSE-30,262093,2.7328983938102693
P3HR-1,sirolimus-bortezomib (250-1 mol-mol),0.1161782637204882
HCC1833,159324,2.7242134281125883
U-937,selumetinib-GDC-0941 (4-1 mol-mol),2.5351871004530713
MCF-7,136227924,2.325387172028071
U-CH1,6610216,3.8100359260465617
MOLM-13,46943432,-0.154947866345158
GDM-1,9911830,1.163129304540652
WM88,12003241,-2.725037582616198
TE-10,54618164,3.9236183962160993
PL-21,9936388,-7.198492921849207
NCI-H196,262093,3.244471483790871
NCI-H1435,11485656,2.194016648354146
COR-L95,6505803,0.0712785503404296
NCI-H661,107985,-3.0533673433660393
CCK-81,9936388,-6.1702645083973335
A-375,54618164,4.173421291280232
MHH-CALL-4,9926054,1.817922343737897
LS123,11485656,2.4615924556875575
SK-N-BE(2),9936388,-4.085977969956083
WM1799,5460769,2.2209273724490335
SF539,sirolimus-bortezomib (250-1 mol-mol),0.2813071974909388
SK-MEL-28,9911830,3.7902815277231663
BT 440,selumetinib-vorinostat (8-1 mol-mol),2.9296723538082543
KU-19-19,409805,5.730069773001202
SK-OV-3,54618164,4.236989567252486
SK-CO-1,9903786,1.8148473241522671
SIG-M5,9927531,4.880658167161108
MV4-11,9926054,1.3518163817603386
RD,6610216,4.20357872595554
KMRC-3,135875424,5.901870515016819
OCI-M1,46943432,1.475072626321256
EHEB,36462,-0.01305148556103
CW-2,tanespimycin-bortezomib (250-1 mol-mol),2.6313334952159844
Hs 940.T,439501,-3.345771956263442
SKM-1,selumetinib-vorinostat (8-1 mol-mol),-1.297292884672553
NCI-H196,107985,-2.614031076452801
NCI-H1838,5460769,4.113464535509182
A3/Kawakami,selumetinib-GDC-0941 (4-1 mol-mol),2.6174879982933317
Karpas-299,159324,-1.063709784546932
A-204,5460769,1.2636887852465275
NCI-H28,136227924,2.9733016664554155
HMCB,12003241,-2.4987094510650834
EBC-1,10296883,3.5123553698394336
RERF-LC-Ad1,3689413,-1.7788688033713365
CAL-51,8515,3.5852991976047863
Panc 04.03,8515,4.900392472396633
ACC-MESO-1,439501,-2.1177142805540163
SU.86.86,107985,-3.2399662487956875
NCI-H196,24180125,2.7124009343781665
HuP-T4,409805,4.746505123210962
PC-3,100016,6.704789318152335
NCI-H810,6505803,1.3479141255635732
KMS-26,9927531,3.4485802259646703
NCI-H2172,159324,3.4766300457250416
GI-1,9903786,1.7362048371434178
MOLP-2,6610216,5.084956215990001
HCC1395,sirolimus-bortezomib (250-1 mol-mol),4.6634118808153735
BT 216,6610216,3.705448664684853
CAL-33,409805,3.659975816516364
BICR 22,5460769,-1.4539525700949456
253J,9911830,2.3790820688592915
JHH-5,5460769,1.8419810692418657
CAL-62,26596,-2.09128877077726
A-673,168313200,1.7801049656035806
NCI-H2052,5460769,4.5383671359434254
HEL 92.1.7,9911830,2.248752452098022
Li-7,26596,-1.7379173085827686
NCI-H1092,6505803,2.777743929422052
OVTOKO,selumetinib-vorinostat (8-1 mol-mol),4.272915839484638
HCT 15,148124,-3.0176054207650993
NCI-H2081,JQ-1-carboplatin (1-1 mol-mol),1.838328263048474
NCI-H2023,9911830,3.443492401360393
KMBC-2,36462,2.9079010396533302
YD-38,26596,-1.5752818654632963
PE/CA-PJ49,11485656,1.6473553373420289
DU145,9927531,4.922928089289864
RERF-LC-Ad2,6505803,1.9541445598040723
TF-1,9926054,1.8165915475907757
NU-DHL-1,9926054,1.5745053582273782
VMRC-RCZ,9911830,3.099943996543876
HCC1500,6918878,3.8452122267855544
Jurkat,selumetinib-vorinostat (8-1 mol-mol),2.341506614269864
DB,100016,4.066938426663746
ZR-75-1,107985,-2.8555700274021176
HCC1195,tanespimycin-bortezomib (250-1 mol-mol),0.0531375858676879
KP-N-SI9s,sirolimus-bortezomib (250-1 mol-mol),0.5710762504018412
786-O,9911830,2.361754210186343
NCI-H660,6505803,2.5478241570945026
WSU-DLCL2,135875424,2.114413324161352
LAMA-84,8515,3.598543173895061
MV4-11,3689413,-0.1876256430889787
NCI-H2228,9926054,2.036678685605589
YKG-1,sirolimus-bortezomib (250-1 mol-mol),0.0311399701967428
NCI-H838,selumetinib-vorinostat (8-1 mol-mol),3.9701798301910873
TTC-709,409805,3.604457775701489
Ri-1,8515,1.7161399430410786
BICR 6,6918878,2.9182093814584276
NCI-H441,11485656,2.293217978905633
PE/CA-PJ34 (clone C12),26596,-1.1037163261022582
NCI-H1650,9936388,1.5331586238984851
ECC12,36462,1.5469230001640613
RD,selumetinib-GDC-0941 (4-1 mol-mol),0.4291937329067764
NCI-H716,136227924,3.096712149885638
ChaGo-K-1,409805,3.8445782197925022
TYK-nu,135423438,1.6233801732572664
DND-41,JQ-1-carboplatin (1-1 mol-mol),-0.1344797725296377
SF295,36462,2.0611349093400926
HCC1954,136227924,3.208934620428715
HCC1171,selumetinib-GDC-0941 (4-1 mol-mol),-0.4155569356036221
Granta-519,46943432,2.0409318821812477
EJM,9926054,1.7534790705740089
NCI-H2126,439501,-1.6048735298353825
SNU-175,8515,2.468175220100517
SCC-25,12003241,-2.271238083973026
MCAS,135875424,3.596680652923431
647V,selumetinib-GDC-0941 (4-1 mol-mol),1.2881187017164255
CAL-27,3689413,-0.5192231908073464
NCI-H650,3689413,-2.023136862594463
SEM,10322450,3.0556839954997685
SNU-899,9936388,1.721308391499284
SIG-M5,selumetinib-vorinostat (8-1 mol-mol),-2.7749557072637083
COLO 320,168313200,1.677967705893316
RERF-LC-MS,6505803,-0.6931241555509828
DMS 273,sirolimus-bortezomib (250-1 mol-mol),0.2700618452232576
NCI-H1373,9911830,2.7658266130985036
PC-3,262093,3.07605084151026
BT 416,100016,4.165407662771479
MOTN-1,136227924,2.565430053126423
SNU-8,6610216,4.841964372920672
NCI-H2052,11485656,3.009511423148426
MOTN-1,46943432,2.0865567355520107
Lu-65,10296883,3.98979643435714
KE-37,3136844,3.055196168383919
GaMG,148198,-2.2602125846072627
KMS-34,3689413,-2.478307053017587
SNU-213,3689413,0.5464532854962126
NCI-H1915,409805,3.8141858706600904
M059K,24180125,3.2410022874201165
NCI-H2228,49836020,2.091075397258879
NCI-H520,9903786,3.332228860924169
GB-1,3689413,-2.42348697309168
LAMA-84,6505803,-0.5453051583932805
HEL,9903786,1.206049982415758
GaMG,6610216,4.2952250564370456
SK-N-FI,107985,-2.4954057138608423
HT-29,159324,3.659418703810202
Hs 729.T,9903786,3.958862053564968
Ri-1,409805,4.02318209858409
HT-1197,3136844,4.18722926919612
MHH-NB-11,44491742,4.127844347820601
TTC-709,6918878,3.4254822690463116
TE 617.T,54618164,3.769426855939867
GMS-10,135875424,3.9988471135126633
A-549,12003241,-1.903076073453771
HEC-151,tanespimycin-bortezomib (250-1 mol-mol),0.2767790074283919
TE-11,36462,0.9380758205359858
NCI-H69,159324,2.8496599319969236
OCUM-1,12003241,-0.8918432074998596
NCI-H1373,3136844,5.712245291278409
NCO2,sirolimus-bortezomib (250-1 mol-mol),-0.0508749295611852
SNU-1079,12003241,-2.81102043929997
U-937,26596,-4.272350751013951
SK-MEL-2,24180125,4.1729350383120485
OVCAR-8,100016,5.760214455598188
RPMI-6666,JQ-1-carboplatin (1-1 mol-mol),0.5557739670518063
JHH-6,3689413,0.376454666699167
NCI-H2196,49836020,4.894055204627393
CFPAC-1,11485656,2.6116197546865663
SNU-410,9936388,2.1346646723856444
HEL,107985,-3.965696416470184
NCI-H2141,11485656,1.4987808894190335
KE-39,9936388,1.1689372039333712
Calu-3,148198,-3.0650277227090643
KYSE-70,9936388,-4.915846401119174
HCC2108,sirolimus-bortezomib (250-1 mol-mol),3.017488658473148
RKO,136227924,3.256787131627037
LNCaP clone FGC,11404337,0.2192821981043099
SK-MEL-28,24180125,3.6660135560508142
HEC-251,sirolimus-bortezomib (250-1 mol-mol),1.5826018331734562
MDA-MB-231,9936388,2.201115810933066
ECC10,439501,-2.678077063421273
HCT 15,8515,2.256673740803226
NCI-H1666,8515,2.2563145228126578
NCI-H1651,148124,-6.206730462770721
COLO 800,9911830,2.243468062819411
NCI-H23,8515,4.438139635205895
KO52,11485656,1.6797102251271416
SCaBER,136227924,3.000538162090115
A-253,49836020,4.493346426084629
Detroit 562,9936388,0.4800991198944179
ESS-1,11485656,1.966597488234831
Pfeiffer,26596,-3.7585498657816414
JK-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8712031645935759
NCI-H1339,selumetinib-vorinostat (8-1 mol-mol),3.4752897958657245
Panc 04.03,9927531,5.313421559596226
NCI-H1838,tanespimycin-bortezomib (250-1 mol-mol),0.7534040164239657
L-363,11404337,-0.847854507325903
NCI-H2106,9911830,2.5796124451187943
MES-SA,10296883,3.8748644308488864
NCI-H1435,9903786,1.8372314189682823
WM793,6610216,4.179764818643997
BT-16,107985,-4.283991863773396
253J-BV,9911830,3.5060206462431065
KMS-28BM,439501,-2.813687034658713
IST-Mes1,6505803,0.837907313306775
ECC12,sirolimus-bortezomib (250-1 mol-mol),1.6381290256709142
SNU-61,46943432,3.2717403410494397
NCI-H526,159324,2.2515086440464676
TOV-112D,6505803,2.1658799335254644
NCI-H2087,9926054,1.8666936138192145
SNU-478,selumetinib-GDC-0941 (4-1 mol-mol),-0.9905008638696244
OCI-AML-3,6505803,-0.781782964907092
JHH-1,26596,-0.7682069189838904
PaTu 8988t,107985,-3.7439330143768106
NCI-H322,9911830,3.326024724200298
Toledo,9927531,3.803347409887559
SF268,9927531,3.0957828421568396
Panc 10.05,9911830,3.323160861046792
KP-2,selumetinib-vorinostat (8-1 mol-mol),0.7110863342407049
DK-MG,6505803,1.1282501869631134
HT-1376,54618164,4.43635672332215
NU-DHL-1,136227924,1.2519389073848997
HT-29,148198,-0.9587327064995448
HCC1195,8515,4.9817766810597135
JJN-3,9936388,-8.876764475546423
TYK-nu,148198,-1.9214322639595771
KE-39,JQ-1-carboplatin (1-1 mol-mol),1.0085240512621525
NCI-H1793,409805,6.049600065269875
DEL,54618164,3.780724488131313
Lu-99,159324,2.0061046344011944
BT 216,9936388,1.282590182354356
KMRC-3,36462,3.377440322331922
SCaBER,3136844,4.826877330172151
SF268,9926054,1.8343424406702535
Peer,439501,-2.3355144214927614
A-375,10296883,4.364928139092641
CAL-51,36462,0.7338920585832341
SNU-1079,262093,2.756274169770221
A-549,409805,5.689640893560965
JHUEM-3,54618164,4.177522311849136
Hs 611.T,107985,-4.128065548423904
COR-L51,10296883,3.6257769468740166
BT 482,5460769,4.579365975157546
SNU-1196,11404337,0.8236083262137488
EN,10296883,4.0657206853664345
Calu-3,439501,-2.024926202935107
A-549,6505803,-0.295425809550202
ESS-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8573739995038356
GSU,136227924,3.064976264970486
RCC10RGB,6610216,4.531223922644925
HEC-6,36462,2.1560073537614293
JM-1,11404337,-2.1014875230304315
T84,11485656,2.016527723529138
SIG-M5,168313200,2.70239683850215
SK-N-AS,12003241,-1.4595382352216486
TE-11,3689413,2.9978037995561126
HCC1195,36462,3.037174861907391
NCI-H322,107985,-3.3534970616476945
Reh,148198,-5.109999259943676
BL-70,6610216,3.096911873339395
PaTu 8988t,9936388,-7.900053622036252
ESS-1,JQ-1-carboplatin (1-1 mol-mol),1.200091134415551
SCC-9,44491742,4.764074483400304
OCI-M1,36462,0.2408416750567704
Hs 888.T,26596,-1.257833689984314
HLF,135875424,3.96007520843582
HEC-1-A,439501,-2.768971793153046
NCI-H520,8515,4.614929200779132
NCI-H460,11404337,1.7201854837770862
NCI-H358,9903786,1.2866771615699664
Yamato-SS,107985,-3.415977953838454
SNU-1076,439501,-2.344859624762999
NCI-H1944,9903786,2.6495499411680785
P3HR-1,54618164,4.280315965962759
Hs 729.T,3136844,4.256267023776523
PLC/PRF/5,3136844,4.290735112780334
NCI-H526,409805,3.795742136868548
NCI-H841,409805,3.6369674230030298
MeWo,9926054,1.733945316459816
F-36P,8515,2.752757057086389
MEC-1,JQ-1-carboplatin (1-1 mol-mol),-0.5603049112570107
SNU-213,439501,-0.6838743591109449
NCI-H2081,168313200,2.364564714683474
FaDu,49836020,4.381495172511739
SNG-M,409805,5.670713500548849
NCI-H460,135875424,3.211754300989152
JHUEM-1,12003241,-0.7244634318456832
Panc 10.05,100016,7.2735240015579645
KNS-62,selumetinib-GDC-0941 (4-1 mol-mol),0.6177155702395645
TE-14,262093,3.712272001874861
PE/CA-PJ49,136227924,2.4190721025981987
SW1271,selumetinib-vorinostat (8-1 mol-mol),1.620526536353516
SNU-1079,sirolimus-bortezomib (250-1 mol-mol),-1.4435273189765718
KG-1-C,168313200,3.846719593184995
SNU-1,selumetinib-GDC-0941 (4-1 mol-mol),0.1369641916187444
HCC1833,3136844,5.079214485702816
PLC/PRF/5,5460769,4.572267252029585
22Rv1,44493528,4.251423815919127
KMBC-2,9903786,2.1846129600819353
NCI-H520,159324,2.1886041190772834
RMG-I,6918878,2.856692727591287
KLE,54618164,4.225211860569233
OCUM-1,sirolimus-bortezomib (250-1 mol-mol),2.078884953433103
IGROV-1,409805,5.990596261907717
BT 416,11404337,-1.6662073764284366
COR-L47,439501,-2.8835443741058437
BT 131,tanespimycin-bortezomib (250-1 mol-mol),-1.406336138935124
HT-144,9927531,5.124270234210206
OPM-2,11485656,1.3184852346481954
SNU-489,107985,-2.42677081085971
KM12,36462,2.407887950750621
22Rv1,36462,1.0860894145139028
JHUEM-3,3136844,3.8764953159961952
GI-1,136227924,2.879759291125734
A-204,36462,0.1490097893290066
CHP-212,3689413,0.1952243777291655
COLO 800,9926054,1.9844303127825855
NCI-H650,135875424,4.813541263439062
HPAC,sirolimus-bortezomib (250-1 mol-mol),0.9709170992825356
TE-4,246676,4.790257687439562
A2058,8515,3.856536936008478
MeWo,107985,-4.390492182026979
TT,9936388,-5.089054710470253
HMCB,246676,5.779204987667754
Rh30,9903786,2.553175737800522
KHM-1B,6918878,3.029851495909813
KO52,44491742,3.2759729423779103
FTC-238,9903786,3.4467406025771705
RERF-LC-MS,3689413,0.4263782886644774
BICR 18,9926054,1.7755527669372533
OV7,9911830,0.5134876234799554
SK-UT-1,148198,-4.4190978779578565
786-O,9926054,1.9189583630988831
SNU-626,3689413,-0.5930983813401607
OAW28,159324,2.7212056331712584
SNU-886,135875424,2.126718157354228
COV644,6610216,4.439145409391099
JURL-MK1,9903786,1.1530539492536125
Hs 746.T,9926054,1.836274642391939
SUP-B15,12003241,-3.8836552178144848
DK-MG,168313200,3.870853059576488
LMSU,135398744,6.91211293627059
Aska-SS,6610216,4.460274887229386
LoVo,6610216,4.332472846182503
BT-16,sirolimus-bortezomib (250-1 mol-mol),3.18518711060972
RCC10RGB,439501,-2.548266242367821
HOS,sirolimus-bortezomib (250-1 mol-mol),0.4034549730700768
AN3-CA,9911830,-0.0740885579254531
SNU-1,136227924,2.7041604085298205
HCC1395,selumetinib-vorinostat (8-1 mol-mol),3.6842342409301305
SNU-81,6505803,-0.5044882096333503
KMH-2,JQ-1-carboplatin (1-1 mol-mol),1.5982474569998335
MSTO-211H,3689413,-2.1873545800685865
SNU-C2A,9936388,-5.314331610228823
SUIT-2,sirolimus-bortezomib (250-1 mol-mol),2.2579269293301527
NCI-H1869,24180125,4.3941927227643145
HT-144,9936388,0.7271233653710654
RERF-LC-A1,selumetinib-GDC-0941 (4-1 mol-mol),3.459186933832629
CL-11,10296883,4.178438273202507
SK-HEP-1,168313200,3.8713243832650335
HeLa,5460769,5.484643109222549
YD-8,11485656,2.558902022570011
PaTu 8988s,selumetinib-GDC-0941 (4-1 mol-mol),-0.6255434999404949
SEM,100016,5.238818929389881
OAW42,54618164,4.146300677714183
MOLM-13,11485656,-3.968420003132376
KYM-1,9911830,2.312875424950125
CHP-126,24180125,1.66827310880367
SUP-T1,sirolimus-bortezomib (250-1 mol-mol),-0.9944486722205774
AsPC-1,9936388,-0.8199656713038528
BL-70,246676,4.317555715151855
DND-41,8515,3.5602022897853596
HSC-2,54618164,4.204268013662146
Hs 944.T,6505803,-0.4446247220242906
CAL-85-1,9936388,-7.895376476927265
KU-19-19,sirolimus-bortezomib (250-1 mol-mol),2.2113915758762133
MHH-ES-1,262093,2.803376777339923
JHH-4,44491742,4.756848275600054
BT 428,36462,0.8626568513499365
KNS-42,135875424,5.020750527542343
Rh18,10322450,3.5568914493716712
EJM,44491742,4.208016925641279
JHUEM-3,409805,6.053062138585062
ESS-1,36462,-0.1255368808432747
Calu-3,136227924,3.506459850502243
SK-OV-3,sirolimus-bortezomib (250-1 mol-mol),1.4473324892897623
HT-1197,11485656,1.6876827017729057
Raji,6505803,2.919386850087895
NCO2,159324,-0.155118322085548
OV-90,JQ-1-carboplatin (1-1 mol-mol),2.6498991971281702
GA-10,6918878,-0.0384952148884959
SNU-475,148198,-3.401436847771516
JK-1,11485656,2.0269272789358332
K029AX,5460769,3.760325914422788
NB4,49836020,-4.1463475414292
SNU-1105,148198,-2.088080435846721
BT 340,168313200,2.246218713505307
SNU-8,262093,2.9266150824116877
NCI-H1299,11404337,0.8410914432786373
PaTu 8988s,11485656,1.7881493862367523
HT-55,159324,3.075227758970609
MDST8,6610216,4.3863838734153
LNCaP clone FGC,10296883,3.861229612453215
SK-LU-1,11404337,-0.1113986286493255
OCI-Ly19,49836020,4.441664761754026
BT 224,9936388,2.154938052183267
TF-1,10322450,2.6855110570299696
YD-10B,246676,3.4440336602109465
TOV-112D,sirolimus-bortezomib (250-1 mol-mol),0.8859708240687075
KE-39,3689413,-1.8420159541718293
EB1,10296883,2.8926613623150685
KNS-62,tanespimycin-bortezomib (250-1 mol-mol),-0.0918486546852887
LP-1,49836020,4.554043159133258
OVCAR-8,9926054,3.028637084123283
SU.86.86,9911830,2.616935639947117
Panc 08.13,9926054,1.852191503455224
RPMI-7951,3689413,-1.832371720912868
SCC-4,11404337,0.119875077583324
KYSE-150,6610216,4.783964747125549
PK-59,107985,-3.7968575257166495
SNU-46,11485656,2.352857034894664
JHH-2,409805,6.415305067677875
A3/Kawakami,6505803,-0.1184666814431136
NCI-H1573,9926054,1.726764013189345
OV56,sirolimus-bortezomib (250-1 mol-mol),0.4454120384496641
LoVo,136227924,4.6796674015936075
PC-14,tanespimycin-bortezomib (250-1 mol-mol),-0.4303356181915626
OUMS-23,49836020,3.7624735721332736
HEC-265,5460769,4.34119097814152
SNU-668,136227924,2.8591825047695925
Caov-3,JQ-1-carboplatin (1-1 mol-mol),0.7058210563631089
PE/CA-PJ15,9927531,4.562949408871821
MOLM-6,439501,-2.481235369301624
2004,selumetinib-GDC-0941 (4-1 mol-mol),4.378845407517423
PF-382,26596,-2.06856872789975
U-CH1,135875424,4.885628111434567
ML-1 [Human thyroid carcinoma],262093,3.5917492591420737
A3/Kawakami,9903786,0.9564213610990896
OCI-Ly3,3136844,3.8876396859692446
SNU-C4,3689413,0.8564713625003593
P31/FUJ,9926054,1.2698752833949425
HMC-1-8,262093,2.6952463235362414
TE-4,159324,3.1903380659828726
KMS-34,11404337,-2.4295348311340375
TE 617.T,6918878,1.9615768244510037
SNU-601,100016,6.491707225104745
HOP-62,262093,4.19078744138027
RL,6610216,4.988986648643106
RERF-LC-MS,136227924,4.560045704487339
NCI-H841,JQ-1-carboplatin (1-1 mol-mol),4.388076170034027
HDLM-2,JQ-1-carboplatin (1-1 mol-mol),4.397812362748352
TTC-709,24180125,2.733519633655364
SH-10-TC,5460769,3.8511006484967223
DU145,11485656,2.5427151524786993
Raji,10296883,3.544688579045074
CAL-27,49836020,4.376742607272952
KMM-1,JQ-1-carboplatin (1-1 mol-mol),5.732885286738059
PaTu 8988t,11485656,1.82057121616084
JL-1,135875424,5.193306419898844
K029AX,439501,-1.43360047701671
HCC38,54618164,4.35878231787182
Fu97,262093,3.1812015946879924
SNU-685,3689413,-2.422498805139559
OCI-AML-3,107985,-5.918636177044622
Tm87-16,6918878,1.682965575041267
MOLP-8,54618164,3.908946135671936
L-540,sirolimus-bortezomib (250-1 mol-mol),-4.16248218477803
SEM,10296883,-0.6538100941325019
HCT 116,selumetinib-GDC-0941 (4-1 mol-mol),2.1704161349367506
BT 179,6505803,-3.5400824860100224
SNU-1076,136227924,3.042119222699605
Calu-1,135875424,4.2506874987837024
NB1,9936388,-7.943927579353001
Mel Ho,9936388,1.523642966825596
SNU-398,6610216,3.625261217273112
VMRC-RCZ,selumetinib-GDC-0941 (4-1 mol-mol),2.964733367482892
NALM-6,439501,-2.425379213431436
HLF,136227924,2.390310427445978
KATO III,tanespimycin-bortezomib (250-1 mol-mol),0.4150623185921985
Kelly,JQ-1-carboplatin (1-1 mol-mol),1.229495862558611
DOV13,sirolimus-bortezomib (250-1 mol-mol),0.9080087228698384
VCaP,54618164,3.6777604686118854
BT 224,selumetinib-vorinostat (8-1 mol-mol),3.8876839551876174
NCI-H716,9911830,-1.2258790072222217
NCI-H1651,6918878,4.974541604880443
AsPC-1,11404337,0.3809720735493328
SK-MEL-5,9911830,3.188235338246222
AGS,36462,4.1696288524979455
LN-229,439501,-1.7560244035844634
G-401,135423438,1.541142645334712
GP2d,9903786,1.6186361299968774
LoVo,6918878,0.5506920931363443
P12-Ichikawa,54618164,3.774064824270636
HEL,26596,-1.8679385890512872
DB,49836020,4.238014398783195
TOV-112D,9927531,5.049724327124321
HEL 92.1.7,6918878,-0.5892639657065724
HLF,tanespimycin-bortezomib (250-1 mol-mol),-1.3704475916887384
TT2609-C02,409805,6.168536428430093
SK-ES-1,148124,-6.718341740227861
LS513,10322450,3.234062312565812
LS180,49836020,0.6204023867713871
YKG-1,3689413,0.6324676509110861
MOLM-13,26596,-2.2068545341754295
B-CPAP,11485656,2.2559715729134204
SNU-478,selumetinib-vorinostat (8-1 mol-mol),0.1819467823622978
OCI-AML-5,9926054,1.291118063021603
DU145,135875424,4.588838795967896
NCI-H211,107985,-4.531026670437544
TM-31,8515,4.489204846953569
KMS-34,9927531,3.5487000216351277
CCK-81,6918878,0.4084117942708226
NB4,46943432,0.4478875833240771
JM-1,24180125,1.1035620934920058
TT2609-C02,selumetinib-GDC-0941 (4-1 mol-mol),0.2335990554024833
TE-5,sirolimus-bortezomib (250-1 mol-mol),-0.3603080832286391
OCI-AML-2,26596,-2.6744696757916215
D283 Med,11485656,1.7629558217294734
HCC2279,135875424,4.219637022812179
ACC-MESO-1,11485656,3.7436435043406
HCC1937,44491742,5.446943100232909
Hs 944.T,5460769,2.3296902245035995
NCI-H661,409805,4.01937565581764
NCI-H1299,JQ-1-carboplatin (1-1 mol-mol),3.860003872097341
SK-N-BE(2),3689413,-2.1106889399644273
TC-71,100016,6.681443396825605
CAL-148,12003241,2.7249507328526015
SNG-M,9936388,-6.347266548904431
EB1,11485656,1.3368120139710602
TT2609-C02,8515,4.138677313481392
WM88,9926054,1.794473369640358
TE-5,135875424,4.0614047836246
COV434,9926054,1.0674163383843658
MKN74,11404337,-0.8129110599609928
SK-MEL-5,6610216,3.979150432082891
L-363,sirolimus-bortezomib (250-1 mol-mol),-5.312309266116436
OC 314,44491742,4.454392522958538
Capan-2,3689413,2.633842483871067
GA-10,135423438,1.5263864558122735
LOX-IMVI,44491742,5.895851784959737
HCC1171,439501,-1.4214133435338303
Tm87-16,439501,-3.529895077478111
SNU-668,5460769,3.895439916502409
AM-38,11404337,-0.5610335090567212
LK-2,107985,-3.2613767647283702
K-562,selumetinib-GDC-0941 (4-1 mol-mol),2.3648746020483284
GA-10,tanespimycin-bortezomib (250-1 mol-mol),-0.5876436517522915
NCI-H2110,selumetinib-vorinostat (8-1 mol-mol),2.8227636055377565
OCI-M1,9903786,1.4970236133945398
639V,148198,-2.584767342306116
SCC-4,3136844,4.171839413738562
Hs 746.T,11485656,1.8868493516636309
SaOS-2,262093,2.7398792490382244
HT115,9877608,5.791889645309291
U-937,3136844,3.3493452871231373
IGR-39,148124,-4.6116706508158405
Li-7,9926054,2.073130645224697
JHOC-5,selumetinib-vorinostat (8-1 mol-mol),2.458385145545893
NB4,148198,-3.6503523996612617
Kasumi-2,46943432,0.9724659287269805
JHH-5,selumetinib-GDC-0941 (4-1 mol-mol),1.0650507170556407
HCC1833,sirolimus-bortezomib (250-1 mol-mol),1.7413887390149827
VCaP,26596,0.7732068358688922
TE-8,36462,2.1560218282432393
SNU-61,6505803,-0.8091898598550518
BHY,136227924,2.366046867351899
HT,12003241,2.790793152125299
HCC202,3136844,4.548132220081696
CCF-STTG1,9926054,1.9394922490252933
LS123,JQ-1-carboplatin (1-1 mol-mol),4.3726195228270175
Kasumi-1,selumetinib-vorinostat (8-1 mol-mol),1.0640333870614955
Hs 611.T,selumetinib-GDC-0941 (4-1 mol-mol),0.4092086039942825
ChaGo-K-1,3689413,-1.075301905965469
BT 187,tanespimycin-bortezomib (250-1 mol-mol),-2.6862986394516453
Namalwa,409805,3.552483226107591
RERF-LC-MS,135875424,2.839581382146162
BT 228,11404337,0.5365763312483942
LS513,439501,-0.8485123993452164
BT 422,148198,-4.041161285965411
OVK18,148198,-3.802684433582173
NCI-H1355,10322450,3.720862951663928
SNU-1077,sirolimus-bortezomib (250-1 mol-mol),1.9799689406124936
TE 617.T,44491742,3.9684227449531697
BT 330,3136844,4.335632368425244
T3M-10,tanespimycin-bortezomib (250-1 mol-mol),-3.2480319159922515
SU-DHL-1,159324,0.2044468524757833
OCI-Ly19,9927531,5.466722325400782
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
CAL-33,3136844,3.8534028197424814
8305C,11404337,-0.9530165105805044
NCI-H1581,409805,5.312436768520535
BT 224,12003241,-0.3430722292852487
OE33,tanespimycin-bortezomib (250-1 mol-mol),-0.7700127207654934
P31/FUJ,246676,3.344572915959865
SET-2,5460769,3.4880653417656022
BT 145,26596,-1.6561784022945174
YKG-1,409805,3.8056431996277578
NCI-H520,12003241,-2.710304641181941
Hs 746.T,44491742,3.728027076014932
SK-LMS-1,5460769,5.744937264039862
Hep 3B2.1-7,6918878,4.528640003086307
NU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.8169816306561488
BT 504,9911830,2.9079127670616978
SK-ES-1,12003241,-1.52997414629941
Caov-3,5460769,3.7832431235533903
NCI-H1299,439501,-2.475221299124019
COLO 201,439501,-0.4470167142560104
MeWo,9927531,4.558706173548934
MFE-319,6505803,1.682030282534213
BT 239,12003241,-1.4894008844853184
HCC38,148124,-4.841006043756389
KYSE-450,136227924,3.5350495950730645
TUHR10TKB,9903786,1.579233705567475
NCI-H2126,9936388,-6.844961041738704
BT 131,135875424,2.7884599516406094
HCC1438,107985,-4.155444801050546
Namalwa,tanespimycin-bortezomib (250-1 mol-mol),0.1758913407069346
COV644,3136844,4.600363797700872
ME-1 [Human leukemia],107985,-4.174267195785912
OVCAR-4,9926054,2.3051007827251095
HEC-108,44484440,3.2684255567443
NCI-H1581,107985,-3.1807375781204192
Hs 611.T,selumetinib-vorinostat (8-1 mol-mol),2.75896517659524
AGS,135875424,4.083494996873591
KMM-1,3689413,1.9155128689282703
SF126,sirolimus-bortezomib (250-1 mol-mol),1.2366353132911738
Hs 895.T,9926054,3.037300507007888
HCC38,11404337,0.6997124930449434
MDA-MB-453,8515,4.14044832994183
CCF-STTG1,10296883,4.282837475963798
NCI-H1092,135875424,3.039549904779009
RPMI-6666,sirolimus-bortezomib (250-1 mol-mol),-5.127028405484722
EBC-1,3689413,0.3969440473796213
CMK,36462,0.4830261270802425
NCI-H1568,10296883,3.9462373745058863
GCT,24180125,3.1414885039024
COR-L51,148198,-5.724973954604913
SK-MM-2,tanespimycin-bortezomib (250-1 mol-mol),1.2255908255092252
TE-4,11404337,-1.2952896861413017
NCI-H1623,selumetinib-vorinostat (8-1 mol-mol),2.11860807065236
SNU-1105,selumetinib-GDC-0941 (4-1 mol-mol),2.42350207909939
KP-3,44484440,2.9520563964934565
L-540,24180125,3.0668574427467994
8505C,9936388,-0.6863572564067597
K-562,sirolimus-bortezomib (250-1 mol-mol),0.4974638580928024
SEM,6918878,-2.4366739995343196
F-36P,9936388,-5.085386931503238
JHH-5,148124,-1.4571127407180036
SW1417,36462,3.4260079153172596
COR-L95,10296883,4.074268886544182
Daoy,36462,0.3997771841968469
LC-1/sq-SF,9936388,2.2105374849729036
CAL-33,135875424,4.580844092260986
BFTC-905,439501,-2.3282671970513524
YD-8,6610216,4.600166157453743
SU-DHL-1,selumetinib-vorinostat (8-1 mol-mol),1.570079304001321
NCI-H727,107985,-2.9799734550318204
BFTC-905,409805,3.630865153119702
COLO 668,6505803,-1.9386091565051409
Peer,26596,-2.3725099322734193
KYSE-450,11404337,-0.7664225185438103
RCC10RGB,44491742,5.1484686760969645
Hs 611.T,6610216,4.160309523547129
HEL 92.1.7,136227924,2.7818707499809188
UACC-257,8515,5.269866695423634
JHUEM-1,6918878,4.919035638288985
Raji,11485656,1.8853842234896017
Namalwa,3689413,-2.4943268400148715
LS1034,148124,-4.182223287132367
ME-1 [Human leukemia],6610216,3.827956045934504
Kelly,3689413,-0.2906048821836837
SW1710,148198,-2.170250492388752
KMM-1,54618164,4.235991930740478
OAW28,262093,2.853078829548121
JK-1,9903786,1.7060026782988165
BICR 18,9903786,1.845690489746328
NCI-H1299,sirolimus-bortezomib (250-1 mol-mol),1.6380242614391785
NCI-H2170,9911830,2.189149980323213
NCI-H2122,44493528,4.295267332742467
TE-10,5460769,3.091987508758681
RPMI-8226,136227924,2.992898649350054
LOX-IMVI,9926054,1.7031980960413209
KMS-26,8515,1.9708227229968656
Ki-JK,3689413,-3.396353931218892
P3HR-1,5460769,3.3454995233869957
ES-2,12003241,0.0508402342945085
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569
OCI-AML-3,9903786,2.1236549190588097
MV4-11,135423438,-3.04560179632734
COV362,10296883,3.813835962370156
SK-MM-2,46943432,0.6521165388255271
BT-16,10296883,4.008579102599456
HPAC,9936388,0.8938610961333106
HCC1438,54618164,4.347012651025305
NCI-H1184,12003241,-1.9901297280698445
Yamato-SS,9926054,1.8348633448645275
Calu-3,10322450,4.307462921709786
Calu-6,JQ-1-carboplatin (1-1 mol-mol),5.26702992417303
Granta-519,5460769,2.1422187145203897
VMRC-RCW,262093,3.5147146159266174
NCI-H1105,selumetinib-vorinostat (8-1 mol-mol),1.804974840497553
NCI-H1581,44493528,4.36885070157506
NCI-H1869,tanespimycin-bortezomib (250-1 mol-mol),-0.2076934173227629
HCC1588,12003241,-0.4884151161938169
HCC2935,10296883,4.009305839829136
Hs 852.T,159324,3.244112139278481
NCI-H2170,8515,5.392751727081425
EKVX,9911830,1.6241739664909705
OE21,46943432,2.2967121363038707
KNS-60,148198,-2.9392498414813075
SHP-77,6610216,4.505956352880749
SNU-407,135875424,3.3406481823919627
PK-1,168313200,4.316243084639225
YKG-1,148124,-3.4477323343219637
SH-10-TC,6918878,4.206721688790107
K-562,9903786,3.6050720376028105
NCI-H1568,136227924,3.032081072579533
SF539,409805,5.790114720226367
KNS-60,439501,-2.666798913296539
TE-9,selumetinib-GDC-0941 (4-1 mol-mol),2.552175387754049
BT 359,168313200,1.7683739360111177
ACC-MESO-1,100016,6.4652465436588775
KYO-1,9927531,4.747865514161547
HOP-92,3689413,-2.4488363425715076
Hs 611.T,49836020,3.6507368971801983
RPMI-8402,262093,1.1284769386432876
TE-1,11485656,2.6145816655687746
SK-MEL-2,148198,-4.089267246303032
GI-1,selumetinib-GDC-0941 (4-1 mol-mol),2.406121419892038
WM1799,262093,3.074804588152201
VMRC-RCW,44491742,5.061613878025198
KMRC-20,439501,-2.469138258710991
EBC-1,44493528,4.198752101317416
HEC-1-A,9926054,1.9825174619243453
OCI-AML-2,10296883,2.8220982332294615
SK-ES-1,sirolimus-bortezomib (250-1 mol-mol),0.3293932534534852
NCI-H1650,10296883,4.859498077632093
GI-1,44493528,4.237962570742694
U-CH1,5460769,3.546164006563716
HSC-3,54618164,4.361792769190993
KP-N-YN,44491742,4.254136072994776
HuP-T3,44491742,4.372770131484514
SNU-16,100016,4.136425652163891
NALM-6,9926054,1.499716705925791
JK-1,12003241,-7.790720782549377
NCI-H522,168313200,1.7984937800694238
MEC-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1834550186065348
CAS-1,159324,3.5765163905763577
HCC2935,selumetinib-vorinostat (8-1 mol-mol),2.9225347430042503
CJM [Human melanoma],36462,0.3474499275701578
KATO III,sirolimus-bortezomib (250-1 mol-mol),0.9695085232942704
M059K,11404337,1.3426444842625342
SU-DHL-1,10322450,2.9485372728674473
Li-7,10322450,3.813696147876763
IGR-39,11404337,1.3258536421281484
SK-N-MC,12003241,-1.5670005679110546
KMS-21-BM,44491742,3.2404662940088205
JJN-3,11404337,-1.3886118473033382
TE-15,107985,-3.356146031116269
SUP-T1,12003241,-2.125139255884817
IGROV-1,9926054,1.8111808945519428
NCI-H2126,409805,4.003964998224064
NCI-H2228,409805,5.240879679587451
CAL-85-1,10296883,4.0142951898227155
NCI-H2029,3689413,-0.5548676180878093
SW1573,sirolimus-bortezomib (250-1 mol-mol),1.011264687291747
Kelly,11404337,-0.935685652893764
SNU-407,159324,1.4869936104521508
PaTu 8902,tanespimycin-bortezomib (250-1 mol-mol),1.9395223164568671
SNU-398,135875424,1.4197381428119091
SU-DHL-1,JQ-1-carboplatin (1-1 mol-mol),3.662871226226577
NCI-H650,12003241,-0.6460655528270789
NCI-H23,44491742,4.066691621644064
OCI-Ly19,100016,6.584850236816641
BT 145,sirolimus-bortezomib (250-1 mol-mol),-0.145853867426896
Namalwa,12003241,-3.0032452893334596
NCI-H1373,5460769,2.0630814106312543
MOLM-13,100016,3.967621300341963
NCI-H929,9911830,2.939236367729051
OCI-Ly3,148198,-4.419938902375586
NCI-H2085,12003241,-2.8100927731995924
NCI-H2126,9903786,3.129084376626642
NCI-H1105,135875424,3.000418011762545
G-361,135398744,6.4148171061967645
CAL-62,46943432,2.920213901722772
TUHR4TKB,44491742,4.24148356171105
RT-4,159324,1.8094112077356237
BT 330,12003241,-0.9920089469814386
IPC-298,439501,-1.1668969195749603
EB1,9911830,0.792353471304689
HL-60,439501,-2.5264411138407836
RMG-I,3689413,-2.168245992738919
OAW42,148198,-4.166593370065839
SNU-175,107985,-3.5287642870069136
JIMT-1,11485656,3.0502841230880327
NCI-H1299,24180125,3.786842850309645
HCC78,11485656,2.324868520427576
U266B1,10322450,4.335564928351158
SF295,3689413,-1.7224429364651286
HLF,6918878,2.2064021316186353
NCI-H2170,sirolimus-bortezomib (250-1 mol-mol),0.3634507455744757
KMS-34,11485656,1.6591350008263417
SW1088,3689413,0.8885196557801914
KLE,11404337,-0.1549034777249487
BT 428,409805,5.8133328152421395
HEC-251,9903786,4.825179909690824
MOLM-13,12003241,-3.578107028375036
Hs 888.Lu,148124,2.240459751770133
KMS-28BM,46943432,0.6714739108250444
CML-T1,6505803,-0.3633146304142068
Ci-1,9926054,1.7408061846273166
MCAS,107985,-3.860765706660282
GaMG,11404337,0.0335653022418154
HCC1395,26596,-1.834868374404667
MHH-CALL-4,100016,6.461754156645112
BT 359,262093,3.411602907811722
J82,100016,6.509431143115434
CAL-54,54618164,4.189782722036381
JHUEM-3,148198,-4.085540837584063
HD-MY-Z,136227924,3.0737298330446103
SNU-1,9927531,3.402077148066899
TE 441.T,9911830,2.062678121502997
NALM-6,6918878,0.7474671178158097
CL-11,148198,-1.969557000481989
HT-1197,10296883,4.022509724629416
SK-N-BE(2),107985,-3.856206997250564
NCI-H1869,selumetinib-vorinostat (8-1 mol-mol),2.952305626055488
Caki-1,36462,4.125503864520119
KNS-62,6610216,4.3698518341430415
A-172,11404337,0.9074451848226016
SNU-308,6610216,4.383994283569161
HH [Human lymphoma],sirolimus-bortezomib (250-1 mol-mol),-8.470809124767328
Detroit 562,9926054,1.947776964101976
TE-11,8515,2.1932181679605476
SK-CO-1,44484440,3.788843022204708
SNU-899,159324,3.687445596334971
MSTO-211H,5460769,-2.0887143253822615
SNU-1214,148198,-3.317197477709626
SK-MEL-28,3689413,3.3385356968233744
CA46,439501,-3.521132637790176
Rh41,JQ-1-carboplatin (1-1 mol-mol),-0.6167510986440503
OAW28,11485656,3.2643123414600645
RL,54618164,3.8601476099735894
KYSE-150,135875424,2.978740895797715
OCI-M1,6918878,-0.1368972853141914
NCI-H2110,9926054,1.839297705521365
A101D,9926054,1.713643305346107
CW-2,9926054,2.0798492458785978
HuP-T4,9903786,1.2000554865922293
SNU-761,107985,-2.3289505375357287
MV4-11,36462,-3.152783197580454
SNU-16,6505803,-5.221093931145045
HCC1395,159324,2.879244601573153
NCI-H1623,9936388,-4.968103162812744
JVM-3,9911830,2.036590776668221
Kelly,12003241,2.7454811269637145
Mino,5460769,1.2525165030578538
JHOC-5,107985,-4.58395080292921
BEN,BRD-K16130065,4.206876741952794
DMS 454,9936388,1.3137576899177168
KE-37,sirolimus-bortezomib (250-1 mol-mol),-5.227534595798211
NCI-H441,148198,-1.1442516258972526
NCI-H1355,selumetinib-GDC-0941 (4-1 mol-mol),2.7709082983519564
BICR 31,439501,-2.4499261286992007
SK-N-AS,selumetinib-GDC-0941 (4-1 mol-mol),-0.6593922451468693
Panc 04.03,54618164,4.2869772681873695
PK-1,44493528,4.319827010327948
KNS-62,9927531,5.413841173671558
PE/CA-PJ15,10296883,4.07189179930938
KNS-60,10296883,3.392658915268081
CHP-126,selumetinib-vorinostat (8-1 mol-mol),2.379492910294905
HEC-151,sirolimus-bortezomib (250-1 mol-mol),0.8769904812641561
SNU-620,148198,-2.4774771616722573
NCI-H460,11404337,1.7201854837770862
SNU-1033,44491742,3.84113608449774
SW982,439501,-3.0027408627821934
HSC-3,49836020,-1.9036219787804456
HCC38,439501,-2.3943608626526536
YAPC,5460769,2.316930709954587
JVM-2,9903786,-0.0734034903257133
HEL 92.1.7,3689413,-2.453708704317935
HT-29,36462,3.3861916836102983
Mino,439501,-5.730054140979018
COR-L105,3689413,-2.1605707630353708
KHM-1B,159324,1.2436512528819574
NCI-H28,8515,4.734021472875567
KYSE-30,135875424,2.992970338382266
SK-N-DZ,5460769,3.5679680619882617
Mel Ho,54618164,4.508267995414237
CAL-51,135875424,4.33643967165441
NCI-H1092,44491742,3.604656167614849
LAMA-84,439501,-2.4301107765097525
SNU-1033,12003241,-0.6294445516416565
Hs 578T,3689413,-0.3709013801718254
PaTu 8902,54618164,4.284638344065584
Hs 888.T,9903786,1.8376079408341344
MES-SA,6505803,-3.213195974579349
LOX-IMVI,135875424,4.258043031810949
T24,246676,4.650292847742773
NH-6,selumetinib-GDC-0941 (4-1 mol-mol),1.9246197081776155
Calu-6,6610216,4.633820357162049
DMS 454,9926054,2.735237319148254
MOLM-6,12003241,-5.9234672860619995
TC-71,54618164,3.730396690506125
MOLP-2,44493528,4.982078328127478
647V,439501,-2.3476085577035506
DU4475,136227924,1.4993153773488237
HMC-1-8,107985,-3.647060266664553
BICR 31,selumetinib-GDC-0941 (4-1 mol-mol),-0.0760223515380139
Hs 729.T,9926054,1.9199617191316192
NCI-H28,262093,2.707398146289125
NALM-6,3689413,-1.8173610448442752
LC-1/sq-SF,9903786,4.361015168836896
HCC-56,148198,-4.2665596925973395
TCCSUP,12003241,-0.9458347981681208
MDA-MB-435S,9903786,3.3965750050470356
Hs 294T,selumetinib-GDC-0941 (4-1 mol-mol),1.293217302318029
Kasumi-1,409805,3.430616862172681
SNB-75,6505803,-1.615420165549335
Hs 852.T,9903786,1.6008538749226255
OCI-AML-3,6610216,3.7243231461323463
KYSE-410,159324,2.9190840710884385
EFM-192A,sirolimus-bortezomib (250-1 mol-mol),-0.607233737838293
WM115,6505803,-4.475953396274594
FaDu,6505803,-3.622954111449815
L-363,36462,-0.2320142299558898
MDST8,107985,-3.301997074358414
DU4475,36462,-2.7502991283141247
HEC-1-A,100016,7.347183870003149
IMR-32,JQ-1-carboplatin (1-1 mol-mol),0.0356823782644729
SNU-423,168313200,4.217782003449994
U-937,selumetinib-vorinostat (8-1 mol-mol),2.4655202685324236
HuT 78,tanespimycin-bortezomib (250-1 mol-mol),-1.2620001487699233
SF268,107985,-3.4740427748665073
T3M-10,JQ-1-carboplatin (1-1 mol-mol),3.984166000628971
CJM [Human melanoma],sirolimus-bortezomib (250-1 mol-mol),0.403265479261487
CHP-212,148198,-4.905957419463446
NCI-H292,11404337,-1.5117614396305947
RKO,selumetinib-vorinostat (8-1 mol-mol),2.2625933360113826
RPMI-7951,9936388,-2.1957578683042205
HCC38,3689413,-2.099341250488443
TM-31,24180125,3.310728036937333
HCC38,JQ-1-carboplatin (1-1 mol-mol),1.2340294143226358
Calu-6,12003241,-0.728129558300084
HCC1195,135875424,2.5037417223701572
TOV-112D,36462,-0.0852741805164054
KMS-11,46943432,0.5072871565715428
ECC12,9926054,2.4969836568853507
NCI-H647,10322450,4.351576478086524
TALL-1 [Human adult T-ALL],9926054,2.0252828062199257
KE-37,6918878,-0.3255573054328273
HCC1438,9927531,4.9957520851932955
697,100016,3.656696343596264
SNU-119,5460769,2.8404840787101593
U-118MG,136227924,3.3662867602003006
BT 164,11404337,-0.5496255890882706
HuT 78,JQ-1-carboplatin (1-1 mol-mol),-2.068765124024036
Becker,439501,-2.817437349005285
OPM-2,44491742,3.727542800888903
COLO 829,9911830,2.286202630624006
Caki-2,3136844,5.101109611661823
SW1353,12003241,-1.0641088251163675
KYSE-410,9927531,5.048506934315496
RPMI-8402,11485656,1.7497353972694758
KYSE-140,6610216,4.474378770774551
HL-60,selumetinib-GDC-0941 (4-1 mol-mol),-2.2086507819126213
SNU-387,12003241,-1.416188991629313
MDA-MB-453,10322450,5.853812101119735
HCC202,262093,3.36035713735401
KMRC-2,9926054,2.0216271093968263
TTC-709,26596,-1.3495496110855745
PE/CA-PJ34 (clone C12),12003241,-0.6178639171957262
AMO1,11485656,2.1088209303297853
Peer,135875424,2.778289251682957
HCC1143,36462,4.303888689757339
COLO 320,26596,0.3070863795461868
U-87MG ATCC,9911830,4.425829488387339
HuP-T3,sirolimus-bortezomib (250-1 mol-mol),0.6074306873304286
WM983B,54618164,3.908984274872335
Kelly,6610216,3.7963593955600863
SNU-398,9903786,4.103035354116066
KMS-26,12003241,-3.93647753580664
SNU-449,9926054,1.9385314164963827
NCI-H1568,9903786,2.4011050725962115
EoL-1,5460769,1.0165285119643896
C2BBe1,3136844,4.240464942850756
L-363,9911830,2.8051693886681557
MHH-ES-1,12003241,-1.3957716684214538
RERF-LC-MS,100016,6.56071523320666
NCI-H929,6918878,1.2577940998028925
GSU,262093,3.0051612017045612
YD-8,6505803,-0.4521993512764767
2004,168313200,1.9308841671916883
IGROV-1,168313200,3.9938362637732983
Panc 02.03,136227924,3.0839082623333387
HT-1197,135875424,3.754015840236683
WSU-DLCL2,6610216,4.106084410539223
JHH-4,12003241,-1.7562385090138668
CAL-54,26596,0.8562356828634801
DK-MG,148124,-4.482230615331879
AU565,6505803,-0.7592801042803803
HEL,12003241,-0.3954740832299299
L-1236,8515,4.228188725172905
SEM,439501,-3.163159816591066
EKVX,135875424,2.863023045597006
AU565,49836020,5.742264990221176
NCI-H1155,246676,5.962550205332117
ALL-SIL,439501,-2.349752310116714
LP-1,409805,3.155835706039454
OVSAHO,36462,4.07027674269764
LCLC-97TM1,159324,3.194316902825419
BT 131,9927531,5.2651806903181235
Daudi,3689413,-4.376822515219121
Hs 746.T,8515,4.584865642264335
BICR 16,selumetinib-vorinostat (8-1 mol-mol),3.7038615941631305
MFE-296,sirolimus-bortezomib (250-1 mol-mol),-4.372432753750482
OVK18,10296883,4.168587177693041
Hs 683,12003241,0.8693905406704602
T84,sirolimus-bortezomib (250-1 mol-mol),0.444201231826254
DU145,439501,-2.7485794982467637
NCI-H2170,10296883,3.9799076581526855
Hs 944.T,9936388,-9.161226763585232
DMS 454,selumetinib-vorinostat (8-1 mol-mol),1.7522201936237716
JM-1,439501,-5.872076466297635
Caov-3,selumetinib-GDC-0941 (4-1 mol-mol),3.787884726335324
NCI-H727,5460769,4.510942150258337
LS411N,12003241,-0.0946051023392001
U-937,3689413,0.9938277330138956
253J,148198,-1.8697055950254904
NCI-H929,9926054,0.4409605375156073
YD-15,36462,1.1625892887713607
NCI-H810,selumetinib-GDC-0941 (4-1 mol-mol),2.904538887533327
Toledo,11485656,1.9100858445006503
CAL-85-1,9927531,5.462917800107974
SNU-1079,3689413,-2.2789240635037182
EoL-1,148198,-7.742780807176134
MEC-1,6505803,0.1083566885748684
TC-71,sirolimus-bortezomib (250-1 mol-mol),0.6072005287356511
SKM-1,9926054,1.2950133266657913
ST486,9927531,3.885019702146961
HPAC,11404337,1.5796437577977354
OVK18,selumetinib-GDC-0941 (4-1 mol-mol),1.2512103740452307
MOTN-1,36462,-1.0452584205395847
SNU-1,3136844,3.798371801554912
SCC-4,selumetinib-GDC-0941 (4-1 mol-mol),1.2085595072680022
Hep-G2,6505803,-2.5933743398692894
ChaGo-K-1,12003241,1.029111103028103
HEC-1-A,9903786,5.533982095458378
DMS 114,JQ-1-carboplatin (1-1 mol-mol),1.3957333814923674
F-36P,26596,-3.451633292118186
SK-MES-1,148198,-4.042000221520934
P12-Ichikawa,JQ-1-carboplatin (1-1 mol-mol),-0.0557948647984977
COLO 205,9903786,2.133695985637416
IGROV-1,44491742,4.406671418311328
D283 Med,tanespimycin-bortezomib (250-1 mol-mol),-0.3446270457541043
GP2d,11404337,0.3964770765746153
ONS-76,409805,3.962852167855045
CML-T1,6610216,3.6071739537574863
SHP-77,12003241,2.3628262056689384
RVH-421,selumetinib-GDC-0941 (4-1 mol-mol),0.2332916793846582
TT,136227924,2.992692937715844
UM-UC-3,sirolimus-bortezomib (250-1 mol-mol),1.1405696257506746
DEL,246676,4.437673993378433
CAL-51,136227924,2.079284078064279
Hs 611.T,3136844,4.24096122939903
GOS-3,136227924,2.1351760440562533
BT 248,439501,-2.3411963573363104
NALM-6,262093,0.7865180544621748
OVCAR-5,12003241,-2.4332289606556903
SK-MM-2,3689413,-2.3519138228022367
YD-15,3689413,2.243668996765499
SW1710,44493528,4.456885248291854
Panc 03.27,9911830,2.184033870746351
SNU-620,tanespimycin-bortezomib (250-1 mol-mol),-1.6605884966990527
SUP-M2,54618164,3.710642593686204
NCI-H1435,262093,2.8121009793990046
HT-29,9911830,3.6715943685585097
HEC-265,6918878,3.3744187717386955
TF-1,5460769,4.30978412133691
SNU-899,409805,3.7254900165561193
JJN-3,135398744,6.34309809291168
MOLT-3,10322450,4.054866374407206
Namalwa,148198,-5.5603375502023
A-375,11485656,2.720000014361131
Hs 934.T,9936388,1.629687666609809
KMS-26,439501,-2.394060102049288
HEC-251,9936388,-5.1528411757611465
FTC-238,6505803,0.5896695785026528
SF268,JQ-1-carboplatin (1-1 mol-mol),2.4555584209908923
BT 139,262093,2.8481987129285256
SIG-M5,148198,-4.503742564102913
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353
NCI-H1299,selumetinib-vorinostat (8-1 mol-mol),3.816207733314422
SK-MEL-5,11404337,-0.86554047446545
WM1799,12003241,-2.735191284404769
GCT,36462,0.8758989390460181
NCI-H1869,107985,-2.86385536497776
KATO III,12003241,-4.840637368540689
PE/CA-PJ15,12003241,-2.2005242909151668
TE-10,9911830,2.740981336326426
WT2-iPS,selumetinib-GDC-0941 (4-1 mol-mol),0.0160943327982104
KU-19-19,9903786,4.470072542277405
VM-CUB-1,5460769,-0.9631116017936964
BT 245,168313200,2.0916764208189895
HCC1143,100016,7.122041956726765
697,3689413,-4.592685729606217
Panc 04.03,3689413,0.3957464459941977
KYSE-180,5460769,3.044274290576871
SNU-16,46943432,1.3599248800373205
WM266-4,9936388,1.925680740660873
Li-7,6505803,-1.5573674441888958
Calu-6,9936388,-7.509028566007479
Kasumi-1,54618164,3.752212844120618
RCC10RGB,72199289,4.762339751475906
BT 245,5460769,4.174087021944073
KNS-42,409805,5.857508375467912
LS1034,12003241,0.7423322156732435
HCC2108,9903786,2.237017286795856
TE-11,262093,3.7294474830562336
J82,11404337,-0.1967629252441953
TE-15,100016,6.263488161224716
HEC-151,3689413,0.5850952885102259
U-CH1,409805,5.934012749257741
COR-L105,168313200,3.683873258385797
HOP-92,136227924,3.2563886907656725
JHH-1,36462,3.4742558280841536
NCI-H1869,3689413,-0.7267032921286074
AsPC-1,107985,-4.227741895863185
RERF-LC-A1,9903786,4.61839139463389
Panc 08.13,11485656,2.1540849890217815
Hs 766T,selumetinib-GDC-0941 (4-1 mol-mol),-2.707404573640349
AU565,3689413,0.8257687517728082
DB,409805,3.899652839809395
JHH-1,3689413,-2.4023532817808304
COLO 829,9936388,-8.135727269739062
HCC1954,9903786,3.647576872659031
JL-1,107985,-3.423075177455306
RERF-LC-Ad2,439501,-3.088259445062755
HOP-62,5460769,2.443615735481444
Hs 578Bst,3689413,-1.7241892879585388
NCI-H810,439501,-2.873270400537551
KMS-12-BM,9903786,0.6537757100604409
SUP-T1,3689413,-3.2638224504497195
HCC1954,9936388,-7.1027886366654585
COR-L105,36462,5.237060103367249
Ri-1,262093,1.5615741003890895
A-204,168313200,1.780434655173201
SIG-M5,262093,1.2071251684519244
DLD-1,9911830,2.6319056960613136
SUIT-2,11404337,0.4217329969696077
BFTC-905,36462,2.198737830407542
NCI-H2171,tanespimycin-bortezomib (250-1 mol-mol),-0.2558464529397277
COR-L88,439501,-1.6986263045412435
KMBC-2,409805,6.016015175624214
KYSE-150,9911830,3.078794736817172
NCI-N87,159324,0.0331676951949142
KNS-60,3136844,3.544395246321499
HT-144,409805,5.790862994048412
UM-UC-1,12003241,-2.5301689860244534
LAMA-84,46943432,2.187677081253157
NCI-H1666,9911830,2.3243808572594
SJSA-1,sirolimus-bortezomib (250-1 mol-mol),0.9111785812193088
Kasumi-2,49836020,6.151495097204233
NCI-H508,44491742,4.239299300064597
U-BLC1,10322450,3.651002961479182
Hs 729.T,148198,-2.5851950903835834
Mel Ho,135875424,3.73335713138188
NCI-H441,54618164,4.199926300298215
42-MG-BA,148198,-6.365227331542155
SNU-308,11485656,2.7823829895443657
PC-3,54618164,4.238833791567503
HMC-1-8,11485656,2.285231442211603
SF295,6610216,4.890664911877899
AML-193,9927531,3.384669993922374
JJN-3,9926054,1.1995633611794354
CHP-212,36462,-1.1784349371893996
KATO III,24180125,3.0892826783746674
CML-T1,11485656,1.9899616795432975
Caov-3,409805,4.119200456986889
NCI-H2110,136227924,4.625762146403413
SNU-245,sirolimus-bortezomib (250-1 mol-mol),2.143003825797964
JURL-MK1,100016,3.373338788856286
BT-16,JQ-1-carboplatin (1-1 mol-mol),4.438873165062089
COLO 699,sirolimus-bortezomib (250-1 mol-mol),-0.458397325764597
BICR 16,262093,3.685769886928711
NCI-H2405,159324,2.074483405739434
SNU-398,409805,5.101188270824189
LOX-IMVI,8515,4.202942492571131
Calu-6,100016,6.484915939204548
Panc 03.27,136227924,3.110606575361216
BT 416,6918878,3.1827229049107864
LS180,135875424,4.384751932486372
MOLP-8,8515,3.727464051425151
IMR-32,5460769,-1.03513215878617
NCI-H520,135423438,3.6436020684370463
KYSE-180,26596,-0.879665743021705
HD-MY-Z,26596,0.1075810605234112
BICR 16,6610216,4.922312774683302
LK-2,54618164,3.851858662918836
253J,JQ-1-carboplatin (1-1 mol-mol),2.6243340273130733
Mel JuSo,selumetinib-GDC-0941 (4-1 mol-mol),1.489805359284141
JHOS-2,100016,8.119351788295337
D283 Med,246676,4.416806480399498
DMS 53,54618164,3.727499516081143
HCC1428,JQ-1-carboplatin (1-1 mol-mol),1.63516660368819
SU-DHL-8,409805,3.916081656156952
NALM-6,9903786,0.8985317533889718
Hs 822.T,3136844,6.341649778749426
KCL-22,5460769,3.17116063608923
MKN7,6610216,4.498643244512437
SUP-T11,11485656,1.9960376933984711
A2780,sirolimus-bortezomib (250-1 mol-mol),-4.6812912688082555
IGROV-1,159324,2.8766947154825044
NCI-H2122,107985,-2.1476502559508828
SNU-738,135875424,5.435883526808027
CAMA-1,439501,-1.1821357093397586
JJN-3,3689413,0.1640237934246712
CAL-12T,36462,3.3360581602750647
U-937,10322450,3.569133925539397
LAMA-84,5460769,3.9784862352409105
Mel JuSo,54618164,4.220783643811767
Aska-SS,5460769,3.7674682150871552
NCI-H2030,44484440,3.521549989015301
NCI-H2228,54618164,4.114234543064267
NCI-H1623,6610216,4.306736710776884
MOLT-3,100016,3.7727587478901734
T98G,sirolimus-bortezomib (250-1 mol-mol),0.3680606799164068
AM-38,409805,-6.133052721162316
IA-LM,262093,2.9896562434219627
Raji,11404337,2.5048803156599586
SNU-8,148198,-1.3128761791294046
SYO-1,10296883,4.0687623186484005
Lu-65,262093,3.3965218788249407
NCI-H520,9927531,5.647411307076465
GA-10,9926054,1.7130115486469382
EC-GI-10,9926054,1.9054317321627203
NCI-H1792,9926054,2.787600202110533
RPMI-7951,11485656,2.1770384312644246
OVISE,tanespimycin-bortezomib (250-1 mol-mol),0.9202514572514084
MHH-CALL-4,3136844,3.580762905250605
KYSE-410,135423438,1.615361831673466
SU-DHL-1,6610216,4.061950863639378
8-MG-BA,tanespimycin-bortezomib (250-1 mol-mol),0.0897901825982692
JeKo-1,9926054,1.771855949205148
TE-5,11485656,1.9147399940941343
8305C,6918878,3.918418468109357
OCUM-1,11404337,-0.1568634600047591
GA-10,10322450,2.465288440600798
SK-MEL-5,JQ-1-carboplatin (1-1 mol-mol),5.709362170357264
SNU-1196,12003241,-1.2616769402260497
KU-19-19,9926054,2.3371072555508445
MDA-MB-453,9926054,1.6596725660557576
ZR-75-30,10322450,4.312003120067809
RL,107985,-3.9156198451425857
NCI-H1373,8515,4.13419356342465
KYSE-180,tanespimycin-bortezomib (250-1 mol-mol),-0.8459544412135208
RPMI-8226,46943432,0.8335520159387311
BT 333,44491742,4.348369839159046
LK-2,9926054,1.788707651887683
SNU-1272,11404337,1.107901220459772
NCI-H1581,6505803,1.0030627815723745
CAL-85-1,44491742,3.820376025852422
SNU-1077,6918878,4.982410606922502
SEM,135875424,2.4848737039506426
G-401,168313200,3.793890782777564
Sq-1,9903786,4.063753255024067
Hs 852.T,409805,3.946655740773064
Calu-3,9903786,3.8990782508172495
MFE-319,262093,3.9047520178061856
NCI-H1703,168313200,3.951606007519328
A2780,9911830,1.8386970616579583
SU-DHL-1,409805,5.150132871505728
JJN-3,6918878,0.1991100012587708
NCI-H2087,6505803,-0.9340345564408612
NALM-6,44493528,3.763100774394441
HuP-T3,9903786,4.0743016574038915
SNU-626,36462,1.8578593274486852
MDA-MB-468,11485656,1.4404367152008126
HCT 116,11485656,2.5700211491492593
DMS 114,100016,6.89872652787532
IGR-37,136227924,2.9944260233382667
Kasumi-1,sirolimus-bortezomib (250-1 mol-mol),0.3681691235754297
RL,409805,3.773572615684441
G-401,54618164,3.8592700204433807
HSC-2,44491742,4.345443441235533
K-562,6505803,-1.797722788015983
SNU-C1,tanespimycin-bortezomib (250-1 mol-mol),-0.731545490498155
NCI-H1341,49836020,4.324192381476246
BT 224,135398744,6.495060752655371
Hs 578T,6505803,0.7930921136576904
NCI-H1693,11404337,-1.060288608943807
SNU-1214,135875424,3.75117609732274
NCI-H520,3689413,0.9100551461140616
SUP-M2,10296883,3.1259811098442176
DEL,5460769,1.5827510666329687
DB,JQ-1-carboplatin (1-1 mol-mol),-0.32501810171376
CAL-120,11485656,3.0524191278812975
HCC1438,9936388,-5.250044991536538
ECC10,54618164,3.9379373119604657
KE-39,selumetinib-vorinostat (8-1 mol-mol),2.460157439364167
HCC1438,148198,-4.23267201662653
NCI-H226,9927531,4.418189277296578
PC-14,3689413,2.901459905806189
JVM-3,JQ-1-carboplatin (1-1 mol-mol),-1.4584140934293672
SYO-1,262093,2.864571024942669
SF126,JQ-1-carboplatin (1-1 mol-mol),5.083897711074173
KU-19-19,selumetinib-GDC-0941 (4-1 mol-mol),1.3867335606828617
HGC-27,10322450,3.112046430554876
Kasumi-2,26596,-3.0246532529835273
MPP 89,12003241,-0.4822573033051652
L-363,9936388,-7.043187460159181
22Rv1,24180125,2.329727344285758
KE-97,selumetinib-GDC-0941 (4-1 mol-mol),2.3217302036143295
MES-SA,12003241,-0.7503338761579216
L-428,26596,-3.3648892390526144
HSC-4,11485656,2.41592786996926
DMS 53,9903786,1.7776029378286846
MSTO-211H,6505803,-0.0669493563910609
JeKo-1,10322450,3.378353270661745
JHH-5,3689413,-2.062402723839909
GaMG,9903786,4.966976399953102
PK-59,3689413,-0.088836641292159
KE-39,409805,5.860910954246773
MOLP-8,5460769,1.8843864880791628
Ci-1,54618164,4.014733685345709
NCI-H1155,JQ-1-carboplatin (1-1 mol-mol),0.0214289604046408
COV362,135423438,3.2580935345525672
BT-20,409805,3.857390251652358
SK-N-DZ,24180125,1.1528831396239576
KE-37,11485656,2.1580092270767195
JHUEM-7,148198,-3.5780143567355336
Ku812,9903786,1.763683139425592
AN3-CA,3689413,0.1719288482065274
HCC78,54618164,4.731393746832609
Panc 08.13,selumetinib-GDC-0941 (4-1 mol-mol),0.8396472898062124
RD,439501,-3.401030731559912
SYO-1,136227924,1.0009147925604558
GCT,selumetinib-vorinostat (8-1 mol-mol),3.339752225403805
Hs 936.T,10296883,3.997542153042743
OVTOKO,8515,3.900067758648506
SET-2,9926054,1.6776501813643687
BT 248,selumetinib-vorinostat (8-1 mol-mol),3.707211778635912
BT 145,9927531,3.3032194302925557
NCI-H28,107985,-4.297660677476404
SF295,9926054,3.0771086967152845
VCaP,sirolimus-bortezomib (250-1 mol-mol),0.185191058575781
COR-L95,9903786,3.7357721387912513
KMH-2,6505803,-1.1271558599433815
HCC2108,3689413,-1.830632797435868
H-STS,3136844,3.9456833945347833
KYO-1,6918878,0.6073514382319011
Calu-6,10296883,3.629960277454761
FaDu,selumetinib-GDC-0941 (4-1 mol-mol),1.0128048472171496
NCI-H1869,9926054,1.781753958996035
TE-6,9927531,3.995869764794834
L3.3,12003241,-0.3315333583144895
BT 286,36462,-0.1751673749960541
EFO-27,9911830,3.273850069923984
ES-2,9936388,2.136137651865657
SNU-182,148198,-3.912494487684412
IM95,6505803,-4.184612620621751
HT-1376,100016,4.270787672820572
THP-1,44493528,4.188998476775423
SNU-C1,6505803,-1.67895267377521
Hs 822.T,10296883,4.102512563950569
RKN,9911830,3.6623648245681744
GDM-1,sirolimus-bortezomib (250-1 mol-mol),1.1359317053602838
Hs 822.T,9926054,3.800948674297046
NCI-H2029,54618164,3.735530661044435
JHOM-1,6610216,4.371443634148573
NCI-H1435,11404337,-0.2240916752478429
SNU-16,3136844,3.4624272365048414
HCC2108,9926054,2.5765466804926445
WM793,409805,4.444302991596743
COR-L51,9927531,4.484495617917877
SW1783,9926054,2.85460969526429
OCUM-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2423134599079573
MSTO-211H,selumetinib-GDC-0941 (4-1 mol-mol),1.2827616524915244
CML-T1,46943432,2.522264418529326
NCI-H841,6918878,2.853214507000159
42-MG-BA,36462,2.13247023966883
CAS-1,11485656,3.26266946526555
KP-3,46943432,0.0179698171752152
HSC-3,26596,-1.4868403003967878
MDA-MB-361,9927531,5.403888941869855
PE/CA-PJ15,148198,-2.65559177778782
SNU-1076,54618164,4.328001812111135
TYK-nu,262093,2.9110323710045285
KMS-20,6918878,1.3372822623967346
NCI-H2228,9903786,2.418550241736446
NCI-H28,148198,-2.5352174155891234
NB1,409805,5.083487988100444
T24,11485656,2.4283497682817945
L3.3,439501,-0.248470622878828
HCC1954,44493528,3.86549842878492
NCI-H727,159324,3.364651085509472
MEC-1,11485656,1.7582938847723142
A-673,6918878,1.2344260030899934
WM1799,9926054,2.0873998071095685
Lu-65,136227924,3.620246561182502
HEC-1-B,262093,2.9636053597230916
BT-474,136227924,2.4914554847870187
HCC202,6505803,-1.9707463625548352
G-401,8515,3.316277000480566
SH-10-TC,135875424,4.945714860516567
BxPC-3,26596,-1.629746525957504
Mono-Mac-1,sirolimus-bortezomib (250-1 mol-mol),-0.8446882860578903
OCI-AML-2,10322450,2.967388898319709
KMS-20,selumetinib-vorinostat (8-1 mol-mol),-0.0574541449020858
NCI-H211,439501,-3.5479428279050955
SNU-308,262093,4.9932279379660764
Panc 03.27,49836020,2.722888568283256
YH-13,107985,-2.561016282380613
ZR-75-30,selumetinib-vorinostat (8-1 mol-mol),4.024339554516039
NCI-H358,44491742,4.317463726649291
COLO 201,6505803,-2.3014705342843365
U-87MG ATCC,3689413,-0.5776108875278053
Mel Ho,12003241,-1.328246141696159
RPMI-8402,3689413,0.0751031286751058
NCI-H1581,54618164,3.710224728811778
BT-20,6610216,4.194352657176605
U-937,9911830,2.552949860232843
A-375,9903786,2.3118659059614877
SK-N-SH,107985,-2.488646937508133
Hs 888.T,6610216,2.876743996028597
OV-90,107985,-2.78767562727801
GSU,107985,-2.4596540151791135
HCC2218,8515,1.7075905965554727
RL,11485656,1.724412415409439
SK-MEL-1,9903786,3.576716533884559
SR,135398744,6.424256669199728
PSN1,selumetinib-vorinostat (8-1 mol-mol),2.2163429397624133
SNU-489,9903786,5.534401948294785
CAL-12T,5460769,3.2968044881057734
NB1,6610216,4.31899163465426
B-CPAP,9936388,2.314754665986152
NCI-H1339,11404337,0.2277853658172252
KYSE-30,9927531,4.7729245028370055
NOMO-1,9936388,-6.523282887173488
MKN1,409805,5.673588155962679
SF539,100016,5.965471494853995
BFTC-909,3136844,3.2427360302120403
SK-MM-2,107985,-3.95683239720485
A101D,6918878,3.0256566976967494
CAL-51,9926054,2.2227862000004577
Caki-1,10296883,4.233557259626662
JHOS-2,168313200,3.8439706585595017
LS123,9903786,4.141854621966089
EoL-1,3689413,-2.5778346492897266
SK-MEL-24,JQ-1-carboplatin (1-1 mol-mol),2.7809090892182744
Kuramochi,3689413,-0.3905926620288846
WM983B,24180125,2.8843311676242345
Hep-G2,262093,4.425755335049499
BHT-101,sirolimus-bortezomib (250-1 mol-mol),1.6700358071481498
NCI-H929,36462,0.845260564861955
NALM-6,46943432,-0.5536160766490446
SNU-387,9927531,5.201038765097566
A-253,6505803,0.0619140769446045
TCC-Pan2,5460769,4.19565263219897
SNU-1066,5460769,2.0075693464583817
COLO 684,148124,-6.705562486596054
PE/CA-PJ15,11404337,-2.320439466084731
KP-3,5460769,4.226589336768475
Namalwa,135423438,1.9520788575137753
NCI-H1563,9936388,1.5935308347912875
Jurkat,sirolimus-bortezomib (250-1 mol-mol),-2.067381581487011
EFO-27,262093,3.0007323703470896
B-CPAP,8515,3.305571052734727
BICR 18,JQ-1-carboplatin (1-1 mol-mol),0.3768377986008463
OE19,5460769,4.447133624333207
SET-2,44491742,3.5989743077742387
NCI-H526,selumetinib-GDC-0941 (4-1 mol-mol),3.379534287031186
P3HR-1,tanespimycin-bortezomib (250-1 mol-mol),1.2081674914796665
SW1088,135875424,2.929496932080149
RD,sirolimus-bortezomib (250-1 mol-mol),0.3715826338530998
SUP-HD1,3136844,3.7614928488620967
NCI-H660,3136844,2.1758382428244354
NCI-H1869,36462,3.1749992742870923
ML-1 [Human thyroid carcinoma],sirolimus-bortezomib (250-1 mol-mol),0.5199068018007997
EJM,36462,0.7713020046102423
PC-14,73707440,4.422438937843538
Pfeiffer,6918878,1.8169844283166063
SNU-16,36462,0.5669347604291369
SNB-75,9926054,1.9842991929062104
A-375,9936388,-2.2482939434629223
DND-41,246676,4.979248741445813
NCI-H810,26596,-3.4871956530659927
CHP-212,46943432,0.8435958840220231
BT 112,10296883,3.9999728699442607
NCO2,9903786,1.4505958737560818
HT115,26596,-1.779298311907341
HEY A8,selumetinib-GDC-0941 (4-1 mol-mol),1.3817126396854498
SH-4,10296883,3.644987847906302
EFE-184,9926054,2.5194211419802723
NCI-H196,selumetinib-GDC-0941 (4-1 mol-mol),1.8347621596974035
HT,46943432,1.075577820528673
NCI-H2081,135875424,3.067653141346589
WM266-4,3136844,4.436906925943649
BT 428,selumetinib-vorinostat (8-1 mol-mol),0.9101675495588571
ChaGo-K-1,10296883,3.916138257208464
PLC/PRF/5,409805,5.993816683766392
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
BT 248,54618164,4.1848059637542585
WM266-4,sirolimus-bortezomib (250-1 mol-mol),0.2916280413347675
BT 159,10322450,4.663429189765849
BT 245,135875424,2.904149434910518
CAL-78,168313200,2.244410124236573
SW1116,9911830,1.7664188791377746
BT 164,3136844,3.8693062963432494
JHH-2,11485656,3.3849117399649513
SU.86.86,136227924,3.0459574781144014
U-251MG,36462,1.3694594348067
KMS-20,3689413,-1.644811207648459
KALS-1,11485656,3.631175776194637
SNU-503,11485656,3.1307090285748953
SH-4,148124,4.2777999739630586
TE-9,9911830,2.430802089645133
HCC15,11485656,2.480533785053976
NCI-N87,selumetinib-vorinostat (8-1 mol-mol),2.348461304209469
Caki-1,246676,5.885712898696045
DLD-1,9927531,4.358823264887286
HCC1500,3689413,-1.6712109221216571
NCI-H2452,262093,3.2163720661137942
Hs 936.T,262093,3.786495505346027
BT 340,sirolimus-bortezomib (250-1 mol-mol),1.036760644305087
YKG-1,9926054,2.005416681797869
RKO,11404337,-0.3534280477619294
HEC-1-A,3689413,-1.724337097738872
BT 416,sirolimus-bortezomib (250-1 mol-mol),0.8644266482137087
YH-13,JQ-1-carboplatin (1-1 mol-mol),2.725669158848688
NCI-H841,107985,-3.953236182986376
NCI-H2452,9926054,2.7849990975548726
NCI-N87,11485656,1.873926788766734
ST486,9903786,1.7386739001111973
KE-37,tanespimycin-bortezomib (250-1 mol-mol),-0.6256036553504546
JM-1,262093,0.3077511100871351
SCaBER,11485656,1.7418324422308689
GSS,6918878,-0.6581972049472502
Hs 895.T,11404337,0.3575168130913553
WM115,135423438,3.926483426744841
TF-1,9911830,1.994265773553068
GOS-3,9936388,2.12022290506738
TE-15,5460769,-0.6910051691918724
BT 159,11404337,0.5861575458896715
GDM-1,10296883,3.3265560717041436
LUDLU-1,3689413,3.1550499386231325
SUP-T1,159324,-0.7674662281240341
SNU-C4,148124,-1.7954485275356942
OCI-Ly10,9927531,5.366378866921267
KYSE-180,36462,3.219917830306027
NCI-H1105,135423438,2.0106385414009025
KM12,3689413,0.1387513220516042
MG-63,9936388,-4.191645899593892
MOLM-13,262093,0.9014616367149992
A-549,selumetinib-GDC-0941 (4-1 mol-mol),1.3040363367013357
Raji,159324,2.512472945563818
NCI-H747,46943432,3.1532320742185553
BT 139,sirolimus-bortezomib (250-1 mol-mol),1.2497154154601016
COLO 792,11404337,-0.504163589197378
SIG-M5,24180125,3.729213633628688
KYSE-510,11404337,0.4094464488051804
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404
KYSE-70,135875424,3.720063911223788
GaMG,12003241,-1.1621616673389346
NCI-H1573,159324,2.583464622792162
SNU-C4,tanespimycin-bortezomib (250-1 mol-mol),0.700839751007814
MM1.S,9911830,2.728285435741644
SNU-398,9936388,-6.365933460277143
KMRC-3,12003241,-2.293511180564156
BFTC-909,262093,3.5924629632259792
CAL-27,6918878,3.243766596468025
COLO 205,tanespimycin-bortezomib (250-1 mol-mol),-2.2778936602109483
WM983B,9911830,2.107261735137238
RMG-I,439501,-1.0670769936155349
KYSE-180,9936388,-5.3897473887689
SNU-478,9911830,2.418817051969649
BT 504,5460769,2.119344247070391
G-402,selumetinib-vorinostat (8-1 mol-mol),3.748451645687271
Rh41,246676,5.784638860753491
CAL-54,6610216,4.030390620028951
MDA-MB-361,100016,6.5281042722822145
LXF 289,9911830,2.045852319971143
SUP-HD1,107985,-2.650415887719213
8305C,9936388,-4.900292137873706
SW579,54618164,4.076406400124359
NCI-H1373,6610216,4.185689398284126
KYO-1,8515,3.150065992884221
PaTu 8988s,44491742,3.6400918872033343
HEC-151,409805,5.612668913895041
BT 187,148198,-3.907036314471468
DV-90,11485656,1.6337920005269289
G-402,11485656,-0.4595745654780468
A2780,3136844,3.626688956130205
SIG-M5,107985,-4.712250940257049
YD-38,135875424,3.801699719504721
JM-1,44491742,3.590859136704876
JVM-2,107985,-4.027941774492786
LS180,439501,-1.9142457865624176
JHOC-5,11404337,-0.7952540156360246
TUHR10TKB,10296883,3.708176518593342
OVCAR-8,sirolimus-bortezomib (250-1 mol-mol),1.6177185023966834
OVK18,24180125,3.28014774472566
LOX-IMVI,selumetinib-GDC-0941 (4-1 mol-mol),1.2506716089378382
PE/CA-PJ34 (clone C12),11404337,0.4327507632811037
COLO 678,100016,6.808142270815235
PC-14,135875424,3.4913396696572523
SNU-761,11485656,2.6338171581508494
LNCaP clone FGC,36462,0.9338803006106506
OV56,5460769,1.208348663787762
TT,9927531,4.594242153757871
G-401,148198,-4.717755806624399
OUMS-23,409805,3.624784880015449
HSC-4,262093,2.780665409693215
OCI-M1,168313200,2.930152484546089
A-375,159324,3.1651524914786333
NCI-H929,6610216,4.64058383232424
SUP-T11,11404337,-1.4432067175867065
HOP-92,6610216,3.934588345083168
HEC-108,159324,3.617209831238773
SK-LMS-1,tanespimycin-bortezomib (250-1 mol-mol),0.2402445839028043
TOV-21G,262093,3.1318910470351327
MOLT-3,tanespimycin-bortezomib (250-1 mol-mol),0.0214957708571904
NCI-H2286,107985,-4.428916091949213
MOR/CPR,12003241,1.56456971518695
SR,44491742,4.371664315658822
A-549,12003241,-1.903076073453771
Caov-3,54618164,3.649978975153443
MJ,36462,-0.8152461099885887
KYM-1,26596,-1.5759790260808906
PSN1,tanespimycin-bortezomib (250-1 mol-mol),-1.4884042212108968
NCI-H2106,409805,4.639383577875326
TTC-709,3689413,-2.3273701449747985
Ishikawa (Heraklio) 02 ER-,100016,6.479675962630039
NCI-H211,6918878,0.8883693609762925
BT 422,9936388,1.1526185364967738
KG-1-C,selumetinib-vorinostat (8-1 mol-mol),2.5432622641170908
SNU-119,9927531,4.042335314323924
C2BBe1,tanespimycin-bortezomib (250-1 mol-mol),0.2943844142837441
MOTN-1,3136844,3.840436817063546
YD-10B,159324,2.234202132974722
WSU-DLCL2,439501,-2.4187850283326933
JHH-2,148124,-4.192242895506193
CAMA-1,11404337,0.4907502800478153
MKN7,12003241,0.0513011107794011
Hs 940.T,6505803,3.2300274365907486
M059K,262093,3.1968962336594644
HEC-1-A,26596,-0.4494032602178983
SNU-1,439501,-3.7780257252431126
H-STS,selumetinib-GDC-0941 (4-1 mol-mol),1.9537724783491248
NCI-H1568,148198,-4.9953315451672005
L-540,11485656,1.982100275891034
GSS,9926054,1.4316065343869406
DMS 454,11485656,2.8091900448674196
KMRC-3,sirolimus-bortezomib (250-1 mol-mol),0.4876779746525405
SNU-1105,sirolimus-bortezomib (250-1 mol-mol),1.4785919320575531
NCI-H1693,44491742,3.504045241968317
JURL-MK1,selumetinib-vorinostat (8-1 mol-mol),-1.5392481517810297
HT115,6918878,1.3713384837650509
Pfeiffer,8515,1.6662943389832352
NCI-H2196,148124,-1.1516038288442412
Panc 05.04,selumetinib-GDC-0941 (4-1 mol-mol),0.8434992349336349
OCI-AML-2,6918878,0.1042527708969983
HEC-251,selumetinib-GDC-0941 (4-1 mol-mol),3.2910402284708757
Daudi,262093,0.7533038243356376
KYSE-520,135398744,6.453499706252085
NCI-H1299,136227924,3.5346618762414392
SK-N-SH,36462,0.1553406914879444
MOLP-8,136227924,1.5113872866650588
SW1990,3136844,6.37521146697811
NCI-H1915,9911830,2.093118330249274
Yamato-SS,11404337,-0.7201649864225125
NCI-H1838,sirolimus-bortezomib (250-1 mol-mol),2.042115006385595
Ku812,24180125,2.3184854542342217
A4/Fukuda,8515,2.244185004641864
OAW28,9911830,2.567685352724645
5637,JQ-1-carboplatin (1-1 mol-mol),0.0353131764923719
COLO 205,9926054,1.7915651258593497
HCC2279,107985,-3.355357540394359
TE-6,3136844,3.3414731966567013
PE/CA-PJ15,107985,-2.5858433218961108
SK-N-BE(2),sirolimus-bortezomib (250-1 mol-mol),1.0543507239868668
NCI-H889,9926054,1.840125789909785
SW1116,selumetinib-GDC-0941 (4-1 mol-mol),0.1535490592284351
LAMA-84,136227924,2.847754951874779
TE 617.T,107985,-4.218073473743226
CML-T1,9926054,1.696565612874625
TE 617.T,11485656,1.686521614831033
DK-MG,54618164,4.452383351866673
HCC2108,11404337,0.8287580393905775
LNCaP clone FGC,148198,-3.4579469990265124
TE 617.T,9927531,4.756324122053051
RPMI-6666,46943432,1.9212112931253864
RL95-2,selumetinib-vorinostat (8-1 mol-mol),-0.5511800242944189
KMRC-2,6610216,4.281887950309424
JIMT-1,262093,3.7926345151691208
VMRC-LCD,selumetinib-vorinostat (8-1 mol-mol),2.297585943130406
HT-1080,6505803,0.5678766317067223
AML-193,10322450,2.9754304486857
BT 498,246676,4.408890433497639
OVCAR-5,107985,-3.75072662127644
OVSAHO,148198,-1.8727352509545991
EFO-27,135875424,4.6207788215281465
ACC-MESO-1,3689413,0.4162012666414902
TM-31,11485656,2.0452435879602087
KMS-20,9911830,3.122947091608452
OCI-Ly19,168313200,3.801805147160126
SNU-175,439501,-1.724461019506839
Panc 08.13,selumetinib-vorinostat (8-1 mol-mol),2.1234456199276193
JHH-5,100016,5.964491744827364
COLO 678,262093,3.3030723786800307
ONS-76,26596,0.1332187247782509
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793
SK-N-DZ,26596,-3.5191168188453603
NCI-H1184,3136844,4.011728616185904
BICR 56,5460769,-1.0977162863448868
TE-9,159324,3.4565682419203827
HeLa,168313200,4.248438421303553
ECC10,135423438,0.2657741812126756
NCI-H1341,3689413,-3.76878307288409
GA-10,selumetinib-GDC-0941 (4-1 mol-mol),0.5759337231249475
Hs 944.T,135875424,1.9575051690352112
Calu-6,sirolimus-bortezomib (250-1 mol-mol),1.0438055867495408
RPMI-8226,54618164,3.2179536432625206
TE-1,36462,2.941259846710762
SNU-620,selumetinib-vorinostat (8-1 mol-mol),-2.832370500615607
ME-1 [Human leukemia],9911830,2.858593636818479
SCC-9,3689413,-0.5284639903905319
CAL-51,26596,-1.4638590943230956
GaMG,sirolimus-bortezomib (250-1 mol-mol),1.2428919572047608
KMS-27,11485656,2.096815262793708
HCC1395,136227924,3.3223803208690135
2004,6505803,1.2288982510543929
HEC-151,11404337,-0.8422867477352739
Fu97,409805,3.71508023088682
MOLM-6,9926054,1.5702726782081282
GB-1,159324,3.060378986435554
TE-14,246676,5.320033654623924
SNU-475,262093,5.097469804639549
MIA PaCa-2,107985,-4.172242964909647
Ri-1,sirolimus-bortezomib (250-1 mol-mol),-9.474135938791196
SR,9936388,-6.002984450827545
LCLC-103H,107985,-2.4603139026976213
RERF-LC-Ad2,6610216,4.489268569667584
KMS-18,262093,1.4721662513603355
BCP-1,148124,-4.388861907430301
HSC-2,3136844,3.906764478885088
EKVX,9927531,4.418248493855361
BT 320,135875424,3.1120862947515255
SNU-81,54618164,-0.3986435357924686
KMS-18,26596,-1.560934239345236
HuH-1,44491742,4.9230469745960255
HGC-27,135398744,6.47323705988127
KYSE-450,100016,6.589468110151047
NCI-H2087,135423438,1.5480624083633234
TC-71,selumetinib-GDC-0941 (4-1 mol-mol),2.572877726139947
NCI-H1666,11485656,1.1104908410257284
RCM-1 [Human rectal adenocarcinoma],107985,-2.8907916820196156
HuH-28,136227924,3.512267666844948
NCI-H322,54618164,4.3212378685636015
P31/FUJ,sirolimus-bortezomib (250-1 mol-mol),0.0617669843942014
KE-39,6610216,4.077734835238396
OAW28,12003241,-0.542287488877267
HOP-92,tanespimycin-bortezomib (250-1 mol-mol),0.1347275198729775
HCC38,11485656,1.880745325077396
MOLM-13,44491742,3.7695621371445975
DAN-G,11485656,1.7552086859966678
HEC-251,tanespimycin-bortezomib (250-1 mol-mol),0.0186342591611023
OS-RC-2,3689413,-2.40669101710066
NCI-N87,8515,4.286102801865053
MHH-CALL-4,409805,3.699144877236461
SK-ES-1,JQ-1-carboplatin (1-1 mol-mol),1.3011647537174793
BT 131,5460769,2.20262518629684
TE-9,sirolimus-bortezomib (250-1 mol-mol),1.65156532299436
MFE-296,54618164,4.2521808435378805
DoHH2,sirolimus-bortezomib (250-1 mol-mol),-6.588812122607576
KE-37,selumetinib-GDC-0941 (4-1 mol-mol),2.002060120469268
HCC1428,44491742,4.031952184974023
NCI-H1341,168313200,1.5932831010867334
COV644,44491742,4.3354697105959055
OCI-Ly19,44493528,4.78987758485686
G-292 clone A141B1,36462,2.8911125971985188
NCI-H522,10296883,3.751667506317718
